Clustering O 0 4.477079528442118e-06
of O 0 5.38987478648778e-07
missense O 0 8.010816827663803e-07
mutations O 0 1.0152709783994851e-08
in O 0 2.194873394145702e-09
the O 0 3.1394918664773286e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.7928952900092554e-07
in O 0 1.3247433150453958e-09
a O 0 2.186358205591432e-09
sporadic B-Disease 0 1.2909496263091569e-06
T I-Disease 1 0.9912601113319397
- I-Disease 0 4.5893706555943936e-05
cell I-Disease 0 1.9384115148568526e-06
leukaemia I-Disease 0 7.09385858499445e-05
. O 0 2.4826309186209983e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.6132133168866858e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.790690952942271e-10
is O 0 1.9424917230281835e-10
a O 0 2.8470256707713304e-10
recessive B-Disease 0 7.833730819584162e-08
multi I-Disease 0 7.700285209466529e-07
- I-Disease 1 0.9983996748924255
system I-Disease 0 9.899372525978833e-05
disorder I-Disease 0 1.0390221177658532e-05
caused O 0 6.952072806321041e-10
by O 0 2.2773999699965408e-11
mutations O 0 2.166088836075275e-10
in O 0 9.667561196025076e-11
the O 0 6.350495684870339e-09
ATM O 0 2.906721647377708e-06
gene O 0 3.2571174646278678e-09
at O 0 2.1843792552544983e-08
11q22 O 0 7.655877197976224e-06
- O 0 2.3354709810519125e-06
q23 O 0 8.843335308483802e-06
( O 0 5.272141390122442e-09
ref O 0 5.496825679074391e-07
. O 0 1.4636858391980923e-09
3 O 0 6.299972454826275e-08
) O 0 1.1139430711182285e-08
. O 0 1.0300131947360569e-07

The O 0 2.294570009553354e-07
risk O 0 3.8021377690711233e-07
of O 0 3.849627461249838e-08
cancer B-Disease 0 5.785697339888429e-06
, O 0 2.350053263100449e-09
especially O 0 8.310458099458629e-09
lymphoid B-Disease 0 1.0662334943845053e-06
neoplasias I-Disease 0 0.01665394753217697
, O 0 3.7628744564699446e-09
is O 0 2.662896847471785e-10
substantially O 0 1.990830833520363e-09
elevated O 0 2.910500711550412e-07
in O 0 8.284467556407549e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.400391328043042e-08
and O 0 7.640340582426575e-10
has O 0 3.1351529705681003e-10
long O 0 4.1526659888546646e-10
been O 0 9.968204039978446e-11
associated O 0 5.501976096944361e-10
with O 0 7.264094659120701e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 3.1578740617987933e-06

By O 0 1.930997939325607e-08
analysing O 0 1.308457285631448e-06
tumour B-Disease 1 1.0
DNA O 0 1.953320776237888e-07
from O 0 5.718607809512832e-10
patients O 0 1.990184544942153e-10
with O 0 2.4850474109050502e-11
sporadic B-Disease 0 3.989922277014557e-07
T I-Disease 0 0.0067682345397770405
- I-Disease 0 4.620752406481188e-06
cell I-Disease 0 8.757585874263896e-07
prolymphocytic I-Disease 1 0.999993085861206
leukaemia I-Disease 1 0.9249367117881775
( O 0 7.483739850044913e-09
T B-Disease 0 0.0016456431476399302
- I-Disease 0 6.408309218386421e-06
PLL I-Disease 0 9.504613990429789e-05
) O 0 5.754156040538305e-10
, O 0 3.9384875916148587e-10
a O 0 5.713527428952148e-10
rare O 0 1.5800557306988594e-08
clonal B-Disease 0 3.35743635559993e-07
malignancy I-Disease 0 4.7449049134229426e-07
with O 0 2.9869823281458707e-10
similarities O 0 2.5023010330471607e-09
to O 0 3.117121838425163e-10
a O 0 8.434742349017199e-10
mature B-Disease 0 4.347878856947318e-08
T I-Disease 0 3.0418348728744604e-07
- I-Disease 0 1.0766050451138653e-07
cell I-Disease 0 7.166796489599392e-09
leukaemia I-Disease 0 1.3277674781875248e-07
seen O 0 1.6518109102747758e-09
in O 0 3.557672489939989e-10
A B-Disease 1 1.0
- I-Disease 0 0.06766147911548615
T I-Disease 1 1.0
, O 0 4.739907355499895e-10
we O 0 7.537553220471338e-11
demonstrate O 0 5.861369029025454e-11
a O 0 1.8663799672413717e-11
high O 0 9.946520274084492e-10
frequency O 0 1.6049770401593833e-09
of O 0 6.92292578818865e-09
ATM O 0 7.632374035893008e-06
mutations O 0 2.108794383559598e-08
in O 0 2.865737336321672e-08
T B-Disease 1 0.9999581575393677
- I-Disease 0 0.0005631922977045178
PLL I-Disease 0 0.0013498089974746108
. O 0 5.277104833112389e-07

In O 0 2.3711892893629738e-08
marked O 0 8.703689324818242e-09
contrast O 0 7.251356182180757e-10
to O 0 5.815735670822164e-10
the O 0 4.97815744182617e-09
ATM O 0 2.166772446798859e-06
mutation O 0 2.4407897925016186e-09
pattern O 0 3.998223530032874e-09
in O 0 1.1847728353941989e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.3062140258313093e-09
the O 0 7.046200289906324e-10
most O 0 1.1856447768021638e-10
frequent O 0 2.6658647511723643e-10
nucleotide O 0 2.5922958224455783e-10
changes O 0 5.833029892432506e-11
in O 0 2.9329535328193046e-11
this O 0 1.3519224628666393e-10
leukaemia B-Disease 0 1.933283471089453e-07
were O 0 2.1814731354652395e-08
missense O 0 2.299696916452376e-06
mutations O 0 3.986240812992037e-07
. O 0 1.4185540919697814e-07

These O 0 3.4977258422941304e-08
clustered O 0 4.0131315159896985e-08
in O 0 6.89910295559315e-10
the O 0 2.927953657305693e-09
region O 0 1.0821281648532022e-08
corresponding O 0 3.791207792147588e-09
to O 0 1.9837316234116997e-09
the O 0 5.4411577465884875e-09
kinase O 0 3.6410575887657615e-08
domain O 0 1.1590114645798621e-08
, O 0 4.504384643055914e-10
which O 0 1.44607534280361e-10
is O 0 2.2139735877946265e-10
highly O 0 1.5376320217086459e-09
conserved O 0 1.000272487061693e-08
in O 0 1.7751723424552779e-09
ATM O 0 1.714907511995989e-06
- O 0 8.903317194608462e-08
related O 0 2.8017991482442994e-08
proteins O 0 1.472328647889043e-10
in O 0 1.852446529504448e-10
mouse O 0 3.143352955703449e-08
, O 0 1.1944842892575025e-09
yeast O 0 1.2531185866748729e-08
and O 0 5.924440493743077e-09
Drosophila O 0 2.44926553705227e-07
. O 0 5.439385830641186e-08

The O 0 2.6998660018762166e-07
resulting O 0 7.721612149680368e-08
amino O 0 7.903892651484057e-09
- O 0 9.6378558467336e-09
acid O 0 6.364647031631421e-09
substitutions O 0 1.0872630795688565e-08
are O 0 9.261556799255999e-11
predicted O 0 1.7099953675270285e-09
to O 0 8.093113956775255e-10
interfere O 0 2.2495232343544558e-08
with O 0 2.3704553875347756e-09
ATP O 0 5.199379666009918e-05
binding O 0 8.005946483535809e-08
or O 0 2.837096113594839e-09
substrate O 0 1.9604124190664152e-07
recognition O 0 3.448031122843531e-07
. O 0 3.395160490526905e-07

Two O 0 6.110325045938225e-08
of O 0 2.2762878870707937e-07
seventeen O 0 1.0129615475307219e-06
mutated O 0 8.453575901512522e-07
T B-Disease 0 2.8628965083044022e-06
- I-Disease 0 8.722719826437242e-07
PLL I-Disease 0 5.04109766552574e-06
samples O 0 1.948771810589278e-09
had O 0 5.037623651560352e-10
a O 0 1.5430784428005495e-10
previously O 0 2.357901651706129e-09
reported O 0 1.2216945677323565e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 5.927432766839047e-07
. O 0 1.688425186330278e-07

In O 0 1.1542970135280939e-08
contrast O 0 6.5089600376211365e-09
, O 0 2.3544950433773693e-09
no O 0 2.3321298225909004e-09
mutations O 0 6.942836860979185e-10
were O 0 2.282480177084878e-10
detected O 0 1.5810769360413701e-09
in O 0 4.1162023789453883e-10
the O 0 8.551803709622163e-09
p53 O 0 5.259408908386831e-08
gene O 0 2.570789581213262e-09
, O 0 5.742260555940959e-10
suggesting O 0 3.388221370137501e-10
that O 0 7.028921195084692e-11
this O 0 4.676516951462872e-10
tumour B-Disease 1 1.0
suppressor O 0 0.0008491000044159591
is O 0 7.394915346736752e-09
not O 0 2.0809667877763616e-10
frequently O 0 1.9195141032213314e-09
altered O 0 7.742772645258356e-09
in O 0 9.98341187496976e-10
this O 0 7.93302668000706e-09
leukaemia B-Disease 0 9.294958545069676e-06
. O 0 4.953373604621447e-07

Occasional O 0 1.9418403098825365e-05
missense O 0 2.053305024674046e-06
mutations O 0 1.6100861088830243e-08
in O 0 9.996178329529926e-10
ATM O 0 6.7717296587943565e-06
were O 0 2.0578736492637972e-09
also O 0 2.451996661267941e-10
found O 0 7.67325439299249e-11
in O 0 2.2183530012931385e-10
tumour B-Disease 1 1.0
DNA O 0 1.7475583646842097e-08
from O 0 4.8057766099951493e-11
patients O 0 1.4017119062681438e-11
with O 0 4.874066861920712e-12
B B-Disease 0 7.241092134790961e-07
- I-Disease 0 2.2978715819022e-08
cell I-Disease 0 3.018917027475254e-08
non I-Disease 1 0.998954176902771
- I-Disease 1 0.9999995231628418
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9996742010116577
( O 0 3.346601884501865e-10
B B-Disease 0 6.846378823865962e-07
- I-Disease 0 2.4334513071266883e-08
NHL I-Disease 1 0.9959126114845276
) O 0 8.078920171739057e-11
and O 0 7.790241368654804e-11
a O 0 5.265626823458547e-10
B B-Disease 0 1.2780213864971302e-06
- I-Disease 0 5.014611588194384e-07
NHL I-Disease 1 0.9998162388801575
cell O 0 1.559647984095136e-07
line O 0 1.337258026978816e-06
. O 0 1.4934870762317587e-07

The O 0 1.9966311270991355e-08
evidence O 0 1.862267562380282e-09
of O 0 3.0384348370660064e-09
a O 0 1.237727004221867e-10
significant O 0 5.077598896896518e-10
proportion O 0 9.608244200265403e-10
of O 0 1.5159518085283707e-09
loss O 0 2.3490418499250154e-08
- O 0 5.327336083382761e-08
of O 0 2.6477161796378823e-08
- O 0 3.995336328443955e-08
function O 0 5.453830720369979e-10
mutations O 0 7.525371298333638e-11
and O 0 4.79614299664366e-11
a O 0 6.706545041534895e-11
complete O 0 5.533897229348383e-10
absence O 0 1.6419382520282966e-09
of O 0 1.5808718778487219e-09
the O 0 6.402338659228235e-10
normal O 0 2.527203168956049e-10
copy O 0 8.93001006474492e-10
of O 0 2.444834112935723e-09
ATM O 0 1.558963731440599e-07
in O 0 2.465456172551228e-10
the O 0 1.2853820230418478e-09
majority O 0 1.917303121823366e-10
of O 0 8.341123347577195e-09
mutated O 0 4.493251140047505e-07
tumours B-Disease 1 1.0
establishes O 0 1.5741305503524927e-07
somatic O 0 1.4492631983387128e-08
inactivation O 0 1.3744036664320447e-07
of O 0 1.7328272150507473e-09
this O 0 2.3467094587004134e-11
gene O 0 6.198081631270114e-11
in O 0 4.8420181059105616e-11
the O 0 2.795136122557551e-09
pathogenesis O 0 5.847458623975399e-07
of O 0 8.394882655693436e-08
sporadic B-Disease 0 0.00011037684453185648
T I-Disease 1 0.9999998807907104
- I-Disease 0 0.0013250792399048805
PLL I-Disease 0 9.505829075351357e-05
and O 0 3.7903187255494686e-09
suggests O 0 2.853974001570947e-10
that O 0 4.592759159094406e-11
ATM O 0 6.342980327644909e-07
acts O 0 1.242304659143656e-08
as O 0 2.8118194439485933e-09
a O 0 2.372790852689377e-08
tumour B-Disease 1 1.0
suppressor O 0 0.0016608141595497727
. O 0 1.724778030620655e-06

As O 0 1.1832879209805469e-07
constitutional O 0 2.451043599194236e-07
DNA O 0 2.0900021269198987e-08
was O 0 1.0486299606426996e-09
not O 0 2.417694863754427e-11
available O 0 5.39434157065255e-11
, O 0 4.1166184350238666e-10
a O 0 3.427064187988549e-09
putative O 0 2.1552787075052038e-06
hereditary O 1 0.9057388305664062
predisposition O 1 0.9966261386871338
to O 0 2.5886058665491873e-06
T B-Disease 1 1.0
- I-Disease 1 0.9997106194496155
PLL I-Disease 0 0.24916937947273254
will O 0 5.3798387966708106e-09
require O 0 2.4752482286061195e-09
further O 0 3.726107422608038e-09
investigation O 0 5.308426587191661e-09
. O 0 5.480455644857329e-09
. O 0 1.3187846548134985e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.8737839127425104e-05
kinase O 0 1.2673535820795223e-07
is O 0 3.2499358759707775e-10
involved O 0 3.8892909726140346e-11
in O 0 6.800302074921882e-12
the O 0 4.993024743660257e-11
modulation O 0 3.783254598488384e-09
of O 0 2.768717255463571e-09
the O 0 1.5105175776852775e-08
Ca2 O 0 1.2406950133936334e-07
+ O 0 1.0509295123029005e-07
homeostasis O 0 2.758456787432806e-07
in O 0 9.454813820752861e-09
skeletal O 0 3.494341945042834e-05
muscle O 0 7.103453299350804e-06
cells O 0 4.364379790899875e-08
. O 0 3.868913367455207e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999991655349731
DM B-Disease 1 1.0
) O 0 1.8126799616879907e-08
, O 0 4.653045726499272e-10
the O 0 6.076371628083166e-10
most O 0 7.926351797138409e-10
prevalent O 0 3.968277155763644e-07
muscular B-Disease 1 1.0
disorder I-Disease 0 0.15101386606693268
in O 0 3.6434016914554945e-10
adults O 0 5.004650027728985e-10
, O 0 5.410054695897948e-11
is O 0 5.944719022599187e-11
caused O 0 1.4856101904214825e-09
by O 0 2.5282975713025735e-10
( O 0 2.9101816512167034e-09
CTG O 0 2.6913854526355863e-05
) O 0 5.740058983683127e-10
n O 0 6.447816169874443e-10
- O 0 7.253074585378272e-09
repeat O 0 1.007612215886411e-08
expansion O 0 5.059426655407151e-09
in O 0 1.0531594346607775e-10
a O 0 2.7510235756089685e-10
gene O 0 1.9729799738410492e-10
encoding O 0 5.37053956861655e-09
a O 0 5.099049626977603e-09
protein O 0 8.183617694612622e-08
kinase O 0 3.562769563814072e-07
( O 0 2.3267547888394802e-08
DM B-Disease 1 1.0
protein O 0 7.735704343758698e-08
kinase O 0 5.3443294234511995e-09
; O 0 6.714685751862959e-11
DMPK O 0 3.1265833968063816e-05
) O 0 7.833645537802525e-11
and O 0 9.275505363781633e-11
involves O 0 3.4348759947455676e-10
changes O 0 1.830913615163965e-10
in O 0 2.0892509944303583e-10
cytoarchitecture O 0 2.1412815840449184e-06
and O 0 4.2356568030754715e-08
ion O 0 1.8140057363780215e-05
homeostasis O 0 8.272079867310822e-05
. O 0 1.65014182584855e-06

To O 0 3.738681542131417e-08
obtain O 0 8.488473923762285e-09
clues O 0 5.666462410403028e-09
to O 0 3.1401681255260883e-10
the O 0 8.819308061625009e-10
normal O 0 9.521624599884149e-10
biological O 0 6.8268235509094666e-09
role O 0 3.51572326806604e-09
of O 0 5.035044381429543e-08
DMPK O 1 1.0
in O 0 5.079851206346575e-08
cellular O 0 1.42127859703578e-07
ion O 0 1.2640308568734326e-06
homeostasis O 0 1.3892225751988008e-06
, O 0 3.5018699051647673e-09
we O 0 6.748521186317191e-10
have O 0 3.5295672634605424e-11
compared O 0 1.426300605400499e-10
the O 0 1.5335609448996479e-09
resting O 0 1.8431549619890575e-07
[ O 0 8.433314491185229e-09
Ca2 O 0 3.4390139624917992e-09
+ O 0 8.915612137450069e-10
] O 0 1.3487397865219464e-09
i O 0 4.64301874725237e-10
, O 0 4.4665934145760033e-11
the O 0 8.870995604759457e-11
amplitude O 0 4.891581029120573e-10
and O 0 3.841569840012937e-10
shape O 0 8.561547026886274e-09
of O 0 1.077300915142132e-08
depolarization O 0 2.4883570759470786e-08
- O 0 1.719765378993543e-07
induced O 0 1.379062126716235e-07
Ca2 O 0 2.1750155010380468e-09
+ O 0 3.898956157932787e-10
transients O 0 1.3309990887222511e-09
, O 0 2.7420328160832064e-11
and O 0 5.867621666322265e-11
the O 0 3.4705294194026237e-10
content O 0 2.0949941781367443e-09
of O 0 2.3466311116493443e-09
ATP O 0 9.5254572443082e-06
- O 0 2.9498906428671035e-07
driven O 0 2.9408449009338256e-08
ion O 0 3.3359114581799076e-08
pumps O 0 2.0194230287984283e-08
in O 0 9.006849710502252e-10
cultured O 0 5.303548711310668e-09
skeletal O 0 4.672874709399366e-08
muscle O 0 8.615013591395382e-09
cells O 0 5.170726347092369e-11
of O 0 8.086293856734983e-10
wild O 0 8.371916493388198e-09
- O 0 1.133344795789526e-08
type O 0 2.7910834532463014e-08
and O 0 3.786734481536769e-09
DMPK O 1 0.9999984502792358
[ O 0 2.1650583548193936e-08
- O 0 1.5371277584108611e-07
/ O 0 3.132657866444788e-07
- O 0 2.188764256061404e-06
] O 0 3.6491718446995947e-07
knockout O 0 0.00015811444609425962
mice O 0 1.459315058127686e-06
. O 0 1.4818165539054462e-07

In O 0 2.459808570165478e-07
vitro O 0 4.2343080508544517e-07
- O 0 1.123266542890633e-06
differentiated O 0 3.4506965675973333e-06
DMPK O 1 0.9999808073043823
[ O 0 4.936320863180299e-08
- O 0 1.9733100486973854e-07
/ O 0 3.745919627817784e-07
- O 0 9.319547302766296e-07
] O 0 4.853787416436717e-08
myotubes O 0 7.954557759148884e-07
exhibit O 0 8.675960394555204e-09
a O 0 5.238499634074856e-10
higher O 0 4.97966690105045e-09
resting O 0 1.1201520777603946e-07
[ O 0 6.498539484312005e-09
Ca2 O 0 4.444103751666262e-09
+ O 0 3.022216699122282e-09
] O 0 3.6481324627857248e-09
i O 0 2.137891641496026e-09
than O 0 3.261952652433564e-10
do O 0 1.2128642534747769e-09
wild O 0 3.950371052496848e-08
- O 0 1.8990274242014493e-08
type O 0 2.0974979975108e-08
myotubes O 0 5.748972284891352e-07
because O 0 7.689608949590365e-10
of O 0 1.5845849077322782e-09
an O 0 1.0984953224824068e-10
altered O 0 2.9308369065006445e-09
open O 0 3.712430141078471e-09
probability O 0 4.005671072615513e-10
of O 0 1.4970534811808989e-09
voltage O 0 1.1496349827666563e-07
- O 0 9.005534451489439e-08
dependent O 0 6.095760340940615e-09
l O 0 1.9590427058346904e-09
- O 0 1.0834003028037387e-08
type O 0 1.0417210205559968e-08
Ca2 O 0 3.104846379997639e-09
+ O 0 1.6029272353890178e-09
and O 0 2.0693944335903325e-09
Na O 0 4.4793900997319724e-06
+ O 0 3.763464917483361e-08
channels O 0 2.419054645486085e-08
. O 0 7.041705885058036e-08

The O 0 2.3797538233338855e-06
mutant O 0 2.2517053821502486e-06
myotubes O 0 6.846308224339737e-06
exhibit O 0 3.0152165209074155e-08
smaller O 0 2.3614719069087187e-08
and O 0 3.2852438547337215e-09
slower O 0 7.2088024438698994e-09
Ca2 O 0 3.757968158879521e-09
+ O 0 1.1559950774397976e-09
responses O 0 1.1410218603291611e-10
upon O 0 4.3434233987227344e-10
triggering O 0 6.500423754829399e-09
by O 0 1.1739210992178783e-10
acetylcholine O 0 1.0286663609804236e-07
or O 0 7.884708885796954e-09
high O 0 1.8013085423262964e-07
external O 0 3.742213152690965e-07
K O 0 3.131757694063708e-06
+ O 0 1.3266307519188558e-07
. O 0 5.558201365829518e-08

In O 0 2.2853924974697293e-08
addition O 0 1.8810602853136515e-08
, O 0 2.5800737102343874e-09
we O 0 4.1793327132388924e-10
observed O 0 3.1262972766121777e-10
that O 0 2.70149944081588e-11
these O 0 3.2383459802609593e-10
Ca2 O 0 9.161193581519456e-09
+ O 0 7.8765776123646e-09
transients O 0 1.8802460033384705e-08
partially O 0 6.6724976655052615e-09
result O 0 9.173826281960729e-11
from O 0 2.0120537180812192e-11
an O 0 8.659678876754562e-12
influx O 0 3.475006948860937e-10
of O 0 7.89581178217702e-10
extracellular O 0 3.857945962693066e-09
Ca2 O 0 4.503012185352873e-09
+ O 0 8.534445372632149e-10
through O 0 1.6962600768444247e-10
the O 0 1.3549538158130758e-09
l O 0 5.25665821982102e-09
- O 0 8.301827847390086e-08
type O 0 9.176761750495643e-08
Ca2 O 0 6.13850019703932e-08
+ O 0 2.8982956479239874e-08
channel O 0 6.641619876290861e-08
. O 0 6.840904376304024e-08

Neither O 0 7.158997163969616e-07
the O 0 2.845638569226594e-08
content O 0 4.336185099873546e-08
nor O 0 1.3057315229048072e-08
the O 0 1.974336250043507e-09
activity O 0 2.8668729612491006e-09
of O 0 2.324758696659046e-08
Na O 0 3.624357850640081e-05
+ O 0 9.912571385939373e-08
/ O 0 2.322231011930853e-07
K O 0 4.692622610491526e-07
+ O 0 1.686155393088029e-08
ATPase O 0 8.222796310519698e-08
and O 0 7.743185648223516e-09
sarcoplasmic O 0 1.828957806537801e-06
reticulum O 0 1.7355311854316824e-07
Ca2 O 0 6.074140657119642e-08
+ O 0 2.0451340176919075e-08
- O 0 4.3059706911208195e-08
ATPase O 0 8.140371221543319e-08
are O 0 1.0193991484275244e-10
affected O 0 6.705691557584714e-10
by O 0 7.542964586271239e-10
DMPK O 1 1.0
absence O 0 7.813971478753956e-07
. O 0 3.125549596916244e-07

In O 0 9.399723666092541e-08
conclusion O 0 3.108806723162161e-08
, O 0 3.7709928513152136e-09
our O 0 1.1450645986954555e-09
data O 0 7.701791981951089e-10
suggest O 0 4.020666577453369e-10
that O 0 1.6646638234529831e-10
DMPK O 0 0.24527806043624878
is O 0 1.0376176584614427e-09
involved O 0 1.868257770709647e-10
in O 0 1.4288110972149326e-10
modulating O 0 2.164426504691619e-08
the O 0 3.1819211709915862e-09
initial O 0 3.6349288023984627e-09
events O 0 1.1407700339916005e-09
of O 0 8.020768937910816e-09
excitation O 0 1.312413644427579e-07
- O 0 2.1736789221904473e-06
contraction O 0 6.953166575840442e-08
coupling O 0 1.6214084297416775e-08
in O 0 1.118513615061545e-09
skeletal O 0 1.2499672266130801e-06
muscle O 0 2.417952771338605e-07
. O 0 1.2658022185974005e-08
. O 0 6.270649066664191e-08

Constitutional O 0 0.00019284323207102716
RB1 O 1 1.0
- O 0 4.283741509425454e-05
gene O 0 1.1080462058998819e-07
mutations O 0 1.3945617993726955e-08
in O 0 5.050380669224808e-10
patients O 0 1.2923783154761281e-09
with O 0 8.875400414609658e-10
isolated O 0 1.0743419807113241e-06
unilateral B-Disease 0 0.0013634831411764026
retinoblastoma I-Disease 1 1.0
. O 0 3.3755093227227917e-06

In O 0 1.5199073999383472e-08
most O 0 2.6625224247567303e-09
patients O 0 8.943305540576318e-10
with O 0 2.448132252474977e-10
isolated O 0 3.2245071679426474e-07
unilateral B-Disease 0 0.00062783487373963
retinoblastoma I-Disease 1 1.0
, O 0 1.2355562262200692e-07
tumor B-Disease 1 0.9999972581863403
development O 0 1.3760898198711402e-08
is O 0 2.1900757596338138e-10
initiated O 0 5.498839161788283e-10
by O 0 2.8559219225621213e-11
somatic O 0 4.094373728946721e-09
inactivation O 0 1.4435227058129385e-07
of O 0 3.764561551378165e-09
both O 0 6.962529441878473e-10
alleles O 0 6.231631322073383e-10
of O 0 5.217362541998227e-09
the O 0 5.919993029124271e-08
RB1 O 0 0.006387854460626841
gene O 0 3.061374513890769e-07
. O 0 2.1537364602863818e-07

However O 0 3.5698636935421746e-08
, O 0 1.7452058687084104e-09
some O 0 2.446615132711827e-10
of O 0 6.864843693499267e-10
these O 0 1.016681183685364e-09
patients O 0 6.737820301694342e-10
can O 0 3.6982653051076397e-10
transmit O 0 7.945295266154062e-08
retinoblastoma B-Disease 0 1.2520141353888903e-05
predisposition O 0 5.536760454560863e-06
to O 0 2.9691950231836017e-08
their O 0 3.422362837568471e-08
offspring O 0 1.4671837789137498e-07
. O 0 3.6677256787243095e-08

To O 0 6.7869398989728325e-09
determine O 0 1.1427998547475227e-09
the O 0 1.3756291938893384e-10
frequency O 0 2.8367808102558456e-10
and O 0 5.935691937963838e-10
nature O 0 2.268472520938758e-08
of O 0 3.7138622843713165e-08
constitutional O 0 8.1933758337982e-06
RB1 O 1 1.0
- O 0 3.7742586300737457e-06
gene O 0 8.522915706521417e-09
mutations O 0 9.561115232870065e-10
in O 0 4.228345104606568e-11
patients O 0 1.4196212261285979e-10
with O 0 6.7375084678023e-11
isolated O 0 5.992620799588622e-08
unilateral B-Disease 0 3.2206514788413187e-06
retinoblastoma I-Disease 1 0.9998759031295776
, O 0 5.0622062097716025e-09
we O 0 5.0505155613223e-10
analyzed O 0 1.154270012904135e-09
DNA O 0 2.028045287261193e-09
from O 0 2.010934474494519e-10
peripheral O 0 1.318323575105751e-05
blood O 0 5.418993698214081e-09
and O 0 2.2376001052037964e-09
from O 0 3.7178369272083955e-09
tumor B-Disease 1 0.9796486496925354
tissue O 0 1.1242643722653156e-06
. O 0 1.384084669098229e-07

The O 0 4.325034197449895e-08
analysis O 0 2.9322346772886476e-09
of O 0 7.697686754681854e-08
tumors B-Disease 1 1.0
from O 0 9.207299811464509e-09
54 O 0 6.400171059794957e-08
( O 0 2.2536006394346941e-10
71 O 0 1.6756269261009038e-08
% O 0 1.7396183105145013e-10
) O 0 9.844425968852377e-11
of O 0 2.6850381917853383e-09
76 O 0 4.2835260671836295e-08
informative O 0 1.3912780261193802e-08
patients O 0 2.4578450386059103e-10
showed O 0 2.2847103375855937e-10
loss O 0 2.827879486133611e-09
of O 0 2.7476806607751314e-08
constitutional O 0 2.521275291655911e-06
heterozygosity O 0 5.614495603367686e-05
( O 0 1.655138959222313e-08
LOH O 1 1.0
) O 0 1.836119167819561e-08
at O 0 1.5814825360394025e-07
intragenic O 0 2.594723082438577e-05
loci O 0 1.7143629520433024e-06
. O 0 2.1578277653588884e-07

Three O 0 1.5335302805397077e-07
of O 0 1.0644174608387402e-07
13 O 0 1.8599243389871845e-07
uninformative O 0 4.0718645323067904e-05
patients O 0 7.476467800415776e-08
had O 0 2.6062295432893734e-08
constitutional O 0 1.506175522081321e-06
deletions O 0 1.5424906223415746e-06
. O 0 4.171787679752015e-07

For O 0 1.5649162321551557e-07
39 O 0 2.51999097145017e-07
randomly O 0 4.656092844612658e-09
selected O 0 3.8176299455017215e-08
tumors B-Disease 1 1.0
, O 0 5.2793087235158964e-08
SSCP O 1 1.0
, O 0 3.721492447539276e-08
hetero O 0 4.58057940022627e-07
- O 0 1.2268575488860733e-08
duplex O 0 3.879885301927288e-09
analysis O 0 6.286735715343994e-11
, O 0 1.4313305748969718e-11
sequencing O 0 3.277550453262279e-10
, O 0 7.297054627208865e-11
and O 0 3.6377773016127435e-10
Southern O 0 2.552147648771097e-08
blot O 0 1.0889275472436566e-06
analysis O 0 3.1742092287956325e-10
were O 0 4.784147036862585e-11
used O 0 2.0623715235590367e-10
to O 0 9.517847621154374e-10
identify O 0 1.4838975381792352e-08
mutations O 0 9.000108747159175e-08
. O 0 1.4270945314365235e-07

Mutations O 0 1.1575031066968222e-07
were O 0 1.8576982174778323e-09
detected O 0 2.605566873370435e-09
in O 0 1.9359817915454158e-10
21 O 0 7.637284582528991e-09
( O 0 8.23515214354309e-11
91 O 0 6.166721355782556e-09
% O 0 6.341483588245822e-11
) O 0 1.1552715034612859e-10
of O 0 1.1388814336044106e-08
23 O 0 5.896581114939181e-06
tumors B-Disease 1 1.0
with O 0 3.932253548555309e-06
LOH O 1 1.0
. O 0 1.1843105312436819e-05

In O 0 5.256811164144892e-08
6 O 0 1.2626897216705402e-07
( O 0 4.261494213064765e-10
38 O 0 4.516060414516687e-09
% O 0 7.16972869962973e-11
) O 0 5.0607146945269577e-11
of O 0 2.2691335477276198e-09
16 O 0 2.332247248659769e-07
tumors B-Disease 1 1.0
without O 0 7.888774433695289e-08
LOH O 1 1.0
, O 0 5.436655126089818e-09
one O 0 5.535121805344545e-10
mutation O 0 2.723561376427597e-10
was O 0 3.2405025884862937e-10
detected O 0 5.963209925852198e-10
, O 0 5.837080818693607e-11
and O 0 1.4395477865303263e-10
in O 0 1.2322315390278504e-10
9 O 0 7.739553886665362e-09
( O 0 8.539993712197713e-11
56 O 0 1.0590964771850508e-09
% O 0 2.1790286588996288e-11
) O 0 2.100633902935023e-11
of O 0 1.201801769212807e-09
the O 0 2.264832410503459e-08
tumors B-Disease 1 1.0
without O 0 2.234961584690609e-07
LOH O 1 1.0
, O 0 7.279490343847783e-09
both O 0 7.701321802500161e-10
mutations O 0 1.4799622638506094e-09
were O 0 3.3750310879376855e-10
found O 0 1.0874741107613772e-09
. O 0 1.7652936890044657e-08

Thus O 0 1.2469200783016277e-07
, O 0 1.6035847094642008e-09
a O 0 2.1830401375488862e-10
total O 0 1.0382962545296692e-10
of O 0 4.920100993288656e-10
45 O 0 2.368304219402262e-09
mutations O 0 3.895232192352438e-10
were O 0 9.290094388214598e-11
identified O 0 3.271585502506724e-10
in O 0 1.6948961123475215e-09
tumors B-Disease 1 1.0
of O 0 6.547781958943233e-05
36 O 0 1.9634280761238188e-06
patients O 0 1.1574827318838743e-08
. O 0 2.2838369417854665e-08

Thirty O 0 8.202727599382342e-07
- O 0 1.2680331451520033e-07
nine O 0 7.508933030919707e-09
of O 0 1.4699920170002656e-09
the O 0 7.900330944998757e-10
mutations O 0 4.666795838659255e-10
- O 0 2.674396926138911e-09
including O 0 4.108209883391112e-10
34 O 0 6.598006585534222e-09
small O 0 1.1031339175460175e-09
mutations O 0 4.2600886707155894e-10
, O 0 6.51553602737387e-11
2 O 0 1.951799610822036e-09
large O 0 1.892322964991422e-09
structural O 0 1.1849343195535766e-07
alterations O 0 1.4082102950396802e-07
, O 0 9.509428799958641e-10
and O 0 1.2503245105932592e-09
hypermethylation O 0 2.2780955077905674e-06
in O 0 3.097429202014723e-09
3 O 0 4.4708626774081495e-06
tumors O 1 1.0
- O 0 4.578203913752077e-07
were O 0 1.5684197274268286e-09
not O 0 8.047147670442456e-11
detected O 0 5.52816903365283e-10
in O 0 4.447627335868454e-11
the O 0 9.175809001504831e-10
corresponding O 0 3.5666971598402597e-09
peripheral O 0 1.3673586636286927e-06
blood O 0 2.0406025313945975e-08
DNA O 0 9.330523909056865e-08
. O 0 2.1548784090441586e-08

In O 0 3.852521857083957e-08
6 O 0 7.99553916408513e-08
( O 0 3.3352720585355655e-10
17 O 0 1.4083325616809361e-09
% O 0 2.801602352886512e-11
) O 0 1.8459169956464017e-11
of O 0 3.7121308804621833e-10
the O 0 8.511735205551929e-10
36 O 0 4.839788569910297e-09
patients O 0 3.6482974974383353e-10
, O 0 1.552463158027706e-10
a O 0 5.673769787328808e-10
mutation O 0 1.477669098193246e-09
was O 0 2.4612241134036594e-09
detected O 0 1.6762493615374296e-09
in O 0 1.6222419241262998e-10
constitutional O 0 6.779888650498833e-09
DNA O 0 5.600656605153631e-10
, O 0 2.2636845523060778e-11
and O 0 2.6920864842905345e-11
1 O 0 1.5969886524302979e-09
of O 0 7.700499682350426e-10
these O 0 3.6750394394324815e-10
mutations O 0 4.851496426816482e-10
is O 0 4.416754115221799e-11
known O 0 1.8120974165647397e-10
to O 0 1.5173221012965143e-10
be O 0 1.4625520239341938e-10
associated O 0 4.730279501430346e-10
with O 0 2.117733322037907e-09
reduced O 0 5.687481348104484e-07
expressivity O 0 4.136745701543987e-05
. O 0 7.852218573134451e-07

The O 0 3.89843961556835e-08
presence O 0 2.5760218402837154e-09
of O 0 1.7512354233417682e-08
a O 0 2.8038984467571026e-09
constitutional O 0 7.441114036055296e-08
mutation O 0 4.389773877733205e-09
was O 0 2.486273187329857e-09
not O 0 3.385803443167745e-11
associated O 0 6.964956389410304e-11
with O 0 6.024093029965982e-11
an O 0 7.610941737956622e-11
early O 0 1.4775676238087954e-09
age O 0 8.010356822296671e-09
at O 0 1.8776729504565992e-08
treatment O 0 1.6348366216334398e-07
. O 0 1.8320899641821597e-07

In O 0 3.5759626371145714e-08
1 O 0 2.304992108292936e-07
patient O 0 4.6590979962957135e-08
, O 0 4.228800865035964e-09
somatic O 0 2.9174091764616605e-07
mosaicism O 0 1.8038070265902206e-05
was O 0 6.114790807032477e-08
demonstrated O 0 1.3764356321388505e-09
by O 0 1.9470272616395334e-11
molecular O 0 2.3151629224837933e-10
analysis O 0 1.4075390158962975e-11
of O 0 1.419028367033448e-10
DNA O 0 4.274201270693112e-10
and O 0 2.0860851934756397e-10
RNA O 0 7.573533622462492e-08
from O 0 4.829801447669979e-09
peripheral O 1 0.880505383014679
blood O 0 9.66183847594948e-07
. O 0 1.7252700956760236e-07

In O 0 2.508892826824649e-08
2 O 0 1.5554115861959872e-07
patients O 0 2.618590455583103e-09
without O 0 3.5431671485675054e-10
a O 0 5.112574252841284e-10
detectable O 0 3.00753498549966e-07
mutation O 0 2.688394618033385e-09
in O 0 5.357778665171509e-10
peripheral O 0 0.06958059966564178
blood O 0 8.57361115436106e-08
, O 0 3.5185003799398373e-09
mosaicism O 0 3.5718228446057765e-06
was O 0 1.0509231707089839e-08
suggested O 0 6.556529208445738e-10
because O 0 1.6916365530583732e-10
1 O 0 2.178823343967906e-09
of O 0 1.0278593531865e-09
the O 0 1.6189570795077657e-09
patients O 0 1.4751037058502448e-09
showed O 0 1.2051491360409727e-08
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 1.376142790832091e-07
the O 0 1.4614492727105244e-08
other O 0 9.477396645252156e-10
later O 0 2.7562401250236235e-09
developed O 0 2.6036458322664657e-08
bilateral B-Disease 0 1.3746644071943592e-05
retinoblastoma I-Disease 1 0.9998708963394165
. O 0 9.643923704061308e-07

In O 0 3.000667447849992e-08
conclusion O 0 1.2220232825654875e-08
, O 0 1.6738086472400937e-09
our O 0 1.0179540543830967e-09
results O 0 7.912572680401908e-11
emphasize O 0 1.4782244317501636e-09
that O 0 3.338694598564729e-11
the O 0 6.177960920616954e-10
manifestation O 0 1.647139669103126e-08
and O 0 1.2997647402812618e-09
transmissibility O 0 4.3887885681215266e-07
of O 0 2.0530837474552754e-08
retinoblastoma B-Disease 0 1.1372256381037005e-07
depend O 0 6.721582734847686e-10
on O 0 1.2947222183257168e-09
the O 0 7.548217606512253e-10
nature O 0 2.723427705575432e-09
of O 0 1.4345572507679094e-09
the O 0 1.0831642249797824e-09
first O 0 2.1667376226552904e-10
mutation O 0 3.8559856696540606e-11
, O 0 1.280298610184527e-11
its O 0 2.1491614043966933e-11
time O 0 1.1184100520700291e-11
in O 0 1.3550299771125651e-11
development O 0 1.1620606560347468e-10
, O 0 6.568241089910387e-11
and O 0 6.30038451965298e-11
the O 0 2.81902973187087e-10
number O 0 6.965607951547881e-11
and O 0 1.2718559538882346e-10
types O 0 4.261520913928507e-09
of O 0 3.3286071676741358e-09
cells O 0 7.128494322605761e-11
that O 0 2.161547676959863e-11
are O 0 5.430235081038681e-11
affected O 0 1.2052864262201979e-09
. O 0 2.292131595638125e-09
. O 0 7.224662113003433e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.8355356454849243
the I-Disease 0 3.22122923535062e-06
fifth I-Disease 0 1.2141777006036136e-07
component I-Disease 0 5.3346774109286343e-08
of I-Disease 0 2.871942328397381e-08
complement I-Disease 0 2.703606760690036e-08
in O 0 8.529990047634328e-09
man O 0 2.2873840066495177e-07
. O 0 2.360058601880155e-07

I O 0 0.040847133845090866
. O 0 1.2754187991959043e-05

Clinical O 0 3.788281901506707e-05
, O 0 2.680664401566446e-08
immunochemical O 0 7.824806743883528e-06
, O 0 1.4948287940796945e-08
and O 0 1.1182751613603159e-08
family O 0 1.125664539358695e-08
studies O 0 6.106957783913458e-08
. O 0 8.894965475292338e-08

The O 0 1.8214696240193007e-07
first O 0 1.0363423896819768e-08
recognized O 0 1.1666715948877027e-07
human O 0 1.6013206760590037e-08
kindred O 0 3.6455719509831397e-06
with O 0 6.6788508057413765e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.6155667901039124
fifth I-Disease 0 4.397750785756216e-07
component I-Disease 0 4.791478431798168e-07
of I-Disease 0 2.405241446012951e-07
complement I-Disease 0 3.324521230751998e-06
( O 0 1.017193707042452e-08
C5 O 1 1.0
) O 0 5.7444431433850696e-09
is O 0 3.926421410227476e-09
described O 0 3.0807800754928394e-08
. O 0 2.0361009944735997e-07

The O 0 1.166763240689761e-06
proband O 0 3.387036485946737e-05
, O 0 2.176490099259354e-08
a O 0 1.5402386033258608e-09
20 O 0 5.777429645803522e-09
- O 0 3.890949784590703e-09
year O 0 2.3828114481538876e-10
- O 0 4.105916495689144e-09
old O 0 4.0029162207133595e-09
black O 0 6.418147679987385e-10
female O 0 1.412512329324045e-10
with O 0 1.086319478815767e-09
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 5.348870217858348e-07
age O 0 5.8476871345192194e-08
11 O 0 4.09298372971989e-09
, O 0 5.726434326724927e-10
lacked O 0 1.1515310660570321e-07
serum O 0 1.9057371503095055e-07
hemolytic O 0 1.7124630176112987e-05
complement O 0 1.686715300763808e-08
activity O 0 6.1468052869884104e-09
, O 0 5.37465627559186e-10
even O 0 2.0840740244665312e-09
during O 0 2.187060132996521e-08
remission O 0 8.490094955959648e-07
. O 0 1.0885667478532923e-07

C5 O 1 0.9999998807907104
was O 0 1.3636615676659858e-06
undetectable O 0 2.429566393402638e-06
in O 0 1.1172235359069305e-09
her O 0 9.273757872740873e-10
serum O 0 9.689626878639501e-10
by O 0 9.969858272285137e-11
both O 0 4.723412327933829e-09
immunodiffusion O 0 6.416314136004075e-05
and O 0 2.169844179888969e-07
hemolytic O 0 0.0010243527358397841
assays O 0 5.151074674358824e-06
. O 0 8.274335527858057e-07

Other O 0 9.273993128999791e-09
complement O 0 1.0481146617280501e-08
components O 0 1.2768643919969236e-08
were O 0 2.424160594483027e-10
normal O 0 5.199944363987186e-10
during O 0 4.1991968235954857e-10
remission O 0 1.6071405539719308e-08
of O 0 9.092119945819377e-09
lupus O 1 1.0
, O 0 8.300731657584492e-09
but O 0 2.76762435191813e-09
C1 O 1 0.9949336647987366
, O 0 1.0613416812077503e-08
C4 O 1 1.0
, O 0 2.6737195568671268e-08
C2 O 0 0.0007848248351365328
, O 0 3.7893208570949355e-09
and O 0 2.6264499908279504e-08
C3 O 1 1.0
levels O 0 1.4954838434277917e-06
fell O 0 2.6625243663147558e-06
during O 0 9.472217499251201e-08
exacerbations O 0 0.0002610633091535419
. O 0 8.333968821716553e-07

A O 0 1.4906026990502141e-06
younger O 0 1.2642000335461034e-08
half O 0 2.057806813837715e-09
- O 0 5.043050776976088e-08
sister O 0 1.470267552150517e-08
, O 0 1.3435071943845855e-09
who O 0 1.1068158611848844e-09
had O 0 4.605562597959079e-09
no O 0 1.1106441100139364e-08
underlying O 0 0.006394794676452875
disease O 1 0.9944517016410828
, O 0 1.813038719156168e-09
was O 0 2.065649162830141e-08
also O 0 1.1731023930039441e-09
found O 0 5.79400138978059e-10
to O 0 1.9726573707856687e-09
lack O 0 6.646562269452261e-07
immunochemically O 1 0.9740162491798401
detectable O 1 0.9999603033065796
C5 O 1 1.0
. O 0 1.7746489220371586e-06

By O 0 1.5863223268297588e-07
hemolytic O 0 1.647068165766541e-05
assay O 0 1.8365437881584512e-07
, O 0 8.64081695084451e-09
she O 0 1.1161522817104697e-09
exhibited O 0 4.367300743268743e-09
1 O 0 1.6677156322586484e-09
- O 0 1.73422587401717e-09
2 O 0 1.9527455208390165e-09
% O 0 4.367029654561705e-11
of O 0 2.756649075674744e-10
the O 0 5.964734262065008e-10
normal O 0 4.132630238018464e-09
serum O 0 9.37860633598575e-09
C5 O 0 2.7321048037265427e-05
level O 0 7.2878121315511635e-09
and O 0 5.551044068852207e-10
normal O 0 9.88876869278954e-10
concentrations O 0 1.2395584558788642e-09
of O 0 8.836955056601425e-10
other O 0 5.723158613690771e-10
complement O 0 1.2155582318484903e-08
components O 0 1.3258882347599865e-07
. O 0 5.9575089750296684e-08

C5 O 0 0.0007790634990669787
levels O 0 4.621289306783183e-08
of O 0 7.350857256227528e-09
other O 0 3.787151703349423e-10
family O 0 9.827053754074555e-11
members O 0 9.408872118921163e-12
were O 0 1.466317206544332e-10
either O 0 6.117514828041237e-10
normal O 0 1.3448967495222064e-09
or O 0 1.0583648540896107e-10
approximately O 0 2.3192822662387869e-10
half O 0 6.455470602517721e-10
- O 0 1.8668918855269112e-08
normal O 0 3.1445808179597634e-09
, O 0 1.3414555577462295e-10
consistent O 0 1.3440684121235336e-09
with O 0 6.005339003856136e-10
autosomal O 0 1.0315054055354267e-07
codominant O 0 2.3569934910483425e-06
inheritance O 0 6.929652585085933e-08
of O 0 1.1575003178165844e-08
the O 0 7.975126337100846e-09
gene O 0 5.267409974862858e-08
determining O 0 0.00010231068881694227
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 3.1387992294185096e-06

Normal O 0 2.7067002520198002e-05
hemolytic O 0 8.0215344496537e-05
titers O 0 3.3467890716565307e-06
were O 0 3.4177685126479673e-09
restored O 0 8.566937381715434e-09
to O 0 7.588941142167016e-10
both O 0 4.530787744982945e-09
homozygous O 0 4.933656600769609e-05
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.5934212171941908e-07
C5D B-Disease 1 1.0
) O 0 1.0560651908519958e-08
sera O 0 1.0390062925580423e-06
by O 0 1.2473655441880283e-10
addition O 0 1.856518827558773e-09
of O 0 8.571563014925232e-09
highly O 0 1.4434320405598555e-07
purified O 0 4.0072194451568066e-07
human O 0 4.480969550968439e-08
C5 O 1 0.9999932050704956
. O 0 3.603219340675423e-07

In O 0 1.4658272107226367e-07
specific O 0 4.640318707060942e-07
C5 O 0 0.0546061210334301
titrations O 0 2.2981885194894858e-06
, O 0 2.7781597022880078e-09
however O 0 5.261289737212849e-10
, O 0 2.6990390478154325e-10
it O 0 2.2497011198385763e-10
was O 0 1.9297081710334396e-09
noted O 0 6.324961665526985e-10
that O 0 5.115507670239161e-11
when O 0 2.33071006938701e-10
limited O 0 6.485026959879292e-10
amounts O 0 1.496197055139703e-09
of O 0 7.328067042067232e-09
C5 O 0 0.00043131824349984527
were O 0 4.7218087217970606e-09
assayed O 0 2.867979276288679e-08
in O 0 1.8934195877839954e-10
the O 0 7.645734600991716e-10
presence O 0 7.35702498921853e-10
of O 0 3.149220439979672e-09
low O 0 1.7745875879882078e-08
dilutions O 0 7.176456051638525e-07
of O 0 5.480092468701514e-08
either O 0 1.324219027765139e-07
C5D B-Disease 1 1.0
serum O 0 2.186138772231061e-07
, O 0 5.37190203431237e-09
curving O 0 5.974053465251927e-07
rather O 0 1.5501442351961714e-09
than O 0 5.427242336097926e-11
linear O 0 8.948731200497662e-10
dose O 0 3.331980025222947e-09
- O 0 1.679888672612151e-09
response O 0 6.738845592657583e-11
plots O 0 2.9759745778790148e-09
were O 0 4.1206404954863274e-10
consistently O 0 1.978354591258835e-09
obtained O 0 2.0400868494530044e-10
, O 0 1.248860459490686e-10
suggesting O 0 6.813265507332744e-10
some O 0 3.08803066451091e-10
inhibitory O 0 3.160586743433669e-07
effect O 0 4.927008490085427e-07
. O 0 3.172064282352949e-07

Further O 0 3.9123099782045756e-07
studies O 0 7.421338210633621e-09
suggested O 0 2.049033609452522e-09
that O 0 7.228332515873959e-11
low O 0 2.3708409457867674e-08
dilutions O 0 1.4878390857120394e-06
of O 0 1.9595040612330195e-07
C5D B-Disease 1 1.0
serum O 0 6.951322717441144e-08
contain O 0 1.710727026704717e-08
a O 0 4.374442752475005e-10
factor O 0 3.967903783319571e-09
( O 0 4.6792715535648455e-11
or O 0 9.010538842835203e-11
factors O 0 5.867646368784563e-10
) O 0 3.43166536853623e-11
interfering O 0 1.082554934583868e-09
at O 0 1.0035015041154338e-09
some O 0 2.8160365705964807e-10
step O 0 3.369790446683396e-09
in O 0 3.4156358297288136e-10
the O 0 1.2766817825138332e-08
hemolytic O 0 9.765627737579052e-07
assay O 0 3.890031408104733e-08
of O 0 1.6547261338928365e-07
C5 O 1 1.0
, O 0 1.0924698923275855e-09
rather O 0 4.494849770164677e-10
than O 0 1.2831521956080394e-10
a O 0 1.1776579711408885e-09
true O 0 3.326228537048337e-08
C5 O 0 0.0002909791946876794
inhibitor O 0 6.491654289675353e-07
or O 0 2.030755830162434e-08
inactivator O 0 1.547718420624733e-05
. O 0 4.956700081493182e-07

Of O 0 4.590896878653439e-06
clinical O 0 6.17375417277799e-06
interest O 0 1.5470760672542383e-08
are O 0 1.5611337222942723e-10
( O 0 3.330788422850617e-11
a O 0 2.8729022633067203e-11
) O 0 2.165587847935413e-11
the O 0 1.2314090025444813e-10
documentation O 0 1.9227984537906195e-08
of O 0 6.987626477439335e-08
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 1.1574292329896707e-05
vasculitis B-Disease 1 1.0
, O 0 6.565169741179488e-08
and O 0 7.932952144074079e-07
arthritis B-Disease 1 1.0
in O 0 1.6747920827953067e-09
an O 0 2.5531818326207656e-10
individual O 0 4.772565120880756e-10
lacking O 0 1.820448147782372e-08
C5 O 1 1.0
( O 0 1.277394023890821e-10
and O 0 3.091654987574799e-10
its O 0 4.901181127614507e-10
biologic O 0 3.708865037310716e-08
functions O 0 1.1300734653607591e-10
) O 0 1.2435924685860744e-11
, O 0 2.129859309751847e-11
and O 0 1.187747539210804e-10
( O 0 1.0998014304819392e-10
b O 0 4.402048947582671e-09
) O 0 1.3780346308500668e-10
a O 0 4.134094455654491e-10
remarkable O 0 1.093395374240913e-09
propensity O 0 2.9696368031295606e-08
to O 0 5.824460913572693e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.6464030139218266e-10
the O 0 1.7882424430126775e-09
proband O 0 1.2811257192879566e-06
, O 0 1.1368863628291592e-09
even O 0 4.523851571125448e-10
during O 0 5.238838807208879e-10
periods O 0 3.7938048258467916e-09
of O 0 1.0810941031280663e-09
low O 0 5.514007916929131e-09
- O 0 8.992126154794278e-09
dose O 0 1.6034325867053667e-08
or O 0 2.635173190768114e-10
alternate O 0 9.747050944142188e-10
- O 0 1.9538418882802944e-08
day O 0 8.048721689135618e-09
corticosteroid O 0 1.8470824215910397e-05
therapy O 0 1.6658762547194783e-07
. O 0 2.2650828768178144e-08

Other O 0 6.6445593915887e-08
observations O 0 1.5829606070383306e-08
indicate O 0 3.054808905833539e-10
that O 0 2.633599241463891e-11
the O 0 2.0164045988479984e-09
C5D B-Disease 1 1.0
state O 0 8.796464889826439e-09
is O 0 3.9551170671892066e-10
compatible O 0 5.611908715508207e-09
with O 0 1.8383357336393402e-10
normal O 0 4.463821312583605e-09
coagulation O 0 1.042949637763968e-08
function O 0 3.227856870680057e-10
and O 0 1.723609865944553e-10
the O 0 1.0557987817350067e-09
capacity O 0 4.934783692789324e-09
to O 0 2.99448532636859e-09
mount O 0 1.3197437510825694e-05
a O 0 4.372429032173386e-07
neutrophilic O 0 0.3207458257675171
leukocytosis O 0 0.00020136097737122327
during O 0 6.363386546581751e-07
pyogenic B-Disease 0 0.00030581187456846237
infection I-Disease 0 1.422117975380388e-06
. O 0 1.1749751394063424e-08
. O 0 1.0378185066883816e-07

Susceptibility O 0 0.00024443736765533686
to O 0 1.4644232351201936e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 6.0466314607765526e-05
twins O 0 1.580433206527232e-07
: O 0 4.927442481816868e-11
the O 0 9.243221466004314e-11
role O 0 3.897639988537094e-10
of O 0 1.4345901133694383e-09
genes O 0 4.157587885078584e-10
, O 0 3.0825050845173507e-10
HLA O 0 1.7779674408302526e-06
, O 0 1.5196978120357585e-09
and O 0 3.575142848433188e-09
the O 0 1.665313220655662e-08
environment O 0 7.805393664739313e-08
. O 0 1.48464408766813e-07

OBJECTIVE O 0 1.751536547089927e-05
To O 0 2.7863851226328507e-09
determine O 0 1.6017719373095929e-09
the O 0 5.497696187184431e-10
relative O 0 7.085540487672404e-10
effects O 0 7.727151540848354e-08
of O 0 1.1373271213699354e-08
genetic O 0 5.162433591721083e-09
and O 0 2.3443397223488205e-10
environmental O 0 2.8792921824560835e-08
factors O 0 9.073353735011835e-10
in O 0 4.5587561503523943e-11
susceptibility O 0 4.7243514700312517e-07
to O 0 8.600142820114343e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9437903761863708
AS B-Disease 1 1.0
) O 0 4.983422741133836e-08
. O 0 1.3762532091732282e-07

METHODS O 0 5.979553407087224e-06
Twins O 0 7.879511088049185e-08
with O 0 1.4770766554317305e-10
AS B-Disease 1 0.9999996423721313
were O 0 3.2970434715728913e-10
identified O 0 8.960272801505909e-11
from O 0 1.6245293305017228e-11
the O 0 5.293288585228595e-10
Royal O 0 8.881911384150953e-08
National O 0 8.54034567510098e-07
Hospital O 0 2.5543362426105887e-05
for O 0 2.996486614392779e-08
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 4.791505716639222e-07
. O 0 1.1768326402261664e-07

Clinical O 0 4.433411049831193e-06
and O 0 1.3605950144324197e-08
radiographic O 0 2.015619202211383e-06
examinations O 0 9.382545584912805e-08
were O 0 3.64169278066484e-10
performed O 0 1.7059654799922441e-09
to O 0 1.8774488907968845e-10
establish O 0 1.8099082232936325e-09
diagnoses O 0 3.061362576772808e-07
, O 0 3.4322580333423502e-09
and O 0 4.654284069260939e-08
disease O 1 0.9945845007896423
severity O 1 0.999734103679657
was O 0 2.459179171410142e-08
assessed O 0 7.728743867119192e-08
using O 0 1.0050664744909454e-09
a O 0 4.571489020666064e-10
combination O 0 3.007484261630111e-09
of O 0 1.7763248649771413e-08
validated O 0 2.3460781051198865e-07
scoring O 0 4.3873029653695994e-07
systems O 0 2.879445901271538e-06
. O 0 3.011538751707121e-07

HLA O 0 7.24428246030584e-05
typing O 0 3.0537142947650864e-07
for O 0 1.08712212565365e-08
HLA O 0 4.193257154838648e-06
- O 0 7.106904149623006e-07
B27 O 0 2.878188524846337e-06
, O 0 1.984613140493252e-09
HLA O 0 4.624560574484349e-07
- O 0 6.296512822245859e-08
B60 O 0 4.758499869694788e-07
, O 0 5.385523693668404e-10
and O 0 9.753932106448815e-10
HLA O 0 1.939593175848131e-06
- O 0 8.432029972027522e-07
DR1 O 1 0.9999969005584717
was O 0 6.518640560670974e-08
performed O 0 4.976951295532217e-09
by O 0 1.9144090479539244e-10
polymerase O 0 3.6224980792809447e-09
chain O 0 4.378034379470819e-09
reaction O 0 5.3544967071328387e-11
with O 0 3.1018070056898495e-11
sequence O 0 1.345986794243359e-10
- O 0 4.885873927662487e-10
specific O 0 2.85424600621198e-10
primers O 0 4.1768406511266676e-09
, O 0 1.883076056197197e-10
and O 0 6.312175226952377e-10
zygosity O 0 1.112641257350333e-06
was O 0 1.0502558822622632e-08
assessed O 0 1.501530277892016e-07
using O 0 2.3342803245895993e-08
microsatellite O 0 1.5725431694590952e-06
markers O 0 2.734855570452055e-06
. O 0 2.5998130581683654e-07

Genetic O 0 7.624711315656896e-07
and O 0 7.895846643179993e-09
environmental O 0 6.418544984398977e-08
variance O 0 5.0531192563596505e-09
components O 0 1.1342373706924036e-09
were O 0 4.54041214348333e-11
assessed O 0 9.155917801706437e-09
with O 0 8.541019974606101e-11
the O 0 2.202859006317226e-09
program O 0 1.5379313378360848e-09
Mx O 0 2.397480420768261e-05
, O 0 3.4533151338500545e-10
using O 0 7.333708640366865e-11
data O 0 5.5110058877483326e-11
from O 0 1.3503188150965073e-11
this O 0 7.93554198047497e-12
and O 0 7.466509355236184e-11
previous O 0 1.9283495633626302e-10
studies O 0 2.616841743297016e-10
of O 0 9.751067731045282e-10
twins O 0 6.551507336638451e-09
with O 0 7.31877447535112e-10
AS B-Disease 1 1.0
. O 0 6.586553809029283e-07

RESULTS O 0 3.06338932887229e-07
Six O 0 1.1037870173424835e-08
of O 0 6.348726877547506e-09
8 O 0 1.0295300967300136e-07
monozygotic O 0 7.443256322403613e-07
( O 0 8.727427669441568e-09
MZ O 1 1.0
) O 0 8.128544948249328e-09
twin O 0 3.590116932628007e-07
pairs O 0 1.0159988406144294e-09
were O 0 2.8724050915585053e-10
disease O 0 2.1066917099688e-08
concordant O 0 1.112329996999506e-07
, O 0 9.615389734429769e-11
compared O 0 3.734677150868393e-11
with O 0 2.0726788341196567e-11
4 O 0 4.473554859885098e-09
of O 0 4.077913562383628e-09
15 O 0 9.350278773467835e-09
B27 O 0 5.09423557559785e-07
- O 0 8.279531016341934e-08
positive O 0 3.5439191581332352e-09
dizygotic O 0 9.530805868962489e-07
( O 0 3.544263771360079e-09
DZ O 1 0.9993975162506104
) O 0 6.932505680623535e-09
twin O 0 2.4341531457139354e-07
pairs O 0 3.1770561181865276e-10
( O 0 1.905159363602138e-11
27 O 0 9.190802563452394e-10
% O 0 1.8372166635249876e-11
) O 0 8.288853978188904e-12
and O 0 1.1383417125587769e-10
4 O 0 4.3913988001520465e-09
of O 0 5.8881099995744535e-09
32 O 0 2.665166505266825e-07
DZ O 1 0.9999637603759766
twin O 0 1.0791023896672414e-06
pairs O 0 9.237673403994506e-10
overall O 0 2.5406985404430316e-09
( O 0 6.638685434712244e-11
12 O 0 1.0656902027506021e-09
. O 0 1.0312502241038857e-10
5 O 0 7.882904995426543e-09
% O 0 9.203309780936308e-10
) O 0 3.4743925514391094e-09
. O 0 8.078023228108577e-08

Nonsignificant O 0 4.1065242839977145e-05
increases O 0 1.540782967879295e-08
in O 0 1.980154235026177e-10
similarity O 0 7.952792868692882e-10
with O 0 6.369704763642403e-11
regard O 0 3.512512725123429e-09
to O 0 5.56231005699459e-10
age O 0 6.755401127378491e-09
at O 0 4.070468850869702e-09
disease O 0 2.826134561928484e-07
onset O 0 7.533855495012176e-08
and O 0 1.9262258454944003e-09
all O 0 8.573209364648449e-10
of O 0 2.8628950321518687e-09
the O 0 3.6555294347095924e-09
disease O 0 4.5976040752293557e-08
severity O 0 5.819558879238684e-08
scores O 0 1.3406811216754022e-09
assessed O 0 1.209644384658759e-08
were O 0 2.0237668485467708e-10
noted O 0 1.0005390960188265e-09
in O 0 8.025003439549039e-10
disease O 0 1.2739131989292218e-06
- O 0 1.1209241165488493e-05
concordant O 0 0.00039239812758751214
MZ O 1 0.9999997615814209
twins O 0 1.180238200504391e-07
compared O 0 1.374507285767379e-09
with O 0 1.7491315063011825e-09
concordant O 0 0.0001830120017984882
DZ O 1 1.0
twins O 0 2.960870233437163e-06
. O 0 2.168214052744588e-07

HLA O 0 0.00021115767594892532
- O 0 2.8186029794596834e-06
B27 O 0 2.9746536256425316e-06
and O 0 3.899449207978023e-09
B60 O 0 3.7122802609701466e-07
were O 0 8.64014901291732e-11
associated O 0 1.3041547008985077e-10
with O 0 6.658696510841722e-11
the O 0 2.220822192811056e-09
disease O 0 1.2501337209869234e-07
in O 0 2.185519126784996e-10
probands O 0 0.02949083037674427
, O 0 6.15763329214758e-10
and O 0 5.021200122357072e-10
the O 0 1.3148502286952635e-09
rate O 0 2.7532662816298625e-09
of O 0 9.461470718008513e-09
disease O 0 8.788953778093855e-07
concordance O 0 5.722924356632575e-08
was O 0 2.8785547279142065e-09
significantly O 0 9.66551949588279e-10
increased O 0 2.382312791482377e-09
among O 0 5.312721818029331e-09
DZ O 0 0.23358625173568726
twin O 0 1.399836264681653e-07
pairs O 0 1.0775711573041136e-10
in O 0 1.6200766422835855e-11
which O 0 3.087163510939739e-11
the O 0 7.23915316580559e-10
co O 0 8.184238176056624e-09
- O 0 5.393835422751181e-08
twin O 0 1.4821162608313898e-07
was O 0 2.5132835812513576e-09
positive O 0 1.176952146852983e-10
for O 0 9.485366658790184e-11
both O 0 6.933665308572756e-10
B27 O 0 2.608622480693157e-06
and O 0 1.1097699825768359e-07
DR1 O 1 0.9999738931655884
. O 0 3.7326431083783973e-06

Additive O 0 9.920455568135367e-07
genetic O 0 1.3630261364028229e-08
effects O 0 1.3606910265195893e-08
were O 0 1.8330242879116554e-10
estimated O 0 1.1175661784879054e-10
to O 0 8.508078269686692e-11
contribute O 0 4.2056894078434937e-10
97 O 0 8.974305742981414e-09
% O 0 6.334955476861026e-11
of O 0 4.897817151849893e-10
the O 0 1.7279623287791424e-09
population O 0 6.402555569051671e-11
variance O 0 1.51120929103854e-08
. O 0 3.203418685870929e-08

CONCLUSION O 0 1.2130011555200326e-06
Susceptibility O 0 2.414901416614157e-07
to O 0 5.062631203145429e-09
AS B-Disease 1 1.0
is O 0 1.0055516419527066e-09
largely O 0 8.952555363705983e-10
genetically O 0 3.146841121015598e-10
determined O 0 2.337561810783484e-10
, O 0 5.661529925427011e-11
and O 0 2.0409585133052133e-10
the O 0 1.5720167390043116e-09
environmental O 0 7.282332603608666e-07
trigger O 0 3.596071707079318e-08
for O 0 3.823966421290237e-10
the O 0 7.980025529263912e-09
disease O 0 1.016362693917472e-05
is O 0 1.03208561696988e-08
probably O 0 5.7933110753083383e-08
ubiquitous O 0 2.6445623007020913e-06
. O 0 6.877534701743571e-07

HLA O 0 0.0007916462491266429
- O 0 4.385125066619366e-06
B27 O 0 1.3665373899129918e-06
accounts O 0 3.045738661278108e-10
for O 0 3.548900756600304e-11
a O 0 6.848309419549281e-11
minority O 0 1.0079783535621445e-10
of O 0 8.441856103047485e-10
the O 0 8.780871030289461e-10
overall O 0 7.488737630012565e-09
genetic O 0 4.557135557803349e-09
susceptibility O 0 3.7134800123794776e-08
to O 0 8.306718868311691e-09
AS B-Disease 1 1.0
. O 0 1.8412399640510557e-06

Cell O 0 3.4873057757067727e-06
cycle O 0 2.7299282123749435e-07
- O 0 9.585738780515385e-08
dependent O 0 1.611751443419962e-08
colocalization O 0 5.672671932188678e-07
of O 0 5.290538140911849e-08
BARD1 O 1 0.9999971389770508
and O 0 2.8615753322469573e-08
BRCA1 O 0 2.1640301994807487e-08
proteins O 0 1.2610969213344703e-10
in O 0 1.1251374831822147e-10
discrete O 0 2.6715380130326594e-08
nuclear O 0 1.1136996818095213e-06
domains O 0 8.933848789638432e-07
. O 0 3.5926134955843736e-07

Germ O 0 1.804536623239983e-05
- O 0 6.085546147005516e-07
line O 0 1.3601400894458493e-07
mutations O 0 2.7607598429568725e-09
of O 0 5.3667918997746256e-09
the O 0 1.5828339527956814e-08
BRCA1 O 0 2.267439498382373e-07
gene O 0 3.4232747747608983e-09
predispose O 0 1.8286678837853287e-08
women O 0 9.625275403102318e-12
to O 0 9.525501915019774e-12
early O 0 5.089350607612175e-10
- O 0 1.3958413092041155e-06
onset O 0 0.0001623577409191057
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 8.620001934467325e-11
compromising O 0 1.1581893666345877e-08
the O 0 2.31603403122449e-09
genes O 0 1.996108389690221e-09
presumptive O 0 2.1524142823636794e-07
function O 0 6.481778225264634e-09
as O 0 1.8846182392451283e-09
a O 0 1.1058521209861283e-08
tumor B-Disease 0 7.12185210431926e-05
suppressor O 0 0.00019003624038305134
. O 0 1.7332416746285162e-06

Although O 0 1.2653345038415864e-07
the O 0 2.1377093872843034e-08
biochemical O 0 3.276634785720489e-08
properties O 0 3.823795324819912e-08
of O 0 5.0642857019056464e-08
BRCA1 O 0 5.4053906239914795e-08
polypeptides O 0 2.698824053126714e-09
are O 0 1.5745448347925795e-11
not O 0 2.1174121483946706e-11
understood O 0 5.812508807601091e-10
, O 0 7.530583101544863e-11
their O 0 1.1578480535456848e-10
expression O 0 2.3577745311698095e-10
pattern O 0 1.0229288527341396e-09
and O 0 5.152426818533229e-10
subcellular O 0 4.383451113199044e-08
localization O 0 2.4829667211179185e-08
suggest O 0 1.852659470280571e-09
a O 0 4.974206602170739e-10
role O 0 2.2012291989170762e-09
in O 0 1.1958428691727363e-09
cell O 0 3.170974949284755e-08
- O 0 1.0285716598446015e-06
cycle O 0 2.1189450194469828e-07
regulation O 0 8.721904691810778e-07
. O 0 1.1482445216870474e-07

When O 0 1.6868028751559905e-07
resting O 0 1.6504172890563495e-06
cells O 0 2.526948872372259e-09
are O 0 1.2881373745443625e-10
induced O 0 5.3051980586360514e-09
to O 0 1.0295129332371644e-10
proliferate O 0 1.5468097913640122e-09
, O 0 2.190577025329432e-10
the O 0 5.872483610502854e-10
steady O 0 5.023272464654838e-09
- O 0 3.5733975778384774e-09
state O 0 3.0380625792858496e-10
levels O 0 1.901759638656131e-09
of O 0 2.0996104854731357e-09
BRCA1 O 0 2.6959428023332066e-09
increase O 0 4.708664014252406e-11
in O 0 1.1007583733402271e-10
late O 0 4.186563096197915e-09
G1 O 0 4.621183506969828e-07
and O 0 1.2957968031912515e-09
reach O 0 1.2302500129734995e-09
a O 0 3.2618593936994955e-10
maximum O 0 5.950918868791177e-09
during O 0 7.736675300407114e-09
S O 0 3.742523631444783e-06
phase O 0 7.447701477758528e-07
. O 0 2.3629232259736455e-07

Moreover O 0 4.969143105881813e-07
, O 0 8.681920071751392e-09
in O 0 3.211057642005244e-09
S O 0 5.931232749389892e-07
phase O 0 2.7346933606509083e-08
cells O 0 7.802364310194321e-10
, O 0 1.2631268253571193e-09
BRCA1 O 0 2.8047612232739993e-08
polypeptides O 0 7.792760214897498e-09
are O 0 1.0380209886085012e-10
hyperphosphorylated O 0 2.0717655502267007e-07
and O 0 4.276095477706576e-09
accumulate O 0 2.620015493448591e-08
into O 0 5.7244715634396925e-09
discrete O 0 3.69022217228121e-08
subnuclear O 0 3.148717041767668e-06
foci O 0 1.9300719031889457e-06
termed O 0 5.339156246009225e-07
" O 0 3.5840068335346587e-07
BRCA1 O 0 2.8040126380801667e-06
nuclear O 0 4.420492132339859e-06
dots O 0 7.95087998994859e-06
. O 0 5.692495506082196e-07

" O 0 1.9771197912632488e-05
BRCA1 O 0 4.078354322700761e-06
associates O 0 4.170752632148833e-08
in O 0 5.342779996198033e-09
vivo O 0 1.9283815788639913e-07
with O 0 1.346359690401755e-09
a O 0 1.017593476149159e-08
structurally O 0 4.7314213702520647e-07
related O 0 5.918074066357804e-07
protein O 0 1.0180252729696804e-06
termed O 0 2.340924766031094e-06
BARD1 O 1 1.0
. O 0 1.4992079968578764e-06

Here O 0 1.0915997883387263e-08
we O 0 9.191538086206208e-10
show O 0 6.042369937730996e-10
that O 0 3.4424428585477784e-11
the O 0 5.522583501615941e-10
steady O 0 5.07583930442479e-09
- O 0 2.1929318361202377e-09
state O 0 3.0028515785041066e-10
levels O 0 1.9544819096495303e-09
of O 0 2.701017631778768e-09
BARD1 O 1 0.9602543115615845
, O 0 3.0689417673812613e-10
unlike O 0 2.342649962905341e-10
those O 0 6.437687188887153e-11
of O 0 2.2512602892987843e-09
BRCA1 O 0 3.614032095811126e-08
, O 0 5.742709086042908e-10
remain O 0 3.741746912311328e-09
relatively O 0 9.39638145069921e-10
constant O 0 3.733463316279995e-09
during O 0 3.6771659051026973e-09
cell O 0 2.1255614512938337e-07
cycle O 0 3.3093300544351223e-07
progression O 0 5.767071797890821e-07
. O 0 1.0332362876397383e-07

However O 0 4.787111720361281e-07
, O 0 6.129234719765009e-08
immunostaining O 0 7.766566341160797e-06
revealed O 0 1.7793428952472823e-08
that O 0 2.5446316165300686e-09
BARD1 O 1 0.9999762773513794
resides O 0 8.676541369823099e-07
within O 0 3.277559557091081e-08
BRCA1 O 0 3.7380004869191907e-07
nuclear O 0 1.6144717562838196e-07
dots O 0 5.686711901375929e-08
during O 0 5.5639048923694645e-09
S O 0 1.7131701213202177e-07
phase O 0 8.071290302780199e-09
of O 0 3.463944464598967e-09
the O 0 2.371034257819815e-09
cell O 0 1.1989672588086364e-09
cycle O 0 2.2099542196230004e-09
, O 0 4.815630880172783e-11
but O 0 5.4922542208624137e-11
not O 0 5.570249123065807e-11
during O 0 8.337873724784117e-10
the O 0 1.186897335969661e-08
G1 O 0 1.1956828529946506e-05
phase O 0 9.59372869147046e-07
. O 0 2.5083502919187595e-07

Nevertheless O 0 3.457419552432839e-06
, O 0 2.041366116145582e-07
BARD1 O 0 0.00032726838253438473
polypeptides O 0 3.920593627526614e-08
are O 0 8.337631279831115e-11
found O 0 2.982028513009993e-11
exclusively O 0 2.2317936387850068e-10
in O 0 2.4562645320469478e-11
the O 0 6.316739353806611e-10
nuclear O 0 6.112619299614153e-09
fractions O 0 1.563858376130156e-09
of O 0 1.8568019344300524e-09
both O 0 1.2757196410362326e-09
G1 O 0 8.382207852264401e-07
- O 0 9.271573730984528e-08
and O 0 1.4263918046708568e-08
S O 0 1.5118196188268485e-06
- O 0 9.836875847213378e-08
phase O 0 1.7390004813933047e-07
cells O 0 5.041797646043733e-09
. O 0 3.045067842322169e-08

Therefore O 0 4.915585236631159e-07
, O 0 1.810040473060326e-08
progression O 0 5.225332699865248e-08
to O 0 1.4361040134858172e-09
S O 0 2.8114411065871536e-07
phase O 0 1.3184019209688813e-08
is O 0 1.1540910588303532e-10
accompanied O 0 2.981745961250226e-10
by O 0 2.0116776300316275e-11
the O 0 5.342206677028116e-10
aggregation O 0 5.420213167184329e-09
of O 0 2.6348443427082202e-08
nuclear O 0 2.6765421807795065e-06
BARD1 O 1 0.9969032406806946
polypeptides O 0 1.7951536790405953e-07
into O 0 3.4056277797844814e-08
BRCA1 O 0 6.388372071342019e-07
nuclear O 0 7.244117341542733e-07
dots O 0 2.059140797427972e-06
. O 0 2.2201081151251856e-07

This O 0 3.086084987558024e-08
cell O 0 4.507010231691311e-08
cycle O 0 1.6358153942519493e-08
- O 0 3.167595963304848e-08
dependent O 0 8.705216991700127e-09
colocalization O 0 5.897998676118732e-07
of O 0 5.5408207799700904e-08
BARD1 O 1 1.0
and O 0 6.107691774559498e-08
BRCA1 O 0 9.146077672994579e-08
indicates O 0 9.099436759640867e-10
a O 0 6.088968218520563e-11
role O 0 6.454534684507962e-10
for O 0 6.535453844769279e-10
BARD1 O 1 0.9999986886978149
in O 0 3.19457171826798e-08
BRCA1 O 0 1.6660251276334748e-05
- O 0 4.672933300753357e-06
mediated O 0 1.6321741895808373e-06
tumor B-Disease 1 0.9973772764205933
suppression O 1 0.6067543029785156
. O 0 1.0305295745638432e-06

Ethnic O 0 8.667162205711065e-07
differences O 0 2.899872697526007e-07
in O 0 8.659295502866371e-09
the O 0 1.3519861852273607e-07
HFE O 0 0.0019292994402348995
codon O 0 2.149145984731149e-06
282 O 0 1.069896370609058e-06
( O 0 1.2210101374421356e-07
Cys O 1 1.0
/ O 0 0.0013470080448314548
Tyr O 0 0.2204095870256424
) O 0 5.1684860835621294e-08
polymorphism O 0 4.179839265816554e-07
. O 0 2.0210615048199543e-07

Recent O 0 3.1019240509522206e-08
studies O 0 1.7686125897142801e-09
have O 0 2.378832200666814e-11
shown O 0 3.441413820581829e-10
that O 0 5.3685424994398545e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.23834800720214844
HH B-Disease 1 1.0
) O 0 5.465830454909337e-09
is O 0 6.566666099772078e-10
likely O 0 1.914839953265357e-10
to O 0 2.379532404450657e-10
be O 0 3.5475627990777525e-10
caused O 0 1.49941958849098e-09
by O 0 2.4609175808265604e-10
homozygosity O 0 9.727241376822349e-07
for O 0 3.308662011036745e-09
a O 0 5.537247105280585e-09
Cys282Tyr O 0 6.479398052761098e-06
mutation O 0 5.6955555827187254e-09
in O 0 1.1332902394300959e-09
the O 0 2.6685077259003265e-08
HFE O 0 0.00025645006098784506
gene O 0 3.127302150573996e-08
located O 0 2.4996745651151286e-07
4 O 0 8.532920787729381e-07
. O 0 3.1768809094501194e-07

5 O 0 2.494048203516286e-05
Mb O 0 0.0002042260894086212
telomeric O 0 0.00010329302313039079
to O 0 4.0070247564472083e-07
HLA O 0 0.014429496601223946
- O 0 5.168191637494601e-05
A O 0 5.2891336963512e-06
. O 0 3.5499090245139087e-07

Population O 0 2.4447270874361493e-09
studies O 0 7.019680947628615e-10
of O 0 5.987439988253129e-10
this O 0 1.6622802093135824e-11
polymorphism O 0 4.484504989576976e-10
are O 0 2.2159456561365865e-11
facilitated O 0 1.2448889141758457e-10
by O 0 1.4078719093313374e-11
the O 0 7.093221010556761e-10
fact O 0 3.0955377150476693e-10
that O 0 1.0109685311121552e-10
the O 0 9.614959495252151e-09
Cys282Tyr O 0 8.409414294874296e-05
mutation O 0 1.453175002552598e-07
creates O 0 1.529300561742275e-07
a O 0 3.792121106016566e-08
Rsal O 0 4.418147727847099e-05
restriction O 0 5.327031544766214e-07
site O 0 4.724450661797164e-07
. O 0 2.699706271869218e-07

We O 0 1.4257531688599556e-07
have O 0 9.846290449644357e-10
studied O 0 1.0762436630784578e-07
the O 0 2.3903156787241642e-08
codon O 0 3.7599997426696063e-07
282 O 0 3.4714210528363765e-07
( O 0 7.267465917948357e-08
Cys O 1 1.0
/ O 0 3.345841105328873e-05
Tyr O 0 8.395015174755827e-05
) O 0 5.27147492324076e-10
polymorphism O 0 1.7355850090439162e-10
in O 0 3.080704788493982e-11
different O 0 4.066336503627532e-11
ethnic O 0 8.13874911909096e-10
groups O 0 2.5776572543101395e-10
. O 0 1.412325278948856e-08

In O 0 2.307494462172599e-08
agreement O 0 5.038003436652616e-08
with O 0 6.104926009165013e-10
previous O 0 7.382049194148976e-09
observations O 0 2.7919618617033848e-08
the O 0 1.337749466756577e-08
Tyr O 0 4.638434256776236e-05
allele O 0 7.206204077903067e-09
appeared O 0 1.1763379159646092e-09
to O 0 2.8928637263447854e-10
be O 0 3.055018460429437e-10
rare O 0 2.486652661559674e-09
or O 0 2.495099682420232e-09
absent O 0 1.1099240637690855e-08
in O 0 1.4825021210640443e-09
Asiatic O 0 1.7805194829634274e-06
( O 0 4.3854203601867425e-10
Indian O 0 1.5866565838962288e-09
, O 0 7.237041521612753e-10
Chinese O 0 6.405530328379427e-09
) O 0 2.0904118436249064e-09
populations O 0 1.552583306363431e-08
. O 0 5.411126124954535e-08

The O 0 1.877279487416672e-07
highest O 0 7.527722090117095e-08
allele O 0 2.404728194349559e-09
frequency O 0 3.4016076622123137e-09
( O 0 1.9545144669397274e-10
7 O 0 4.546118592685389e-09
. O 0 1.8298627890711572e-10
5 O 0 3.132207826439526e-09
% O 0 1.2664094772851797e-10
) O 0 1.261862003776315e-10
was O 0 5.03816410812874e-09
found O 0 8.368655768364874e-10
in O 0 3.208106891250395e-09
Swedes O 0 4.730988621304277e-06
. O 0 4.924274890072411e-07

Saamis O 0 0.00016870744002517313
( O 0 7.723876649379235e-09
2 O 0 3.3918844621894095e-08
% O 0 5.370506261925811e-10
) O 0 1.6195089713733068e-10
and O 0 1.2061371901239681e-09
Mordvinians O 0 1.845957058321801e-06
( O 0 1.3353823602457737e-10
1 O 0 2.088132555755351e-09
. O 0 9.314544274774406e-11
8 O 0 2.4459256842135346e-09
% O 0 1.4603443454497267e-10
) O 0 8.230693210320439e-11
had O 0 1.7708834398888484e-10
significantly O 0 1.8982650173970939e-10
lower O 0 7.652430911164743e-10
frequencies O 0 2.2873887228769263e-09
of O 0 1.1331222182775491e-08
the O 0 1.0624337676290452e-07
Tyr O 0 0.00029480078956112266
allele O 0 6.02574516506138e-07
. O 0 3.1423346058545576e-07

Comparisons O 0 3.1282752388506196e-07
with O 0 2.7846531747144354e-09
allele O 0 4.1107122150663145e-09
frequencies O 0 2.4196902259632225e-09
based O 0 4.135001230309854e-10
on O 0 3.5898886086016546e-09
prevalence O 0 2.055191394845224e-08
estimates O 0 2.8776654392714818e-09
of O 0 2.7914506262050054e-08
HH B-Disease 1 1.0
showed O 0 4.3101618274477005e-08
some O 0 1.8341023144685664e-09
disagreements O 0 3.1267393296730006e-07
with O 0 9.951302004651552e-10
the O 0 8.303154608313434e-09
RFLP O 0 8.63470631884411e-07
data O 0 2.792642117555033e-09
, O 0 1.1660910015365289e-09
particularly O 0 6.601228896840894e-09
in O 0 1.5965021304964466e-08
Finns O 0 2.07077700906666e-05
. O 0 6.688376288366271e-07

The O 0 1.1331371752021369e-06
newly O 0 2.7357216367818182e-06
described O 0 4.5119904257262533e-07
HFE O 1 0.9671267867088318
marker O 0 7.759060281387065e-06
provides O 0 4.212571624861994e-09
a O 0 1.4911594181654664e-10
new O 0 9.047824295338458e-11
approach O 0 3.0631988612306316e-10
to O 0 3.801080283860614e-11
the O 0 1.1266579336144389e-10
screening O 0 2.486519656841324e-09
of O 0 1.0868359545668227e-08
HH B-Disease 1 1.0
as O 0 7.848309557800803e-09
well O 0 7.890091358042639e-10
as O 0 1.3382533969874544e-10
studies O 0 2.8288868469950046e-10
of O 0 1.0516143511551945e-09
the O 0 1.0229854741083955e-09
relationship O 0 2.7317764716983106e-10
between O 0 7.702086191052615e-10
the O 0 1.666444404690992e-08
HFE O 0 0.0054307435639202595
Tyr O 0 9.133595449384302e-05
allele O 0 1.5183253765371774e-08
and O 0 3.0566402742238097e-09
different O 0 1.1264205568295438e-08
disorders O 1 0.9999948740005493
including O 0 4.708707820100244e-06
cancer B-Disease 1 1.0

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9986529350280762
associated O 0 2.8498645221475272e-08
with O 0 2.6750142101406027e-09
a O 0 7.540393198723905e-09
missense O 0 2.57892452282249e-07
mutation O 0 1.0661623583985147e-08
encoding O 0 2.4509612117640245e-08
Gly23 O 0 0.00024348319857381284
- O 0 3.360319897183217e-05
- O 0 5.4636930144624785e-06
> O 0 2.2930998966330662e-07
Val O 0 1.675466023698391e-06
in O 0 8.306052734496916e-09
neurophysin O 0 6.84526312397793e-05
II O 1 1.0
. O 0 2.4598489289928693e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.4024890333530493e-06
ADNDI B-Disease 1 1.0
) O 0 4.5116287594737514e-08
is O 0 2.589208625281003e-09
an O 0 4.115913831981288e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 9.824572089200956e-07
by O 0 1.4353563893010346e-09
progressive O 0 0.0005432427860796452
degeneration O 1 1.0
of O 1 0.9979514479637146
the O 0 8.11065092420904e-07
magnocellular O 0 1.1256161087658256e-05
neurons O 0 3.5485271610014024e-08
of O 0 1.2022468354189186e-06
the O 0 3.4972638331964845e-06
hypothalamus O 0 8.505708137818146e-06
leading O 0 1.6692509063886973e-07
to O 0 2.570108126320747e-09
decreased O 0 1.8368970344795343e-08
ability O 0 8.659836181479363e-10
to O 0 8.138702489723926e-10
produce O 0 2.5838472694772463e-08
the O 0 2.6602496205896387e-08
hormone O 0 3.5343293802725384e-07
arginine O 0 7.656583420612151e-07
vasopressin O 0 2.9375930807873374e-06
( O 0 9.261640343538602e-08
AVP O 0 0.015132916159927845
) O 0 7.295617621139172e-08
. O 0 1.803596489935444e-07

Affected O 0 4.4214391436980804e-07
individuals O 0 4.560715693990858e-10
are O 0 3.776185961146261e-11
not O 0 9.033063880226067e-11
symptomatic O 0 2.3521575798213235e-08
at O 0 1.7094801130213e-09
birth O 0 2.4009882970688068e-09
, O 0 3.500759404584386e-10
but O 0 7.267777490937988e-10
usually O 0 1.5325616331551828e-08
develop O 0 8.248847507275059e-07
diabetes B-Disease 1 0.9999676942825317
insipidus I-Disease 0 3.899550574715249e-05
at O 0 3.3632939988592625e-08
1 O 0 1.2494852796862688e-07
- O 0 4.774473723045958e-07
6 O 0 4.968560460838489e-07
yr O 0 1.5130013707675971e-05
of O 0 1.468967525397602e-07
age O 0 2.2760707452107454e-07
. O 0 7.28677278516443e-08

The O 0 9.532389810829045e-08
genetic O 0 2.143515231978199e-08
locus O 0 4.799499819796438e-08
of O 0 9.181572835359475e-09
the O 0 1.2719639563840701e-08
disease O 0 9.444313036510721e-06
is O 0 1.5132045616539358e-09
the O 0 1.3697604828166732e-08
AVP O 1 0.9977800250053406
- O 0 7.855627700337209e-06
neurophysin O 1 0.9997705817222595
II O 1 1.0
( O 0 1.624002088362886e-08
NPII O 1 1.0
) O 0 1.1386072085173282e-09
gene O 0 7.506981702931625e-10
, O 0 2.5778490453376435e-10
and O 0 2.1279409345709155e-09
mutations O 0 4.457780367062014e-09
that O 0 1.215564038314909e-10
cause O 0 1.7508078542505245e-08
ADNDI B-Disease 1 1.0
have O 0 1.9111219551337655e-10
been O 0 4.279428200693047e-11
found O 0 1.458918229280126e-11
in O 0 7.855245967580693e-12
both O 0 7.814632968505819e-11
the O 0 3.761967959370338e-10
signal O 0 1.1486059880994048e-09
peptide O 0 1.0283299767266385e-09
of O 0 1.0406486339320509e-08
the O 0 5.341244602163897e-08
prepro O 0 0.0033293189480900764
- O 0 0.37261444330215454
AVP O 1 0.9999986886978149
- O 0 2.3803211661288515e-05
NPII O 1 0.9999996423721313
precursor O 0 2.671319521141413e-07
and O 0 7.423575087983636e-09
within O 0 1.3209517035761564e-08
NPII O 1 0.9987252354621887
itself O 0 2.0402062261837273e-07
. O 0 1.0543467965362652e-07

An O 0 3.9457326295178063e-08
affected O 0 4.697431421618603e-08
girl O 0 3.249052582532386e-08
who O 0 8.483921343227507e-10
presented O 0 1.298917196024263e-09
at O 0 1.9793509054011338e-09
9 O 0 2.5599660169461913e-09
months O 0 1.6995470308867056e-10
of O 0 5.119121793129011e-10
age O 0 6.874985025717706e-10
and O 0 1.5128082120341446e-10
her O 0 3.028510775493487e-10
similarly O 0 1.7167003929507985e-10
affected O 0 1.070426636218258e-09
younger O 0 1.7421361020453219e-09
brother O 0 4.170527923008649e-09
and O 0 4.610317461128943e-09
father O 0 4.422111121726857e-09
were O 0 8.479504876035548e-10
all O 0 3.2697139440429623e-10
found O 0 3.050981342567205e-11
to O 0 8.213035113113776e-11
have O 0 7.856838790676335e-11
a O 0 1.8902595044778536e-09
novel O 0 1.4296063000074355e-07
missense O 0 3.2491712431692577e-07
mutation O 0 9.416156743213833e-09
( O 0 3.589954999938527e-10
G1758 O 0 8.321229643115657e-07
- O 0 4.353140354851348e-07
- O 0 3.995855308858154e-07
> O 0 3.942324866557101e-08
T O 0 3.852918339930511e-08
) O 0 6.747796765793623e-11
encoding O 0 3.006278559425368e-10
the O 0 5.07329067644946e-10
amino O 0 4.870447378735321e-10
acid O 0 5.149204396204254e-10
substitution O 0 3.400342452053451e-09
Gly23 O 0 9.84647613222478e-06
- O 0 8.217516551667359e-06
- O 0 1.5719142538728192e-05
> O 0 2.399818640697049e-06
Val O 0 5.2258052164688706e-05
within O 0 4.007915208603663e-07
NPII O 1 0.9999750852584839
. O 0 1.1530754591149162e-06

The O 0 1.1152662864333251e-06
mutation O 0 1.0496174951413195e-07
was O 0 2.357048423107244e-08
confirmed O 0 3.5565617118038517e-09
by O 0 6.609263136780896e-10
restriction O 0 8.545823249050954e-08
endonuclease O 0 3.810573844020837e-06
analysis O 0 6.935893992476849e-08
. O 0 3.0152145313877554e-07

A O 0 3.17620906571392e-05
T1 O 0 0.00010936602484434843
- O 0 6.165572017380327e-07
weighted O 0 2.899380149301578e-07
magnetic O 0 1.0804514616324923e-08
resonance O 0 2.8748785574350677e-09
imaging O 0 1.0953105089583914e-07
of O 0 3.666326620077598e-08
the O 0 7.905538979002813e-08
fathers O 0 5.46951355318015e-07
pituitary O 1 0.9997639060020447
gland O 0 0.08102698624134064
demonstrates O 0 5.391078516936432e-08
an O 0 1.6693131321687815e-09
attenuated O 0 7.275215011759428e-06
posterior O 0 2.8953623768757097e-05
pituitary O 1 1.0
bright O 0 0.0002512735081836581
spot O 0 4.61917879874818e-05
. O 0 1.2592565781233134e-06

This O 0 2.0016221569107984e-08
mutation O 0 1.007054972745891e-08
may O 0 1.896354323571714e-10
be O 0 5.065417876815026e-11
valuable O 0 9.331904138321079e-10
for O 0 3.077245749882884e-11
developing O 0 1.9364286563128275e-10
models O 0 5.595466867625021e-10
of O 0 5.085791787706739e-09
dominantly B-Disease 1 0.9993476271629333
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 2.788831166000705e-09
as O 0 1.0773738151614864e-10
the O 0 6.435010857508416e-11
early O 0 7.969385568129539e-11
age O 0 8.782161109444075e-10
of O 0 1.506126778849648e-09
onset O 0 3.977081178163644e-06
of O 0 5.357965164876077e-06
symptoms O 1 0.9999994039535522
suggests O 0 1.2112714165013472e-09
that O 0 1.020881296165399e-11
this O 0 2.4271109427820292e-11
mutation O 0 6.880179759249927e-10
may O 0 7.45101688681693e-11
be O 0 1.2419386352657824e-10
particularly O 0 1.7197587798278846e-09
deleterious O 0 3.0550773999493686e-07
to O 0 8.384109406733842e-09
the O 0 1.1927414789170143e-07
magnocellular O 0 3.26143745041918e-05
neuron O 0 8.115114837892179e-07
. O 0 4.990652158198827e-08
. O 0 4.3722329223783163e-07

Frequent O 0 1.8774278487398988e-06
inactivation O 0 0.00013333022070582956
of O 0 2.2047483071219176e-05
PTEN O 1 1.0
/ O 1 0.9853436350822449
MMAC1 O 1 1.0
in O 0 1.113170426947363e-07
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.931569593391032e-07

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 8.722308120923117e-05
the O 0 5.996519547579737e-08
most O 0 7.747908981059481e-10
common O 0 2.9326430173171047e-09
male B-Disease 0 9.037635084752083e-10
cancer I-Disease 0 8.935393536191327e-10
in O 0 2.726720411960759e-11
the O 0 9.699426817277867e-10
Western O 0 3.887405952696099e-08
world O 0 4.717080615002089e-10
, O 0 4.7494612409604287e-11
yet O 0 4.985478349595063e-11
many O 0 1.2949630083525232e-11
of O 0 2.9528646194876274e-10
the O 0 4.879011084035767e-10
major O 0 1.586001019404648e-08
genetic O 0 6.626635684625626e-09
events O 0 4.678791798440329e-10
involved O 0 1.3490196459908788e-10
in O 0 8.551322150385232e-11
the O 0 8.956671515569781e-10
progression O 0 1.6184916518113823e-08
of O 0 2.241487218057614e-09
this O 0 6.304414212898735e-10
often O 0 1.5919683349352454e-08
fatal O 0 9.375670742883813e-06
cancer B-Disease 0 1.601682379259728e-05
remain O 0 4.776850914822717e-08
to O 0 6.4026717261356225e-09
be O 0 1.590908915716227e-08
elucidated O 0 1.3611626854981296e-05
. O 0 6.546875397361873e-07

Numerous O 0 5.4359597925213166e-06
cytogenetic O 0 0.00013641666737385094
and O 0 1.8639036625245353e-07
allelotype O 0 2.6297029762645252e-05
studies O 0 1.7701895060895367e-08
have O 0 1.7159472454064684e-10
reported O 0 8.866467005042011e-10
frequent O 0 8.139560137010449e-09
loss O 0 5.0095540160555174e-08
of O 0 6.104279748342378e-08
heterozygosity O 0 1.6067509932327084e-05
on O 0 5.190234446672548e-07
chromosomal O 0 7.279044802999124e-05
arm O 0 7.79877882450819e-06
10q O 0 1.9100845747743733e-05
in O 0 2.665420062442081e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0692608611861942e-06

Deletion O 0 1.777185570972506e-05
mapping O 0 2.1080667522710428e-07
studies O 0 2.7275724789888045e-08
have O 0 1.0847769349453529e-09
unambiguously O 0 1.785059424719293e-07
identified O 0 1.4872403308885396e-09
a O 0 8.413195695666786e-10
region O 0 3.323989972159325e-08
of O 0 9.643871834441597e-08
chromosome O 0 2.533367080559401e-07
10q23 O 0 3.0560596542272833e-07
to O 0 5.829718374705806e-10
be O 0 1.4572863749062748e-10
the O 0 7.01960045645933e-10
minimal O 0 4.424694921567607e-08
area O 0 1.538182203830729e-07
of O 0 2.412767514670122e-07
loss O 0 6.909459443704691e-06
. O 0 9.508617040410172e-07

A O 0 2.7238297661824618e-06
new O 0 5.3006186107040776e-08
tumor B-Disease 0 1.2813769899366889e-05
suppressor O 0 1.0469234439369757e-05
gene O 0 1.0024061936064754e-07
, O 0 2.746873661862992e-08
PTEN O 1 1.0
/ O 0 0.06664717942476273
MMAC1 O 1 1.0
, O 0 4.795674612978473e-08
was O 0 1.7029032051141257e-07
isolated O 0 3.0491769109630695e-08
recently O 0 2.305575286243311e-09
at O 0 1.069075938886499e-09
this O 0 5.7438456768643675e-11
region O 0 8.543000085126096e-09
of O 0 1.739586963367401e-08
chromosome O 0 3.91447407821488e-08
10q23 O 0 2.386735218351532e-07
and O 0 5.464785290953955e-10
found O 0 8.966529602139062e-11
to O 0 2.5079415974516017e-11
be O 0 3.361711256588684e-11
inactivated O 0 1.6253471457616797e-08
by O 0 4.6910225703911124e-11
mutation O 0 9.595314542920619e-10
in O 0 4.704591161086569e-10
three O 0 6.834226695673351e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.2079763059300603e-06
lines O 0 4.638478117158229e-07
. O 0 1.251272720992347e-07

We O 0 1.6927621970808104e-07
screened O 0 2.3246823275258066e-06
80 O 0 7.058392839098815e-06
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 6.246009043309186e-09
microsatellite O 0 7.284938874363434e-08
analysis O 0 3.740646126182412e-10
and O 0 3.087671507362444e-10
found O 0 5.426945004494144e-10
chromosome O 0 1.1325647086835033e-08
10q23 O 0 1.6176250028365757e-07
to O 0 1.2449321573626548e-09
be O 0 1.1064423821594005e-09
deleted O 0 2.1405288208597995e-08
in O 0 1.7694257170575156e-09
23 O 0 8.708126841838748e-08
cases O 0 1.1614590178510298e-08
. O 0 6.01308158820757e-08

We O 0 1.8216955766092724e-07
then O 0 2.907490692649617e-09
proceeded O 0 2.482236194367715e-09
with O 0 8.577649875107785e-12
sequence O 0 1.8717522323741242e-11
analysis O 0 1.373151245487314e-11
of O 0 5.548884685069311e-10
the O 0 8.477083035529631e-09
entire O 0 1.3363592188397888e-06
PTEN O 1 0.9999964237213135
/ O 0 2.7608470190898515e-05
MMAC1 O 1 1.0
coding O 0 1.9154050789893518e-07
region O 0 4.277729104273931e-08
and O 0 1.7340241464935957e-09
tested O 0 2.959784639600116e-09
for O 0 3.647302460052515e-10
homozygous O 0 5.562132976422163e-09
deletion O 0 1.2994673115329647e-09
with O 0 3.068594683908188e-11
new O 0 1.0867753363896782e-09
intragenic O 0 5.345922886590415e-07
markers O 0 2.3796753012561567e-08
in O 0 6.73690478403266e-11
these O 0 1.166688967657592e-10
23 O 0 7.245010147372e-10
cases O 0 9.596078098805805e-11
with O 0 1.3374648610842144e-10
10q23 O 0 8.306385097966995e-06
loss O 0 8.945954732553218e-07
of O 0 3.035514055227395e-06
heterozygosity O 0 0.0016147432615980506
. O 0 1.4275750572778634e-06

The O 0 1.595132559373269e-08
identification O 0 4.3096166635336886e-09
of O 0 4.242252327202323e-09
the O 0 6.747867598022594e-09
second O 0 1.3130464715516155e-08
mutational O 0 8.06842820111342e-07
event O 0 3.401296133631604e-09
in O 0 6.5230248980086e-10
10 O 0 5.828453719658455e-09
( O 0 2.85423518153749e-10
43 O 0 1.997968190892152e-08
% O 0 3.0924587335334763e-09
) O 0 1.7373628224959248e-07
tumors B-Disease 1 1.0
establishes O 0 0.017555413767695427
PTEN O 1 1.0
/ O 0 4.615788930095732e-05
MMAC1 O 1 1.0
as O 0 2.7452695672280925e-09
a O 0 2.4218776983886414e-10
main O 0 7.864523254852429e-09
inactivation O 0 9.464343975196243e-08
target O 0 8.53057535721291e-09
of O 0 8.335699241968086e-09
10q O 0 5.297240477375453e-06
loss O 0 2.516758286219556e-07
in O 0 8.554168928753825e-09
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.061529068621894e-08
. O 0 8.0738331575958e-08

Risk O 0 3.18013371725101e-05
reversals O 0 4.696598239206651e-07
in O 0 1.7384815809151632e-09
predictive O 0 1.5370470407560788e-07
testing O 0 2.7289825510479204e-08
for O 0 9.091859709542405e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.952456720275222e-07

The O 0 8.078870905592339e-08
first O 0 2.2810104916004548e-09
predictive O 0 2.5291585714626308e-08
testing O 0 5.153490967302332e-09
for O 0 3.6718672546953712e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.5177425982670911e-09
HD B-Disease 1 1.0
) O 0 3.936962977846292e-10
was O 0 1.2365547474857408e-09
based O 0 2.2333947191643944e-10
on O 0 7.493863307672655e-10
analysis O 0 3.202896281528922e-10
of O 0 1.0493582669468537e-09
linked O 0 1.82679240623429e-08
polymorphic O 0 9.60937072136403e-08
DNA O 0 1.0274933792686625e-08
markers O 0 4.192236779942959e-09
to O 0 3.781000165736792e-11
estimate O 0 1.1461805810020209e-10
the O 0 2.1602587774172122e-10
likelihood O 0 2.040698721117451e-09
of O 0 1.4414092142089885e-08
inheriting O 0 7.000940627222008e-08
the O 0 6.981482947310269e-09
mutation O 0 2.684618305437425e-09
for O 0 4.70244021499866e-09
HD B-Disease 1 0.9991070628166199
. O 0 7.809672979419702e-07

Limits O 0 1.3975009096611757e-06
to O 0 2.1786237258680785e-09
accuracy O 0 1.2863242915273077e-08
included O 0 1.0742554623632827e-09
recombination O 0 7.175966765249342e-11
between O 0 1.155857770607227e-10
the O 0 2.4728499803394755e-10
DNA O 0 1.6376565659115272e-09
markers O 0 7.157998638263052e-09
and O 0 7.497366061315347e-10
the O 0 3.1499955976954652e-09
mutation O 0 1.0111849135796547e-09
, O 0 2.3978749541520017e-10
pedigree O 0 1.9317603516810777e-08
structure O 0 8.059013900663103e-09
, O 0 5.697389227066196e-10
and O 0 3.7865013902127487e-10
whether O 0 1.6240746247841997e-10
DNA O 0 2.7812652181324893e-10
samples O 0 2.8535042384536524e-11
were O 0 8.293850849161455e-12
available O 0 5.4999168414004984e-11
from O 0 1.3293315059836885e-10
family O 0 7.637193655263275e-10
members O 0 8.133922424491402e-10
. O 0 6.862754986514119e-08

With O 0 8.259795514220514e-09
direct O 0 2.9255586841969716e-09
tests O 0 1.7849768885191963e-10
for O 0 6.55792711801162e-11
the O 0 1.8294276094010797e-09
HD B-Disease 1 0.9160016775131226
mutation O 0 2.9229372255912267e-09
, O 0 2.538464161094822e-10
we O 0 1.0687675050524703e-10
have O 0 7.738597089523847e-12
assessed O 0 5.3903770336205525e-09
the O 0 3.520203573081915e-10
accuracy O 0 2.8837918719659683e-09
of O 0 2.8534745677433193e-09
results O 0 2.638870233440116e-10
obtained O 0 1.5225200267199313e-10
by O 0 5.530075009030355e-11
linkage O 0 8.67437233154078e-09
approaches O 0 8.25581025765132e-09
when O 0 1.8417961600292188e-10
requested O 0 7.195145035332473e-10
to O 0 3.9913716776140973e-10
do O 0 8.35548130684316e-10
so O 0 7.542572122432034e-11
by O 0 4.945916939891326e-11
the O 0 1.9464723166606746e-09
test O 0 4.39828928833208e-09
individuals O 0 7.921727718240845e-10
. O 0 5.559727966897299e-08

For O 0 1.580652586596898e-08
six O 0 8.337063261976141e-10
such O 0 9.429087372003764e-11
individuals O 0 5.248935834589741e-12
, O 0 3.074107288170147e-11
there O 0 7.341308116970424e-11
was O 0 1.9134753781457903e-09
significant O 0 4.8785016026897665e-09
disparity O 0 4.30209610158272e-08
between O 0 1.7956044429112694e-09
the O 0 3.068944920414651e-08
tests O 0 3.9203992940883836e-08
. O 0 1.0637842251526308e-07

Three O 0 1.208233584293339e-07
went O 0 3.0145265839109925e-08
from O 0 7.861669093500723e-10
a O 0 3.0511226878360276e-10
decreased O 0 2.0765114072673896e-09
risk O 0 7.457660045062653e-10
to O 0 3.1289148355595486e-11
an O 0 1.5764349894920038e-11
increased O 0 1.398033355748396e-10
risk O 0 2.7938462654475416e-09
, O 0 8.470060763876575e-11
while O 0 7.515230798782468e-11
in O 0 7.527409945362606e-11
another O 0 5.310550332815467e-10
three O 0 2.5916729873287636e-10
the O 0 2.3128339243783103e-09
risk O 0 4.908605077957873e-08
was O 0 1.0597520372357394e-07
decreased O 0 7.93794640685519e-07
. O 0 2.45655712660664e-07

Knowledge O 0 1.9012641416793485e-07
of O 0 2.7017611259338992e-08
the O 0 5.149629611622686e-09
potential O 0 3.668556125546729e-09
reasons O 0 1.07569264606866e-09
for O 0 5.298669836228953e-11
these O 0 5.2713822890071427e-11
changes O 0 1.517692638230983e-10
in O 0 2.830499203076986e-11
results O 0 3.321291505709034e-11
and O 0 8.174776133795802e-11
impact O 0 8.841646526036584e-09
of O 0 1.7025653109570271e-09
these O 0 2.63164240399405e-10
risk O 0 1.8976433757700306e-09
reversals O 0 2.5904285383404613e-09
on O 0 2.3461925735546174e-09
both O 0 4.924523011595738e-10
patients O 0 4.3493175727604694e-10
and O 0 2.540159471653425e-10
the O 0 1.4743498644165243e-09
counseling O 0 2.1748941536614552e-10
team O 0 5.260414326357932e-11
can O 0 1.0802622685268659e-11
assist O 0 3.051408015153356e-10
in O 0 5.1051173705074504e-11
the O 0 4.861148150681061e-10
development O 0 2.742876481498513e-10
of O 0 7.251397260432668e-10
strategies O 0 8.791664063423354e-10
for O 0 1.8316043126631598e-11
the O 0 3.8501871829632606e-11
prevention O 0 7.136786273065354e-09
and O 0 1.6744623743125686e-10
, O 0 5.0754275782161073e-11
where O 0 1.166829133314451e-10
necessary O 0 8.84650019905564e-10
, O 0 1.1097006646920704e-10
management O 0 2.4239583673590914e-09
of O 0 6.4604006588808716e-09
a O 0 3.1213058804269167e-09
risk O 0 3.86447354117081e-08
reversal O 0 3.5378608931324607e-09
in O 0 2.1902638036586097e-10
any O 0 2.16535034347487e-09
predictive O 0 8.408627572009664e-09
testing O 0 2.4971089640501987e-09
program O 0 7.325338113872704e-10
. O 0 9.570055858887372e-10
. O 0 2.873586169016562e-08

A O 0 5.147627234691754e-06
novel O 0 1.6178547639356111e-06
common O 0 1.7086276216105034e-07
missense O 0 6.891539783282497e-07
mutation O 0 2.9041890670100656e-08
G301C O 0 3.2224014034909487e-07
in O 0 7.730786011350688e-10
the O 0 6.937876051438252e-09
N O 0 7.64826495469606e-08
- O 0 6.275662656207714e-08
acetylgalactosamine O 0 3.413911372263101e-06
- O 0 5.204827289162495e-07
6 O 0 5.537872880267969e-07
- O 0 8.36176866414462e-07
sulfate O 0 1.3839991197528434e-06
sulfatase O 0 1.9340524886501953e-05
gene O 0 1.4152186089688712e-08
in O 0 5.331877162007004e-09
mucopolysaccharidosis B-Disease 1 0.7572516798973083
IVA I-Disease 1 1.0
. O 0 1.221340244228486e-05

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 1 0.9621047973632812
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.094789977036271e-07
is O 0 4.059195646277658e-09
an O 0 4.513907914116544e-09
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 7.363110654523553e-08
by O 0 2.251293595989523e-10
a O 0 6.755040526940093e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.900254842368554e-09
N O 0 7.873727270180098e-08
- O 0 4.7973212957685973e-08
acetylgalactosamine O 0 6.881741228426108e-06
- O 0 8.095018415588129e-07
6 O 0 1.1024793593605864e-06
- O 0 3.3837961836979957e-06
sulfate O 0 3.1744355055707274e-06
sulfatase O 0 0.00018028753402177244
( O 0 5.7851594625901726e-09
GALNS O 1 0.9999994039535522
) O 0 2.275405996954305e-08
. O 0 1.0076451673057818e-07

In O 0 4.794010166619955e-08
previous O 0 2.0505515507807104e-08
studies O 0 1.3487345684737306e-09
, O 0 2.3513613278680623e-10
we O 0 8.474650148304619e-11
have O 0 9.968199009280365e-12
found O 0 2.9019587080569842e-11
two O 0 2.1976526501377158e-11
common O 0 1.2590732623163348e-10
mutations O 0 5.416879791941831e-11
in O 0 4.953497681481345e-11
Caucasians O 0 1.0942743600139693e-08
and O 0 8.324335110110326e-10
Japanese O 0 6.548011555196354e-08
, O 0 2.771068263740517e-09
respectively O 0 2.0914578513497872e-08
. O 0 1.9324059508107894e-07

To O 0 2.860446670638339e-07
characterize O 0 1.4894660580466734e-06
the O 0 1.398515223627328e-07
mutational O 0 4.178446943114977e-06
spectrum O 0 8.033418907871237e-08
in O 0 4.125429442503048e-10
various O 0 9.68973679071894e-10
ethnic O 0 9.90273640866235e-10
groups O 0 3.029924922071103e-11
, O 0 6.469667163111481e-11
mutations O 0 1.4308373930127516e-10
in O 0 8.947361601618908e-11
the O 0 9.590397809233764e-09
GALNS O 1 0.9858158826828003
gene O 0 2.953215227918804e-09
in O 0 4.699631239724056e-10
Colombian O 0 4.3623140300042e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.3934803746451507e-06
were O 0 8.370236170840428e-10
investigated O 0 6.951254238884985e-09
, O 0 2.34569946799823e-10
and O 0 7.470900564854333e-10
genetic O 0 4.659860053379816e-09
backgrounds O 0 1.6622525578213754e-10
were O 0 4.629583869042442e-11
extensively O 0 5.803823532879449e-10
analyzed O 0 5.210816222955827e-10
to O 0 6.407870067892674e-11
identify O 0 1.711812080973374e-10
racial O 0 5.179701667579195e-10
origin O 0 2.958630215821323e-11
, O 0 1.7287123121878523e-11
based O 0 7.633344650814777e-11
on O 0 2.0245323195666742e-09
mitochondrial O 0 4.917533047432698e-09
DNA O 0 1.7616276437593115e-08
( O 0 1.0334935129918676e-09
mtDNA O 0 1.0423411467286314e-08
) O 0 3.247725421928749e-09
lineages O 0 2.6576582712323216e-08
. O 0 4.998577907144863e-08

Three O 0 3.94885006471668e-07
novel O 0 1.2860884908150183e-06
missense O 0 1.4878362435410963e-06
mutations O 0 2.9537970291926285e-08
never O 0 1.1643535913208325e-08
identified O 0 3.148330207647376e-10
previously O 0 6.618876002839613e-10
in O 0 9.581117843548981e-11
other O 0 2.2172995384206473e-10
populations O 0 2.260674009102459e-10
and O 0 6.864839946496559e-11
found O 0 4.870983824623032e-11
in O 0 5.851259754496851e-11
16 O 0 1.1005993894031008e-09
out O 0 1.3508451301991187e-10
of O 0 8.853116573170894e-10
19 O 0 1.2511505609325013e-08
Colombian O 0 2.4185570168810955e-07
MPS B-Disease 1 0.9999996423721313
IVA I-Disease 1 1.0
unrelated O 0 4.007588813692564e-06
alleles O 0 4.751613325026938e-09
account O 0 3.7199701652390615e-10
for O 0 6.673665509104865e-10
84 O 0 4.801386239705607e-07
. O 0 2.0001382949885738e-07

2 O 0 1.7068653335172712e-07
% O 0 1.690047435332076e-09
of O 0 1.91245375091853e-09
the O 0 2.8378539518314483e-09
alleles O 0 3.7382494322280024e-10
in O 0 2.2120952292148388e-10
this O 0 8.918333294083425e-10
study O 0 7.491352427280162e-09
. O 0 5.6703029827076534e-08

The O 0 1.074893361874274e-06
G301C O 0 1.1503841960802674e-05
and O 0 5.8775771805130717e-08
S162F O 0 6.409598881873535e-06
mutations O 0 2.471414539684247e-08
account O 0 2.384149100365107e-09
for O 0 7.692781522905534e-09
68 O 0 1.1046105328205158e-06
. O 0 3.9565250631312665e-07

4 O 0 1.6033337715271045e-06
% O 0 1.947981154160061e-08
and O 0 1.6482051279353982e-08
10 O 0 1.58468012045887e-07
. O 0 3.2171504926736816e-07

5 O 0 9.333051309567963e-08
% O 0 1.7903650784134584e-09
of O 0 2.268324417187273e-09
mutations O 0 1.1746428274506115e-09
, O 0 3.495461697866631e-10
respectively O 0 1.227034807094185e-09
, O 0 4.2711209569112896e-10
whereas O 0 7.986889483113657e-10
the O 0 2.642548402320699e-09
remaining O 0 9.183800386836083e-08
F69V O 1 0.9999759197235107
is O 0 1.4694565564354889e-09
limited O 0 7.592140249812473e-10
to O 0 7.525676748443288e-10
a O 0 2.5197970376922285e-09
single O 0 1.095909851756005e-08
allele O 0 5.6757350819225394e-08
. O 0 1.7506918936760485e-07

The O 0 1.5511423612224462e-07
skewed O 0 7.243828292757826e-08
prevalence O 0 1.1342535088942896e-07
of O 0 1.9640983950353075e-08
G301C O 0 9.800652378544328e-07
in O 0 5.328671948134911e-10
only O 0 3.8069519758821e-10
Colombian O 0 1.8927064360241275e-08
patients O 0 1.0709145792375807e-09
and O 0 2.666464826717174e-10
haplotype O 0 1.3398426812472053e-09
analysis O 0 6.455836559782213e-11
by O 0 1.7294443654947145e-11
restriction O 0 2.0167663095094213e-09
fragment O 0 2.5594828478858744e-09
length O 0 1.9610129076141902e-09
polymorphisms O 0 1.2745594579754993e-09
in O 0 6.242563688196867e-10
the O 0 2.168335555552403e-08
GALNS O 1 0.9999780654907227
gene O 0 1.1185396608937026e-08
suggest O 0 2.7519748702076186e-09
that O 0 2.6716778789293016e-10
G301C O 0 4.3706026531253883e-07
originated O 0 1.2140307648067505e-09
from O 0 6.504562444220596e-10
a O 0 1.1710278302601296e-09
common O 0 1.2889129763493656e-08
ancestor O 0 6.84510652604331e-08
. O 0 1.5207373849079886e-07

Investigation O 0 1.5253010587912286e-07
of O 0 5.203610697890326e-08
the O 0 3.877710152977443e-09
genetic O 0 2.5065762798703872e-09
background O 0 3.036417228763355e-10
by O 0 5.2444149717389976e-11
means O 0 4.583513568690023e-09
of O 0 1.3023016443014512e-08
mtDNA O 0 2.3590800424244662e-09
lineages O 0 2.9826899283769137e-10
indicate O 0 7.718685413049542e-11
that O 0 1.993868785354902e-11
all O 0 2.264817222652482e-10
our O 0 4.670125952621618e-10
patients O 0 6.91722998324984e-11
are O 0 7.111609478388514e-12
probably O 0 2.0284852964014277e-10
of O 0 3.817577365339275e-09
native O 0 8.44374810071713e-08
American O 0 2.4756846528362075e-07
descent O 0 1.556552660986199e-06

Low O 0 2.1156597540539224e-07
frequency O 0 2.105675278585295e-08
of O 0 9.004640588727852e-08
BRCA1 O 0 3.20272306453262e-07
germline O 0 5.658278467990385e-08
mutations O 0 6.934274265901763e-10
in O 0 1.1354618634218383e-10
45 O 0 8.05188538066659e-09
German O 1 1.0
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.2088502421292446e-09
. O 0 6.255809648081367e-09

In O 0 2.5744515852466066e-08
this O 0 5.411595060955676e-10
study O 0 1.1287082379851654e-09
we O 0 1.9027381059633086e-10
investigated O 0 2.3419988171013983e-09
45 O 0 7.51715933944297e-09
German O 1 0.9975963234901428
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.9277418203400565e-11
for O 0 4.763850425248961e-11
germline O 0 3.184617014539981e-09
mutations O 0 9.810217915795505e-11
in O 0 6.396915636086575e-11
the O 0 8.029830134148597e-09
BRCA1 O 0 3.8347440067809657e-07
gene O 0 2.1095184266073375e-08
. O 0 6.714964229104226e-08

We O 0 7.742937668808736e-08
identified O 0 1.242589053873644e-08
four O 0 4.221226035383552e-09
germline O 0 3.35299468190442e-08
mutations O 0 3.5004541487637653e-09
in O 0 3.9549660768578576e-10
three O 0 1.3465780712706987e-09
breast B-Disease 0 1.5021046237961855e-06
cancer I-Disease 0 1.9701841935670927e-08
families O 0 2.453631698859371e-12
and O 0 1.956430677185761e-11
in O 0 1.0362209007519496e-10
one O 0 2.9558822944864005e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.56058291289618e-10
. O 0 4.641703688079701e-12
among O 0 1.6798731459696792e-12
these O 0 9.520996838152662e-12
were O 0 6.761504550700792e-11
one O 0 5.044354378647142e-10
frameshift O 0 1.0758619595208074e-07
mutation O 0 5.287488669125651e-09
, O 0 6.561207688271509e-10
one O 0 1.4566119421743906e-09
nonsense O 0 6.243486438961554e-08
mutation O 0 2.513599772768771e-09
, O 0 4.812584775137907e-10
one O 0 8.7699081330328e-10
novel O 0 3.4476784094295e-08
splice O 0 9.610415929728333e-08
site O 0 6.259342377745725e-09
mutation O 0 1.6801481317330058e-09
, O 0 5.805550484794253e-10
and O 0 3.854959906846034e-09
one O 0 3.581833496468789e-08
missense O 0 3.965518317272654e-06
mutation O 0 3.084043669332459e-07
. O 0 1.9417534247168078e-07

The O 0 3.4692109238676494e-06
missense O 0 5.047014383308124e-06
mutation O 0 1.0057596711021688e-07
was O 0 3.463721753860227e-08
also O 0 3.5071436865763417e-09
found O 0 9.881566676028797e-10
in O 0 1.8487412711820639e-09
2 O 0 7.826933483556786e-07
. O 0 2.4100839368657034e-07

8 O 0 1.268965803546962e-07
% O 0 1.9372350390511883e-09
of O 0 3.1744831208158075e-09
the O 0 1.4885174204337659e-09
general O 0 5.901700794730402e-10
population O 0 1.2438634844347263e-10
, O 0 1.234678193018368e-10
suggesting O 0 3.367578715884889e-10
that O 0 4.793052066354164e-11
it O 0 3.5355521288416014e-10
is O 0 7.660418965826921e-10
not O 0 1.5080412474333116e-09
disease O 0 8.384976268871469e-08
associated O 0 1.1662076815355249e-07
. O 0 1.030297653414891e-06

The O 0 7.32746912035509e-08
average O 0 6.2177201165525275e-09
age O 0 9.253602328840316e-09
of O 0 4.584152168973787e-09
disease O 0 6.238867626962019e-07
onset O 0 5.166386429777958e-08
in O 0 2.4525534381147907e-10
those O 0 4.704232003938102e-10
families O 0 4.2240246023173e-11
harbouring O 0 9.267683509506242e-08
causative O 0 2.5227106448255654e-07
mutations O 0 1.752986555914049e-08
was O 0 1.532637661227909e-08
between O 0 1.519997283594421e-08
32 O 0 1.0070781399917905e-06
. O 0 2.2967812185470393e-07

3 O 0 4.0202480704465415e-06
and O 0 3.1431588354280393e-07
37 O 0 1.9132082798023475e-06
. O 0 4.6033954959057155e-07

4 O 0 5.000561600354558e-07
years O 0 4.519972840455466e-09
, O 0 6.008089026288133e-10
whereas O 0 7.110206312610501e-10
the O 0 1.5061066838129022e-09
family O 0 2.561323819705308e-09
harbouring O 0 5.336117396836926e-07
the O 0 3.60374841079647e-08
missense O 0 3.382626800885191e-07
mutation O 0 1.2101891044835611e-08
had O 0 1.5445573708916527e-09
an O 0 8.037208398814499e-11
average O 0 1.6131028457433416e-10
age O 0 9.904739250998773e-10
of O 0 5.910828715371963e-09
onset O 0 5.067619213150465e-07
of O 0 3.324518274894217e-06
51 O 0 1.021600382955512e-05
. O 0 3.763895790598326e-07

2 O 0 1.6203923223656602e-05
years O 0 5.85239547490346e-07
. O 0 1.1047253565266146e-06

These O 0 4.854148372146483e-08
findings O 0 6.286322573600955e-09
show O 0 3.444153851006604e-09
that O 0 8.8653168139885e-10
BRCA1 O 0 2.7536151492313365e-07
is O 0 1.4079404309086385e-09
implicated O 0 6.527782758780631e-09
in O 0 2.992610881324964e-10
a O 0 3.2235439317851444e-10
small O 0 9.529600442093056e-10
fraction O 0 3.6412919346417993e-09
of O 0 3.2108181358125876e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.8630047157741636e-11
suggesting O 0 4.0171692361479217e-11
the O 0 5.7993502361464166e-11
involvement O 0 3.2717975551044276e-10
of O 0 1.9325481215304308e-09
another O 0 1.388435588722814e-09
susceptibility O 0 1.9836213027701888e-07
gene O 0 7.903066290282368e-08
( O 0 1.6819477366425417e-08
s O 0 1.742411541272304e-06
) O 0 6.698589345432993e-07

Paternal O 0 0.0011477628722786903
transmission O 1 0.9999587535858154
of O 1 0.9999978542327881
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0003750154282897711

We O 0 1.092177086547963e-07
report O 0 6.798276164232675e-09
a O 0 1.1167697877567662e-09
rare O 0 2.278623068008301e-09
case O 0 1.8457041450758993e-09
of O 0 3.874496101730074e-08
paternally O 1 0.9999982118606567
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.00035286255297251046
DM B-Disease 1 1.0
) O 0 6.126441576270736e-08
. O 0 1.0599279676171136e-07

The O 0 5.364921094042074e-07
proband O 0 2.0394452803884633e-05
is O 0 3.495550293663996e-09
a O 0 4.684488907891193e-10
23 O 0 3.762422373654317e-09
year O 0 1.394991344660923e-10
old O 0 5.114900858416149e-08
, O 0 1.397418802895345e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 3.004017798957648e-07
who O 0 5.475829567558321e-08
suffers O 1 0.9999964237213135
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 0.0002296748134540394

He O 0 1.9921846217130224e-07
presented O 0 6.379988093385691e-08
with O 0 8.256471950573996e-09
respiratory O 1 0.9999991655349731
and O 0 3.078154620084206e-08
feeding O 0 3.970377292716876e-06
difficulties O 0 1.185357632493833e-06
at O 0 1.3723290237521724e-07
birth O 0 3.194904252268316e-07
. O 0 2.0632241160001286e-07

His O 0 4.599358817358734e-06
two O 0 6.165430477267364e-07
sibs O 1 0.6002762913703918
suffer O 0 9.331500336884346e-07
from O 0 4.2390187360297205e-08
childhood O 0 0.0005384852411225438
onset O 1 0.9999997615814209
DM B-Disease 1 1.0
. O 0 5.79279230805696e-06

Their O 0 2.953013833462137e-08
late O 0 1.4298784378752316e-08
father O 0 1.0607487332947585e-08
had O 0 1.0897726054892587e-09
the O 0 3.0026509056924056e-10
adult O 0 1.1100695918031533e-09
type O 0 2.6107955797272098e-09
of O 0 7.089602149790153e-08
DM B-Disease 1 1.0
, O 0 1.3471360915673358e-08
with O 0 2.5350299637239004e-09
onset O 0 2.0154616322543006e-06
around O 0 2.5576248674497037e-08
30 O 0 4.831554889506151e-08
years O 0 1.614612799016868e-08
. O 0 1.0931211846809674e-07

Only O 0 1.356581069700269e-08
six O 0 6.517826278695793e-10
other O 0 3.066114376282236e-11
cases O 0 4.5017798516733265e-11
of O 0 5.868139307807496e-10
paternal O 0 5.023500193601649e-07
transmission O 1 0.9999701976776123
of O 1 1.0
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 2.476033955645107e-07
been O 0 3.598471298715822e-09
reported O 0 4.872493963858915e-09
recently O 0 4.586996737998561e-08
. O 0 1.380452943067212e-07

We O 0 5.793355839500691e-08
review O 0 1.5434654443424733e-08
the O 0 1.5457185531531081e-09
sex O 0 1.5097095795724158e-10
related O 0 6.626973969581229e-10
effects O 0 1.502294466604326e-08
on O 0 9.924826294138711e-09
transmission O 0 2.8461001875257352e-06
of O 0 5.655383210978471e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.873105065897107e-05

Decreased O 0 5.219378635956673e-06
fertility O 0 1.7956195108581596e-07
of O 0 5.280776704807977e-09
males O 0 3.344509114100447e-10
with O 0 6.518991596538015e-11
adult O 0 3.713947549499608e-08
onset O 0 2.624440185172716e-06
DM B-Disease 1 1.0
and O 0 5.2813938111739844e-08
contraction O 0 1.2937947602154054e-08
of O 0 1.4380227009169744e-09
the O 0 9.47177558607848e-10
repeat O 0 4.096654571128511e-09
upon O 0 5.141765346827754e-10
male O 0 3.2488509105199626e-10
transmission O 0 1.5205176007171417e-10
contribute O 0 7.15870071554825e-11
to O 0 8.40775296606644e-11
the O 0 8.449443367197773e-10
almost O 0 5.952369153128245e-10
absent O 0 2.788735242731377e-09
occurrence O 0 2.5048034757446658e-09
of O 0 2.1943626915543746e-09
paternal O 0 2.4399957965215435e-07
transmission O 0 7.445305072906194e-06
of O 0 4.164814527030103e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.1385661309759598e-05

Also O 0 5.652669088362927e-08
the O 0 8.855232103144317e-09
fathers O 0 7.463612838876088e-09
of O 0 5.481469944612627e-09
the O 0 4.164772082759782e-09
reported O 0 5.075161624290558e-09
congenitally O 0 1.8725162931332306e-07
affected O 0 2.9331352902062235e-09
children O 0 2.77164818873743e-10
showed O 0 2.830057854730228e-10
, O 0 1.0466292416078105e-10
on O 0 1.6600164576274778e-09
average O 0 1.0005868356088854e-09
, O 0 1.2319735231969275e-09
shorter O 0 3.8061540408307337e-07
CTG O 0 0.0006693564355373383
repeat O 0 1.3569282941716665e-07
lengths O 0 9.418963031748717e-08
and O 0 3.769123235741745e-09
hence O 0 1.3197453796465197e-08
less O 0 2.512995811443375e-09
severe O 0 2.899944604450866e-07
clinical O 0 3.4935635540023213e-06
symptoms O 0 5.705257066779268e-08
than O 0 1.0656057633506855e-11
the O 0 5.117635135110099e-11
mothers O 0 4.617933813122477e-11
of O 0 1.2316439534920676e-10
children O 0 4.5711051610553e-10
with O 0 1.9426419584078758e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.3887344721297268e-05

We O 0 1.1419423628922232e-07
conclude O 0 1.5831659538889653e-08
that O 0 7.849573768758944e-11
paternal O 0 1.1705208891044094e-07
transmission O 0 1.118848922487814e-05
of O 1 0.7487481236457825
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 4.2627996776900545e-07
rare O 0 4.552609400576557e-09
and O 0 9.339738982205859e-10
preferentially O 0 1.872389798762697e-09
occurs O 0 4.828857452787716e-11
with O 0 2.4456804637029705e-11
onset O 0 4.352176574684563e-08
of O 0 2.360625899200386e-07
DM B-Disease 1 1.0
past O 0 1.1594828919214706e-07
30 O 0 3.1149065549129773e-09
years O 0 5.85514553508304e-11
in O 0 3.049335089988503e-11
the O 0 8.616652391602031e-10
father O 0 6.365144411546453e-09
. O 0 7.444844740689405e-09
. O 0 1.693895796961442e-07

The O 0 4.820444701181259e-06
RB1 O 0 0.004981097299605608
gene O 0 6.51334559620409e-08
mutation O 0 5.636968225530836e-09
in O 0 3.541701099063488e-10
a O 0 4.318486901411234e-09
child O 0 1.1377637321174916e-07
with O 0 2.137130934443121e-07
ectopic B-Disease 1 0.9938701391220093
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 8.103012078208849e-06

The O 0 3.92295351048233e-06
RB1 O 1 0.9990273714065552
gene O 0 2.307213406993469e-07
mutation O 0 3.056041464333248e-08
was O 0 8.582048849348212e-09
investigated O 0 7.109695054907661e-09
in O 0 8.935837070289665e-10
a O 0 7.935342161147219e-09
child O 0 1.8907117294020281e-07
with O 0 9.512737619843392e-08
ectopic B-Disease 0 0.0016811416717246175
intracranial I-Disease 1 0.999935507774353
retinoblastoma I-Disease 0 2.71515418717172e-05
using O 0 1.8852186478568456e-09
DNA O 0 1.1571841262991711e-09
obtained O 0 5.115410178779811e-11
from O 0 4.6003426762419863e-11
both O 0 3.0878186119132067e-10
the O 0 3.820957328315444e-09
pineal B-Disease 0 5.535864329431206e-05
and I-Disease 0 1.3160232015252404e-07
retinal I-Disease 1 0.9999991655349731
tumours I-Disease 1 1.0
of O 1 0.9999805688858032
the O 0 6.08616619501845e-06
patient O 0 8.416155310442264e-07
. O 0 6.011131858940644e-08

A O 0 6.229715381778078e-06
nonsense O 0 1.9062764522459474e-06
mutation O 0 1.6479914322076183e-08
in O 0 3.7669027896924945e-09
exon O 0 6.517446990983444e-07
17 O 0 8.385488570183952e-08
( O 0 9.47864342570881e-10
codon O 0 1.1332042859635294e-08
556 O 0 3.231585443685958e-09
) O 0 9.564905117942502e-11
of O 0 2.503217633176291e-09
the O 0 1.7404000018927945e-08
RB1 O 1 0.8705296516418457
gene O 0 2.641349139409499e-09
was O 0 1.7478575253804252e-09
found O 0 2.902700475815312e-11
to O 0 4.706213196925546e-11
be O 0 5.081723930544513e-11
present O 0 1.5192681834808042e-10
homozygously O 0 1.7024956378008937e-07
in O 0 6.239028738086461e-10
both O 0 3.3488640749368415e-09
the O 0 1.2419279826758611e-08
retinal B-Disease 0 1.1221681006645667e-06
and I-Disease 0 1.3328904913123552e-07
the I-Disease 0 2.3588891053805128e-06
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 1.67721609614091e-05

The O 0 1.1151935552788927e-07
same O 0 1.902358048866404e-09
mutation O 0 1.9190895539367148e-09
was O 0 2.2307136138266515e-09
present O 0 8.569727150131712e-10
heterozygously O 0 1.441057975171134e-07
in O 0 2.7675700620122257e-10
the O 0 6.561746146438452e-10
DNA O 0 3.2412195150044454e-10
from O 0 3.3878320288005526e-11
the O 0 6.227923732282648e-10
constitutional O 0 9.079070828477143e-09
cells O 0 8.109318772042684e-11
of O 0 1.5202631375998976e-09
the O 0 2.1341313161116204e-09
patient O 0 2.996182191239427e-09
, O 0 1.639793578700477e-10
proving O 0 8.336129120323221e-09
it O 0 8.35460103876251e-11
to O 0 1.4595201436318206e-10
be O 0 6.838392629937573e-10
of O 0 1.3819316357910338e-08
germline O 0 2.3895594836176315e-07
origin O 0 6.1408638174498265e-09
. O 0 4.245978146855123e-08

The O 0 1.2687128503330314e-07
initial O 0 1.9855152189052205e-08
mutation O 0 5.339245490176836e-09
was O 0 2.1508037573170213e-09
shown O 0 3.0775584858311333e-10
to O 0 4.798707542441605e-10
have O 0 7.88043102994962e-11
occurred O 0 2.718148761626793e-10
in O 0 2.1924623228031237e-10
the O 0 1.659646997609343e-08
paternally O 0 1.0655727464836673e-06
derived O 0 1.421579582938648e-07
RB1 O 0 0.0004511308507062495
allele O 0 7.248374913615407e-07
. O 0 3.115740696557623e-07

The O 0 1.950149055574002e-07
mutation O 0 5.407574388271996e-09
is O 0 2.2128505972052182e-10
in O 0 4.184906587934023e-11
an O 0 3.199567000233827e-11
area O 0 5.035397432351374e-09
of O 0 6.037362165756122e-09
the O 0 3.707434137467658e-09
gene O 0 4.0988409888420563e-10
that O 0 7.346798863716586e-11
encodes O 0 4.859739277662811e-10
the O 0 5.041084216728109e-10
protein O 0 4.757542138023041e-10
- O 0 3.1578459847025897e-09
binding O 0 5.24407051116782e-09
region O 0 9.763579278398993e-09
known O 0 1.8320533978766207e-09
as O 0 2.775690233214334e-10
the O 0 1.8361885345541396e-09
pocket O 1 0.9999997615814209
region O 0 4.314666148275137e-05
and O 0 1.2982719965748402e-07
has O 0 9.658042365856545e-09
been O 0 6.3882255041392e-10
detected O 0 2.089471262678444e-09
in O 0 8.713663818271655e-11
other O 0 4.271903109032138e-10
cases O 0 1.0698000263431595e-09
of O 0 7.172827221069156e-09
retinoblastoma B-Disease 0 9.515914825897198e-06
. O 0 4.690707910981473e-08
. O 0 3.390811684766959e-07

Low O 0 4.0950365587377746e-07
levels O 0 1.6631801713629102e-08
of O 0 1.0981340281546181e-08
beta O 0 1.6673132563482795e-07
hexosaminidase O 0 9.515198144072201e-06
A O 0 8.321136135691631e-08
in O 0 1.440671915098335e-09
healthy O 0 1.2602494159352773e-08
individuals O 0 2.631038789613349e-11
with O 0 1.8540619040052775e-10
apparent O 0 1.2560288098484307e-07
deficiency O 0 7.936695328680798e-05
of O 0 1.8085206647810992e-06
this O 0 6.713475997344176e-09
enzyme O 0 7.720139194589137e-08
. O 0 4.2836568070470094e-08

Appreciable O 0 5.704091745428741e-05
beta O 0 3.4894151212938596e-06
hexosaminidase O 0 7.695704698562622e-05
A O 0 2.105247403960675e-06
( O 0 1.6920415291110658e-08
hex O 0 6.781343836337328e-05
A O 0 3.772139507418615e-07
) O 0 9.145545987188086e-10
activity O 0 1.6626909848937999e-09
has O 0 3.776043921988048e-10
been O 0 1.8279058822123773e-10
detected O 0 1.699376084296489e-09
in O 0 3.809522974851376e-10
cultured O 0 1.2992499520692036e-08
skin O 0 1.3800635088045965e-06
fibroblasts O 0 1.5361672822677974e-08
and O 0 7.222898545933276e-08
melanoma B-Disease 1 1.0
tissue O 0 9.014588613354135e-06
from O 0 2.850798042075553e-09
healthy O 0 1.013852468645382e-08
individuals O 0 2.175240673349399e-12
previously O 0 9.416991492150473e-11
reported O 0 6.643992994659342e-11
as O 0 2.6170063338604166e-10
having O 0 9.98166527210742e-09
deficiency B-Disease 0 1.3065659913991112e-05
of I-Disease 0 7.996780368557665e-06
hex I-Disease 1 0.9999953508377075
A I-Disease 0 2.81473006680244e-07
activity O 0 1.925116510648195e-09
indistinguishable O 0 3.9850731048396426e-10
from O 0 3.474559615718187e-12
that O 0 1.5170918991544435e-12
of O 0 8.49987094597715e-11
patients O 0 5.3332244870363255e-11
with O 0 6.52653431298944e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.590897238036632e-08
TSD B-Disease 1 1.0
) O 0 3.293345329780095e-08
. O 0 1.4406305126613006e-07

Identification O 0 1.149974906411444e-07
and O 0 2.852017999543932e-08
quantitation O 0 6.904729616508121e-06
of O 0 2.1155760805413593e-06
hex O 0 0.0061330352909862995
A O 0 1.3548985862144036e-06
, O 0 5.874066122402155e-09
amounting O 0 6.178897393738225e-08
to O 0 6.626572623957827e-09
3 O 0 8.470894954371033e-07
. O 0 4.0582696669844154e-07

5 O 0 1.3572548596130218e-06
% O 0 4.4903984530719754e-08
- O 0 6.146913733573456e-07
6 O 0 1.1529083394634654e-06
. O 0 3.2169512564905745e-07

9 O 0 2.219871078068536e-07
% O 0 2.183811576017547e-09
of O 0 5.510906397887538e-09
total O 0 2.8278630548328465e-09
beta O 0 6.211831049540706e-08
hexosaminidase O 0 8.863505058798182e-07
activity O 0 1.2470663390828918e-09
, O 0 2.9643143495405866e-10
has O 0 1.4028733730242493e-10
been O 0 1.3026431322504806e-10
obtained O 0 8.914247118241292e-11
by O 0 1.2311414387955466e-10
cellulose O 0 1.0820702982528019e-06
acetate O 0 8.96864378319151e-07
gel O 0 4.76893092127284e-07
electrophoresis O 0 3.2926102733199514e-08
, O 0 1.339464539285018e-09
DEAE O 0 0.00010410248796688393
- O 0 4.315672796906256e-08
cellulose O 0 2.3123502046473732e-07
ion O 0 5.700013616660726e-07
- O 0 4.103633273189189e-07
exchange O 0 1.3099247908598954e-08
chromatography O 0 2.2787899922604993e-07
, O 0 8.479213997603097e-10
radial O 0 1.6555247839278309e-07
immunodiffusion O 0 1.655728510741028e-06
, O 0 3.3688267730980215e-09
and O 0 1.907875102347134e-08
radioimmunoassay O 0 6.844348536105826e-05
. O 0 7.088066809046722e-07

Previous O 0 5.9778594732051715e-06
family O 0 1.6348764120266424e-08
studies O 0 3.2550682149690147e-09
suggested O 0 1.1837766322742027e-09
that O 0 3.401597406527124e-11
these O 0 2.1123951199353286e-10
individuals O 0 1.7484793127242604e-11
may O 0 1.2733365750694503e-10
be O 0 1.2365589108220831e-10
compound O 0 4.532168529358671e-10
heterozygotes O 0 1.8127664702660695e-08
for O 0 3.8328751283955853e-10
the O 0 3.4505847068544426e-09
common O 0 1.5442370937535088e-08
mutant O 0 2.947568020772451e-07
TSD B-Disease 0 0.00014396112237591296
gene O 0 2.268644605507575e-09
and O 0 9.979185255915013e-10
a O 0 2.6673818709355146e-09
rare O 0 1.4156235295104125e-08
( O 0 4.826679944613943e-09
allelic O 0 2.7099392809759593e-06
) O 0 1.934961169069993e-08
mutant O 0 7.27453084437002e-07
gene O 0 6.612194880517563e-08
. O 0 8.14764078427288e-08

Thus O 0 5.423896709544351e-07
, O 0 1.6357967425051356e-08
the O 0 2.685059996565542e-08
postulated O 0 1.6756085585711844e-07
rate O 0 2.739788840244728e-08
mutant O 0 6.26352516519546e-08
gene O 0 9.970699821337803e-10
appears O 0 3.703764239748608e-10
to O 0 2.9531953271710876e-11
code O 0 1.0486454760094688e-10
for O 0 5.403691730188065e-11
the O 0 4.943552234237814e-10
expression O 0 3.523381031378392e-10
of O 0 9.61913659836e-10
low O 0 8.513151072975234e-09
amounts O 0 8.301998200010985e-09
of O 0 4.929819397148094e-08
hex O 0 6.573795690201223e-05
A O 0 2.3736702132737264e-06
. O 0 4.251902225860249e-07

Heterozygotes O 0 5.809106369270012e-06
for O 0 1.1450716819183526e-08
the O 0 2.175215918498452e-08
rare O 0 2.263709575345274e-08
mutant O 0 9.916409027255213e-08
may O 0 2.375532548448689e-10
be O 0 8.645573146282004e-11
indistinguishable O 0 1.8278615288025435e-09
from O 0 5.2427950869571305e-11
heterozygotes O 0 6.315948208879263e-09
for O 0 2.3052133812928588e-10
the O 0 3.79363118696574e-09
common O 0 5.6866902298224886e-08
TSD B-Disease 0 0.0013560665538534522
mutant O 0 4.819313744519604e-06
. O 0 1.8056375949981884e-07

However O 0 1.0466128230746108e-07
, O 0 5.675082626055428e-09
direct O 0 2.6274806774750914e-09
visualization O 0 1.2022998596705747e-08
and O 0 3.023727490614192e-09
quantitation O 0 1.3626073496197932e-06
of O 0 7.378715167760674e-07
hex O 0 0.013124605640769005
A O 0 7.100197763065808e-08
by O 0 9.941640566335508e-11
the O 0 4.4635128926273637e-10
methods O 0 8.451506716689039e-10
described O 0 2.0160037528249575e-10
may O 0 1.4395203085104669e-10
prevent O 0 4.9572834726063775e-09
false O 0 4.5050740915542065e-09
- O 0 1.656812997907764e-08
positive O 0 7.517613753726948e-10
prenatal O 0 4.4683532429701245e-09
diagnosis O 0 4.7090731314369805e-09
of O 0 8.231705983519078e-09
TSD B-Disease 1 0.9999920129776001
in O 0 4.305853451569419e-09
fetuses O 0 2.7625837617506477e-08
having O 0 2.1370955005650671e-10
the O 0 5.708658545877654e-10
incomplete O 0 3.2513778336351606e-08
hex B-Disease 0 0.00039897076203487813
A I-Disease 0 1.5153316326177446e-06
deficiency I-Disease 0 1.03917955129873e-05
of O 0 1.7433278287626308e-07
the O 0 1.5365129613087447e-08
type O 0 7.51532667209176e-08
described O 0 4.5800069292667445e-10
in O 0 2.8864208245771295e-10
the O 0 2.009590716056664e-08
four O 0 3.29763807371819e-08
healthy O 0 3.593494284359622e-07
individuals O 0 2.3567832130311217e-08

The O 0 5.083475116407499e-06
tumor B-Disease 0 0.004791757091879845
suppressor O 0 0.0006862704758532345
gene O 0 1.0152989489142783e-06
Smad4 O 1 0.8715284466743469
/ O 0 9.40754671319155e-06
Dpc4 O 0 0.0011276744771748781
is O 0 1.4887785448891577e-09
required O 0 4.3594916565581343e-10
for O 0 2.087510164727746e-10
gastrulation O 0 2.5479549137230606e-08
and O 0 6.501214011578327e-10
later O 0 1.6204244612794128e-09
for O 0 8.986052457693461e-10
anterior O 0 2.5399009473403567e-07
development O 0 1.5980194945086623e-08
of O 0 1.5806470798906957e-07
the O 0 1.9864722844431526e-07
mouse O 0 8.681615213390614e-07
embryo O 0 3.074467258556979e-07
. O 0 1.5099278982688702e-07

Mutations O 0 5.403957175076357e-07
in O 0 1.4215789434501858e-08
the O 0 1.3948178434475267e-07
SMAD4 O 1 1.0
/ O 1 0.8777503371238708
DPC4 O 1 1.0
tumor B-Disease 0 0.03507833555340767
suppressor O 0 4.2409133129694965e-06
gene O 0 4.196741176798469e-09
, O 0 4.257846575317359e-10
a O 0 6.355011517023001e-10
key O 0 4.03820870076288e-08
signal O 0 1.8018766922978102e-08
transducer O 0 3.5957356203653035e-08
in O 0 9.835534608981789e-10
most O 0 4.7269357317247795e-09
TGFbeta O 0 5.927741221967153e-05
- O 0 2.702818449051847e-07
related O 0 6.031700650055427e-08
pathways O 0 7.81505793412407e-09
, O 0 5.6499763201323105e-11
are O 0 4.287522593904303e-12
involved O 0 1.2034886975875736e-11
in O 0 9.951766841154175e-12
50 O 0 8.295979458949887e-10
% O 0 2.639026219775076e-10
of O 0 1.6353288501136376e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.6464419988769805e-06

Homozygous O 0 0.00011616553092608228
Smad4 O 0 0.0008768187835812569
mutant O 0 1.041421819536481e-05
mice O 0 3.7669948937946174e-07
die O 0 7.049742833942219e-08
before O 0 1.5948274922905625e-09
day O 0 3.911948986967673e-09
7 O 0 1.770605564388461e-07
. O 0 1.2925188741519378e-07

5 O 0 3.209190936104278e-06
of O 0 1.0037739457402495e-06
embryogenesis O 0 1.3165168866180466e-06
. O 0 1.2846223853557603e-06

Mutant O 0 2.8441872927942313e-06
embryos O 0 1.694140649988185e-08
have O 0 1.1455642684454759e-10
reduced O 0 9.16433484654533e-10
size O 0 2.6488613524833227e-09
, O 0 9.74039737755561e-10
fail O 0 9.417395752109314e-09
to O 0 3.266586334760291e-09
gastrulate O 0 6.435415798478061e-06
or O 0 1.2404104410279615e-08
express O 0 3.995928921085579e-09
a O 0 5.873043162907265e-10
mesodermal O 0 1.0546082052087513e-07
marker O 0 3.4423536021677137e-07
, O 0 1.8939767532089036e-09
and O 0 4.280665599765143e-09
show O 0 1.6767978650022997e-07
abnormal O 0 3.142556295188115e-07
visceral O 0 6.764920271962183e-06
endoderm O 0 2.353025774937123e-05
development O 0 7.97532550222968e-07
. O 0 4.402294848659949e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 3.946360720874509e-06
the O 0 1.6180200645976583e-07
Smad4 O 0 0.004727633204311132
- O 0 1.784109372238163e-06
deficient O 0 5.495468258231995e-07
embryos O 0 3.500674417011851e-09
results O 0 4.052562105338886e-11
from O 0 2.546765402733353e-11
reduced O 0 1.658972070828213e-09
cell O 0 1.2807028770822626e-09
proliferation O 0 1.7854050327059667e-07
rather O 0 1.4669053749472027e-09
than O 0 3.6577105233526197e-10
increased O 0 7.508947241774422e-09
apoptosis O 0 2.7858001772074203e-07
. O 0 2.859388246179151e-07

Aggregation O 0 2.009508079936495e-06
of O 0 8.789037337919581e-07
mutant O 0 3.094778776357998e-06
Smad4 O 0 0.00028595273033715785
ES O 0 0.00012161875929450616
cells O 0 6.803694829748963e-10
with O 0 3.8708283800481524e-10
wild O 0 1.902439521472843e-07
- O 0 2.3461183218387305e-07
type O 0 2.990520329149149e-07
tetraploid O 0 6.431339443224715e-07
morulae O 0 5.5732180044287816e-06
rescues O 0 3.029900881301728e-07
the O 0 4.2693741875154956e-08
gastrulation B-Disease 0 4.8332276492146775e-06
defect I-Disease 0 6.48723744234303e-06
. O 0 5.159641318641661e-07

These O 0 2.5014870175255055e-07
results O 0 7.060397155811415e-09
indicate O 0 2.209819216503206e-09
that O 0 1.874943950097574e-10
Smad4 O 0 3.393885890545789e-06
is O 0 3.5588465507885303e-10
initially O 0 1.696929957661908e-10
required O 0 3.268889325891422e-11
for O 0 2.795309296532711e-11
the O 0 2.2583596104297499e-10
differentiation O 0 7.808825253086127e-10
of O 0 4.72592631695079e-09
the O 0 7.1615491314958035e-09
visceral O 0 3.279667737388081e-07
endoderm O 0 2.9407951274151856e-07
and O 0 3.846865936907307e-09
that O 0 2.3466747989253633e-10
the O 0 6.220210568841367e-09
gastrulation B-Disease 0 1.3849586366632138e-07
defect I-Disease 0 2.811917632072891e-08
in O 0 5.719055229391756e-10
the O 0 1.0458300891968975e-08
epiblast O 0 8.140244176502165e-07
is O 0 1.0806611161484625e-09
secondary O 0 3.417855154452809e-08
and O 0 1.984601816218401e-09
non O 0 1.3148882089808467e-06
- O 0 6.777047474315623e-06
cell O 0 2.493541842341074e-06
autonomous O 0 7.584275590488687e-05
. O 0 5.575821546699444e-07

Rescued O 0 1.8765686036203988e-06
embryos O 0 7.822607273055837e-08
show O 0 5.865101471158596e-08
severe O 0 6.396854132617591e-06
anterior O 0 6.527095683850348e-05
truncations O 0 0.0004902477958239615
, O 0 2.3645501556757154e-08
indicating O 0 7.200338103530157e-09
a O 0 4.874731729387349e-10
second O 0 7.301345639199042e-10
important O 0 1.684377193278408e-09
role O 0 3.932882020052375e-09
for O 0 3.3555775935667498e-09
Smad4 O 0 5.63714602321852e-05
in O 0 2.2912498565119677e-08
anterior O 0 1.184903612738708e-05
patterning O 0 5.075210992799839e-06
during O 0 1.9050011701438052e-07
embryogenesis O 0 1.0169259212489123e-06
. O 0 4.6082712401585013e-07

Prevalence O 0 2.3168820916907862e-05
of O 0 8.95418281743332e-07
p16 O 0 4.493149845075095e-06
and O 0 2.3400448867505474e-07
CDK4 O 1 1.0
germline O 0 2.510966623958666e-06
mutations O 0 2.293724854496304e-08
in O 0 1.8182402250488394e-09
48 O 0 1.7309889699390624e-07
melanoma B-Disease 1 0.9999048709869385
- O 0 1.7104915968957357e-05
prone O 0 3.188896926076268e-06
families O 0 2.392297193676285e-10
in O 0 7.680491243000631e-10
France O 0 7.81855590048508e-07
. O 0 2.642008496422932e-07

The O 0 5.329772193363169e-06
French O 0 0.0002934100339189172
Familial B-Disease 1 0.9999979734420776
Melanoma I-Disease 1 1.0
Study O 0 7.265032877512567e-07
Group O 0 8.008421303884461e-08
. O 0 6.951243847197475e-08

Germline O 0 1.815111500036437e-05
mutations O 0 4.6917726592710096e-08
in O 0 2.5082600441095337e-09
the O 0 2.2940442434560282e-08
p16 O 0 3.3672935728645825e-07
and O 0 2.7630424170865808e-08
CDK4 O 1 1.0
genes O 0 4.6026555899914e-09
have O 0 1.2942821814299066e-10
been O 0 1.2128174853298646e-10
reported O 0 3.0408861539932275e-10
in O 0 1.395060594822084e-10
a O 0 7.147571978727285e-10
subset O 0 1.0751127987873588e-08
of O 0 1.4571266859775278e-08
melanoma B-Disease 0 0.22080086171627045
pedigrees O 0 5.4625395762286644e-08
, O 0 3.899514045002661e-10
but O 0 4.722128243983548e-11
their O 0 1.0745335871087391e-10
prevalence O 0 9.702613823492356e-09
is O 0 1.6376931755157642e-10
not O 0 1.211088312969011e-10
well O 0 2.6054973734090936e-09
known O 0 8.967277409510643e-08
. O 0 4.143651040067198e-07

We O 0 4.0542769141893586e-08
searched O 0 2.555957046013191e-08
for O 0 1.0702183583788383e-09
such O 0 6.635793248221944e-09
germline O 0 1.1277344924565114e-07
mutations O 0 4.063301695111932e-09
in O 0 7.728397366513207e-10
48 O 0 5.439209971314085e-08
French O 0 3.900049705407582e-06
melanoma B-Disease 1 1.0
- O 0 9.61539444688242e-06
prone O 0 2.8081745995223173e-07
families O 0 7.677305839670634e-12
selected O 0 3.6646290169084494e-11
according O 0 1.1421857383508982e-12
to O 0 1.4009527912750563e-11
two O 0 1.2498082430090207e-11
major O 0 9.374524490013414e-10
criteria O 0 7.74723307728209e-09
families O 0 1.8630997352525602e-12
with O 0 5.806463816704355e-12
at O 0 9.545937373900415e-10
least O 0 1.0756162627245658e-10
three O 0 1.1583340536747144e-10
affected O 0 1.1121549237103068e-09
members O 0 6.731266238846345e-11
( O 0 1.5259972452330572e-10
n O 0 1.076400746313766e-09
= O 0 3.5358421746067847e-10
20 O 0 4.998592095795118e-10
) O 0 1.5984498447085826e-11
or O 0 2.6534146407852788e-11
families O 0 5.533604173837969e-13
with O 0 3.210679118403892e-12
two O 0 1.634375274006672e-11
affected O 0 1.2971290708208016e-10
members O 0 4.572260105251136e-12
, O 0 2.7755511430860302e-11
one O 0 1.7304506785831286e-11
of O 0 1.7872661683959734e-10
them O 0 2.8048263364666148e-11
affected O 0 4.871067438294574e-11
before O 0 3.821441774132239e-11
the O 0 3.6803635139470714e-10
age O 0 7.925762268712333e-10
of O 0 1.4372054657485478e-09
50 O 0 2.963433942682059e-09
( O 0 1.6919721179675662e-10
n O 0 6.944346209181163e-10
= O 0 7.927486445069576e-10
28 O 0 1.7305680222179376e-09
) O 0 9.081070617700249e-11
, O 0 1.0163413860508896e-10
and O 0 3.291011907435859e-10
one O 0 4.5645970336849473e-10
additional O 0 4.1941881079310406e-09
minor O 0 6.112429673521547e-07
criterion O 0 5.744026566389948e-05
. O 0 3.639561612089892e-07

Sixteen O 0 3.7333957152441144e-05
different O 0 1.1425044021962094e-07
p16 O 0 1.7864691699287505e-06
germline O 0 2.2074029004670592e-07
mutations O 0 3.255577141203503e-09
were O 0 1.922048353808492e-10
found O 0 2.6616922207955973e-11
in O 0 1.9780318008533193e-11
21 O 0 9.926506283619574e-10
families O 0 3.7814599541941e-12
, O 0 3.059168543484425e-11
while O 0 4.9411486013895e-10
one O 0 1.883716294059923e-09
germline O 0 2.3520636105445192e-08
mutation O 0 3.5935947551024583e-09
, O 0 1.1567361513087349e-09
Arg24His O 0 0.0001381304900860414
, O 0 6.292560250642509e-09
was O 0 2.1288146356823745e-08
detected O 0 8.506447990441757e-09
in O 0 2.1889283718934394e-09
the O 0 8.480855484549465e-08
CDK4 O 1 0.9999953508377075
gene O 0 5.981806907584541e-07
. O 0 4.03494510692326e-07

The O 0 9.034540937591373e-08
frequency O 0 3.2081086231983136e-08
of O 0 5.4484612377336816e-08
p16 O 0 1.2241407887358946e-07
gene O 0 2.601574289329278e-09
mutation O 0 8.22617640672263e-10
in O 0 1.8378625010750937e-10
our O 0 5.045758810773293e-10
sample O 0 1.8612829333353176e-10
( O 0 2.3705525389883242e-11
44 O 0 8.649469473986926e-10
% O 0 2.6049185378185236e-11
) O 0 2.2113307712734454e-11
is O 0 1.998902779409839e-11
among O 0 7.435141044509486e-12
the O 0 5.142762951604318e-11
highest O 0 4.572544010095214e-10
rates O 0 3.891103550479613e-10
yet O 0 1.300694135730751e-10
reported O 0 2.1574998732010187e-10
and O 0 7.75367436922636e-10
the O 0 8.045222266162e-09
CDK4 O 1 0.9996814727783203
mutation O 0 7.049874017894808e-09
is O 0 5.062860686244619e-10
the O 0 1.8421589809136663e-09
second O 0 8.937580453505234e-09
mutation O 0 3.1521771859388537e-09
detected O 0 2.993132186546177e-09
in O 0 4.47252068713766e-10
this O 0 9.294175429275242e-10
gene O 0 7.705028615134779e-09
worldwide O 0 7.304413962572198e-09
. O 0 2.7191478579879913e-07

In O 0 4.810010878486537e-08
summary O 0 3.5183546742700855e-08
, O 0 1.3283285582588178e-09
our O 0 6.919239625702289e-10
results O 0 2.051226272170581e-10
show O 0 1.389590664757634e-09
frequent O 0 1.2041238006688104e-09
involvement O 0 4.739394210417913e-09
of O 0 1.142615069227304e-08
the O 0 2.485624683856713e-08
p16 O 0 1.743317739055783e-07
gene O 0 2.3406054872054938e-09
in O 0 1.5332567437909006e-09
familial B-Disease 0 3.150002612528624e-06
melanoma I-Disease 1 0.9964680671691895
and O 0 7.386932732167395e-10
confirm O 0 1.94637472805681e-10
the O 0 4.591132196640757e-10
role O 0 2.0483537088722414e-09
of O 0 1.9339060131073893e-08
the O 0 4.3841367869390524e-08
CDK4 O 1 1.0
gene O 0 2.251240083239736e-08
as O 0 5.444417361388787e-09
a O 0 1.865098120390485e-08
melanoma B-Disease 1 0.9996803998947144
- O 0 6.892081728437915e-05
predisposing O 0 1.857610732258763e-05
gene O 0 2.3865890597107864e-08
. O 0 4.245514162448671e-09
. O 0 6.568149757413266e-08

Progression O 0 8.856578460836317e-06
of O 0 8.259544870270474e-07
somatic O 0 6.074846169212833e-06
CTG O 0 0.0006084814667701721
repeat O 0 1.2823245754134405e-07
length O 0 6.396446927681154e-09
heterogeneity O 0 1.7531471385723307e-08
in O 0 1.7601747837048265e-10
the O 0 7.974620408468525e-10
blood O 0 1.2030769713788914e-09
cells O 0 5.595477969855267e-10
of O 0 5.816396253521816e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 6.446115548897069e-06
. O 0 5.913019407444153e-08

The O 0 9.21879603765774e-08
genetic O 0 3.267846793164608e-08
basis O 0 8.69605631947934e-09
of O 0 4.2556831658657757e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.03785696253180504
DM B-Disease 1 1.0
) O 0 9.120200705758919e-10
is O 0 1.0869924405021436e-10
the O 0 1.985872993826021e-10
expansion O 0 9.012283364029372e-09
of O 0 7.07267577837456e-09
an O 0 1.7818482245246514e-09
unstable O 0 2.7867966423400503e-07
CTG O 0 5.832874740008265e-05
repeat O 0 3.435868833889799e-08
in O 0 4.4322334691315746e-10
the O 0 4.514217888385019e-09
34 O 0 1.9316718891104756e-08
UTR O 0 1.6441788829979487e-05
of O 0 7.219868791707995e-08
the O 0 2.2035287372546009e-07
DM B-Disease 1 1.0
protein O 0 3.5619069649328594e-07
kinase O 0 6.282765241394372e-08
gene O 0 2.1593535848296597e-09
on O 0 1.3424165778985753e-08
chromosome O 0 1.5507016826177278e-07
19 O 0 1.2824247619391826e-07
. O 0 7.899253517962279e-08

One O 0 1.9449998944764957e-08
of O 0 6.64131372118959e-09
the O 0 1.493704937516327e-09
principal O 0 2.6647644091326583e-08
features O 0 3.794890179875665e-09
of O 0 2.6471859371213213e-08
the O 0 5.789389661003952e-07
DM B-Disease 1 1.0
mutation O 0 1.1552202039410986e-07
is O 0 4.0029599079893785e-10
an O 0 1.0261683863754811e-10
extraordinarily O 0 6.874621316654839e-09
high O 0 7.83243052637772e-08
level O 0 6.702692445514913e-08
of O 0 1.6828340676511289e-07
somatic O 0 2.314597168151522e-06
mosaicism O 0 2.6502520995563827e-05
, O 0 1.0830526475658075e-09
due O 0 5.868802777087012e-09
to O 0 6.763313797897297e-10
an O 0 1.2383857828091038e-10
extremely O 0 1.3730400150180344e-09
high O 0 7.1757422226426115e-09
degree O 0 2.199239901301553e-09
of O 0 4.7246375700638055e-09
somatic O 0 5.368575983766277e-08
instability O 0 2.334574134010836e-08
both O 0 1.0821400442395657e-09
within O 0 4.2864312099766266e-10
and O 0 1.9357712655043713e-10
between O 0 2.5546481596805393e-10
different O 0 2.1249111359367134e-09
tissues O 0 2.4942357867985265e-07
. O 0 8.971981912964111e-08

This O 0 1.555239492745386e-07
instability O 0 3.296110548944853e-07
appears O 0 2.9390714306742893e-09
to O 0 2.615050398446783e-10
be O 0 8.868982631637934e-11
biased O 0 2.0649073562140075e-09
towards O 0 6.278721986774372e-10
further O 0 4.5107123591847653e-10
expansion O 0 5.5167852508475335e-09
and O 0 7.239719934659661e-10
continuous O 0 1.2405849680874326e-09
throughout O 0 1.5904705330527236e-10
the O 0 1.1227692109372356e-09
life O 0 1.5477769066407632e-10
of O 0 2.9170380000387297e-10
an O 0 2.8586194175672652e-11
individual O 0 1.788632783550348e-11
, O 0 1.9137436427230092e-11
features O 0 2.3203750032507742e-10
that O 0 8.854052907514287e-12
could O 0 5.502498456877447e-11
be O 0 1.7183372780227302e-11
associated O 0 2.5426884556201124e-11
with O 0 1.1966204416236081e-10
the O 0 5.635162558803586e-09
progressive O 0 2.1564864027823205e-07
nature O 0 4.054199465031161e-08
of O 0 5.532351821102566e-08
the O 0 1.6948330028299097e-07
disease O 0 6.14427262917161e-05
. O 0 2.7537674895938835e-07

Although O 0 7.78508280063761e-08
increasing O 0 3.0228754610561737e-08
measured O 0 1.1992766779655994e-08
allele O 0 3.5489178262793075e-09
size O 0 5.353950616182601e-09
between O 0 5.031672412059152e-09
patients O 0 1.1087075257876222e-08
clearly O 0 3.697695705184856e-09
correlates O 0 7.763090614787416e-09
with O 0 6.450740636099184e-11
an O 0 2.8079365221866937e-11
increased O 0 1.367970736687596e-10
severity O 0 1.7864576307147217e-07
of O 0 1.725891429771309e-08
symptoms O 0 2.2534345589519944e-06
and O 0 3.283350535898677e-10
an O 0 2.976437152302225e-11
earlier O 0 3.3206346006231513e-10
age O 0 4.185796598221714e-09
of O 0 3.243243673622942e-09
onset O 0 4.597893621394178e-08
, O 0 1.9336017509363757e-10
this O 0 1.0240307733722087e-11
correlation O 0 2.2000821997547604e-10
is O 0 8.113015814714686e-11
not O 0 2.3629686748960488e-11
precise O 0 2.0602572980976674e-09
and O 0 9.259459310406726e-10
measured O 0 4.9031472215688154e-09
allele O 0 1.144097372396402e-09
length O 0 2.5903250655545662e-09
cannot O 0 5.589685381224285e-10
be O 0 5.980805434235847e-11
used O 0 1.560639534270436e-10
as O 0 1.2732516430080665e-10
an O 0 2.5044280885233583e-11
accurate O 0 4.38321468010372e-09
predictor O 0 3.065093210352643e-07
of O 0 3.070912413249971e-08
age O 0 5.19432923340446e-08
of O 0 6.33042347431001e-08
onset O 0 3.7312267977540614e-06
. O 0 2.833761527654133e-07

In O 0 2.752758376800557e-08
order O 0 7.269417068300754e-09
to O 0 9.897070940567687e-10
further O 0 5.135808667233732e-09
characterize O 0 4.828487121244507e-08
the O 0 2.2077772499073944e-08
dynamics O 0 1.755870329134268e-07
of O 0 1.7440773945054389e-06
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 0 1.4412381688089226e-06
somatic O 0 2.3641177904210053e-07
instability O 0 7.32889517962576e-08
, O 0 6.338100599911911e-10
we O 0 2.537844379091325e-10
have O 0 2.8296353107859495e-11
studied O 0 4.0240135668057064e-09
repeat O 0 1.0999110511278332e-09
length O 0 1.9483135937914398e-10
changes O 0 1.0873864308980075e-10
over O 0 6.188540235818607e-10
time O 0 4.4679843158590415e-10
in O 0 7.499654786080612e-10
111 O 0 2.748483211689745e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 6.770147109591562e-08
with O 0 8.955573782554183e-11
varying O 0 1.4808770876229005e-09
clinical O 0 2.0355878760369706e-08
severity O 0 1.6764620625053794e-07
and O 0 3.907460133234508e-09
CTG O 0 1.803449595172424e-05
repeat O 0 1.8927777123423084e-09
size O 0 3.96300797733673e-10
over O 0 4.124642849490101e-10
time O 0 1.3345317906310328e-10
intervals O 0 4.965390876243703e-10
of O 0 3.8123870726991527e-10
1 O 0 7.924239930900967e-09
- O 0 3.272992898928351e-08
7 O 0 3.5342747395361584e-08
years O 0 9.44086675502831e-09
. O 0 7.781935806860929e-08

We O 0 1.336683794761484e-07
have O 0 5.853450502080193e-10
found O 0 3.8450154171698614e-10
a O 0 9.048876925543681e-11
direct O 0 3.93898358375111e-10
progression O 0 2.2013257883202186e-09
of O 0 6.068588409569031e-10
the O 0 1.0149664442238304e-09
size O 0 6.646103667407033e-09
heterogeneity O 0 1.737060628670406e-08
over O 0 7.679616942368739e-09
time O 0 1.012269490452411e-09
related O 0 4.925023500135239e-09
to O 0 7.683407243774809e-10
initial O 0 1.1711423830718104e-08
CTG O 0 4.863481080974452e-06
repeat O 0 3.120454783456239e-09
size O 0 8.15749134908117e-10
and O 0 3.3575156543896867e-10
the O 0 7.139532853805974e-10
time O 0 2.431161660876313e-10
interval O 0 2.0028663172411143e-09
and O 0 1.098070634419912e-09
always O 0 2.8417752595544243e-09
biased O 0 1.2631298673682068e-08
towards O 0 7.4503279101634234e-09
further O 0 2.0096864616903076e-08
expansion O 0 8.64794174049166e-07
. O 0 4.424915118761419e-07

Attempts O 0 4.534659296950849e-07
to O 0 4.249005591816513e-09
mathematically O 0 2.3532826798344786e-09
model O 0 9.146488011424481e-10
the O 0 1.5288296184579053e-09
dynamics O 0 2.813414212710086e-08
have O 0 4.836658296092367e-10
proved O 0 1.576242070200351e-08
only O 0 1.083784173516733e-09
partially O 0 6.096809102018597e-08
successful O 0 8.206560764278947e-09
suggesting O 0 8.780620119885896e-10
that O 0 4.963607996844033e-11
individual O 0 5.5704618001639616e-11
specific O 0 3.8710348815307327e-10
genetic O 0 1.1183236559020315e-09
and O 0 9.328025019073038e-10
/ O 0 3.768938938719657e-07
or O 0 1.227374202272813e-09
environmental O 0 1.7195898749378102e-07
factors O 0 2.3532154003191863e-09
also O 0 7.079984515323545e-11
play O 0 3.039866802723168e-09
a O 0 8.313181254493429e-10
role O 0 1.2439502761196763e-08
in O 0 9.778730714060657e-09
somatic O 0 9.378749723509827e-07
mosaicism O 0 6.15539966020151e-06
. O 0 2.3715330144113977e-08
. O 0 1.8082637609495578e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 5.108972800371703e-07
Palestinian O 0 2.8786587336071534e-07
Arabs O 0 2.2152732981339796e-07
. O 0 2.5738677322806325e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.8963424563407898
AGU B-Disease 1 1.0
) O 0 5.10491098282273e-08
is O 0 6.1579532584232766e-09
a O 0 3.019906325008037e-09
rare O 0 4.790043703906122e-07
disorder B-Disease 1 1.0
of I-Disease 1 0.9983177185058594
glycoprotein I-Disease 0 0.1504216343164444
metabolism I-Disease 0 4.6263690478554054e-07
caused O 0 2.124586950813523e-09
by O 0 5.3190528370716805e-11
the O 0 8.166898268768819e-09
deficiency B-Disease 0 6.695227784803137e-05
of I-Disease 0 3.6164258290227735e-06
the I-Disease 0 1.5479579360544449e-06
lysosomal I-Disease 0 0.0032083168625831604
enzyme I-Disease 0 3.3959992151721963e-07
aspartylglucosaminidase I-Disease 0 1.7264699636143632e-05
( O 0 5.392844837359689e-09
AGA O 0 0.00037654992775060236
) O 0 5.8088129861744164e-08
. O 0 2.141578647751885e-07

AGU B-Disease 1 1.0
is O 0 9.873997441900428e-07
inherited O 0 3.0370798413059674e-05
as O 0 2.2289626144811336e-08
an O 0 1.695029538950621e-08
autosomal O 0 0.00026961229741573334
recessive O 0 5.783755568700144e-06
trait O 0 2.0113819232392416e-07
and O 0 6.210509884141402e-10
occurs O 0 8.269134682548085e-11
with O 0 9.814237096616996e-12
a O 0 6.841102684340683e-11
high O 0 7.470933205411256e-09
frequency O 0 2.347902539057145e-09
in O 0 1.0207887868318721e-09
Finland O 0 7.042538641144347e-07
because O 0 8.355023339845502e-09
of O 0 6.933010610055135e-08
a O 0 2.7198474583656207e-08
founder O 0 4.808351263818622e-07
effect O 0 6.890783197377459e-07
. O 0 3.561424364306731e-07

While O 0 9.158628699879046e-08
very O 0 2.3220718681216113e-09
few O 0 3.861406305816217e-09
patients O 0 2.960879985636211e-09
with O 0 4.942479314706816e-09
AGU B-Disease 1 1.0
have O 0 7.643463639794845e-09
been O 0 6.215878922688489e-10
reported O 0 1.7420788422928268e-10
from O 0 9.247488885755217e-11
non O 0 6.00938960815256e-08
- O 0 2.6142652487237683e-08
Finnish O 0 1.184493157779798e-06
origin O 0 3.3277866573477866e-10
, O 0 9.91017545803885e-11
we O 0 3.718168273270095e-10
diagnosed O 0 1.127513016285775e-07
the O 0 8.38938785108212e-09
disorder O 0 9.681220944912639e-06
in O 0 7.83210996058159e-10
8 O 0 2.9354369601719554e-08
patients O 0 1.4051711183515891e-10
originating O 0 2.6759093205153128e-11
from O 0 1.4477691615000232e-11
3 O 0 1.1115187659171966e-09
unrelated O 0 4.931788866180398e-10
families O 0 4.237771158294157e-13
, O 0 2.972322258112947e-12
all O 0 1.729754534052219e-11
Palestinian O 0 8.142098106844742e-11
Arabs O 0 2.386175632085319e-11
from O 0 1.2513204881992035e-11
the O 0 3.1647542919621685e-10
region O 0 1.1010513389919652e-08
of O 0 8.543541696326429e-08
Jerusalem O 0 4.311503289500251e-06
. O 0 5.673677492268325e-07

The O 0 4.5276848936737224e-07
clinical O 0 3.0405349207285326e-06
diagnosis O 0 2.4745855625951663e-05
of O 0 0.04244982823729515
AGU B-Disease 1 1.0
is O 0 1.1471834149290316e-08
often O 0 2.3895654899241947e-10
difficult O 0 5.72564773371198e-10
, O 0 3.0952292812136406e-11
in O 0 2.007943811221935e-11
particular O 0 6.711049077567921e-11
early O 0 5.41566097522761e-11
in O 0 3.359038394656899e-11
the O 0 3.439878104583016e-10
course O 0 2.080499328371843e-09
of O 0 8.992944722230334e-10
the O 0 9.380086707366786e-10
disease O 0 7.5098533613982e-08
, O 0 1.3709981760978707e-10
and O 0 1.5955993470928576e-10
most O 0 1.5160579736051005e-10
of O 0 7.549887937052802e-10
the O 0 1.3427489120587666e-09
patients O 0 5.109756506804786e-10
are O 0 4.244360071736786e-11
diagnosed O 0 3.1710154502206933e-09
after O 0 2.1948472206378966e-10
the O 0 8.475624091452971e-10
age O 0 1.280624717381329e-09
of O 0 2.4281645583101863e-09
5 O 0 3.6114272461418295e-08
years O 0 8.895182368462429e-09
. O 0 7.501836307710619e-08

However O 0 1.2125416049002524e-07
, O 0 1.0732954081049684e-08
since O 0 1.3697468714823913e-09
these O 0 1.953069705962207e-09
patients O 0 4.0222158936842334e-10
excrete O 0 1.9486797953049972e-08
early O 0 2.598072312842703e-10
large O 0 1.4962485694880456e-09
amounts O 0 2.9686499924963528e-09
of O 0 1.0780389025910608e-08
aspartylglucosamine O 0 6.914171990501927e-07
in O 0 6.591198142835708e-10
urine O 0 2.7408173508547407e-09
, O 0 8.420705105427473e-11
biochemical O 0 3.9753175751222614e-10
screening O 0 1.7484911296605787e-09
is O 0 9.871670841876679e-11
easy O 0 5.263698921176285e-10
by O 0 8.607334983645742e-11
urine O 0 7.76671882363189e-09
chromatography O 0 2.408992543223576e-07
. O 0 9.503195563809186e-09
. O 0 1.0000897532336239e-07

Detection O 0 1.3696112546313088e-06
of O 0 8.982940613577739e-08
heterozygous O 0 1.2569198126755055e-08
carriers O 0 8.742151447194146e-10
of O 0 5.685906412367103e-09
the O 0 2.864404677893617e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.383783019397015e-08
ATM O 0 7.939330680528656e-05
) O 0 1.303195440449656e-09
gene O 0 5.129804914183467e-10
by O 0 1.43761877402504e-10
G2 O 0 2.145742837456055e-05
phase O 0 2.302759867234272e-07
chromosomal O 0 8.502021842105023e-07
radiosensitivity O 0 9.87156181508908e-06
of O 0 2.725856802499038e-07
peripheral O 1 0.9999911785125732
blood O 0 1.781846094672801e-06
lymphocytes O 0 8.324801683556871e-07
. O 0 9.70774465258728e-08

In O 0 4.2432925511093345e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.4971327547973488e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5078772674925744e-09
patients O 0 1.2033477547745974e-09
, O 0 1.0426861457579761e-10
mutations O 0 1.3639089857520048e-10
in O 0 5.488159579569718e-11
a O 0 1.443518082844264e-10
single O 0 9.215336826962073e-11
gene O 0 1.0257261012780461e-10
, O 0 2.922188879761478e-10
ATM O 0 5.187020178709645e-06
, O 0 4.172753531594964e-10
result O 0 1.691536494208279e-10
in O 0 2.5610244480667177e-10
an O 0 6.169005928313709e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 4.32122249094391e-09
embraces O 0 2.685362154863924e-08
a O 0 1.1405540401021597e-10
variety O 0 1.872564769911378e-09
of O 0 1.3001864029860144e-09
clinical O 0 2.344274818710801e-08
features O 0 2.713224089845312e-09
and O 0 1.3347413174713552e-09
manifests O 0 9.85777592887871e-09
extreme O 0 6.700225441136354e-08
radiosensitivity O 0 2.228683570137946e-06
and O 0 8.180149890790744e-09
a O 0 3.4275213778300895e-09
strong O 0 1.5604237901811757e-08
pre O 0 2.0778174985025544e-06
- O 0 3.5958157695858972e-06
disposition O 0 7.847023880458437e-06
to O 0 1.6869347518877476e-07
malignancy B-Disease 0 0.0004843624192290008
. O 0 3.870825651119958e-07

Heterozygotes O 0 6.483069228124805e-06
for O 0 2.526468279029359e-08
the O 0 3.83883467236501e-08
ATM O 0 1.736777562655334e-06
gene O 0 1.7652592720907023e-09
have O 0 1.7909448923880689e-10
no O 0 4.764161842807368e-10
clinical O 0 4.326088376416237e-09
expression O 0 1.5372618455966602e-10
of O 0 6.824050657883163e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 7.854550343466826e-10
may O 0 5.219599197303637e-10
be O 0 4.1255240890158973e-10
cancer B-Disease 0 3.5513167517819966e-08
prone O 0 3.9290156905735785e-08
with O 0 2.48227743915308e-10
a O 0 1.228561696819952e-09
moderate O 0 6.289332610265319e-09
increase O 0 7.139696056590594e-10
in O 0 7.988580352780161e-10
in O 0 5.056127072577965e-09
vitro O 0 4.581208656873059e-07
radiosensitivity O 0 2.3629672796232626e-05
. O 0 4.3205488964304095e-07

We O 0 1.7218380321537552e-07
performed O 0 1.2925286796416913e-07
a O 0 1.6186213258606585e-08
blind O 0 1.2915035085825366e-07
chromosomal O 0 4.154412991397294e-08
analysis O 0 1.2802852111803986e-09
on O 0 2.010514599248836e-08
G2 O 0 4.419939614308532e-06
- O 0 4.809048093079582e-08
phase O 0 3.578487195454727e-08
lymphocytes O 0 2.161760326302442e-09
from O 0 2.4000712528504664e-10
7 O 0 7.528121237498908e-09
unrelated O 0 1.3906392837270687e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.317369738439993e-09
, O 0 1.1498943464083311e-10
13 O 0 2.2503974239640456e-09
obligate O 0 9.624595520563162e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.2904767743293633e-07
( O 0 4.97615837424803e-11
parents O 0 6.641151604341866e-12
of O 0 3.513058247084366e-11
the O 0 3.731074477153484e-11
patients O 0 4.300717334343451e-12
) O 0 2.8933574286460484e-12
, O 0 2.1830891261398477e-11
and O 0 4.06851885514925e-10
14 O 0 7.553938807802751e-09
normal O 0 1.2897631851416236e-09
controls O 0 1.5131012887081852e-08
following O 0 1.214929601367487e-09
X O 0 1.1827530954633403e-07
- O 0 1.1355345996832966e-08
irradiation O 0 1.537738469892247e-08
with O 0 1.245722552889461e-10
1 O 0 1.1391247056735665e-08
Gy O 0 1.8286508520759526e-06
in O 0 6.686198816829858e-11
order O 0 1.2039531871455011e-10
to O 0 7.391833672931725e-11
evaluate O 0 3.0325526534369374e-09
this O 0 8.526045147672079e-11
cytogenetic O 0 7.712353777833414e-08
method O 0 8.075889956771221e-10
as O 0 1.0660555771480063e-10
a O 0 6.66290148054749e-11
tool O 0 2.568701473748547e-09
for O 0 1.0238906944515236e-10
detection O 0 8.150936281481336e-08
of O 0 1.6957935145001102e-07
ATM O 0 0.015456846915185452
carriers O 0 8.81071457570215e-07
. O 0 3.4936897463921923e-07

Both O 0 3.803421861903189e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 2.1904532331973314e-05
and O 0 2.0069322204108175e-08
heterozygotes O 0 1.7013074682381557e-07
showed O 0 1.102364199923045e-09
significantly O 0 3.231657441649105e-10
increased O 0 3.64033164723665e-10
levels O 0 1.374688252120393e-09
of O 0 1.0029868047212176e-09
radiation O 0 5.5437553783121984e-06
- O 0 2.058579184449627e-06
induced O 0 1.2026871445414145e-06
chromatid O 0 2.171863798139384e-06
damage O 0 2.8493462878032005e-07
relative O 0 2.066668614020273e-09
to O 0 1.2569041640819734e-10
that O 0 9.772716663691838e-11
of O 0 1.240793867651746e-08
normal O 0 1.299604832638579e-07
controls O 0 3.6111700865149032e-06
. O 0 7.18666740340268e-07

These O 0 5.74898457728068e-08
results O 0 2.302995349978687e-09
show O 0 1.3936676257486624e-09
that O 0 2.21096072006155e-10
the O 0 1.2483949873853817e-08
G2 O 0 7.963578536873683e-05
- O 0 2.306648866579053e-06
phase O 0 1.20682341275824e-06
chromosomal O 0 1.007183755064034e-06
radiosensitivity O 0 6.918320991644578e-07
assay O 0 4.941206999120595e-09
can O 0 1.9947437798761847e-11
be O 0 2.2882973727683664e-12
used O 0 5.2900127854582646e-12
for O 0 4.404007540592669e-12
the O 0 2.0919573365252297e-11
detection O 0 4.430536826305342e-09
of O 0 5.4401748883492473e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.4607807315769605e-05
. O 0 2.5152181137855223e-07

In O 0 1.4463297759448324e-07
combination O 0 1.577457737766963e-07
with O 0 1.2471591537277504e-09
molecular O 0 2.052797931639816e-08
genetic O 0 1.7842357591391078e-09
analyses O 0 1.4314276430837936e-09
, O 0 1.0824408730458757e-10
this O 0 1.0467405588132639e-11
test O 0 1.6065902774808904e-10
may O 0 2.5177863266501177e-11
be O 0 1.2295707854659277e-11
of O 0 1.1832163027136744e-10
value O 0 1.942810495814129e-10
in O 0 8.067768675346088e-12
studies O 0 1.7992854428605654e-10
of O 0 6.95070667688924e-10
familial B-Disease 0 4.2466744787361677e-08
and I-Disease 0 1.5783117035539362e-08
sporadic I-Disease 0 2.1319369807315525e-06
cancers I-Disease 0 0.00016159462393261492
aimed O 0 4.484765980805605e-08
at O 0 1.0308888187537946e-09
determination O 0 1.6878473063641763e-09
of O 0 7.720441508318743e-10
the O 0 5.357594368149421e-10
potential O 0 1.868112775582631e-09
involvement O 0 9.709569814830843e-10
of O 0 3.702037432162797e-08
ATM O 1 0.9999794960021973
mutations O 0 7.517735411965987e-08
in O 0 3.423444860928271e-09
tumor B-Disease 1 1.0
risk O 0 1.4000514738654601e-06
or O 0 5.944155168080556e-10
development O 0 1.1085758977458227e-09
. O 0 1.9218184821312434e-09
. O 0 4.2273196498854304e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 4.5189385566857254e-09
identification O 0 1.199109034288881e-09
and O 0 8.388099936862403e-11
detection O 0 6.556309983807296e-08
of O 0 5.553506809974351e-08
founder O 0 4.518362928251918e-08
- O 0 5.5586891534176175e-08
effect O 0 1.888271405903197e-08
mutations O 0 5.222278165462058e-10
in O 0 4.903871753114686e-11
the O 0 1.9791206451458265e-09
ATM O 0 6.039599043106136e-07
gene O 0 9.396865507937946e-10
in O 0 3.2950067674342165e-10
ethnic O 0 1.3554766198353718e-08
populations O 0 1.0912874159885178e-08
. O 0 1.9789629490674088e-08

To O 0 2.8769207460754842e-08
facilitate O 0 9.544248946724565e-09
the O 0 1.2968180973516041e-09
evaluation O 0 7.813061309036584e-09
of O 0 2.6149731269242693e-08
ATM O 0 0.0008757872856222093
heterozygotes O 0 1.3541941257244616e-07
for O 0 3.7754246950960635e-10
susceptibility O 0 2.9131598466847208e-08
to O 0 1.9900855963150832e-10
other O 0 1.6734638119686451e-09
diseases O 1 0.9988632202148438
, O 0 2.6904453664933214e-10
such O 0 2.2982429292994766e-09
as O 0 1.3749800409357249e-08
breast B-Disease 1 0.9999998807907104
cancer I-Disease 0 4.041989450342953e-05
, O 0 3.455647712424792e-10
we O 0 2.3510743352161967e-10
have O 0 4.574940773438563e-11
attempted O 0 2.4357020844689714e-09
to O 0 7.18184123282839e-11
define O 0 4.668718744937905e-10
the O 0 1.3871193083048183e-10
most O 0 5.868595887026373e-11
common O 0 9.712991522192738e-11
mutations O 0 2.3072710408911234e-11
and O 0 3.409561175060638e-11
their O 0 4.725489097245905e-11
frequencies O 0 1.6329592122943382e-09
in O 0 4.620519966636039e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.704168302145263e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.781733732248881e-09
homozygotes O 0 2.6228963179164566e-07
from O 0 5.296793004205824e-10
10 O 0 3.587369734603385e-09
ethnic O 0 4.2569228142497195e-09
populations O 0 7.3636972075519225e-09
. O 0 2.1817186279804446e-08

Both O 0 1.5203023906451563e-07
genomic O 0 1.2296082729790214e-07
mutations O 0 3.1830258429010883e-09
and O 0 5.890297694044477e-10
their O 0 2.3854487829488846e-10
effects O 0 1.2985810649013274e-08
on O 0 5.7047429002921035e-09
cDNA O 0 2.5044462503842624e-08
were O 0 1.993593290450235e-09
characterized O 0 5.8871588493047966e-08
. O 0 1.5862829627621977e-07

Protein O 0 6.505449618998682e-07
- O 0 1.0911838188576439e-07
truncation O 0 3.254896512316918e-07
testing O 0 1.1354869933200007e-08
of O 0 8.596072298416857e-09
the O 0 1.0316013820954595e-08
entire O 0 1.5136936326598516e-07
ATM O 0 2.1849853055755375e-06
cDNA O 0 4.922396712458976e-08
detected O 0 1.8356290709675704e-08
92 O 0 8.374683346801248e-08
( O 0 3.790013303195394e-10
66 O 0 2.8613133196131457e-08
% O 0 4.4776846119809477e-10
) O 0 6.190393753158219e-10
truncating O 0 2.1608714462217904e-07
mutations O 0 2.252892539189588e-09
in O 0 4.843351275596319e-10
140 O 0 2.7920791012547852e-08
mutant O 0 6.372824401523758e-08
alleles O 0 2.3301331975034145e-09
screened O 0 1.3374145169109397e-07
. O 0 7.167906090899123e-08

The O 0 4.6677351406287926e-07
haplotyping O 0 5.027515362598933e-05
of O 0 4.5967536266289244e-07
patients O 0 3.2411922035180396e-08
with O 0 1.7128940488220223e-09
identical O 0 9.483081697680973e-08
mutations O 0 4.975081679958748e-09
indicates O 0 5.310418771387049e-10
that O 0 1.954550757354845e-11
almost O 0 4.0653671401491565e-11
all O 0 1.613058991933869e-11
of O 0 5.0750015301304074e-11
these O 0 4.7335805414272514e-11
represent O 0 1.3092932987790462e-11
common O 0 8.602870499307969e-11
ancestry O 0 2.7566790863908786e-11
and O 0 6.248696005073384e-11
that O 0 5.737648203774093e-11
very O 0 5.804044467261349e-10
few O 0 1.7201402968680668e-08
spontaneously O 0 8.045870458772697e-08
recurring O 0 3.223042585887015e-05
ATM O 0 0.001600538264028728
mutations O 0 1.0295884749211837e-06
exist O 0 2.4447567170682305e-07
. O 0 3.643774562078761e-07

Assays O 0 4.028019702673191e-06
requiring O 0 2.5343359766338835e-07
minimal O 0 1.9954096330820903e-07
amounts O 0 2.0696202085446203e-08
of O 0 7.825827985641354e-09
genomic O 0 2.1402539740478232e-09
DNA O 0 1.0731413535580714e-09
were O 0 3.1947493261963444e-11
designed O 0 1.3808953980287697e-09
to O 0 1.9761663139217234e-10
allow O 0 1.714834940713672e-10
rapid O 0 6.73512190463299e-10
screening O 0 1.2814089789259242e-09
for O 0 2.3973262264220807e-10
common O 0 2.8762496828704798e-09
ethnic O 0 1.9338617818220882e-08
mutations O 0 4.873509595881842e-08
. O 0 3.0545322715624934e-08

These O 0 1.1206885375258935e-07
rapid O 0 1.4013109250754496e-07
assays O 0 5.9562026422099734e-08
detected O 0 4.426442501426209e-08
mutations O 0 1.3465677461965697e-09
in O 0 2.332448956199329e-10
76 O 0 1.2119168779634037e-08
% O 0 7.241289512460725e-11
of O 0 9.981413473525436e-10
Costa O 0 2.161862795446723e-07
Rican O 0 5.956645168225805e-07
patients O 0 9.25832965847917e-10
( O 0 9.831211365829429e-12
3 O 0 8.372726956196175e-10
) O 0 3.4892651268325636e-11
, O 0 4.72547070917706e-11
50 O 0 2.577033031414544e-10
% O 0 4.1797291322476227e-11
of O 0 1.9214618784957338e-10
Norwegian O 0 1.4377245172170205e-08
patients O 0 1.4177081730792906e-10
( O 0 7.683472781627732e-12
1 O 0 8.030255349567028e-10
) O 0 3.947502741352693e-11
, O 0 3.600334960718321e-11
25 O 0 2.7755683862373814e-10
% O 0 1.984823069789421e-11
of O 0 1.5156763344403856e-10
Polish O 0 3.427167882819049e-07
patients O 0 9.663289057826319e-10
( O 0 1.6756596110667488e-11
4 O 0 1.1900793683849997e-09
) O 0 3.94541031789597e-11
, O 0 3.6878455150768374e-11
and O 0 8.6491189210669e-11
14 O 0 7.112186950486432e-10
% O 0 2.235878496237298e-11
of O 0 1.4365252043457843e-10
Italian O 0 5.252331192195925e-08
patients O 0 5.406076142300265e-10
( O 0 1.082719070649718e-11
1 O 0 2.0299493197484253e-09
) O 0 9.082629787160457e-11
, O 0 5.582938278347882e-11
as O 0 6.39619607278874e-11
well O 0 8.024892556024454e-11
as O 0 1.215698652856645e-10
in O 0 1.6021500792717802e-10
patients O 0 7.286265479855558e-10
of O 0 3.2554279272289932e-09
Amish O 0 1.0186094812070223e-07
/ O 0 8.588094857486794e-08
Mennonite O 0 7.407538760162424e-08
and O 0 2.6174817868707123e-09
Irish O 0 2.0737145689508907e-07
English O 0 5.8116832235555194e-08
backgrounds O 0 2.7734810004176325e-08
. O 0 4.466140168801758e-08

Additional O 0 3.012113438671804e-07
mutations O 0 1.3264784826105824e-08
were O 0 7.593023987340075e-10
observed O 0 7.924387257496335e-10
in O 0 2.0059161276453352e-10
Japanese O 0 4.6350955074103695e-08
, O 0 1.390134118928188e-09
Utah O 0 7.054813266904603e-08
Mormon O 0 1.1229704943716001e-09
, O 0 4.216788029864915e-11
and O 0 1.542489747041742e-10
African O 0 5.591583862596394e-10
American O 0 8.28575164035783e-09
patients O 0 8.744606816435407e-09
. O 0 2.6566395305849255e-08

These O 0 2.7706256844339805e-08
assays O 0 1.4711483586893337e-08
should O 0 1.5691013766083728e-10
facilitate O 0 4.7126445107403825e-11
screening O 0 3.483733856946003e-10
for O 0 5.109386247426073e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.5337788283886766e-07
in O 0 8.469499546137627e-10
the O 0 2.55435694818118e-09
populations O 0 1.070026511840183e-09
studied O 0 1.2823192285793539e-08
. O 0 3.1190205973530283e-09
. O 0 5.0775071258613025e-08

The O 0 6.972675237193471e-06
von B-Disease 1 0.9999997615814209
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999974966049194
Lindau I-Disease 1 1.0
tumor I-Disease 1 0.9998983144760132
suppressor O 0 1.5486722986679524e-05
gene O 0 7.838645288416046e-09
is O 0 1.4471542020277894e-10
required O 0 1.4815544624458e-10
for O 0 3.360693667797676e-10
cell O 0 2.8252484796098543e-09
cycle O 0 1.3597180270608078e-08
exit O 0 8.850673083315996e-09
upon O 0 4.376665252436851e-09
serum O 0 4.698435418504232e-08
withdrawal O 0 1.3276736865464045e-07
. O 0 2.1551171869305108e-07

The O 0 1.4994095920428663e-07
inactivation O 0 3.875452421198133e-06
of O 0 1.2859936759923585e-07
the O 0 7.29467117821514e-08
von B-Disease 1 0.9999983310699463
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 5.45470982160623e-07
VHL I-Disease 1 1.0
) I-Disease 0 6.290630949479237e-08
tumor I-Disease 0 0.47633352875709534
suppressor O 0 0.0006747281295247376
gene O 0 1.0903454494837206e-07
predisposes O 0 1.1199512783832688e-07
affected O 0 1.0702633224113356e-09
individuals O 0 1.3201387032146794e-11
to O 0 3.7660870949585146e-11
the O 0 2.3760684531026754e-09
human O 0 1.8713784811552614e-05
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.9963672936995636e-09
is O 0 9.857766686272029e-11
associated O 0 3.362559397590559e-10
with O 0 3.0456631661124334e-10
sporadic B-Disease 0 0.0026583438739180565
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 0.010785279795527458
RCC B-Disease 1 1.0
) O 0 3.5245344065515383e-07
and O 0 2.153848527086666e-06
brain B-Disease 1 0.9998581409454346
hemangioblastomas I-Disease 1 0.997195839881897
. O 0 8.428508522229095e-07

VHL O 1 0.9999935626983643
- O 0 2.5952180294552818e-05
negative O 0 8.880969630808977e-07
786 O 0 1.0726876098487992e-06
- O 0 3.6620568266698683e-07
0 O 0 1.7566290466675127e-07
RCC B-Disease 0 0.00034429540392011404
cells O 0 2.768067774994165e-09
are O 0 3.896576949991015e-10
tumorigenic O 0 2.2433118829212617e-06
in O 0 5.0855395450355445e-09
nude O 0 1.4894802689013886e-06
mice O 0 5.519374735030169e-09
which O 0 5.213248929769598e-11
is O 0 4.674748782518279e-11
suppressed O 0 2.582077440749231e-09
by O 0 2.035596344263091e-11
the O 0 2.24643059709706e-09
reintroduction O 0 9.135875416177441e-07
of O 0 4.2587689108586346e-07
VHL B-Disease 1 0.9996089339256287
. O 0 2.417257292108843e-06

Remarkably O 0 1.5558135828541708e-06
, O 0 3.791388536455997e-09
this O 0 3.563701764242033e-11
occurs O 0 1.1358085305612775e-10
without O 0 1.2306436425468803e-10
affecting O 0 5.617924458967138e-10
the O 0 2.935271470327905e-10
growth O 0 4.80554041004666e-10
rate O 0 5.857594409519606e-10
and O 0 2.2003297794892518e-10
cell O 0 5.94405302756229e-10
cycle O 0 7.352269904004061e-10
profile O 0 6.053663126337483e-10
of O 0 8.695487663246126e-10
these O 0 3.8702527294098843e-10
cells O 0 6.280791164936517e-11
in O 0 2.6893778870551444e-10
culture O 0 1.7357324466615864e-08
. O 0 5.273552261542136e-08

The O 0 5.843834856023022e-07
786 O 0 8.58362170674809e-07
- O 0 6.979448130550736e-08
0 O 0 1.0539522143915292e-08
cell O 0 2.3342034971562953e-09
line O 0 1.1743347982928753e-07
, O 0 7.782210986739813e-10
like O 0 1.670408811271784e-09
many O 0 1.1482598205603267e-09
cancer B-Disease 0 9.103676923416515e-09
cells O 0 6.986018014076834e-11
, O 0 1.3977159707412312e-10
fails O 0 1.4955979787956153e-09
to O 0 2.116553182718306e-10
exit O 0 1.1659647469741685e-08
the O 0 2.4094568562560426e-09
cell O 0 5.440513817234205e-09
cycle O 0 8.452993860430524e-09
upon O 0 2.559048306594036e-09
serum O 0 2.3671583804230067e-08
withdrawal O 0 1.2749399047606857e-07
. O 0 2.164773889035132e-07

Here O 0 1.8082529251728374e-08
, O 0 1.898562862479025e-09
it O 0 1.7217238745814711e-10
is O 0 3.232512868489579e-11
shown O 0 1.4454899950611111e-11
that O 0 9.468623801689446e-12
reintroduction O 0 4.790956964484394e-08
of O 0 4.586705681930425e-09
the O 0 4.4780796848442606e-09
wild O 0 1.7728596901633864e-07
- O 0 6.623731678701006e-07
type O 0 1.5735768101876602e-06
VHL B-Disease 1 0.9925325512886047
gene O 0 2.453178105099596e-08
restores O 0 2.554295086554248e-08
the O 0 2.3697410700407318e-09
ability O 0 2.2160999701981154e-09
of O 0 2.794561915209215e-08
VHL O 1 1.0
- O 0 0.00012198903277749196
negative O 0 1.2689248478636728e-06
RCC B-Disease 1 0.999953031539917
cancer I-Disease 0 4.069054853061971e-07
cells O 0 1.4044716778460753e-10
to O 0 1.8514891009235868e-10
exit O 0 6.998774892963411e-09
the O 0 2.595819781348041e-09
cell O 0 5.35404254264904e-09
cycle O 0 1.3040987845158725e-08
and O 0 4.5160950534750555e-09
enter O 0 1.0426636976035297e-07
G0 O 0 0.00013357758871279657
/ O 0 2.842598405550234e-06
quiescence O 0 1.6108374438772444e-06
in O 0 1.1645934883119935e-08
low O 0 5.946791930000472e-07
serum O 0 2.226288557949374e-07
. O 0 1.1449432690824324e-07

Both O 0 3.146969902445562e-06
VHL O 1 0.9999998807907104
- O 0 6.033155841578264e-06
positive O 0 1.80838739538558e-08
and O 0 1.1072534888967311e-08
VHL O 1 0.9667918086051941
- O 0 6.150959848127968e-07
negative O 0 9.330132400009461e-08
RCC B-Disease 0 8.463482663501054e-05
cells O 0 3.773014345398451e-09
exit O 0 1.683889649939374e-08
the O 0 2.2185020487341944e-09
cell O 0 8.482679447752162e-09
cycle O 0 6.299260668640727e-09
by O 0 3.395240477654937e-10
contact O 0 1.2434377971715094e-08
inhibition O 0 3.634990264345106e-07
. O 0 3.9530851836389047e-07

The O 0 3.142567265967955e-06
cyclin O 0 2.691195550141856e-05
- O 0 6.208358627191046e-06
dependent O 0 3.5172348589185276e-07
kinase O 0 1.9131157102947327e-07
inhibitor O 0 5.189684415540796e-08
, O 0 3.786734481536769e-09
p27 O 0 3.6879640674669645e-07
, O 0 1.2377604496904837e-09
accumulates O 0 7.434202586864558e-09
upon O 0 6.234294191997947e-10
serum O 0 9.328131600483403e-10
withdrawal O 0 7.95948473797381e-10
, O 0 1.1656389742320528e-10
only O 0 1.4674693751826062e-11
in O 0 1.7843905172898467e-11
the O 0 3.3765121254525354e-10
presence O 0 5.423395621484417e-10
of O 0 1.519588543885675e-08
VHL B-Disease 1 0.999990701675415
, O 0 2.0365809039191163e-09
as O 0 3.3350303074719534e-10
a O 0 7.453560685322103e-11
result O 0 9.689547081359606e-11
of O 0 4.938086606287584e-10
the O 0 4.6464385117239715e-10
stabilization O 0 5.01431465238511e-08
of O 0 4.6185924418296054e-08
the O 0 4.381261220487431e-08
protein O 0 7.686478653567974e-08
. O 0 5.7631908134681e-08

We O 0 4.45506245227989e-08
propose O 0 1.2403087445989058e-08
that O 0 8.867866163608795e-11
the O 0 1.172283825567888e-09
loss O 0 3.002304538313183e-08
of O 0 9.129502842597503e-08
wild O 0 4.12542067351751e-06
- O 0 9.351400876767002e-06
type O 0 7.234774329845095e-06
VHL B-Disease 1 0.9998705387115479
gene O 0 1.3292486000793247e-09
results O 0 8.599933265518445e-11
in O 0 3.0691980207331326e-11
a O 0 1.6848775152844553e-10
specific O 0 3.0028872721743483e-09
cellular O 0 3.16443156123114e-08
defect O 0 1.7256379436503266e-08
in O 0 3.630180878122502e-10
serum O 0 9.11690012372901e-09
- O 0 1.154415230075756e-07
dependent O 0 5.3719841908161925e-09
growth O 0 2.026970147284146e-09
control O 0 1.0525701199526338e-08
, O 0 3.3457467352171477e-10
which O 0 2.470846305335783e-10
may O 0 2.1615582657119603e-09
initiate O 0 1.675017387015032e-07
tumor B-Disease 0 5.5288684961851686e-05
formation O 0 2.1310017928044545e-06
. O 0 5.630587907035078e-07

This O 0 1.9088979286152608e-08
is O 0 2.018609723819509e-09
corrected O 0 1.2882370725719738e-08
by O 0 7.816168545726754e-11
the O 0 1.3308137924994412e-09
reintroduction O 0 7.786864841818897e-08
of O 0 1.4206492870982856e-08
wild O 0 4.724450661797164e-07
- O 0 4.7442354116356e-06
type O 0 0.0892690047621727
VHL B-Disease 1 1.0
, O 0 3.2801615645894344e-08
implicating O 0 1.3864358152204659e-05
VHL B-Disease 1 1.0
as O 0 7.001712987175779e-09
the O 0 7.793801160005387e-09
first O 0 3.886054589230525e-09
tumor B-Disease 0 8.552261760996771e-07
suppressor O 0 2.3441278074187721e-07
involved O 0 1.3349041871890677e-09
in O 0 2.2504864638506206e-10
the O 0 1.487095668828431e-09
regulation O 0 2.658474329564342e-08
of O 0 2.2634116803033066e-08
cell O 0 5.763572286099361e-09
cycle O 0 5.1388759914061666e-09
exit O 0 3.093019174116307e-09
, O 0 8.066818046881252e-11
which O 0 4.803503428352229e-11
is O 0 7.867215212620238e-11
consistent O 0 4.571663048125174e-10
with O 0 2.898506781812138e-11
its O 0 8.740584367394888e-10
gatekeeper O 0 4.2581756787285485e-08
function O 0 7.193799445026627e-10
in O 0 2.364178020020091e-10
the O 0 2.7260380619509306e-08
kidney O 0 1.1149792953801807e-05
. O 0 1.963087115086637e-08
. O 0 1.8067245832753542e-07

Piebaldism B-Disease 1 1.0
with O 0 0.427411824464798
deafness B-Disease 1 1.0
: O 0 2.7863228169167087e-08
molecular O 0 6.991570433712013e-09
evidence O 0 6.522054563085078e-10
for O 0 1.5860053548255593e-10
an O 0 7.535788104640062e-10
expanded O 0 5.793140189780388e-06
syndrome O 1 0.9999474287033081
. O 0 4.3629736978800793e-07

In O 0 1.3776785934282998e-08
a O 0 1.725679932285118e-09
South O 0 1.3600034876048994e-08
African O 0 8.560872566398814e-10
girl O 0 1.7967930476814331e-09
of O 0 8.194215861401233e-10
Xhosa O 0 2.935667282599752e-07
stock O 0 1.580951192181601e-08
with O 0 1.8366955178983346e-10
severe O 0 9.704261856313678e-07
piebaldism B-Disease 1 0.9999961853027344
and O 0 4.0530245314585045e-05
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 3.948318408220075e-06
identified O 0 4.219342653044578e-09
a O 0 4.594671310087506e-10
novel O 0 1.1978661618172737e-08
missense O 0 8.82089423726029e-09
substitution O 0 3.2155378359988163e-09
at O 0 2.4603556969537976e-09
a O 0 3.690753536123026e-10
highly O 0 3.2316347375882515e-09
conserved O 0 3.836755624320176e-08
residue O 0 5.153247784051018e-08
in O 0 7.938531498830059e-10
the O 0 4.662064956306722e-09
intracellular O 0 1.5115148244149168e-08
kinase O 0 4.162122024808923e-08
domain O 0 9.91701121222377e-09
of O 0 7.577446226036955e-09
the O 0 2.4578897139804212e-08
KIT O 0 0.0004980922676622868
proto O 0 0.00011598280252655968
- O 0 0.00010730504436651245
oncogene O 0 2.79407267953502e-05
, O 0 5.6444164897584415e-08
R796G O 0 2.4633662178530358e-05
. O 0 5.183660505281296e-07

Though O 0 2.833264431956195e-07
auditory B-Disease 0 4.989032731828047e-06
anomalies I-Disease 0 3.693081680467003e-06
have O 0 7.602805607298535e-10
been O 0 3.546398730236433e-10
observed O 0 4.77967110334987e-10
in O 0 1.6634006672067159e-10
mice O 0 5.320022200550056e-09
with O 0 5.995405283343302e-10
dominant O 0 8.877624395609018e-07
white O 0 2.0001948541903403e-08
spotting O 0 3.364501390024088e-05
( O 0 7.993370410019907e-09
W O 0 0.0005034893401898444
) O 0 3.278832205744209e-10
due O 0 1.8353971675821867e-09
to O 0 3.4100505752476806e-10
KIT O 1 0.9999998807907104
mutations O 0 3.073344601034478e-07
, O 0 2.0142993051308622e-08
deafness B-Disease 1 1.0
is O 0 8.165091713863148e-09
not O 0 4.098856809520157e-10
typical O 0 8.464012601905324e-09
in O 0 1.394162230106133e-09
human O 0 1.3365609063953343e-08
piebaldism B-Disease 0 2.802988819894381e-05
. O 0 3.641155501554749e-07

Thus O 0 7.968819915049608e-08
, O 0 1.4753063215522388e-09
the O 0 9.791435440220653e-10
occurrence O 0 4.175591783450727e-08
of O 0 1.4295069377112668e-06
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 5.8206628636980895e-06
this O 0 1.70985927638867e-08
patient O 0 4.059461389260832e-08
extends O 0 3.6234724110073557e-09
considerably O 0 5.240108347237538e-10
the O 0 6.208153435771635e-10
phenotypic O 0 1.1421057166671744e-07
range O 0 7.068983620683866e-08
of O 0 1.58601913824441e-08
piebaldism B-Disease 0 1.1297856872261036e-06
due O 0 7.393420542456397e-09
to O 0 1.2067032928442245e-09
KIT O 0 3.934858978027478e-05
gene O 0 8.750329349993535e-09
mutation O 0 8.520181227211765e-10
in O 0 8.488627162295259e-11
humans O 0 5.314025885994056e-10
and O 0 4.933050079536372e-10
tightens O 0 1.5854995183417486e-07
the O 0 2.248067954013777e-09
clinical O 0 1.4299002870643562e-08
similarity O 0 9.63636170858706e-10
between O 0 1.766171098260827e-10
piebaldism B-Disease 0 9.57619903374507e-08
and O 0 6.100828731092633e-10
the O 0 3.451833541223692e-10
various O 0 1.0034536535030725e-09
forms O 0 1.4604460751854731e-08
of O 0 1.7559384559717728e-06
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.311419322609254e-08
. O 0 1.2873557864168106e-07

Cycloheximide O 0 8.097775571513921e-05
facilitates O 0 5.2645471981804803e-08
the O 0 5.131147950976356e-09
identification O 0 4.904232131508479e-09
of O 0 3.392434422266888e-08
aberrant O 0 5.123434476672628e-08
transcripts O 0 1.4640550105582406e-08
resulting O 0 1.0180245091362394e-08
from O 0 8.712704446800501e-10
a O 0 1.4675211046366599e-09
novel O 0 1.93119689129162e-08
splice O 0 1.3487050409821677e-07
- O 0 3.510812973672728e-08
site O 0 1.8216985253616258e-08
mutation O 0 1.8572022808527322e-09
in O 0 4.602249414897841e-10
COL17A1 O 1 0.9999008178710938
in O 0 3.111866098137739e-09
a O 0 5.169222383472061e-09
patient O 0 2.0024280900088343e-08
with O 0 7.844268345991168e-09
generalized O 0 0.00010299481073161587
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 1.1298286153760273e-05

Patients O 0 3.095085958193522e-06
with O 0 1.3610925009288621e-07
generalized O 0 0.0002803306852001697
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
often O 0 5.065918173841055e-08
show O 0 1.3948224797388775e-08
decreased O 0 2.9007455992768882e-08
expression O 0 2.7047812878322475e-09
of O 0 9.830832148338686e-09
type O 0 2.2445730792242102e-05
XVII O 1 1.0
collagen O 1 0.9999994039535522
, O 0 2.6347489523459444e-08
a O 0 9.102843812058836e-09
transmembrane O 0 5.4281823480550884e-08
hemidesmosomal O 0 8.115393939078785e-07
protein O 0 5.240860634359024e-09
encoded O 0 2.940785948091218e-10
by O 0 7.72041208740859e-10
COL17A1 O 1 0.9995492100715637
. O 0 7.775502695039904e-07

This O 0 1.0359768154444282e-08
report O 0 4.40835901116543e-09
documents O 0 1.2896653522886936e-08
a O 0 6.67146649035999e-09
novel O 0 1.0461936028605123e-07
splice O 0 4.1157909436151385e-07
- O 0 8.993398381562656e-08
site O 0 2.9513360644273234e-08
mutation O 0 3.319122976463973e-09
in O 0 6.068727187447109e-10
COL17A1 O 1 0.9999994039535522
in O 0 3.4442195762096617e-09
a O 0 5.247942969077712e-09
patient O 0 1.0718409271248674e-08
with O 0 3.7644682926440964e-09
generalized O 0 7.9957208072301e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 3.5124070763004056e-08
and O 0 7.1537948898026116e-09
applies O 0 1.5742049441769268e-08
a O 0 1.8678517066383904e-10
new O 0 1.750979916614881e-10
methodology O 0 5.093021004931586e-10
to O 0 1.3452758351739647e-10
define O 0 3.918991797746685e-09
and O 0 9.260589517445794e-10
characterize O 0 3.357179778618047e-08
the O 0 1.405625660311216e-08
resulting O 0 1.7481651681805488e-08
mRNA O 0 9.604221418157977e-08
splice O 0 1.1256430525463657e-06
variants O 0 6.109813170951384e-07
. O 0 4.171031662281166e-07

Mutational O 0 7.474023732356727e-05
analysis O 0 6.731403345838771e-08
of O 0 2.5518804136481776e-07
COL17A1 O 1 0.9999998807907104
identified O 0 6.624060233662021e-08
a O 0 1.7285566755731452e-08
maternally O 0 5.954169068900228e-07
inherited O 0 3.883688350470038e-06
G O 0 2.2298272597254254e-06
- O 0 3.445765628384834e-08
to O 0 5.263460334248293e-09
- O 0 1.7880491895994055e-06
T O 0 2.2010556222085143e-06
transversion O 0 1.3151616258255672e-06
at O 0 2.458521608517117e-09
the O 0 6.827575171897138e-10
- O 0 5.8835634142440085e-09
1 O 0 1.2574377983298746e-08
position O 0 7.473213159414627e-09
of O 0 1.9214565938341366e-08
exon O 0 1.840669369812531e-06
32 O 0 1.198946961267211e-06
. O 0 3.047049688120751e-07

This O 0 1.255597137372888e-08
acceptor O 0 2.11982675857314e-09
splice O 0 1.7455137424349232e-07
- O 0 5.0411273377903854e-08
site O 0 1.7948689645663762e-08
mutation O 0 1.6619237097614814e-09
led O 0 7.872202889558366e-10
to O 0 1.8188635320104396e-10
the O 0 9.081438934188668e-10
formation O 0 5.87061643742004e-09
of O 0 3.7216697279518485e-08
aberrant O 0 1.6875551622774765e-08
transcripts O 0 1.083396217183008e-08
present O 0 5.201306052526888e-09
at O 0 6.631911020349435e-08
extremely O 0 7.444080551977095e-08
low O 0 9.20168247375841e-07
levels O 0 4.7249281465155946e-07
. O 0 2.26717119744535e-07

Based O 0 1.802654168159279e-07
on O 0 5.20944034576587e-08
our O 0 7.3750263673844074e-09
recent O 0 1.882566991184831e-09
finding O 0 1.0849878773200317e-09
that O 0 2.2960247592074268e-10
cycloheximide O 0 5.596611117653083e-06
stabilized O 0 2.418825488348375e-06
mutant O 0 1.4912595815985696e-06
COL17A1 O 0 0.00026942676049657166
transcripts O 0 4.530885533426954e-08
in O 0 2.804679599677229e-09
keratinocytes O 0 4.238517448129642e-08
homozygous O 0 2.7848670924868202e-08
for O 0 9.032292691557586e-10
a O 0 2.307968705039798e-09
frameshift O 0 5.3188074389254325e-08
mutation O 0 1.1238812103187001e-09
, O 0 8.063464479457494e-11
the O 0 3.2868716082212757e-10
effects O 0 7.75433264266212e-08
of O 0 1.6375386380218515e-08
the O 0 5.833903582441735e-09
splice O 0 9.806508671772463e-08
- O 0 1.9245192106609466e-08
site O 0 5.483812515194586e-09
mutation O 0 3.6757477617221923e-10
on O 0 6.241421268704528e-10
splicing O 0 4.752628512960655e-09
of O 0 1.5214475013181072e-08
COL17A1 O 0 0.004448620602488518
transcripts O 0 7.581279959367748e-08
were O 0 2.913869590059903e-09
determined O 0 2.1748205458749226e-09
using O 0 4.591526325814499e-10
reverse O 0 2.920685915341892e-09
transcriptase O 0 1.0369113345731762e-09
polymerase O 0 4.4487580286300954e-10
chain O 0 4.602424830135732e-10
reaction O 0 2.6239123721016888e-11
of O 0 8.436351062179881e-10
total O 0 4.709546641556983e-10
RNA O 0 5.398031799330738e-09
from O 0 5.274693459789148e-10
keratinocytes O 0 5.181126194742092e-09
incubated O 0 3.4654379366116927e-09
for O 0 3.036683682289265e-10
2 O 0 9.08158597212605e-08
. O 0 7.972209203899183e-08

5 O 0 2.4254447339444596e-07
h O 0 6.909681271594081e-09
in O 0 2.2199994620386576e-10
the O 0 1.230430646259606e-09
presence O 0 1.4593064534551559e-09
or O 0 9.372503884108596e-10
absence O 0 9.790861454916922e-09
of O 0 2.5075435061694407e-08
10 O 0 3.934249903636555e-08
microg O 0 3.942418061342323e-06
cycloheximide O 0 9.108835911320057e-06
per O 0 4.248465046430283e-08
ml O 0 5.267101641948102e-06
. O 0 2.3227602241604473e-07

Using O 0 2.7381695133499306e-08
this O 0 4.2755057827470466e-10
approach O 0 7.3683619206121875e-09
, O 0 1.8742121188353167e-09
an O 0 1.3309229274227619e-09
abnormally O 0 7.775808086307734e-08
spliced O 0 2.0168216963156738e-07
transcript O 0 3.250379521091418e-08
was O 0 1.9875955103998422e-08
identified O 0 4.571785172657883e-10
that O 0 3.9217545877434645e-11
contains O 0 1.1338393557380755e-09
an O 0 7.392016859730788e-11
extra O 0 3.4992591047000587e-09
264 O 0 2.2285744361028037e-09
bases O 0 8.594334133249504e-09
upstream O 0 1.9649602833737845e-08
from O 0 1.1244750686145721e-09
exon O 0 1.2795808856935764e-07
32 O 0 3.587754804357246e-08
, O 0 4.265706676775949e-10
resulting O 0 7.862404061143025e-10
in O 0 4.745379644788272e-10
a O 0 8.421388031365495e-09
premature O 0 1.5389922225494956e-07
termination O 0 1.3579330016000313e-07
codon O 0 2.560407779128582e-07
27 O 0 9.392518762751934e-08
bp O 0 8.808254392533854e-08
downstream O 0 1.6074693576229038e-07
from O 0 2.4535886655741024e-09
the O 0 5.162003091641054e-08
cryptic O 0 1.6245246570179006e-06
splice O 0 2.5214098968717735e-06
site O 0 9.59737121775106e-07
. O 0 5.07581319197925e-07

Three O 0 7.630459464280648e-08
other O 0 2.4147108756977786e-09
splice O 0 1.8882785113305545e-08
variants O 0 4.8880295366871e-09
, O 0 2.3529225789964414e-10
including O 0 3.4870181742086004e-10
one O 0 8.808964668816088e-11
derived O 0 3.7893459203797164e-11
from O 0 2.2678981956292255e-11
the O 0 8.76265171534385e-10
skipping O 0 2.3701943518972257e-08
of O 0 1.2102860047491504e-08
exon O 0 1.596537941850329e-07
32 O 0 4.5395701420147816e-08
, O 0 8.291549669081633e-10
were O 0 8.645659743677925e-10
also O 0 3.7873988389947044e-09
identified O 0 1.9762246949994733e-08
. O 0 1.0144583484361647e-07

These O 0 2.3635993784409948e-07
results O 0 4.320958701953259e-09
indicate O 0 7.055278028467171e-10
the O 0 1.7941322871806165e-09
usefulness O 0 5.130817726239911e-08
of O 0 1.3750192984218756e-08
cycloheximide O 0 1.0887883945542853e-06
treatment O 0 4.108690276893867e-09
in O 0 8.593276090707036e-11
evaluating O 0 5.646610290455101e-09
the O 0 1.2978127461593658e-09
abnormal O 0 4.934489483687798e-10
processing O 0 1.8802273071827358e-09
of O 0 2.418361289002746e-09
mRNA O 0 3.3373990238061424e-09
due O 0 3.843521501067926e-09
to O 0 5.879062237035271e-10
splice O 0 7.044997829552813e-08
- O 0 2.843799329355079e-08
site O 0 8.709318599642302e-09
mutations O 0 2.3685571282072715e-09
, O 0 1.863983134509084e-10
because O 0 8.243343785352408e-10
( O 0 8.528424078058094e-10
i O 0 1.1893106943716703e-08
) O 0 1.5966781230503102e-09
aberrant O 0 1.1014378742402187e-08
splicing O 0 8.464900780325024e-09
often O 0 3.2343275280233286e-10
generates O 0 8.03034694296656e-10
a O 0 6.228209059599976e-10
premature O 0 1.3395315967557053e-08
termination O 0 2.0993631721921702e-08
codon O 0 1.5120539487156748e-08
, O 0 5.080834641901788e-10
( O 0 2.512443586510926e-10
ii O 0 4.552568100280041e-07
) O 0 1.2274280480895072e-09
transcripts O 0 9.775654064014816e-09
with O 0 1.5960629484723654e-09
premature O 0 5.528195856641105e-08
termination O 0 5.4371977142864125e-08
codons O 0 7.27180591297838e-08
can O 0 2.0575781356502176e-10
occur O 0 8.156584435647929e-11
at O 0 1.1936780452970197e-09
low O 0 4.183835144999648e-08
or O 0 2.658924413978525e-09
undetectable O 0 1.0140752237930428e-07
levels O 0 5.724785090421847e-10
due O 0 9.435766612497787e-10
to O 0 5.261279745205627e-10
nonsense O 0 1.789509163074854e-08
- O 0 7.963452119952308e-09
mediated O 0 2.127465981160981e-09
mRNA O 0 5.855024798329111e-10
decay O 0 5.003497616229424e-09
, O 0 5.2935381772423185e-11
and O 0 2.0124844846147738e-10
( O 0 3.3610011995754974e-10
iii O 0 1.1681901014526375e-05
) O 0 1.1042496916857658e-09
the O 0 5.79756131990905e-10
levels O 0 9.333221973051309e-10
of O 0 5.260447077937158e-10
these O 0 1.1580114644971218e-10
transcripts O 0 4.705551504002869e-10
can O 0 7.750078356849599e-11
be O 0 7.021525028072517e-11
increased O 0 6.212678149708495e-10
by O 0 1.3324926717572794e-09
cycloheximide O 0 1.0998151992680505e-05
. O 0 3.735790983228071e-07

A O 0 3.9497867874160875e-06
deletion O 0 2.904979510276462e-07
mutation O 0 7.688043979214854e-09
in O 0 1.226622914352049e-09
COL17A1 O 1 0.9999949932098389
in O 0 3.304222229161269e-09
five O 0 2.1255475157744286e-09
Austrian O 0 8.599093348493625e-08
families O 0 9.092891023465555e-11
with O 0 1.3731866754795874e-09
generalized O 0 8.482151315547526e-06
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999134361743927
represents O 0 4.8991392276320767e-08
propagation O 0 3.459878783473869e-08
of O 0 4.183707602578579e-08
an O 0 3.4562295248008468e-09
ancestral O 0 5.162240199751977e-07
allele O 0 5.857800715602934e-07
. O 0 3.721997074990213e-07

Patients O 0 4.459008778212592e-06
with O 0 1.3084282102227007e-07
generalized O 0 0.0007921367650851607
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 7.696086612440922e-08
a O 0 2.2785970887895246e-09
usually O 0 6.81312284367408e-10
nonlethal O 0 1.873048489642315e-07
form O 0 3.9406762297744535e-09
of O 0 9.915502374724383e-08
junctional B-Disease 1 0.9624080061912537
epidermolysis I-Disease 1 0.9999988079071045
bullosa I-Disease 1 0.9999569654464722
, O 0 1.7713547961761833e-08
have O 0 1.0698529839814341e-09
generalized O 0 3.760544231568019e-08
blistering B-Disease 0 4.699232931670849e-07
, O 0 9.999691741313654e-09
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 4.308248662709957e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 4.310523422645929e-07
and O 0 1.99538021661283e-06
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 7.127388812477875e-07

Skin B-Disease 1 1.0
fragility I-Disease 0 1.9907078240066767e-05
in O 0 3.290185235371723e-09
most O 0 3.7797473484424415e-10
cases O 0 4.4235937135539416e-10
is O 0 4.779149298528296e-11
due O 0 9.617778795600884e-10
to O 0 4.881291482128347e-10
mutations O 0 9.295434422185167e-10
in O 0 2.087510164727746e-10
the O 0 5.582017514882409e-09
gene O 0 4.864498581724774e-09
encoding O 0 4.7170225059289805e-08
type O 0 0.00010420259786769748
XVII O 1 1.0
collagen O 1 1.0
( O 0 1.404913092528659e-07
COL17A1 O 1 1.0
) O 0 4.736676473271473e-08
. O 0 1.0259329741302281e-07

Recently O 0 1.085978055925807e-06
, O 0 2.0309263604190164e-08
we O 0 1.8641155286047706e-09
reported O 0 1.2394117954173112e-09
five O 0 4.629612804230021e-10
Austrian O 0 6.307715239017853e-08
families O 0 4.8018915232983517e-11
with O 0 1.8827106540442173e-09
generalized O 0 9.93556750472635e-06
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 3.9188000755530084e-07
share O 0 1.2762994217041523e-08
the O 0 1.510898073320277e-08
same O 0 2.4191006531282255e-08
COL17A1 O 1 1.0
mutation O 0 1.2325451734795934e-06
. O 0 2.516614472369838e-07

Affected O 0 1.8499596876608848e-07
individuals O 0 2.826961165158792e-10
in O 0 1.0827794910683863e-10
three O 0 1.2938403126661058e-10
families O 0 5.644189976505842e-12
are O 0 8.65109459763369e-12
homozygous O 0 4.1484546353665053e-10
for O 0 4.494298683210829e-11
4003delTC O 0 3.575608076289427e-08
, O 0 1.8588384997908491e-10
whereas O 0 2.4203861137550575e-10
those O 0 8.512184707099024e-11
in O 0 8.001599383078428e-11
two O 0 3.378786139762724e-10
others O 0 7.666791645988269e-10
are O 0 3.11667580632502e-10
compound O 0 1.4795847214088553e-08
heterozygotes O 0 5.90461127103481e-07
. O 0 2.659347444478044e-07

To O 0 1.9265280926106243e-08
determine O 0 6.193738855131414e-09
if O 0 6.367107951987805e-10
the O 0 1.4278910276388501e-09
occurrence O 0 7.289466363857855e-09
of O 0 1.4145332016823886e-08
4003delTC O 0 3.4027777928713476e-07
in O 0 3.2929273197090936e-10
these O 0 1.1923195764040884e-09
unrelated O 0 8.166820109067885e-09
families O 0 9.641278227168204e-12
signifies O 0 2.2591956083672926e-10
propagation O 0 1.7586656575474535e-09
of O 0 3.2997000687373657e-09
an O 0 9.419438562474625e-10
ancestral O 0 6.046698786121851e-08
allele O 0 2.222620132386055e-08
or O 0 1.0203591749302632e-08
a O 0 1.3397001730197644e-08
mutational O 0 7.2174975684902165e-06
hot O 0 7.042631750664441e-06
spot O 0 4.787011675944086e-07
, O 0 1.4722563168589886e-09
haplotypes O 0 1.3798343578841354e-09
were O 0 8.887423436076958e-11
determined O 0 2.6185242862908353e-10
for O 0 7.52237230838837e-11
polymorphisms O 0 1.0670345718111207e-09
both O 0 6.663591345379416e-10
within O 0 3.345391075271209e-09
and O 0 1.4343609855416162e-08
flanking O 0 0.0002483292482793331
COL17A1 O 1 1.0
. O 0 2.695260945984046e-06

Five O 0 9.284621569349838e-07
intragenic O 0 3.6779786114493618e-06
polymorphisms O 0 1.0177720888293607e-08
were O 0 1.222666079492285e-09
chosen O 0 8.307696752751781e-10
based O 0 2.9618277275211824e-10
on O 0 4.553772914306364e-09
their O 0 6.1734763967535855e-09
informativeness O 0 1.9334789612912573e-05
. O 0 6.751783985237125e-07

One O 0 1.764990820163348e-08
of O 0 3.816689186919575e-09
these O 0 2.798036524698233e-10
, O 0 1.2854499409353792e-10
not O 0 6.847603734039254e-11
previously O 0 2.7099864574609e-09
reported O 0 1.2106454727600635e-09
, O 0 1.4661138969529475e-09
was O 0 2.8307894694989955e-08
2988 O 0 1.4171401744533796e-05
A O 0 1.9810295270872302e-07
or O 0 2.442746005471008e-09
C O 0 8.981947274833146e-08
that O 0 2.945945154486651e-10
introduces O 0 2.2211962047435918e-08
a O 0 3.373518964178146e-10
new O 0 4.5424414230055277e-10
restriction O 0 6.2899800923332805e-09
site O 0 7.855198269623997e-09
for O 0 4.541195863794201e-09
Eco0109 O 0 1.6043728464865126e-05
I O 0 3.0213766876840964e-05
. O 0 9.305426260652894e-07

All O 0 1.9481601043480623e-07
the O 0 3.212878851854839e-08
4003delTC O 0 8.42073063722637e-07
alleles O 0 2.648573360630735e-09
showed O 0 9.733025496672099e-10
the O 0 1.2073894106734429e-09
same O 0 5.079449083567056e-10
haplotype O 0 1.1334204685908844e-08
for O 0 4.643470330467636e-10
these O 0 1.2618457390090043e-09
five O 0 1.41012801435636e-09
polymorphic O 0 2.4919341967688524e-07
markers O 0 1.8627802091941703e-06
. O 0 2.8855436084995745e-07

Fourteen O 0 1.0372756150900386e-05
microsatellite O 0 1.1737116665244685e-06
polymorphisms O 0 1.8401792090116942e-08
were O 0 1.2601597543238086e-09
selected O 0 1.3114890284882108e-09
based O 0 1.1323345733282864e-10
on O 0 5.956276027951901e-10
their O 0 4.079257487354937e-10
high O 0 2.75701452778776e-08
heterozygosity O 0 4.2545471501398424e-07
and O 0 2.6773212535857738e-09
their O 0 1.6373067346364678e-09
location O 0 1.767247681527806e-08
within O 0 9.230229025547487e-09
10q23 O 0 3.12291467707837e-06
- O 0 3.2285918223351473e-06
q25 O 0 3.399229171918705e-05
near O 0 9.944526027538814e-06
COL17A1 O 1 0.9999892711639404
. O 0 2.2710737539455295e-06

Three O 0 4.798968689101457e-08
families O 0 3.8485370446039724e-10
shared O 0 2.098877738276883e-09
microsatellite O 0 4.2816719059146635e-08
polymorphisms O 0 4.978964351920467e-09
covering O 0 4.033744858134014e-07
at O 0 1.34025226472545e-08
most O 0 7.908940724554725e-10
19 O 0 3.8923748668651115e-09
cM O 0 5.4050090625423763e-08
, O 0 3.527684533377595e-10
whereas O 0 2.4063417924935493e-10
the O 0 8.543093454882467e-10
others O 0 4.2268719080418293e-10
shared O 0 5.208898312680788e-10
smaller O 0 4.78036632500789e-09
regions O 0 1.5129224095744576e-08
consistent O 0 2.965294010337516e-09
with O 0 9.139647372258253e-11
cross O 0 4.99557328836886e-09
- O 0 3.034833895299016e-08
over O 0 5.537923453147187e-09
events O 0 8.217488911554938e-10
during O 0 2.7099594790414017e-10
passage O 0 3.5113184582158397e-10
of O 0 2.284213651559952e-10
this O 0 3.230355913319549e-11
mutation O 0 4.778549778094998e-10
through O 0 2.6152849330607353e-10
several O 0 5.085869503318463e-09
generations O 0 5.067358443966441e-08
. O 0 1.022639111170065e-07

These O 0 1.7154427212062728e-07
results O 0 1.3911347629402826e-08
indicate O 0 3.2393980831102454e-09
that O 0 3.9482578317873163e-10
4003delTC O 0 1.7560931553362025e-07
occurs O 0 5.099144440023906e-10
on O 0 2.7425797188840306e-09
a O 0 1.2343420729976629e-09
single O 0 3.3607916449795994e-09
ancestral O 0 3.081449762021293e-08
allele O 0 1.6970448157849205e-08
. O 0 1.709210373235237e-08
. O 0 3.0242802040447714e-07

The O 0 3.226313992854557e-06
haptoglobin O 0 4.71996572741773e-05
- O 0 2.1086591459607007e-06
gene O 0 6.037421940163767e-08
deletion O 0 9.546982937536086e-08
responsible O 0 3.524237968122179e-08
for O 0 1.6406868752483206e-08
anhaptoglobinemia B-Disease 0 0.0007531715673394501
. O 0 7.023610351097886e-07

We O 0 8.161701003928101e-08
have O 0 4.705120737469315e-10
found O 0 1.1545137762469793e-10
an O 0 7.210802788204518e-11
allelic O 0 1.362522539238853e-07
deletion O 0 6.172501798573649e-08
of O 0 1.364129502690048e-07
the O 0 2.1604614630632568e-07
haptoglobin O 0 3.104519782937132e-05
( O 0 5.5201319071329635e-09
Hp O 0 8.551236874154711e-08
) O 0 6.240361560827523e-10
gene O 0 4.2812914324841245e-10
from O 0 2.183015157530832e-10
an O 0 1.644338137873902e-10
individual O 0 3.9276401575527586e-10
with O 0 1.1031802138461444e-09
anhaptoglobinemia B-Disease 0 0.0001027607504511252
. O 0 8.165669669324416e-07

The O 0 2.6184952730545774e-06
Hp O 0 8.030551725823898e-07
gene O 0 5.757606391654235e-09
cluster O 0 1.9839518472508644e-08
consists O 0 8.650888339012397e-10
of O 0 7.012841973796924e-10
coding O 0 7.208513785883497e-09
regions O 0 5.439209971314085e-08
of O 0 1.426129983883584e-06
the O 0 2.055588197436009e-07
alpha O 0 3.5520482555284616e-08
chain O 0 1.7624869341759108e-09
and O 0 3.2805458349827177e-10
beta O 0 1.225919543657028e-08
chain O 0 3.2948199724103233e-09
of O 0 3.8330671969788455e-09
the O 0 7.176193417279819e-09
haptoglobin O 0 5.375106866267743e-07
gene O 0 1.4032166539834634e-09
( O 0 9.923113025722685e-11
Hp O 0 4.668026409859749e-09
) O 0 5.00127890490365e-11
and O 0 3.896725719876315e-10
of O 0 5.615270470826772e-09
the O 0 4.964076705249454e-09
alpha O 0 7.290578807328529e-09
chain O 0 5.547435288910663e-10
and O 0 2.157787976075909e-10
beta O 0 7.946519886559145e-09
chain O 0 1.6032819516453856e-09
of O 0 2.494785711348868e-09
the O 0 3.777154589101883e-09
haptoglobin O 0 2.214170677916627e-07
- O 0 5.593701501993564e-08
related O 0 3.19089323852495e-08
gene O 0 2.1477948308756822e-09
( O 0 1.6265981617191727e-10
Hpr O 0 1.131537388232573e-07
) O 0 2.816471778022134e-10
, O 0 1.7483167691345614e-10
in O 0 1.37340860906221e-10
tandem O 0 3.0055402611139925e-09
from O 0 2.365571905027508e-10
the O 0 2.9875084628372406e-09
5 O 0 6.401037921932584e-08
side O 0 6.174215627652302e-07
. O 0 3.531819174895645e-07

Southern O 0 1.5584149878122844e-05
blot O 0 0.000134931891807355
and O 0 5.1002682965872737e-08
PCR O 0 5.538517200420756e-08
analyses O 0 1.3091604245119015e-08
have O 0 4.678414600167713e-11
indicated O 0 8.853517918794296e-11
that O 0 8.324644792945257e-12
the O 0 1.4864569297667884e-10
individual O 0 1.6392111626406525e-11
with O 0 2.9622328895362315e-11
anhaptoglobinemia B-Disease 0 9.415178965355153e-07
was O 0 3.135377113494542e-08
homozygous O 0 9.140702417198554e-09
for O 0 4.038628598213023e-10
the O 0 2.566243439972027e-09
gene O 0 3.2349878331672244e-10
deletion O 0 1.427986284774363e-09
and O 0 2.283751798781708e-10
that O 0 2.7560639534462972e-11
the O 0 6.393394147430342e-10
gene O 0 2.1464340027588236e-10
deletion O 0 1.3819677624482551e-09
was O 0 1.2336665022871784e-09
included O 0 6.632840943154861e-10
at O 0 1.05429354135822e-09
least O 0 2.080053143616034e-11
from O 0 4.73914518739349e-11
the O 0 7.05753899765682e-10
promoter O 0 1.4329287978398497e-06
region O 0 1.8046837340079946e-06
of O 0 3.601670869102236e-06
Hp O 0 1.5236189483402995e-06
to O 0 4.560450506119196e-08
Hpr O 0 2.884712330342154e-06
alpha O 0 2.7198369778602682e-08
but O 0 3.0128338712742675e-10
not O 0 1.606293015266047e-10
to O 0 2.465156301312277e-09
Hpr O 0 5.107719061925309e-06
beta O 0 9.499797783973918e-07
( O 0 1.297924878684853e-08
Hpdel O 0 8.390557195525616e-05
) O 0 8.215930336064048e-08
. O 0 2.412063508927531e-07

In O 0 7.61966401086056e-09
addition O 0 5.715034667730379e-09
, O 0 5.660129032136751e-10
we O 0 1.3598983050755464e-10
found O 0 7.379254846062722e-11
seven O 0 4.3996774973242836e-11
individuals O 0 6.000669796127345e-13
with O 0 7.216165165413457e-12
hypohaptoglobinemia B-Disease 0 9.044023840942828e-08
in O 0 1.4473419684968292e-10
three O 0 9.570926690072312e-11
families O 0 1.7415918967395028e-12
, O 0 8.091223004103032e-12
and O 0 5.348810630523282e-11
the O 0 5.190619600803359e-10
genotypes O 0 2.6037536571266173e-09
of O 0 6.179696754315955e-09
six O 0 5.808186154254713e-10
of O 0 8.59748272574734e-09
the O 0 1.0248079718166991e-08
seven O 0 1.1829393020690304e-09
individuals O 0 2.0633661446112228e-11
were O 0 5.495041574543613e-11
found O 0 1.7179842271008994e-10
to O 0 1.1380513198488984e-09
be O 0 2.008130728370361e-08
Hp2 O 1 0.999957799911499
/ O 0 0.004920871462672949
Hpdel O 1 0.9999831914901733
. O 0 3.0376481845451053e-06

The O 0 1.411665948580776e-07
phenotypes O 0 3.83949334548106e-08
and O 0 2.0058978922321558e-09
genotypes O 0 6.777198802154771e-09
in O 0 8.197541256915741e-11
one O 0 6.181105627334205e-11
of O 0 2.8695409937107286e-10
these O 0 2.912183341696739e-11
three O 0 1.2056577090857612e-11
families O 0 6.460695693710772e-13
showed O 0 3.135850953905894e-11
the O 0 6.536525765099555e-10
father O 0 2.4994342151529736e-09
to O 0 1.381593506266654e-09
be O 0 6.745976222077843e-09
hypohaptoglobinemic B-Disease 0 1.8863938748836517e-05
( O 0 7.706468352353113e-09
Hp2 O 0 0.00040007452480494976
) O 0 6.2513607623770895e-09
and O 0 1.99352587770818e-08
Hp2 O 0 0.0006526108481921256
/ O 0 6.028118946233008e-07
Hpdel O 0 0.00029349621036089957
, O 0 3.719879737573706e-09
the O 0 5.609329445377398e-09
mother O 0 1.1436261937447512e-09
to O 0 3.1784500031939444e-10
be O 0 3.3257244180795453e-10
Hp2 O 0 9.72104544416652e-07
- O 0 4.288594723789174e-08
1 O 0 3.674090010008513e-08
and O 0 3.730828979087164e-09
Hp1 O 0 1.761931889632251e-05
/ O 0 1.494167918281164e-07
Hp2 O 0 1.0297426342731342e-05
, O 0 5.294509830555683e-10
one O 0 7.887228370417887e-11
of O 0 2.4961124833744464e-10
the O 0 2.2821407263950988e-10
two O 0 5.222175816776975e-11
children O 0 2.8992036202324378e-11
to O 0 4.61620776326388e-11
be O 0 7.52345186150194e-10
hypohaptoglobinemic B-Disease 0 3.3449130114604486e-06
( O 0 3.941465820389567e-09
Hp2 O 0 0.0005097334505990148
) O 0 3.082647692664864e-09
and O 0 8.988558342082342e-09
Hp2 O 0 0.006676127202808857
/ O 0 6.861328074592166e-07
Hpdel O 0 0.08821450918912888
, O 0 7.656300038405561e-10
and O 0 3.8430356119611986e-10
the O 0 3.5669198150678483e-10
other O 0 1.9024151698410208e-10
child O 0 2.5411481252568535e-10
to O 0 6.489973142231875e-11
be O 0 1.0288224716603622e-09
Hp1 O 0 2.8920672775711864e-05
and O 0 4.517544383020322e-08
Hp1 O 1 0.9999251365661621
/ O 0 1.3562504136643838e-05
Hpdel O 1 0.9950811862945557
, O 0 1.0540648354151472e-08
showing O 0 1.3422451594635731e-08
an O 0 1.95015870119164e-09
anomalous O 0 2.481637011442217e-07
inheritance O 0 7.045440497677191e-07
of O 0 7.534292763011763e-07
Hp O 0 6.736091222592222e-07
phenotypes O 0 3.1538629485794445e-08
in O 0 3.7027825250390833e-10
the O 0 5.004022529675467e-09
child O 0 8.356234815209973e-09
with O 0 3.753398036820954e-09
Hp1 O 0 0.0012021510628983378
. O 0 9.161509524346911e-07

The O 0 2.77123945124913e-06
Hp2 O 0 0.011197955347597599
/ O 0 1.2677428458118811e-05
Hpdel O 0 0.0020619987044483423
individuals O 0 1.6884492692881281e-09
had O 0 1.6639664091044892e-09
an O 0 1.7451184941563724e-10
extremely O 0 1.9955030960971953e-09
low O 0 1.332284949029372e-08
level O 0 4.2457511284510474e-08
of O 0 3.1335633821072406e-07
Hp O 0 1.78075038093084e-06
( O 0 3.801076786658086e-09
mean O 0 3.073894916383324e-08
+ O 0 5.5772391149844225e-09
/ O 0 3.7250575957159526e-08
- O 0 3.2695245977265586e-07
SD O 0 0.00027347958530299366
= O 0 1.380008818330225e-08
0 O 0 3.6901710576131563e-09
. O 0 5.872057839972911e-10
049 O 0 5.923980097577441e-07
+ O 0 2.518518726901675e-09
/ O 0 8.738071599623254e-09
- O 0 2.9350898600455366e-08
0 O 0 1.1562205415316384e-08
. O 0 1.3501656459524725e-09
043 O 0 1.4499511280519073e-06
mg O 0 3.8356404274964007e-07
/ O 0 4.80210040620932e-08
ml O 0 3.22201039182346e-08
; O 0 1.1661682730590428e-10
n O 0 1.5005689746327988e-10
= O 0 9.029343245314791e-11
6 O 0 3.714170637714176e-10
) O 0 2.0181340973368656e-11
, O 0 1.8131334975080016e-11
compared O 0 1.3820718007540034e-11
with O 0 1.4112890543704903e-11
the O 0 2.5496632582999723e-10
level O 0 1.6443515438169243e-09
( O 0 5.219387769206385e-11
1 O 0 3.405054460614565e-09
. O 0 4.452985480352112e-10
64 O 0 1.0771016079047513e-08
+ O 0 1.0400844629998574e-09
/ O 0 5.530059521419162e-09
- O 0 3.241390089669949e-08
1 O 0 3.0871209588667625e-08
. O 0 2.1578057118887273e-09
07 O 0 1.8734572222456336e-06
mg O 0 6.512787535939424e-07
/ O 0 1.1201007765748727e-07
ml O 0 4.399231201546172e-08
) O 0 4.839663739208966e-11
obtained O 0 1.0074804879245391e-10
from O 0 1.7108688077360767e-10
52 O 0 9.748561957678703e-09
healthy O 0 3.541574367105227e-09
volunteers O 0 8.641735660397387e-10
having O 0 1.8862473805114632e-09
phenotype O 0 8.517601735036351e-09
Hp2 O 0 3.0241699278121814e-06
, O 0 2.1735848676485148e-09
whereas O 0 1.2096760260149608e-09
the O 0 1.4052280450371768e-09
serum O 0 3.2527467386245235e-09
Hp O 0 7.257779710556633e-09
level O 0 3.471689824507962e-09
of O 0 5.1093498321108655e-09
an O 0 4.937267261695411e-10
individual O 0 5.134435099307666e-10
with O 0 9.65895918803028e-10
Hp1 O 0 0.020564723759889603
/ O 0 6.47504884909722e-06
Hpdel O 0 0.0006957878940738738
was O 0 4.049011010920367e-07
0 O 0 3.8178200156835373e-07
. O 0 1.4560548322606337e-07

50 O 0 3.769093382288702e-06
mg O 0 1.3591909009846859e-05
/ O 0 1.510490960754396e-06
ml O 0 9.391889079779503e-07
, O 0 9.4377283765823e-10
which O 0 7.242809824115071e-11
was O 0 4.590028912510036e-10
approximately O 0 8.099116516335769e-11
half O 0 6.23574178404418e-11
the O 0 1.9855056487827483e-10
level O 0 2.5081163812501472e-09
of O 0 8.233967285775634e-09
Hp O 0 3.455512853633991e-08
in O 0 1.218687151194331e-09
control O 0 7.247586495395808e-07
sera O 0 8.336754399351776e-05
from O 0 7.1048686933750105e-09
the O 0 2.0729981287104238e-08
Hp1 O 0 5.049315404903609e-06
phenotype O 0 1.8309705973607038e-09
( O 0 2.3932316198238546e-11
1 O 0 2.0448327475719452e-09
. O 0 1.896057616468383e-10
26 O 0 3.4102605184216372e-09
+ O 0 3.867131614931907e-10
/ O 0 2.9281155278226834e-09
- O 0 1.0833796970644016e-08
0 O 0 3.796439607128832e-09
. O 0 3.886349020376656e-10
33 O 0 2.242737018320895e-08
mg O 0 2.0869475747531396e-07
/ O 0 8.100627013618578e-08
ml O 0 7.484799624535299e-08
; O 0 2.0850987603182602e-10
n O 0 4.3095815804861104e-10
= O 0 3.322104258351999e-10
9 O 0 1.2073319011207673e-09
) O 0 1.7737093738201537e-10
, O 0 3.711734253286636e-10
showing O 0 2.8691813369619013e-09
a O 0 1.5859032975740206e-09
gene O 0 3.898556588666224e-09
- O 0 8.067291190627657e-08
dosage O 0 7.496564649045467e-07
effect O 0 9.764327302264064e-08
. O 0 6.586415679521451e-08

The O 0 1.2573615038036223e-07
other O 0 8.934597062193461e-09
allele O 0 6.6954961575049765e-09
( O 0 5.969400529437507e-10
Hp2 O 0 6.244092219276354e-06
) O 0 1.0571629127653637e-09
of O 0 8.599155165711636e-09
individuals O 0 1.1123538201651684e-10
with O 0 6.393625073819464e-10
Hp2 O 1 0.9999998807907104
/ O 0 5.591450826614164e-05
Hpdel O 1 0.9999936819076538
was O 0 1.7258749096527026e-08
found O 0 7.368635562832182e-11
to O 0 3.6124828822758914e-11
have O 0 8.474484135267968e-12
, O 0 2.1954700210602418e-11
in O 0 2.701205752131397e-11
all O 0 5.648460033036429e-10
exons O 0 1.3324323866470422e-08
, O 0 7.265865131778071e-10
no O 0 1.362017054695741e-09
mutation O 0 3.8752753783732885e-10
, O 0 1.255770626373831e-10
by O 0 1.260524601365276e-10
DNA O 0 1.792935755418057e-08
sequencing O 0 6.158988696824963e-08
. O 0 8.486276215080579e-08

On O 0 5.876702502405351e-08
the O 0 1.2253461578737301e-09
basis O 0 9.458958061259182e-10
of O 0 3.9751205105353904e-10
the O 0 4.702841449599759e-10
present O 0 1.0361952268445052e-10
study O 0 1.0699484354059763e-10
, O 0 6.616474729215227e-11
the O 0 1.9491537550653248e-10
mechanism O 0 2.8244833139012826e-09
of O 0 2.9753615127248167e-09
anhaptoglobinemia B-Disease 0 6.753355137334438e-07
and O 0 1.3815145694096032e-09
the O 0 2.8259705686650705e-09
mechanism O 0 1.8954521507907884e-08
of O 0 1.4757742583526579e-08
anomalous O 0 2.7047008188674226e-07
inheritance O 0 3.9829498632570903e-07
of O 0 9.140686074715632e-07
Hp O 0 9.407648349224473e-07
phenotypes O 0 1.150244699488212e-07
were O 0 2.313402802656128e-09
well O 0 8.642696336380595e-09
explained O 0 1.3322269865057024e-07
. O 0 1.5866339708736632e-07

However O 0 7.895773990185262e-08
, O 0 4.416868204515367e-09
the O 0 3.6169542916297814e-09
mechanism O 0 4.215652182892882e-08
of O 0 9.984791660144765e-08
hypohaptoglobinemia B-Disease 0 0.0004003963549621403
remains O 0 1.171988515125122e-05
unknown O 0 3.3968133266171208e-06

ATM O 0 0.007540401071310043
mutations O 0 6.516440294035419e-07
and O 0 2.957371059153502e-08
phenotypes O 0 1.1954670071645523e-06
in O 0 5.0322697120464e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 6.747838399157047e-10
in O 0 4.5451600816370785e-11
the O 0 3.029949346977645e-10
British O 0 4.933143893381953e-10
Isles O 0 2.238066265647376e-08
: O 0 5.218352486235922e-11
expression O 0 6.348212233664441e-11
of O 0 3.149927818579812e-10
mutant O 0 3.2215110579159045e-09
ATM O 0 4.5745203181013494e-08
and O 0 1.2168004104307073e-10
the O 0 2.1710730435664516e-10
risk O 0 5.46845857485323e-09
of O 0 4.7463508678902144e-09
leukemia B-Disease 1 1.0
, O 0 1.8125975032035058e-07
lymphoma B-Disease 1 1.0
, O 0 4.3971846253043623e-07
and O 0 1.9216511191189056e-06
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999815225601196
. O 0 1.9080030710938445e-07

We O 0 2.43820874601397e-08
report O 0 8.557167197054127e-10
the O 0 1.1890968210082065e-09
spectrum O 0 9.239951914707945e-09
of O 0 2.784065245009515e-08
59 O 0 1.8839477888832334e-07
ATM O 0 7.972550520207733e-06
mutations O 0 1.3521249897507914e-08
observed O 0 4.148899446221321e-09
in O 0 9.4010292883695e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.3106640608384623e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.6646329870084742e-09
patients O 0 3.016306648895295e-10
in O 0 5.304656019999854e-11
the O 0 4.114438567626166e-09
British O 0 3.971229389776454e-08
Isles O 0 1.987237055800506e-06
. O 0 2.3981706931408553e-07

Of O 0 1.8530035958974622e-05
51 O 0 1.4563158401870169e-05
ATM O 0 9.510044037597254e-05
mutations O 0 1.460398824093545e-08
identified O 0 4.697462974156963e-10
in O 0 5.043639464408223e-11
families O 0 7.311023314526821e-12
native O 0 1.0358532781529206e-10
to O 0 7.423072573287115e-11
the O 0 9.890805952039727e-10
British O 0 2.8087747683258613e-09
Isles O 0 9.776888276746831e-08
, O 0 1.7553948294946053e-09
11 O 0 6.234083471667873e-09
were O 0 2.8090105796962916e-09
founder O 0 2.6589360047069022e-08
mutations O 0 1.1769528684979491e-09
, O 0 1.4894169231283172e-10
and O 0 2.854474989710809e-10
2 O 0 6.116048112403405e-09
of O 0 3.178924457003518e-09
these O 0 1.0378116144238447e-09
11 O 0 2.7877780084395454e-09
conferred O 0 1.8452967154303224e-08
a O 0 1.625442336283811e-09
milder O 0 1.9130901307562453e-07
clinical O 0 6.302063582097617e-08
phenotype O 0 8.900727932470431e-10
with O 0 3.691983871401128e-11
respect O 0 9.71781433101171e-10
to O 0 1.7081762671011802e-09
both O 0 1.5162625288667186e-07
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9391435980796814
cellular O 0 2.4172848043235717e-06
features O 0 4.410085523431917e-07
. O 0 1.3953300026514626e-07

We O 0 1.6674141178896207e-08
report O 0 1.1375803632418524e-09
, O 0 2.6682608900152616e-10
in O 0 8.8918324092635e-11
two O 0 2.6534868746708185e-10
A B-Disease 1 0.9979367256164551
- I-Disease 0 0.00038858846528455615
T I-Disease 1 1.0
families O 0 8.052828542881585e-11
, O 0 8.660707567775816e-11
an O 0 3.0206706580493403e-10
ATM O 0 6.0430543271650095e-06
mutation O 0 1.7431274201840097e-08
( O 0 8.877398816053983e-10
7271T O 0 1.1596437161642825e-06
- O 0 7.311274430321646e-07
- O 0 8.13662779819424e-07
> O 0 4.479705140170154e-08
G O 0 3.1276607614927343e-07
) O 0 3.5795467284716054e-11
that O 0 4.5294852937805e-12
may O 0 1.4584562724184735e-11
be O 0 5.386565759407658e-12
associated O 0 1.2709702214286356e-11
with O 0 1.5359833197003958e-11
an O 0 3.038698806467899e-11
increased O 0 6.286834386415308e-10
risk O 0 2.5563469563394392e-08
of O 0 2.5812662229895977e-08
breast B-Disease 1 0.9866199493408203
cancer I-Disease 0 3.555360024165566e-07
in O 0 2.0589796534409288e-10
both O 0 2.3056145881383827e-09
homozygotes O 0 5.778875902251457e-07
and O 0 4.401604414283611e-09
heterozygotes O 0 4.237563544506884e-08
( O 0 9.26132712186778e-11
relative O 0 3.979740426096612e-10
risk O 0 1.6512942124791152e-09
12 O 0 2.865105930283107e-10
. O 0 3.971405149183482e-11
7 O 0 3.0150888452595836e-09
; O 0 8.30318147571063e-10
P O 0 1.9113120686142793e-07
= O 0 1.6740703268069979e-09
. O 0 2.659470699217792e-10
0025 O 0 1.0027160612935404e-07
) O 0 2.530516907128799e-10
, O 0 8.337408541336799e-11
although O 0 6.029243077021462e-11
there O 0 8.874007778603143e-11
is O 0 7.985194450110811e-11
a O 0 9.065945216768512e-11
less O 0 9.46393852174765e-10
severe O 0 8.998146222438663e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.0977313502635866e-09
in O 0 1.5862828411927765e-11
terms O 0 1.489965234524604e-10
of O 0 1.7099455185132229e-10
the O 0 5.076398190695386e-10
degree O 0 1.7969618681945576e-08
of O 0 1.4249212654249277e-07
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 2.1601725165965036e-05

This O 0 3.814296789528271e-08
mutation O 0 5.108407208354038e-08
( O 0 1.5352642490640278e-09
7271T O 0 1.2343354001131956e-06
- O 0 4.5227088207866473e-07
- O 0 2.931258507032908e-07
> O 0 4.403445430511965e-08
G O 0 1.4983916685196164e-07
) O 0 6.715236700038929e-11
also O 0 4.766922620524916e-11
allows O 0 6.915910899518707e-11
expression O 0 3.1960475932457655e-11
of O 0 2.2829592383200037e-10
full O 0 5.507131417559208e-10
- O 0 3.0967144404314695e-09
length O 0 1.8917671873452946e-09
ATM O 0 2.1096174407375656e-07
protein O 0 6.92279011893504e-10
at O 0 1.0148560880551827e-09
a O 0 8.767194609182738e-11
level O 0 4.2414330381213006e-10
comparable O 0 1.2715170027988165e-09
with O 0 8.35756533423826e-11
that O 0 1.300111268642823e-10
in O 0 1.421995854400393e-09
unaffected O 0 8.753019073992618e-07
individuals O 0 2.1629522617416796e-09
. O 0 7.23632993526735e-08

In O 0 6.916603734197224e-09
addition O 0 5.038760075848359e-09
, O 0 8.198765000244634e-10
we O 0 1.8162080173134143e-10
have O 0 2.1269444538951632e-11
studied O 0 6.111908312789183e-09
18 O 0 1.8535120105411806e-08
A B-Disease 1 0.9999990463256836
- I-Disease 1 0.9998906850814819
T I-Disease 1 1.0
patients O 0 1.4640738621451987e-09
, O 0 1.739162980296527e-11
in O 0 9.707097105293716e-12
15 O 0 2.223711909055126e-10
families O 0 1.911258477871325e-12
, O 0 3.381647392664e-11
who O 0 1.2082318479045284e-10
developed O 0 2.3427418227583985e-08
leukemia B-Disease 1 1.0
, O 0 3.44667995477721e-07
lymphoma B-Disease 1 1.0
, O 0 9.858682403773855e-08
preleukemic O 1 0.9979877471923828
T O 0 0.00013335807307157665
- O 0 5.199642032494012e-07
cell O 0 2.057922330322981e-07
proliferation O 1 1.0
, O 0 5.2580424458881225e-09
or O 0 1.5635616534837027e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 1.6203758335109342e-08
mostly O 0 1.4265435499538626e-09
in O 0 1.1723017001585845e-09
childhood O 0 6.900964422129618e-07
. O 0 1.6817801906654495e-07

A O 0 2.0036791283928324e-06
wide O 0 5.671080884894764e-07
variety O 0 1.0696682295474602e-07
of O 0 6.905296601189548e-08
ATM O 0 1.3226102964836173e-05
mutation O 0 4.2626182583660466e-09
types O 0 7.60968621449365e-09
, O 0 2.597621562294705e-10
including O 0 1.7437219446136965e-09
missense O 0 5.927201485178557e-08
mutations O 0 1.3067597004479126e-09
and O 0 2.2910202901460508e-10
in O 0 1.369304669651683e-10
- O 0 2.456015124607802e-08
frame O 0 1.0368920833059292e-08
deletions O 0 1.0595960553416717e-08
, O 0 3.315230034939276e-10
were O 0 2.7640251198945975e-10
seen O 0 1.2672316529460659e-09
in O 0 2.5476995513251666e-10
these O 0 2.72851274907282e-09
patients O 0 5.347266185395938e-09
. O 0 2.3291525153013026e-08

We O 0 3.528953484988051e-08
also O 0 1.0433310881907687e-09
show O 0 2.1469008515406784e-10
that O 0 1.1383192999314673e-11
25 O 0 2.2943087707449905e-10
% O 0 1.3818266843268479e-11
of O 0 2.2063140203698595e-10
all O 0 1.0606651112965437e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.1517923826385186e-09
carried O 0 2.5292190564130124e-10
in O 0 4.8180109207818234e-11
- O 0 2.5290283645063028e-08
frame O 0 3.170352158576861e-08
deletions O 0 4.586357960079113e-08
or O 0 3.313809227023512e-09
missense O 0 1.3788880259824055e-08
mutations O 0 3.289305217091254e-10
, O 0 1.642534892820624e-11
many O 0 7.634330667638523e-12
of O 0 5.612010162137082e-11
which O 0 5.275936371812451e-12
were O 0 1.1249695619497402e-11
also O 0 6.9816721848248164e-12
associated O 0 2.9804821805035075e-11
with O 0 8.372068316386816e-11
expression O 0 1.5299352895681295e-09
of O 0 2.4165320411384528e-08
mutant O 0 6.17700152361067e-07
ATM O 0 2.3681332095293328e-05
protein O 0 3.902479761563882e-07
. O 0 8.980028809446594e-08

The O 0 1.747500391502399e-06
DMPK O 1 1.0
gene O 0 4.0869252870834316e-07
of O 0 6.503948384306568e-07
severely O 1 1.0
affected O 1 0.9999995231628418
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0219575185328722
is O 0 4.037375322951675e-09
hypermethylated O 0 1.565682055115758e-06
proximal O 0 3.2691815476937336e-07
to O 0 3.959028660460717e-09
the O 0 3.459548736373108e-08
largely O 0 9.780767129541346e-08
expanded O 0 6.544890425175254e-07
CTG O 0 0.0016955609899014235
repeat O 0 2.8889410259580472e-06
. O 0 2.8850266176050354e-07

Using O 0 8.879641910652936e-08
methylation O 0 4.827501811632828e-07
- O 0 5.544160899262351e-07
sensitive O 0 3.0880167400937353e-07
restriction O 0 6.664815366264065e-09
enzymes O 0 1.554546935622625e-09
, O 0 3.9800063245110096e-10
we O 0 5.65822999565313e-10
characterized O 0 2.8440962918097057e-09
the O 0 1.4097059075623974e-09
methylation O 0 5.354655385758633e-09
pattern O 0 2.6787667639638357e-09
on O 0 1.0069622913277954e-09
the O 0 5.041372319602999e-10
5 O 0 2.4731010572764944e-09
side O 0 9.30764532114381e-09
of O 0 1.1333058935747431e-08
the O 0 1.7562630461043227e-08
CTG O 0 4.058544072904624e-05
repeat O 0 1.5611977488561024e-08
in O 0 2.578753877102713e-10
the O 0 2.5866220276782315e-09
DMPK O 1 0.9938648343086243
gene O 0 1.5045303891625394e-09
of O 0 3.190836928013141e-09
normal O 0 1.8187882311337944e-09
individuals O 0 5.156472471234963e-12
and O 0 5.5039889312880064e-11
of O 0 1.6061958429958167e-09
patients O 0 7.853112049538424e-10
affected O 0 1.3472510884682265e-09
with O 0 1.042792519001523e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.735348575948592e-08
showing O 0 8.337686985271375e-09
expansions O 0 8.569686826831457e-08
of O 0 1.6773567423911118e-08
the O 0 2.2211875005950787e-08
repetitive O 0 1.1382621778466273e-06
sequence O 0 4.2998482996381426e-08
. O 0 3.8155775428094785e-08

The O 0 1.4572095778930816e-06
gene O 0 3.639113543840722e-08
segment O 0 4.2088554863539684e-08
analyzed O 0 7.248178501839675e-09
corresponds O 0 1.653440606652623e-09
to O 0 1.185643250245505e-09
the O 0 2.2027926149803534e-08
genomic O 0 2.651486852300877e-07
SacI O 0 1.7841393855633214e-05
- O 0 7.363334475485317e-07
HindIII O 0 8.593437996751163e-06
fragment O 0 5.1385352861643696e-08
carrying O 0 4.732736869073051e-09
exons O 0 3.612984400547248e-08
11 O 0 1.5388621932288515e-08
- O 0 1.3577231072758877e-07
15 O 0 8.210901114580338e-08
. O 0 7.81640281388718e-08

There O 0 1.2405743632371014e-07
is O 0 1.0454750842825433e-08
constitutive O 0 1.261336848301653e-07
methylation O 0 5.8771512101429835e-08
in O 0 9.955882340761946e-09
intron O 0 1.038368509398424e-06
12 O 0 3.561172334798357e-08
at O 0 3.615664212475167e-09
restriction O 0 2.187380054863297e-09
sites O 0 1.6480596887191723e-09
of O 0 5.605874875413974e-09
SacII O 0 5.386841166910017e-06
and O 0 1.6990819418083447e-08
HhaI O 0 4.8986872570822015e-05
, O 0 3.6759388866158815e-09
localized O 0 1.393323429965676e-07
1 O 0 3.628883149531248e-08
, O 0 3.7104888606087627e-10
159 O 0 2.5970035011368964e-09
- O 0 5.71760772061225e-09
1 O 0 2.2923819287257174e-08
, O 0 9.402619793874578e-10
232 O 0 3.817788307713954e-09
bp O 0 3.418942018384996e-09
upstream O 0 1.2531806703464099e-08
of O 0 3.976009743666964e-09
the O 0 2.4414385180193676e-08
CTG O 0 6.274937913985923e-05
repeat O 0 2.631524509411065e-08
, O 0 3.9863426448683015e-10
whereas O 0 1.252806608453838e-10
most O 0 3.9876709573283264e-11
, O 0 2.1715190409721252e-11
if O 0 1.106534048417318e-11
not O 0 3.5710822320067503e-12
all O 0 1.8734879966841866e-11
, O 0 2.0039763251600284e-11
of O 0 1.6598890317798265e-10
the O 0 1.8984822047762862e-10
other O 0 7.534965706934571e-11
sites O 0 9.030380887509182e-10
of O 0 4.7432555660975595e-09
SacII O 0 7.814560376573354e-06
, O 0 3.0256541716511265e-09
HhaI O 0 1.8146909496863373e-05
, O 0 1.807931360175985e-09
and O 0 3.0005971041191515e-09
HpaII O 0 1.652053470024839e-06
in O 0 2.3060532650109877e-10
this O 0 3.2867947946657594e-11
region O 0 4.1333314548808175e-09
are O 0 1.5255519070223045e-10
unmethylated O 0 6.59493935017963e-08
, O 0 3.6918096357752006e-10
in O 0 9.594724320605152e-11
normal O 0 8.163204001654378e-10
individuals O 0 4.385047446681112e-12
and O 0 5.551898871192229e-11
most O 0 1.657592119119755e-10
of O 0 2.8847986222046984e-09
the O 0 2.9539659607280555e-08
patients O 0 3.379144075665863e-08
. O 0 6.506305538778179e-08

In O 0 6.465775470587687e-09
a O 0 2.2430599044831467e-10
number O 0 5.7329665320571266e-11
of O 0 1.1033444158314865e-09
young O 0 1.7264667473426698e-09
and O 0 1.120668224885435e-09
severely O 0 1.5552379863947863e-06
affected O 0 1.6409277492357432e-08
patients O 0 5.457493346128217e-10
, O 0 2.77378345986401e-11
however O 0 8.459179190456467e-11
, O 0 1.6072707054171076e-10
complete O 0 6.102562344345586e-10
methylation O 0 6.193597190673472e-09
of O 0 1.367776381044905e-08
these O 0 8.50993275847145e-10
restriction O 0 1.916642178301231e-09
sites O 0 1.5620370552582585e-09
was O 0 1.9540606910339875e-09
found O 0 1.0439318159916056e-10
in O 0 1.7223544812594582e-10
the O 0 1.01154808973547e-08
mutated O 0 9.438889492230373e-08
allele O 0 3.2709646546891236e-08
. O 0 1.0434774111445222e-07

In O 0 9.804672629343258e-09
most O 0 6.014108100416138e-10
of O 0 6.931351603789437e-10
these O 0 9.950234386435497e-11
patients O 0 1.874379124133796e-10
, O 0 3.919787758266402e-11
the O 0 3.864823183707955e-10
onset O 0 1.3068851778541557e-08
of O 0 1.95619467291408e-08
the O 0 3.2011840289669635e-07
disease O 1 1.0
was O 0 0.37863847613334656
congenital O 1 1.0
. O 0 6.5747199187171645e-06

Preliminary O 0 2.2260326204559533e-06
in O 0 9.676392664914601e-08
vivo O 0 2.488752215867862e-06
footprinting O 0 3.627371825132286e-06
data O 0 3.6072125286779055e-09
gave O 0 2.729907855325564e-09
evidence O 0 6.629615745268325e-10
for O 0 1.2064288457125372e-10
protein O 0 6.041044331439593e-10
- O 0 3.6836662609118775e-09
DNA O 0 4.44653736053624e-09
contact O 0 1.8417013747384914e-10
in O 0 9.513795307114492e-11
normal O 0 1.9819426100298188e-09
genes O 0 1.535046811884655e-10
at O 0 1.2789842518401429e-09
an O 0 7.280042124691022e-10
Sp1 O 0 1.1660196832963265e-05
consensus O 0 2.1721353604675642e-08
binding O 0 1.2250523262480328e-08
site O 0 7.168108773214499e-09
upstream O 0 8.773961113206497e-09
of O 0 3.743003240685994e-09
the O 0 9.839067338646146e-09
CTG O 0 2.1634978111251257e-05
repeat O 0 5.4781983394036615e-09
and O 0 1.309418823369768e-10
for O 0 9.158389324692706e-11
a O 0 2.56452793029327e-11
significant O 0 6.193733026460535e-11
reduction O 0 2.4588637792533063e-09
of O 0 8.963661479732821e-10
this O 0 3.771953235864878e-11
interaction O 0 1.5618784043880396e-10
in O 0 1.3423308298232683e-10
cells O 0 1.3298234735614756e-10
with O 0 3.512249657777744e-10
a O 0 1.5818407916867727e-08
hypermethylated O 0 2.4164774004020728e-05
DMPK O 1 0.9998828172683716
gene O 0 5.8056230045622215e-08
. O 0 1.1503385799471744e-08
. O 0 1.5180928869540367e-07

The O 0 6.234434749785578e-06
hemochromatosis B-Disease 1 0.9999992847442627
gene O 0 4.399231201546172e-08
product O 0 8.136362694699528e-09
complexes O 0 1.6385126588858157e-09
with O 0 2.204253168880399e-10
the O 0 6.363360061101275e-09
transferrin O 0 1.8911626398221415e-07
receptor O 0 7.04136793316934e-09
and O 0 2.9592315264892477e-09
lowers O 0 1.5266458319729281e-07
its O 0 7.570132853906841e-10
affinity O 0 4.18423018455627e-10
for O 0 4.1348516277572855e-10
ligand O 0 3.0431113628992534e-08
binding O 0 1.0818747853136301e-07
. O 0 8.79492532135373e-08

We O 0 2.6112607542927435e-07
recently O 0 3.766566791796322e-08
reported O 0 4.55526727449751e-09
the O 0 5.6054685337869614e-09
positional O 0 1.4588319174890785e-07
cloning O 0 7.3695143321117484e-09
of O 0 2.3470831944649717e-09
a O 0 3.2251798454119296e-10
candidate O 0 1.8227681586324707e-09
gene O 0 7.217800579439881e-09
for O 0 5.689532756036897e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 1.0
. O 0 1.2179880286566913e-06

The O 0 1.409985372902156e-07
gene O 0 9.717573412615366e-10
product O 0 3.0364883940592335e-09
, O 0 1.9632648284861887e-10
a O 0 1.0905685382534003e-10
member O 0 9.397164990598839e-11
of O 0 3.882868693239061e-09
the O 0 1.3574559254436736e-08
major O 0 2.2267599320002773e-07
histocompatibility O 0 1.1993874977633823e-05
complex O 0 6.705288058128644e-08
class O 0 8.799229678224663e-10
I O 0 3.144030813473364e-08
- O 0 1.97409608659882e-08
like O 0 1.6598391550104452e-09
family O 0 3.615662491629479e-10
, O 0 1.957569939481374e-10
was O 0 1.2996110854146536e-09
found O 0 1.176678338099535e-10
to O 0 2.0335678974081617e-10
have O 0 2.3054157194390967e-10
a O 0 1.2147117756100556e-09
mutation O 0 8.091312508895498e-09
, O 0 4.911627549120112e-09
Cys O 1 0.7111920714378357
- O 0 2.8864817522844533e-06
282 O 0 8.381808243029809e-07
- O 0 5.772641088697128e-06
- O 0 7.627179002156481e-06
> O 0 4.756635121339059e-07
Tyr O 0 0.0003755595535039902
( O 0 9.268453227129214e-10
C282Y O 0 4.0544051671531633e-07
) O 0 2.549556399333852e-10
, O 0 1.2012098260516524e-10
in O 0 1.3068539306271276e-10
85 O 0 2.030693835308739e-08
% O 0 6.111135486541741e-10
of O 0 9.69061009215011e-09
patient O 0 6.003730135262231e-08
chromosomes O 0 1.8610682772646214e-08
. O 0 4.931098374072462e-08

This O 0 2.465303516885342e-08
mutation O 0 2.538253696116044e-08
eliminates O 0 1.0077797440999348e-07
the O 0 4.2267447319943585e-09
ability O 0 2.405700527674526e-09
of O 0 2.9432467130163786e-08
HFE O 0 0.000989182386547327
to O 0 1.208717215206434e-08
associate O 0 1.2453485354058103e-08
with O 0 7.212402342027247e-10
beta2 O 0 0.0002938868128694594
- O 0 7.164698763517663e-05
microglobulin O 0 0.09951886534690857
( O 0 4.3307939456838085e-09
beta2m O 0 1.6748695998103358e-05
) O 0 1.715738662255717e-09
and O 0 3.572279805297285e-09
prevents O 0 2.3850601493791146e-08
cell O 0 1.5995777147281842e-08
- O 0 2.5624791533118696e-07
surface O 0 5.836955665472487e-07
expression O 0 6.780472716627628e-08
. O 0 5.020477900075093e-08

A O 0 4.231710590829607e-06
second O 0 3.647438617804255e-08
mutation O 0 1.410585315220203e-09
that O 0 3.4446629576523335e-11
has O 0 1.866163751307326e-10
no O 0 1.5206859382832505e-10
effect O 0 9.553040580811967e-10
on O 0 6.264071927830628e-09
beta2m O 0 2.8988044959987747e-06
association O 0 1.3787477826099348e-09
, O 0 2.1053809806659274e-09
H63D O 1 1.0
, O 0 3.8032088589545765e-09
was O 0 6.513678929565003e-09
found O 0 1.6091418475472352e-10
in O 0 7.04001787421582e-11
eight O 0 3.763970524151006e-10
out O 0 1.9710841292486236e-10
of O 0 7.175491867350559e-10
nine O 0 1.3980446800232471e-09
patients O 0 3.292267847232466e-10
heterozygous O 0 7.537110935373903e-10
for O 0 3.724670016858056e-10
the O 0 2.935520804214775e-08
C282Y O 0 1.8293090761289932e-05
mutant O 0 2.2934857497602934e-06
. O 0 1.9876301848853473e-07

In O 0 1.940878924244771e-08
this O 0 2.267964149815782e-10
report O 0 1.1596588134210606e-09
, O 0 6.468139912563231e-10
we O 0 3.400807968567676e-10
demonstrate O 0 9.66109525712966e-10
in O 0 1.126982951404898e-09
cultured O 0 7.911856059195088e-09
293 O 0 4.039502954356067e-08
cells O 0 1.19339582660416e-09
overexpressing O 0 4.3171098695893306e-07
wild O 0 4.900812200503424e-08
- O 0 4.6034301703912206e-08
type O 0 3.2412046380159154e-08
or O 0 1.4538140691300327e-09
mutant O 0 3.884292709699366e-08
HFE O 0 6.690851250823471e-07
proteins O 0 2.1448615453167896e-11
that O 0 3.5054196958345107e-12
both O 0 2.6063151636890325e-11
the O 0 2.338899629528157e-10
wild O 0 1.3065162285386123e-08
- O 0 1.5832295474638158e-08
type O 0 3.066464060452745e-08
and O 0 1.34099886750505e-08
H63D O 1 0.9999943971633911
HFE O 0 3.0594575946452096e-05
proteins O 0 4.5245421298467647e-10
form O 0 3.8159208431975955e-11
stable O 0 2.0749227336303022e-10
complexes O 0 8.643791932216871e-11
with O 0 3.3142610184055954e-11
the O 0 2.771216145447397e-09
transferrin O 0 1.0123106903847656e-06
receptor O 0 1.8176434934957797e-07
( O 0 8.627462300125899e-09
TfR O 0 4.112489477847703e-06
) O 0 9.030196146397884e-09
. O 0 7.428719328572697e-08

The O 0 1.7976566368815838e-06
C282Y O 0 3.02423595712753e-05
mutation O 0 6.153212694925969e-08
nearly O 0 3.778660939701695e-09
completely O 0 7.575350124966462e-09
prevents O 0 3.255297809090507e-09
the O 0 1.012821826407162e-09
association O 0 2.1999060906274792e-10
of O 0 5.357515320270068e-09
the O 0 3.1743940809292326e-08
mutant O 0 4.436712686128885e-07
HFE O 0 5.537516335607506e-05
protein O 0 1.7148563458135868e-08
with O 0 1.412405303824471e-09
the O 0 1.0171475395281959e-07
TfR O 0 2.3209067876450717e-05
. O 0 1.8119719413789426e-07

Studies O 0 7.476067764855543e-08
on O 0 1.9871672307658628e-08
cell O 0 8.710381749210683e-09
- O 0 4.9749800723475346e-08
associated O 0 1.1291394486079298e-08
transferrin O 0 2.65115289721507e-07
at O 0 3.4095403833589444e-08
37 O 0 3.157028416467256e-08
degrees O 0 1.279502281903433e-08
C O 0 3.921438462839433e-08
suggest O 0 6.00553440310847e-10
that O 0 6.148944547978985e-11
the O 0 2.850928604303249e-09
overexpressed O 0 7.033852966742415e-07
wild O 0 5.484588427862036e-07
- O 0 5.34423008957674e-07
type O 0 2.467891420110391e-07
HFE O 0 2.5407844077562913e-05
protein O 0 2.4019135569375294e-09
decreases O 0 1.2688811112937515e-09
the O 0 1.375726199626115e-10
affinity O 0 2.844962876391577e-10
of O 0 4.626543148589235e-09
the O 0 3.316517194207336e-08
TfR O 0 1.1225833986827638e-06
for O 0 8.778379800844505e-09
transferrin O 0 3.899707280652365e-06
. O 0 2.8074381930309755e-07

The O 0 1.4600177564716432e-05
overexpressed O 0 0.0003540550242178142
H63D O 1 0.9999940395355225
protein O 0 6.292719234579636e-08
does O 0 7.586755668143041e-10
not O 0 4.195072067503247e-11
have O 0 1.2339524367577237e-11
this O 0 5.186082032565542e-12
effect O 0 8.542458407312381e-10
, O 0 8.106859628043139e-11
providing O 0 2.3694776696281394e-10
the O 0 2.1044567477535026e-10
first O 0 9.40659772297181e-11
direct O 0 2.247723951409597e-10
evidence O 0 1.843771524345783e-10
for O 0 1.918997044603188e-10
a O 0 3.8625388998347887e-10
functional O 0 2.339798932382564e-08
consequence O 0 1.0804122929641835e-08
of O 0 1.4061860120762049e-08
the O 0 7.600218054903962e-08
H63D O 1 0.9999998807907104
mutation O 0 4.325129054905119e-07
. O 0 1.0758783730580035e-07

Addition O 0 3.762209246360726e-07
of O 0 3.078976931192301e-07
soluble O 0 3.864558493660297e-06
wild O 0 3.1673532703280216e-06
- O 0 6.316182862065034e-06
type O 0 0.012165036052465439
HFE O 1 1.0
/ O 1 0.9448685050010681
beta2m O 0 0.002868461888283491
heterodimers O 0 3.839248620352009e-06
to O 0 2.9775473198156988e-09
cultured O 0 1.1282476064522484e-09
cells O 0 1.354539674869315e-10
also O 0 8.973202042517059e-11
decreased O 0 1.6642646150089035e-09
the O 0 2.1582491349647626e-10
apparent O 0 7.09358571882035e-10
affinity O 0 3.6471980990882e-10
of O 0 3.856269081836672e-09
the O 0 6.269570640426991e-09
TfR O 0 6.40147774788602e-08
for O 0 6.959883364077157e-11
its O 0 1.0153977658688973e-10
ligand O 0 3.7989802970095354e-10
under O 0 6.517851258713847e-10
steady O 0 4.144201870559527e-09
- O 0 2.466986170901464e-09
state O 0 4.3579206909782897e-10
conditions O 0 3.0282523155733543e-09
, O 0 1.722686299165943e-10
both O 0 1.4265753855990937e-10
in O 0 1.8547657854028898e-10
293 O 0 3.192584197009296e-09
cells O 0 7.56359072595636e-11
and O 0 6.69883981618824e-10
in O 0 4.984275658870274e-09
HeLa O 0 5.502115072886227e-06
cells O 0 1.8264440626580836e-08
. O 0 6.976866018248984e-08

Furthermore O 0 8.441363092970278e-07
, O 0 7.105708910160047e-09
at O 0 5.9719091893839504e-09
4 O 0 1.0563894647930283e-08
degrees O 0 1.4794098390780164e-08
C O 0 5.715222783919671e-08
, O 0 5.782608281101886e-10
the O 0 3.2328308918749826e-09
added O 0 2.1318866672004333e-08
soluble O 0 1.243817848717299e-07
complex O 0 8.275394236534339e-08
of O 0 1.7479892733263114e-07
HFE O 1 0.9999854564666748
/ O 0 4.9321229198540095e-06
beta2m O 0 6.32148521617637e-06
inhibited O 0 5.287088455929734e-08
binding O 0 5.480092468701514e-08
of O 0 2.952957700586012e-08
transferrin O 0 5.751099934059312e-07
to O 0 2.381741381896063e-08
HeLa O 0 8.520662049704697e-06
cell O 0 1.3200101989241375e-07
TfR O 0 5.204996114116511e-07
in O 0 5.00065211461731e-10
a O 0 1.1592053983378037e-09
concentration O 0 6.269895891364285e-08
- O 0 2.004994854587494e-07
dependent O 0 2.6634786820523004e-08
manner O 0 5.237914990630088e-08
. O 0 5.586025508819148e-08

Scatchard O 0 6.547506927745417e-05
plots O 0 8.820853736324352e-07
of O 0 1.3632502771088184e-07
these O 0 1.1199760008295812e-09
data O 0 4.842528600335072e-10
indicate O 0 1.7675055863364264e-10
that O 0 9.072553819322593e-11
the O 0 6.246676509391591e-09
added O 0 5.524579904658822e-08
heterodimer O 0 6.459701040739674e-08
substantially O 0 3.82250986419308e-09
reduced O 0 3.7587786216874974e-09
the O 0 1.474752098218346e-09
affinity O 0 5.148755199968491e-09
of O 0 4.819828447466534e-08
TfR O 0 2.9828777314833133e-06
for O 0 1.8756255215635065e-08
transferrin O 0 3.7562326724582817e-06
. O 0 4.585448607485887e-07

These O 0 7.301742499521424e-08
results O 0 5.361778576684628e-09
establish O 0 5.583401740949512e-09
a O 0 4.981611789744989e-10
molecular O 0 5.953007864434312e-09
link O 0 8.304215093346556e-09
between O 0 2.682657873620542e-09
HFE O 0 0.09366492927074432
and O 0 2.5299257799815678e-08
a O 0 3.079679844475436e-09
key O 0 6.169900501618031e-08
protein O 0 2.076190552813273e-09
involved O 0 3.8180197892145884e-10
in O 0 4.72710481869143e-10
iron O 0 6.36070853943238e-06
transport O 0 2.4024048528303865e-08
, O 0 1.0231083757972215e-09
the O 0 4.065837000410966e-09
TfR O 0 2.92117050548768e-07
, O 0 2.1800068694677321e-10
and O 0 3.111816915257748e-10
raise O 0 2.925530928621356e-09
the O 0 1.4915584323205167e-09
possibility O 0 4.066961434290306e-09
that O 0 4.6493264099778386e-11
alterations O 0 1.5516270934767817e-08
in O 0 3.297433437410291e-10
this O 0 4.9177904803965333e-11
regulatory O 0 5.629243293725494e-09
mechanism O 0 5.26278798318458e-09
may O 0 1.3861300995898773e-10
play O 0 4.465677605480778e-09
a O 0 2.4415758304030533e-10
role O 0 1.1471829042264403e-09
in O 0 1.6607948349900425e-10
the O 0 5.664905877722504e-09
pathogenesis O 0 6.06883731961716e-05
of O 0 0.34295254945755005
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.1273251402599271e-05
. O 0 6.307306534836243e-07

Genomic O 0 7.925178238110675e-07
organization O 0 1.0151876672637172e-08
of O 0 3.3415215483501015e-08
the O 0 1.1403534472265164e-07
UBE3A O 1 0.9999998807907104
/ O 0 9.27734436118044e-05
E6 O 1 1.0
- O 0 5.152185167389689e-06
AP O 0 7.677424036955927e-06
gene O 0 1.1651022369107977e-08
and O 0 4.718153423510785e-09
related O 0 1.982651127718782e-07
pseudogenes O 0 3.187510401403415e-06
. O 0 1.4766364131446608e-07

The O 0 6.938619662832934e-06
UBE3A O 0 0.0010538077913224697
gene O 0 9.017755076001777e-08
encodes O 0 2.257134568139918e-08
the O 0 1.6584603912406237e-08
E6 O 0 0.001982461428269744
- O 0 1.115056875278242e-06
AP O 0 3.484486569504952e-06
ubiquitin O 0 2.2883637029735837e-07
- O 0 7.088087983220248e-08
protein O 0 4.4703818424807196e-09
ligase O 0 2.8462561196818115e-09
and O 0 5.828317273248729e-10
has O 0 3.531030190462303e-10
recently O 0 9.776319753740381e-10
been O 0 1.4218812238731005e-10
shown O 0 3.8322518769451364e-11
to O 0 3.399820008853638e-11
be O 0 2.1239457415056506e-10
mutated O 0 3.7373052208522495e-08
in O 0 6.710367728146593e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.547309859186498e-07
who O 0 1.7328469770205857e-09
lack O 0 2.335954896182102e-08
15q11 O 0 7.58442047299468e-06
- O 0 2.132892859663116e-06
q13 O 0 1.293422064918559e-05
deletions O 0 5.064643460173102e-07
or O 0 3.3601843085762084e-08
chromosome O 0 3.128182868294971e-07
15 O 0 1.1606267946717708e-07
paternal O 0 3.4855836474889657e-06
uniparental B-Disease 1 0.9998809099197388
disomy I-Disease 1 0.9791828989982605
. O 0 3.6288668070483254e-06

Previous O 0 1.4011912753630895e-05
UBE3A O 0 0.0007270430214703083
cDNA O 0 9.005980672327496e-08
analysis O 0 3.1156375257523905e-09
has O 0 2.413286792624092e-10
shown O 0 1.0827794910683863e-10
a O 0 1.1221820694906626e-10
coding O 0 2.236440543867957e-08
region O 0 3.476760923604161e-08
of O 0 3.508470314272927e-08
approximately O 0 1.3224440209569366e-08
2 O 0 1.6893270071705047e-07
. O 0 8.365343973082418e-08

6 O 0 1.0372093129262794e-05
kb O 0 1.887054168037139e-05
and O 0 2.5988629914763806e-08
a O 0 3.844181417633763e-09
3 O 0 3.215521005017763e-08
- O 0 3.075256245210767e-07
untranslated O 0 0.0003423322341404855
region O 0 5.448429192256299e-07
( O 0 6.361915882990843e-09
UTR O 0 0.04688171669840813
) O 0 2.332054105380621e-09
of O 0 2.3081678790504156e-08
< O 0 9.650091215007706e-08
50 O 0 1.0921995752255498e-08
bp O 0 1.1288832979516883e-08
, O 0 1.262975057869653e-09
whereas O 0 2.1642851955050446e-09
Northern O 0 1.8432354309538823e-08
analysis O 0 6.588621870307065e-10
has O 0 1.8681579894153089e-10
indicated O 0 1.0276197254244224e-10
mRNA O 0 6.164331267655143e-10
sizes O 0 1.3432431833493297e-09
of O 0 2.136493648663418e-09
5 O 0 3.4890504707618675e-08
- O 0 3.1089314234122867e-07
8 O 0 5.669004394803778e-07
kb O 0 2.9099142921040766e-05
. O 0 6.782670993743523e-07

We O 0 2.9233302711872966e-07
have O 0 2.137920285250061e-09
analyzed O 0 5.347643217135101e-09
additional O 0 2.0280686019447103e-09
cDNA O 0 1.5275363196565195e-08
clones O 0 2.1702387442701365e-08
and O 0 1.621938694462699e-10
provide O 0 2.7784113551532208e-11
evidence O 0 1.1498241248020236e-10
for O 0 4.0153536745579643e-11
an O 0 5.107610515087124e-11
additional O 0 2.2369515129128104e-09
0 O 0 6.033760513446396e-08
. O 0 7.338840646298195e-08

5 O 0 2.2388364868675126e-06
kb O 0 8.88067461346509e-06
of O 0 2.0775469522504864e-07
5 O 0 3.2789671422506217e-07
- O 0 8.509241524734534e-07
UTR O 0 0.00041465688263997436
and O 0 1.7193201529153157e-08
> O 0 5.146735304606409e-08
2 O 0 5.949038239805304e-08
kb O 0 9.154487088380847e-07
of O 0 3.596922226734023e-08
3 O 0 7.336894327636401e-07
- O 0 8.40215761854779e-06
UTR O 0 0.2557992935180664
. O 0 3.6115105217504606e-07

We O 0 9.57108596821854e-08
have O 0 4.1498632308289984e-10
established O 0 8.449926869324997e-10
the O 0 4.67677563342761e-10
genomic O 0 1.6727809137861982e-09
organization O 0 1.0269633060611127e-10
of O 0 3.35747252222518e-09
UBE3A O 0 0.00019838724983856082
and O 0 4.593411428999161e-09
the O 0 2.923561837064881e-09
sequence O 0 1.3566140433241003e-09
of O 0 1.155407147734877e-08
intron O 0 5.910808340559015e-06
- O 0 2.4334562112926506e-05
exon O 0 8.118436198856216e-06
borders O 0 1.550354227219941e-06
. O 0 4.1709841980264173e-07

We O 0 2.0655197374708223e-07
have O 0 2.7694144755230354e-09
also O 0 2.5555704219470954e-09
mapped O 0 6.943889019339622e-08
two O 0 1.6436679795006626e-09
highly O 0 2.0441007109184284e-08
homologous O 0 2.990792058454872e-09
processed O 0 2.5242909984513062e-08
pseudogenes O 0 5.566965199932383e-08
, O 0 1.6023525839514718e-09
UBE3AP1 O 1 0.9933956265449524
and O 0 3.90834884456126e-08
UBE3AP2 O 1 0.9999992847442627
, O 0 1.7908364791097142e-09
to O 0 3.4841660112583384e-10
chromosomes O 0 3.218885227807e-11
2 O 0 3.943253223948062e-10
and O 0 9.956404450894851e-11
21 O 0 2.7012188041908303e-09
, O 0 1.7240965599629732e-10
respectively O 0 9.488718699657284e-10
, O 0 3.333459619447865e-10
and O 0 6.128936802518581e-10
determined O 0 4.4302668200657536e-09
their O 0 9.038824688722968e-10
genomic O 0 5.080859111217251e-08
organization O 0 5.933261437718329e-09
. O 0 6.810517305666508e-08

These O 0 5.269500036320096e-08
results O 0 1.8599034534716452e-09
will O 0 1.8847144678257877e-10
form O 0 3.6765240157832224e-11
the O 0 8.94207277668535e-11
basis O 0 7.268689122819083e-11
for O 0 4.099814238101018e-12
studies O 0 4.2090577551112673e-11
of O 0 2.818003053128848e-10
mutation O 0 4.2615025397374495e-10
and O 0 1.016780104556858e-09
imprinting O 0 6.193009767230251e-07
of O 0 8.896507779354579e-07
UBE3A O 1 0.9999998807907104
. O 0 2.214763071606285e-06

Mutation O 0 2.4281303012685385e-06
spectrum O 0 5.668377980327932e-07
and O 0 1.1532736543529154e-08
genotype O 0 1.0797431571063498e-07
- O 0 1.056256948572809e-07
phenotype O 0 1.1801139621070433e-08
analyses O 0 6.585006762094281e-09
in O 0 1.2140840555119325e-09
Cowden B-Disease 1 0.9999988079071045
disease I-Disease 0 0.0013309796340763569
and O 0 1.771000057715355e-08
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.3454465985773822e-08
two O 0 1.4714009566318964e-08
hamartoma B-Disease 1 0.9988237023353577
syndromes I-Disease 0 0.00010040197958005592
with O 0 1.229024491067321e-07
germline O 0 0.0003742340486496687
PTEN O 1 1.0
mutation O 0 2.729193738559843e-06
. O 0 1.384639176649216e-07

The O 0 1.216343207488535e-05
tumour B-Disease 1 1.0
suppressor O 1 0.999077320098877
gene O 0 9.663435776019469e-06
PTEN O 1 0.9969895482063293
, O 0 1.3090705408558279e-08
which O 0 1.4928334124419962e-09
maps O 0 4.771441908246743e-08
to O 0 2.6502979366682666e-08
10q23 O 0 4.348086440586485e-05
. O 0 7.703869755459891e-07

3 O 0 7.172042728598171e-07
and O 0 1.7233421800710857e-08
encodes O 0 1.4186157137885402e-08
a O 0 2.4074908733240363e-09
403 O 0 6.764014237603533e-09
amino O 0 5.528487889705502e-09
acid O 0 2.2547636646663705e-08
dual O 0 1.0712853537597766e-07
specificity O 0 4.613459907432116e-07
phosphatase O 0 0.00047021062346175313
( O 0 4.632496697354327e-08
protein O 0 3.1190850791062985e-07
tyrosine O 0 4.036596124024072e-07
phosphatase O 0 1.171618123407825e-06
; O 0 8.037288612428029e-10
PTPase O 0 5.72041972191073e-06
) O 0 5.1888676688705e-10
, O 0 4.327100622258939e-10
was O 0 2.2367081520258125e-09
shown O 0 1.939141486273499e-10
recently O 0 6.466499558044347e-10
to O 0 3.1184954618623806e-10
play O 0 1.7651792916240083e-08
a O 0 1.5642521722369906e-09
broad O 0 3.488731081802143e-08
role O 0 1.0000874794968695e-08
in O 0 5.5078168692546114e-09
human O 0 1.1832405277800717e-07
malignancy B-Disease 0 0.00023691338719800115
. O 0 3.578972496143251e-07

Somatic O 0 0.000128862913697958
PTEN O 0 0.0002153925597667694
deletions O 0 2.806292513923836e-07
and O 0 2.425014145046589e-08
mutations O 0 4.5418717675715925e-09
were O 0 2.9196373096951334e-10
observed O 0 3.9341857549501924e-10
in O 0 1.63306118627915e-10
sporadic B-Disease 0 2.7132932700624224e-06
breast I-Disease 1 1.0
, I-Disease 0 2.753727983417775e-07
brain I-Disease 1 1.0
, I-Disease 0 3.960299110872256e-08
prostate I-Disease 1 1.0
and I-Disease 1 0.992027223110199
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9984939098358154
cell O 0 8.262095896327537e-09
lines O 0 2.2867516769053964e-09
and O 0 1.800384008543432e-10
in O 0 7.636053594994863e-11
several O 0 1.1450448367256172e-09
primary O 0 5.906503588448686e-07
tumours B-Disease 1 1.0
such O 0 8.649989524656121e-08
as O 0 3.9305825794144766e-07
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.999879002571106
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 1.4382490007847082e-05

In O 0 2.057015180412236e-08
addition O 0 2.978355517768705e-08
, O 0 3.5328259428979436e-08
PTEN O 0 0.024333322420716286
was O 0 6.912122785251995e-08
identified O 0 3.803818593439701e-09
as O 0 5.465973229590304e-10
the O 0 1.3289038758301785e-09
susceptibility O 0 4.2825455182082806e-08
gene O 0 2.5639144141109682e-09
for O 0 1.2142276073490166e-09
two O 0 6.309496569656403e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.242770135221008e-09
CD B-Disease 1 1.0
; O 0 3.387765801221576e-08
MIM O 1 0.9999903440475464
158350 O 0 2.229304300271906e-06
) O 0 5.315252682436267e-10
and O 0 2.2077044636859e-09
Bannayan B-Disease 0 0.0009078234434127808
- I-Disease 0 3.4515025618020445e-05
Zonana I-Disease 0 0.3656166195869446
( I-Disease 0 3.479766164105058e-08
BZS I-Disease 0 0.1085650622844696
) I-Disease 0 2.6605022629411224e-09
or I-Disease 0 9.130156075620732e-10
Ruvalcaba I-Disease 0 2.679159706531209e-06
- I-Disease 0 1.992507634440699e-07
Riley I-Disease 0 7.591026587761007e-06
- I-Disease 1 0.9999614953994751
Smith I-Disease 1 0.9998852014541626
syndrome I-Disease 1 1.0
( O 0 7.674407243030146e-08
MIM O 1 1.0
153480 O 0 0.0001409561955370009
) O 0 5.5956437705617645e-08
. O 0 1.906667819184804e-07

Constitutive O 0 2.6302334390493343e-06
DNA O 0 5.5767209516943694e-08
from O 0 5.111570056115511e-10
37 O 0 5.021385529602185e-09
CD B-Disease 0 2.203786152676912e-06
families O 0 1.2190723430727246e-10
and O 0 8.527057948626293e-10
seven O 0 2.1366728386595923e-09
BZS B-Disease 0 2.4280896468553692e-05
families O 0 8.504833642897225e-11
was O 0 2.4267152731738406e-09
screened O 0 1.2188509401767078e-07
for O 0 8.33969480140695e-08
germline O 0 2.4318786017829552e-05
PTEN O 1 0.996653139591217
mutations O 0 1.6493269185957615e-06
. O 0 3.2511053404959966e-07

PTEN O 0 0.0018616484012454748
mutations O 0 1.3797777853596926e-07
were O 0 1.5132103348136638e-09
identified O 0 1.6218243414911626e-10
in O 0 4.972031467098681e-11
30 O 0 1.768545088154383e-09
of O 0 2.4691562128253963e-09
37 O 0 1.642308689042693e-08
( O 0 1.720512482483727e-10
81 O 0 1.725147669162652e-08
% O 0 6.584083278582398e-11
) O 0 3.512575993958045e-11
CD B-Disease 0 2.411015657344251e-06
families O 0 5.1275227119784716e-11
, O 0 1.0094115820979965e-10
including O 0 5.669529290486253e-10
missense O 0 4.152970944915069e-08
and O 0 1.2486331080197033e-08
nonsense O 0 5.877386115571426e-07
point O 0 3.2419004014627717e-07
mutations O 0 6.305812760842855e-09
, O 0 6.899589788389449e-10
deletions O 0 2.874644167150109e-08
, O 0 5.3644995112733795e-09
insertions O 0 2.565780334862211e-07
, O 0 7.907043908517153e-09
a O 0 9.935130051985652e-09
deletion O 0 3.0015092988833203e-07
/ O 0 3.4790434710885165e-07
insertion O 0 5.217604126528386e-08
and O 0 7.439309168688624e-09
splice O 0 1.7114699630838004e-06
site O 0 3.763501013054338e-07
mutations O 0 2.578929354513093e-07
. O 0 1.0354675339385722e-07

These O 0 5.145616555068955e-08
mutations O 0 6.5311205332818645e-09
were O 0 3.3729141701854815e-10
scattered O 0 4.415865895168736e-09
over O 0 1.67487834712432e-09
the O 0 3.1789850751806625e-09
entire O 0 5.218556697883514e-09
length O 0 1.6931448465484777e-09
of O 0 9.337179029955678e-09
PTEN O 0 2.024634159170091e-05
, O 0 1.828505680201431e-10
with O 0 2.1353752099884105e-11
the O 0 2.5276852833044927e-10
exception O 0 2.543097121776583e-10
of O 0 3.9800293616387705e-10
the O 0 7.482680031145605e-10
first O 0 9.333720463189366e-10
, O 0 8.592887512648417e-10
fourth O 0 1.68143774459395e-08
and O 0 5.222499765977773e-09
last O 0 4.1557523644542016e-08
exons O 0 4.485160388867371e-06
. O 0 9.173215858027106e-07

A O 0 1.2590220649144612e-05
hot O 0 8.505723599228077e-06
spot O 0 1.1553198646652163e-06
for O 0 3.8740228802680576e-08
PTEN O 0 0.00012179840996395797
mutation O 0 8.544384755282408e-09
in O 0 5.022972593415886e-10
CD B-Disease 1 0.9993390440940857
was O 0 6.665783303105854e-08
identified O 0 1.246880820815477e-09
in O 0 3.536671788761936e-10
exon O 0 4.883298032609673e-08
5 O 0 4.70646899231042e-09
that O 0 5.533778643651566e-11
contains O 0 1.5073280401622924e-09
the O 0 3.274265303332413e-09
PTPase O 0 2.2765925677958876e-06
core O 0 2.4378701368732436e-07
motif O 0 8.86532180999211e-09
, O 0 7.758878262098534e-11
with O 0 2.901659988674421e-11
13 O 0 1.884082889702654e-09
of O 0 1.9647194982042038e-09
30 O 0 7.671813406773254e-09
( O 0 1.9237207660172118e-10
43 O 0 8.432059495078192e-09
% O 0 2.339881344237682e-10
) O 0 6.410219577368537e-10
CD B-Disease 0 0.0018746001878753304
mutations O 0 8.605160140007229e-09
identified O 0 5.206852171646403e-10
in O 0 2.2878980654450487e-10
this O 0 2.234900042807908e-09
exon O 0 3.248807161071454e-06
. O 0 4.60599494545022e-07

Seven O 0 5.7058120006558966e-08
of O 0 1.8104064025692423e-08
30 O 0 1.1128601151710882e-08
( O 0 1.3051525138418896e-10
23 O 0 2.0328243532929946e-09
% O 0 5.7619402304975864e-11
) O 0 3.352170971360202e-11
were O 0 2.0695986591157123e-10
within O 0 1.8583033722929798e-10
the O 0 5.49455148046718e-10
core O 0 3.661546443822772e-08
motif O 0 2.7946724934224676e-09
, O 0 4.4084218914219875e-11
the O 0 3.2599187238524507e-10
majority O 0 3.249419483486449e-11
( O 0 3.683128455000961e-11
five O 0 7.079403729903788e-11
of O 0 5.000747593797428e-10
seven O 0 1.1506073177569576e-10
) O 0 1.640606227260033e-11
of O 0 3.853259933350728e-10
which O 0 1.4746473486759726e-10
were O 0 7.059343110071836e-10
missense O 0 1.3378698326960148e-07
mutations O 0 5.673956859908458e-09
, O 0 3.1763772168069693e-10
possibly O 0 1.0585814447239272e-09
pointing O 0 6.705515698257614e-09
to O 0 1.7949938757588768e-10
the O 0 9.135155409900619e-10
functional O 0 1.462146315134305e-08
significance O 0 5.713914674743137e-08
of O 0 1.2371263125032783e-08
this O 0 1.3804661858074496e-09
region O 0 3.089474773787515e-07
. O 0 4.84804672851169e-07

Germline O 0 0.0003439644060563296
PTEN O 0 0.0009327151346951723
mutations O 0 3.8122458079214994e-08
were O 0 6.904881666436324e-10
identified O 0 1.0179963122469715e-10
in O 0 3.241224302841239e-11
four O 0 1.6335252595034433e-10
of O 0 1.4905913170437657e-09
seven O 0 7.925429756916458e-10
( O 0 1.678949201888713e-10
57 O 0 1.815860173337569e-08
% O 0 9.105756704208545e-10
) O 0 5.602721397934829e-09
BZS B-Disease 0 0.0013703495496883988
families O 0 4.115984442165654e-09
studied O 0 2.3133340221193066e-07
. O 0 1.4703577733143902e-07

Interestingly O 0 2.8560171472236107e-07
, O 0 4.430571021174501e-09
none O 0 1.4109324819600033e-09
of O 0 1.365812796194632e-09
these O 0 4.867030112265525e-10
mutations O 0 1.6308986383606339e-09
was O 0 2.7537232494267982e-09
observed O 0 1.513057235058568e-09
in O 0 8.597970113655151e-10
the O 0 3.442106688567037e-08
PTPase O 0 0.00027734131435863674
core O 0 0.0001172793417936191
motif O 0 6.814792868681252e-06
. O 0 3.81030872631527e-07

It O 0 3.467945575152953e-08
is O 0 1.6895381760306805e-09
also O 0 3.999769682128118e-10
worthy O 0 5.4583217945491924e-08
of O 0 4.705553724448919e-09
note O 0 1.1121337184505364e-09
that O 0 4.50396109297202e-11
a O 0 3.566395789800225e-10
single O 0 1.955552164645269e-09
nonsense O 0 6.679121611341543e-08
point O 0 6.765719717805041e-08
mutation O 0 1.4498680034336076e-09
, O 0 5.04544128698825e-10
R233X O 0 4.962886919201992e-07
, O 0 2.1508530512193147e-09
was O 0 3.144484672645831e-09
observed O 0 7.576748672910583e-10
in O 0 2.4365187645258857e-10
the O 0 2.3009447680522044e-09
germline O 0 3.549669225222374e-09
DNA O 0 8.995844069659142e-10
from O 0 7.334128443448051e-11
two O 0 6.725439649635234e-11
unrelated O 0 5.6967075501290765e-09
CD B-Disease 0 1.248338412551675e-05
families O 0 1.6692963678011097e-10
and O 0 2.4279238619584476e-09
one O 0 1.639716984414008e-08
BZS B-Disease 1 0.9813723564147949
family O 0 1.9709439413873042e-07
. O 0 4.797262249667256e-07

Genotype O 0 4.640138286049478e-06
- O 0 4.578867560667277e-07
phenotype O 0 5.34495114834499e-09
studies O 0 4.193338176694539e-10
were O 0 6.128115376258236e-11
not O 0 5.975249808831684e-12
performed O 0 1.6218335008311158e-10
on O 0 3.0872532308379164e-10
this O 0 2.1804466218688923e-11
small O 0 1.1014897882688501e-09
group O 0 4.433247935420326e-10
of O 0 2.590983605443853e-08
BZS B-Disease 1 0.9991611242294312
families O 0 7.363627041456766e-09
. O 0 9.665011191373196e-08

However O 0 2.0872342076927453e-07
, O 0 2.3544108884721027e-08
genotype O 0 1.0739326938846716e-07
- O 0 8.481389812686757e-08
phenotype O 0 5.971886540834248e-09
analysis O 0 3.2683733497407275e-10
inthe O 0 1.1990455739407935e-08
group O 0 5.408538200635249e-11
of O 0 8.769188708512843e-10
CD B-Disease 0 0.09237900376319885
families O 0 1.2435598384374913e-10
revealed O 0 4.4712325508733386e-10
two O 0 4.171717138401476e-11
possible O 0 3.050942276594526e-10
associations O 0 7.837351601036602e-11
worthy O 0 2.0516822019089886e-08
of O 0 5.364632293947125e-09
follow O 0 1.5189240976098972e-09
- O 0 2.3200986021265635e-08
up O 0 1.3089582751035778e-08
in O 0 8.776317450553961e-10
independent O 0 1.492253431933932e-08
analyses O 0 1.6780968792318163e-07
. O 0 1.358831980269315e-07

The O 0 1.817364392309173e-07
first O 0 1.229790846934975e-08
was O 0 2.153547207228712e-08
an O 0 5.057957386256362e-10
association O 0 2.6556640220221084e-10
noted O 0 5.626417665105521e-10
in O 0 1.3614917526716397e-10
the O 0 1.0245456705249012e-09
group O 0 3.95086220683627e-11
of O 0 1.0007853434856884e-09
CD B-Disease 1 1.0
families O 0 1.0977816433666021e-09
with O 0 1.4877233667220935e-08
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.5407350057757867e-07

A O 0 7.229183438539621e-07
correlation O 0 3.367620138305938e-08
was O 0 6.742296942974235e-09
observed O 0 2.6209526216014467e-10
between O 0 1.2775792923580553e-10
the O 0 4.743433978937617e-10
presence O 0 1.517088454860982e-09
/ O 0 1.8807524782005203e-07
absence O 0 2.45789912867167e-08
of O 0 7.021883163815801e-08
a O 0 1.4074873710967495e-08
PTEN O 0 4.8795296606840566e-05
mutation O 0 1.3569866341711645e-09
and O 0 1.521306691731894e-10
the O 0 3.573695783742892e-10
type O 0 1.4353818578172195e-08
of O 0 5.513043177529653e-08
breast O 1 0.9999996423721313
involvement O 0 6.456572236857028e-07
( O 0 6.0921920841394694e-09
unaffected O 0 2.909478553192457e-06
versus O 0 1.5993533452274278e-05
benign O 1 0.9889194369316101
versus O 0 0.0011302561033517122
malignant O 1 0.9999995231628418
) O 0 4.184385815619862e-08
. O 0 8.485289271220608e-08

Specifically O 0 1.0677420192450882e-07
and O 0 4.052836732881815e-09
more O 0 5.684100759517641e-11
directly O 0 3.2107436154227287e-10
, O 0 2.4969315504108636e-10
an O 0 1.8326537509771867e-10
association O 0 5.987085827108274e-10
was O 0 8.895844061385105e-09
also O 0 4.92205332047746e-10
observed O 0 4.6378675899738653e-10
between O 0 7.937453472273148e-11
the O 0 7.462412909831073e-10
presence O 0 8.00076449536391e-10
of O 0 1.1392812027111177e-08
a O 0 3.949000060288199e-08
PTEN O 1 1.0
mutation O 0 3.6490293950919295e-06
and O 0 4.429112777870614e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.2571878705311974e-07

Secondly O 0 1.9635197077150224e-06
, O 0 1.2221724077221552e-08
there O 0 1.1174090541743453e-09
appeared O 0 5.618267517881748e-10
to O 0 1.45748385582678e-10
be O 0 2.856288261465778e-10
an O 0 4.409012599460027e-10
interdependent O 0 1.9697282027664187e-07
association O 0 4.070655368337839e-09
between O 0 1.106649705207019e-08
mutations O 0 1.98920719896023e-08
upstream O 0 3.094212530641016e-08
and O 0 1.0281554496671674e-09
within O 0 1.6215436771105374e-09
the O 0 6.915759076520089e-09
PTPase O 0 0.00019754427194129676
core O 0 4.241101487423293e-05
motif O 0 1.5676437215006445e-07
, O 0 7.408662572316871e-10
the O 0 7.492519937812858e-10
core O 0 2.6660099905484458e-08
motif O 0 1.7235516347469115e-09
containing O 0 1.488652950909497e-10
the O 0 2.933883413991367e-10
majority O 0 5.654482784778203e-11
of O 0 1.3952555777407838e-09
missense O 0 1.6717770279228716e-08
mutations O 0 3.9024825038147526e-10
, O 0 2.5474797618607603e-11
and O 0 4.632436795271033e-11
the O 0 1.8570985027555054e-10
involvement O 0 4.959257449144161e-10
of O 0 7.928412593116718e-09
all O 0 8.775228876878316e-10
major O 0 6.02616978540027e-08
organ O 1 0.9999986886978149
systems O 1 1.0
( O 0 5.6495079725493724e-09
central O 1 0.9999985694885254
nervous O 0 0.18473301827907562
system O 1 0.9999977350234985
, O 0 7.838065130272298e-08
thyroid O 1 1.0
, O 0 1.8696412098506698e-06
breast O 1 1.0
, O 0 2.0281939328015142e-07
skin O 1 1.0
and O 0 0.03758368268609047
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 1.1002435940099531e-07
. O 0 2.212279639479675e-07

However O 0 1.9419940144871362e-07
, O 0 7.560092996072854e-09
these O 0 1.1184558834642644e-09
observations O 0 4.397366470954012e-09
would O 0 2.369541229896299e-10
need O 0 3.016611682671311e-10
to O 0 2.061844583955974e-10
be O 0 1.4132399417388086e-10
confirmed O 0 7.111830568895527e-11
by O 0 3.633386300161412e-11
studying O 0 1.067400945409247e-09
a O 0 5.631611149636839e-11
larger O 0 6.506858385435521e-10
number O 0 2.975439616914599e-10
of O 0 2.975111712544276e-09
CD B-Disease 0 0.001184820313937962
families O 0 3.2845295372396777e-09
. O 0 5.613796005832228e-08

Molecular O 0 0.010888632386922836
defects O 1 0.9921293258666992
leading O 0 6.60478320924085e-08
to O 0 1.1275119726761318e-09
human O 0 5.173572237282542e-09
complement B-Disease 0 6.013579877617303e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.0376017822721906e-09
an O 0 1.5071835446356374e-10
African O 0 1.998103488221048e-10
- O 0 1.0948191686566133e-08
American O 0 4.121302854542819e-09
family O 0 5.490887300396707e-09
. O 0 3.255144065406057e-08

Complement B-Disease 0 0.0003941773029509932
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.043627927468151e-08
C6D B-Disease 1 1.0
) O 0 7.072810781494354e-09
was O 0 1.1274269695604744e-07
diagnosed O 0 9.533626155189268e-08
in O 0 4.763289207510013e-10
a O 0 7.442910177068995e-10
16 O 0 2.8625291026429522e-09
- O 0 1.924918224815997e-09
year O 0 1.5465434488604046e-10
- O 0 5.5549129740484204e-09
old O 0 6.942270758258928e-09
African O 0 1.609120336976133e-10
- O 0 2.0931487654252123e-09
American O 0 3.1419833401713504e-10
male O 0 4.4493941864232056e-10
with O 0 5.351446508150559e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 4.661018238039105e-07

The O 0 1.1086635254287103e-07
patients O 0 1.2333472909631382e-08
father O 0 1.2961280937417996e-09
and O 0 1.712684882804183e-09
two O 0 1.715470321350665e-09
brothers O 0 2.496500783877309e-08
also O 0 1.5111624174224403e-09
had O 0 4.810935649857129e-09
C6D B-Disease 1 1.0
, O 0 1.0667823291399259e-09
but O 0 1.6230064514566322e-10
gave O 0 1.4710802576090032e-09
no O 0 7.90940757333658e-10
history O 0 2.0331385464089635e-09
of O 0 1.14486642388556e-08
meningitis B-Disease 1 1.0
or O 0 2.259464970677527e-08
other O 0 1.7391590390047895e-08
neisserial B-Disease 1 0.6830257177352905
infection I-Disease 0 5.3785341151524335e-05
. O 0 3.3367584251209337e-07

By O 0 9.185776583819916e-09
using O 0 9.584509186311152e-09
exon O 0 1.534168063699326e-07
- O 0 7.106592647687648e-08
specific O 0 6.975080513171861e-09
polymerase O 0 8.587730526699033e-09
chain O 0 6.4441314506780145e-09
reaction O 0 2.2626107931689177e-10
( O 0 8.443123977741607e-11
PCR O 0 1.8062571882637712e-08
) O 0 5.075729836434562e-10
/ O 0 5.761385590830059e-09
single O 0 4.874778358754384e-10
- O 0 3.781595037111174e-09
strand O 0 6.143192066154768e-10
conformation O 0 8.660790140613273e-11
polymorphism O 0 3.976885487588788e-11
as O 0 2.2879710279144483e-11
a O 0 1.1386559230219806e-11
screening O 0 5.648492229504143e-10
step O 0 8.217300728752264e-10
and O 0 7.11987899193467e-11
nucleotide O 0 1.703948510067832e-10
sequencing O 0 2.2724805370799572e-10
of O 0 3.7291483789836377e-10
target O 0 3.441967155737302e-09
exons O 0 1.1059342774899505e-08
, O 0 4.769762917966602e-10
we O 0 2.4781901530879225e-10
determined O 0 4.895014948935739e-10
that O 0 2.754949914030025e-11
the O 0 1.7303039001603793e-09
proband O 0 2.5932238258974394e-06
was O 0 4.1737127531860096e-08
a O 0 2.730334847100835e-09
compound O 0 7.346862673784926e-09
heterozygote O 0 6.149222997464676e-08
for O 0 2.211480554237255e-09
two O 0 9.388251953623694e-09
C6 O 1 0.9999887943267822
gene O 0 6.102335987634433e-07
mutations O 0 4.818266461370513e-07
. O 0 1.8780818322738924e-07

The O 0 4.920190690427262e-07
first O 0 1.894740009333873e-08
, O 0 5.630510280241197e-09
1195delC O 0 3.1911920927996107e-07
located O 0 2.445539770690175e-08
in O 0 1.4277139470664224e-09
exon O 0 1.0519643467432616e-07
7 O 0 4.093798011695071e-08
, O 0 7.13855252687523e-10
is O 0 1.655588860449697e-10
a O 0 9.433980679984799e-11
novel O 0 9.123802269250803e-10
mutation O 0 5.243474751615018e-11
, O 0 1.865792589872406e-11
while O 0 5.91549170758654e-11
the O 0 5.496836319451859e-10
second O 0 4.097185701823491e-09
, O 0 6.492291704240927e-10
1936delG O 0 1.0594246901973747e-07
in O 0 8.166567977418993e-10
exon O 0 7.005883162491955e-08
12 O 0 2.6674493724954118e-08
, O 0 7.793439782410871e-10
has O 0 1.6106678490945825e-10
been O 0 1.0639450431781938e-10
described O 0 9.509495274562241e-11
before O 0 2.3681223648708283e-10
to O 0 4.895649996505824e-10
cause O 0 2.6805210495695064e-08
C6D B-Disease 1 0.9999992847442627
in O 0 4.352298965670798e-09
an O 0 9.709940629321068e-10
unrelated O 0 4.442140166815989e-08
African O 0 2.0651909071744967e-09
- O 0 7.773079602202415e-08
American O 0 1.574625230205129e-08
individual O 0 5.109174416872975e-09
. O 0 1.601192423095199e-08

Both O 0 5.569241920966306e-07
mutations O 0 9.972706038752222e-08
result O 0 8.081364022416437e-09
in O 0 2.4959565525506378e-09
premature O 0 8.268310836001547e-08
termination O 0 6.77460363363025e-08
codons O 0 4.300652278743655e-07
and O 0 7.669958534961552e-08
C6 O 1 0.9884628653526306
null O 0 7.2390462264593225e-06
alleles O 0 1.1669654043089395e-07
. O 0 1.2711664965081582e-07

Allele O 0 7.438629836542532e-07
- O 0 1.1085345619221698e-07
specific O 0 8.095264014684744e-09
PCR O 0 1.44158240900083e-08
indicated O 0 8.811573692923957e-10
that O 0 3.3932964077498795e-11
the O 0 1.1828219514953275e-09
probands O 0 1.9886172140104463e-06
two O 0 1.6309918970947024e-09
brothers O 0 2.387617925592167e-08
also O 0 4.7858672580503026e-09
inherited O 0 7.240277568598685e-07
the O 0 3.784974467180291e-08
1195delC O 0 3.753106909698545e-07
mutation O 0 5.2844612019598e-10
from O 0 3.6245610679497275e-11
their O 0 3.1966529423499424e-10
heterozygous O 0 2.0610042561486352e-09
mother O 0 5.522488577547335e-10
and O 0 4.427848088184305e-10
the O 0 3.6207365994300744e-09
1936delG O 0 1.1420991796740054e-07
mutation O 0 7.298756043994103e-10
from O 0 1.0140816658621432e-10
their O 0 8.42299008319003e-10
homozygous O 0 2.625648498622013e-08
father O 0 1.6531892299553874e-08
. O 0 7.1010211044608695e-09
. O 0 9.329492201004541e-08

PAX6 O 1 0.9949642419815063
mutations O 0 3.481343446765095e-05
reviewed O 0 1.2346730727585964e-05
. O 0 3.2141713290911866e-06

Mutations O 0 6.135094849923917e-07
in O 0 1.6284438686398062e-08
PAX6 O 0 0.0018140198662877083
are O 0 1.5922347884611554e-09
responsible O 0 3.4151943495430714e-09
for O 0 9.67116275951696e-10
human O 0 1.1192332394216464e-08
aniridia B-Disease 1 1.0
and O 0 3.315666958769725e-07
have O 0 8.990818090026664e-10
also O 0 3.028192974152688e-10
been O 0 1.0778301168246074e-10
found O 0 1.1749239602065753e-11
in O 0 8.156113805168896e-12
patients O 0 2.534534561393631e-11
with O 0 1.9468081660645176e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.7673826846476004e-08
with O 0 0.0008871267782524228
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 8.273173989437055e-06
with O 0 2.0151578610239085e-06
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 0.9999995231628418
, O 0 2.968400858449627e-09
and O 0 6.188130452500218e-09
with O 0 6.219999448831004e-08
isolated B-Disease 1 0.9999998807907104
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.00011332467693137005

No O 0 4.7378603085235227e-07
locus O 0 1.7354153669657535e-07
other O 0 1.7255251671954852e-09
than O 0 3.892001720906535e-10
chromosome O 0 2.1067721789336247e-08
11p13 O 0 6.191143029354862e-07
has O 0 1.1811627231850252e-09
been O 0 9.490184194049789e-10
implicated O 0 4.3555461459732214e-09
in O 0 9.105269871412247e-10
aniridia B-Disease 1 1.0
, O 0 6.487306691838057e-09
and O 0 1.2007872918218254e-08
PAX6 O 1 0.9999661445617676
is O 0 2.9246771671154193e-09
clearly O 0 1.951449890569279e-09
the O 0 1.2409754335251932e-09
major O 0 2.6520526219542262e-08
, O 0 8.03143440641918e-10
if O 0 2.680053401427074e-10
not O 0 1.0046366516469618e-10
only O 0 2.913540242399648e-10
, O 0 1.337761457165243e-09
gene O 0 1.0297260821801046e-08
responsible O 0 2.0427235369879782e-07
. O 0 4.133610502776719e-07

Twenty O 0 8.309493750857655e-07
- O 0 8.11129510225328e-08
eight O 0 6.696850185505809e-09
percent O 0 1.272885574721272e-09
of O 0 1.5222246796398053e-09
identified O 0 4.207977966075305e-09
PAX6 O 0 0.001880328985862434
mutations O 0 9.703242653813504e-09
are O 0 1.2545281480313974e-10
C O 0 1.8346250385548046e-07
- O 0 2.2519329831993673e-06
T O 0 2.1169787487451686e-06
changes O 0 3.648306323711381e-09
at O 0 6.221835935349418e-09
CpG O 0 3.1891903518044273e-07
dinucleotides O 0 5.510593155122478e-07
, O 0 7.043258198891067e-10
20 O 0 1.2724826747856355e-09
% O 0 2.889211786483159e-11
are O 0 2.7090573707921894e-12
splicing O 0 4.4662293308128653e-10
errors O 0 1.7357921322513903e-08
, O 0 1.5399617692146705e-10
and O 0 2.6580762590988627e-10
more O 0 2.8075080454881274e-11
than O 0 2.7487196546660542e-11
30 O 0 6.034768240681387e-10
% O 0 7.628628978517682e-11
are O 0 3.3748944611167175e-11
deletion O 0 1.2644050251253702e-08
or O 0 2.234443963189392e-09
insertion O 0 2.681932542714094e-08
events O 0 1.9643644932898496e-08
. O 0 9.222629415717165e-08

There O 0 1.4111571999819716e-07
is O 0 1.4089001965089665e-08
a O 0 3.688714445004848e-09
noticeably O 0 2.102012217619631e-07
elevated O 0 6.906784051352588e-07
level O 0 1.543356553668218e-08
of O 0 1.2200854548893858e-08
mutation O 0 2.119883379947396e-09
in O 0 1.962168066915737e-10
the O 0 1.9353809666000643e-09
paired O 0 2.781479047087032e-09
domain O 0 4.717656265640358e-10
compared O 0 4.737446546165813e-11
with O 0 4.321580940325198e-11
the O 0 1.9168653331291807e-09
rest O 0 5.991441565100786e-09
of O 0 1.178912523158715e-08
the O 0 5.1413785229215136e-08
gene O 0 9.299556325004232e-08
. O 0 2.1881035650039848e-07

Increased O 0 3.4907753843071987e-07
mutation O 0 5.641948686019305e-09
in O 0 3.397708780994435e-10
the O 0 3.980129559266743e-09
homeodomain O 0 4.295086171168805e-07
is O 0 8.387623373629083e-10
accounted O 0 1.4614985888172782e-09
for O 0 3.5236411011219104e-11
by O 0 9.490885855001352e-11
the O 0 1.8929881662188563e-08
hypermutable O 0 1.5271687516360544e-05
CpG O 0 1.182431515189819e-05
dinucleotide O 0 4.920340415992541e-06
in O 0 7.55813616137857e-08
codon O 0 2.045217797785881e-06
240 O 0 2.7888756903848844e-07
. O 0 1.4736455966612994e-07

Very O 0 8.633901416033041e-08
nearly O 0 3.6726097718542405e-09
all O 0 1.0393428340194077e-09
mutations O 0 1.3589966929572483e-09
appear O 0 4.981079992916193e-10
to O 0 2.670271781468614e-10
cause O 0 3.442118146068651e-09
loss O 0 1.925951309544871e-08
of O 0 1.3344110705304502e-08
function O 0 6.161862131648377e-10
of O 0 1.7771779603492632e-09
the O 0 2.2001713784192134e-09
mutant O 0 7.810066371405355e-09
allele O 0 8.735395740089302e-11
, O 0 3.4583957225775563e-11
and O 0 8.253566580185279e-11
more O 0 7.21835438644014e-12
than O 0 1.4181131095802879e-11
80 O 0 8.274708696021094e-10
% O 0 8.87778323077626e-11
of O 0 1.269186089558616e-09
exonic O 0 1.1767288015107624e-06
substitutions O 0 5.760630372719788e-08
result O 0 2.7472653041371586e-09
in O 0 4.2209040707064105e-09
nonsense O 0 1.0376626278230106e-06
codons O 0 3.658493369584903e-06
. O 0 2.321263252724748e-07

In O 0 5.624706389539824e-08
a O 0 4.431619071709747e-09
gene O 0 6.447853362345768e-10
with O 0 2.569494061965827e-10
such O 0 6.72622846309423e-09
extraordinarily O 0 4.743312587152104e-08
high O 0 1.3804832121877553e-07
sequence O 0 1.153541484555376e-09
conservation O 0 5.908123767994766e-09
throughout O 0 1.9439556908640299e-10
evolution O 0 3.146337079762418e-10
, O 0 4.403581319034622e-11
there O 0 6.62349480817781e-11
are O 0 1.642535829571301e-10
presumed O 0 4.402656017532536e-08
undiscovered O 0 8.28223619464552e-06
missense O 0 1.0690625629194983e-07
mutations O 0 5.780934841936869e-09
, O 0 2.2570850743974802e-10
these O 0 1.7799994811440456e-10
are O 0 2.2066876104176458e-11
hypothesized O 0 1.2574874475035358e-09
to O 0 1.208785155304426e-10
exist O 0 3.3152808276426526e-10
in O 0 1.2491153944527156e-10
as O 0 1.4251402280507364e-09
- O 0 1.0760281554667017e-07
yet O 0 5.858368012923165e-09
unidentified O 0 3.604139919843874e-08
phenotypes O 0 4.478346937730748e-08
. O 0 5.571806127591117e-09
. O 0 9.620264052045968e-08

Genetic O 0 1.5345352721851668e-06
heterogeneity O 0 4.485339673010458e-07
and O 0 7.417687353239444e-09
penetrance O 0 1.2473184085592948e-07
analysis O 0 2.821746447612128e-10
of O 0 3.484739385939406e-09
the O 0 2.709124835575949e-08
BRCA1 O 0 8.862144795784843e-07
and O 0 7.552141312316962e-08
BRCA2 O 0 9.123562449531164e-06
genes O 0 7.070140473075526e-09
in O 0 2.5173854112381377e-09
breast B-Disease 1 0.9999986886978149
cancer I-Disease 0 2.3593936930410564e-05
families O 0 9.794312028077456e-10
. O 0 2.753588113080241e-08

The O 0 8.754281589062884e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 2.8166572519694455e-05
Consortium O 0 8.246220204455312e-07
. O 0 8.522221150997211e-08

The O 0 3.505821055682645e-08
contribution O 0 4.030483324868328e-08
of O 0 1.6434312044566468e-07
BRCA1 O 0 9.573776651450316e-07
and O 0 1.1301030156118941e-07
BRCA2 O 0 0.33086758852005005
to O 0 1.666381592713151e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 9.301826509044986e-08
assessed O 0 4.4714930425016064e-08
by O 0 9.648623566782533e-11
linkage O 0 1.92299278722885e-08
and O 0 9.777886278428127e-10
mutation O 0 1.3364345741173622e-10
analysis O 0 1.6417017051351124e-11
in O 0 2.6061958147138853e-11
237 O 0 5.066889130489471e-10
families O 0 1.2017654666546251e-12
, O 0 5.77823639630326e-12
each O 0 1.6893164384718107e-12
with O 0 4.185048141369663e-12
at O 0 5.469644182021227e-10
least O 0 4.3576607600126493e-11
four O 0 3.655023853021966e-11
cases O 0 2.744127147735753e-10
of O 0 1.7809622221420796e-08
breast B-Disease 1 1.0
cancer I-Disease 0 2.659249548742082e-05
, O 0 1.843775132570613e-10
collected O 0 2.8432486920415556e-10
by O 0 9.957543817273873e-11
the O 0 5.70949154621303e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 2.951712986032362e-06
Consortium O 0 1.8158537784529472e-07
. O 0 3.563489414659671e-08

Families O 0 1.994574505559399e-09
were O 0 2.121840203539449e-10
included O 0 7.769752063957469e-10
without O 0 5.564581018191461e-10
regard O 0 1.3470532467252383e-09
to O 0 1.8025486658856948e-10
the O 0 8.225455316868135e-10
occurrence O 0 3.659096137198503e-08
of O 0 4.356968202046119e-05
ovarian B-Disease 1 1.0
or I-Disease 0 2.8325100629444933e-06
other I-Disease 0 2.7541771032701945e-06
cancers I-Disease 1 1.0
. O 0 6.748005034751259e-07

Overall O 0 4.555842315312475e-05
, O 0 7.805497403978734e-08
disease O 0 4.954160249326378e-05
was O 0 7.372751298362346e-08
linked O 0 5.5372183282997867e-08
to O 0 9.819924429166349e-09
BRCA1 O 0 3.9009311336712926e-08
in O 0 1.617360551042779e-10
an O 0 5.98398899875896e-11
estimated O 0 2.046728064808434e-10
52 O 0 4.2846162728871207e-10
% O 0 1.0644194727016387e-11
of O 0 1.317327219529929e-10
families O 0 6.785117172974919e-12
, O 0 8.910133048045665e-11
to O 0 1.572055707832476e-09
BRCA2 O 0 3.7518326223562326e-08
in O 0 1.877295124907974e-10
32 O 0 1.6744025055359657e-09
% O 0 1.4429694418505168e-11
of O 0 7.638937399301327e-11
families O 0 2.8051833859260578e-12
, O 0 1.7238852706435992e-11
and O 0 7.741199348210159e-11
to O 0 4.979588963394121e-10
neither O 0 3.248871394134767e-09
gene O 0 2.0322572791275917e-10
in O 0 2.0376096643293096e-10
16 O 0 9.571794024054725e-09
% O 0 1.9719340049739742e-10
( O 0 6.303413346842035e-11
95 O 0 2.1929706051082576e-08
% O 0 1.087476220185124e-09
confidence O 0 9.255756161508089e-09
interval O 0 7.627229337003882e-08
[ O 0 1.1949889255902235e-07
CI O 1 0.999998927116394
] O 0 1.5122184393590032e-08
6 O 0 5.64877522535312e-09
% O 0 7.282204700365114e-11
- O 0 2.071874671827345e-09
28 O 0 2.7273889813272945e-09
% O 0 1.2742550070665715e-10
) O 0 1.035385180370163e-10
, O 0 4.1391282068481416e-10
suggesting O 0 3.5521821040163104e-09
other O 0 6.5135421500883695e-09
predisposition O 0 3.093870191150927e-06
genes O 0 1.009750008051924e-07
. O 0 1.0245426551591663e-07

The O 0 2.2318985770652944e-07
majority O 0 2.34593300341146e-09
( O 0 3.344757804057963e-10
81 O 0 1.3979333246538772e-08
% O 0 6.824889264844813e-11
) O 0 3.2249810461015826e-11
of O 0 1.1166867430745242e-09
the O 0 7.186250172708242e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.0943364150447525e-12
were O 0 1.8283573439970002e-12
due O 0 8.169694781789971e-11
to O 0 1.5190132485187746e-10
BRCA1 O 0 3.24373861104732e-09
, O 0 3.349371821559366e-11
with O 0 2.7347518347098365e-11
most O 0 2.58525950647126e-10
others O 0 2.557290490479147e-10
( O 0 1.0017359164393724e-10
14 O 0 3.5080267579701285e-09
% O 0 1.312264047426126e-10
) O 0 1.7925579076649711e-10
due O 0 2.5221783772622075e-08
to O 0 1.3488001116002124e-07
BRCA2 O 0 5.0822083721868694e-05
. O 0 3.3050312708837737e-07

Conversely O 0 1.2838101781653677e-07
, O 0 7.948607327890045e-10
the O 0 5.374133915658774e-10
majority O 0 3.222546535175397e-11
of O 0 3.3027461321388785e-10
families O 0 5.7446430425101e-12
with O 0 2.412968262699433e-11
male B-Disease 0 1.0376512982190889e-09
and I-Disease 0 1.445342623362933e-09
female I-Disease 0 7.716323580098106e-09
breast I-Disease 0 0.04227353632450104
cancer I-Disease 0 1.8066106122205383e-06
were O 0 3.88491100400401e-10
due O 0 6.593857193593067e-08
to O 0 6.736592439438027e-08
BRCA2 O 0 9.501795830146875e-06
( O 0 5.554888771186484e-10
76 O 0 3.2792297588457586e-07
% O 0 2.8187947531677082e-09
) O 0 4.19777324012216e-09
. O 0 8.002191265177316e-08

The O 0 2.3243602242928318e-07
largest O 0 4.580500956308242e-08
proportion O 0 6.095318472176814e-09
( O 0 1.0780953213496147e-10
67 O 0 5.178844020292672e-09
% O 0 4.482723914289721e-11
) O 0 2.8865678944334228e-11
of O 0 8.048994248888164e-10
families O 0 1.1051967500896875e-11
due O 0 3.272627724371091e-10
to O 0 7.566144932802388e-11
other O 0 7.864755374731303e-11
genes O 0 4.385819485364095e-11
was O 0 4.2749354056681454e-10
found O 0 2.3891449582591484e-11
in O 0 2.180995661849039e-11
families O 0 9.694196400483746e-13
with O 0 5.87391116649294e-12
four O 0 5.857758722527251e-11
or O 0 8.717968708049639e-11
five O 0 7.358762210696312e-11
cases O 0 1.7773330029946521e-10
of O 0 2.1802792460334786e-08
female O 0 1.9080248137015587e-07
breast B-Disease 1 0.9999994039535522
cancer I-Disease 0 0.11327921599149704
only O 0 1.2354378853274284e-08
. O 0 5.618916176786115e-08

These O 0 2.731664494604047e-08
estimates O 0 4.296452082996893e-09
were O 0 3.642817991700298e-10
not O 0 1.340302036023644e-10
substantially O 0 1.8209332930396727e-09
affected O 0 2.757453709811841e-10
either O 0 7.844066368667413e-11
by O 0 1.7646986302799483e-11
changing O 0 1.6785561829379958e-09
the O 0 8.375793947301702e-10
assumed O 0 6.437792077207405e-09
penetrance O 0 4.27823536597316e-08
model O 0 6.711091127264979e-10
for O 0 3.0934246830760515e-10
BRCA1 O 0 8.934665451931778e-09
or O 0 1.925559017790235e-11
by O 0 9.796918484794581e-12
including O 0 1.5554071364221045e-09
or O 0 2.2666993615416686e-08
excluding O 0 3.270259185228497e-06
BRCA1 O 0 9.530605780128099e-07
mutation O 0 3.496812084335943e-08
data O 0 1.3232440032595605e-08
. O 0 7.23003878988493e-08

Among O 0 1.9146481733400833e-08
those O 0 9.937246581159798e-10
families O 0 1.8002731250188475e-11
with O 0 5.900178262630007e-11
disease O 0 2.834385952610319e-07
due O 0 3.8233139321164344e-08
to O 0 1.7047661060587416e-08
BRCA1 O 0 4.9186613892970854e-08
that O 0 8.025994452376395e-11
were O 0 1.8658860567732916e-10
tested O 0 2.7863253371229746e-10
by O 0 4.086955166654471e-12
one O 0 5.032838382157401e-11
of O 0 2.041982555267552e-10
the O 0 1.3158078793207295e-10
standard O 0 4.677204179515115e-10
screening O 0 5.321582063899655e-10
methods O 0 6.004354236033294e-10
, O 0 2.5437957296148284e-10
mutations O 0 5.702292527054453e-10
were O 0 1.1228928897821788e-10
detected O 0 1.2127069348721875e-09
in O 0 7.786275096899331e-11
the O 0 1.0124779903364356e-09
coding O 0 7.378037292227191e-09
sequence O 0 6.165189470053178e-10
or O 0 1.9075346857633235e-10
splice O 0 8.17545409148579e-09
sites O 0 1.0674946482325254e-09
in O 0 1.0099854980127887e-10
an O 0 1.0248461107531526e-10
estimated O 0 4.836768763283317e-10
63 O 0 2.2692645984534465e-08
% O 0 6.803396179755339e-10
( O 0 3.226865719074823e-10
95 O 0 1.4001994941281737e-07
% O 0 1.0991272780813688e-08
CI O 1 0.9999822378158569
51 O 0 8.908600079848839e-08
% O 0 3.672874226978706e-10
- O 0 1.2535153359749529e-08
77 O 0 1.4897906908117875e-08
% O 0 8.983755961367024e-10
) O 0 2.2725943349399813e-09
. O 0 5.723928353518204e-08

The O 0 1.3087689865187713e-07
estimated O 0 6.0447820082742965e-09
sensitivity O 0 3.702531969906886e-08
was O 0 1.3318073754930992e-08
identical O 0 2.9838180815033866e-09
for O 0 4.1802655781353337e-10
direct O 0 1.2716746544683133e-09
sequencing O 0 1.257446702318532e-09
and O 0 1.0281142603929538e-09
other O 0 1.7302312915745688e-09
techniques O 0 6.359479698403447e-08
. O 0 8.104753135285137e-08

The O 0 8.829615580907557e-07
penetrance O 0 1.0245158591715153e-05
of O 0 3.365378006492392e-06
BRCA2 O 0 1.0823720003827475e-05
was O 0 4.1512504544982676e-09
estimated O 0 2.0444027026833567e-10
by O 0 4.754537041851137e-11
maximizing O 0 1.220917056343751e-07
the O 0 7.343738062104421e-09
LOD O 1 0.9999544620513916
score O 0 1.2051978615090775e-07
in O 0 5.742558872867676e-09
BRCA2 O 0 4.815528313883988e-07
- O 0 1.0379645587477171e-08
mutation O 0 2.697906620330315e-10
families O 0 1.643160759366713e-12
, O 0 6.7072450024574515e-12
over O 0 3.308092411113961e-10
all O 0 8.964960995783144e-10
possible O 0 5.3187036996860115e-09
penetrance O 0 9.801316309676622e-07
functions O 0 1.2632966672754264e-07
. O 0 1.7919789740972192e-07

The O 0 2.1297529073649457e-08
estimated O 0 2.1548609563382115e-09
cumulative O 0 3.7580704770334705e-08
risk O 0 5.332419306114389e-08
of O 0 8.782537719298489e-08
breast B-Disease 1 0.999790608882904
cancer I-Disease 0 1.972325480892323e-05
reached O 0 6.286874132399589e-09
28 O 0 1.0862971855374326e-08
% O 0 2.0757381924418894e-10
( O 0 1.2889166123297713e-10
95 O 0 6.897214888113012e-08
% O 0 4.103708928226979e-09
CI O 1 0.9924728870391846
9 O 0 1.1717971482028133e-08
% O 0 6.317484035900378e-11
- O 0 6.930571672114638e-10
44 O 0 6.672659647044554e-10
% O 0 8.514323794617251e-12
) O 0 2.9142044680185997e-12
by O 0 5.9871825379420596e-12
age O 0 4.161419819848078e-10
50 O 0 2.983731317574012e-10
years O 0 7.431628923360023e-11
and O 0 4.119375118794011e-10
84 O 0 3.831263839515486e-08
% O 0 6.194586510410716e-10
( O 0 3.5602248926736024e-10
95 O 0 1.0886289913969449e-07
% O 0 9.650584331666323e-09
CI O 1 0.9996864795684814
43 O 0 3.194888265056761e-08
% O 0 1.9624300795495486e-10
- O 0 3.6909382217231723e-09
95 O 0 4.91462603946502e-09
% O 0 6.578697309134185e-11
) O 0 2.1582190895541586e-11
by O 0 7.727449929939567e-11
age O 0 7.912067445658977e-09
70 O 0 1.4285482130560467e-08
years O 0 5.1074691143071504e-09
. O 0 6.740833669027779e-08

The O 0 1.2756273690683884e-06
corresponding O 0 0.14240823686122894
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.0006179737974889576
were O 0 5.300312633238491e-09
0 O 0 4.2275857481399726e-08
. O 0 1.8326904438481506e-08

4 O 0 2.5307858777523506e-06
% O 0 3.6885122511876034e-08
( O 0 3.2124665150234932e-09
95 O 0 2.5055123842321336e-07
% O 0 1.254385928461943e-08
CI O 0 0.0036398014053702354
0 O 0 4.826799404611393e-09
% O 0 3.7618515941195696e-11
- O 0 3.0829575003998855e-10
1 O 0 5.727897600671383e-10
% O 0 7.411962536785222e-12
) O 0 1.7376501713212145e-12
by O 0 2.9480500072370797e-12
age O 0 2.4346699656341286e-10
50 O 0 1.7507661986826406e-10
years O 0 5.371978903379038e-11
and O 0 2.1075577394391587e-10
27 O 0 3.5116016761094215e-09
% O 0 1.6806570024563428e-10
( O 0 1.3292554557065017e-10
95 O 0 4.334357583957171e-08
% O 0 4.416640830839924e-09
CI O 0 0.0006830660277046263
0 O 0 7.0249348560480485e-09
% O 0 9.568481423860575e-11
- O 0 2.379479058234324e-09
47 O 0 2.5901520928073296e-09
% O 0 4.719570914635263e-11
) O 0 1.788257562862494e-11
by O 0 5.081093878978038e-11
age O 0 6.637021154887179e-09
70 O 0 1.476241617837104e-08
years O 0 1.0362989577572534e-08
. O 0 1.0772870240316479e-07

The O 0 1.9162563091867924e-07
lifetime O 0 4.799774728780903e-07
risk O 0 8.255875627583009e-07
of O 0 9.677791013018577e-07
breast B-Disease 1 1.0
cancer I-Disease 0 0.2791929543018341
appears O 0 9.335607842331228e-10
similar O 0 5.3211129946717506e-11
to O 0 6.93683652186472e-11
the O 0 1.075009747886213e-09
risk O 0 1.2105515700966407e-08
in O 0 7.685503344845301e-10
BRCA1 O 0 1.73108389844856e-08
carriers O 0 6.820560227716044e-10
, O 0 5.4154954826080015e-11
but O 0 2.7200609820088317e-11
there O 0 8.098452464189165e-11
was O 0 8.92621254688919e-10
some O 0 4.0079696506101214e-11
suggestion O 0 5.487254650660134e-09
of O 0 3.957458361014687e-09
a O 0 1.277180361469732e-09
lower O 0 5.237385991563315e-08
risk O 0 6.44733049171009e-08
in O 0 6.371533523008566e-09
BRCA2 O 0 1.1622876172623364e-06
carriers O 0 7.618574215939589e-09
< O 0 1.1152547330084417e-08
50 O 0 1.761546020162541e-09
years O 0 5.784085987947662e-10
of O 0 9.541190948425537e-09
age O 0 6.413454656239992e-08
. O 0 7.022392622957341e-08

Eye B-Disease 1 1.0
movement I-Disease 0 2.4337286959053017e-06
abnormalities I-Disease 0 1.2360751497908495e-05
correlate O 0 4.983251500334518e-08
with O 0 8.796628425677966e-10
genotype O 0 2.050105685214021e-08
in O 0 5.927775159619841e-09
autosomal O 1 0.9997859597206116
dominant O 1 1.0
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.5381630191768636e-06

We O 0 3.0547948881576303e-07
compared O 0 8.907410631309176e-08
horizontal O 0 1.254318590326875e-06
eye O 0 0.0015953462570905685
movements O 0 1.8025922088327206e-07
( O 0 7.2917747395706556e-09
visually O 0 1.648066927373293e-08
guided O 0 2.398010678916762e-07
saccades O 0 1.1710283160937252e-06
, O 0 1.3233795170819462e-09
antisaccades O 0 2.2055679949062323e-07
, O 0 7.277876079569978e-10
and O 0 1.9183321597893155e-09
smooth O 0 1.508827374152588e-08
pursuit O 0 6.565242127720694e-09
) O 0 1.0237442144012121e-10
in O 0 2.2101932783957778e-10
control O 0 5.267661151719949e-08
subjects O 0 2.1906927827330946e-07
( O 0 4.733375358334513e-10
n O 0 4.32975300057592e-09
= O 0 2.47606068981554e-09
14 O 0 1.2872171106792507e-09
) O 0 8.151204017314839e-11
and O 0 1.6341297759403517e-10
patients O 0 3.4314821817371666e-11
with O 0 3.268158096578211e-12
three O 0 3.676152438014668e-11
forms O 0 1.4334275988403533e-09
of O 0 8.797089634526856e-08
autosomal O 1 0.6052543520927429
dominant O 1 0.9999666213989258
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999961853027344
type I-Disease 1 0.9963635802268982
I I-Disease 0 0.019160602241754532
spinocerebellar B-Disease 1 1.0
ataxias I-Disease 0 0.00045141647569835186
1 I-Disease 0 2.644567302922951e-07
and I-Disease 0 3.116903402045068e-09
2 I-Disease 0 5.9568954213773395e-08
( O 0 1.0991058063680725e-09
SCA1 B-Disease 1 0.9773491024971008
, O 0 3.4245417612766005e-09
n O 0 1.5250144480560834e-09
= O 0 4.750542181852779e-10
11 O 0 5.237041356132011e-10
; O 0 1.8230557341514242e-10
SCA2 B-Disease 0 4.53169850516133e-05
, O 0 1.0790669469074032e-09
n O 0 3.859762232050201e-10
= O 0 1.8362225628898443e-10
10 O 0 3.2949248884861504e-10
) O 0 1.8138644752863087e-10
and O 0 4.902829253694563e-09
SCA3 B-Disease 1 1.0
/ O 0 1.588297777743719e-06
Machado B-Disease 0 6.153755748528056e-06
- I-Disease 0 4.1822235630206706e-07
Joseph I-Disease 0 7.619210464326898e-06
disease I-Disease 0 0.2945537865161896
( O 0 7.179821626124294e-09
MJD B-Disease 1 1.0
) O 0 5.311495243631725e-09
( O 0 7.233880716661645e-10
n O 0 4.1091601232778885e-09
= O 0 4.906571593465969e-09
16 O 0 1.5029652189468834e-08
) O 0 5.112508194571319e-09
. O 0 6.583489664535591e-08

In O 0 6.431056931432977e-07
SCA1 B-Disease 1 0.9979167580604553
, O 0 7.952815650469347e-08
saccade O 0 6.372459893100313e-07
amplitude O 0 7.054961770336377e-08
was O 0 1.1306911851249879e-08
significantly O 0 2.002079613205865e-09
increased O 0 1.8809769297689627e-09
, O 0 9.599890882228124e-10
resulting O 0 6.844894873125895e-09
in O 0 7.744810126553148e-09
hypermetria B-Disease 0 9.293706534663215e-05
. O 0 9.901154953695368e-07

The O 0 3.5792088510788744e-06
smooth O 0 2.5577137421350926e-06
pursuit O 0 2.348124553464004e-06
gain O 0 3.6174120054965897e-07
was O 0 3.273905235801067e-07
decreased O 0 1.6814846048873733e-06
. O 0 5.003805654268945e-07

In O 0 9.254573569705826e-07
SCA2 B-Disease 1 0.9999972581863403
, O 0 2.3599100984483812e-07
saccade O 0 4.6016402848181315e-06
velocity O 0 4.1892735680448823e-07
was O 0 1.4419266847198742e-07
markedly O 0 3.192014048636338e-07
decreased O 0 9.42370320444752e-07
. O 0 3.7402148223009135e-07

The O 0 1.0175065767725755e-07
percentage O 0 3.214282529029333e-08
of O 0 1.7876566005270433e-08
errors O 0 1.3403963521341211e-06
in O 0 7.36032745862758e-09
antisaccades O 1 0.8463347554206848
was O 0 7.54723146201286e-08
greatly O 0 8.68243255069956e-09
increased O 0 4.06407663078312e-09
and O 0 2.4755362204587072e-09
was O 0 6.006613428866103e-09
significantly O 0 1.152217654620813e-09
correlated O 0 5.395128788165948e-09
with O 0 4.4315659475380187e-10
age O 0 1.751843470287895e-08
at O 0 5.15555846902771e-08
disease O 0 3.794306394411251e-06
onset O 0 4.632215677702334e-06
. O 0 4.922669063489593e-07

In O 0 2.3008581706562836e-08
addition O 0 1.248387881958024e-08
, O 0 1.3272268839514823e-09
a O 0 2.7017274528695623e-10
correlation O 0 9.556411217914729e-10
between O 0 2.020967393434603e-09
smooth O 0 5.536912084380674e-08
pursuit O 0 2.9282066549285446e-08
gain O 0 7.779657473783175e-10
and O 0 2.6955457310684494e-10
the O 0 1.1542566902278395e-09
number O 0 5.72385694397326e-10
of O 0 3.499300760267943e-08
trinucleotide O 0 5.99434088144335e-06
repeats O 0 5.8798192981157626e-08
was O 0 4.638721762262321e-08
found O 0 1.5841990830267605e-08
. O 0 1.0891420032521637e-07

In O 0 3.285873049208021e-07
SCA3 B-Disease 1 1.0
, O 0 4.065548466769542e-07
gaze B-Disease 0 5.7388911955058575e-05
- I-Disease 0 3.8013931771274656e-05
evoked I-Disease 0 2.4023649984883377e-06
nystagmus I-Disease 0 1.1139239177282434e-05
was O 0 9.491638586212048e-09
often O 0 2.3737525833844586e-10
present O 0 2.014543115658185e-10
as O 0 3.8327946372263e-10
was O 0 1.6345087061608865e-08
saccade O 0 5.412766768131405e-07
hypometria O 0 4.325027930462966e-06
and O 0 2.1144737161193916e-07
smooth O 0 4.2568544813548215e-06
pursuit O 0 2.301083441125229e-06
gain O 0 2.3848377850299585e-07
was O 0 2.3531679005373007e-07
markedly O 0 3.1411062195729755e-07
decreased O 0 1.1412665799070965e-06
. O 0 3.4564101270007086e-07

Three O 0 1.4640221479567117e-07
major O 0 1.5418126508848218e-07
criteria O 0 6.180843001857284e-07
, O 0 5.512168055332722e-09
saccade O 0 2.1271024763791502e-07
amplitude O 0 4.430615518913328e-08
, O 0 3.772734125107036e-09
saccade O 0 1.2405435256823694e-07
velocity O 0 6.887023840107531e-09
, O 0 3.6441941131393207e-10
and O 0 6.285107989612015e-10
presence O 0 3.4220737354928588e-09
of O 0 3.8567858240412534e-08
gaze B-Disease 0 2.5952478608815e-05
- I-Disease 0 1.988688927667681e-05
evoked I-Disease 0 8.447837558378524e-07
nystagmus I-Disease 0 1.5378578837044188e-06
, O 0 4.1666137207130305e-10
permitted O 0 7.932719481296147e-10
the O 0 2.0149273916025834e-10
correct O 0 2.2883650530047817e-10
assignment O 0 2.8341415325705555e-10
of O 0 4.3931810966846285e-10
90 O 0 1.989600928453683e-09
% O 0 5.5472629961750286e-11
of O 0 8.786433247642833e-10
the O 0 4.458545976859796e-09
SCA1 B-Disease 1 0.9995050430297852
, O 0 6.083515358135116e-10
90 O 0 1.3007618315796776e-09
% O 0 2.428412332333707e-11
of O 0 1.544839395295483e-10
the O 0 1.3287922984162037e-09
SCA2 B-Disease 1 0.999940037727356
, O 0 7.021381254190828e-10
and O 0 4.687045196405393e-10
93 O 0 6.735523694345602e-09
% O 0 5.057221655335731e-11
of O 0 3.0014998819716254e-10
the O 0 1.0291070218215737e-09
patients O 0 4.7025366933795e-10
with O 0 7.041243144101372e-10
SCA3 B-Disease 1 1.0
to O 0 1.211445432858227e-08
their O 0 3.5913132467868536e-09
genetically O 0 7.094604015378536e-09
confirmed O 0 2.0606295836334e-10
patient O 0 6.365942217811948e-10
group O 0 1.4185107949371556e-11
and O 0 1.1549367018304224e-10
, O 0 2.2785742737063686e-10
therefore O 0 5.345376918874933e-10
, O 0 2.827942879868317e-10
may O 0 4.536588327219704e-10
help O 0 2.238522034403445e-09
orient O 0 5.573104999712086e-07
diagnoses O 0 6.566321530954156e-08
of O 0 3.042513441187111e-08
SCA1 B-Disease 1 1.0
, O 0 1.0197735100803129e-08
SCA2 B-Disease 1 1.0
, O 0 6.0260987311266945e-09
and O 0 2.5477119081074306e-08
SCA3 B-Disease 1 1.0
at O 0 4.091502958658566e-08
early O 0 4.370592332492151e-09
clinical O 0 2.616295091684151e-08
stages O 0 1.107716141035553e-08
of O 0 5.035858396951198e-09
the O 0 2.0930421840148483e-08
diseases O 0 3.5819816730509046e-06
. O 0 1.1164636326554955e-08
. O 0 1.4632028921823803e-07

Genetic O 0 3.003622452979471e-07
basis O 0 7.446946614919625e-09
and O 0 4.983332080321645e-10
molecular O 0 4.6934641062534865e-08
mechanism O 0 2.676108294963342e-07
for O 0 1.1627777212197543e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 1.5345091014751233e-05

Ventricular B-Disease 1 1.0
fibrillation I-Disease 0 0.018367057666182518
causes O 0 1.1191611548611036e-07
more O 0 1.677928074261814e-10
than O 0 3.107568716242959e-11
300 O 0 5.801543689898381e-10
, O 0 2.398853893303965e-10
000 O 0 9.568124959002944e-09
sudden O 0 1.3583072444589561e-09
deaths O 0 1.0067505162858481e-10
each O 0 1.2925250279793854e-11
year O 0 6.806429725392249e-11
in O 0 2.7119034795575203e-10
the O 0 4.618918936216687e-08
USA O 0 1.2023698218399659e-05
alone O 0 7.670178092666902e-08
. O 0 1.1442970304642586e-07

In O 0 2.0868474948088078e-08
approximately O 0 2.2632853369231043e-09
5 O 0 3.14561265923885e-09
- O 0 4.55346027550263e-09
12 O 0 1.1077684325400128e-09
% O 0 2.2478983952023412e-11
of O 0 2.79100995786985e-11
these O 0 1.0212610271342903e-11
cases O 0 1.591304171766339e-11
, O 0 6.108181235114918e-12
there O 0 9.401696435262785e-12
are O 0 2.524306458306924e-11
no O 0 1.2667289439605156e-09
demonstrable O 0 0.00011428115249145776
cardiac O 1 0.9997225403785706
or O 0 1.424127873406178e-07
non O 1 1.0
- O 1 0.9999998807907104
cardiac O 1 0.9985105395317078
causes O 0 4.576358847430129e-09
to O 0 8.050709404683332e-11
account O 0 3.3413067451748546e-11
for O 0 5.878834918870979e-11
the O 0 9.008000456667276e-10
episode O 0 2.894002149034236e-09
, O 0 9.447233273451872e-11
which O 0 4.064707945228285e-11
is O 0 4.974868086926598e-11
therefore O 0 1.0187499455138749e-10
classified O 0 2.1134248129328626e-08
as O 0 4.839671419176739e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 5.642048108711606e-07
IVF B-Disease 1 1.0
) O 0 2.9056295147711353e-08
. O 0 1.2621381983990432e-07

A O 0 1.062990691025334e-06
distinct O 0 4.613706039435783e-08
group O 0 7.047409877891653e-10
of O 0 4.1824147700708636e-08
IVF B-Disease 1 1.0
patients O 0 1.652813885755222e-08
has O 0 8.695085623733334e-11
been O 0 6.205794211844307e-11
found O 0 1.825243428621448e-11
to O 0 2.898020365349474e-11
present O 0 1.642084662689669e-10
with O 0 3.2607955224861485e-10
a O 0 5.887515364122464e-09
characteristic O 0 1.7891288734972477e-06
electrocardiographic O 0 0.0001094968756660819
pattern O 0 2.3838470042392146e-06
. O 0 3.8526985690623405e-07

Because O 0 1.0766025404507218e-08
of O 0 7.343836649909008e-09
the O 0 5.900778199396939e-10
small O 0 1.5792375740453224e-10
size O 0 3.947520088587453e-10
of O 0 2.4931399167371637e-09
most O 0 2.918390251682723e-10
pedigrees O 0 1.1805658672869868e-09
and O 0 2.5352753230123426e-10
the O 0 6.189531664979597e-10
high O 0 1.9958200425662653e-08
incidence O 0 1.1542996247726478e-07
of O 0 7.374340071919505e-08
sudden B-Disease 0 6.459072920961262e-08
death I-Disease 0 4.521009699942624e-08
, O 0 1.1802709920516463e-09
however O 0 1.4679746307422192e-09
, O 0 6.632486782010005e-10
molecular O 0 4.735734471239539e-09
genetic O 0 6.614925829317997e-10
studies O 0 3.1788319199144155e-10
of O 0 3.7198299995822026e-09
IVF B-Disease 1 1.0
have O 0 2.3597224174665143e-10
not O 0 9.66289687154287e-11
yet O 0 6.851644807071011e-10
been O 0 1.5635571726235753e-09
done O 0 2.613816363350452e-08
. O 0 1.2653562464493007e-07

Because O 0 5.974810392217478e-06
IVF B-Disease 1 1.0
causes O 0 0.00223524053581059
cardiac O 1 0.9999998807907104
rhythm O 1 0.9999738931655884
disturbance O 1 0.9998986721038818
, O 0 4.449549173557443e-09
we O 0 1.3863450387674447e-09
investigated O 0 1.1062318172605501e-08
whether O 0 3.766550626949083e-09
malfunction O 0 2.7996361495752353e-06
of O 0 9.008279455713364e-09
ion O 0 2.6343323611399683e-07
channels O 0 1.617707745538155e-08
could O 0 2.412915423022355e-09
cause O 0 7.226506504309782e-09
the O 0 2.7713906725068682e-09
disorder O 0 9.8898489397925e-09
by O 0 5.461510757531762e-11
studying O 0 2.9861637607098146e-09
mutations O 0 8.35796820641832e-10
in O 0 2.6270985387100154e-10
the O 0 1.0407319450678187e-08
cardiac O 0 5.12184215040179e-07
sodium O 0 1.1533213495340533e-07
channel O 0 1.964241249652332e-07
gene O 0 4.167497138496401e-07
SCN5A O 1 0.9999998807907104
. O 0 2.0273598693165695e-06

We O 0 7.12861307761159e-08
have O 0 7.532713341973363e-10
now O 0 1.4403394033024597e-09
identified O 0 1.6099347410758469e-09
a O 0 2.6377542372557627e-09
missense O 0 1.9814224572201056e-07
mutation O 0 1.851268649488702e-08
, O 0 1.5552499288418176e-09
a O 0 7.55985885003696e-10
splice O 0 7.188237560740163e-08
- O 0 1.5450620338697263e-08
donor O 0 4.164452949151354e-10
mutation O 0 1.2727447984417495e-09
, O 0 1.9492503444684672e-10
and O 0 1.799444260264238e-09
a O 0 5.477707176737567e-09
frameshift O 0 1.1824463541643127e-07
mutation O 0 7.438495930323086e-10
in O 0 6.383545081423136e-11
the O 0 5.787021417624771e-10
coding O 0 9.266884148928511e-09
region O 0 1.9196836120727312e-08
of O 0 1.5046752821490372e-07
SCN5A O 1 1.0
in O 0 7.006522029229245e-09
three O 0 1.0188442089997807e-08
IVF B-Disease 0 0.011673287488520145
families O 0 7.720912797992696e-10
. O 0 2.1454130916254144e-08

We O 0 2.823795242079541e-08
show O 0 2.0304371517454456e-09
that O 0 3.504351669958439e-11
sodium O 0 4.905922890152681e-10
channels O 0 1.9792441297017405e-10
with O 0 1.3185513791924564e-10
the O 0 2.01839878144483e-08
missense O 0 6.246881412153016e-07
mutation O 0 2.2562952395333014e-08
recover O 0 8.220173874917691e-09
from O 0 5.014568205119474e-10
inactivation O 0 8.71347481279372e-07
more O 0 5.144528900102863e-11
rapidly O 0 1.9088085279062028e-10
than O 0 1.2415115810404664e-11
normal O 0 4.655253613150556e-11
and O 0 3.209309554219608e-11
that O 0 2.357890098447779e-11
the O 0 2.8121627249078074e-09
frameshift O 0 2.1038552233676455e-07
mutation O 0 4.667403352698329e-09
causes O 0 1.944824523647526e-09
the O 0 9.243542598014187e-10
sodium O 0 2.7896822629713824e-09
channel O 0 1.1976095670718223e-09
to O 0 2.619253425262258e-10
be O 0 1.1946005296081808e-09
non O 0 3.627527007665776e-07
- O 0 1.455903770875011e-06
functional O 0 1.1312919241390773e-06
. O 0 9.319621341319362e-08

Our O 0 4.243529190262052e-07
results O 0 3.632066425396374e-09
indicate O 0 6.028740284769185e-10
that O 0 2.2571883251387703e-10
mutations O 0 2.564613854616482e-09
in O 0 8.845082999364706e-10
cardiac O 0 2.996303862801142e-07
ion O 0 1.6798421142993902e-07
- O 0 4.3265279714432836e-07
channel O 0 7.07770952956821e-09
genes O 0 2.399274945386054e-10
contribute O 0 1.2655354542090436e-10
to O 0 4.448297286074876e-11
the O 0 4.3504297386753876e-10
risk O 0 4.650049234555809e-09
of O 0 5.732666341629056e-09
developing O 0 9.069952966456185e-08
IVF B-Disease 1 0.9999996423721313
. O 0 7.1179715455116366e-09
. O 0 3.7694704246860056e-08

Molecular O 0 3.569776254153112e-06
heterogeneity O 0 1.7845551383288694e-06
in O 0 3.1128831068372165e-08
mucopolysaccharidosis B-Disease 0 0.015901995822787285
IVA I-Disease 1 1.0
in O 0 1.077576339270081e-08
Australia O 0 8.000871076774274e-10
and O 0 2.968727763619228e-10
Northern O 0 2.8196620149856244e-08
Ireland O 0 1.7264412122131034e-08
: O 0 4.318929658353454e-10
nine O 0 1.0554968010723087e-09
novel O 0 7.087206377320854e-09
mutations O 0 8.843952237214125e-10
including O 0 6.194042501128649e-10
T312S O 0 1.9178373804606963e-06
, O 0 1.5305452460978586e-09
a O 0 4.152412580449294e-10
common O 0 1.4729950592595742e-09
allele O 0 1.84257709090474e-09
that O 0 3.169653428614083e-10
confers O 0 4.7296302341237606e-07
a O 0 4.896981309343573e-08
mild O 0 1.169488768937299e-05
phenotype O 0 1.2196315992696327e-06
. O 0 2.488258132871124e-07

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 1 0.8174551129341125
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.3536661331036157e-07
is O 0 4.502059169908534e-09
an O 0 5.729386742814313e-09
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 5.2991026677773334e-08
by O 0 2.0192515715056203e-10
a O 0 7.836656656934338e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.087762185354336e-09
N O 0 1.0366789382487696e-07
- O 0 5.422935700494236e-08
acetylgalactosamine O 0 1.595596404513344e-05
- O 0 1.244660779775586e-06
6 O 0 2.447201950417366e-06
- O 0 8.382101441384293e-06
sulfate O 0 6.090851911721984e-06
sulfatase O 0 0.00027920506545342505
( O 0 1.3658212338896192e-08
GALNS O 1 0.9999954700469971
) O 0 5.865459584697419e-08
. O 0 1.5758008942157176e-07

Previous O 0 1.4199292763805715e-07
studies O 0 5.6386673108477225e-09
of O 0 3.4969172002519144e-09
patients O 0 4.1124198491004904e-10
from O 0 3.91796387000376e-11
a O 0 9.9206712289579e-11
British O 0 4.521177598970638e-10
- O 0 1.7201893243168342e-08
Irish O 0 1.4098088030323197e-08
population O 0 3.4546310256899915e-11
showed O 0 5.186144222402156e-11
that O 0 6.9796481962092205e-12
the O 0 5.914704837017837e-10
I113F O 0 3.241387389607553e-07
mutation O 0 2.287467104622465e-09
is O 0 6.664070684170298e-11
the O 0 9.919725457718798e-11
most O 0 7.083901520932301e-11
common O 0 4.0945202783859713e-10
single O 0 2.4248633656576146e-10
mutation O 0 1.0712947196012124e-09
among O 0 1.9748520596607477e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0031485226936638355
and O 0 1.1730315385705126e-08
produces O 0 6.314011358199423e-08
a O 0 8.354131608712123e-09
severe O 0 1.0740822290244978e-05
clinical O 0 0.00011802393419202417
phenotype O 0 3.2560203067077964e-07
. O 0 5.032692484974177e-08

We O 0 1.3840252677255194e-07
studied O 0 2.0890583130039886e-07
mutations O 0 4.324982150194501e-09
in O 0 5.329800489839442e-10
the O 0 7.442118921119345e-09
GALNS O 0 0.03201025351881981
gene O 0 9.873577511143594e-10
from O 0 1.1588886794644537e-10
23 O 0 4.157303834517734e-09
additional O 0 1.3970884005232165e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.569408306702826e-07
( O 0 6.642168065562615e-11
15 O 0 3.2104008340638757e-10
from O 0 1.8752149139045216e-11
Australia O 0 1.968325676060534e-11
, O 0 1.1773197867992469e-11
8 O 0 1.2777449931444806e-10
from O 0 1.30341293314018e-11
Northern O 0 2.7745377106924707e-09
Ireland O 0 2.2398973786863507e-09
) O 0 1.7825953213534973e-10
, O 0 3.53457957347203e-11
with O 0 2.0006345538559067e-11
various O 0 2.0063839478723366e-09
clinical O 0 4.46778045670726e-07
phenotypes O 0 1.9073625878718303e-07
( O 0 6.028395005408527e-10
severe O 0 0.009676109999418259
, O 0 5.429129368295094e-10
16 O 0 7.802602453033103e-10
cases O 0 5.972495414896528e-11
; O 0 1.9315733040814465e-11
intermediate O 0 1.3772530671474215e-08
, O 0 6.39237829336281e-11
4 O 0 1.6175309980326347e-09
cases O 0 3.3395625154142294e-10
; O 0 2.82311396482271e-10
mild O 0 8.756578040447494e-08
, O 0 8.34418978357121e-10
3 O 0 1.307503438852109e-08
cases O 0 1.1529827093070821e-09
) O 0 2.695248912942816e-09
. O 0 7.474356777947833e-08

We O 0 6.447650235941182e-08
found O 0 1.730336984806513e-09
two O 0 1.8472494367482994e-10
common O 0 6.298765398149442e-10
mutations O 0 1.284758688324672e-10
that O 0 2.1199255892390134e-11
together O 0 5.177881387541383e-11
accounted O 0 1.2047531861014704e-09
for O 0 8.676381835215352e-11
32 O 0 3.030112827318021e-09
% O 0 6.769040189480435e-11
of O 0 8.094797054880587e-10
the O 0 6.656087681022882e-09
44 O 0 2.4976628765216446e-08
unrelated O 0 2.9576588289614847e-08
alleles O 0 8.217865277160286e-10
in O 0 3.8603367724654447e-10
these O 0 8.402792239792234e-09
patients O 0 9.547379775654008e-09
. O 0 2.965222023476599e-08

One O 0 8.390720296347354e-08
is O 0 3.216151345242224e-09
the O 0 5.761681798333029e-09
T312S O 0 3.822297003353015e-06
mutation O 0 1.4660670011323873e-08
, O 0 1.4402899983778639e-09
a O 0 1.4653115387730509e-09
novel O 0 7.620845110523078e-08
mutation O 0 2.770043083799578e-09
found O 0 2.629519935126723e-10
exclusively O 0 5.7508673378947606e-09
in O 0 1.4126046998796937e-09
milder O 0 3.2636603464197833e-06
patients O 0 1.247672969384439e-07
. O 0 1.1802448796061071e-07

The O 0 8.414102126153011e-08
other O 0 5.385444090677538e-09
is O 0 6.871013202847109e-10
the O 0 1.537831528786171e-09
previously O 0 1.5630272187650007e-08
described O 0 4.436743861191417e-09
I113F O 0 1.0587838232822833e-06
that O 0 5.892724641576308e-10
produces O 0 6.540397379239948e-08
a O 0 1.6728135321386617e-08
severe O 0 7.491492851841031e-06
phenotype O 0 1.28536987631378e-06
. O 0 3.0691677466165856e-07

The O 0 1.6164080989256036e-06
I113F O 0 1.475201679568272e-05
and O 0 1.2178585961919453e-07
T312S O 0 4.5895963012299035e-06
mutations O 0 5.660283353137174e-09
accounted O 0 4.831137268013208e-09
for O 0 7.69777852571707e-11
8 O 0 2.0394264055312306e-09
( O 0 2.7700296917343437e-11
18 O 0 4.4954501232652433e-10
% O 0 1.874832233905721e-11
) O 0 1.1398488923564098e-11
and O 0 1.522409698306859e-10
6 O 0 8.501208625943946e-09
( O 0 6.460616069903224e-11
14 O 0 1.214100264768092e-09
% O 0 3.7913849143533795e-11
) O 0 4.087285024323428e-11
of O 0 1.143264150016421e-09
44 O 0 6.775402461300928e-09
unrelated O 0 1.6782465195319674e-08
alleles O 0 4.90330387403759e-10
, O 0 7.177722860518543e-10
respectively O 0 1.2222376000181612e-08
. O 0 1.6433308758223575e-07

The O 0 5.39380380359944e-07
relatively O 0 6.951084685624664e-08
high O 0 4.275746903203981e-07
residual O 0 7.097912020981312e-05
GALNS O 1 0.9999884366989136
activity O 0 2.788848441070968e-08
seen O 0 5.956528603690003e-09
when O 0 7.711331573290181e-10
the O 0 4.725917435166593e-09
T312S O 0 1.259477699022682e-06
mutant O 0 1.0878236622602344e-07
cDNA O 0 3.693151384709381e-08
is O 0 1.4948992044239162e-09
overexpressed O 0 1.380730765276894e-07
in O 0 1.8410385438372145e-09
mutant O 0 5.052563167851076e-08
cells O 0 1.0064932220998912e-10
provides O 0 2.7480748579500336e-11
an O 0 4.512274234813596e-12
explanation O 0 3.736451426039622e-11
for O 0 6.87132434284976e-11
the O 0 4.5196966169669395e-09
mild O 0 6.047553142707329e-07
phenotype O 0 7.882213992616016e-09
in O 0 2.428895418127297e-10
patients O 0 1.7170997956839074e-10
with O 0 2.2048194867063664e-11
this O 0 4.1561606933804285e-10
mutation O 0 3.168792517271868e-08
. O 0 4.072591153203575e-08

The O 0 3.296405637343014e-08
distribution O 0 2.420281086656928e-09
and O 0 1.605983679375811e-10
relative O 0 1.3298565026964582e-10
frequencies O 0 4.908646822343599e-10
of O 0 2.1412096540274206e-09
the O 0 8.309190668853716e-09
I113F O 0 1.4873737654852448e-06
and O 0 2.4564556611039734e-08
T312S O 0 2.6924967642116826e-06
mutations O 0 4.570096301392823e-09
in O 0 3.500585654681032e-10
Australia O 0 2.458590553366946e-10
corresponded O 0 1.6513722334021708e-10
to O 0 6.3548874496e-11
those O 0 3.161518963290533e-11
observed O 0 2.3633744267170798e-11
in O 0 2.3184494254979704e-11
Northern O 0 5.565411687058486e-09
Ireland O 0 1.9929051742195725e-09
and O 0 4.0657882616201846e-10
are O 0 1.9182386581939603e-11
unique O 0 1.839723859364817e-11
to O 0 1.1938042568382379e-11
these O 0 3.799499950773999e-11
two O 0 3.1091931113058635e-11
populations O 0 1.8264212364726973e-10
, O 0 1.1111493669613282e-10
suggesting O 0 3.560360617438363e-10
that O 0 5.138242956115313e-11
both O 0 4.6471829162619827e-10
mutations O 0 1.2372861624143638e-09
were O 0 6.895708448695359e-10
probably O 0 7.941075574890988e-10
introduced O 0 2.5195937003452684e-10
to O 0 1.1514174336202387e-10
Australia O 0 2.6105537870302342e-11
by O 0 2.2045462677589e-11
Irish O 0 6.4704268609716564e-09
migrants O 0 7.640394567021147e-11
during O 0 1.2170674190681297e-10
the O 0 1.823171502657317e-09
19th O 0 7.208214469756058e-08
century O 0 3.726198087861121e-07
. O 0 5.88587852234923e-07

Haplotype O 0 1.4583520169253461e-05
analysis O 0 3.9403627027922994e-08
using O 0 2.454146752484121e-08
6 O 0 4.744896102693019e-07
RFLPs O 0 2.4523731553927064e-05
provides O 0 3.7040699396584387e-09
additional O 0 6.503272920177494e-10
data O 0 3.9992892331142116e-10
that O 0 1.0071384698440156e-10
the O 0 6.5263017212657815e-09
I113F O 0 2.1022117380198324e-06
mutation O 0 8.288723485350147e-09
originated O 0 1.0183462961776968e-09
from O 0 4.2056091942299645e-10
a O 0 1.6131775915084745e-09
common O 0 1.3598711490203641e-08
ancestor O 0 4.167349132444542e-08
. O 0 1.2001237337244675e-07

The O 0 8.018783859142786e-08
other O 0 7.271843571743375e-09
9 O 0 5.048960005638037e-08
novel O 0 3.5079882110267135e-08
mutations O 0 1.7307396626975446e-09
identified O 0 1.315118014488803e-10
in O 0 2.6746745443451125e-11
these O 0 1.5610295001078356e-10
23 O 0 1.4988134067195347e-09
patients O 0 2.6702143968160286e-11
were O 0 1.1251412128376881e-11
each O 0 1.1950528240600722e-11
limited O 0 1.8924375955187145e-10
to O 0 1.5974874201241107e-10
a O 0 7.88712706256689e-10
single O 0 5.066031594225251e-09
family O 0 8.623694647269531e-09
. O 0 2.0187171401175874e-07

These O 0 6.8099588190762e-08
data O 0 3.418518357278799e-09
provide O 0 3.1367619612865383e-10
further O 0 6.933691953925347e-10
evidence O 0 5.651585310850749e-10
for O 0 3.133042714154044e-10
extensive O 0 3.831972605894407e-08
allelic O 0 3.830153616490861e-07
heterogeneity O 0 5.179608209004982e-08
in O 0 1.1522995890800303e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 1.675093308506348e-08
British O 0 1.0674993333736893e-08
- O 0 2.208485199162169e-07
Irish O 0 3.414004368096357e-08
patients O 0 2.3460483555837186e-10
and O 0 7.772560373098258e-12
provide O 0 5.3998151436362996e-12
evidence O 0 8.116912524058773e-12
for O 0 1.2051679099123191e-11
their O 0 2.373991281334753e-11
transmission O 0 4.562777655703343e-10
to O 0 1.1134703575832461e-10
Australia O 0 6.940383684428397e-11
by O 0 2.4116982716426705e-11
British O 0 8.307411980545965e-10
- O 0 4.1537475681252545e-08
Irish O 0 2.774533669480661e-08
migrants O 0 1.0530871313862988e-10
. O 0 2.6205526637568255e-10
. O 0 1.5649005646878322e-08

Identification O 0 2.7797679535979114e-07
of O 0 3.0663474603898067e-07
constitutional O 0 0.00012995982251595706
WT1 O 1 1.0
mutations O 0 3.3727798154359334e-07
, O 0 9.096799424845869e-10
in O 0 1.7952471453863694e-10
patients O 0 6.590871737266468e-10
with O 0 4.3582862319091475e-10
isolated O 0 1.2921351299155504e-05
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.2709319697232786e-09
and O 0 3.149663307944195e-10
analysis O 0 3.3131566934407886e-10
of O 0 6.3779048709022845e-09
genotype O 0 8.667296924613765e-08
/ O 0 1.1823516388176358e-07
phenotype O 0 3.0142088824902658e-09
correlations O 0 1.6721333206959343e-09
by O 0 1.6282674861201052e-11
use O 0 8.221596736746051e-10
of O 0 9.976982795478762e-09
a O 0 7.56981854976857e-09
computerized O 0 1.0011916629082407e-06
mutation O 0 6.176257727474876e-08
database O 0 5.982753492617121e-08
. O 0 1.1781869346805252e-07

Constitutional O 0 9.951176252798177e-06
mutations O 0 5.1094499298187657e-08
of O 0 6.409247532701556e-08
the O 0 5.709654971042255e-08
WT1 O 0 0.00013684036093764007
gene O 0 4.257052488298996e-09
, O 0 6.852245992838846e-10
encoding O 0 1.1171558789158098e-08
a O 0 3.6026952532353107e-09
zinc O 0 1.6905822803892079e-06
- O 0 2.640812226673006e-07
finger O 0 2.033172222581925e-06
transcription O 0 3.236935981476563e-07
factor O 0 4.5403755422057657e-08
involved O 0 6.132140906167649e-10
in O 0 7.688215619694461e-10
renal O 1 1.0
and O 0 3.8025586945877876e-07
gonadal O 1 1.0
development O 0 2.6807716935195458e-08
, O 0 2.3552618189093266e-10
are O 0 1.2845350651213838e-11
found O 0 9.371028258930991e-12
in O 0 6.881052151685996e-12
most O 0 3.162544184864835e-11
patients O 0 2.0813944318076594e-11
with O 0 1.8768358395204743e-11
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.989260312029728e-08
DDS B-Disease 1 1.0
) O 0 3.454615038478437e-09
, O 0 9.470583206550032e-10
or O 0 1.4385474145228727e-08
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 3.269742165912248e-08
DMS B-Disease 1 0.9999998807907104
) O 0 6.154917547851468e-11
associated O 0 1.8611161223258677e-10
with O 0 5.013028325784319e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 3.818468314875645e-07
/ O 0 6.933566328370944e-05
or O 0 2.5833111294559785e-07
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 1.0969412045369609e-07
WT B-Disease 1 1.0
) O 0 2.707755974995507e-08
. O 0 8.621658054153158e-08

Most O 0 4.4409625843400136e-07
mutations O 0 1.8908343690782203e-07
in O 0 1.5361290905957503e-08
DDS B-Disease 1 1.0
patients O 0 5.852345452694863e-07
lie O 0 7.377885680170948e-08
in O 0 1.3013672361950057e-09
exon O 0 8.744694213191906e-08
8 O 0 3.514799828963078e-08
or O 0 9.074443418910505e-10
exon O 0 4.3703611396495035e-08
9 O 0 2.3644870950079167e-08
, O 0 1.1898524387987663e-09
encoding O 0 2.917714247985259e-08
zinc O 0 1.6062356280599488e-06
finger O 0 2.442357299514697e-06
2 O 0 1.1510649073898094e-06
or O 0 7.319937100902507e-09
zinc O 0 6.230971507648064e-07
finger O 0 2.9954182423352904e-07
3 O 0 2.882077865251631e-08
, O 0 1.874647242994243e-10
respectively O 0 5.451272766521242e-10
, O 0 2.9858435168783615e-10
with O 0 3.8278852310114075e-10
a O 0 5.745298015114031e-09
hot O 0 9.656007478042739e-07
spot O 0 5.070645556770614e-07
( O 0 2.4017392519226632e-09
R394W O 0 1.0941553227894474e-06
) O 0 1.6455625750921854e-09
in O 0 2.6074413739252122e-09
exon O 0 1.4484502344203065e-06
9 O 0 1.0199173630098812e-06
. O 0 3.0748631729693443e-07

We O 0 5.7513972251399537e-08
analyzed O 0 2.702389778619363e-08
a O 0 3.8769906729463344e-10
series O 0 1.0415198703483952e-09
of O 0 3.243163293475959e-09
24 O 0 5.670851788153186e-09
patients O 0 2.2353466300195635e-10
, O 0 7.02701785648685e-11
10 O 0 1.706232377607364e-09
with O 0 2.699081402823822e-09
isolated B-Disease 0 4.826443273486802e-06
DMS I-Disease 1 1.0
( O 0 2.9376549193216306e-08
IDMS B-Disease 1 1.0
) O 0 7.546763769461506e-10
, O 0 1.31255187274526e-10
10 O 0 4.064524272706649e-10
with O 0 1.6578007022705066e-10
DDS B-Disease 1 1.0
, O 0 9.188068084142742e-10
and O 0 5.621150767076699e-10
4 O 0 1.6364333887963767e-08
with O 0 2.547642541372852e-09
urogenital B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 1.0
and O 0 5.213098006606742e-07
/ O 1 0.7728769183158875
or O 0 3.2511625249753706e-06
WT B-Disease 1 1.0
. O 0 4.235184292156191e-07

We O 0 3.787245930197969e-07
report O 0 1.32833605448468e-07
WT1 O 0 0.003289580112323165
heterozygous O 0 2.2494123186334036e-07
mutations O 0 3.2126321602987673e-09
in O 0 2.1981319542341282e-10
16 O 0 4.182085788784207e-09
patients O 0 1.499361607093519e-10
, O 0 3.317973673588881e-11
4 O 0 1.546963113163713e-09
of O 0 3.048814756212437e-09
whom O 0 2.1018180529353003e-09
presented O 0 1.5108316375744835e-08
with O 0 5.964887606069169e-08
IDMS B-Disease 1 1.0
. O 0 4.725027338281507e-06

One O 0 1.332265071596339e-07
male O 0 7.381655287019839e-09
and O 0 4.290259258965534e-10
two O 0 6.179233791314687e-10
female O 0 6.366941196489506e-09
IDMS B-Disease 1 1.0
patients O 0 2.677669819206585e-08
with O 0 1.1264334354166294e-08
WT1 O 1 1.0
mutations O 0 0.0805545300245285
underwent O 0 0.00023442487872671336
normal O 0 1.896115691124578e-06
puberty O 0 2.5951239877031185e-06
. O 0 5.072822162333068e-08

Two O 0 1.5936552699713502e-07
mutations O 0 1.7426987852786624e-08
associated O 0 4.006643905540841e-09
with O 0 3.6075289422399237e-09
IDMS B-Disease 1 1.0
are O 0 2.4460036773810145e-10
different O 0 2.866044380989141e-11
from O 0 1.8070090562760655e-11
those O 0 1.676753874635395e-10
described O 0 5.871587660521982e-10
in O 0 7.411676605784123e-09
DDS B-Disease 1 1.0
patients O 0 2.4096179913613014e-06
. O 0 1.5312153323066013e-07

No O 0 9.077964023163076e-06
WT1 O 1 0.9941264390945435
mutations O 0 1.3529859188565752e-07
were O 0 2.479964456014727e-09
detected O 0 4.648071705304346e-09
in O 0 1.2709926167087104e-10
the O 0 2.099958873458263e-09
six O 0 2.045526859006941e-09
other O 0 3.848891427793433e-09
IDMS B-Disease 1 1.0
patients O 0 8.829650965935798e-08
, O 0 8.255239269949755e-10
suggesting O 0 1.922962455935817e-09
genetic O 0 7.152184622327695e-09
heterogeneity O 0 6.09968253684201e-08
of O 0 8.047712185543787e-08
this O 0 1.4533878989198001e-08
disease O 0 1.4807127627136651e-05
. O 0 3.055039599075826e-07

We O 0 1.0046099987448542e-06
analyzed O 0 1.0571422990324209e-06
genotype O 0 8.83256291217549e-07
/ O 0 4.879086077380634e-07
phenotype O 0 1.0014942652958325e-08
correlations O 0 8.396655815090526e-09
, O 0 8.89147575011684e-11
on O 0 2.8076804770016395e-10
the O 0 9.823025032273947e-11
basis O 0 1.0640709147136107e-10
of O 0 1.9186968680529048e-10
the O 0 5.921206303050042e-10
constitution O 0 1.6804013736049228e-09
of O 0 1.1335264282763546e-08
a O 0 1.3496720185912636e-08
WT1 O 0 0.0002494479122105986
mutation O 0 7.027293857930772e-09
database O 0 2.2690427314842054e-09
of O 0 1.7673354335556724e-08
84 O 0 9.542922896343953e-08
germ O 0 7.953473186717019e-07
- O 0 3.366989631103934e-06
line O 0 1.745391955410014e-06
mutations O 0 8.479149049556156e-10
, O 0 3.885331639752465e-11
to O 0 1.6433120489378616e-11
compare O 0 1.9753747249051656e-10
the O 0 1.0528260901976338e-10
distribution O 0 2.4387225572297666e-10
and O 0 9.535886663636362e-11
type O 0 1.0271250516780128e-08
of O 0 1.6004870317942732e-08
mutations O 0 1.0562176688821978e-09
, O 0 3.3349396161286293e-11
according O 0 1.2920615966027782e-11
to O 0 1.6731821483872977e-10
the O 0 3.225119948879751e-09
different O 0 1.5373689876696517e-08
symptoms O 0 1.145705027738586e-06
. O 0 1.834499130382028e-07

This O 0 5.90364024333212e-09
demonstrated O 0 6.547434594494916e-09
( O 0 2.781923302830336e-10
1 O 0 6.974361976830323e-09
) O 0 3.820015415101352e-10
the O 0 1.430537910351859e-09
association O 0 1.9593893174629784e-10
between O 0 3.5350464222538847e-10
mutations O 0 2.3944471405634715e-10
in O 0 8.365012849065323e-11
exons O 0 4.072767456619886e-09
8 O 0 2.0427080027474176e-09
and O 0 3.671515313996565e-10
9 O 0 1.7720712008895134e-08
and O 0 4.510430695603418e-09
DMS B-Disease 1 0.9288924932479858
; O 0 4.564893185676766e-10
( O 0 9.209363133200199e-11
2 O 0 6.768853921812479e-09
) O 0 3.0576008391847154e-10
among O 0 1.1275458344783829e-10
patients O 0 2.767754914145826e-10
with O 0 1.6303597361044808e-10
DMS B-Disease 1 0.9999955892562866
, O 0 7.14551362523963e-10
a O 0 9.394870992274207e-11
higher O 0 1.2706533047968094e-10
frequency O 0 2.7984581318918345e-10
of O 0 1.3443377522293076e-09
exon O 0 4.7387004542542854e-08
8 O 0 2.8341661462150114e-08
mutations O 0 8.080573987712114e-10
among O 0 2.9152524838593763e-10
46 O 0 8.566970244316963e-09
, O 0 1.7775033667177809e-09
XY O 0 0.0001014055305859074
patients O 0 2.6397059538219025e-10
with O 0 2.5158469058039756e-11
female O 0 2.8453156497576515e-10
phenotype O 0 1.0617070417273666e-10
than O 0 1.8166712925649087e-11
among O 0 9.945168299996254e-11
46 O 0 8.635281822932939e-09
, O 0 2.8900195570003007e-09
XY O 0 0.003480088897049427
patients O 0 7.637164234353122e-10
with O 0 1.3174754343037165e-10
sexual O 0 6.10821349056323e-09
ambiguity O 0 4.561007571624032e-08
or O 0 1.6494685617374216e-09
male O 0 4.864858516029358e-10
phenotype O 0 1.1874554117774494e-10
; O 0 1.1070913283339756e-11
and O 0 2.132547333166812e-10
( O 0 1.4311156426582983e-10
3 O 0 8.654573058208825e-09
) O 0 2.251735881086958e-10
statistically O 0 2.8295990550653016e-10
significant O 0 2.8433572163422127e-10
evidence O 0 1.1425856094593456e-10
that O 0 2.1089520754746793e-11
mutations O 0 1.5848199141910158e-10
in O 0 2.3649085467702946e-10
exons O 0 4.094157191047998e-08
8 O 0 1.5298221356374597e-08
and O 0 2.5749313792289286e-09
9 O 0 2.987025382594766e-08
preferentially O 0 8.757876202025727e-09
affect O 0 1.8816372904240097e-09
amino O 0 7.043392535877047e-10
acids O 0 5.459833973819883e-11
with O 0 3.588205904278552e-12
different O 0 1.8091609807480147e-11
functions O 0 7.264534529483058e-10
. O 0 1.7199982549342963e-09
. O 0 7.789792277890228e-08

The O 0 7.608275609527482e-06
185delAG O 0 8.075566438492388e-05
BRCA1 O 0 1.6400538243033225e-06
mutation O 0 2.068392124243701e-09
originated O 0 1.6622461740389838e-10
before O 0 2.5247784765647374e-11
the O 0 2.2248052358730952e-11
dispersion O 0 2.6261881558298228e-09
of O 0 7.75293496069196e-10
Jews O 0 3.118745262042921e-10
in O 0 3.243673038499928e-11
the O 0 3.9499151172073255e-10
diaspora O 0 1.3435474954803794e-10
and O 0 3.830463168874587e-10
is O 0 2.9902316733831924e-10
not O 0 1.734598853442293e-10
limited O 0 6.707946198503123e-09
to O 0 2.0142914891607688e-08
Ashkenazim O 0 3.48655303241685e-05
. O 0 7.963636221575143e-07

The O 0 1.08718643332395e-06
185delAG O 0 8.125190106511582e-06
mutation O 0 4.60573126304098e-08
in O 0 4.671678599521556e-09
BRCA1 O 0 1.7786904038530338e-07
is O 0 2.8829433285082473e-10
detected O 0 4.529904229499948e-10
in O 0 2.7295355212175743e-11
Ashkenazi O 0 1.2954730621572708e-09
Jews O 0 7.464832640913244e-10
both O 0 7.493059644980704e-11
in O 0 2.724589998059912e-10
familial B-Disease 1 0.8799144625663757
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.311202310233966e-09
in O 0 3.0595204147942923e-10
the O 0 2.2635098240186835e-09
general O 0 2.508872221085312e-09
population O 0 1.0591832966255765e-09
. O 0 2.6808994135762987e-08

All O 0 2.4208668492065044e-07
tested O 0 9.756582386444279e-08
Ashkenazi O 0 7.117879619045198e-08
mutation O 0 4.465005254417065e-09
carriers O 0 1.892849876838909e-09
share O 0 2.9653887678726676e-10
the O 0 6.216471226672127e-10
same O 0 5.176600259559905e-10
allelic O 0 3.382952797892358e-07
pattern O 0 2.4410146792774867e-08
at O 0 3.7858551849012656e-08
the O 0 2.5173392259603133e-07
BRCA1 O 0 2.587226163086598e-06
locus O 0 7.837279554223642e-06
. O 0 5.598312213805912e-07

Our O 0 1.0214017720500124e-06
previous O 0 6.11336758993275e-08
study O 0 3.53753715209848e-09
showed O 0 7.569829763021119e-10
that O 0 3.742963924913134e-11
this O 0 1.1242579783798945e-10
Ashkenazi O 0 3.705612172666406e-08
mutation O 0 1.986067310610906e-09
also O 0 2.3971249984988674e-10
occurs O 0 4.0695797426382185e-11
in O 0 1.4440185158726138e-11
Iraqi O 0 4.138338560721877e-10
Jews O 0 3.866386377726627e-10
with O 0 1.1129013682831257e-10
a O 0 1.40388600744501e-09
similar O 0 8.755955960282336e-09
allelic O 0 7.0100259108585306e-06
pattern O 0 2.385115749348188e-06
. O 0 5.151597406438668e-07

We O 0 2.1487265655650845e-07
extended O 0 2.4735506087836256e-08
our O 0 6.234199267929341e-10
analysis O 0 5.222026630558041e-11
to O 0 6.567402177637405e-11
other O 0 6.178467737427695e-10
non O 0 4.259605290712898e-08
- O 0 3.990827224242821e-08
Ashkenazi O 0 1.6369828159668032e-08
subsets O 0 8.043381072297962e-09
354 O 0 1.732751275795863e-09
of O 0 4.513457663168907e-10
Moroccan O 0 3.629499190083152e-08
origin O 0 4.435387890300291e-10
, O 0 3.383119617783592e-10
200 O 0 2.3405652971320023e-09
Yemenites O 0 2.160160619268936e-07
and O 0 2.688338218703734e-09
150 O 0 7.533435208983974e-09
Iranian O 0 3.150123362161139e-08
Jews O 0 4.6410047360723183e-08
. O 0 1.389803969686909e-07

Heteroduplex O 0 0.0001121272289310582
analysis O 0 2.2532503862748854e-08
complemented O 0 3.239511059405231e-08
by O 0 1.7849632882871447e-10
direct O 0 2.471375326607017e-09
DNA O 0 1.902550561538874e-09
sequencing O 0 1.1944615296854977e-09
of O 0 4.769128203463424e-09
abnormally O 0 9.444396376068198e-09
migrating O 0 5.003771841316507e-10
bands O 0 1.938784777166802e-08
were O 0 1.7766695892262874e-09
employed O 0 2.4698216805063566e-08
. O 0 8.979772303518985e-08

Four O 0 4.631436567592573e-08
of O 0 1.303922214646036e-08
Moroccan O 0 2.4669731146786944e-08
origin O 0 2.4798546549575917e-10
( O 0 8.253798686186364e-12
1 O 0 2.3540222549023326e-10
. O 0 8.829667032250743e-12
1 O 0 3.3722322156926055e-10
% O 0 1.2632894730302269e-11
) O 0 1.0687241022711014e-11
and O 0 1.3146339572500665e-10
none O 0 3.1698407787494887e-10
of O 0 1.1544747380298759e-09
the O 0 3.525426395256659e-09
Yemenites O 0 3.339499698995496e-07
or O 0 8.790490002574813e-10
Iranians O 0 9.100894482472199e-10
was O 0 2.4599380310519336e-09
a O 0 2.667644993792351e-10
carrier O 0 3.393701319964748e-09
of O 0 1.6277978076573163e-08
the O 0 6.972316413111912e-08
185delAG O 0 6.5477643147460185e-06
mutation O 0 2.4377280283260916e-07
. O 0 1.5552988941180956e-07

BRCA1 O 0 1.5451789295184426e-05
allelic O 0 5.946870942352689e-07
patterns O 0 2.261076215148705e-09
were O 0 6.302595945140155e-11
determined O 0 5.23102845761958e-11
for O 0 1.683110248396069e-11
four O 0 1.3301628028206114e-11
of O 0 6.149496190044346e-11
these O 0 1.8260025436145355e-11
individuals O 0 4.498247477627282e-13
and O 0 1.8841744137132466e-11
for O 0 5.333549921160419e-11
12 O 0 5.605401698360879e-10
additional O 0 6.530095353340926e-10
non O 0 2.8883237135346462e-08
- O 0 6.184404099940366e-08
Ashkenazi O 0 3.1056654137273654e-08
185delAG O 0 1.582324387072731e-07
mutation O 0 2.89449331170033e-09
carriers O 0 1.3965015810413206e-09
who O 0 1.5371981465506224e-09
had O 0 3.621350401772361e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.157744678603194e-07

Six O 0 4.2126382027163345e-07
non O 0 4.70307952582516e-07
- O 0 1.0683714180004245e-07
Ashkenazi O 0 1.7028552790065987e-08
individuals O 0 8.959247232986911e-11
shared O 0 1.2574988272895382e-10
the O 0 2.353627293061322e-10
common O 0 7.646229760460699e-10
Ashkenazi O 0 4.212274529180604e-09
haplotype O 0 1.8134857171503427e-08
, O 0 2.349999306261452e-09
four O 0 2.621093786459028e-09
had O 0 3.887752342279782e-09
a O 0 5.126694069268467e-10
closely O 0 2.534922549646268e-10
related O 0 2.7316267026122887e-09
pattern O 0 8.269837259433643e-09
, O 0 1.391414622409215e-10
and O 0 7.369651555677592e-10
the O 0 2.0345863660509167e-08
rest O 0 3.5654540653240474e-08
( O 0 1.748737932238953e-09
n O 0 9.037536052858286e-09
= O 0 4.148709820128715e-09
6 O 0 9.326731387204745e-09
) O 0 5.469852903949857e-10
displayed O 0 2.4345190752228518e-08
a O 0 9.321342808732425e-09
distinct O 0 1.0661750593499164e-07
BRCA1 O 0 1.4196816664480139e-06
allelic O 0 4.688624358095694e-06
pattern O 0 7.705662596890761e-07
. O 0 1.491169996370445e-07

We O 0 7.803100743331015e-08
conclude O 0 2.706950397168839e-08
that O 0 3.1806757228025617e-10
the O 0 1.4088922029031892e-08
185delAG O 0 1.1787677976826672e-05
BRCA1 O 0 4.1546994111740787e-07
mutation O 0 1.266472926531037e-09
occurs O 0 9.105543402609939e-11
in O 0 2.3398800258478403e-11
some O 0 2.0683475765448378e-10
non O 0 3.6515036327955386e-08
- O 0 8.682188479269826e-08
Ashkenazi O 0 1.9968595665886824e-08
populations O 0 6.4898153517845e-10
at O 0 3.2507849190288596e-10
rates O 0 1.1978694425263114e-10
comparable O 0 1.5368660510883814e-10
with O 0 2.9374377930047046e-11
that O 0 1.541387018022533e-10
of O 0 5.2322533861115517e-08
Ashkenazim O 0 2.1060581275378354e-05
. O 0 3.9558381104143336e-07

The O 0 1.0231718050590644e-07
majority O 0 4.362305627836349e-09
of O 0 1.3021675293600765e-08
Jewish O 0 7.326993767264867e-08
185delAG O 0 4.97386110964726e-07
mutation O 0 3.035000251117026e-09
carriers O 0 8.657259908950721e-10
have O 0 5.2476471085194376e-11
a O 0 2.784285302315226e-10
common O 0 2.4358091099685453e-09
allelic O 0 1.080251905705154e-07
pattern O 0 8.107796212186713e-09
, O 0 2.8083341208073875e-10
supporting O 0 3.825419980785227e-09
the O 0 2.132740739568817e-08
founder O 0 8.284870745001172e-08
effect O 0 4.8422105436429774e-08
notion O 0 1.0029183705739797e-08
, O 0 3.733034159569826e-10
but O 0 1.4707933482238644e-10
dating O 0 2.082825162341706e-10
the O 0 6.392784079878311e-10
mutations O 0 2.4986418489802986e-10
origin O 0 4.034891865067891e-11
to O 0 5.1480236740175656e-11
an O 0 3.694131806009082e-11
earlier O 0 1.95691671200926e-10
date O 0 4.27445634443302e-09
than O 0 6.716059930411689e-10
currently O 0 9.662612043825902e-09
estimated O 0 1.507719815663222e-08
. O 0 1.8439357063471107e-07

However O 0 8.33697484381446e-08
, O 0 3.418883398609296e-09
the O 0 1.927420223424292e-09
different O 0 6.060155710585491e-10
allelic O 0 1.2335735277702042e-07
pattern O 0 7.571103743941876e-09
at O 0 5.1381801036143315e-09
the O 0 2.2181815495514456e-08
BRCA1 O 0 7.878789887172388e-08
locus O 0 3.1489697960296326e-08
even O 0 4.3829784246440795e-10
in O 0 1.6826520732315942e-10
some O 0 3.001362491872328e-10
Jewish O 0 3.746174481733533e-09
mutation O 0 3.8382957923133176e-10
carriers O 0 4.017952637269673e-10
, O 0 2.034541701778636e-10
might O 0 5.179721096482126e-10
suggest O 0 2.0943817513607854e-10
that O 0 8.762814085461201e-11
the O 0 4.173065892842942e-09
mutation O 0 3.0700555431195653e-09
arose O 0 1.0066319999779694e-09
independently O 0 1.3668525200571935e-09
. O 0 3.906386769614301e-09
. O 0 1.2828174078549637e-07

Crystal O 0 6.09434346188209e-06
structure O 0 1.4987290342105553e-07
of O 0 3.76901112986161e-07
the O 0 4.994670916858013e-07
hemochromatosis B-Disease 1 1.0
protein O 0 5.045831699135306e-07
HFE O 0 0.00026650456129573286
and O 0 5.571274552806926e-09
characterization O 0 2.1247988257755424e-08
of O 0 4.07927700507571e-08
its O 0 4.25404955706199e-09
interaction O 0 2.4069903847845353e-09
with O 0 1.4525833869072358e-09
transferrin O 0 8.843747991704731e-07
receptor O 0 4.254754060184496e-07
. O 0 1.535658213924762e-07

HFE O 1 0.999998927116394
is O 0 2.6479187908989843e-07
an O 0 1.1007237787907798e-08
MHC O 0 8.422919563599862e-06
- O 0 2.550067961237801e-07
related O 0 5.47739666956204e-08
protein O 0 1.9576942289489807e-09
that O 0 1.1945969387305855e-11
is O 0 5.26829621594338e-11
mutated O 0 1.6493584276133788e-09
in O 0 1.1057244009293754e-10
the O 0 9.155883162748069e-09
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.0007668457110412419

HFE O 0 0.0032479329966008663
binds O 0 8.354459168913309e-07
to O 0 4.876978110246455e-08
transferrin O 0 1.8974362774315523e-06
receptor O 0 7.599420115411704e-08
( O 0 1.7353872783232305e-09
TfR O 0 2.0198436345708615e-07
) O 0 5.765787847167303e-11
and O 0 1.1177281322716226e-10
reduces O 0 2.5099635703185186e-09
its O 0 1.1697415258637989e-10
affinity O 0 4.4708486912625744e-10
for O 0 4.713213153095808e-10
iron O 0 2.7057328111368406e-07
- O 0 8.505916326839724e-08
loaded O 0 3.597574149694083e-08
transferrin O 0 1.316761313319148e-07
, O 0 5.956790172234605e-09
implicating O 0 3.5027580906898947e-06
HFE O 1 0.9999994039535522
in O 0 8.613363888798631e-07
iron O 1 0.9999250173568726
metabolism O 0 5.178133142180741e-05
. O 0 5.192526373321016e-07

The O 0 4.346193691162625e-06
2 O 0 9.2080190370325e-06
. O 0 1.356580582978495e-06

6 O 0 8.875297680788208e-06
A O 0 1.4030803185960394e-06
crystal O 0 1.415863266629458e-06
structure O 0 1.0659005766910923e-07
of O 0 3.875368861372408e-07
HFE O 1 0.992183268070221
reveals O 0 3.2779222891576865e-08
the O 0 1.2455165787628175e-09
locations O 0 4.117162166750177e-09
of O 0 8.886487279369248e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 2.8848199917774764e-07
and O 0 1.1956861278861197e-08
a O 0 3.8037093474940775e-09
patch O 0 0.14710989594459534
of O 0 0.004773355554789305
histidines O 1 0.9991719722747803
that O 0 5.800127045318959e-10
could O 0 5.27290322516194e-10
be O 0 1.6409669456596276e-10
involved O 0 2.5274538018038584e-10
in O 0 4.696710242946267e-10
pH O 0 1.2378091014397796e-05
- O 0 1.2284519925742643e-06
dependent O 0 7.806614377159349e-08
interactions O 0 5.693288684938125e-08
. O 0 3.912197499289505e-08

We O 0 1.1087841045309688e-07
also O 0 4.825897459426187e-09
demonstrate O 0 5.6922542235327e-09
that O 0 3.8900865861890566e-10
soluble O 0 7.875151482039655e-07
TfR O 0 1.8055910686598509e-06
and O 0 1.6333212116137474e-08
HFE O 0 2.833138933056034e-05
bind O 0 9.293346536765057e-09
tightly O 0 1.912987457330928e-08
at O 0 3.1189255622621204e-09
the O 0 1.7620634951143188e-09
basic O 0 9.618297269753384e-09
pH O 0 7.948099067789371e-08
of O 0 1.268383265085049e-08
the O 0 6.760286996865261e-09
cell O 0 1.041627117892574e-09
surface O 0 1.421427153758259e-08
, O 0 2.97568941709514e-10
but O 0 2.1397712768322918e-10
not O 0 1.2559528417277477e-10
at O 0 3.1450366755336745e-09
the O 0 1.0123297755626481e-08
acidic O 0 3.776887297135545e-06
pH O 0 8.107958819891792e-06
of O 0 3.688604124363337e-07
intracellular O 0 8.564439326619322e-07
vesicles O 0 5.818720637762453e-06
. O 0 1.2526044201877085e-06

TfR O 0 0.0038194400258362293
HFE O 0 0.0029051322489976883
stoichiometry O 0 3.379503596079303e-06
( O 0 9.623619234844227e-09
2 O 0 7.142481450728155e-08
1 O 0 3.119426850162199e-08
) O 0 5.74023495403253e-10
differs O 0 2.133561549655383e-09
from O 0 2.5129573977267228e-09
TfR O 0 1.245916109837708e-06
transferrin O 0 9.425468761037337e-08
stoichiometry O 0 2.3903156787241642e-08
( O 0 1.4542654580562697e-10
2 O 0 6.048069156605607e-09
2 O 0 8.833421105691741e-09
) O 0 3.9257452844054797e-10
, O 0 2.569146007047607e-10
implying O 0 8.702887854816765e-10
a O 0 2.3820740518987193e-11
different O 0 2.8323500229215925e-12
mode O 0 4.615805238028514e-10
of O 0 1.172654473524659e-10
binding O 0 1.250119452400611e-09
for O 0 9.574382398014336e-10
HFE O 0 0.0002532654907554388
and O 0 2.916746133507786e-08
transferrin O 0 1.832058416084692e-07
to O 0 3.5779532669977243e-09
TfR O 0 3.910310795163241e-07
, O 0 2.1281224005242905e-10
consistent O 0 5.299198302388675e-10
with O 0 6.598364216126029e-11
our O 0 8.893193403913813e-10
demonstration O 0 6.314839762211477e-09
that O 0 3.2901584234856784e-10
HFE O 0 5.922644049860537e-05
, O 0 7.806774782181947e-09
transferrin O 0 2.2726914039594703e-07
, O 0 5.322610796554272e-09
and O 0 1.6942408365139272e-08
TfR O 0 4.765889116242761e-06
form O 0 5.318744111804108e-09
a O 0 6.4287242196314764e-09
ternary O 0 4.765957157815137e-07
complex O 0 2.5386325432918966e-06
. O 0 5.759937380389601e-07

Identification O 0 2.1710405917474418e-07
of O 0 7.022740788897863e-08
three O 0 4.849926238392754e-09
novel O 0 2.3035147123096067e-08
mutations O 0 9.542768797388135e-10
and O 0 2.722990166681427e-10
a O 0 1.1553332596170307e-10
high O 0 2.7594542206799133e-09
frequency O 0 6.340084013345404e-10
of O 0 3.727891328964006e-09
the O 0 1.436274654764702e-08
Arg778Leu O 0 7.462117355316877e-05
mutation O 0 8.522997418936029e-09
in O 0 6.284988640636868e-10
Korean O 0 3.1660047739023867e-07
patients O 0 1.742638033874755e-09
with O 0 7.967915216511301e-10
Wilson B-Disease 0 2.4575518182246014e-05
disease I-Disease 0 0.00017537765961606055
. O 0 4.141253384659649e-07

Four O 0 1.4475676834990736e-07
mutations O 0 2.0153329671757092e-08
- O 0 4.10638882897274e-08
- O 0 6.46595097464342e-08
R778L O 0 8.561972322240763e-07
, O 0 1.079116351831999e-09
A874V O 0 2.3130252202463453e-07
, O 0 6.204661229247677e-10
L1083F O 0 1.7581004385647248e-07
, O 0 4.5072978682725306e-10
and O 0 3.079731192290325e-10
2304delC O 0 2.54949092948209e-08
- O 0 6.678659847381141e-09
- O 0 9.165423087154068e-09
in O 0 5.329180430280189e-10
the O 0 3.4056844011587373e-09
copper O 0 1.806835925322048e-08
- O 0 1.1403529676101698e-08
transporting O 0 9.797251010468244e-09
enzyme O 0 7.312606631337815e-10
, O 0 3.088478084389834e-10
P O 0 1.0647138992680993e-07
- O 0 9.340798357015956e-08
type O 0 1.8301865623016056e-07
ATPase O 0 2.175158471118266e-07
( O 0 4.6481402060649657e-10
ATP7B O 1 1.0
) O 0 4.738994197062141e-10
, O 0 1.0304323366794321e-10
were O 0 1.2295103823944942e-10
identified O 0 1.0476059603137244e-10
in O 0 4.5149019939350055e-11
Korean O 0 4.31997229100034e-08
Patients O 0 1.0414681339554477e-09
with O 0 2.920283459495465e-10
Wilson B-Disease 0 8.548399819119368e-06
disease I-Disease 0 8.368822454940528e-05
. O 0 2.5715490892253e-07

Arg778Leu O 0 0.0046134949661791325
, O 0 4.3627402135371085e-08
the O 0 1.332767851636163e-08
most O 0 1.697769258512949e-09
frequently O 0 9.786805810207966e-10
reported O 0 1.6730161700451163e-10
mutation O 0 1.926555442954836e-10
of O 0 3.0065422373937167e-10
this O 0 1.6202188896086156e-11
enzyme O 0 4.7064466907054125e-11
, O 0 3.050644112323475e-11
was O 0 5.953288972904147e-10
found O 0 7.459734219228409e-11
in O 0 6.48229109279086e-11
six O 0 6.050269729662716e-10
of O 0 3.0491926761300192e-09
eight O 0 5.146958415025438e-09
unrelated O 0 1.7519104389407403e-08
patients O 0 2.8324773082566423e-10
studied O 0 2.8806035334838498e-09
, O 0 1.4403771231297213e-10
an O 0 5.999863800232319e-11
allele O 0 4.1207739998050386e-10
frequency O 0 3.649204272093698e-09
of O 0 1.0541537420749592e-07
37 O 0 1.7468006490162225e-06
. O 0 4.4327373416308546e-07

5 O 0 5.458747978082101e-07
% O 0 7.959746639585319e-09
, O 0 8.423922115419202e-10
which O 0 2.4476978777165925e-10
is O 0 7.136997243195609e-11
considerably O 0 1.0172160336274771e-10
higher O 0 1.85311793687859e-10
than O 0 1.575031424727591e-11
those O 0 4.731991881667952e-11
in O 0 1.164474627834977e-10
other O 0 1.9668564554820023e-09
Asian O 0 1.8988897565463958e-08
populations O 0 1.7688124742676337e-08
. O 0 7.02744387126586e-08

The O 0 5.758031420555199e-07
novel O 0 3.122451062154141e-07
single O 0 2.7427731197349203e-09
nucleotide O 0 3.686182470374888e-09
deletion O 0 8.021840081084974e-09
, O 0 7.285153591496396e-10
2304delC O 0 2.2644917407887988e-07
, O 0 1.2267469262638997e-09
was O 0 7.901857834724524e-09
found O 0 6.642868477513275e-10
in O 0 9.82649739356134e-10
one O 0 8.86484752271599e-09
patient O 0 7.042028471460071e-08
. O 0 9.517038535022948e-08

Since O 0 1.7391995754678646e-07
a O 0 1.2419421935305763e-08
mutation O 0 5.208393716316095e-09
at O 0 9.21084808425121e-09
cDNA O 0 9.159484193332901e-08
nucleotide O 0 1.222467744810274e-07
2302 O 0 9.79130436462583e-06
( O 0 1.871001131803496e-09
2302insC O 0 3.663125767161546e-07
) O 0 1.470987553986447e-09
had O 0 2.068770932339703e-09
been O 0 3.129799752699114e-10
previously O 0 1.7706073274226242e-09
described O 0 2.149719985355958e-10
, O 0 4.638785536248413e-11
this O 0 1.1237986236034558e-11
region O 0 2.139250110388957e-09
of O 0 7.9266895269825e-09
the O 0 2.2914420583219908e-08
ATP7B O 1 1.0
gene O 0 1.4409915038982035e-08
may O 0 6.749563685737314e-10
be O 0 4.4206416305314633e-10
susceptible O 0 1.2325409670665977e-07
to O 0 6.8636420991197156e-09
gene O 0 3.0157809760567034e-07
rearrangements O 1 0.9999463558197021
causing O 1 0.9999963045120239
Wilson B-Disease 1 0.9999282360076904
disease I-Disease 1 0.9996960163116455
. O 0 6.821430815762142e-07

Disruption O 0 9.613203474145848e-06
of O 0 3.23053370721027e-07
splicing O 0 8.565993425690976e-08
regulated O 0 1.851547537512488e-08
by O 0 3.3662300724657257e-10
a O 0 3.3726068604522652e-09
CUG O 0 0.00040818299748934805
- O 0 2.593814940610173e-07
binding O 0 1.8219076025616232e-07
protein O 0 1.1693349222241523e-07
in O 0 1.8903760334865183e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.5942716345307417e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999982118606567
DM B-Disease 1 1.0
) O 0 9.3316273819255e-08
is O 0 2.954020805745472e-09
caused O 0 4.745943193995572e-09
by O 0 3.0231836478655794e-10
a O 0 6.657014495203839e-09
CTG O 0 8.103846630547196e-05
expansion O 0 5.4219736256300166e-08
in O 0 2.9704552706455445e-10
the O 0 8.008382290647376e-10
3 O 0 1.2360130696720262e-08
untranslated O 0 4.132366939302301e-06
region O 0 4.441165657453894e-08
of O 0 8.096240122767995e-08
the O 0 4.6651717866552644e-07
DM B-Disease 1 1.0
gene O 0 1.0815163022925844e-06
. O 0 2.30459221484125e-07

One O 0 1.4627674715939065e-07
model O 0 7.729996553962337e-08
of O 0 5.911530251978547e-07
DM B-Disease 1 1.0
pathogenesis O 0 0.001137112034484744
suggests O 0 5.446151973842461e-09
that O 0 3.75013110842648e-11
RNAs O 0 7.577185989759982e-09
from O 0 1.7495009607682022e-10
the O 0 1.4280625570961547e-09
expanded O 0 2.8084268244299437e-09
allele O 0 5.938647351655391e-10
create O 0 9.32604993231223e-10
a O 0 3.685667326891462e-10
gain O 0 5.766813693242057e-10
- O 0 6.181123168857994e-09
of O 0 5.862391905253617e-09
- O 0 2.926709896655666e-08
function O 0 4.098621997350449e-10
mutation O 0 6.068758690025433e-11
by O 0 5.391777302410361e-12
the O 0 2.629484963101447e-10
inappropriate O 0 2.1476227463068653e-09
binding O 0 1.3784769992142287e-09
of O 0 2.355078798643717e-09
proteins O 0 9.835191688845057e-11
to O 0 4.3429845830722513e-10
the O 0 3.4866957321355585e-08
CUG O 1 1.0
repeats O 0 8.433653988504375e-07
. O 0 5.045648663326574e-07

Data O 0 1.3060332548775477e-07
presented O 0 3.998225750478923e-08
here O 0 9.741735196300283e-10
indicate O 0 9.5151797552262e-10
that O 0 1.3790758812692872e-10
the O 0 2.796981535269083e-09
conserved O 0 1.8660948342130723e-07
heterogeneous O 0 1.7262938456497068e-07
nuclear O 0 1.2110523357478087e-06
ribonucleoprotein O 0 2.1926125555182807e-06
, O 0 1.533789983909628e-08
CUG O 0 0.0005540870479308069
- O 0 1.1507263764087838e-07
binding O 0 5.603932251574406e-08
protein O 0 4.700458244855099e-09
( O 0 2.1431163788054874e-10
CUG O 1 1.0
- O 0 7.734272458037594e-07
BP O 0 5.070781412541692e-07
) O 0 9.520390031880765e-10
, O 0 5.71371283619726e-10
may O 0 7.412125357930677e-10
mediate O 0 6.613743330774469e-09
the O 0 6.806696983829852e-09
trans O 0 1.1851784620375838e-07
- O 0 9.388918442709837e-08
dominant O 0 3.621898869710094e-08
effect O 0 5.028113037042203e-09
of O 0 1.906873769996764e-09
the O 0 3.117016422748975e-09
RNA O 0 3.1862535365689837e-07
. O 0 8.833491449422581e-08

CUG O 1 1.0
- O 0 0.0036273389123380184
BP O 0 2.1524894691538066e-05
was O 0 5.322785767702953e-08
found O 0 3.141623905467128e-10
to O 0 8.921221400504109e-11
bind O 0 2.5621141319653873e-10
to O 0 5.04000674528271e-10
the O 0 2.018568245887309e-08
human O 0 2.4579185264883563e-07
cardiac O 1 0.9999864101409912
troponin O 1 0.9999997615814209
T O 1 0.9999988079071045
( O 0 8.238742132959942e-09
cTNT O 0 2.3728416636004113e-06
) O 0 7.831647552691834e-10
pre O 0 1.8175828131461458e-07
- O 0 7.315292549492369e-08
messenger O 0 4.994677560432592e-09
RNA O 0 9.818314161691433e-09
and O 0 6.717519873689071e-10
regulate O 0 1.3251584718432241e-08
its O 0 2.1379609194127625e-09
alternative O 0 1.2618657230234476e-08
splicing O 0 9.535954603734353e-08
. O 0 4.9035236315830844e-08

Splicing O 0 6.257345148696913e-07
of O 0 2.5792539304347883e-07
cTNT O 0 3.377257235115394e-05
was O 0 2.3790155978531402e-07
disrupted O 0 8.610251143181813e-07
in O 0 1.0907344005772757e-07
DM B-Disease 1 1.0
striated O 1 0.9999988079071045
muscle O 0 2.7067597329732962e-05
and O 0 1.2513821090465171e-08
in O 0 1.3435687007401498e-09
normal O 0 1.0897005076060395e-08
cells O 0 2.666515619420551e-10
expressing O 0 4.945136522493954e-10
transcripts O 0 6.9946382019736575e-09
that O 0 1.412941541545365e-09
contain O 0 6.541932293657737e-07
CUG O 1 0.9988886713981628
repeats O 0 1.5655028846595087e-06
. O 0 3.5589187064033467e-07

Altered O 0 1.8092779328071629e-06
expression O 0 4.847394663443083e-08
of O 0 2.7043544292837396e-08
genes O 0 5.929889912437147e-09
regulated O 0 4.175560164298986e-08
posttranscriptionally O 0 5.19872003224009e-07
by O 0 2.933258302917352e-09
CUG O 1 1.0
- O 0 0.00022449552488978952
BP O 0 7.66128232498886e-06
therefore O 0 2.454889846958963e-09
may O 0 6.48199716124509e-10
contribute O 0 3.738608089776108e-09
to O 0 1.6548327153032005e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.08127719908952713
. O 0 3.447849650228818e-08
. O 0 2.209780802786554e-07

Identification O 0 2.0886719198642822e-07
of O 0 4.849021806307974e-08
a O 0 2.9151481228950615e-09
novel O 0 4.103272743805064e-08
nonsense O 0 5.1493966424231985e-08
mutation O 0 7.407786606350442e-10
and O 0 7.113733491159735e-10
a O 0 6.509799921339265e-10
missense O 0 5.718098439189134e-09
substitution O 0 1.603664201432764e-09
in O 0 2.9388794176021804e-10
the O 0 3.307930152018912e-09
vasopressin O 0 1.0533779004617827e-07
- O 0 1.332069530235458e-07
neurophysin O 0 2.6481559416424716e-06
II O 1 1.0
gene O 0 2.959242850764099e-09
in O 0 1.4069624632018218e-10
two O 0 1.0650210574558727e-10
Spanish O 0 4.818045340471144e-08
kindreds O 0 3.849268068734091e-06
with O 0 4.057758218323215e-08
familial B-Disease 1 0.9998350143432617
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 3.763701897696592e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.4774615010537673e-05
FNDI B-Disease 1 1.0
) O 0 3.539118154094467e-08
is O 0 2.4016937327786536e-09
an O 0 4.775973838633263e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 5.0059725253959186e-08
by O 0 9.130974309989881e-10
deficiency O 0 0.06382967531681061
in O 0 1.093235368898604e-08
the O 0 2.6392463041702285e-06
antidiuretic O 0 0.0039381911046803
hormone O 0 3.8755561035941355e-06
arginine O 0 7.487361699531903e-07
vasopressin O 0 5.866298238288437e-07
( O 0 5.243140144273184e-09
AVP O 0 1.3928592125012074e-05
) O 0 1.6429431426434604e-10
encoded O 0 3.1124981064722945e-11
by O 0 6.044695299856073e-11
the O 0 1.4073183507434806e-08
AVP O 0 0.0007148691802285612
- O 0 2.4653468244650867e-06
neurophysin O 0 0.2398843616247177
II O 1 1.0
( O 0 3.5970910516880394e-07
AVP O 1 0.9999997615814209
- O 0 1.6454792785225436e-05
NPII O 1 0.999998927116394
) O 0 3.4665816883716616e-09
gene O 0 4.021773136742013e-09
on O 0 2.3160529494248294e-08
chromosome O 0 3.9288622133426543e-07
20p13 O 0 7.861683116061613e-06
. O 0 2.2588235992770933e-07

In O 0 2.2525801668393797e-08
this O 0 3.769869139080839e-10
study O 0 5.786469636781533e-10
, O 0 1.8357812492375558e-10
we O 0 5.319671786407909e-11
analyzed O 0 1.811496092019027e-10
two O 0 2.2247119077500876e-11
families O 0 2.9709112774056745e-12
with O 0 9.062989247965447e-11
FNDI B-Disease 1 1.0
using O 0 7.403199830946505e-09
direct O 0 7.960233361359315e-09
automated O 0 2.8207862712292808e-08
fluorescent O 0 3.2407097450004585e-08
, O 0 1.157568152443389e-09
solid O 0 1.2039543584307921e-08
phase O 0 1.041909847288025e-08
, O 0 8.159105335803218e-11
single O 0 1.0994658655727463e-10
- O 0 9.700055203509805e-10
stranded O 0 1.766366358735283e-10
DNA O 0 4.3296085466826284e-11
sequencing O 0 1.0198270006256394e-10
of O 0 4.1679648621339993e-10
PCR O 0 8.972666165618648e-08
- O 0 1.2224718375364318e-06
amplified O 0 3.133562358925701e-06
AVP O 0 0.004111256916075945
- O 0 6.067232789064292e-06
NPII O 0 0.005757761653512716
DNA O 0 7.215958248707466e-07
. O 0 7.818430702855039e-08

In O 0 1.390179882321263e-08
one O 0 1.2520523506864834e-09
of O 0 1.4957548533089948e-09
the O 0 5.436372463307748e-10
families O 0 1.3937433672450705e-11
, O 0 6.020176024357227e-11
affected O 0 5.441933015326583e-10
individuals O 0 1.2210870335704893e-11
presented O 0 2.199277870928995e-09
a O 0 1.3036454138415365e-09
novel O 0 4.224586902523697e-08
nonsense O 0 1.2834448170906398e-08
mutation O 0 2.2873525296063235e-10
in O 0 7.883498021055146e-11
exon O 0 8.326070499720117e-09
3 O 0 5.292665417044873e-09
of O 0 2.053070824459269e-09
the O 0 8.128354656022907e-10
gene O 0 1.0330653693602088e-10
, O 0 7.899889770124346e-11
consisting O 0 9.058617050916595e-11
in O 0 7.627319609238015e-11
a O 0 7.305469562624012e-10
G O 0 1.4531224223901518e-07
to O 0 5.689616333626191e-09
T O 0 1.0272150348100695e-06
transition O 0 1.1969343738371663e-08
at O 0 7.998738560388574e-09
nucleotide O 0 9.459395045041674e-09
2101 O 0 6.544790380758059e-07
, O 0 6.898168702917928e-10
which O 0 1.8627284437133795e-10
produces O 0 2.4704562839872324e-09
a O 0 4.0803935230648847e-10
stop O 0 4.136557318901168e-09
signal O 0 5.163467875490824e-09
in O 0 3.1297473501723516e-09
codon O 0 2.4259307451757195e-07
82 O 0 5.477537001752353e-07
( O 0 1.9050714783475087e-08
Glu O 1 0.9999525547027588
) O 0 3.41892416599876e-08
of O 0 4.2694028934420203e-07
NPII O 1 0.9999998807907104
. O 0 9.354203029943164e-07

The O 0 7.238427315314766e-07
premature O 0 3.7253133200465527e-07
termination O 0 8.39227283222499e-08
eliminates O 0 2.94213066354132e-07
part O 0 1.4266366754611681e-08
of O 0 3.2707337283000015e-08
the O 0 1.21441576794723e-08
C O 0 1.551009347622312e-07
- O 0 2.750134520113079e-08
terminal O 0 1.6007284386887477e-08
domain O 0 3.191719555317718e-09
of O 0 9.05760622060825e-09
NPII O 1 1.0
, O 0 2.8743081248450153e-09
including O 0 8.228546732880204e-10
a O 0 3.9995715073182225e-10
cysteine O 0 5.445359163580576e-10
residue O 0 1.3737217585685357e-08
in O 0 1.2589292108788896e-10
position O 0 2.145076338777585e-09
85 O 0 6.23767526519714e-09
, O 0 9.449828419771933e-11
which O 0 3.831009467991642e-11
could O 0 1.0638314534849869e-10
be O 0 9.224428859644362e-11
involved O 0 1.2855480568951805e-10
in O 0 7.343240598922662e-11
the O 0 1.47035650321925e-09
correct O 0 2.672851495688633e-09
folding O 0 5.506412037448172e-08
of O 0 7.854018235775584e-08
the O 0 7.801104402460624e-07
prohormone O 0 0.001377943903207779
. O 0 1.1212426898055128e-06

In O 0 1.4875815246284674e-08
the O 0 1.30977486634265e-08
second O 0 9.225634478582379e-09
family O 0 1.0518711457407903e-09
, O 0 1.0821648022130148e-09
a O 0 9.41706823631705e-10
G279A O 0 8.3275196516297e-08
substitution O 0 2.6196944613587902e-09
at O 0 1.6500443233979922e-09
position O 0 9.066761785803124e-10
- O 0 1.7921246708851868e-09
1 O 0 4.1872101341766665e-09
of O 0 1.882803912778286e-09
the O 0 1.2739785892890154e-09
signal O 0 2.828456580061811e-09
peptide O 0 4.281628829261308e-09
was O 0 4.594025160287174e-09
observed O 0 1.15087128715885e-09
in O 0 3.787613833683423e-10
all O 0 2.1704986696846618e-09
affected O 0 8.649276850292154e-09
individuals O 0 6.70402955371685e-10
. O 0 4.9786912370564096e-08

This O 0 1.194699592588222e-07
missense O 0 3.0266830890468555e-06
mutation O 0 3.3991380377074165e-08
, O 0 1.8779264809865026e-09
which O 0 1.4479225596275569e-09
replaces O 0 8.669626367918681e-07
Ala O 0 3.1479273729928536e-06
with O 0 4.46484316185547e-09
Thr O 1 0.9999451637268066
, O 0 1.269269045423016e-08
is O 0 1.0165920327764866e-09
frequent O 0 5.873158848146431e-09
among O 0 3.773684031926905e-09
FNDI B-Disease 1 1.0
patients O 0 4.968939038008102e-08
and O 0 1.0263841998536805e-09
is O 0 3.5916675189540115e-10
thought O 0 2.701469881127849e-10
to O 0 5.828359322945786e-11
reduce O 0 7.228849963070161e-09
the O 0 1.477804434379948e-09
efficiency O 0 2.725071368558929e-08
of O 0 1.0681082684982357e-08
cleavage O 0 5.157365201569064e-09
by O 0 1.0952801998698192e-09
signal O 0 1.1318416426320255e-07
peptidases O 0 1.0888755923588178e-06
. O 0 4.624463656455191e-08
. O 0 3.338903979965835e-07

Genetic O 0 2.3341883661487373e-06
heterogeneity O 0 1.2827468935938668e-06
of O 0 5.030528313909599e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.489670609089444e-09
due O 0 1.1765382446071726e-08
to O 0 4.710007495134505e-09
TWIST O 0 3.239077341277152e-05
and O 0 1.851629320981374e-07
FGFR O 1 1.0
mutations O 0 1.6586523088335525e-06
. O 0 2.356078141474427e-07

Thirty O 0 6.23705727775814e-06
- O 0 1.250877176062204e-06
two O 0 1.7119337059057216e-09
unrelated O 0 1.8892945874426914e-08
patients O 0 7.401017299013546e-11
with O 0 2.0946393491233506e-12
features O 0 1.5398567976276922e-09
of O 0 3.634972145505344e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.439006715654784e-10
a O 0 6.997477042247624e-10
common O 0 5.262389208837703e-07
autosomal B-Disease 1 0.9997627139091492
dominant I-Disease 1 0.9997121691703796
condition I-Disease 0 5.0371381803415716e-06
of O 0 0.14525464177131653
craniosynostosis B-Disease 1 1.0
and O 0 0.05087490752339363
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999951124191284
, O 0 1.0409260120525232e-09
were O 0 2.743959504059035e-10
screened O 0 9.366825537426848e-09
for O 0 5.745864894990405e-10
mutations O 0 5.670275360358801e-10
in O 0 1.5286948096271402e-10
TWIST O 0 3.892231688951142e-06
, O 0 1.9870676215560934e-09
FGFR2 O 1 0.9999997615814209
, O 0 1.8238193177921858e-08
and O 0 1.0329800659292232e-07
FGFR3 O 1 1.0
. O 0 2.2328745217237156e-06

Nine O 0 3.438229612129362e-07
novel O 0 7.036590687903299e-08
and O 0 5.673491898505745e-09
three O 0 6.531245322349832e-09
recurrent O 0 2.1371693947003223e-05
TWIST O 0 1.0145188753085677e-05
mutations O 0 2.0593300398275005e-09
were O 0 1.307621788626534e-10
found O 0 6.587725503992559e-11
in O 0 9.508244191991366e-11
12 O 0 1.0632361657769707e-08
families O 0 1.8657721201353894e-10
. O 0 2.1556839868708266e-08

Seven O 0 8.469265111443747e-08
families O 0 1.0937808297972751e-10
were O 0 8.249836230822538e-11
found O 0 2.5253996810414847e-11
to O 0 8.008026880501617e-11
have O 0 8.80484851695229e-11
the O 0 2.489889405765666e-09
FGFR3 O 1 0.9999735355377197
P250R O 0 9.173652983918146e-07
mutation O 0 7.490790765452005e-10
, O 0 1.137139479800986e-10
and O 0 5.012664727743754e-10
one O 0 3.857392738559895e-10
individual O 0 1.3781660535006068e-10
was O 0 1.1621520412674613e-09
found O 0 8.83320916411634e-11
to O 0 4.145432885849232e-10
have O 0 4.462508140790078e-10
an O 0 2.3930419867923547e-09
FGFR2 O 1 0.9973806738853455
VV269 O 0 3.065585406147875e-05
- O 0 4.637926394934766e-06
270 O 0 1.3080817780064535e-06
deletion O 0 1.664040723881044e-06
. O 0 1.7515871775231062e-07

To O 0 1.573520336251022e-08
date O 0 2.3828956585703054e-08
, O 0 9.40649447223052e-10
our O 0 1.723149678500846e-10
detection O 0 1.6509983380430526e-09
rate O 0 2.870351178962949e-10
for O 0 1.4022580319128508e-10
TWIST O 0 6.659263931396708e-07
or O 0 6.138732189242546e-09
FGFR O 1 0.9996705055236816
mutations O 0 4.70155248066817e-09
is O 0 3.219746413929414e-10
68 O 0 4.495691818817704e-09
% O 0 7.737803453533587e-11
in O 0 1.0137644890217956e-10
our O 0 4.3467491828153015e-09
Saethre B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 5.511326950369266e-09
, O 0 6.126994051003365e-11
including O 0 2.2771924623743445e-10
our O 0 3.1398039723740112e-09
five O 0 8.49208092734699e-10
patients O 0 1.8506313148591857e-10
elsewhere O 0 3.250537061738612e-10
reported O 0 2.850340241611349e-10
with O 0 2.137920285250061e-09
TWIST O 0 4.9436595872975886e-05
mutations O 0 3.0110564352980873e-07
. O 0 1.1171117364483507e-07

More O 0 1.0168930586473834e-08
than O 0 6.355387882628349e-10
35 O 0 3.135770310080943e-09
different O 0 1.7201089164142758e-10
TWIST O 0 1.2859470643888926e-07
mutations O 0 8.328004397206712e-10
are O 0 2.824836024817312e-11
now O 0 6.821961745506755e-11
known O 0 1.6250972789677576e-10
in O 0 2.5230514899554635e-10
the O 0 5.228061095152725e-09
literature O 0 3.090785583026445e-08
. O 0 6.676955877082946e-08

The O 0 1.4877920762046415e-07
most O 0 2.6928801410974756e-09
common O 0 1.641337066260462e-09
phenotypic O 0 2.9357561714959957e-08
features O 0 1.5247062501444475e-09
, O 0 7.889770781144279e-11
present O 0 2.0504977923940793e-11
in O 0 1.0237632790122131e-11
more O 0 3.966777427366619e-12
than O 0 7.67328041384463e-12
a O 0 2.5750268237145768e-11
third O 0 4.564901789905207e-10
of O 0 1.6285766069046304e-09
our O 0 1.3114890284882108e-09
patients O 0 1.8320245320779804e-10
with O 0 1.100191604486156e-10
TWIST O 0 9.042485544341616e-06
mutations O 0 1.0576919784455185e-08
, O 0 1.388109849287389e-09
are O 0 1.2073686495028824e-09
coronal B-Disease 0 6.245997610676568e-06
synostosis I-Disease 0 1.7409036445314996e-05
, O 0 8.873661805353095e-09
brachycephaly B-Disease 0 1.7348078472423367e-05
, O 0 2.091828754657854e-08
low B-Disease 0 2.928421054093633e-05
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 2.2489048205898143e-06
facial B-Disease 1 1.0
asymmetry I-Disease 0 0.032547615468502045
, O 0 3.754287547508284e-08
ptosis B-Disease 1 0.9999998807907104
, O 0 3.521436298115077e-08
hypertelorism B-Disease 0 0.015508169308304787
, O 0 3.875988952017906e-08
broad B-Disease 0 0.00013858087186235934
great I-Disease 0 0.0017095470102503896
toes I-Disease 1 0.9982283711433411
, O 0 2.724878811477538e-08
and O 0 1.596271488324419e-07
clinodactyly B-Disease 0 0.032098736613988876
. O 0 2.301610265931231e-06

Significant O 0 6.700725407426944e-06
intra O 0 4.1646075260359794e-05
- O 0 1.8361320144322235e-06
and O 0 2.8280911834599465e-08
interfamilial O 0 8.77240836416604e-06
phenotypic O 0 1.0995214552167454e-06
variability O 0 5.671200753454286e-08
is O 0 1.0458769961196879e-10
present O 0 7.196183926527766e-11
for O 0 2.3161743356592268e-10
either O 0 2.9869555717709773e-09
TWIST O 0 8.606805749877822e-06
mutations O 0 4.7278128079142334e-08
or O 0 2.2481376760197236e-08
FGFR O 1 1.0
mutations O 0 1.1772608559112996e-06
. O 0 1.8596848860852333e-07

The O 0 2.1858824084119988e-07
overlap O 0 4.383868912327671e-08
in O 0 3.900466061246277e-10
clinical O 0 4.06007849562684e-09
features O 0 5.304516825788141e-10
and O 0 2.1059343158214006e-10
the O 0 5.192679619625551e-10
presence O 0 1.704829333259994e-10
, O 0 6.720310419261466e-11
in O 0 2.088217966600414e-11
the O 0 1.5511193718342753e-10
same O 0 1.8613778920983926e-11
genes O 0 1.461985220385653e-11
, O 0 3.37469496791698e-11
of O 0 3.068257037330824e-10
mutations O 0 5.3730957183528716e-11
for O 0 2.4036753490386253e-11
more O 0 6.052491407365634e-12
than O 0 3.3906891183654864e-11
one O 0 2.5151378202359354e-10
craniosynostotic B-Disease 0 1.5587050938847824e-07
condition I-Disease 0 3.10208814191526e-09
- O 0 1.1811790656679477e-08
such O 0 1.7669671281694832e-09
as O 0 2.2118940012916255e-09
Saethre B-Disease 0 1.0218460374744609e-05
- I-Disease 0 1.987948650139515e-07
Chotzen I-Disease 0 6.224893149919808e-05
, I-Disease 0 2.2344652794714648e-09
Crouzon I-Disease 0 0.0015047428896650672
, I-Disease 0 6.283397802064883e-09
and I-Disease 0 5.078785747514303e-08
Pfeiffer I-Disease 0 0.207185298204422
syndromes I-Disease 0 1.1484441984066507e-06
- O 0 1.4718556151649409e-08
support O 0 1.1869192295677067e-09
the O 0 1.6118028023370812e-09
hypothesis O 0 4.780491558165068e-10
that O 0 1.2452847780730636e-11
TWIST O 0 6.349347358991508e-08
and O 0 4.0368958176273395e-10
FGFRs O 0 1.3304461390362121e-06
are O 0 7.582961342178507e-11
components O 0 1.976039110118677e-09
of O 0 4.7028976268848055e-09
the O 0 3.004858140087663e-09
same O 0 1.8615244068431736e-10
molecular O 0 3.6021385874107636e-09
pathway O 0 3.691668637451073e-10
involved O 0 1.6619917247995275e-11
in O 0 1.1707855171461112e-11
the O 0 5.128122371189647e-10
modulation O 0 1.0517216253447259e-07
of O 0 1.5536562614215654e-06
craniofacial O 1 1.0
and O 1 0.9964937567710876
limb O 1 1.0
development O 0 9.613312812462027e-08
in O 0 3.573131790446382e-09
humans O 0 3.4208860189011148e-09
. O 0 1.455090159474537e-09
. O 0 2.663011500203538e-08

Mutation O 0 7.098979182273979e-08
analysis O 0 2.179629587928389e-09
of O 0 1.841675079106153e-08
UBE3A O 1 1.0
in O 0 0.0005661313771270216
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.3728302292292938e-05
. O 0 8.328773759558317e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.155446044431301e-06
AS B-Disease 1 1.0
) O 0 3.096527123602755e-08
is O 0 1.7279887520871284e-09
caused O 0 2.9243425458957972e-09
by O 0 7.026525472575429e-10
chromosome O 0 8.015312857878598e-08
15q11 O 0 2.2031263142707758e-06
- O 0 3.9806408835829643e-07
q13 O 0 1.7959326896743733e-06
deletions O 0 1.1266891419836611e-08
of O 0 7.455672523803969e-09
maternal O 0 7.4063208899133315e-09
origin O 0 2.463378390160642e-10
, O 0 4.343239309867464e-11
by O 0 1.6987530826462205e-10
paternal O 0 1.5668007335989387e-06
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 1.0
( O 0 3.064610893943609e-07
UPD B-Disease 1 1.0
) O 0 3.995288544444975e-09
15 O 0 5.986746653974251e-09
, O 0 1.436401830812173e-10
by O 0 1.5281116649834559e-10
imprinting O 0 2.8870902042399393e-06
defects O 0 1.088660974346567e-05
, O 0 4.497328065511397e-10
and O 0 3.1062608041310114e-10
by O 0 1.2718268105338382e-10
mutations O 0 3.0898763547781982e-09
in O 0 1.2072258748219156e-09
the O 0 1.0824795282360355e-07
UBE3A O 1 0.9999302625656128
gene O 0 4.913059115096985e-07
. O 0 2.5883196030918043e-07

UBE3A O 1 0.6838534474372864
encodes O 0 2.2773788259655703e-06
a O 0 4.4884458816341066e-08
ubiquitin O 0 3.2235723779194814e-07
- O 0 1.200778569909744e-07
protein O 0 6.159562193630563e-09
ligase O 0 5.876116926373243e-09
and O 0 2.385400099669255e-09
shows O 0 1.6767971899867007e-08
brain O 0 4.166674330008391e-07
- O 0 3.5836552569890046e-07
specific O 0 1.2480073507958878e-07
imprinting O 0 8.991425602289382e-06
. O 0 2.446914493248187e-07

Here O 0 9.774352349722903e-08
we O 0 2.234394003153284e-08
describe O 0 5.774270661618175e-08
UBE3A O 0 0.0011123736621811986
coding O 0 3.3572744086995954e-06
- O 0 0.00018734206969384104
region O 0 3.399907882339903e-06
mutations O 0 5.721505402789262e-08
detected O 0 6.2400791200900585e-09
by O 0 1.0847060055718671e-10
SSCP O 0 1.2173319191788323e-05
analysis O 0 6.582425576828754e-11
in O 0 5.804639754969365e-11
13 O 0 4.0673184820150254e-09
AS B-Disease 1 1.0
individuals O 0 1.5396621477758998e-10
or O 0 4.776526951744131e-10
families O 0 9.614638252219976e-11
. O 0 1.4011795279600392e-08

Two O 0 1.174058184005844e-07
identical O 0 6.973486676997709e-08
de O 0 7.700125024712179e-06
novo O 0 6.567463060491718e-06
5 O 0 3.667617534119927e-07
- O 0 2.2480826089577022e-07
bp O 0 1.101555966442902e-07
duplications O 0 3.7849750356144796e-07
in O 0 3.192145658914569e-09
exon O 0 2.296402215051785e-07
16 O 0 2.9145327928858933e-08
were O 0 1.4249526003595747e-09
found O 0 3.2281108897080912e-09
. O 0 5.109644973799732e-08

Among O 0 3.893193323278865e-08
the O 0 3.3779437025316383e-09
other O 0 4.856162694188981e-10
11 O 0 1.5749428428080137e-09
unique O 0 4.677962461840934e-10
mutations O 0 2.0203996808909608e-10
, O 0 1.7863323320543856e-10
8 O 0 6.281899445070849e-09
were O 0 1.1129167587498046e-09
small O 0 8.205371493374969e-09
deletions O 0 1.5915729534299317e-07
or O 0 1.3125758258070164e-08
insertions O 0 1.914402361080647e-07
predicted O 0 2.0542390899436214e-08
to O 0 4.356626170931577e-09
cause O 0 2.9777021737231735e-08
frameshifts O 0 4.353191798145417e-06
, O 0 2.271519639052144e-09
1 O 0 3.0680318729991995e-08
was O 0 1.5869026981363277e-08
a O 0 7.733381157670749e-10
mutation O 0 5.078432119276499e-10
to O 0 5.927761059787429e-10
a O 0 1.2517276104517805e-09
stop O 0 8.59630144844914e-09
codon O 0 6.4837073487922225e-09
, O 0 2.569469637059285e-10
1 O 0 6.9013701420317375e-09
was O 0 8.768759052202313e-09
a O 0 1.3786900510126543e-09
missense O 0 1.4886686550141803e-08
mutation O 0 6.771497251811809e-10
, O 0 1.072281499703287e-10
and O 0 2.451566727401655e-10
1 O 0 1.7165186605438976e-08
was O 0 1.4117811808489478e-08
predicted O 0 3.514831536932661e-09
to O 0 1.0297490637967144e-09
cause O 0 4.306149214983179e-09
insertion O 0 7.996267648024968e-09
of O 0 1.7464953927515126e-08
an O 0 2.171455015798074e-09
isoleucine O 0 2.2513358999276534e-06
in O 0 2.7853810369293797e-09
the O 0 2.5323638297436446e-08
hect O 0 1.7452153997510322e-06
domain O 0 8.279006813438627e-09
of O 0 1.4131983583354213e-08
the O 0 1.505871871643194e-08
UBE3A O 0 8.141351281665266e-05
protein O 0 3.889383926036771e-09
, O 0 1.405018323907825e-10
which O 0 4.041631612716756e-11
functions O 0 3.35893146630184e-10
in O 0 2.1296817087623765e-10
E2 O 0 1.0306986268915352e-06
binding O 0 8.702543574656829e-09
and O 0 3.3731601956077384e-09
ubiquitin O 0 2.2719416392646963e-07
transfer O 0 8.180510349120595e-07
. O 0 2.7862600404660043e-07

Eight O 0 5.4409944993949466e-08
of O 0 7.2461330269391055e-09
the O 0 6.760527693217e-10
cases O 0 2.2091270479585035e-10
were O 0 2.1189930365927978e-10
familial O 0 1.2265464199856524e-08
, O 0 6.369452187904301e-10
and O 0 1.5647714235456078e-09
five O 0 2.3687198869026815e-09
were O 0 2.4489832384233523e-09
sporadic O 0 1.4456046528721345e-06
. O 0 5.656896746586426e-07

In O 0 4.4830471779278014e-08
two O 0 3.084782873585823e-09
familial O 0 4.3005208283375396e-08
cases O 0 8.921837713060654e-10
and O 0 4.1257286476081845e-10
one O 0 1.3905152029813905e-10
sporadic O 0 1.490245438162674e-08
case O 0 5.358087751261564e-09
, O 0 2.0928454524948847e-09
mosaicism O 0 2.0920458609907655e-06
for O 0 4.1803893680025794e-08
UBE3A O 1 1.0
mutations O 0 3.2570444119528474e-08
was O 0 3.322055075472008e-09
detected O 0 4.5994674735538865e-10
in O 0 2.2262570259501402e-11
the O 0 2.3057190878805756e-10
mother O 0 6.111470357561544e-11
of O 0 4.289506250199082e-10
three O 0 1.8568648008088218e-10
AS B-Disease 1 1.0
sons O 0 5.884035036984869e-09
, O 0 8.251489075350449e-11
in O 0 4.920361687532626e-11
the O 0 8.114382499257999e-10
maternal O 0 4.911028028686815e-09
grandfather O 0 3.3185847403416346e-09
of O 0 1.606509236751208e-08
two O 0 1.526195836376587e-09
AS B-Disease 1 1.0
first O 0 4.1437986375569835e-09
cousins O 0 9.15371778376084e-09
, O 0 1.8731211026690175e-10
and O 0 4.2139436384758255e-10
in O 0 2.7871704944004705e-10
the O 0 4.2460324145565664e-09
mother O 0 3.0570135312046887e-09
of O 0 1.0326723476339339e-08
an O 0 2.555799571979378e-09
AS B-Disease 1 1.0
daughter O 0 4.623123913916061e-06
. O 0 1.0697127663661377e-06

The O 0 4.1905597214508816e-08
frequencies O 0 5.9137832408850954e-09
with O 0 3.6629257960107964e-10
which O 0 3.8189010287403846e-10
we O 0 6.651578732252972e-10
detected O 0 3.302734974397481e-09
mutations O 0 2.866548942659364e-10
were O 0 1.3411204091706708e-10
5 O 0 1.4168223261279422e-09
( O 0 4.1410527784613294e-11
14 O 0 4.4979542312972853e-10
% O 0 1.9757204552939278e-11
) O 0 1.1961747564681602e-11
of O 0 3.578088103584065e-10
35 O 0 1.3323249170582585e-09
in O 0 4.29224607245704e-11
sporadic O 0 6.5655427761157625e-09
cases O 0 4.087465921287503e-10
and O 0 2.6819144127721017e-10
8 O 0 4.702951805768407e-09
( O 0 5.1263590594707864e-11
80 O 0 1.4753344101947619e-09
% O 0 4.330417968656519e-11
) O 0 2.317918773586669e-11
of O 0 6.62088439629116e-10
10 O 0 1.8273420554493214e-09
in O 0 3.985392016403466e-10
familial O 0 8.622990321782709e-08
cases O 0 2.4383144392459144e-09
. O 0 2.286424605202342e-09
. O 0 3.743818766110962e-08

The O 0 3.237576311221346e-05
hemochromatosis B-Disease 1 1.0
845 O 0 5.697155211237259e-05
G O 0 7.668913895031437e-06
- O 0 3.436708766457741e-07
- O 0 1.719504609809519e-07
> O 0 1.6873363151148624e-08
A O 0 1.4672979276042497e-08
and O 0 4.1487946411677967e-10
187 O 0 3.3343576788524842e-09
C O 0 7.463231099791301e-08
- O 0 2.5294656325058895e-07
- O 0 1.2464223573260824e-06
> O 0 2.494495277005626e-07
G O 0 6.170504548208555e-06
mutations O 0 3.920778368637912e-09
: O 0 5.965516275407978e-11
prevalence O 0 1.6358957521944717e-09
in O 0 1.211550443303011e-10
non O 0 1.1954574574701837e-07
- O 0 2.7045976480621903e-07
Caucasian O 0 2.8405150942489854e-07
populations O 0 1.8269595614128775e-08
. O 0 2.5125226343902796e-08

Hemochromatosis B-Disease 1 0.9813176989555359
, O 0 6.010512976217797e-08
the O 0 7.709683131906786e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 0 0.00022565310064237565
, O 0 1.8199054485634747e-09
leads O 0 1.5669883168811793e-08
, O 0 7.891219899747171e-10
if O 0 6.013491482548261e-09
untreated O 1 0.9813412427902222
, O 0 9.279968460340626e-10
to O 0 1.1640627128883807e-08
progressive O 1 0.9997252821922302
iron B-Disease 1 1.0
overload I-Disease 1 0.9898170232772827
and O 0 1.1660891914289095e-06
premature B-Disease 0 5.639515620714519e-06
death I-Disease 0 1.224190214088594e-06
. O 0 3.601226978844352e-07

The O 0 1.7667407519184053e-05
hemochromatosis B-Disease 1 1.0
gene O 0 6.157063694445242e-07
, O 0 7.661565604166753e-08
HFE O 1 1.0
, O 0 5.973495120770167e-08
recently O 0 2.696216938602447e-08
has O 0 8.85488959934122e-10
been O 0 1.6174037109628614e-10
identified O 0 9.32380492257856e-11
, O 0 5.436452676921277e-11
and O 0 1.6355361509567956e-10
characterization O 0 1.3138983234739499e-08
of O 0 2.8289923292845742e-08
this O 0 2.7062710405978407e-10
gene O 0 1.041156383330133e-09
has O 0 1.7308575406271842e-10
shown O 0 3.7497806942843326e-11
that O 0 6.39343656141933e-12
it O 0 2.928805462043549e-11
contains O 0 2.478072191891556e-10
two O 0 4.040899212465199e-11
mutations O 0 1.4200030040711908e-10
that O 0 1.5183318144429414e-11
result O 0 3.897610290071185e-10
in O 0 3.4484903821407897e-10
amino O 0 1.3197850590174198e-09
acid O 0 1.0541567618815861e-09
substitutions O 0 2.9455700101266302e-09
- O 0 7.934282564292516e-09
cDNA O 0 7.063845508525901e-09
nucleotides O 0 1.5645834627875388e-09
845 O 0 7.644166544196196e-08
G O 0 5.304562833430282e-08
- O 0 2.702389778619363e-08
- O 0 8.761222147768422e-08
> O 0 2.280132882503949e-08
A O 0 2.9673721257950092e-08
( O 0 1.2108319902282005e-10
C282Y O 0 8.621543656772701e-08
) O 0 5.785275036807036e-11
and O 0 1.662848747585599e-10
187 O 0 2.933151943551593e-09
C O 0 3.7468481650648755e-08
- O 0 1.2449500275124592e-07
- O 0 6.80119626395026e-07
> O 0 2.0932782263116678e-07
G O 0 7.27598535377183e-06
( O 0 3.4883034238930577e-09
H63D O 1 0.9999983310699463
) O 0 2.836199364253389e-08
. O 0 1.1896617024831357e-07

Although O 0 4.5489064177672844e-06
hemochromatosis B-Disease 1 1.0
is O 0 1.1873592775657471e-08
common O 0 2.9448792293607085e-09
in O 0 8.819677765892209e-10
Caucasians O 0 1.6745794937378378e-06
, O 0 7.182670902494692e-09
affecting O 0 1.8339918028686952e-07
> O 0 5.061707142317573e-08
= O 0 2.7340765207384266e-09
1 O 0 3.310233864795009e-09
/ O 0 3.1023899005333533e-09
300 O 0 4.4157455469928664e-10
individuals O 0 2.9816173401781e-12
of O 0 1.2118392400672917e-10
northern O 0 3.1682045875669473e-09
European O 0 2.1605977007510546e-09
origin O 0 6.68153241067948e-11
, O 0 1.4665458084039962e-11
it O 0 1.7849929867530534e-11
has O 0 2.8509040614355108e-11
not O 0 2.4171045373555522e-11
been O 0 1.0351126900065566e-10
recognized O 0 8.413644780880247e-10
in O 0 1.8983446758991107e-10
other O 0 1.2630545498382162e-09
populations O 0 1.9923740879335128e-08
. O 0 7.333817109156371e-08

The O 0 3.413552462916414e-07
present O 0 7.848115046726889e-09
study O 0 9.874143724886153e-10
used O 0 2.9879854146486196e-10
PCR O 0 1.7637725946428873e-08
and O 0 2.3352186850900125e-09
restriction O 0 1.928314752319693e-08
- O 0 1.2441162766663183e-08
enzyme O 0 6.272952157715395e-10
digestion O 0 1.3086005612450435e-09
to O 0 5.770518438086292e-11
analyze O 0 9.673228884565788e-10
the O 0 2.02956901285134e-10
frequency O 0 8.313879029664406e-10
of O 0 5.091858046313291e-09
the O 0 8.30947577412644e-09
845 O 0 4.102130901628698e-07
G O 0 2.784963442081789e-07
- O 0 7.448966954370917e-08
- O 0 9.328139327635654e-08
> O 0 1.2334601784402821e-08
A O 0 9.832370473361607e-09
and O 0 2.876396343332033e-10
187 O 0 3.6827387805971057e-09
C O 0 1.935323012958179e-08
- O 0 4.010874121718189e-08
- O 0 1.5550081400306226e-07
> O 0 1.0742543565811502e-07
G O 0 1.8969332131746341e-06
mutations O 0 5.0485433611413555e-09
in O 0 7.703466753383736e-10
HLA O 0 2.059653297692421e-06
- O 0 8.904743253879133e-08
typed O 0 7.306490523717457e-09
samples O 0 1.394970111645577e-10
from O 0 2.1650467876832558e-11
non O 0 7.005853674968421e-09
- O 0 1.0983058018609881e-08
Caucasian O 0 1.061941024005364e-08
populations O 0 4.999211600242859e-10
, O 0 4.460489269608736e-11
comprising O 0 1.1224603885251483e-10
Australian O 0 8.559223885207246e-10
Aboriginal O 0 1.6387250445504264e-09
, O 0 1.0344021472707965e-10
Chinese O 0 9.81915215803042e-10
, O 0 2.6376423267748805e-10
and O 0 2.747637450895013e-09
Pacific O 0 2.943079095985013e-07
Islanders O 0 2.5920419375324855e-06
. O 0 2.2388482534552168e-07

Results O 0 9.602958073173795e-08
showed O 0 5.495413901712709e-09
that O 0 3.219918498498231e-10
the O 0 5.739580366537211e-09
845 O 0 5.56512759430916e-07
G O 0 1.2290519180169213e-06
- O 0 4.0792113509269257e-07
- O 0 6.07970491728338e-07
> O 0 6.03726064696275e-08
A O 0 3.810333737419569e-08
mutation O 0 1.2557905826326987e-09
was O 0 6.824099063607036e-10
present O 0 4.272194403798224e-11
in O 0 4.4528304654622985e-11
these O 0 9.235784359518107e-11
populations O 0 6.358124443606172e-11
( O 0 6.1572036531842844e-12
allele O 0 8.368982590267748e-12
frequency O 0 3.957952021682587e-11
0 O 0 1.789606240976127e-10
. O 0 2.4099968548574324e-11
32 O 0 6.002018326789482e-10
% O 0 1.723392088759379e-11
) O 0 1.475558043806391e-11
, O 0 5.0987724459217176e-11
and O 0 2.3652424463449506e-10
, O 0 1.446155278861383e-10
furthermore O 0 6.675306973846773e-10
, O 0 6.433759774937542e-11
it O 0 9.741879525293484e-11
was O 0 5.5224598227709976e-09
always O 0 4.025103805815888e-09
seen O 0 1.6969404770250662e-09
in O 0 1.5393715468992042e-10
conjunction O 0 6.301700494759643e-09
with O 0 1.9780752591458395e-09
HLA O 0 9.190560376737267e-06
haplotypes O 0 3.6502573408370154e-08
common O 0 9.390183075552727e-10
in O 0 1.4582234031390584e-10
Caucasians O 0 3.725412867083833e-08
, O 0 3.3295005641420516e-10
suggesting O 0 3.701158546309813e-10
that O 0 1.753439615725938e-10
845 O 0 2.0663314614921546e-07
G O 0 1.8073964156428701e-06
- O 0 2.060741962850443e-06
- O 0 5.571496330958325e-06
> O 0 1.1307218272804676e-07
A O 0 1.3118780373133632e-07
may O 0 5.368970268371243e-10
have O 0 5.276401537912534e-11
been O 0 1.0238829228903512e-10
introduced O 0 2.0661197752680494e-10
into O 0 1.1147496120633704e-10
these O 0 5.539554925881873e-11
populations O 0 8.300090476032196e-11
by O 0 1.0071077999329603e-10
Caucasian O 0 5.353606411517831e-07
admixture O 0 1.053713049259386e-06
. O 0 4.2430798430359573e-07

187 O 0 1.3200194644014118e-06
C O 0 1.1904884331670473e-06
- O 0 3.251198279485834e-07
- O 0 2.488514496690186e-07
> O 0 3.7028918598025484e-08
G O 0 2.1759592527814675e-07
was O 0 3.284611027609685e-09
present O 0 1.0782619241922475e-10
at O 0 5.419176773990841e-10
an O 0 5.851952256108461e-11
allele O 0 5.834546179528388e-10
frequency O 0 3.303037399149389e-09
of O 0 2.405555044049379e-08
2 O 0 2.1696776002499973e-06
. O 0 4.863211984229565e-07

68 O 0 1.0742702443167218e-06
% O 0 2.8282354236353058e-09
in O 0 3.0703234399354074e-10
the O 0 1.8694672476726737e-09
two O 0 2.659156228546067e-10
populations O 0 6.694764742576353e-10
analyzed O 0 1.5357094484969025e-09
( O 0 2.7719548878479827e-10
Australian O 0 6.639527594387573e-09
Aboriginal O 0 1.9348947333241995e-08
and O 0 9.650450438769553e-10
Chinese O 0 1.0052644938696176e-08
) O 0 5.588110862930762e-09
. O 0 6.272419739161705e-08

In O 0 5.2398238636897077e-08
the O 0 1.2722915165852555e-08
Australian O 0 1.5378734730120414e-08
Aboriginal O 0 7.72075470223399e-09
samples O 0 3.215217536656212e-10
, O 0 9.580643223205954e-11
187 O 0 1.0200920108616174e-09
C O 0 5.0724544564673124e-08
- O 0 1.9071225665356906e-07
- O 0 7.704016411480552e-07
> O 0 6.391619677970084e-08
G O 0 1.3226328974269563e-06
was O 0 2.4894526440277787e-09
found O 0 4.148950974447452e-11
to O 0 3.069706988600984e-11
be O 0 4.541953618764083e-11
associated O 0 4.71710726035468e-10
with O 0 2.596676429433842e-09
HLA O 0 0.00010812314576469362
haplotypes O 0 5.9315219402833463e-08
common O 0 2.9758042696670373e-09
in O 0 4.853106805313701e-10
Caucasians O 0 1.0446702702893162e-07
, O 0 4.3685813300164966e-10
suggesting O 0 4.984862522761091e-10
that O 0 2.1903085248298204e-11
it O 0 8.826202962941565e-11
was O 0 8.258231876112632e-10
introduced O 0 5.020243110109845e-10
by O 0 1.707295971264955e-10
recent O 0 1.3200398996104923e-08
admixture O 0 1.1906644203918404e-06
. O 0 6.939042123121908e-07

In O 0 1.4467616438196274e-07
the O 0 6.453198864164733e-08
Chinese O 0 1.6189888540907305e-08
samples O 0 8.890987945875395e-10
analyzed O 0 1.848815212035504e-09
, O 0 1.974357899392487e-10
187 O 0 2.256036024661512e-09
C O 0 2.0592997529433887e-08
- O 0 2.9655558009267224e-08
- O 0 9.844401915870549e-08
> O 0 1.8669915391456016e-08
G O 0 1.9324592415159714e-07
was O 0 1.400331739453975e-09
present O 0 1.229888135778623e-10
in O 0 4.423979585443938e-11
association O 0 6.306130617694805e-11
with O 0 5.61739647852999e-11
a O 0 4.292338151579145e-10
wide O 0 5.915827827607245e-08
variety O 0 5.47775194092992e-08
of O 0 1.0764078695046919e-07
HLA O 0 9.145282092504203e-05
haplotypes O 0 2.0311393456040605e-08
, O 0 3.63878344122881e-10
showing O 0 6.001263375132737e-10
this O 0 2.216862977910683e-11
mutation O 0 7.859881495653198e-11
to O 0 2.9669940115883975e-11
be O 0 4.975114764604882e-11
widespread O 0 4.973674805341943e-10
and O 0 7.127151646635355e-10
likely O 0 9.208138140870403e-10
to O 0 4.597537905937088e-10
predate O 0 3.69477213268965e-08
the O 0 8.411996432755586e-09
more O 0 8.822605979119658e-10
genetically O 0 7.497226839348059e-09
restricted O 0 7.696597137396566e-09
845 O 0 3.252581564083812e-07
G O 0 2.1712301077059237e-06
- O 0 1.4609944400945096e-06
- O 0 2.935523980340804e-06
> O 0 3.389311302726128e-07
A O 0 4.674256786074693e-07
mutation O 0 1.881688973526252e-07
. O 0 4.441894319029416e-08

Genotype O 0 6.390684120560763e-06
- O 0 2.6599916509439936e-06
phenotype O 0 1.0466148125942709e-07
correlations O 0 2.534563350309327e-07
in O 0 5.3830436996804565e-08
attenuated B-Disease 1 0.9502615928649902
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 1.0574413863650989e-05

Germ O 0 0.0002871868491638452
- O 0 1.0414227290311828e-05
line O 0 1.1899799119419185e-06
mutations O 0 2.509701602093628e-08
of O 0 1.3160049938676366e-08
the O 0 1.6518496792627957e-08
tumor B-Disease 0 4.5058168325340375e-05
suppressor O 0 2.165605292248074e-05
APC O 0 2.2613828605244635e-06
are O 0 5.602195374265762e-10
implicated O 0 1.9840463494347205e-08
in O 0 7.984578331843295e-09
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.4301643861690536e-06
AAPC B-Disease 1 1.0
) O 0 2.1391357574174208e-09
, O 0 1.4311429819002797e-10
a O 0 1.9369236770039322e-10
variant O 0 3.451818031408038e-07
of O 0 2.332210215172381e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.0077257002194528e-06
FAP B-Disease 1 1.0
) O 0 4.9396454926409206e-08
. O 0 9.19435194646212e-08

AAPC B-Disease 1 1.0
is O 0 1.4057681596568727e-07
recognized O 0 1.0913541181878372e-08
by O 0 1.2680771710460448e-10
the O 0 2.362542828038272e-09
occurrence O 0 1.2010621830427226e-08
of O 0 3.948050775193224e-08
< O 0 1.3998057966091437e-06
100 O 0 1.1998697857507068e-07
colonic B-Disease 0 0.0020281272009015083
adenomas I-Disease 0 0.000288729730527848
and O 0 1.261601045854377e-08
a O 0 1.4781031953958745e-09
later O 0 4.625219762743882e-09
onset O 0 2.5480184717707743e-07
of O 0 4.5522306209022645e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.0459395833636336e-09
age O 0 5.693470583878479e-09
> O 0 3.2193918642065e-09
40 O 0 2.249101571649703e-09
years O 0 9.01310470702299e-10
) O 0 3.5719189828142817e-09
. O 0 6.871045599154968e-08

The O 0 2.398182346041722e-07
aim O 0 4.519996821272798e-07
of O 0 1.9122396111015405e-08
this O 0 1.515890191150504e-10
study O 0 3.410928761660159e-10
was O 0 1.1660264975787982e-09
to O 0 4.177101442515152e-10
assess O 0 4.580640577955819e-08
genotype O 0 7.356582898410124e-08
- O 0 3.3383435038558673e-07
phenotype O 0 4.910168627247913e-08
correlations O 0 1.4650892410372762e-07
in O 0 4.37291234334225e-08
AAPC B-Disease 1 1.0
families O 0 3.9103024818132326e-08
. O 0 2.1294040664088243e-07

By O 0 1.9838269693650545e-08
protein O 0 1.7571107235880845e-08
- O 0 5.38300284347315e-08
truncation O 0 2.999014157012425e-07
test O 0 1.8179150629293872e-08
( O 0 1.9105215187664726e-09
PTT O 0 1.7282787666772492e-05
) O 0 1.93504420820112e-10
assay O 0 1.7162035126361275e-09
, O 0 7.571702986819417e-11
the O 0 1.2185678854859106e-10
entire O 0 5.798467817008657e-10
coding O 0 2.866599624340438e-09
region O 0 8.96436702646497e-09
of O 0 8.858999756000685e-09
the O 0 1.8384811895089115e-08
APC B-Disease 0 2.0963288704933802e-07
gene O 0 6.617942305275903e-10
was O 0 9.542987511323986e-10
screened O 0 5.7891997862213884e-09
in O 0 1.339131722177811e-10
affected O 0 1.1092018414871063e-09
individuals O 0 3.611821605686849e-11
from O 0 5.360528132491993e-10
11 O 0 1.7987798628382734e-07
AAPC B-Disease 1 1.0
kindreds O 0 5.744238478655461e-06
, O 0 1.7776220495591133e-09
and O 0 1.4670146208928259e-09
their O 0 2.12188577819461e-09
phenotypic O 0 6.328334620775422e-07
differences O 0 5.762465349334889e-08
were O 0 5.708269412707523e-09
examined O 0 3.12236778654551e-07
. O 0 1.320385507597166e-07

Five O 0 4.043173191803362e-07
novel O 0 2.0847933512868622e-07
germ O 0 2.7847559067595284e-06
- O 0 1.3079494465273456e-06
line O 0 1.4515685506921727e-06
APC B-Disease 0 4.4048570657651e-07
mutations O 0 2.9025097880719386e-09
were O 0 1.52487994453665e-10
identified O 0 2.1100554636888091e-10
in O 0 6.080220216198029e-10
seven O 0 2.1741540123798586e-08
kindreds O 0 1.4452695722866338e-05
. O 0 3.6388851754054485e-07

Mutations O 0 1.3466537041040283e-07
were O 0 1.325089482584474e-09
located O 0 2.943245203113065e-09
in O 0 7.397080170612469e-11
three O 0 3.2513974151937575e-11
different O 0 5.680412737407714e-12
regions O 0 2.8150645703384214e-10
of O 0 4.660437813441831e-09
the O 0 1.9138413520636277e-08
APC B-Disease 0 1.4814887094871665e-07
gene O 0 3.3615463190805883e-10
( O 0 2.0344977438857548e-11
1 O 0 1.4661585279185374e-09
) O 0 2.0766081562650918e-11
at O 0 4.618156135283158e-10
the O 0 4.0723927008379235e-10
5 O 0 2.686206146407244e-09
end O 0 1.3421881384090284e-09
spanning O 0 2.1037513953103826e-09
exons O 0 5.108190759273157e-09
4 O 0 2.3449489017224323e-09
and O 0 3.2707370145601544e-10
5 O 0 3.0511999593585415e-09
, O 0 2.0944417034041152e-10
( O 0 3.523970351637651e-11
2 O 0 2.7350990361441063e-09
) O 0 2.074970195664605e-10
within O 0 1.8488355291168546e-10
exon O 0 6.517879569400975e-09
9 O 0 3.6559339999797658e-09
, O 0 1.608862487678664e-10
and O 0 1.9153184593889705e-10
( O 0 6.873618341174392e-11
3 O 0 1.6109760192506428e-09
) O 0 4.802661046632295e-11
at O 0 7.093815534986447e-10
the O 0 7.929799594741382e-10
3 O 0 1.3669835929874807e-08
distal O 0 2.3650740388347913e-07
end O 0 1.2536349736080865e-08
of O 0 3.5670797871034665e-08
the O 0 7.245293431878963e-08
gene O 0 1.0282799678407173e-07
. O 0 1.7695083442959003e-07

Variability O 0 1.526364712844952e-06
in O 0 1.5893311111625508e-09
the O 0 1.4236594125804913e-09
number O 0 1.0854039889096612e-09
of O 0 1.5846197243263305e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 2.068316234726808e-06
most O 0 1.6208788755633918e-09
apparent O 0 2.270770238510522e-09
in O 0 6.678997632736383e-11
individuals O 0 1.2942790068859455e-11
with O 0 2.67501628486988e-11
mutations O 0 5.173875772257475e-10
in O 0 9.126790989633093e-11
region O 0 2.810469723613096e-08
1 O 0 5.101289843878476e-07
, O 0 6.648002148779142e-10
and O 0 1.8242219956832173e-09
upper O 0 2.3990544377738843e-06
- O 1 0.702362060546875
gastrointestinal O 1 1.0
manifestations O 0 0.022159500047564507
were O 0 2.2602482108169397e-09
more O 0 2.1206303379983638e-10
severe O 0 7.3646276632644e-08
in O 0 1.630671597752098e-09
them O 0 8.642762061583653e-09
. O 0 6.996454970931154e-08

In O 0 2.4410008236941394e-08
individuals O 0 9.441617487837561e-10
with O 0 1.384882902799589e-10
mutations O 0 3.5354105754059617e-10
in O 0 1.1056337095860513e-10
either O 0 5.040401429567964e-10
region O 0 5.0411150809281935e-09
2 O 0 2.671563237299779e-08
or O 0 4.1202555256525386e-10
region O 0 3.0894284908100644e-09
3 O 0 2.1069849864829848e-08
, O 0 2.7340960051525087e-10
the O 0 6.548417919027827e-10
average O 0 4.782589324570097e-10
number O 0 4.149609822423628e-10
of O 0 8.867417911062603e-09
adenomas B-Disease 0 1.609603532415349e-05
tended O 0 3.740685627917628e-08
to O 0 4.520789853579288e-10
be O 0 8.735845380414275e-11
lower O 0 6.025015486521568e-10
than O 0 2.4918253224703868e-11
those O 0 2.8653229094954824e-11
in O 0 1.9566471706755628e-11
individuals O 0 4.293578513558938e-12
with O 0 1.9498071560097863e-11
mutations O 0 2.367995799446021e-10
in O 0 5.7938109171429275e-11
region O 0 6.1094951320228574e-09
1 O 0 2.7766354548930394e-08
, O 0 2.386705000301248e-10
although O 0 3.6604327902090006e-10
age O 0 1.5199993486092467e-09
at O 0 1.7378152250557832e-09
diagnosis O 0 2.1000960970241067e-08
was O 0 1.3483134608804903e-08
similar O 0 5.799790159244367e-08
. O 0 3.077843757637311e-07

In O 0 2.1751273493464396e-07
all O 0 3.80960017309917e-07
AAPC B-Disease 1 1.0
kindreds O 0 2.8397336791385897e-05
, O 0 5.115376122688531e-09
a O 0 1.1524858845035624e-09
predominance O 0 7.567079052250847e-08
of O 0 7.884773367550224e-08
right O 0 5.887995030207094e-06
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.999910831451416
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 0 5.921318916080054e-06
was O 0 1.3086615524571243e-07
observed O 0 1.3288415345868998e-07
. O 0 1.3564573464464047e-07

No O 0 1.730568146740552e-05
desmoid B-Disease 1 0.9999983310699463
tumors I-Disease 1 1.0
were O 0 1.1596616111830826e-08
found O 0 8.000290985243907e-10
in O 0 7.872053009450042e-10
these O 0 7.848578675861972e-09
kindreds O 0 9.512366887065582e-06
. O 0 1.8375807542270195e-07

Our O 0 3.981028555699595e-07
data O 0 6.462175239363432e-09
suggest O 0 6.516484019059021e-10
that O 0 8.097170156595723e-11
, O 0 6.492663073842664e-10
in O 0 2.49158071952138e-09
AAPC B-Disease 1 1.0
families O 0 6.42052300214857e-10
, O 0 1.1107065961413198e-10
the O 0 1.1550643774782543e-10
location O 0 1.8116282918256843e-09
of O 0 1.2291341278114487e-08
the O 0 6.422476417355938e-08
APC B-Disease 0 5.837815842824057e-05
mutation O 0 1.4221558330973494e-07
may O 0 5.208771192144468e-09
partially O 0 1.8816744784544426e-07
predict O 0 2.0242705289774676e-08
specific O 0 1.763382329045271e-08
phenotypic O 0 2.82872247225896e-06
expression O 0 6.028388099821314e-08
. O 0 7.944765201273185e-08

This O 0 5.041586259579844e-09
should O 0 8.517581084888093e-10
help O 0 2.525174791490059e-10
in O 0 6.506854777210691e-11
the O 0 6.010759112662356e-10
design O 0 2.500498830215747e-08
of O 0 1.0351827839372163e-08
tailored O 0 3.514618640565459e-08
clinical O 0 1.3754907968177577e-07
- O 0 3.1045814807839633e-08
management O 0 4.957935839655647e-09
protocols O 0 2.443134050622575e-08
in O 0 3.027759709617328e-10
this O 0 1.752189227044454e-10
subset O 0 1.2320023223821863e-08
of O 0 1.0991881183031182e-08
FAP B-Disease 1 0.9996911287307739
patients O 0 1.157862516976138e-08
. O 0 1.992806364370381e-09
. O 0 5.0971465270777117e-08

Wilms B-Disease 1 1.0
' I-Disease 0 2.733374094532337e-05
tumor I-Disease 0 0.0018809785833582282
1 O 0 5.203799560149491e-07
and O 0 2.022229139697629e-08
Dax O 1 0.9999983310699463
- O 0 3.110100124104065e-07
1 O 0 6.563341514720378e-08
modulate O 0 2.4915676632986106e-08
the O 0 4.746685711154441e-09
orphan O 0 4.833380273794319e-08
nuclear O 0 9.187357363771298e-08
receptor O 0 5.1279414492455544e-08
SF O 1 1.0
- O 0 1.9425387165483698e-07
1 O 0 1.9275205431767972e-08
in O 0 1.216842321349887e-10
sex O 0 2.191567621823154e-10
- O 0 1.033834684527335e-09
specific O 0 8.746838253692601e-10
gene O 0 1.8992873940248955e-09
expression O 0 7.541543389777416e-09
. O 0 3.0191586120054126e-08

Products O 0 7.961054393490485e-07
of O 0 2.7724979645427084e-07
steroidogenic O 0 1.3560809748014435e-05
factor O 0 1.4468693620983686e-07
1 O 0 8.915110072393873e-08
( O 0 1.3558069111851978e-09
SF O 1 1.0
- O 0 3.316309005185758e-07
1 O 0 7.451240691125349e-08
) O 0 9.590740424059163e-10
and O 0 5.991967366725248e-09
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999996423721313
1 O 0 9.085654255613917e-07
( O 0 3.085288691195842e-09
WT1 O 0 8.653247641632333e-05
) O 0 3.2848412878649924e-10
genes O 0 7.397052415036853e-11
are O 0 4.8979431621631875e-12
essential O 0 4.4123021902819914e-10
for O 0 1.0753987977896173e-10
mammalian O 0 2.8479735902919856e-08
gonadogenesis O 0 1.1029651432181709e-06
prior O 0 1.144892625148941e-08
to O 0 6.056865675674317e-09
sexual O 0 2.5323588559444943e-08
differentiation O 0 5.486179333047403e-08
. O 0 7.368814181063499e-08

In O 0 5.63248967466734e-08
males O 0 2.8352257430697136e-08
, O 0 5.7967906030853555e-09
SF O 1 1.0
- O 0 1.506428361608414e-06
1 O 0 1.0265475935966606e-07
participates O 0 5.5872795279299226e-09
in O 0 1.1794601406656113e-10
sexual O 0 1.4877814258351663e-10
development O 0 1.1481820702541334e-11
by O 0 4.546155119022899e-12
regulating O 0 1.3551406219391993e-08
expression O 0 6.891474613190951e-10
of O 0 1.8033337045864073e-09
the O 0 8.260125916592642e-09
polypeptide O 0 5.124607582729368e-07
hormone O 0 1.3901632200941094e-07
Mullerian O 0 4.1388251702301204e-05
inhibiting O 0 1.9701783458003774e-06
substance O 0 3.0379155191440077e-07
( O 0 1.0304785469372746e-08
MIS O 1 0.9999998807907104
) O 0 2.978849700241426e-08
. O 0 1.3513519547814212e-07

Here O 0 4.17865138047091e-08
, O 0 7.1705295034973915e-09
we O 0 8.062485123971896e-10
show O 0 3.3893605699830687e-09
that O 0 1.93595695030524e-09
WT1 O 0 0.0023925411514937878
- O 0 2.4228971597040072e-05
KTS O 0 0.08842559903860092
isoforms O 0 3.256609559798562e-08
associate O 0 4.112988705173848e-08
and O 0 4.640311690451426e-09
synergize O 0 3.828177796094678e-06
with O 0 1.1021544565892327e-08
SF O 1 1.0
- O 0 4.060653282067506e-06
1 O 0 2.772059133349103e-07
to O 0 9.156878810756552e-09
promote O 0 1.4756722066522343e-06
MIS O 1 1.0
expression O 0 3.709042459831835e-07
. O 0 1.453732210165981e-07

In O 0 4.9835463755698584e-08
contrast O 0 9.985572546611365e-08
, O 0 7.297663273675425e-08
WT1 O 0 0.480448842048645
missense O 0 1.7286871525357128e-06
mutations O 0 2.2628118045986412e-08
, O 0 2.2454227366353052e-10
associated O 0 1.1015081208265443e-10
with O 0 1.8163327786258066e-10
male B-Disease 0 9.671240697173289e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.813709626929949e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.597733387929793e-09
fail O 0 2.976844903912479e-08
to O 0 3.828741323985696e-09
synergize O 0 1.514446375949774e-05
with O 0 8.293739739428929e-08
SF O 1 1.0
- O 1 0.999923586845398
1 O 0 2.831377787515521e-05
. O 0 3.94004757708899e-07

Additionally O 0 9.184464033751283e-07
, O 0 5.998542551566288e-09
the O 0 2.406448817993123e-09
X O 0 1.0649977184584714e-06
- O 0 1.4611154597332643e-07
linked O 0 8.133278583954962e-08
, O 0 9.497355124565843e-10
candidate O 0 1.779508207455649e-09
dosage O 0 2.07048969969037e-07
- O 0 6.227086402077475e-08
sensitive O 0 3.3609285310376436e-07
sex O 0 2.3453514685911614e-09
- O 0 5.68612357199072e-09
reversal O 0 3.8647440803174504e-09
gene O 0 5.141372882988549e-10
, O 0 6.459177637196944e-10
Dax O 1 0.9999630451202393
- O 0 2.750405485585361e-07
1 O 0 1.6702495031495346e-07
, O 0 4.291480504292622e-09
antagonizes O 0 1.0575062105999677e-06
synergy O 0 3.177771645823668e-07
between O 0 1.1422708112718283e-08
SF O 1 1.0
- O 0 2.705965016502887e-07
1 O 0 4.7301401906452156e-08
and O 0 4.871397507599795e-09
WT1 O 0 0.0006641547661274672
, O 0 1.1900634921957476e-09
most O 0 2.465912196658593e-10
likely O 0 1.2564344009646788e-10
through O 0 3.70348682277033e-11
a O 0 1.310825614719846e-10
direct O 0 7.376654842516928e-10
interaction O 0 1.0320200249935851e-09
with O 0 2.6026960586733594e-09
SF O 1 1.0
- O 0 0.00042767447303049266
1 O 0 4.603035904438002e-06
. O 0 1.954766872813707e-07

We O 0 2.5765768896235386e-07
propose O 0 1.8185329508924042e-07
that O 0 4.452002766441865e-09
WT1 O 0 0.011392838321626186
and O 0 2.475099165621941e-07
Dax O 1 0.9999991655349731
- O 0 7.311567173928779e-07
1 O 0 9.149236035455033e-08
functionally O 0 8.593908695786467e-09
oppose O 0 1.0569431996287904e-09
each O 0 2.4014712093900492e-11
other O 0 6.415121212022257e-11
in O 0 2.122536313375889e-10
testis O 0 2.109225079038879e-07
development O 0 9.332865591460404e-10
by O 0 7.672175117434676e-10
modulating O 0 1.9527187760104425e-06
SF O 1 1.0
- O 0 2.707753810682334e-05
1 O 0 1.8336768334847875e-06
- O 0 7.828598427295219e-07
mediated O 0 1.4741965514986077e-07
transactivation O 0 2.6220261588605354e-06
. O 0 9.509705023447168e-09
. O 0 6.118126805176871e-08

A O 0 1.4085878774494631e-06
mouse O 0 1.4752824029073963e-07
model O 0 5.199718433601674e-09
for O 0 8.253716821116086e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.6337018013000488
- O 0 0.00029511720640584826
centre O 0 5.810037237097276e-06
mutations O 0 4.3653378156705003e-07
. O 0 4.9107683253168943e-08

Imprinting O 0 1.7298008970101364e-05
in O 0 1.909939406630201e-08
the O 0 3.599584985636284e-08
15q11 O 0 6.304507223831024e-06
- O 0 8.707543202035595e-07
q13 O 0 3.868474323098781e-06
region O 0 6.453259970840008e-08
involves O 0 9.975497761161023e-09
an O 0 5.957752624574653e-10
imprinting O 0 6.069184337320621e-07
centre O 0 5.990860927340691e-07
( O 0 3.486999800017543e-09
IC O 0 1.879718547570519e-05
) O 0 8.802267803531549e-10
, O 0 2.4410773402649966e-10
mapping O 0 3.906683032628422e-10
in O 0 7.814021651952885e-11
part O 0 1.5678516263051279e-09
to O 0 3.833489359283959e-10
the O 0 9.015064250661453e-10
promoter O 0 1.4471534370841255e-07
and O 0 6.841970989768242e-09
first O 0 1.322229703504263e-08
exon O 0 7.163764621509472e-07
of O 0 1.6921599126362707e-06
SNRPN O 1 1.0
. O 0 1.5363627881015418e-06

Deletion O 0 5.554350082093151e-06
of O 0 2.92473572471863e-07
this O 0 1.1851305714571936e-08
IC O 0 4.8005491407820955e-05
abolishes O 0 2.3460920601792168e-06
local O 0 1.7046749789528803e-08
paternally O 0 9.593511407501865e-08
derived O 0 7.353307407420573e-10
gene O 0 3.045674823454192e-10
expression O 0 5.149761866940494e-11
and O 0 2.924317732411197e-11
results O 0 6.709603012078347e-11
in O 0 8.215718105830661e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.966971568544977e-07
PWS B-Disease 1 1.0
) O 0 5.571447658780926e-08
. O 0 9.735985173620065e-08

We O 0 5.401536284921349e-08
have O 0 3.8979003358363684e-10
created O 0 2.2226400719915773e-09
two O 0 9.39039734859648e-10
deletion O 0 2.5988581953129142e-08
mutations O 0 1.002047889109292e-09
in O 0 2.3410598459783216e-10
mice O 0 1.0003068595665354e-08
to O 0 2.243210728281042e-09
understand O 0 3.506784196360968e-08
PWS B-Disease 1 1.0
and O 0 1.2744506783235465e-08
the O 0 5.202962949368839e-09
mechanism O 0 1.355825762772156e-08
of O 0 5.469699804194761e-09
this O 0 2.7954878412117523e-09
IC O 0 0.00046157219912856817
. O 0 6.965922239032807e-07

Mice O 0 9.839226549956948e-05
harbouring O 0 3.5152046621078625e-05
an O 0 2.8780018368479432e-08
intragenic O 0 1.4645958799519576e-05
deletion O 0 3.667684040919994e-07
in O 0 4.882596993383004e-09
Snrpn O 1 0.9956823587417603
are O 0 6.123588747186659e-09
phenotypically O 0 2.9475199880835135e-07
normal O 0 5.229726429689663e-09
, O 0 1.9279304541708342e-10
suggesting O 0 2.1413962270067088e-10
that O 0 7.532910406560234e-11
mutations O 0 3.2713625142122282e-09
of O 0 8.627050185339158e-09
SNRPN O 1 0.9999138116836548
are O 0 3.933240122488968e-10
not O 0 1.2960532647099399e-10
sufficient O 0 6.007323971601863e-09
to O 0 1.5663339070215443e-08
induce O 0 1.4603127965528984e-05
PWS B-Disease 1 1.0
. O 0 1.0459503755555488e-05

Mice O 0 6.052237608855648e-07
with O 0 1.6728064489157646e-09
a O 0 2.105204455205012e-09
larger O 0 2.2273646038684092e-08
deletion O 0 3.2401413108118504e-08
involving O 0 2.5373665391015265e-09
both O 0 1.5058710944870768e-09
Snrpn O 0 8.840612281346694e-06
and O 0 3.397762293744222e-09
the O 0 1.9287524466449213e-08
putative O 0 2.8146705517428927e-06
PWS O 1 1.0
- O 0 2.4447399482596666e-05
IC O 0 0.0012687057023867965
lack O 0 7.109928645832042e-08
expression O 0 2.339819893393269e-09
of O 0 5.6596785036333586e-09
the O 0 9.397282063616785e-09
imprinted O 0 1.8854072436624847e-07
genes O 0 1.1653067844008547e-08
Zfp127 O 0 5.404088824434439e-06
( O 0 2.0441386361369496e-09
mouse O 0 6.277662123466143e-08
homologue O 0 1.5759179916585708e-07
of O 0 3.2169321428909825e-08
ZNF127 O 1 1.0
) O 0 6.048876954878324e-09
, O 0 7.608612406784232e-09
Ndn O 0 9.4727729447186e-06
and O 0 1.865624632557683e-08
Ipw O 0 1.810857497730467e-06
, O 0 1.910907876379042e-09
and O 0 1.4281414939532056e-09
manifest O 0 1.4453984675810716e-08
several O 0 1.1389721388255225e-09
phenotypes O 0 1.4666746039893042e-07
common O 0 1.2571260477045598e-08
to O 0 4.154983201942741e-08
PWS B-Disease 1 1.0
infants O 0 0.0014179123099893332
. O 0 3.21692652960337e-07

These O 0 1.4081989796466132e-08
data O 0 7.350460795585434e-10
demonstrate O 0 1.7906852389781847e-10
that O 0 1.0073627695894594e-11
both O 0 3.3286481210259566e-11
the O 0 1.346246031319609e-10
position O 0 9.85352355264979e-10
of O 0 1.7169107247028137e-09
the O 0 1.82256298941752e-09
IC O 0 1.4304071100923466e-06
and O 0 1.1855663117898985e-09
its O 0 6.583069089849403e-10
role O 0 8.721066646621978e-10
in O 0 7.446995797799616e-11
the O 0 5.566300753656606e-10
coordinate O 0 7.743151675398963e-10
expression O 0 2.439229651596264e-10
of O 0 2.6812254638741706e-09
genes O 0 5.160944449578153e-10
is O 0 8.598900064216153e-11
conserved O 0 3.6895164701178373e-09
between O 0 4.596687475100225e-10
mouse O 0 2.1083035761648716e-08
and O 0 1.1724582416050566e-09
human O 0 5.273818048934231e-10
, O 0 8.313716381991298e-11
and O 0 1.7369494731411805e-10
indicate O 0 1.9117597782614126e-10
that O 0 2.1024054025486905e-11
the O 0 6.853866918454798e-10
mouse O 0 1.3251938213443282e-08
is O 0 1.2550450956272385e-10
a O 0 3.22125590090927e-11
suitable O 0 7.57114315685925e-10
model O 0 9.764500319420222e-11
system O 0 2.5537907899497725e-10
in O 0 2.2878138619675248e-11
which O 0 4.052446225810691e-11
to O 0 1.0345698603364539e-10
investigate O 0 8.210094271099422e-10
the O 0 1.2826339990112956e-09
molecular O 0 2.7596227525350514e-09
mechanisms O 0 6.733275714765341e-09
of O 0 5.231073352263138e-09
imprinting O 0 5.01605583735909e-08
in O 0 2.834703860532528e-10
this O 0 8.477786528349185e-11
region O 0 1.252019465880494e-08
of O 0 1.2614493449802922e-08
the O 0 7.272828561610822e-09
genome O 0 1.9244483784319755e-09
. O 0 2.404553667290088e-09
. O 0 6.109357997274856e-08

Mutations O 0 5.160005684956559e-07
of O 0 2.517891459774546e-07
the O 0 1.3763056472271273e-07
ATM O 0 0.00011626185005297884
gene O 0 2.1343685929764433e-08
detected O 0 1.2730683174311253e-08
in O 0 1.672085470083573e-09
Japanese O 1 0.9927499294281006
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 1.709602344135419e-07
: O 0 9.947097832918583e-12
possible O 0 2.0205604550627143e-11
preponderance O 0 9.504228515311297e-09
of O 0 4.666406372422216e-09
the O 0 2.797813758448342e-09
two O 0 1.1305245628534522e-09
founder O 0 7.694897874443996e-08
mutations O 0 2.1183929277412972e-08
4612del165 O 0 1.4792793763263035e-06
and O 0 6.377202055318776e-08
7883del5 O 0 2.8830299925175495e-05
. O 0 5.180912694413564e-07

The O 0 8.633504080535204e-07
ATM O 0 0.004004041664302349
( O 0 6.844897626478996e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 9.165720626924667e-09
mutated O 0 1.0031862451853613e-08
) O 0 3.096553291559445e-10
gene O 0 1.0087674029435334e-09
on O 0 8.006981744301811e-09
human O 0 1.1319212234184306e-08
chromosome O 0 1.2667808846344997e-07
11q22 O 0 7.107790224836208e-06
. O 0 1.7921054507041845e-07

3 O 0 3.778191285164212e-06
has O 0 1.0797098326520427e-08
recently O 0 5.067500641331435e-09
been O 0 4.1785036541952536e-10
identified O 0 2.1380905379508874e-10
as O 0 1.1112002290536438e-10
the O 0 3.2827743301488965e-10
gene O 0 1.869644578045282e-10
responsible O 0 3.284828520300209e-10
for O 0 1.364442309137459e-10
the O 0 3.5990137536856537e-09
human O 0 1.7943338548320753e-07
recessive B-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.172864009888144e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.869917009069468e-08
. O 0 1.0769767300189415e-07

In O 0 1.909305780145587e-08
order O 0 4.8449884104684315e-09
to O 0 4.0051442717903285e-10
define O 0 2.5379620627319355e-09
the O 0 2.974804014233001e-10
types O 0 9.139029089055839e-09
of O 0 1.0064616695615314e-08
disease O 0 9.659653733251616e-05
- O 0 8.042009540076833e-06
causing O 0 1.857541633398796e-06
ATM O 0 3.6683661164715886e-05
mutations O 0 1.8336964169307635e-09
in O 0 1.3163251044723268e-10
Japanese O 0 6.181886647027568e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.187279912746476e-09
as O 0 3.4140121285552993e-11
well O 0 3.988386357289819e-11
as O 0 2.2936206753310096e-11
to O 0 4.582888235571403e-11
look O 0 2.2931886944910218e-10
for O 0 2.2778355590613586e-10
possible O 0 5.455103035956199e-09
mutational O 0 1.5454311323992442e-06
hotspots O 0 1.4546392890224524e-07
, O 0 1.639844482426156e-09
reverse O 0 8.565042008967794e-09
- O 0 1.7422665976596363e-08
transcribed O 0 4.244728568636447e-09
RNA O 0 5.707354588935232e-09
derived O 0 1.1010376638198593e-10
from O 0 2.469709506347506e-11
ten O 0 1.8027112025365e-09
patients O 0 5.29671966009726e-11
belonging O 0 2.402153823077846e-11
to O 0 1.996846021867782e-10
eight O 0 2.074650451433513e-09
unrelated O 0 1.261743065583687e-08
Japanese O 0 2.0750817952830403e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 3.694056449621286e-10
was O 0 8.362783798787632e-10
analyzed O 0 9.230275987981429e-10
for O 0 2.6965690791413977e-10
mutations O 0 3.257134284506691e-10
by O 0 4.5299281686839166e-11
the O 0 3.409005300269996e-09
restriction O 0 1.5067566749848993e-08
endonuclease O 0 2.533722067710187e-07
fingerprinting O 0 1.270544771614368e-07
method O 0 4.261393371507438e-08
. O 0 5.016610771235719e-08

As O 0 1.2006273664155742e-07
has O 0 2.3117754377466326e-09
been O 0 2.0552640145332646e-10
reported O 0 5.951253378988497e-11
by O 0 2.473504387423553e-11
others O 0 3.498376310862028e-10
, O 0 4.2017286872031434e-10
mutations O 0 4.882278470397239e-10
that O 0 1.244651465226454e-10
lead O 0 8.647280225204668e-09
to O 0 9.596234917808033e-09
exon O 0 3.5963919344794704e-06
skipping O 0 1.8756131794361863e-06
or O 0 2.3209926425238336e-08
premature O 0 1.899650570180711e-08
protein O 0 2.176272939635737e-09
truncation O 0 3.534652393000215e-08
were O 0 5.618417397990072e-10
also O 0 1.080271649911424e-09
predominant O 0 5.918322187881131e-08
in O 0 2.128066611817303e-09
our O 0 3.213577670635459e-08
mutants O 0 1.1314100589743248e-07
. O 0 8.722073374656247e-08

Six O 0 7.161005299849421e-08
different O 0 3.0228378133934086e-10
mutations O 0 6.270954311382582e-10
were O 0 6.397025964499647e-11
identified O 0 6.717490452778918e-11
on O 0 7.433362259057219e-10
12 O 0 2.3768480517105672e-09
of O 0 2.9982687443919076e-09
the O 0 1.046684250383123e-08
16 O 0 1.299924576869671e-07
alleles O 0 2.5059083696987727e-08
examined O 0 4.543251748145849e-07
. O 0 3.0344293122652743e-07

Four O 0 1.2309011765410105e-07
were O 0 6.421469578299366e-09
deletions O 0 4.7840721606462466e-08
involving O 0 2.0822790602892383e-08
a O 0 2.1991812815258527e-09
loss O 0 5.139966674505558e-08
of O 0 5.707270389621044e-08
a O 0 7.468539564570165e-09
single O 0 8.08339883917597e-09
exon O 0 1.917214262903144e-07
exon O 0 2.113280288540409e-07
7 O 0 1.254434351949385e-07
, O 0 4.063301695111932e-09
exon O 0 1.3413588817456912e-07
16 O 0 6.820032183441072e-08
, O 0 6.504578653476756e-09
exon O 0 5.839461323375872e-07
33 O 0 2.854405067864718e-07
or O 0 1.331802224058265e-08
exon O 0 1.3692769016415696e-06
35 O 0 9.348763114758185e-07
. O 0 2.515318726636906e-07

The O 0 8.488348157698056e-08
others O 0 2.193404569084123e-09
were O 0 8.716959376542377e-10
minute O 0 5.307984096702967e-08
deletions O 0 5.22138741132494e-08
, O 0 5.319961360328307e-09
4649delA O 0 3.6625704069592757e-07
in O 0 4.0046725935383165e-09
exon O 0 4.208141319850256e-07
33 O 0 1.4314235841084155e-07
and O 0 1.0426036034516528e-08
7883del5 O 0 1.822517219807196e-06
in O 0 1.5763772509558294e-08
exon O 0 5.344471901480574e-06
55 O 0 1.4313241081254091e-06
. O 0 4.050945960898389e-07

The O 0 1.2489948630900471e-06
mutations O 0 3.6388772883810816e-08
4612del165 O 0 4.575471450607438e-07
and O 0 4.2783958598136e-09
7883del5 O 0 2.6488584126127535e-07
were O 0 2.9276953084078627e-10
found O 0 3.132581000153678e-11
in O 0 1.3848160465568249e-11
more O 0 6.8208520428991726e-12
than O 0 1.1069499483706835e-11
two O 0 2.3048517955315262e-11
unrelated O 0 4.0350253693866023e-10
families O 0 1.0825017097981782e-12
; O 0 6.564129882008496e-12
44 O 0 5.834323579811951e-10
% O 0 3.887889316045445e-11
( O 0 1.4417343187356213e-11
7 O 0 1.8443703231341146e-09
of O 0 1.2819345585057818e-09
16 O 0 1.4504405454474067e-09
) O 0 5.426227869809175e-11
of O 0 9.495254582603252e-10
the O 0 2.2726507342696323e-09
mutant O 0 1.532143656390872e-08
alleles O 0 5.344813133745241e-11
had O 0 1.3369676199470604e-10
one O 0 5.52144337195859e-11
of O 0 6.577496880488809e-10
the O 0 4.819440402314967e-09
two O 0 5.5735278614577055e-09
mutations O 0 1.2432580831500673e-07
. O 0 1.3153280065125728e-07

The O 0 7.580802048323676e-07
4612del165 O 0 2.5653007469372824e-06
mutations O 0 2.4167197132385354e-09
in O 0 1.0339603478959347e-10
three O 0 4.124428229501653e-11
different O 0 1.8617143417165583e-12
families O 0 3.229434406525067e-13
were O 0 8.711216643864095e-12
all O 0 3.3349076972166714e-11
ascribed O 0 3.4235163592910567e-09
to O 0 3.6169525707840933e-10
the O 0 3.4453631059250256e-09
same O 0 2.0925940980021096e-09
T O 0 6.811802677475498e-07
- O 0 3.428083346079802e-07
- O 0 2.4227122707998205e-07
> O 0 1.5996691971054133e-08
A O 0 1.0829891650132595e-08
substitution O 0 1.8297975357128848e-09
at O 0 1.9565222775241864e-09
the O 0 2.4269144471844584e-09
splice O 0 4.474880199722975e-08
donor O 0 8.755918212699498e-10
site O 0 2.1834630103967356e-08
in O 0 8.748927804447248e-09
intron O 0 2.3154465452535078e-05
33 O 0 5.933557531534461e-06
. O 0 5.944716008343676e-07

Microsatellite O 0 8.26158793643117e-05
genotyping O 0 3.865605322062038e-06
around O 0 5.2274256034934297e-08
the O 0 5.978749584301113e-08
ATM O 0 0.00020324821525719017
locus O 0 1.4898580502631376e-06
also O 0 4.5574659601754774e-09
indicated O 0 1.1881492456566889e-09
that O 0 4.380285370531034e-11
a O 0 2.092541001585957e-10
common O 0 1.0109246773026825e-09
haplotype O 0 1.2554199457781579e-08
was O 0 5.478386633228638e-09
shared O 0 1.4771020517834188e-10
by O 0 3.039081139522004e-11
the O 0 1.5046106582872198e-09
mutant O 0 2.308735957967656e-08
alleles O 0 1.891131418130243e-10
in O 0 2.2730831106265725e-10
both O 0 8.064334089397107e-09
mutations O 0 5.755962462217212e-08
. O 0 8.699029763192812e-08

This O 0 1.53427563986952e-08
suggests O 0 2.4196809000898156e-09
that O 0 4.830552277623745e-11
these O 0 6.795433660222727e-10
two O 0 6.798181462208674e-10
founder O 0 4.392623864646339e-08
mutations O 0 7.1251573530162204e-09
may O 0 3.612098953276188e-10
be O 0 1.4843433426836583e-10
predominant O 0 1.9257896610724856e-08
among O 0 8.887564018067451e-10
Japanese O 0 4.256925123513611e-08
ATM O 0 1.0911106983257923e-05
mutant O 0 1.195334789372282e-06
alleles O 0 3.0827667529820246e-08
. O 0 4.9232227183892974e-08

W474C O 0 0.00013774997205473483
amino O 0 1.898491888141507e-07
acid O 0 5.284655824056017e-09
substitution O 0 1.931306226055085e-09
affects O 0 7.166478521725139e-10
early O 0 3.249004537630995e-11
processing O 0 9.55385992540414e-10
of O 0 1.5857278823361298e-09
the O 0 2.103972107647678e-09
alpha O 0 1.6265121471903399e-09
- O 0 2.818208777455311e-09
subunit O 0 6.516173156612126e-10
of O 0 1.36093947222804e-09
beta O 0 8.770414616776634e-09
- O 0 1.7694132381507188e-08
hexosaminidase O 0 3.9720706013213203e-07
A O 0 7.832636761406775e-09
and O 0 2.157878598030294e-10
is O 0 7.204974117325236e-11
associated O 0 4.283766674717526e-10
with O 0 4.108987816664467e-09
subacute O 1 0.9997001886367798
G B-Disease 1 0.9250547289848328
( I-Disease 0 1.8833938852935717e-08
M2 I-Disease 1 1.0
) I-Disease 0 1.5297733568786498e-07
gangliosidosis I-Disease 0 0.00011228430230403319
. O 0 5.802639293506218e-07

Mutations O 0 5.696438165614381e-07
in O 0 7.547774849570033e-09
the O 0 8.883233704182203e-08
HEXA O 0 0.00010501156793907285
gene O 0 1.988075926107058e-09
, O 0 3.7233915950452e-10
encoding O 0 4.397087416396772e-10
the O 0 1.1231933161326424e-09
alpha O 0 2.0709738368651642e-09
- O 0 2.122383602198852e-09
subunit O 0 5.736732200389838e-10
of O 0 1.3584861013882232e-09
beta O 0 1.9768616965620822e-08
- O 0 5.621381404807835e-08
hexosaminidase O 0 1.6502550579389208e-06
A O 0 6.904532767748606e-08
( O 0 5.493503429931934e-10
Hex O 0 3.142081595797208e-06
A O 0 1.791113923843568e-08
) O 0 1.3383656682908196e-10
, O 0 1.300423796424255e-10
that O 0 5.967894928238238e-11
abolish O 0 3.166533133480698e-07
Hex O 0 6.286370080488268e-06
A O 0 2.863868431290939e-08
enzyme O 0 5.195532892798838e-10
activity O 0 5.681231041165802e-10
cause O 0 1.312904203132348e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 5.8190341434283255e-09
TSD B-Disease 1 1.0
) O 0 8.60151283532673e-10
, O 0 4.5702858164631266e-10
the O 0 8.733505474367576e-09
fatal O 0 2.623361751830089e-06
infantile B-Disease 0 9.286277418141253e-07
form I-Disease 0 1.1318515014124841e-09
of I-Disease 0 1.010181520655351e-07
G I-Disease 0 0.0004581333778332919
( I-Disease 0 9.105791121122309e-10
M2 I-Disease 1 0.9999998807907104
) I-Disease 0 2.974578583447851e-09
gangliosidosis I-Disease 0 1.0572441624390194e-06
, I-Disease 0 1.7229041526789501e-09
Type I-Disease 0 1.5912723938527051e-07
1 I-Disease 0 4.4165756207803497e-07
. O 0 1.242956955138652e-07

Less O 0 8.628121577203274e-07
severe O 1 0.5387343764305115
, O 0 8.922237526576282e-08
subacute O 1 0.9999632835388184
( O 0 5.583838724732004e-09
juvenile O 1 0.9999996423721313
- O 0 0.0015405025333166122
onset O 0 1.361726208415348e-05
) O 0 1.201609256540337e-09
and O 0 1.6656436230277905e-08
chronic O 1 1.0
( O 0 2.5709563367115607e-09
adult O 0 1.9660194539028453e-06
- O 0 4.057707428728463e-06
onset O 0 2.434900636671955e-07
) O 0 1.4614366661280798e-10
variants O 0 3.837251405514053e-09
are O 0 2.1065158298250175e-11
characterized O 0 4.9524207651474583e-11
by O 0 8.127679085312423e-12
a O 0 1.6589649098897041e-10
broad O 0 7.396947054871816e-09
spectrum O 0 1.0619632284658564e-08
of O 0 2.011234734311529e-09
clinical O 0 3.085143163161774e-08
manifestations O 0 9.168185322039335e-09
and O 0 1.4771696366100429e-10
are O 0 4.5698193493204364e-12
associated O 0 2.167182752699226e-11
with O 0 5.4327105314389e-11
residual O 0 8.10426445241319e-06
levels O 0 8.876899215692902e-08
of O 0 7.04525291439495e-08
Hex O 0 0.0001209295223816298
A O 0 3.3757046935534163e-07
enzyme O 0 1.1419767353970656e-08
activity O 0 1.2861477216574713e-08
. O 0 2.776174845564583e-08

We O 0 1.925232027133461e-07
identified O 0 2.508653373922698e-08
a O 0 6.655122675169878e-09
1422 O 0 9.14175107027404e-05
G O 0 6.842769653303549e-05
- O 0 1.6466266970383003e-05
- O 0 6.52493690722622e-06
> O 0 1.8172049465192686e-07
C O 0 7.411375690935529e-07
( O 0 5.238609546154294e-10
amino O 0 2.6451452139752973e-09
acid O 0 1.5631517191749822e-09
W474C O 0 1.0011600437564994e-08
) O 0 4.5304784229704964e-12
substitution O 0 6.779429101433365e-11
in O 0 1.3426987820197578e-11
the O 0 1.9376590609798683e-10
first O 0 1.3442190416323996e-10
position O 0 6.024004073346134e-10
of O 0 1.8065146045742608e-09
exon O 0 4.0030023740200704e-08
13 O 0 1.1172369696055284e-08
of O 0 2.7846120076446823e-08
HEXA O 1 0.9969168901443481
of O 0 9.176114446063366e-08
a O 0 3.2769329472159825e-09
non O 0 1.0392228944056114e-07
- O 0 7.032874549395274e-08
Jewish O 0 3.041329676989335e-08
proband O 0 4.539026576821925e-06
who O 0 4.402787912027861e-09
manifested O 0 4.0714027704780165e-08
a O 0 3.75178021982947e-09
subacute O 0 9.572650014888495e-06
variant O 0 5.600886083811929e-07
of O 0 3.056787136301864e-06
G B-Disease 1 0.9942692518234253
( I-Disease 0 6.615522352149128e-09
M2 I-Disease 1 1.0
) I-Disease 0 4.999502678515455e-08
gangliosidosis I-Disease 0 4.3654032197082415e-05
. O 0 3.415770208903268e-07

On O 0 2.9091185638208117e-07
the O 0 3.7234944016972804e-08
second O 0 4.135809916760991e-08
maternally O 0 5.173486670173588e-07
inherited O 0 5.8456572560317e-07
allele O 0 8.907644399869241e-09
, O 0 4.227146133128912e-10
we O 0 2.3037453888985482e-10
identified O 0 4.469749015356683e-10
the O 0 1.2911021141093215e-09
common O 0 1.5309875323055167e-07
infantile O 1 0.9998897314071655
disease O 1 1.0
- O 0 0.10054098814725876
causing O 0 2.177629357902333e-05
4 O 0 1.1386335927454638e-06
- O 0 1.6692081317160046e-07
bp O 0 2.6700707422833148e-08
insertion O 0 1.743064359516211e-08
, O 0 2.2306667624150123e-09
+ O 0 3.4486124178556565e-08
TATC O 0 0.0024144998751580715
1278 O 0 0.00011383588571334258
, O 0 1.859982390328696e-08
in O 0 1.579576647259273e-08
exon O 0 4.108969278604491e-06
11 O 0 5.214719180912653e-07
. O 0 2.4540796061955916e-07

Pulse O 0 8.298912871396169e-05
- O 0 1.7563705796419526e-06
chase O 0 8.418196273396461e-08
analysis O 0 9.254003674463718e-10
using O 0 2.985161451363183e-09
proband O 0 2.551179932197556e-06
fibroblasts O 0 5.566728411565691e-09
revealed O 0 5.417154280706882e-09
that O 0 1.7407236763133938e-10
the O 0 3.847460128270086e-09
W474C O 0 2.2049623282782704e-07
- O 0 2.3254770553648996e-08
containing O 0 3.868748876811878e-09
alpha O 0 5.041691952811789e-09
- O 0 3.85781406819774e-09
subunit O 0 1.0492943181006353e-09
precursor O 0 6.341876801485569e-09
was O 0 2.013038402637335e-09
normally O 0 1.4326587138846492e-10
synthesized O 0 6.825922049813471e-10
, O 0 7.071009749948232e-11
but O 0 5.6157471034490314e-11
not O 0 5.0301703774513484e-11
phosphorylated O 0 4.3767318658183285e-09
or O 0 2.8095448190157413e-10
secreted O 0 3.405357940078346e-10
, O 0 1.762079510081449e-10
and O 0 6.535976759813877e-10
the O 0 1.5238551753782303e-08
mature O 0 1.9252797756053042e-07
lysosomal O 0 4.576841945436172e-07
alpha O 0 2.823827749409702e-08
- O 0 3.563938122397303e-08
subunit O 0 1.0873834277447259e-08
was O 0 1.7480751068887912e-08
not O 0 2.080174033025628e-09
detected O 0 1.243738410039441e-07
. O 0 1.0631249836023926e-07

When O 0 1.5712734580120014e-07
the O 0 3.0234058812084186e-08
W474C O 0 6.914376058375638e-07
- O 0 2.6057971780346634e-08
containing O 0 4.448954982194664e-09
alpha O 0 3.2234594993241217e-09
- O 0 3.726363217992912e-09
subunit O 0 3.985280105922584e-09
was O 0 1.3630054418456439e-08
transiently O 0 1.4643371848421793e-08
co O 0 5.380762058138089e-09
- O 0 5.926972690417642e-09
expressed O 0 2.389802522539952e-10
with O 0 5.58318322130269e-11
the O 0 8.221439640188066e-10
beta O 0 2.883049354807099e-09
- O 0 2.3009052441125277e-09
subunit O 0 3.133861503634705e-10
to O 0 1.362099599777622e-10
produce O 0 3.3391374110181005e-09
Hex O 0 2.474384928063955e-05
A O 0 2.3127627457597555e-07
( O 0 1.0947079909229274e-09
alphabeta O 0 3.12642299604704e-07
) O 0 6.255734819049508e-10
in O 0 7.41376571244956e-10
COS O 0 1.610090293979738e-05
- O 0 2.0962103164379187e-08
7 O 0 4.081990745419262e-09
cells O 0 2.5456825883396483e-11
, O 0 5.2691302709906296e-11
the O 0 3.32117916501673e-10
mature O 0 1.5461047997433752e-09
alpha O 0 5.171152950289581e-10
- O 0 6.375469041586257e-10
subunit O 0 1.706163127446203e-10
was O 0 5.338682274036444e-10
present O 0 9.259896321944794e-11
, O 0 6.129249885411525e-11
but O 0 2.4218578531520762e-11
its O 0 8.234225801206918e-11
level O 0 2.136611776393238e-09
was O 0 2.7648647815681215e-09
much O 0 6.54595821991677e-10
lower O 0 2.245980512682877e-09
than O 0 1.2155362827392935e-10
that O 0 4.520830584886504e-11
from O 0 3.014673233270315e-10
normal O 0 5.172731132319086e-10
alpha O 0 1.2223722034576667e-09
- O 0 4.735427161506323e-09
subunit O 0 2.8188325007505455e-09
transfections O 0 3.643440891210048e-07
, O 0 2.9502919551838147e-10
although O 0 6.35870661680471e-11
higher O 0 1.7423779086200852e-10
than O 0 8.638101518798624e-12
in O 0 2.4652996657992254e-11
those O 0 2.0833575142820138e-10
cells O 0 4.3572367935951206e-11
transfected O 0 2.3882362754079622e-09
with O 0 5.667926544772328e-11
an O 0 1.5832549160599285e-10
alpha O 0 5.1966053682406255e-09
- O 0 1.3520064179317615e-08
subunit O 0 6.405370900353091e-09
associated O 0 8.123646644264682e-09
with O 0 5.361423305316748e-08
infantile O 0 0.16692659258842468
TSD B-Disease 1 0.9999998807907104
. O 0 9.614079772291007e-07

Furthermore O 0 2.9920894917268015e-07
, O 0 6.1060356770781254e-09
the O 0 2.1225616819720017e-09
precursor O 0 8.135772944228847e-09
level O 0 1.0116985471597673e-08
of O 0 1.6764740706776138e-08
the O 0 1.7841582433675285e-08
W474C O 0 4.6779803142271703e-07
alpha O 0 9.633756903326685e-09
- O 0 8.472670565140561e-09
subunit O 0 1.489627865502996e-09
was O 0 2.309060720406819e-09
found O 0 8.114547922488669e-11
to O 0 1.1834531965515538e-10
accumulate O 0 1.5241653494868501e-09
in O 0 9.715084292594156e-11
comparison O 0 9.897618280518827e-10
to O 0 4.244014306653554e-10
the O 0 2.6150617227216344e-09
normal O 0 3.1462665806003542e-09
alpha O 0 1.5151227827914227e-08
- O 0 5.2320139332096005e-08
subunit O 0 3.005261106636681e-08
precursor O 0 2.0767031116974977e-07
levels O 0 1.2372730395782128e-07
. O 0 5.706965922058771e-08

We O 0 7.346851305101154e-08
conclude O 0 1.4096555034370795e-08
that O 0 1.916930086887092e-10
the O 0 1.0234387559648894e-08
1422 O 0 5.920503826928325e-05
G O 0 4.1999526729341596e-05
- O 0 5.3824251153855585e-06
- O 0 1.7459345826864592e-06
> O 0 5.131306934913482e-08
C O 0 1.895257497608327e-07
mutation O 0 4.0465319983695736e-10
is O 0 2.937387486023901e-11
the O 0 8.451470079329226e-11
cause O 0 1.0111541604018726e-09
of O 0 7.931090451052114e-09
Hex B-Disease 1 0.9999994039535522
A I-Disease 0 2.56965995504288e-05
enzyme I-Disease 1 0.9999949932098389
deficiency I-Disease 1 1.0
in O 0 4.510585682737656e-09
the O 0 8.219848268709029e-08
proband O 0 3.883925819536671e-05
. O 0 3.8012677805454587e-07

The O 0 4.6576408863074903e-07
resulting O 0 1.1382770281898047e-07
W474C O 0 2.012568984355312e-06
substitution O 0 4.867870373459482e-08
clearly O 0 2.2266466004339236e-08
interferes O 0 2.2168114455212162e-08
with O 0 6.618547931935836e-10
alpha O 0 7.813954816526802e-09
- O 0 2.8702651366785403e-09
subunit O 0 2.725520642510304e-10
processing O 0 5.292066784789995e-10
, O 0 4.3670875943258025e-11
but O 0 1.916841338434061e-11
because O 0 5.8150560755532155e-11
the O 0 1.2151653294711906e-10
base O 0 1.186260645269499e-09
substitution O 0 4.891125726658174e-09
falls O 0 2.086326134076444e-08
at O 0 1.376472269498663e-09
the O 0 1.3502069462489885e-09
first O 0 1.1527783172482486e-09
position O 0 8.308365551101815e-09
of O 0 2.7933628743426198e-08
exon O 0 7.072596872603754e-07
13 O 0 1.3659520448072726e-07
, O 0 6.280306052985907e-09
aberrant O 0 2.0988668580912417e-08
splicing O 0 1.3296777900961843e-08
may O 0 3.0472085965627116e-10
also O 0 1.598215865206143e-10
contribute O 0 1.0634059188774359e-09
to O 0 3.401458448237804e-09
Hex B-Disease 1 0.9999946355819702
A I-Disease 0 1.112851532525383e-05
deficiency I-Disease 0 2.229793153674109e-06
in O 0 1.399533378076967e-09
this O 0 1.4920591429046226e-09
proband O 0 3.355584340170026e-06
. O 0 2.1618932422029502e-08
. O 0 2.0293236957513727e-07

Two O 0 3.447659651101276e-07
frequent O 0 7.332963605222176e-07
missense O 0 8.521345080225728e-06
mutations O 0 8.944990668169339e-07
in O 0 2.7801019086837186e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.085829004907282e-06

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 3.220450537355646e-07
an O 0 9.315246529695287e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.1611516015364032e-07
by O 0 1.260844345596368e-10
early O 0 7.577503957634235e-09
childhood O 1 0.9999961853027344
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 0 7.205631845863536e-05

A O 0 5.87510555760673e-07
century O 0 6.180085776463784e-09
after O 0 3.236524659389062e-10
its O 0 8.268850881787415e-11
recognition O 0 8.199250167706396e-10
as O 0 1.1244022379841567e-09
a O 0 8.255526928735435e-09
syndrome O 0 1.2394406212479225e-06
by O 0 3.55855483968881e-10
Vaughan O 0 7.054139814499649e-07
Pendred O 1 0.9951205849647522
, O 0 2.9216664643172408e-09
the O 0 6.978859712347685e-09
disease O 0 1.5193447325145826e-05
gene O 0 3.6322344243444604e-08
( O 0 5.880556930293324e-09
PDS O 1 1.0
) O 0 5.891087173637288e-09
was O 0 5.589819451756739e-08
mapped O 0 1.2165074281256238e-07
to O 0 1.9596342326622107e-08
chromosome O 0 1.0824088576555368e-06
7q22 O 0 2.2702251953887753e-05
- O 0 1.4167429071676452e-05
q31 O 0 6.128320092102513e-05
. O 0 5.145469685885473e-07

1 O 0 9.814345958147896e-07
and O 0 2.0740067441238352e-08
, O 0 5.027202210072801e-09
recently O 0 7.938793622486173e-09
, O 0 5.822917148456952e-10
found O 0 1.428415996596044e-10
to O 0 3.4599412224167736e-10
encode O 0 4.936252295806298e-09
a O 0 9.188036997898053e-09
putative O 0 1.0881914249694091e-06
sulfate O 0 7.130067274374596e-07
transporter O 0 8.001433343451936e-06
. O 0 5.473103783515398e-07

We O 0 5.1211678453455534e-08
performed O 0 4.5701837869671635e-09
mutation O 0 1.7146649378130263e-10
analysis O 0 9.09103556323565e-11
of O 0 1.3817095245727273e-09
the O 0 1.5816569387538948e-08
PDS B-Disease 1 0.9999992847442627
gene O 0 3.0274438511668222e-09
in O 0 2.287300210346288e-10
patients O 0 2.1357836332835944e-10
from O 0 8.268992435223055e-11
14 O 0 3.330887121677506e-09
Pendred B-Disease 0 2.392640112702793e-07
families O 0 5.934372784843767e-12
originating O 0 1.7974391072761442e-11
from O 0 3.067881018670171e-11
seven O 0 4.1852181442703085e-11
countries O 0 1.117439907966089e-11
and O 0 3.96194216323309e-10
identified O 0 1.409471983571109e-09
all O 0 5.78738879042362e-09
mutations O 0 1.1010223488483462e-07
. O 0 1.1386385523337594e-07

The O 0 2.453602121477161e-07
mutations O 0 1.2414211880695802e-08
include O 0 3.3587534975509925e-09
three O 0 4.5661904812810405e-10
single O 0 2.1333121380529008e-10
base O 0 7.3983859039117306e-09
deletions O 0 4.144187926158338e-08
, O 0 7.07679204126066e-09
one O 0 4.203357661936025e-09
splice O 0 2.7768271593231475e-07
site O 0 3.988658647813281e-08
mutation O 0 3.5447438317959268e-09
and O 0 4.845857493052108e-09
10 O 0 1.4152232097330852e-07
missense O 0 3.437886107349186e-06
mutations O 0 6.815435540374892e-07
. O 0 1.8788234967814788e-07

One O 0 2.409523858659668e-06
missense O 0 5.892769422644051e-06
mutation O 0 1.267846840846687e-07
( O 0 2.489262573845963e-09
L236P O 0 9.804102774069179e-07
) O 0 9.371341480601814e-10
was O 0 3.933812386947011e-09
found O 0 1.6191475937787914e-10
in O 0 1.0573641268107892e-10
a O 0 3.7709046996070583e-10
homozygous O 0 1.2393125414789097e-09
state O 0 1.7343210201303805e-10
in O 0 1.347057743128488e-10
two O 0 1.4806052217597454e-10
consanguineous O 0 1.8927858391748487e-08
families O 0 6.317600956262659e-12
and O 0 3.2446507286509885e-11
in O 0 5.5538053322923275e-11
a O 0 6.101666394364713e-10
heterozygous O 0 1.294435669763061e-09
state O 0 1.3487391758992828e-10
in O 0 7.497819726198784e-11
five O 0 8.771660481299293e-11
additional O 0 1.1070649952316103e-09
non O 0 1.162263885134962e-07
- O 0 6.252030857467616e-07
consanguineous O 0 2.414347591184196e-06
families O 0 1.6552487158705276e-09
. O 0 2.6709367162425224e-08

Another O 0 5.4822535275889095e-06
missense O 0 8.86168891156558e-06
mutation O 0 1.2987275965770095e-07
( O 0 3.1660720711812473e-09
T416P O 0 5.530984594770416e-07
) O 0 4.700294597981269e-10
was O 0 1.6037438044236296e-09
found O 0 5.53862511409875e-11
in O 0 7.132778395702033e-11
a O 0 2.9685406910395784e-10
homozygous O 0 1.4053862518181859e-09
state O 0 2.3156752904096578e-10
in O 0 6.903654037326845e-11
one O 0 1.279967104528268e-10
family O 0 2.2236429711441907e-11
and O 0 5.838439454119992e-11
in O 0 7.495932347056922e-11
a O 0 4.968886968548247e-10
heterozygous O 0 1.4111801727167972e-09
state O 0 2.5393842584264803e-10
in O 0 2.9252561484227613e-10
four O 0 1.0477543277431778e-09
families O 0 8.642588728013934e-11
. O 0 9.409029999574159e-09

Pendred B-Disease 0 0.0035962648689746857
patients O 0 9.15208033802628e-08
in O 0 1.2616412359278684e-09
three O 0 1.3527460263063062e-09
non O 0 6.73528148809055e-08
- O 0 2.6721799883944186e-08
consanguineous O 0 6.952569719942403e-08
families O 0 1.726721716999169e-11
were O 0 2.8215459482727745e-11
shown O 0 3.6797578872871384e-11
to O 0 1.1085414530764837e-10
be O 0 2.8309324329178764e-10
compound O 0 2.5191722041739695e-09
heterozygotes O 0 4.435679912262458e-08
for O 0 9.136588374758503e-09
L236P O 0 6.041066171746934e-06
and O 0 1.3214739169598033e-07
T416P O 0 5.067747042630799e-05
. O 0 7.73008423493593e-07

In O 0 8.339484658392848e-09
total O 0 3.0082243362983263e-09
, O 0 2.3462631837389836e-10
one O 0 5.06780485631797e-11
or O 0 4.989369334351679e-11
both O 0 3.357085096022949e-11
of O 0 4.579500390011759e-10
these O 0 9.259808197992214e-11
mutations O 0 2.434065102252525e-11
were O 0 1.4152569741132659e-11
found O 0 9.583727908490935e-12
in O 0 1.611945646406987e-11
nine O 0 6.117887862977511e-10
of O 0 1.4872800768728212e-09
the O 0 3.1043609904912728e-09
14 O 0 9.242700826916916e-09
families O 0 1.0152872986779471e-10
analyzed O 0 2.2659687459736233e-08
. O 0 5.41851079560729e-08

The O 0 9.355147767564631e-09
identification O 0 3.753520161353663e-09
of O 0 9.30020949141408e-09
two O 0 7.553834779905344e-10
frequent O 0 4.488873983632402e-08
PDS B-Disease 1 0.9999994039535522
mutations O 0 1.697614671059e-08
will O 0 2.4509866358712884e-10
facilitate O 0 1.7891634840339066e-09
the O 0 1.1466534388659966e-09
molecular O 0 6.998323698326203e-08
diagnosis O 0 6.060023451937013e-07
of O 0 0.06406977772712708
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.081459337612614e-06

Insertional O 0 0.00047435503802262247
mutation O 0 1.1304458524818983e-07
by O 0 9.314264914905834e-10
transposable O 0 1.7617437606531894e-06
element O 0 5.8276562242554064e-08
, O 0 5.473342223893951e-09
L1 O 0 8.547078323317692e-05
, O 0 2.7112792011507736e-09
in O 0 1.5907262174152947e-09
the O 0 6.718192224752784e-08
DMD B-Disease 1 1.0
gene O 0 1.2646052205411706e-08
results O 0 4.940545195175616e-10
in O 0 6.892881265763151e-10
X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999973773956299
dilated I-Disease 0 0.00010576871864032
cardiomyopathy I-Disease 1 1.0
. O 0 8.166276757037849e-07

X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 1.0
dilated I-Disease 1 0.9999927282333374
cardiomyopathy I-Disease 1 1.0
( O 0 1.380346361656848e-07
XLDCM B-Disease 1 1.0
) O 0 7.95100696393547e-09
is O 0 1.4223918709532768e-09
a O 0 7.718586325644594e-10
clinical O 0 1.1803754773609398e-07
phenotype O 0 3.735229459067568e-09
of O 0 7.367054966067599e-09
dystrophinopathy B-Disease 0 3.4066990338033065e-05
which O 0 3.853958263633217e-10
is O 0 1.390167841952561e-10
characterized O 0 3.5039460222208163e-10
by O 0 2.1520667192742593e-10
preferential O 0 8.511416353940149e-07
myocardial B-Disease 0 6.186154223541962e-06
involvement I-Disease 0 3.7769549265931346e-08
without O 0 2.670487164735391e-09
any O 0 1.5028095434743705e-09
overt O 0 4.448515866783964e-08
clinical O 0 3.532678078954632e-07
signs O 0 2.232640326838009e-06
of O 0 0.000138278744998388
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 1.954294930328615e-05

To O 0 9.378337217924582e-09
date O 0 1.0298635721994742e-08
, O 0 3.9816844266127305e-10
several O 0 3.10969305861164e-10
mutations O 0 3.284953975501992e-10
in O 0 2.0468490791181182e-10
the O 0 1.440634633809168e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 2.4901411961764097e-05
, O 0 1.577977748468129e-08
DMD O 1 1.0
, O 0 3.992987718248742e-09
have O 0 1.0511165549065282e-10
been O 0 1.0935659322530711e-10
identified O 0 8.813434704268985e-11
in O 0 3.736479875504628e-11
patients O 0 1.3670943543875325e-10
with O 0 9.266151040909776e-11
XLDCM B-Disease 1 1.0
, O 0 2.9369477960727863e-09
but O 0 2.33922076153803e-10
a O 0 1.4961820671288706e-10
pathogenic O 0 4.850249535337525e-09
correlation O 0 1.5219981941427818e-09
of O 0 3.4923113290119545e-09
these O 0 1.5969886524302979e-09
cardiospecific O 0 2.858427706087241e-06
mutations O 0 7.684099578852965e-09
in O 0 1.472767463539526e-09
DMD O 1 1.0
with O 0 9.224315533629124e-09
the O 0 1.0999119837151738e-07
XLDCM B-Disease 1 1.0
phenotype O 0 1.0301979358473545e-07
has O 0 3.386142699568495e-09
remained O 0 2.686063815815487e-08
to O 0 1.872961341575774e-09
be O 0 5.9748943570525626e-09
elucidated O 0 6.936859790585004e-06
. O 0 4.103085586848465e-07

We O 0 5.5358032824415204e-08
report O 0 7.809108915068919e-10
here O 0 1.2783586689213422e-11
the O 0 7.021457720801649e-11
identification O 0 1.519143699724168e-10
of O 0 1.4036690698659982e-09
a O 0 1.562811768884842e-09
unique O 0 5.473320907611878e-09
de O 0 9.48064280237304e-06
novo O 0 3.181092324666679e-05
L1 O 0 4.157956573180854e-05
insertion O 0 1.2928524029121036e-08
in O 0 3.3088620732257823e-10
the O 0 2.6319197932167526e-09
muscle O 0 1.3184219049833246e-08
exon O 0 5.165736283174738e-08
1 O 0 3.036883811091684e-08
in O 0 3.0518285676350843e-09
DMD O 1 1.0
in O 0 2.7858433337968336e-09
three O 0 3.2921061432489296e-09
XLDCM B-Disease 1 0.9999982118606567
patients O 0 1.253538606249549e-09
from O 0 6.105749933427163e-11
two O 0 2.1463644750419064e-10
unrelated O 0 1.6418638892901072e-08
Japanese O 0 2.7633216603817345e-08
families O 0 3.481840926689017e-10
. O 0 1.7090961534904636e-08

The O 0 2.90346719111767e-07
insertion O 0 8.369509885142179e-08
was O 0 2.1227734237072582e-08
a O 0 6.656769580004607e-10
5 O 0 7.580929661799019e-09
- O 0 2.9403851797837888e-08
truncated O 0 3.208622700867636e-08
form O 0 2.704915402773622e-09
of O 0 1.7487620240785873e-08
human O 0 1.4606411191664392e-08
L1 O 0 6.936092631804058e-06
inversely O 0 3.383291158343127e-08
integrated O 0 4.077540083358144e-09
in O 0 5.2903081221300496e-11
the O 0 2.794655062920981e-10
5 O 0 1.8336020479736703e-09
- O 0 1.8485271979784557e-08
untranslated O 0 4.49916979050613e-06
region O 0 3.536553805361109e-08
in O 0 8.126122552631898e-10
the O 0 3.8558791715104235e-09
muscle O 0 1.2263708271120777e-08
exon O 0 1.9039962495526197e-08
1 O 0 9.85022108324074e-09
, O 0 7.308866012412096e-11
which O 0 6.3616147939760115e-12
affected O 0 3.266981823957238e-11
the O 0 4.3304096419838345e-11
transcription O 0 5.093263588662467e-10
or O 0 5.471833056103215e-11
the O 0 4.450149415635707e-10
stability O 0 1.7774230087752585e-08
of O 0 1.0972337705084101e-08
the O 0 7.979355842735458e-09
muscle O 0 3.754760413698932e-08
form O 0 8.649733151955274e-10
of O 0 1.5743189862860163e-08
dystrophin O 0 5.8666007163310496e-08
transcripts O 0 1.6859842411065529e-09
but O 0 4.6758635158239414e-11
not O 0 8.453336121372335e-12
that O 0 5.841588931326802e-12
of O 0 1.4168249906632013e-09
the O 0 1.9838722664644592e-08
brain O 0 2.7986964141746284e-06
or O 0 2.1182756881898968e-08
Purkinje O 0 0.00015218008775264025
cell O 0 7.736633733657072e-08
form O 0 1.621364265069758e-09
, O 0 4.734792558025447e-10
probably O 0 4.725725366583333e-10
due O 0 9.263804723325109e-10
to O 0 1.8427204206972192e-10
its O 0 4.39666802964922e-10
unique O 0 4.0303871351454745e-10
site O 0 3.6661289559702936e-09
of O 0 1.7960060105792763e-08
integration O 0 4.550840344563767e-07
. O 0 3.927502518763504e-07

We O 0 1.5691918520133186e-07
speculate O 0 2.757182926416135e-08
that O 0 6.264997548521833e-11
this O 0 1.2171132157678954e-11
insertion O 0 7.36023908487482e-10
of O 0 1.371030289298858e-09
an O 0 9.775779075127389e-10
L1 O 0 1.853304092946928e-05
sequence O 0 1.9541726015148697e-09
in O 0 1.5634796790564565e-09
DMD O 1 1.0
is O 0 1.0959907426055793e-09
responsible O 0 2.6173557765574174e-10
for O 0 1.3217133117138236e-11
some O 0 6.71039309188548e-12
of O 0 9.843675180531974e-11
the O 0 5.011094664220117e-11
population O 0 2.8743311984019693e-12
of O 0 8.315143712467332e-11
Japanese O 0 1.4774641066139793e-08
patients O 0 4.913470741385595e-10
with O 0 4.284975985147099e-10
XLDCM B-Disease 1 1.0
. O 0 4.240886752882034e-08
. O 0 2.185313405789202e-07

Severe O 1 0.9779701232910156
early O 0 1.235862612247729e-07
- O 0 0.00037666966090910137
onset O 0 0.0003398893750272691
obesity B-Disease 1 1.0
, O 0 3.8210032471397426e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.1138027957713348e-06
red O 1 0.9798328876495361
hair O 0 7.50996041460894e-05
pigmentation O 1 0.9983483552932739
caused O 0 5.978715762466891e-07
by O 0 1.2797268134079332e-08
POMC O 1 0.9999996423721313
mutations O 0 1.1912090513988005e-07
in O 0 4.803362152472346e-09
humans O 0 3.010447002793626e-08
. O 0 5.34303730148622e-08

Sequential O 0 8.651455232211447e-07
cleavage O 0 6.4314249925701e-08
of O 0 7.753948239042074e-08
the O 0 1.0574055409051653e-08
precursor O 0 1.1578824121727394e-08
protein O 0 1.5907990480457102e-09
pre O 0 1.0040863429594538e-07
- O 0 1.8773490637613577e-06
pro O 0 3.9183825720101595e-05
- O 0 1.0757920790638309e-05
opiomelanocortin O 0 4.416379306348972e-05
( O 0 1.098069102312138e-08
POMC O 0 2.8708896934404038e-05
) O 0 1.6526933155347479e-09
generates O 0 2.8755255954138192e-09
the O 0 3.937618231475426e-09
melanocortin O 0 3.890925199812045e-06
peptides O 0 1.333306975936921e-08
adrenocorticotrophin O 0 1.1642113122434239e-06
( O 0 3.317597530028138e-09
ACTH O 0 2.1146199742361205e-06
) O 0 1.334573229705427e-09
, O 0 1.665954374452383e-09
melanocyte O 0 2.055001459666528e-06
- O 0 1.8209536847280106e-06
stimulating O 0 2.958093091365299e-06
hormones O 0 9.784405818891173e-08
( O 0 8.164340870031594e-10
MSH O 0 0.00012275380140636116
) O 0 2.79814865722372e-10
alpha O 0 1.7069387014956305e-09
, O 0 1.0318483567584025e-10
beta O 0 2.1564725560807574e-09
and O 0 2.3820390104845046e-10
gamma O 0 6.756792902962161e-09
as O 0 1.0891341994945236e-10
well O 0 1.1288498608097441e-10
as O 0 1.0842840514335705e-10
the O 0 4.849183277144675e-10
opioid O 0 7.602276497209459e-08
- O 0 3.9308218902078806e-08
receptor O 0 3.6135063830045056e-09
ligand O 0 2.1070412969947938e-08
beta O 0 1.8860475847759517e-07
- O 0 9.829783493842115e-07
endorphin O 0 3.088326411671005e-05
. O 0 2.2812514544057194e-07

While O 0 6.25939264864428e-08
a O 0 1.0952572182532094e-09
few O 0 6.125746021545808e-10
cases O 0 5.332067565255727e-10
of O 0 1.386234682598797e-08
isolated O 1 0.5365489721298218
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
have O 0 5.304678918349737e-10
been O 0 8.9577995021628e-10
reported O 0 2.291808298693354e-09
( O 0 3.614926358253001e-09
OMIM O 1 0.9999974966049194
201400 O 0 9.690846127341501e-06
) O 0 1.1583478620735832e-09
, O 0 1.292338902558754e-09
an O 0 5.290959670389839e-09
inherited O 1 1.0
POMC O 1 1.0
defect O 1 0.8599791526794434
has O 0 9.48378442444664e-09
not O 0 5.378441025882807e-10
been O 0 7.807828272810013e-10
described O 0 8.187513445001571e-10
so O 0 1.45354794867103e-09
far O 0 1.800416704611507e-08
. O 0 9.108057241746792e-08

Recent O 0 3.828904766578489e-07
studies O 0 1.55257424694355e-08
in O 0 4.4227499440552265e-10
animal O 0 4.734705072451106e-09
models O 0 2.210169158800568e-09
elucidated O 0 3.16382831044848e-08
a O 0 9.595237104864651e-11
central O 0 2.7770048482977927e-09
role O 0 4.73620431762356e-09
of O 0 9.391118105384066e-09
alpha O 0 2.5495102917716395e-08
- O 0 6.963743430787872e-07
MSH O 1 0.9998399019241333
in O 0 1.1807527178220312e-09
the O 0 2.2621977624481815e-09
regulation O 0 1.2155466855290342e-08
of O 0 1.8242010124680519e-09
food O 0 2.692190637088032e-10
intake O 0 9.076533968865874e-11
by O 0 1.2304546487609813e-12
activation O 0 1.1617198314439747e-09
of O 0 1.3656961783681254e-08
the O 0 1.2103394908535847e-07
brain O 0 4.1251277593801206e-07
melanocortin O 0 6.8529775489878375e-06
- O 0 2.1514291859148216e-07
4 O 0 5.408711700738422e-08
- O 0 2.4158362421644597e-08
receptor O 0 2.9908322485283634e-09
( O 0 3.966902639707115e-10
MC4 O 0 0.0003165283123962581
- O 0 3.0313054821817786e-07
R O 0 1.6476636233164754e-07
; O 0 9.266787337480764e-11
refs O 0 7.907903665227423e-09
3 O 0 9.4378005410789e-10
- O 0 6.359764936902934e-10
5 O 0 2.9301422399541366e-10
) O 0 1.7948970434944478e-11
and O 0 8.103319404373366e-11
the O 0 5.409572789716321e-10
linkage O 0 3.262416115035194e-08
of O 0 2.9396222345212664e-08
human O 0 2.7820588499594123e-08
obesity B-Disease 1 1.0
to O 0 9.219948138294853e-10
chromosome O 0 1.6851483541913126e-09
2 O 0 1.7339281122019656e-09
in O 0 1.071469857283347e-10
close O 0 1.0560384788860233e-09
proximity O 0 4.501869987905138e-09
to O 0 6.184810996678891e-10
the O 0 1.3216320482456467e-08
POMC O 0 2.2375630578608252e-05
locus O 0 2.0393969180076965e-07
, O 0 1.4186908314783864e-09
led O 0 1.0592601240588806e-09
to O 0 1.056974924251719e-10
the O 0 5.518518975122788e-10
proposal O 0 6.136540164902726e-10
of O 0 1.5648490281350291e-09
an O 0 1.8501830623129933e-10
association O 0 6.603744218125485e-10
of O 0 6.832975429915678e-08
POMC O 1 0.9999996423721313
with O 0 7.288412717798565e-08
human O 0 6.1495316003856715e-06
obesity B-Disease 1 1.0
. O 0 7.933647907520935e-07

The O 0 1.2483073419389257e-07
dual O 0 3.1302297998081485e-07
role O 0 5.94675810816625e-08
of O 0 1.1456903337148105e-07
alpha O 0 1.0634691989253042e-06
- O 0 4.9687278078636155e-05
MSH O 1 1.0
in O 0 7.45081152331295e-09
regulating O 0 6.852421279290866e-07
food O 0 3.3546687649987916e-09
intake O 0 1.8466900231217664e-09
and O 0 2.5429416905531355e-10
influencing O 0 6.496063775784933e-08
hair O 0 4.2554765400382166e-07
pigmentation O 0 9.197618965117726e-06
predicts O 0 2.276356703134752e-08
that O 0 1.1536707006376545e-10
the O 0 5.237930089663223e-10
phenotype O 0 4.407944842466094e-10
associated O 0 1.5871250147458937e-10
with O 0 3.125772418677286e-10
a O 0 3.425155714609218e-09
defect O 0 1.8163299841944536e-07
in O 0 5.521427759447306e-09
POMC O 1 0.999971866607666
function O 0 9.854580262924628e-09
would O 0 3.73599012837289e-10
include O 0 3.4517583458182344e-08
obesity B-Disease 1 1.0
, O 0 6.483818371094685e-09
alteration O 0 2.3201367582714738e-07
in O 0 3.781710944394945e-09
pigmentation O 1 0.9999945163726807
and O 0 2.188793041568715e-05
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999294281005859
. O 0 6.832518124610942e-07

The O 0 9.7810662680331e-08
observation O 0 1.2525967463261622e-07
of O 0 2.4319712466081e-08
these O 0 5.8679634484803955e-09
symptoms O 0 6.628957862631069e-07
in O 0 9.167551162647669e-10
two O 0 4.226277106056386e-09
probands O 0 5.167261861060979e-06
prompted O 0 1.5876050696306265e-08
us O 0 3.109242030507886e-10
to O 0 4.774431960896663e-10
search O 0 8.575499199636738e-10
for O 0 6.38709252154257e-10
mutations O 0 9.432945979881424e-09
within O 0 6.6187788583249585e-09
their O 0 1.4709828022319016e-08
POMC O 0 0.00025031730183400214
genes O 0 2.3010497329778445e-07
. O 0 1.1661987997513279e-07

Patient O 0 1.1764800547098275e-05
1 O 0 3.353449358201033e-07
was O 0 1.2546299998916766e-08
found O 0 2.2492077644820085e-10
to O 0 1.2110375202656343e-10
be O 0 1.372217200978909e-10
a O 0 1.8378694399689977e-10
compound O 0 7.126798595713524e-10
heterozygote O 0 9.49649070491887e-09
for O 0 1.6653783907472075e-10
two O 0 3.725600938864204e-10
mutations O 0 2.5070101550284107e-10
in O 0 3.4630312506500616e-10
exon O 0 1.0603262978747807e-07
3 O 0 7.86481137993178e-08
( O 0 9.038462200905428e-10
G7013T O 0 1.3291145251059788e-06
, O 0 1.758263201701027e-09
C7133delta O 0 1.3133040965840337e-06
) O 0 2.6383065176993625e-10
which O 0 4.169306913603954e-11
interfere O 0 5.865319341324948e-10
with O 0 3.0857743443801766e-11
appropriate O 0 6.294333387835138e-10
synthesis O 0 1.2180991770804894e-09
of O 0 1.0638934178075488e-08
ACTH O 0 9.524803317617625e-06
and O 0 3.4048483144033526e-08
alpha O 0 3.59318300979794e-06
- O 0 0.00011047477164538577
MSH O 1 1.0
. O 0 1.4438135167438304e-06

Patient O 0 4.106955657334765e-06
2 O 0 2.39031152204916e-07
was O 0 5.3720075499086306e-08
homozygous O 0 3.095576417422308e-08
for O 0 9.443201776093701e-10
a O 0 1.1867812288457458e-09
mutation O 0 1.0514459303223589e-09
in O 0 4.826760102716321e-10
exon O 0 1.1271473709939528e-07
2 O 0 1.8287663294813683e-07
( O 0 3.079350996415542e-09
C3804A O 0 1.4559759620169643e-06
) O 0 1.9242061277680023e-09
which O 0 3.5487486282903546e-09
abolishes O 0 8.022147994779516e-06
POMC O 0 0.00016714594676159322
translation O 0 3.07470770621876e-07
. O 0 2.5042248807949363e-07

These O 0 2.740750737473263e-08
findings O 0 5.143200088042477e-09
represent O 0 3.1434518876771733e-10
the O 0 2.858637215830129e-10
first O 0 8.221498482008371e-11
examples O 0 1.0630611946282897e-09
of O 0 7.0644516902973464e-09
a O 0 1.6749496012380405e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 8.81120865159346e-09
the O 0 1.4993689845255176e-08
POMC O 0 4.017785977339372e-05
gene O 0 8.947212415399974e-10
and O 0 5.452250317894425e-10
define O 0 2.134517895768795e-09
a O 0 2.5729809949304183e-10
new O 0 7.2840178333422045e-09
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9995900988578796
resulting O 0 5.138493186507276e-09
in O 0 4.341955267550546e-11
early O 0 1.3067248394449393e-09
- O 0 8.553280963496945e-07
onset O 0 2.1283623937051743e-05
obesity B-Disease 1 1.0
, O 0 9.677795276274992e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 9.795990081329364e-07
red O 0 0.0001646232994971797
hair O 0 4.438982614374254e-06
pigmentation O 0 0.00023959821555763483
. O 0 5.1185995886271485e-08
. O 0 2.1568278896211268e-07

A O 0 4.678382538259029e-06
European O 0 8.82589404227474e-07
multicenter O 0 2.5564464522176422e-05
study O 0 5.286987558861256e-08
of O 0 1.104102807403251e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.113292373375543e-09
classification O 0 1.9638324744164493e-08
of O 0 2.9051253847001135e-08
105 O 0 6.852186373862423e-08
mutations O 0 1.1492196083651152e-09
and O 0 3.5667974129793834e-10
a O 0 1.6438395089579672e-10
general O 0 1.2139167449021215e-10
system O 0 9.126935318626295e-10
for O 0 1.7770210303247325e-10
genotype O 0 9.901376385457183e-10
- O 0 3.3482188133149293e-09
based O 0 1.5862784419340414e-09
prediction O 0 7.172761939955308e-08
of O 0 6.620119563649496e-08
metabolic O 0 0.0005730878910981119
phenotype O 0 3.135955068955809e-07
. O 0 4.901747274743684e-08

Phenylketonuria B-Disease 1 0.9999929666519165
( O 0 8.085775107247173e-07
PKU B-Disease 1 1.0
) O 0 1.2375747537873849e-08
and O 0 8.136797013946762e-09
mild B-Disease 1 0.9987737536430359
hyperphenylalaninemia I-Disease 1 1.0
( O 0 3.3484300274722045e-06
MHP B-Disease 1 1.0
) O 0 2.278311406200828e-08
are O 0 2.2135737687278834e-09
allelic B-Disease 1 0.9990894794464111
disorders I-Disease 1 0.9999953508377075
caused O 0 2.603008697477094e-09
by O 0 5.2427149427325404e-11
mutations O 0 4.133234865477675e-10
in O 0 4.451369481350831e-11
the O 0 2.016073974431265e-09
gene O 0 5.725235396880635e-09
encoding O 0 8.519100447301753e-08
phenylalanine O 0 7.104083579179132e-06
hydroxylase O 0 8.32487057778053e-05
( O 0 8.4752926454712e-08
PAH O 1 1.0
) O 0 2.9361547149164835e-07
. O 0 4.957248620485188e-07

Previous O 0 4.648765639103658e-07
studies O 0 1.7813734487504007e-08
have O 0 1.6239043443277978e-10
suggested O 0 2.106492758002787e-10
that O 0 1.3432136479474277e-11
the O 0 2.0948173751200727e-10
highly O 0 1.7929666640270625e-08
variable O 0 7.527233947257628e-08
metabolic O 0 1.3078984920866787e-05
phenotypes O 0 6.233622116269544e-07
of O 0 5.849812168889912e-06
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 1.605537249815825e-06
with O 0 1.2733542575915635e-07
PAH O 1 1.0
genotypes O 0 0.3501146733760834
. O 0 5.574093506766076e-07

We O 0 6.926151030484107e-08
identified O 0 7.74154607086075e-09
both O 0 3.1649853848847442e-09
causative O 0 3.063003930492414e-07
mutations O 0 1.2115077829832899e-08
in O 0 1.122101300765621e-09
686 O 0 5.054544089944102e-07
patients O 0 2.1945050221461315e-09
from O 0 5.823850290909149e-10
seven O 0 3.4164651108170574e-09
European O 0 2.525692543997593e-08
centers O 0 6.442806466111506e-08
. O 0 7.534617196824911e-08

On O 0 1.631696733284116e-07
the O 0 7.864042750327371e-09
basis O 0 3.1538007760900655e-09
of O 0 1.3377920993207226e-09
the O 0 1.576598962493847e-09
phenotypic O 0 4.1656971916381735e-07
characteristics O 0 1.3259471742799178e-08
of O 0 1.3113346852833274e-08
297 O 0 1.0116372806123763e-07
functionally O 0 1.913024334498914e-07
hemizygous O 0 1.970606490431237e-06
patients O 0 1.5460310809345401e-09
, O 0 7.615007235894922e-11
105 O 0 5.667975422340987e-09
of O 0 2.6269095787512242e-09
the O 0 2.3665340798117995e-09
mutations O 0 2.1293526664134532e-10
were O 0 3.1245190462714234e-11
assigned O 0 1.5192913593864432e-10
to O 0 4.5995793979125565e-11
one O 0 1.402359756097482e-10
of O 0 3.4008678095887035e-09
four O 0 2.1410051509462846e-09
arbitrary O 0 2.087934269923153e-08
phenotype O 0 4.21373869130548e-08
categories O 0 9.542031165210574e-08
. O 0 6.253628725971794e-08

We O 0 6.741296232348759e-08
proposed O 0 2.477252181165568e-08
and O 0 4.335769521190969e-09
tested O 0 5.338970154866729e-09
a O 0 8.880171598057984e-11
simple O 0 6.82749343172695e-11
model O 0 3.432228459776532e-11
for O 0 1.463302048976267e-11
correlation O 0 1.4367798617520577e-10
between O 0 2.731177228820769e-10
genotype O 0 2.5779143264514914e-09
and O 0 3.063644449241565e-09
phenotypic O 0 1.446291321371973e-06
outcome O 0 2.5122932356680394e-07
. O 0 1.9384692961921246e-07

The O 0 5.848634714311629e-07
observed O 0 6.202679259104116e-08
phenotype O 0 2.0939245004569784e-08
matched O 0 1.3726479508591183e-08
the O 0 4.227550753910236e-09
predicted O 0 8.578939336700842e-09
phenotype O 0 6.472657410050431e-10
in O 0 7.383323119558582e-11
79 O 0 3.4639313639672764e-09
% O 0 2.448060851256706e-11
of O 0 1.3205372906277546e-10
the O 0 1.2882775402012214e-10
cases O 0 1.0904208785911251e-10
, O 0 4.02996212789386e-11
and O 0 7.930960749247262e-11
in O 0 7.36939467782527e-11
only O 0 6.003308961055609e-11
5 O 0 8.904463277836783e-10
of O 0 6.556541420899009e-10
184 O 0 1.9294101871736302e-09
patients O 0 4.507272055587208e-10
was O 0 2.1865707022783454e-09
the O 0 1.8331405282623336e-09
observed O 0 1.7727632695141438e-09
phenotype O 0 2.1531915139760827e-10
more O 0 4.825806854819037e-12
than O 0 1.9301516981928835e-11
one O 0 6.085670856137426e-11
category O 0 3.3598027138204145e-10
away O 0 8.998949918570531e-10
from O 0 1.736588234324543e-10
that O 0 1.440536578911633e-10
expected O 0 2.487754535707154e-08
. O 0 2.0082022444967151e-07

Among O 0 7.332418761052395e-08
the O 0 1.4409117454761144e-08
seven O 0 1.9850863175463473e-09
contributing O 0 1.3403232967945655e-09
centers O 0 9.049347382550366e-10
, O 0 8.041117771639961e-11
the O 0 9.600308048529627e-11
proportion O 0 2.817540922794848e-10
of O 0 3.9583772371010184e-10
patients O 0 4.838722478250901e-11
for O 0 5.0491548442277434e-11
whom O 0 4.1399966788091547e-10
the O 0 1.8427880332794189e-09
observed O 0 3.084376754003415e-09
phenotype O 0 1.0650176296422842e-09
did O 0 1.887945355605325e-10
not O 0 5.158481281020144e-11
match O 0 7.158244219596099e-09
the O 0 4.931010710862438e-09
predicted O 0 5.081060017175787e-09
phenotype O 0 9.147482771254545e-10
was O 0 8.605484103085814e-10
4 O 0 2.6169626465843976e-09
% O 0 7.841448323997469e-11
- O 0 5.9456999323970194e-09
23 O 0 1.2652253467138053e-08
% O 0 1.443940078615924e-09
( O 0 1.3536829435167874e-09
P O 0 3.971396438373631e-07
< O 0 1.6239152245134392e-08
. O 0 3.723440999969796e-10
0001 O 0 4.610372172919597e-08
) O 0 2.5172497419845286e-10
, O 0 2.149363326209297e-10
suggesting O 0 2.89979124046269e-10
that O 0 3.792426442328356e-11
differences O 0 1.1412357725504307e-09
in O 0 3.794162900527809e-11
methods O 0 4.0417494351352445e-10
used O 0 2.989524461316506e-10
for O 0 6.342225078448394e-10
mutation O 0 1.2534531634855739e-08
detection O 0 2.3665772914682748e-06
or O 0 3.5160265809963676e-08
phenotype O 0 3.373934021055902e-08
classification O 0 1.1528953791639651e-08
may O 0 1.0833124675091454e-10
account O 0 2.87716846875119e-11
for O 0 3.6229644284624385e-11
a O 0 3.841494830569836e-11
considerable O 0 6.910033656382097e-10
proportion O 0 1.7530292772960365e-09
of O 0 4.298164935079285e-09
genotype O 0 1.009784682537429e-07
- O 0 1.336579657618131e-06
phenotype O 0 2.792862972000876e-07
inconsistencies O 0 3.664471250885981e-06
. O 0 6.602880375794484e-07

Our O 0 4.640637314423657e-07
data O 0 1.616295186579464e-08
indicate O 0 1.5915425644053016e-09
that O 0 1.6070929309552895e-10
the O 0 9.374688580976454e-09
PAH O 1 1.0
- O 0 5.243311079539126e-06
mutation O 0 9.447819415697722e-09
genotype O 0 7.840404991910077e-10
is O 0 2.261324114072316e-11
the O 0 4.786492729946801e-11
main O 0 9.638792874966384e-09
determinant O 0 1.6166042371423828e-07
of O 0 2.621910333289179e-08
metabolic O 0 8.084318687906489e-05
phenotype O 0 4.535950282047452e-09
in O 0 8.68696295452942e-11
most O 0 1.2568592833162029e-09
patients O 0 4.581747869991659e-09
with O 0 1.2406879079662758e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.4800702956563327e-05

In O 0 2.347989003226303e-08
the O 0 9.090801889044542e-09
present O 0 6.57550236482507e-10
study O 0 2.6241989137254507e-10
, O 0 1.2695608453405782e-10
the O 0 2.454926262274171e-10
classification O 0 1.3289247036141205e-08
of O 0 1.1544444511457641e-08
105 O 0 3.0417559173656628e-06
PAH O 1 1.0
mutations O 0 3.12472074881498e-08
may O 0 1.9894558223043646e-10
allow O 0 1.413293926333381e-10
the O 0 2.9338162454983774e-10
prediction O 0 8.200990109230588e-09
of O 0 1.093164492260712e-08
the O 0 1.7346104996818212e-08
biochemical O 0 7.717018490893679e-08
phenotype O 0 2.6659880969504e-09
in O 0 2.2006069189117738e-10
> O 0 6.84653977955918e-09
10 O 0 2.402261722878052e-09
, O 0 2.4239341089860034e-10
000 O 0 8.591122480083868e-09
genotypes O 0 2.5680954252038646e-08
, O 0 1.844513708437745e-10
which O 0 4.938225175998845e-11
may O 0 3.014280838820049e-11
be O 0 2.07162360182922e-11
useful O 0 7.985102856711279e-11
for O 0 3.507246923439844e-11
the O 0 4.169109779628144e-10
management O 0 7.756873365849515e-09
of O 0 4.845860246405209e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.9193728917343833e-07
newborns O 0 1.937869910761947e-06
. O 0 1.2413329386617988e-07

Somatic O 0 1.116604107664898e-05
instability O 0 1.1657000413833885e-06
of O 0 6.716564371345157e-07
the O 0 3.787141622524359e-07
CTG O 1 0.849766731262207
repeat O 0 1.625274848038316e-07
in O 0 1.468352661682104e-09
mice O 0 1.0937150740630841e-08
transgenic O 0 3.4805562876272234e-08
for O 0 7.046819239242552e-10
the O 0 4.4793118547659105e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.004406754393130541
is O 0 2.4460002912007894e-09
age O 0 1.436843755087125e-09
dependent O 0 2.7797061874501594e-10
but O 0 2.9089744502108772e-11
not O 0 1.936941232405509e-11
correlated O 0 4.7776932410315e-10
to O 0 2.3278044769536876e-10
the O 0 3.0842710607714707e-09
relative O 0 1.3179844771116223e-08
intertissue O 0 1.4260730267778854e-06
transcription O 0 1.2898676970962697e-07
levels O 0 7.87797844736815e-08
and O 0 4.677261955521317e-08
proliferative O 0 0.005245565436780453
capacities O 0 6.88670770614408e-05
. O 0 1.3147528079571202e-06

A O 0 3.261394158471376e-05
( O 0 2.495682451808534e-07
CTG O 0 0.0010023213690146804
) O 0 2.644163110687714e-08
nexpansion O 0 1.932963868966908e-06
in O 0 9.039445303393734e-10
the O 0 1.9580939092378458e-09
3 O 0 2.1454990672964414e-08
- O 0 1.2136960947373154e-07
untranslated O 0 1.9943297957070172e-05
region O 0 4.494776817409729e-08
( O 0 9.990726024255991e-10
UTR O 0 7.746485789539292e-05
) O 0 4.3940692751043287e-10
of O 0 5.868646013595935e-09
the O 0 4.4914944652418853e-08
DM O 1 1.0
protein O 0 2.725822980664816e-07
kinase O 0 4.4503575935550543e-08
gene O 0 3.926840630441575e-09
( O 0 2.4119892194640613e-10
DMPK O 1 1.0
) O 0 3.026033590369792e-10
is O 0 6.448784561907672e-11
responsible O 0 2.189161213417279e-10
for O 0 8.215013114210024e-10
causing O 0 0.0002465434081386775
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.626219379133545e-05
DM B-Disease 1 1.0
) O 0 1.1086148532513107e-07
. O 0 1.4518396085350105e-07

Major O 0 4.628844908438623e-05
instability O 0 2.3043687633617083e-06
, O 0 4.374503870252511e-09
with O 0 3.910343437940611e-10
very O 0 5.369953370859548e-10
large O 0 4.5596308950734965e-09
expansions O 0 4.132017039637503e-08
between O 0 1.8811672219953834e-09
generations O 0 1.5360345217985127e-09
and O 0 2.485939787355562e-10
high O 0 1.009951855479585e-08
levels O 0 4.30978941423632e-09
of O 0 1.417176953566468e-08
somatic O 0 1.9212427559978096e-07
mosaicism O 0 2.8404926979419542e-06
, O 0 2.451792102675654e-09
is O 0 5.421720294940258e-10
observed O 0 2.4489974492780675e-09
in O 0 1.8940129464795064e-09
patients O 0 2.3666258286425546e-08
. O 0 6.686718023729554e-08

There O 0 5.151990123408723e-08
is O 0 3.5998375391699255e-09
a O 0 4.774568518328692e-10
good O 0 6.465586954718106e-10
correlation O 0 3.521244407167501e-10
between O 0 2.1998766697173266e-10
repeat O 0 3.864589093183213e-09
size O 0 2.990335978836356e-09
( O 0 1.017423645333082e-10
at O 0 1.4223512367905755e-09
least O 0 4.410036572033427e-11
in O 0 7.109362404333908e-11
leucocytes O 0 3.9201680124278937e-07
) O 0 7.924281231197483e-10
, O 0 2.1997842436505266e-10
clinical O 0 5.450027984466033e-09
severity O 0 1.881157096761399e-08
and O 0 9.75653779988761e-10
age O 0 9.64896518240721e-09
of O 0 1.9450220989369882e-08
onset O 0 1.69294435181655e-06
. O 0 2.368893348148049e-07

The O 0 2.100542360494728e-06
trinucleotide O 0 6.327540177153423e-05
repeat O 0 6.539973469443794e-07
instability O 0 9.577039605801474e-08
mechanisms O 0 9.44594873431015e-08
involved O 0 2.1740242939216614e-09
in O 0 1.9210122381707606e-09
DM B-Disease 1 1.0
and O 0 2.011318684935759e-07
other O 0 1.6490572463112585e-08
human O 0 1.4898282074682356e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 6.914199768282003e-10
unknown O 0 8.853779931428107e-09
. O 0 1.065432631008889e-08

We O 0 2.386607889093284e-07
studied O 0 6.130661631686962e-07
somatic O 0 3.287932202056254e-07
instability O 0 2.433135648516327e-08
by O 0 2.5420399119013837e-10
measuring O 0 1.4316599390440388e-06
the O 0 6.551184839054258e-08
CTG O 0 0.0002658191660884768
repeat O 0 2.510386210019533e-08
length O 0 1.1596410498526666e-09
at O 0 4.957498855873155e-10
several O 0 1.888723344389831e-10
ages O 0 1.825898737761733e-10
in O 0 3.776589110882078e-11
various O 0 1.0248779602761715e-09
tissues O 0 9.490659813593538e-09
of O 0 8.945971075036141e-09
transgenic O 0 1.024998041998515e-07
mice O 0 5.623233878537803e-09
carrying O 0 1.2405707572327174e-09
a O 0 3.586779484532343e-10
( O 0 1.273427141512684e-09
CTG O 0 9.923435573000461e-05
) O 0 4.169159684153101e-09
55expansion O 0 5.758388397225644e-07
surrounded O 0 2.3054752773532527e-08
by O 0 9.781499915595404e-11
45 O 0 3.619894162198989e-09
kb O 0 1.6156978688286472e-07
of O 0 2.1956031659442488e-08
the O 0 2.3467846332891895e-08
human O 0 6.664181739779451e-08
DM B-Disease 1 1.0
region O 0 1.592092075952678e-06
, O 0 7.160179671394928e-10
using O 0 7.476018137886342e-10
small O 0 7.934706225398713e-09
- O 0 1.4866178332795243e-07
pool O 0 1.3420023492471955e-07
PCR O 0 2.980046929224045e-07
. O 0 2.8748525338073705e-08

These O 0 1.9362946090950572e-07
mice O 0 6.28604865937632e-08
have O 0 8.550082863933994e-11
been O 0 6.00675689743646e-11
shown O 0 2.883700916944676e-11
to O 0 4.8776961636409766e-11
reproduce O 0 1.2713424757393454e-09
the O 0 8.571149900937769e-10
intergenerational O 0 1.093777690641673e-08
and O 0 2.387325226393955e-09
somatic O 0 8.527553774229091e-08
instability O 0 9.177969673146436e-08
of O 0 6.317323908433536e-08
the O 0 7.244270960882204e-08
55 O 0 2.3325274867147527e-07
CTG O 0 0.00012693939788732678
repeat O 0 4.232442663010261e-08
suggesting O 0 1.008721217665709e-09
that O 0 4.081317575566068e-11
surrounding O 0 5.626570764860617e-09
sequences O 0 4.1207032230872187e-10
and O 0 3.710375340304495e-10
the O 0 7.406881774585372e-10
chromatin O 0 2.051109948553176e-09
environment O 0 8.406811913275192e-10
are O 0 4.8050063927718156e-11
involved O 0 1.2098000379268115e-10
in O 0 4.2523032317554055e-10
instability O 0 1.8710737492710905e-07
mechanisms O 0 8.566137807974883e-07
. O 0 3.0718794619133405e-07

As O 0 4.2626776775023245e-08
observed O 0 1.3771577211940667e-09
in O 0 7.523334039083451e-11
some O 0 7.229476739478713e-11
of O 0 8.625581915389091e-10
the O 0 1.3852613500731081e-09
tissues O 0 2.437050916626049e-08
of O 0 2.9871938522774144e-07
DM B-Disease 1 1.0
patients O 0 4.949812648646912e-08
, O 0 5.925406693085833e-11
there O 0 4.934854261340327e-11
is O 0 6.292902310356396e-11
a O 0 6.520831791201331e-11
tendency O 0 5.988216589258855e-10
for O 0 1.2018790129797452e-10
repeat O 0 3.137230253358325e-09
length O 0 1.2098467783161482e-09
and O 0 5.2336783795681185e-09
somatic O 0 5.308227102318597e-08
mosaicism O 0 7.026545034705123e-08
to O 0 4.110504298049378e-11
increase O 0 1.944318317459448e-11
with O 0 7.5220524253794e-12
the O 0 4.5062834019837794e-10
age O 0 8.960277519953763e-10
of O 0 1.775700697592697e-09
the O 0 9.840005255057349e-09
mouse O 0 7.563637041130278e-07
. O 0 1.8195044049207354e-07

Furthermore O 0 1.145405690294865e-06
, O 0 1.2240900737481297e-08
we O 0 1.051851161726347e-09
observed O 0 7.514173172573635e-10
no O 0 1.4529290270903772e-10
correlation O 0 1.9296300668436572e-10
between O 0 1.3799837661476744e-10
the O 0 1.5210317449998456e-09
somatic O 0 1.017498352240409e-08
mutation O 0 1.012700145963663e-09
rate O 0 7.730578954756595e-10
and O 0 1.2409114846789748e-09
tissue O 0 1.4091023103901534e-07
proliferation O 0 3.7002617318648845e-05
capacity O 0 1.0343221674702363e-06
. O 0 3.393189160760812e-07

The O 0 4.739414976029366e-07
somatic O 0 2.951840940568218e-07
mutation O 0 2.270237553503307e-09
rates O 0 7.813116265076303e-10
in O 0 4.3176587305460146e-11
different O 0 5.5228120687811355e-11
tissues O 0 9.682623591800166e-10
were O 0 2.322735059845371e-10
also O 0 1.5740111991568995e-10
not O 0 3.578516302726875e-11
correlated O 0 5.699117289204025e-10
to O 0 1.2409392957657417e-10
the O 0 1.463624332842528e-09
relative O 0 2.2211610328781717e-09
inter O 0 4.139251359447371e-07
- O 0 3.278316853538854e-07
tissue O 0 1.2308842833874678e-08
difference O 0 2.274875621210981e-09
in O 0 4.128088149091269e-11
transcriptional O 0 1.1812049949266878e-10
levels O 0 2.0498379382782872e-10
of O 0 3.018965633039272e-10
the O 0 5.411450731962475e-10
three O 0 2.5074836651484134e-10
genes O 0 3.284991723084829e-10
( O 0 3.008240045954125e-10
DMAHP O 1 0.9999998807907104
, O 0 5.422426063717012e-09
DMPK O 1 0.9990390539169312
and O 0 1.4926463620668073e-08
59 O 0 4.166212619338694e-08
) O 0 4.695259181453082e-10
surrounding O 0 1.1524099363668938e-07
the O 0 1.6497777366453192e-08
repeat O 0 4.490775040721928e-08
. O 0 6.915442440913466e-09
. O 0 1.088919745484418e-07

A O 0 6.169245352793951e-06
novel O 0 1.737954107738915e-06
missense O 0 2.255931121908361e-06
mutation O 0 3.388315050756319e-08
in O 0 4.4454834258189635e-10
patients O 0 6.198959678904714e-10
from O 0 1.1437303187866732e-10
a O 0 1.0736245226183883e-09
retinoblastoma B-Disease 0 7.536110615546932e-07
pedigree O 0 8.874461343566509e-08
showing O 0 2.2390270970618076e-08
only O 0 1.3011587363109811e-09
mild O 0 4.810745224403945e-08
expression O 0 1.803416194157137e-09
of O 0 6.696454057930623e-09
the O 0 2.2559209611472397e-08
tumor B-Disease 0 2.6997400709660724e-05
phenotype O 0 1.385246690688291e-07
. O 0 4.9647326250124024e-08

We O 0 7.414549685336169e-08
have O 0 2.1752179224510115e-10
used O 0 4.263535080539782e-10
single O 0 7.20314974334002e-10
strand O 0 7.112132549558225e-10
conformation O 0 3.3864835935482063e-10
polymorphism O 0 1.2012922601112308e-10
analysis O 0 4.045110080230785e-11
to O 0 4.992225036137832e-11
study O 0 7.827924419778753e-11
the O 0 3.8953434922106567e-10
27 O 0 4.435999567675708e-09
exons O 0 1.4232258038759937e-08
of O 0 1.67472595791196e-08
the O 0 4.05160207606059e-08
RB1 O 0 0.0009521092288196087
gene O 0 7.344574948220384e-10
in O 0 8.24801060783642e-11
individuals O 0 1.6714683456764412e-11
from O 0 2.7987985193322906e-11
a O 0 2.625886175167125e-10
family O 0 9.366248887587858e-10
showing O 0 1.4105457246671449e-08
mild O 0 7.290587973329821e-07
expression O 0 1.0459976884646949e-08
of O 0 2.826451783732864e-08
the O 0 1.2257399362169963e-07
retinoblastoma B-Disease 0 8.070562762441114e-05
phenotype O 0 1.5575549241475528e-06
. O 0 1.445994683990648e-07

In O 0 1.395700799378119e-08
this O 0 5.382905232664825e-10
family O 0 9.393550381986415e-10
affected O 0 3.896430289529462e-09
individuals O 0 1.224819828893331e-10
developed O 0 3.325372333051746e-08
unilateral B-Disease 1 0.9999887943267822
tumors I-Disease 1 1.0
and O 0 3.3109083119597926e-07
, O 0 1.3153118594289026e-09
as O 0 6.076221192863329e-10
a O 0 2.1570803476755884e-10
result O 0 1.2633580848131487e-09
of O 0 4.352606275404014e-09
linkage O 0 6.684598652384466e-09
analysis O 0 4.790002283705519e-10
, O 0 8.324748668186999e-10
unaffected O 0 4.191775104800399e-08
mutation O 0 1.8826458170195792e-09
carriers O 0 6.353909065559549e-10
were O 0 3.034431594883813e-10
also O 0 7.257152656592325e-10
identified O 0 1.115569081555634e-09
within O 0 1.5818129028843941e-09
the O 0 1.5859102475701548e-08
pedigree O 0 2.1156042748771142e-06
. O 0 5.150182573743223e-07

A O 0 2.0101865629840177e-06
single O 0 1.3045988289661636e-08
band O 0 2.6923473228634975e-08
shift O 0 2.5469040210168714e-09
using O 0 3.3062141913120513e-09
SSCP O 1 0.9997918009757996
was O 0 7.10778564894099e-08
identified O 0 2.4144806154424714e-09
in O 0 1.0490360802251075e-09
exon O 0 1.6653045520342857e-07
21 O 0 2.0119339083635168e-08
which O 0 1.3174326907172684e-10
resulted O 0 2.496285178565927e-09
in O 0 4.696100730505748e-10
a O 0 4.157652888636676e-09
missense O 0 3.2570514463259315e-07
mutation O 0 1.4177393481418221e-08
converting O 0 7.613711261456046e-08
a O 0 1.1277577094404023e-08
cys O 0 0.0014026378048583865
- O 0 7.827702575013973e-06
- O 0 1.5626866343154688e-06
> O 0 1.1760248241898807e-07
arg O 0 9.810237315832637e-07
at O 0 1.265078175549661e-08
nucleotide O 0 5.114771273184715e-09
position O 0 1.6671145575131163e-09
28 O 0 4.170233491862518e-09
in O 0 4.5858461472647605e-10
the O 0 4.908810780079875e-08
exon O 0 6.081506853661267e-06
. O 0 6.650823252130067e-07

The O 0 1.4276160982262809e-06
mutation O 0 2.0134393707849085e-07
destroyed O 0 1.1940597914872342e-06
an O 0 2.8996559819916e-08
NdeI O 0 2.845171002263669e-05
restriction O 0 4.4765963025383826e-07
enzyme O 0 3.5169119172451246e-08
site O 0 9.277641055405184e-08
. O 0 1.2860476772402762e-07

Analysis O 0 1.2322468379011298e-08
of O 0 1.313640218825185e-08
all O 0 7.681634217604483e-10
family O 0 6.072707614546147e-11
members O 0 3.815089303499386e-12
demonstrated O 0 4.457827162962502e-11
that O 0 3.2963815704833976e-11
the O 0 3.325256514585817e-09
missense O 0 8.331681300433047e-08
mutation O 0 1.3166252088581132e-08
co O 0 1.599513588246282e-08
- O 0 6.72959359349079e-08
segregated O 0 1.0064097999418209e-08
with O 0 1.6775919542411089e-10
patients O 0 9.551491819692615e-10
with O 0 5.899810084919466e-10
tumors B-Disease 1 1.0
or O 0 2.3138217386531323e-07
who O 0 1.5900588623551926e-09
, O 0 2.788382857943361e-10
as O 0 3.815893434566675e-10
a O 0 2.3744589627838764e-10
result O 0 1.7968582177729786e-09
of O 0 7.699680892869765e-09
linkage O 0 1.2192712617320467e-08
analysis O 0 6.399701324433238e-10
had O 0 1.5366030670094233e-09
been O 0 6.735944579894237e-10
predicted O 0 2.6295361443828824e-09
to O 0 9.155424751661201e-10
carry O 0 7.991205919211097e-09
the O 0 1.5322344282253653e-08
predisposing O 0 5.516110832104459e-06
mutation O 0 4.4855619307782035e-07
. O 0 1.9905152726096276e-07

These O 0 6.21127398403587e-08
observations O 0 6.335230295917427e-08
point O 0 2.7689669224173485e-08
to O 0 4.706547374055958e-10
another O 0 7.317280670271487e-10
region O 0 1.2893210943332178e-08
of O 0 2.6642611672400562e-08
the O 0 5.713348372182736e-08
RB1 O 0 0.022485001012682915
gene O 0 5.171243877555298e-09
where O 0 3.041136897863339e-09
mutations O 0 6.496676530076684e-10
only O 0 7.44547618003466e-11
modify O 0 1.4010504978401173e-09
the O 0 4.0987471749964755e-10
function O 0 1.2340801991417294e-10
of O 0 5.972407568499705e-10
the O 0 1.080698197597485e-09
gene O 0 2.7347635267460646e-10
and O 0 4.147180654445748e-10
raise O 0 3.5748701776583403e-09
important O 0 4.2905070607446305e-09
questions O 0 2.407027022144348e-09
for O 0 2.804234067177447e-10
genetic O 0 2.5651276658322786e-09
counseling O 0 9.279150364749356e-11
in O 0 7.359824555353e-12
families O 0 1.1655666666207654e-12
with O 0 9.20173832963389e-12
these O 0 4.5654763303204504e-10
distinctive O 0 3.8152425219095676e-08
phenotypes O 0 5.9269982699561297e-08
. O 0 4.361390359974848e-09
. O 0 1.0024559315979786e-07

Maternal B-Disease 0 6.545409269165248e-05
disomy I-Disease 0 0.00028278445824980736
and O 0 8.105314918793738e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 1.7230419189218082e-06
with O 0 1.990398068585364e-09
gamete O 0 1.2010099226245075e-07
complementation O 0 2.647186363446963e-07
in O 0 2.2027989154960181e-10
a O 0 3.10445419371419e-10
case O 0 2.480797345327801e-09
of O 0 3.630115230635056e-08
familial O 0 8.125864496832946e-07
translocation O 0 7.836032978048024e-08
( O 0 1.0209869061306165e-10
3 O 0 2.9408546708964423e-09
; O 0 1.0723263943468453e-10
15 O 0 2.8637905380435313e-09
) O 0 5.223393939601806e-10
( O 0 7.653029321375016e-10
p25 O 0 4.4899442741552775e-07
; O 0 6.213045633529646e-10
q11 O 0 3.8127731727399805e-07
. O 0 1.0831889829532315e-09
2 O 0 6.33125623039632e-08
) O 0 1.7528462237237363e-08
. O 0 1.311832988903916e-07

Maternal B-Disease 1 0.9411569237709045
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 0 1.554431401018519e-05
UPD I-Disease 1 1.0
) I-Disease 0 1.4521187807758906e-08
for I-Disease 0 1.6546173320364232e-09
chromosome I-Disease 0 8.44859382453933e-09
15 I-Disease 0 1.8197181539392204e-09
is O 0 6.299879368176775e-11
responsible O 0 3.044385576966846e-10
for O 0 7.494888737413774e-11
an O 0 2.8180662664523126e-11
estimated O 0 1.0078918255551628e-10
30 O 0 4.325755864620362e-10
% O 0 1.3391131085949137e-11
of O 0 4.075405637959939e-11
cases O 0 8.309499616165894e-11
of O 0 3.194669062622779e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.0531221000273945e-06
PWS B-Disease 1 1.0
) O 0 1.6390048074299557e-07
. O 0 3.128328955881443e-07

We O 0 4.2019010493277165e-08
report O 0 1.0271009598383785e-09
on O 0 2.277858346388939e-09
an O 0 9.074647283613402e-11
unusual O 0 9.229431108259689e-10
case O 0 9.449544480233385e-10
of O 0 6.258698004302232e-09
maternal B-Disease 0 1.5195863056760572e-07
disomy I-Disease 0 9.533678530715406e-05
15 I-Disease 0 5.453025053725469e-08
in O 0 4.108094309174248e-09
PWS B-Disease 1 1.0
that O 0 1.7094963222774595e-09
is O 0 4.831890998424626e-10
most O 0 6.149285247669667e-11
consistent O 0 3.6433395189661155e-10
with O 0 1.8848573743457386e-11
adjacent O 0 3.6558642779738193e-09
- O 0 9.01157903854255e-09
1 O 0 2.199438320360514e-08
segregation O 0 5.1431733538720437e-08
of O 0 8.04442379376269e-09
a O 0 1.8894448228223837e-09
paternal O 0 3.6342928666499574e-08
t O 0 6.431079224711311e-09
( O 0 9.388421984279915e-11
3 O 0 2.7045852224460987e-09
; O 0 7.991105693827549e-11
15 O 0 2.595215820022645e-09
) O 0 4.3814654682172716e-10
( O 0 4.58213023080134e-10
p25 O 0 2.1306269104570674e-07
; O 0 2.4661758746269413e-10
q11 O 0 6.409235453475048e-08
. O 0 5.041234790725824e-11
2 O 0 1.194074172872206e-09
) O 0 6.685969139441639e-11
with O 0 1.0278314310774306e-10
simultaneous O 0 7.338501362141869e-09
maternal O 0 1.2437621421668155e-07
meiotic O 0 2.426761966489721e-06
nondisjunction O 0 5.407517164712772e-06
for O 0 1.3081170813222798e-08
chromosome O 0 6.388060569406662e-08
15 O 0 3.0746512891255406e-08
. O 0 3.2132650318317246e-08

The O 0 7.911374382274516e-07
patient O 0 2.072737999014862e-07
( O 0 4.661564467767221e-10
J O 0 1.8671343582354893e-07
. O 0 1.5142141707169543e-10
B O 0 1.0762534863317796e-08
. O 0 1.8819690597582373e-11
) O 0 3.6588041624208145e-11
, O 0 7.926016093451338e-11
a O 0 1.389733050860542e-10
17 O 0 1.1632542706863092e-09
- O 0 1.134694005422432e-09
year O 0 9.050965532608757e-11
- O 0 8.473268309217019e-09
old O 0 1.6679264192021037e-08
white O 0 9.586680338458109e-10
male O 0 3.148846461353827e-10
with O 0 1.2005410554571938e-10
PWS B-Disease 1 1.0
, O 0 4.967572131420184e-09
was O 0 6.855817691331367e-09
found O 0 3.2880256850553735e-10
to O 0 3.1433258773638784e-10
have O 0 2.2839521940376528e-10
47 O 0 4.8303543387362424e-09
chromosomes O 0 8.866344464175668e-11
with O 0 9.179165066930395e-11
a O 0 2.3386954595139287e-09
supernumerary O 0 1.5507475836784579e-06
, O 0 6.823491105478752e-09
paternal O 0 3.6439899986362434e-07
der O 1 0.9999746084213257
( O 0 5.555227944320507e-10
15 O 0 1.0489180635175899e-09
) O 0 2.0512135393002673e-11
consisting O 0 6.126526369554242e-11
of O 0 4.1105532866403394e-10
the O 0 9.963095903842145e-10
short O 0 2.733278936517536e-09
arm O 0 2.4380181429251024e-08
and O 0 2.4120272446026547e-09
the O 0 2.0460353411522192e-08
proximal O 0 7.890030246926472e-06
long O 0 5.526709045966527e-08
arm O 0 3.5383359886509425e-07
of O 0 1.3270154397559963e-07
chromosome O 0 1.566349538961731e-07
15 O 0 2.101205964777364e-08
, O 0 1.7510809469101218e-09
and O 0 4.687622023880067e-08
distal O 0 0.012768705375492573
chromosome O 0 0.00028011910035274923
arm O 0 8.366324618691579e-05
3p O 0 0.0005706500960513949
. O 0 3.6249650747777196e-06

The O 0 8.50250899020466e-07
t O 0 8.243524973750027e-08
( O 0 4.6042158974302083e-10
3 O 0 3.473729970338013e-09
; O 0 4.467581860012615e-11
15 O 0 4.3879971878268975e-10
) O 0 4.1784697230040635e-11
was O 0 6.522739015579759e-10
present O 0 8.008851914986792e-11
in O 0 4.062909730873088e-11
the O 0 5.351171172840452e-10
balanced O 0 3.78684994473133e-09
state O 0 1.7730125700943233e-10
in O 0 8.185416927597444e-11
the O 0 9.016853375065637e-10
patients O 0 5.400346281270174e-10
father O 0 1.5280368081960205e-09
and O 0 6.875067182221528e-09
a O 0 3.122367431274142e-08
sister O 0 1.608728325663833e-06
. O 0 7.984488092915853e-07

Fluorescent O 0 3.0817238439340144e-05
in O 0 8.49793835300261e-08
situ O 0 1.934900410560658e-06
hybridization O 0 1.0555576857029791e-08
analysis O 0 3.086075561764545e-10
demonstrated O 0 1.355503764788324e-10
that O 0 2.227620518602258e-11
the O 0 3.342814247631054e-09
PWS B-Disease 1 1.0
critical O 0 6.650873842772853e-07
region O 0 2.8154710207672906e-07
resided O 0 8.153112673880969e-08
on O 0 1.837422480832629e-08
the O 0 6.186041456857083e-09
derivative O 0 1.3936232612365984e-08
chromosome O 0 1.257485116035184e-09
3 O 0 7.203795893140352e-10
and O 0 6.124539764229553e-11
that O 0 9.78604870749411e-12
there O 0 4.7218399329418403e-11
was O 0 1.1714971215326386e-09
no O 0 6.727149393093157e-10
deletion O 0 3.646789759059743e-09
of O 0 6.276965169860205e-09
the O 0 6.096204430150465e-08
PWS B-Disease 1 1.0
region O 0 3.9840784893385717e-07
on O 0 3.924663616317048e-08
the O 0 4.841164358282413e-09
normal O 0 1.3853564961863185e-09
pair O 0 5.436714411999333e-10
of O 0 1.7651043959787671e-09
15s O 0 3.68485615354075e-07
present O 0 5.95055604790673e-09
in O 0 1.1397267130064392e-08
J O 0 0.0004338919825386256
. O 0 6.90764068167482e-07

B O 0 0.02911987528204918
. O 0 4.607094069797313e-06

Methylation O 0 4.2650364662222273e-07
analysis O 0 8.4632540975349e-09
at O 0 1.6969089244867064e-08
exon O 0 5.6087440469809735e-08
alpha O 0 7.79858932986599e-09
of O 0 3.4962837069940633e-09
the O 0 2.587929648356635e-09
small O 0 9.950793966595484e-09
nuclear O 0 2.8016020792165364e-07
ribonucleoprotein O 0 9.414774808647053e-07
- O 0 8.87310704911215e-08
associated O 0 6.522605566772199e-09
polypeptide O 0 5.243402938504005e-07
N O 0 3.3977968882936693e-07
( O 0 1.2680052563496247e-09
SNRPN O 1 0.9999589920043945
) O 0 2.0213952733882934e-09
gene O 0 6.392503748564593e-10
showed O 0 2.4467830539443014e-10
a O 0 4.95950086554231e-11
pattern O 0 7.065862894783947e-10
characteristic O 0 2.900290452245713e-09
of O 0 2.241546948056339e-09
only O 0 1.393869047960905e-10
the O 0 5.088224286353693e-10
maternal O 0 6.471697844290247e-09
chromosome O 0 2.0085176188899823e-08
15 O 0 8.918235039345745e-09
in O 0 6.050215439756812e-09
J O 0 0.0002776066539809108
. O 0 4.701120133177028e-07

B O 0 0.0355505645275116
. O 0 4.7503294808848295e-06

Maternal B-Disease 0 0.00033324287505820394
disomy I-Disease 0 0.0013033044524490833
was O 0 4.881408131041098e-07
confirmed O 0 1.0598223632030113e-08
by O 0 2.5532062575273073e-10
polymerase O 0 3.116951141635127e-09
chain O 0 3.985303198561496e-09
reaction O 0 7.145183056334048e-11
analysis O 0 5.763225660593285e-11
of O 0 4.301232259251719e-09
microsatellite O 0 1.8392287870483415e-07
repeats O 0 4.582263901653505e-09
at O 0 3.6326344154957724e-09
the O 0 7.468454299441873e-09
gamma O 0 5.447597573038365e-07
- O 0 6.135060175438412e-07
aminobutyric O 0 7.250404451042414e-06
acid O 0 2.059196475556746e-07
receptor O 0 1.4462808728410437e-08
beta3 O 0 1.0592585795166087e-06
subunit O 0 3.6062647978951645e-08
( O 0 4.608629033953093e-09
GABRB3 O 1 0.9735260009765625
) O 0 3.823291905291626e-08
locus O 0 3.0928551950637484e-06
. O 0 1.83284839749831e-07

A O 0 3.467354690656066e-05
niece O 0 8.452515430690255e-06
( O 0 5.145250892013564e-09
B O 0 2.0603691552878445e-07
. O 0 8.969095605104727e-11
B O 0 1.1251365172881833e-08
. O 0 1.873230910665047e-11
) O 0 1.6733376836941538e-11
with O 0 4.52073552204002e-11
45 O 0 1.1257069720826962e-09
chromosomes O 0 4.652005169969442e-11
and O 0 4.748754861561011e-11
the O 0 1.8647156041495805e-10
derivative O 0 1.1427234714034284e-09
3 O 0 4.404045461647854e-10
but O 0 2.5448377780068476e-11
without O 0 9.077382595590322e-11
the O 0 5.73412817228558e-10
der O 0 3.970888792537153e-05
( O 0 9.51508871693818e-10
15 O 0 4.727990887687383e-09
) O 0 3.6081052035008554e-10
demonstrated O 0 1.2841272489794164e-09
a O 0 6.258814022608306e-10
phenotype O 0 2.7477631281414006e-09
consistent O 0 3.842478557558593e-10
with O 0 1.4692561403628623e-11
that O 0 1.947803550395033e-11
reported O 0 2.96297458790562e-10
for O 0 6.811511354953836e-10
haploinsufficiency O 0 6.036908416717779e-06
of O 0 4.773271484737052e-07
distal O 0 0.0010595460189506412
3 O 0 4.623374479706399e-05
p O 0 2.1298194496921496e-06
. O 0 2.0490783469995222e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.0467125832747115e-07
with O 0 5.429401372936127e-09
unbalanced O 0 5.882645837118616e-07
segregation O 0 4.672375837344589e-07
of O 0 8.539273466112718e-08
non O 0 0.0024504330940544605
- O 0 3.872106390190311e-05
Robertsonian O 1 0.9990554451942444
translocations O 0 2.3612344648427097e-06
has O 0 1.8931531897692366e-09
been O 0 2.5042909412853476e-10
reported O 0 1.7837584187496702e-10
previously O 0 2.4669670750654404e-09
but O 0 7.667314699810746e-11
has O 0 1.0004183592648985e-10
not O 0 3.919428670506875e-11
, O 0 5.0611976415426696e-11
to O 0 8.506391424578652e-11
our O 0 7.221349629382701e-10
knowledge O 0 1.0181404608289313e-09
, O 0 3.0034127962430546e-10
been O 0 3.5000516374061874e-10
observed O 0 5.470395803008898e-10
in O 0 2.540202770351385e-10
a O 0 1.137556493446823e-09
case O 0 5.3545123890330615e-09
of O 0 3.309670830731193e-07
PWS B-Disease 1 1.0
. O 0 4.623741006071214e-06

Furthermore O 0 2.595111482150969e-06
, O 0 2.4506388029976733e-08
our O 0 5.822953230705252e-09
findings O 0 7.16889825280731e-10
are O 0 8.172858223520763e-11
best O 0 1.9921526650534815e-09
interpreted O 0 2.650625274824847e-09
as O 0 2.2787924880418586e-09
true O 0 1.9582181209898408e-08
gamete O 0 2.80097168570137e-07
complementation O 0 1.420515900463215e-06
resulting O 0 2.3268611926141602e-08
in O 0 8.006584728548205e-09
maternal B-Disease 0 1.3684382793144323e-05
UPD I-Disease 1 1.0
15 I-Disease 0 2.0850984583375975e-05
and O 0 4.900999101664638e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9979361295700073
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 9.77367790255812e-07
2 I-Disease 0 2.3522031256106857e-07
and O 0 7.009289149095821e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 5.612676434729735e-10
a O 0 1.1105032171609963e-10
case O 0 2.7498589516561367e-10
for O 0 1.0228776159415531e-10
" O 0 5.233668165516292e-09
lumping O 0 3.6803257330575434e-07
" O 0 1.3721380298648e-07
. O 0 1.5825416710413265e-07

Recent O 0 8.187473810039592e-08
studies O 0 3.6735485764438636e-09
demonstrated O 0 1.7932700879796926e-09
the O 0 1.3235385010190726e-09
existence O 0 9.69827995689343e-10
of O 0 2.432146262165702e-09
a O 0 1.150346817802017e-09
genetically O 0 6.412840036773559e-09
distinct O 0 5.454954266070899e-10
, O 0 4.567459604976065e-11
usually O 0 1.4849316221088316e-11
lethal O 0 9.836073622260244e-11
form O 0 2.7670344314445483e-12
of O 0 6.597571794442203e-11
the O 0 4.3044226516464335e-10
Schwartz B-Disease 0 5.583985966950422e-06
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.171752721049415e-09
SJS B-Disease 1 1.0
) O 0 1.2898548895634576e-08
of O 0 6.597882702408242e-07
myotonia B-Disease 1 1.0
and O 0 2.0837985630350886e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 3.098226786235614e-09
which O 0 1.419275474923154e-09
we O 0 3.460121300591368e-09
called O 0 4.95484719920114e-08
SJS B-Disease 1 1.0
type I-Disease 0 0.02729536034166813
2 I-Disease 0 3.2473293686052784e-05
. O 0 5.267154392640805e-07

This O 0 2.9435161863489157e-08
disorder O 0 2.0558445612550713e-05
is O 0 1.1347415229678859e-09
reminiscent O 0 1.4814768078963425e-08
of O 0 1.869336152537926e-08
another O 0 1.2166455620743477e-09
rare O 0 2.8179885092072254e-09
condition O 0 4.8853641132495795e-09
, O 0 2.626076578415848e-10
the O 0 1.4794683256269536e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.918817684389069e-08
SWS B-Disease 1 1.0
) O 0 2.067271909211854e-09
, O 0 3.288966321512987e-10
which O 0 2.356560502292382e-10
comprises O 0 4.694025612650421e-09
campomelia B-Disease 0 4.74134083106037e-07
at O 0 5.77853143113316e-09
birth O 0 5.101647548855226e-09
with O 0 2.6502713357245966e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 4.5119989522390824e-08
contractures B-Disease 1 0.9999797344207764
, O 0 5.249003898200044e-09
and O 0 3.6646188306121985e-09
early B-Disease 0 2.4601035875093658e-08
death I-Disease 0 1.5775449924149143e-07
. O 0 1.4752767185655102e-07

To O 0 1.2653556424879753e-08
test O 0 1.067238186713837e-09
for O 0 1.1079073075626056e-10
possible O 0 2.65086796957803e-09
nosologic O 0 1.8877115053328453e-06
identity O 0 1.5889551896464127e-09
between O 0 6.102201521862582e-10
these O 0 3.3568321455845762e-09
disorders O 0 4.864241873292485e-06
, O 0 4.4284226285995487e-10
we O 0 2.421581823952579e-10
reviewed O 0 1.7648552619320412e-09
the O 0 5.873155295432753e-10
literature O 0 4.1212300239124033e-10
and O 0 1.3591307246318962e-10
obtained O 0 1.0618649709526196e-10
a O 0 2.990891909138149e-11
follow O 0 5.7036923795106276e-11
- O 0 4.0377889920506504e-10
up O 0 4.775789208544268e-10
of O 0 4.4368772544878254e-10
the O 0 2.8468519208679766e-10
only O 0 2.5727244987172604e-11
two O 0 3.5091873851200717e-11
surviving O 0 4.9346611241674054e-09
patients O 0 4.6335701942012975e-10
, O 0 1.7236821692190318e-10
one O 0 2.547116406681482e-10
with O 0 4.202193593094705e-10
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 4.69091787635989e-07
2 I-Disease 0 3.071603416060498e-08
at O 0 1.5642014350447653e-09
age O 0 4.737665260101664e-10
10 O 0 1.013621409029497e-10
years O 0 4.0882981028333987e-11
and O 0 1.420534107010596e-10
another O 0 7.321035999652281e-10
with O 0 1.0092215951829075e-09
SWS B-Disease 0 5.858316217199899e-05
at O 0 5.830657912042625e-08
age O 0 2.822696565374372e-08
7 O 0 5.6968733730400345e-08
years O 0 1.1081112916144775e-08
. O 0 1.1010916978193563e-07

Patients O 0 5.350482297217241e-07
reported O 0 2.8399764762099267e-09
as O 0 1.583775222080419e-09
having O 0 1.1568338287304414e-08
either O 0 8.07178537343134e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 6.079889499233104e-05
SWS B-Disease 1 0.9999972581863403
presented O 0 2.829801637460605e-08
a O 0 2.835320311866951e-10
combination O 0 8.548863283941444e-10
of O 0 1.7086455583736893e-09
a O 0 5.404808267606143e-10
severe O 0 3.277879159213626e-07
, O 0 1.247594472175706e-09
prenatal O 0 4.104243771507754e-07
- O 0 1.0512565495446324e-05
onset O 0 0.29745396971702576
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 5.483103748815665e-08
with O 0 1.186625740956515e-05
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 0 2.2435375285567716e-05
respiratory O 1 1.0
and O 0 1.8330423756651726e-07
feeding O 0 0.017568625509738922
difficulties O 0 0.00045619101729243994
, O 0 1.791376269544287e-09
tendency O 0 2.5912209267175967e-08
to O 0 3.631643874513202e-09
hyperthermia B-Disease 0 0.0023342762142419815
, O 0 8.594166489572785e-10
and O 0 9.575862325306161e-10
frequent O 0 8.750095759069154e-09
death O 0 1.3063767845267193e-08
in O 0 6.104506899973217e-10
infancy O 0 6.120925988284398e-09
) O 0 8.953336683159563e-11
with O 0 1.4690494654079345e-10
a O 0 2.7729716300939344e-09
distinct O 0 6.29127896445425e-08
campomelic B-Disease 0 0.0758843943476677
- I-Disease 1 0.9951229691505432
metaphyseal I-Disease 1 0.9999980926513672
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 5.527211669686949e-06

The O 0 1.1047225711990905e-07
similarity O 0 3.429773087759713e-08
of O 0 1.9833501951893595e-08
the O 0 8.640751225641452e-09
clinical O 0 1.4427244821035856e-07
and O 0 3.6326484043058827e-09
radiographic O 0 0.00022691351477988064
findings O 0 9.100829423402956e-09
is O 0 3.5113587038004823e-10
so O 0 5.555034557347405e-11
extensive O 0 4.44991377079873e-09
that O 0 2.745844385199092e-10
these O 0 6.656785789260766e-09
disorders O 0 5.27156862517586e-06
appear O 0 6.599827906406119e-10
to O 0 1.9406512508091112e-10
be O 0 3.9665998263771485e-10
a O 0 1.3196893577926971e-09
single O 0 1.466198451538503e-08
entity O 0 4.4263160248192435e-07
. O 0 3.1466291261494916e-07

The O 0 3.8415521430579247e-07
follow O 0 2.8188713585564074e-08
- O 0 3.7645129680186074e-08
up O 0 4.343284842889261e-09
observation O 0 9.873130757398485e-09
of O 0 1.8630279541298478e-09
an O 0 7.785948274996457e-11
identical O 0 5.431480265549737e-10
and O 0 2.927505737826408e-10
unique O 0 1.5592269697606298e-09
pattern O 0 9.444792503643384e-09
of O 0 1.0482430212732652e-07
progressive O 1 0.9999990463256836
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 3.2872369271075286e-09
the O 0 3.224045386218677e-08
two O 0 7.205128715881415e-10
patients O 0 5.114008105877588e-10
( O 0 1.3484991769063814e-11
one O 0 1.6507108180352503e-10
with O 0 2.939053167505534e-10
SJS B-Disease 1 1.0
type I-Disease 0 1.8453887605573982e-05
2 I-Disease 0 3.156330592446466e-07
, O 0 1.9062580680628827e-10
one O 0 1.2969658680361817e-10
with O 0 6.865812363088253e-10
SWS B-Disease 1 0.9935291409492493
) O 0 1.1163636237654373e-08
surviving O 0 1.4619183730246732e-07
beyond O 0 1.0181315701629501e-07
infancy O 0 8.445629084974371e-09
adds O 0 1.1366645819022025e-10
to O 0 2.7324264378902896e-11
the O 0 6.031013882745739e-11
evidence O 0 5.225404137165768e-11
in O 0 5.606275513270198e-11
favor O 0 3.3973930335662317e-09
of O 0 8.554560615436912e-09
identity O 0 1.2392186832244079e-08
. O 0 3.75773367977672e-08

The O 0 5.05001992223697e-07
hypothesis O 0 8.643375792871666e-08
that O 0 1.9461048328395236e-09
SWS B-Disease 1 0.9870870113372803
and O 0 2.3080762900917762e-07
SJS B-Disease 1 1.0
type I-Disease 0 4.150958375248592e-06
2 I-Disease 0 9.819198254490402e-08
are O 0 3.3134266164136505e-11
the O 0 2.488658445987113e-10
same O 0 1.401879057283395e-09
disorder O 0 5.429729981187847e-07
should O 0 1.6714860606725779e-09
be O 0 3.62368496320542e-10
testable O 0 1.4491664757088074e-08
by O 0 5.937138281009169e-11
molecular O 0 3.2443387976144322e-09
methods O 0 1.2459393516905948e-09
. O 0 1.9291968023082973e-09
. O 0 4.648996210221412e-08

A O 0 3.4364043131063227e-06
mouse O 0 3.3818463407442323e-07
model O 0 6.272560693076912e-09
of O 0 8.26534307662996e-09
severe O 1 0.9905809760093689
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 2.367407887504669e-06
defects O 1 0.9999983310699463
in O 0 2.4675378185179397e-08
hemostasis O 1 1.0
and O 0 4.710854682343779e-06
thrombosis B-Disease 1 0.5196416974067688
. O 0 7.140478146538953e-07

von B-Disease 1 0.999546468257904
Willebrand I-Disease 1 1.0
factor I-Disease 0 0.07439157366752625
( I-Disease 0 1.213308905789745e-06
vWf I-Disease 1 1.0
) I-Disease 0 0.43795451521873474
deficiency I-Disease 1 1.0
causes O 1 0.9988325238227844
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 6.483808192569995e-07
humans O 0 2.457173309267091e-07
. O 0 5.106819500610982e-08

We O 0 1.4608298215534887e-07
generated O 0 6.7788925584011395e-09
a O 0 1.1838512392614575e-09
mouse O 0 7.93231524909288e-09
model O 0 5.440511374743551e-10
for O 0 7.692333575670673e-11
this O 0 3.9771966969803785e-11
disease O 0 2.1872965660918453e-09
by O 0 6.028012117242909e-11
using O 0 1.7694629095288406e-09
gene O 0 8.562984099569348e-09
targeting O 0 2.0980988324481586e-07
. O 0 1.66277800417447e-07

vWf B-Disease 0 0.0048202890902757645
- I-Disease 1 0.9689452052116394
deficient I-Disease 0 0.08969036489725113
mice O 0 2.6406914912513457e-06
appeared O 0 9.607919793097608e-09
normal O 0 1.3805055987248238e-09
at O 0 3.615165944381715e-10
birth O 0 1.1010964362512254e-10
; O 0 5.660425687198378e-12
they O 0 1.0498297543792834e-11
were O 0 1.2524577208683496e-10
viable O 0 1.2926452797046295e-08
and O 0 5.300696770405011e-09
fertile O 0 1.1886482980116853e-06
. O 0 2.460718917518534e-07

Neither O 0 6.5537155023776e-05
vWf O 0 0.0009686797857284546
nor O 0 1.61767329700524e-05
vWf O 0 0.00035861044307239354
propolypeptide O 0 9.424082963960245e-05
( O 0 6.790658346744749e-08
von B-Disease 0 0.00037858125870116055
Willebrand I-Disease 1 0.9999173879623413
antigen O 0 2.605862619020627e-06
II O 1 1.0
) O 0 3.5563310074593346e-09
were O 0 8.258656536419551e-10
detectable O 0 1.1341366956685306e-07
in O 0 3.99440286402708e-10
plasma O 0 1.999294774179816e-08
, O 0 2.0695709035400967e-10
platelets O 0 1.951941275279978e-09
, O 0 1.1874734529015996e-10
or O 0 3.941611967372971e-11
endothelial O 0 1.7677954933237316e-10
cells O 0 3.685166408140539e-11
of O 0 1.3230211370895972e-09
the O 0 1.818164818701007e-08
homozygous O 0 2.856066032563831e-07
mutant O 0 6.635086151618452e-07
mice O 0 3.027806769750896e-07
. O 0 5.242073086719756e-08

The O 0 2.062143494185875e-06
mutant O 0 1.1272918527538422e-05
mice O 0 3.0460896596196108e-06
exhibited O 0 3.828316494036699e-06
defects O 0 3.664925679913722e-05
in O 0 1.86589410589022e-09
hemostasis O 0 9.473097634327132e-06
with O 0 4.133218767243818e-10
a O 0 1.4212041543615328e-09
highly O 0 2.1181126896863134e-07
prolonged O 0 4.560669367492665e-06
bleeding O 1 0.9999710321426392
time O 0 4.3899417434545285e-09
and O 0 2.9624462882793523e-08
spontaneous O 0 8.479157287410999e-08
bleeding O 0 1.1660380323519348e-06
events O 0 5.2439974584928e-10
in O 0 5.899964544697767e-11
approximately O 0 1.6131243563144437e-10
10 O 0 5.588779439236191e-10
% O 0 2.2193687165827924e-10
of O 0 6.0567506565689655e-09
neonates O 0 1.4764295883651357e-06
. O 0 2.3928433279252204e-07

As O 0 3.893520172937315e-08
in O 0 1.002325111798541e-09
the O 0 2.5757909138945934e-09
human O 0 1.4053943564462656e-09
disease O 0 2.8641634841619634e-08
, O 0 1.7184954848037393e-10
the O 0 9.409868440002356e-10
factor O 0 2.488959971458371e-08
VIII O 1 0.5150877237319946
level O 0 7.991757655645415e-08
in O 0 6.76308176128515e-10
these O 0 1.1461068760709736e-09
mice O 0 7.467171769803826e-09
was O 0 2.187471759285131e-09
reduced O 0 3.7086083093385014e-09
strongly O 0 5.319451545915399e-10
as O 0 1.5623580207346777e-10
a O 0 2.4215575725183847e-11
result O 0 6.105482092122472e-11
of O 0 4.6196188541181016e-10
the O 0 4.1268383155212973e-10
lack O 0 1.3675957033498776e-09
of O 0 2.6644733086556016e-09
protection O 0 5.62498527756361e-08
provided O 0 1.1184752013448929e-09
by O 0 2.7726754225909644e-09
vWf O 0 6.569120159838349e-05
. O 0 9.818108992476482e-07

Defective O 1 1.0
thrombosis B-Disease 0 0.00016885581135284156
in O 0 1.1772906560736374e-07
mutant O 0 2.781406465146574e-06
mice O 0 8.559378983363786e-08
was O 0 6.976224931065644e-09
also O 0 6.199929458716724e-10
evident O 0 2.9601121553923804e-09
in O 0 1.1137826078089219e-10
an O 0 1.0160836061423595e-10
in O 0 2.563062262428417e-10
vivo O 0 8.30935178441905e-08
model O 0 1.266659577225937e-08
of O 0 1.4904506429047615e-07
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 2.83027679870429e-06

In O 0 7.0233006077558e-09
this O 0 8.832704012640136e-11
model O 0 6.929329332550083e-10
, O 0 3.709285378850069e-10
the O 0 1.931685700284902e-09
exteriorized O 0 2.73870296041423e-06
mesentery O 0 2.5452707632211968e-05
was O 0 2.1466701127792476e-07
superfused O 0 9.585346560925245e-06
with O 0 2.144378008495096e-08
ferric O 0 4.2792948079295456e-05
chloride O 0 1.338265462891286e-07
and O 0 3.5584903912422305e-08
the O 0 5.604691111216198e-08
accumulation O 0 2.8917747840750962e-06
of O 0 1.4401335874936194e-06
fluorescently O 0 5.663645424647257e-05
labeled O 0 1.4407669368665665e-06
platelets O 0 3.690292942337692e-07
was O 0 3.446573870746761e-08
observed O 0 3.7246221662456946e-09
by O 0 8.059840017615727e-10
intravital O 0 5.013075224269414e-06
microscopy O 0 9.447534665696367e-08
. O 0 3.175981078129553e-07

We O 0 1.984512465469379e-07
conclude O 0 3.885863719688132e-08
that O 0 1.63581384549083e-10
these O 0 1.85680903985741e-09
mice O 0 2.1115392101478392e-08
very O 0 5.092943289319862e-10
closely O 0 1.0454074050869622e-08
mimic O 0 0.00016528277774341404
severe O 1 0.9999966621398926
human O 0 0.0026028903666883707
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 2.980815949626958e-08
will O 0 2.8541316532404437e-10
be O 0 4.6027209821275505e-11
very O 0 8.937703008249365e-12
useful O 0 2.905725139668025e-11
for O 0 1.1261138722906683e-11
investigating O 0 3.519290692199917e-10
the O 0 5.936608982182179e-10
role O 0 2.494871198521764e-09
of O 0 2.2416037026573576e-08
vWf O 0 6.1711284615739714e-06
in O 0 5.3410684763832705e-09
normal O 0 2.5221927657526066e-08
physiology O 0 9.504627307421742e-09
and O 0 4.0878092577578684e-10
in O 0 4.3976744468210427e-10
disease O 0 3.6540953374242235e-08
models O 0 3.5117826424624354e-09
. O 0 2.906581642037054e-09
. O 0 3.933409331580151e-08

Oral O 0 3.1227184081217274e-05
contraceptives O 0 2.754891511358437e-06
and O 0 2.8911772975703798e-09
the O 0 2.931060283373199e-09
risk O 0 7.94780874002754e-07
of O 0 2.1290079530444928e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.6846307744344813e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 0.011552528478205204
Study O 0 5.6018162553073125e-08
Group O 0 7.261075296582931e-09
. O 0 2.1682609485651483e-08

BACKGROUND O 0 7.298899163288297e-06
Women O 0 1.880614552973725e-09
with O 0 1.0777499726000173e-10
mutations O 0 2.7730179263940613e-10
in O 0 6.099720034624667e-11
either O 0 5.699965499594839e-10
the O 0 6.2906404529883275e-09
BRCA1 O 0 1.113017589204901e-07
or O 0 1.433187013510917e-09
the O 0 2.0771183883994127e-08
BRCA2 O 0 4.2912046183118946e-07
gene O 0 3.0395233552305e-10
have O 0 2.638858749570705e-11
a O 0 8.48603687320093e-11
high O 0 1.8086046438270387e-08
lifetime O 0 4.5989370534016416e-08
risk O 0 8.583294288655452e-07
of O 0 0.0003897444694302976
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.101844635646557e-07

Oral O 0 0.0006948435911908746
contraceptives O 1 0.9994959831237793
protect O 1 0.9999886751174927
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.7231275295515047e-09
general O 0 4.1490874624905416e-10
, O 0 6.766200794094956e-11
but O 0 3.39093510215438e-11
it O 0 4.998341671114126e-11
is O 0 3.478055690675497e-11
not O 0 1.2297092163993106e-11
known O 0 1.3500954521017405e-10
whether O 0 9.936407946442571e-11
they O 0 5.932259544705332e-11
also O 0 3.4951216920653394e-10
protect O 0 1.4960722438672747e-08
against O 0 1.9875656676049402e-07
hereditary B-Disease 1 0.9999972581863403
forms I-Disease 1 0.997527539730072
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.853804741993372e-07

METHODS O 0 2.0205479813739657e-06
We O 0 9.400759282129911e-09
enrolled O 0 1.2128973381209107e-08
207 O 0 3.422164995825483e-09
women O 0 6.822703513265083e-11
with O 0 2.7696311910574423e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.7949195463273782e-09
161 O 0 8.18713874473076e-10
of O 0 5.803313940511146e-10
their O 0 9.117017696347318e-10
sisters O 0 1.9428382458386295e-08
as O 0 7.725847739337155e-10
controls O 0 7.238773491735628e-08
in O 0 1.5538860198560656e-09
a O 0 1.9798795936054603e-09
case O 0 6.230826077313623e-09
- O 0 3.5328869785189454e-07
control O 0 7.616499146934075e-07
study O 0 7.371260579702721e-08
. O 0 7.528497292241809e-08

All O 0 8.203919321658759e-08
the O 0 1.3206518545416657e-08
patients O 0 1.0173776265887113e-09
carried O 0 6.476176817038493e-10
a O 0 1.499670526650121e-10
pathogenic O 0 6.6038987611705124e-09
mutation O 0 1.270135441266973e-09
in O 0 3.980757945498681e-10
either O 0 1.2672565219418175e-08
BRCA1 O 0 5.395564173227285e-08
( O 0 1.1259791016238196e-10
179 O 0 4.5184553876254085e-09
women O 0 2.3614096789081884e-11
) O 0 1.3095287354492058e-10
or O 0 3.9713787813866475e-09
BRCA2 O 0 8.33316562420805e-07
( O 0 2.6822266629977776e-10
28 O 0 3.755089750256957e-08
women O 0 1.3162271272904036e-10
) O 0 7.805757706869088e-10
. O 0 2.5334603748206064e-08

The O 0 1.9653354854654026e-07
control O 0 1.752019755940637e-07
women O 0 1.7890534886877418e-10
were O 0 5.268024905191737e-11
enrolled O 0 4.0991382510568997e-10
regardless O 0 8.617748875616726e-11
of O 0 2.0599183470082494e-10
whether O 0 1.1867919147423578e-10
or O 0 7.897795611944147e-11
not O 0 3.723347324902093e-11
they O 0 1.6720719253626726e-10
had O 0 3.729164532728646e-09
either O 0 1.892399659197963e-08
mutation O 0 7.767818033244112e-08
. O 0 1.334220627313698e-07

Lifetime O 0 6.665175078524044e-06
histories O 0 3.7956672827021976e-07
of O 0 1.421031896597924e-07
oral O 0 7.602993150612747e-07
- O 0 9.513390608617556e-08
contraceptive O 0 1.5939585651381094e-08
use O 0 1.4028572747903922e-10
were O 0 4.100371778226197e-11
obtained O 0 1.365350367488194e-11
by O 0 1.0865276560412251e-11
interview O 0 6.519492168344243e-10
or O 0 7.643513599830953e-11
by O 0 8.59176445267007e-12
written O 0 5.992704249502268e-11
questionnaire O 0 4.91768743782206e-11
and O 0 2.8753582848040082e-11
were O 0 3.4228012785186834e-11
compared O 0 8.271074797283617e-11
between O 0 6.840489286119578e-11
patients O 0 8.143837687546451e-11
and O 0 1.7480900060817817e-10
control O 0 1.9884643620571296e-07
women O 0 9.553854929400529e-11
, O 0 2.0073541787124505e-11
after O 0 5.1331591754966155e-11
adjustment O 0 9.240480380867666e-09
for O 0 8.444944049612602e-11
year O 0 2.0991650084845048e-10
of O 0 2.8023108278318887e-09
birth O 0 3.4399130210971407e-09
and O 0 6.7126304514886215e-09
parity O 0 1.9512779090291588e-06
. O 0 2.8210291702635004e-07

RESULTS O 0 7.751462476335291e-07
The O 0 2.4834969636344795e-08
adjusted O 0 4.5852033281335025e-08
odds O 0 7.104871713181637e-08
ratio O 0 1.3683798272268177e-07
for O 0 8.11889506735497e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.1223753038080986e-09
with O 0 1.0084109935970531e-10
any O 0 1.4762070454921172e-09
past O 0 2.032859214295968e-09
use O 0 8.992293021314879e-10
of O 0 6.376177363875968e-09
oral O 0 4.396043777887826e-07
contraceptives O 0 1.3878479876439087e-06
was O 0 3.689905270221061e-08
0 O 0 8.340649060301075e-08
. O 0 3.947696924910815e-08

5 O 0 9.505026810074924e-07
( O 0 7.974001015043086e-09
95 O 0 1.8250899813665455e-07
percent O 0 1.98492458025612e-08
confidence O 0 3.370844936512185e-09
interval O 0 3.357978561879804e-09
, O 0 2.1117746440424412e-10
0 O 0 4.090983940496784e-10
. O 0 3.375950213824197e-11
3 O 0 5.202493991163237e-10
to O 0 1.0037057990297527e-10
0 O 0 1.4311928309140853e-09
. O 0 2.935271470327905e-10
8 O 0 2.8388244643906546e-08
) O 0 1.315749109664921e-08
. O 0 1.3574525326021103e-07

The O 0 3.1425204838342324e-07
risk O 0 1.4987377028319315e-07
decreased O 0 4.8637103233772905e-09
with O 0 8.67064128828865e-11
increasing O 0 1.127086202146188e-09
duration O 0 6.954967712857751e-09
of O 0 2.807928556336492e-09
use O 0 4.3077923450596245e-09
( O 0 1.1545936429158132e-09
P O 0 1.683366974702949e-07
for O 0 5.299096716981921e-10
trend O 0 1.4173257234517678e-08
, O 0 1.6293214000207001e-10
< O 0 3.907362877697551e-09
0 O 0 7.335209661896158e-10
. O 0 4.402162315231273e-11
001 O 0 2.0760200225566905e-09
) O 0 4.589735709548126e-12
; O 0 2.3846820785405898e-12
use O 0 1.9628033573471093e-11
for O 0 1.7259579182526963e-11
six O 0 8.829453140846155e-11
or O 0 2.290556112838349e-11
more O 0 3.921819900082335e-12
years O 0 4.760852823082473e-11
was O 0 1.833059259936931e-10
associated O 0 5.381557005579296e-11
with O 0 1.0292026952907207e-10
a O 0 7.158527659534286e-10
60 O 0 3.529853520589654e-09
percent O 0 1.4427204986233733e-09
reduction O 0 5.572223571448376e-08
in O 0 6.415874498344465e-09
risk O 0 1.2410989711497677e-06
. O 0 1.5270039455117512e-07

Oral O 0 3.5677574487635866e-05
- O 0 9.513551617601479e-07
contraceptive O 0 1.3964042011593847e-07
use O 0 7.084300701620805e-09
protected O 1 0.9999991655349731
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 2.8710961386124723e-10
for O 0 5.401157299189663e-11
carriers O 0 3.0380162274745715e-10
of O 0 1.5383450069350602e-09
the O 0 1.0247102721905321e-08
BRCA1 O 0 9.082867791221361e-08
mutation O 0 7.268137758309479e-10
( O 0 4.385217189373236e-11
odds O 0 1.5567762190471512e-08
ratio O 0 1.2015886063920789e-09
, O 0 3.158933184477242e-11
0 O 0 1.1393300192175104e-10
. O 0 1.3600168734251294e-11
5 O 0 2.597452808394962e-10
; O 0 3.807240633868503e-11
95 O 0 6.243376926562405e-09
percent O 0 1.308767760832552e-09
confidence O 0 8.397932904635752e-10
interval O 0 1.2751454336878965e-09
, O 0 9.327344452358943e-11
0 O 0 1.4841876339044546e-10
. O 0 2.3724702757910165e-11
3 O 0 2.816955280149358e-10
to O 0 2.8282055516970495e-11
0 O 0 3.100637246955529e-10
. O 0 2.966043383123562e-11
9 O 0 5.90762438967829e-10
) O 0 1.5042389209241058e-11
and O 0 2.1897405763637856e-11
for O 0 3.191137978864056e-11
carriers O 0 3.4954750205429264e-10
of O 0 3.010216076404504e-09
the O 0 4.075668513792152e-08
BRCA2 O 0 1.28168790070049e-06
mutation O 0 2.901386242371018e-09
( O 0 1.120659190445572e-10
odds O 0 2.76393326004154e-08
ratio O 0 2.393571563175101e-09
, O 0 3.180619656539818e-11
0 O 0 1.0806172623389898e-10
. O 0 2.001932300488285e-11
4 O 0 5.540476966103824e-10
; O 0 6.09112899008224e-11
95 O 0 9.498882569403122e-09
percent O 0 2.9509572563313213e-09
confidence O 0 7.576055338631704e-10
interval O 0 8.447895716301446e-10
, O 0 9.135638773249966e-11
0 O 0 3.0184704735702894e-10
. O 0 2.187131725728264e-11
2 O 0 5.645003353649258e-10
to O 0 7.874512153449587e-11
1 O 0 2.459356496231635e-09
. O 0 2.977222079980635e-10
1 O 0 3.011951932307966e-08
) O 0 1.0901536562357705e-08
. O 0 8.510266269468048e-08

CONCLUSIONS O 0 2.3674490876146592e-05
Oral O 0 2.4634413421154022e-05
- O 0 6.221957278285117e-07
contraceptive O 0 3.83124145741931e-08
use O 0 2.6775651140731327e-10
may O 0 1.249617510162837e-11
reduce O 0 1.0119645121875465e-09
the O 0 3.0085270386059904e-10
risk O 0 7.247463429393974e-08
of O 0 0.0003086115757469088
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.2441109253913396e-09
women O 0 5.917790996817773e-12
with O 0 2.9944976619872277e-12
pathogenic O 0 2.5779292034400214e-09
mutations O 0 5.557686533208539e-10
in O 0 1.5371651174156398e-10
the O 0 1.5899928484941483e-08
BRCA1 O 0 2.038577576968237e-06
or O 0 1.8022828385255707e-07
BRCA2 O 0 4.135992276133038e-05
gene O 0 2.672955588423065e-06

A O 0 2.4017672330955975e-06
Japanese O 0 7.657035894226283e-07
family O 0 1.3371907137127437e-08
with O 0 3.026082850965395e-08
adrenoleukodystrophy B-Disease 1 1.0
with O 0 6.701503707517986e-08
a O 0 6.112901473898091e-08
codon O 0 1.4537017989368906e-07
291 O 0 2.058439818597435e-08
deletion O 0 1.2675029914532843e-08
: O 0 1.3531607778727306e-10
a O 0 1.7685340691908635e-10
clinical O 0 2.0779504339429877e-08
, O 0 2.4165250356311674e-10
biochemical O 0 2.223349326868629e-08
, O 0 8.337031620619939e-10
pathological O 0 7.777720156809664e-07
, O 0 8.991504207855883e-10
and O 0 5.020532878319273e-09
genetic O 0 6.55801031257397e-08
report O 0 4.2528327526270004e-09
. O 0 7.615410879679985e-08

We O 0 6.28532959012773e-08
report O 0 3.357075506471574e-09
a O 0 8.534363216128327e-10
Japanese O 0 2.5178042761808683e-08
family O 0 3.359484024301196e-09
with O 0 2.7498511911971946e-08
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.035720353887882e-05
ALD B-Disease 1 1.0
) O 0 2.152901190655143e-09
with O 0 2.3049057107371596e-10
a O 0 5.442109540787499e-10
three O 0 4.506051642927389e-10
base O 0 1.7419143460983832e-08
pair O 0 1.3651024310945559e-08
deletion O 0 8.671182882835637e-08
( O 0 1.367452262535096e-09
delGAG O 0 2.093844159389846e-06
291 O 0 1.2112790770402171e-08
) O 0 2.809705801354312e-10
in O 0 1.1771705832330781e-09
the O 0 1.222345389351176e-07
ALD B-Disease 1 1.0
gene O 0 1.5928940229059663e-06
. O 0 3.538467581165605e-07

A O 0 3.519576807775593e-07
variety O 0 5.531064672936736e-08
of O 0 2.8685755992796658e-08
phenotypes O 0 5.745169673332384e-08
were O 0 9.3298402337183e-10
observed O 0 7.134931534480415e-10
within O 0 3.384552638152627e-10
this O 0 9.118925753393015e-11
family O 0 2.4746062976532812e-09
. O 0 7.477764540908538e-08

While O 0 1.0062508692953998e-07
the O 0 6.888615899924844e-08
proband O 0 4.385736974654719e-05
( O 0 5.130003088993362e-09
patient O 0 1.4711932116995285e-08
1 O 0 2.6782215556409028e-08
) O 0 3.774157375513454e-10
was O 0 2.6165334343630775e-09
classified O 0 1.1823850343262166e-08
as O 0 1.1907059782600982e-09
having O 0 2.0361536900992405e-09
a O 0 3.093932054998305e-10
rare O 0 8.581585997369245e-10
intermediate O 0 4.290108179816343e-08
type O 0 1.214531675231001e-08
of O 0 1.968444962585636e-08
adult O 0 9.411838846062892e-07
cerebral O 0 2.69768378302615e-07
and O 0 1.3150365241187956e-08
cerebello O 1 0.9999932050704956
- O 0 0.0002161319280276075
brain O 0 3.678578082144668e-07
stem O 0 7.78686182201227e-09
forms O 0 6.859555701232978e-10
, O 0 4.2468705635512194e-11
his O 0 8.248644545183481e-10
younger O 0 5.282710713316874e-09
brother O 0 4.253741359150354e-09
( O 0 2.4533722275954517e-10
patient O 0 2.498633522307614e-09
2 O 0 7.0829631049207364e-09
) O 0 4.871088532532042e-10
and O 0 9.607314943593792e-09
nephew O 0 2.660651034602779e-06
( O 0 1.5987259294192313e-09
patient O 0 1.0141793183038317e-08
3 O 0 1.983630149027249e-08
) O 0 4.572570100336293e-10
had O 0 5.415129677999175e-09
a O 0 1.6746971809311617e-08
childhood O 0 2.7145018975716084e-05
ALD B-Disease 1 1.0
type O 0 0.025142712518572807
. O 0 3.9909801330395567e-07

Another O 0 3.312918579467805e-06
nephew O 0 9.551510629535187e-06
( O 0 1.3752213590123574e-08
patient O 0 5.743942210756359e-08
4 O 0 3.1216053741900396e-08
) O 0 3.9354838832217354e-10
of O 0 4.741356196547031e-09
patient O 0 9.33888966159202e-09
1 O 0 2.0916532506021213e-08
was O 0 4.128304809114525e-09
classified O 0 1.315485587127796e-08
as O 0 2.2972042046376373e-09
having O 0 5.005988956696683e-09
an O 0 1.1571686941991288e-09
adolescent O 0 3.126575336409587e-07
form O 0 1.0726753707501757e-08
. O 0 1.0183666887542131e-07

The O 0 4.645326612262579e-07
tau O 0 4.0045645732789126e-07
level O 0 1.145017147763383e-08
in O 0 8.193512535115133e-10
the O 0 2.0794848509808617e-08
cerebrospinal O 0 9.010755093186162e-07
fluid O 0 4.4122901954324334e-07
( O 0 1.0454252574731981e-08
CSF O 1 1.0
) O 0 1.058428011901924e-09
in O 0 2.5816179749504897e-10
patient O 0 2.4976425372358335e-09
1 O 0 5.96118887585817e-09
was O 0 1.9420147712168045e-09
as O 0 1.4530149305969076e-10
high O 0 6.521709838835932e-09
as O 0 1.2868237031504748e-10
that O 0 1.7709162261625444e-11
of O 0 1.087129830601441e-09
patients O 0 1.7127371743086428e-09
with O 0 4.4668366783184865e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.403998362015102e-09
AD B-Disease 0 1.2539981071313377e-06
) O 0 1.4303231488099755e-08
. O 0 6.9078787134913e-08

His O 0 4.73821273772046e-05
brain O 0 0.00022449596144724637
magnetic O 0 1.024481548483891e-06
resonance O 0 2.588065228792402e-07
image O 0 2.7685663894772006e-07
( O 0 1.8343542240728539e-09
MRI O 1 0.989134669303894
) O 0 9.848563076175765e-10
showed O 0 4.0538803425249625e-09
abnormalities B-Disease 0 3.818234972641221e-07
in I-Disease 0 3.7292549603940017e-10
the I-Disease 0 8.607983659203455e-09
bilateral I-Disease 0 0.00642342958599329
cerebellar I-Disease 1 1.0
hemispheres I-Disease 0 0.00023633964883629233
and O 0 1.4783069879342747e-08
brain O 0 6.528320284360234e-08
stem O 0 6.31474295076373e-09
, O 0 2.1455450263663245e-11
but O 0 7.707897688169485e-12
not O 0 5.874975853026321e-12
in O 0 3.498454650974203e-11
the O 0 1.4887558963394554e-09
cerebral O 0 2.855261804768361e-08
white O 0 1.3438556933920154e-09
matter O 0 1.639056446123277e-09
, O 0 4.934816791313246e-11
where O 0 4.684504520402477e-11
marked O 0 9.70793445631557e-11
reductions O 0 1.4545609161586981e-08
of O 0 8.584553512491766e-09
the O 0 1.605069677168558e-08
cerebral O 0 2.151297735508706e-07
blood O 0 5.293482541190997e-09
flow O 0 6.952076248012418e-09
and O 0 1.479612210530945e-09
oxygen O 0 8.458667100086359e-10
metabolism O 0 7.49247719422641e-10
were O 0 3.254575775546442e-10
clearly O 0 9.40825417572455e-10
demonstrated O 0 7.886931108203044e-10
by O 0 2.7299168481320635e-10
positron O 0 5.197699124437349e-07
emission O 0 4.38913320977008e-06
tomography O 0 3.344962635765114e-07
( O 0 1.2909574742536734e-08
PET O 0 0.00012737077486235648
) O 0 1.7446209810145774e-08
. O 0 9.100295272901349e-08

In O 0 3.5488788796556037e-08
patients O 0 6.52067733142303e-09
2 O 0 5.503815625473862e-09
and O 0 4.842944378857794e-10
3 O 0 9.545758850038055e-09
, O 0 3.201827414311964e-10
the O 0 7.390005274388045e-10
autopsy O 0 1.3522694075618347e-08
findings O 0 4.576068690642643e-10
showed O 0 1.4940297887733323e-09
massive O 0 7.133032227102376e-07
demyelination B-Disease 1 1.0
of I-Disease 1 0.9987069368362427
the I-Disease 0 1.6158256812559557e-06
cerebral I-Disease 0 1.6321696705290378e-07
white I-Disease 0 1.1719238912633045e-09
matter I-Disease 0 7.863019124698667e-10
with O 0 4.766795291821779e-11
sparing O 0 1.5283115217812338e-08
of O 0 2.275649180205619e-08
the O 0 4.117776697398767e-08
U O 0 7.49467290006578e-06
- O 0 9.389829642714176e-07
fibers O 0 2.0036013381741213e-07
, O 0 6.175074895864441e-10
compatible O 0 6.444807354455406e-09
with O 0 1.5292371535746696e-10
the O 0 2.330128756611316e-09
findings O 0 3.593752406771955e-09
of O 0 6.36934842646042e-08
childhood O 0 0.0004697742697317153
ALD B-Disease 1 1.0
. O 0 6.456673872889951e-06

Oleic O 0 0.04013735055923462
and O 0 2.18827995013271e-06
erucic O 0 0.011908162385225296
acids O 0 3.913728221505153e-07
( O 0 2.0747377149632484e-09
Lorenzos O 0 4.41113024862716e-06
Oil O 0 3.8567858240412534e-08
) O 0 3.6515973578232774e-10
were O 0 2.1376092562697124e-10
administered O 0 1.1386158682569203e-09
to O 0 9.510365411857791e-11
patients O 0 7.554752656790953e-11
1 O 0 6.177560130105064e-10
and O 0 2.0232689135202264e-10
4 O 0 5.637871502983671e-09
, O 0 1.032312915705269e-10
but O 0 3.9119003175658307e-11
sufficient O 0 1.4232955924953217e-09
effectiveness O 0 6.002845776009735e-09
was O 0 6.276557940054772e-09
not O 0 5.340689002153454e-10
obtained O 0 5.01648367290386e-09
. O 0 9.175064263899912e-08

The O 0 4.0852498273125093e-07
findings O 0 1.0804204642056447e-08
in O 0 4.709806988856258e-10
this O 0 1.1555888190795116e-10
family O 0 3.24219040503948e-10
suggest O 0 3.5752772964414703e-10
that O 0 3.778808516097243e-11
delGAG291 O 0 5.0059433931437525e-08
is O 0 3.20617837834547e-10
part O 0 1.6539674074778077e-09
of O 0 6.839700361638279e-09
the O 0 7.0904651039427335e-09
cause O 0 3.229775558111214e-08
of O 0 1.6450275097668055e-07
Japanese O 0 1.9051161871175282e-05
ALD B-Disease 1 1.0
with O 0 1.4937747039311944e-07
phenotypic O 0 6.975207361392677e-05
variations O 0 5.9309213611413725e-06
. O 0 1.8499119391890417e-07

Moreover O 0 2.5338309228573053e-07
, O 0 2.0522252786037143e-09
although O 0 1.6572601624353922e-10
the O 0 1.9793612582308384e-10
scale O 0 9.916009346966348e-09
of O 0 4.119731222829159e-09
the O 0 1.0322248611416285e-09
study O 0 1.651230541188653e-10
is O 0 4.949653881203275e-11
limited O 0 2.0074508721990014e-10
, O 0 1.0693770868819286e-10
there O 0 2.2228892337938788e-10
is O 0 4.625843874617175e-10
a O 0 4.089969751763789e-10
possibility O 0 6.256048123987057e-09
that O 0 4.918037088685878e-10
PET O 0 0.0001352221006527543
can O 0 1.9246135796180397e-09
detect O 0 1.3783837005121313e-07
an O 0 2.673443022516153e-09
insidious B-Disease 0 3.677947006508475e-06
lesion I-Disease 0 0.09187789261341095
which O 0 6.428614085507434e-09
is O 0 2.848070002059444e-09
undetectable O 0 9.550570467808939e-08
by O 0 9.100976916531778e-11
computed O 0 3.922261626598811e-08
tomogram O 0 2.1839725377503783e-05
( O 0 6.892740156416721e-09
CT O 1 0.9961447715759277
) O 0 1.2748293531927857e-09
or O 0 4.3759953993749434e-10
MRI O 0 8.841228549272273e-08
analysis O 0 6.324789997291802e-11
, O 0 1.984281836064916e-11
and O 0 3.4265770776364946e-11
that O 0 6.468034875056761e-12
the O 0 7.012250502480555e-11
higher O 0 2.0400478528692645e-10
level O 0 1.0033693875755034e-09
of O 0 1.8194785678105063e-09
tau O 0 2.5425757499419888e-08
reflects O 0 4.939433306816454e-10
the O 0 3.982238983013531e-10
process O 0 3.8821554304568906e-10
of O 0 8.536533258052259e-09
neuronal B-Disease 0 2.333582870051032e-06
degeneration I-Disease 1 1.0
in O 0 1.7480224414612167e-05
ALD B-Disease 1 1.0
. O 0 2.0020359443151392e-05

Lorenzos O 0 0.0001472616131650284
Oil O 0 4.400960165185097e-07
should O 0 1.0080960510805426e-09
be O 0 4.03156882877731e-11
given O 0 2.7182199199837775e-11
in O 0 2.136858225088023e-11
the O 0 4.6321035895857676e-10
early O 0 1.163906637735579e-09
stage O 0 4.465816516585619e-08
. O 0 8.543749707712323e-09
. O 0 1.5122537888601073e-07

Nonsense O 0 9.975851753551979e-06
mutation O 0 2.474621929593468e-08
in O 0 1.8350960750979084e-09
exon O 0 1.7545697517107328e-07
4 O 0 7.055150064161353e-08
of O 0 1.5869087377495816e-08
human O 0 5.216367338078953e-09
complement O 0 4.402941655712311e-08
C9 O 1 0.9986366629600525
gene O 0 7.343304186946398e-09
is O 0 2.879316507442553e-10
the O 0 8.337842083427915e-10
major O 0 1.6768513688703024e-08
cause O 0 1.2776196989250366e-08
of O 0 1.7393846363233934e-08
Japanese O 0 6.23477546923823e-07
complement B-Disease 0 6.298413609329145e-06
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9998866319656372
. O 0 1.169985807791818e-06

Deficiency B-Disease 1 0.9649855494499207
of I-Disease 0 1.9458293536445126e-06
the I-Disease 0 1.8392569245406776e-07
ninth I-Disease 0 1.928171826648395e-07
component I-Disease 0 1.3488927663729555e-07
of I-Disease 0 3.5318485913649056e-08
human I-Disease 0 6.225812754223625e-09
complement I-Disease 0 6.603598734500338e-08
( O 0 1.7809717034467099e-09
C9 O 1 1.0
) O 0 8.44045555670192e-10
is O 0 5.001660544068365e-11
the O 0 8.691885405864852e-11
most O 0 7.036647653446693e-11
common O 0 6.3074963030373965e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.683803121023459e-10
Japan O 0 1.5341585779538036e-08
but O 0 3.611871635111896e-10
is O 0 1.752637063257012e-10
rare O 0 4.1612133183654976e-10
in O 0 1.0693893687241385e-10
other O 0 1.4548070526032575e-09
countries O 0 1.6404075875442459e-09
. O 0 8.15126242059705e-08

We O 0 1.0805733552388119e-07
studied O 0 6.826409304494518e-08
the O 0 1.140119665343775e-09
molecular O 0 1.2761625090007556e-09
basis O 0 8.822454433676796e-10
of O 0 1.0778209436068664e-08
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999951124191284
in O 0 6.01521277232564e-09
four O 0 2.4654853714167757e-09
Japanese O 0 1.7312365230282012e-07
C9 B-Disease 1 1.0
- I-Disease 1 0.7229358553886414
deficient I-Disease 1 0.8646817803382874
patients O 0 1.1004051714280649e-07
who O 0 1.2637654256408837e-09
had O 0 6.494722981642553e-09
suffered O 0 5.335501782610663e-07
from O 0 5.6565951922493696e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.5385079166208016e-07

Direct O 0 3.7878422176618187e-07
sequencing O 0 1.3332386572528776e-07
of O 0 1.2849933739289554e-07
amplified O 0 1.4425224890146637e-06
C9 O 0 0.00020736856095027179
cDNA O 0 9.484782736990383e-08
and O 0 5.9156106679836284e-09
DNA O 0 1.5102985528869795e-08
revealed O 0 4.561527155999556e-09
a O 0 5.870848251987582e-10
nonsense O 0 1.867810794919933e-08
substitution O 0 7.0201395807600875e-09
( O 0 1.6494182686344061e-09
CGA O 0 2.5203948098351248e-05
- O 0 8.448760127066635e-06
- O 0 3.486554305709433e-06
> O 0 3.3681928357509605e-07
TGA O 0 7.68441259424435e-06
) O 0 8.433503340121717e-10
at O 0 4.026209143859205e-09
codon O 0 7.114334010793755e-09
95 O 0 3.075154353382459e-09
in O 0 1.17362564111545e-10
exon O 0 1.2151943451499392e-08
4 O 0 7.093305054439725e-09
in O 0 3.2320396359253323e-10
the O 0 3.823552585657808e-09
four O 0 8.039086729638711e-09
C9 B-Disease 1 0.9998953342437744
- I-Disease 0 2.3948479793034494e-05
deficient I-Disease 0 3.717846766448929e-06
individuals O 0 8.349575253419061e-09
. O 0 5.194993235591028e-08

An O 0 5.045696482852691e-08
allele O 0 5.001420078087904e-08
- O 0 1.1967772195475845e-07
specific O 0 1.1444079461853107e-08
polymerase O 0 8.268007611889061e-09
chain O 0 1.101851765383799e-08
reaction O 0 2.74033490343939e-10
system O 0 1.0730942801018273e-09
designed O 0 4.802290121119768e-09
to O 0 4.5433945494721684e-10
detect O 0 4.91912777178527e-09
exclusively O 0 1.1460455917600143e-09
only O 0 4.836784792128235e-11
one O 0 4.903955713730923e-11
of O 0 6.6853350633167e-10
the O 0 1.1127067045535455e-09
normal O 0 2.435451396110011e-09
and O 0 1.592280307605165e-09
mutant O 0 2.8036167165623738e-08
alleles O 0 1.9714226084932562e-10
indicated O 0 1.079150796501338e-10
that O 0 4.7531379873677615e-12
all O 0 4.664088212869011e-11
the O 0 8.812308521788381e-11
four O 0 4.284729168690937e-11
patients O 0 1.2569059508471536e-11
were O 0 1.9096633996351642e-11
homozygous O 0 2.6562008148545146e-10
for O 0 8.825226660569285e-11
the O 0 7.268554091943713e-10
mutation O 0 1.4940804149432552e-10
in O 0 5.314864867655977e-11
exon O 0 1.3855315117439204e-08
4 O 0 4.12008427375099e-09
and O 0 9.201918393930697e-11
that O 0 1.7627069942571794e-11
the O 0 2.874937232721919e-10
parents O 0 9.800810163440588e-11
of O 0 5.130205704695356e-10
patient O 0 1.8698773640579702e-09
2 O 0 1.9242879290004566e-08
were O 0 9.852476168248359e-09
heterozygous O 0 1.3371300155995414e-07
. O 0 6.597958446263874e-08

The O 0 7.207196404124261e-07
common O 0 1.8026231884959998e-07
mutation O 0 1.7001097418756217e-08
at O 0 2.7479792663598346e-08
codon O 0 6.61847820992989e-08
95 O 0 3.7168742750282036e-08
in O 0 8.138050233696958e-10
exon O 0 7.910395538601733e-08
4 O 0 3.6913345269340425e-08
might O 0 5.645950373889264e-10
be O 0 4.803265424291325e-11
responsible O 0 3.065577791616647e-10
for O 0 1.6024342963660843e-10
most O 0 1.224724655024545e-09
Japanese O 0 4.758835814300255e-07
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.005697932094335556
. O 0 4.07671798541287e-08
. O 0 2.2387629883269256e-07

BRCA1 O 0 2.4327032406290527e-06
required O 0 8.885703728367389e-09
for O 0 1.5504961758949776e-09
transcription O 0 2.706470638713654e-07
- O 0 4.195878489099414e-07
coupled O 0 1.1324442539262236e-07
repair O 0 3.21200957387191e-07
of O 0 1.7538937413519307e-07
oxidative O 0 1.5116726217456744e-06
DNA O 0 9.774909131010645e-07
damage O 0 4.766455094795674e-05
. O 0 5.608764581666037e-07

The O 0 2.9949064810352866e-06
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 6.153266440378502e-05
gene O 0 1.0234625591465374e-07
BRCA1 O 0 4.655305474443594e-07
encodes O 0 9.40807787230824e-09
a O 0 1.1673861877170566e-09
zinc O 0 5.057326575297338e-07
finger O 0 7.68747383972368e-07
protein O 0 7.521820499789555e-09
of O 0 9.001323242330272e-09
unknown O 0 5.562589056040679e-09
function O 0 4.3540593352986434e-09
. O 0 1.8070151597271433e-08

Association O 0 2.8004214414067974e-07
of O 0 2.2883941142026742e-07
the O 0 1.121276511639735e-07
BRCA1 O 0 5.573615879939098e-08
protein O 0 4.516307883228876e-10
with O 0 2.2762793386310598e-11
the O 0 8.941343776491806e-10
DNA O 0 4.425832589305401e-09
repair O 0 1.9471269041559935e-08
protein O 0 4.683919474501863e-09
Rad51 O 0 1.3465445647398155e-07
and O 0 5.793625579286754e-10
changes O 0 3.387536362531307e-10
in O 0 6.183439871243479e-11
the O 0 1.6365503396897907e-10
phosphorylation O 0 1.1974217450916314e-10
and O 0 3.0588959143429406e-10
cellular O 0 3.3026076318165565e-10
localization O 0 8.206059831650236e-09
of O 0 8.492036407403702e-09
the O 0 4.151646582073454e-09
protein O 0 1.6337566854929264e-09
after O 0 3.0184935106980504e-10
exposure O 0 1.604059640669675e-08
to O 0 5.523573820553906e-10
DNA O 0 4.318307844641822e-08
- O 0 7.275190228028805e-08
damaging O 0 1.8141574287255935e-07
agents O 0 2.106400331935987e-10
are O 0 1.2959512803167872e-11
consistent O 0 9.06537483968961e-11
with O 0 9.347535766257575e-12
a O 0 1.0311557857578535e-10
role O 0 1.2427969764416957e-09
for O 0 1.723656883889646e-09
BRCA1 O 0 4.7744823206130604e-08
in O 0 1.943456284791978e-09
DNA O 0 1.3301246326591354e-07
repair O 0 1.5114044344954891e-06
. O 0 4.782092446475872e-07

Here O 0 1.4485805444053312e-08
, O 0 2.338427895764994e-09
it O 0 3.4126079739849047e-10
is O 0 1.9321748367939762e-10
shown O 0 1.9554766139684432e-10
that O 0 2.0752709273264003e-10
mouse O 0 1.1413870026899531e-07
embryonic O 0 1.0154069229884044e-07
stem O 0 8.783325000649711e-08
cells O 0 9.822992419472598e-10
deficient B-Disease 0 3.754058397476001e-08
in I-Disease 0 9.406817547130686e-10
BRCA1 I-Disease 0 2.4833692435777266e-08
are O 0 6.372571914603498e-11
defective O 0 4.9548161129564505e-09
in O 0 8.824149744235399e-11
the O 0 7.115796285539489e-10
ability O 0 2.466100379461267e-10
to O 0 2.0020288205024883e-10
carry O 0 9.59149093482381e-10
out O 0 6.927717288718327e-10
transcription O 0 1.639101121497788e-08
- O 0 6.508701488883162e-08
coupled O 0 1.6353412846115134e-08
repair O 0 4.767257166804484e-08
of O 0 9.797007649581246e-09
oxidative O 0 9.540316980860553e-09
DNA O 0 4.506199857701176e-09
damage O 0 5.4925660464277826e-08
, O 0 1.4687720484296563e-10
and O 0 7.070919405549603e-10
are O 0 6.545108899302932e-10
hypersensitive O 0 2.006585646086023e-06
to O 0 2.534006604548722e-08
ionizing O 0 0.00014759873738512397
radiation O 0 0.00011693962733261287
and O 0 2.4579458468565463e-08
hydrogen O 0 3.146148230825929e-08
peroxide O 0 1.0035616782033685e-07
. O 0 2.9442629667641995e-08

These O 0 3.3053967740670487e-07
results O 0 8.962486752750465e-09
suggest O 0 4.081057269900157e-09
that O 0 1.5398656794118892e-09
BRCA1 O 0 5.5743068827496245e-08
participates O 0 1.4677877580027143e-08
, O 0 8.717990218620741e-10
directly O 0 1.5493135663291469e-09
or O 0 8.041659005364465e-10
indirectly O 0 4.40773684218243e-09
, O 0 4.5149214922268754e-10
in O 0 7.702967708134167e-10
transcription O 0 2.4471898996125674e-07
- O 0 3.416803053823969e-07
coupled O 0 6.868228297207679e-08
repair O 0 1.1570438829267005e-07
of O 0 5.241663103561223e-08
oxidative O 0 1.6330510277384747e-07
DNA O 0 1.1641541419749046e-07
damage O 0 8.419222012889804e-07
. O 0 1.1745427741516323e-08
. O 0 6.781183969906124e-08

Truncation O 0 2.058616519207135e-05
mutations O 0 6.432860288896336e-08
in O 0 1.135687766051774e-09
the O 0 3.2644191794162225e-09
transactivation O 0 1.48226195051393e-06
region O 0 1.3875194326828932e-07
of O 0 4.969261340193043e-07
PAX6 O 1 0.9999997615814209
result O 0 1.926057713319551e-08
in O 0 2.9026259174003144e-09
dominant O 0 6.547236921505828e-07
- O 0 7.240229820126842e-07
negative O 0 9.98039340061041e-08
mutants O 0 1.130087952105896e-07
. O 0 2.7815334036063177e-08

PAX6 O 1 0.9995507597923279
is O 0 9.442202042464487e-08
a O 0 2.7091802135004173e-09
transcription O 0 2.0435587444467274e-08
factor O 0 3.5223208794121774e-09
with O 0 9.282619811701309e-11
two O 0 1.4330303610421424e-10
DNA O 0 4.570724243535551e-09
- O 0 1.568971086385318e-08
binding O 0 2.2927842735498416e-08
domains O 0 7.827633652368604e-09
( O 0 1.5706103084767165e-10
paired O 0 7.371117050070097e-09
box O 0 5.387686741187281e-08
and O 0 4.514527862653495e-09
homeobox O 0 1.2887757350199536e-07
) O 0 1.6469621499926035e-10
and O 0 5.586743845320541e-10
a O 0 1.5152638033200105e-09
proline O 0 1.2685701733516908e-07
- O 0 6.065388191700549e-08
serine O 0 2.059802639564623e-08
- O 0 1.535905767013901e-07
threonine O 0 1.5851638579533756e-07
( O 0 1.0610820000422905e-09
PST O 1 1.0
) O 0 1.984882835870394e-08
- O 0 6.040635867066158e-07
rich O 0 4.127590358393718e-08
transactivation O 0 1.1216845450690016e-05
domain O 0 6.832218559793546e-07
. O 0 1.4570564133009611e-07

PAX6 O 1 1.0
regulates O 0 0.0011559834238141775
eye O 1 0.99089515209198
development O 0 1.0055352106519422e-07
in O 0 4.559317812180552e-09
animals O 0 1.4011098947719347e-08
ranging O 0 2.771471407925219e-08
from O 0 6.459645596201824e-10
jellyfish O 0 3.0567921527335784e-09
to O 0 5.016260740120515e-10
Drosophila O 0 2.6871758151969516e-08
to O 0 3.2826257267970504e-09
humans O 0 2.185291947398582e-08
. O 0 7.098532961435922e-08

Heterozygous O 0 2.0811294234590605e-06
mutations O 0 1.2105722646538197e-08
in O 0 9.015889701480262e-10
the O 0 1.1508960007233782e-08
human O 0 1.1638141117487066e-08
PAX6 O 0 0.006265296600759029
gene O 0 2.1230475155675776e-09
result O 0 3.114067337328663e-10
in O 0 6.951750980421778e-11
various O 0 5.702303074173187e-10
phenotypes O 0 4.487895832738786e-09
, O 0 7.721866202015093e-11
including O 0 5.812375580838136e-10
aniridia B-Disease 1 1.0
, O 0 1.8860395911701744e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.1542048500577948e-07
autosomal B-Disease 0 0.02060353197157383
dominant I-Disease 0 0.4934055507183075
keratitis I-Disease 1 0.9999611377716064
, O 0 7.709765981189776e-08
and O 0 6.340458185150055e-07
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 2.1979507437208667e-05

It O 0 5.139338909998514e-08
is O 0 1.3854040137317725e-09
believed O 0 2.704346468984653e-10
that O 0 1.853032137455468e-11
the O 0 4.012545573583992e-10
mutated O 0 4.9292525616806415e-09
allele O 0 4.49469750307685e-09
of O 0 4.730022951093815e-08
PAX6 O 1 0.9999998807907104
produces O 0 1.8435348181355948e-07
an O 0 7.797484324889581e-10
inactive O 0 6.402820673656606e-08
protein O 0 6.0662075362927226e-09
and O 0 6.701577515144663e-09
aniridia B-Disease 1 1.0
is O 0 1.546090722115423e-08
caused O 0 2.333292137279841e-08
due O 0 4.10549567675389e-08
to O 0 2.4558653777262407e-08
genetic O 0 7.771965897518385e-07
haploinsufficiency O 0 7.439436740241945e-05
. O 0 8.83093775883026e-07

However O 0 1.7132616392245836e-07
, O 0 9.636623943265477e-09
several O 0 3.169709605899129e-09
truncation O 0 2.5541154968777846e-07
mutations O 0 3.885061605757301e-09
have O 0 1.75800748958288e-10
been O 0 1.012346179107837e-10
found O 0 2.405812875305724e-11
to O 0 3.410315779772688e-11
occur O 0 1.3329640342896187e-11
in O 0 3.080411273281847e-11
the O 0 8.670529849652553e-10
C O 0 2.0785966725611615e-08
- O 0 8.658668448902063e-09
terminal O 0 5.228788957367669e-09
half O 0 7.899125797905526e-10
of O 0 9.451820659478471e-09
PAX6 O 0 0.011745242401957512
in O 0 1.2627390244546177e-09
patients O 0 6.068426317007436e-10
with O 0 2.9060698292227016e-10
Aniridia B-Disease 1 1.0
resulting O 0 4.1278582330050995e-08
in O 0 6.880547243071078e-10
mutant O 0 8.684073016240745e-09
proteins O 0 1.8691551778582394e-11
that O 0 1.4789787450286696e-11
retain O 0 2.4211121996131624e-09
the O 0 6.747928882333554e-10
DNA O 0 2.4905733031488353e-09
- O 0 4.692709776321635e-09
binding O 0 3.5517619956237922e-09
domains O 0 1.7677256325399071e-09
but O 0 1.2945611249648437e-10
have O 0 1.380549841112355e-10
lost O 0 1.488228562607219e-08
most O 0 6.754457548829862e-10
of O 0 8.852631516731435e-09
the O 0 4.4212363548012945e-08
transactivation O 0 2.565360591688659e-05
domain O 0 2.1589239622699097e-06
. O 0 5.323897767084418e-07

It O 0 2.7833854332470764e-08
is O 0 7.411659064260334e-10
not O 0 1.0150646989615097e-10
clear O 0 9.575825687946349e-10
whether O 0 3.018505168039809e-10
such O 0 1.2983674135824685e-09
mutants O 0 3.945310922404133e-08
really O 0 5.0204946866472255e-09
behave O 0 1.0631438090991097e-10
as O 0 1.5865014857396886e-10
loss O 0 4.977492640279024e-09
- O 0 2.2508363173301404e-08
of O 0 3.1554272084122204e-08
- O 0 9.708170978228736e-08
function O 0 3.352532251810203e-09
mutants O 0 3.412414129044805e-09
as O 0 3.073452325974557e-10
predicted O 0 3.6493295052508756e-09
by O 0 2.115573494165801e-09
haploinsufficiency O 0 2.2496411475003697e-05
. O 0 7.067877163535741e-07

Contrary O 0 8.536844120499154e-07
to O 0 4.668097464133325e-09
this O 0 1.242014407987213e-10
theory O 0 2.2201869231963656e-09
, O 0 2.3283242001070903e-10
our O 0 2.380331209916875e-10
data O 0 1.6333726038375573e-10
showed O 0 1.439858093865709e-10
that O 0 2.0513151940959595e-11
these O 0 1.398220011994411e-10
mutants O 0 9.386583732506892e-10
are O 0 6.568241089910387e-11
dominant O 0 1.09766071787476e-08
- O 0 1.8485446062754818e-08
negative O 0 3.994922614936058e-09
in O 0 1.9590082334097758e-10
transient O 0 9.684821833388924e-10
transfection O 0 5.681513037814057e-10
assays O 0 5.676563108458765e-10
when O 0 1.6629629617792574e-10
they O 0 9.906395148640001e-11
are O 0 4.720741506036852e-11
coexpressed O 0 2.952412216927769e-07
with O 0 1.7359633730507085e-09
wild O 0 1.2125373132221284e-06
- O 0 5.333504304871894e-06
type O 0 1.1898178854607977e-05
PAX6 O 1 0.9999991655349731
. O 0 1.7329193724435754e-06

We O 0 1.6521584100814835e-08
found O 0 4.691284583024924e-10
that O 0 5.52658474539669e-11
the O 0 1.3477060578637179e-09
dominant O 0 7.410577040900534e-08
- O 0 8.978607013432338e-08
negative O 0 1.3521817443518103e-08
effects O 0 3.2848319619915856e-08
result O 0 2.756932737657536e-10
from O 0 6.240156308345846e-11
the O 0 3.393473002599734e-10
enhanced O 0 4.204520287487412e-09
DNA O 0 1.997974674594616e-09
binding O 0 2.054042269605816e-09
ability O 0 1.2965137852205544e-09
of O 0 9.48378442444664e-09
these O 0 7.077817443246204e-09
mutants O 0 4.567911560116045e-08
. O 0 4.7048558826645603e-08

Kinetic O 0 1.4392012417374644e-06
studies O 0 1.4585169516578844e-08
of O 0 3.731654985017485e-09
binding O 0 1.84979338513358e-08
and O 0 2.20678653128914e-09
dissociation O 0 1.1278351585986002e-08
revealed O 0 1.1439752478636933e-09
that O 0 3.270074142025514e-11
various O 0 6.815500941392827e-10
truncation O 0 6.645941397209754e-08
mutants O 0 3.2244558134664203e-09
have O 0 4.9243987360059194e-11
3 O 0 1.749358435887416e-09
- O 0 6.6629337602819305e-09
5 O 0 6.781026407054469e-09
- O 0 8.798646256025222e-09
fold O 0 1.4975103379555321e-09
higher O 0 2.1087118162732565e-10
affinity O 0 2.8780137995010335e-11
to O 0 4.1054583344024564e-11
various O 0 1.7871912283418112e-10
DNA O 0 3.292933425935729e-10
- O 0 7.562829806850857e-10
binding O 0 5.885356646473383e-10
sites O 0 4.974045064720656e-10
when O 0 3.764370759551383e-11
compared O 0 5.501070779456718e-11
with O 0 5.566319280503329e-11
the O 0 3.7025864596529345e-09
wild O 0 9.152601023743046e-07
- O 0 4.797578185389284e-06
type O 0 1.1798913874372374e-05
PAX6 O 1 0.9999972581863403
. O 0 1.1063795000154641e-06

These O 0 4.028569478009558e-08
results O 0 1.0451276510892171e-09
provide O 0 2.570244017618961e-10
a O 0 1.3790128761126397e-10
new O 0 3.9776765214938337e-10
insight O 0 5.403591463171153e-10
into O 0 6.077655045899633e-11
the O 0 1.6309474604181418e-10
role O 0 2.3902320123170284e-09
of O 0 2.626880757361505e-08
mutant O 0 2.2392935079551535e-06
PAX6 O 1 0.8761734962463379
in O 0 5.259810009761168e-08
causing O 0 5.457506176753668e-06
aniridia B-Disease 1 1.0
. O 0 1.8515869726343226e-07
. O 0 4.0862474293135165e-07

Reversal O 0 5.132921160111437e-06
of O 0 2.4204175588238286e-06
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 3.572486662051233e-07
excellent O 0 2.862924475266482e-07
neuropsychologic O 0 3.122497673757607e-06
outcome O 0 2.595390569126721e-08
in O 0 6.041517286448084e-10
very B-Disease 0 1.1225079754595413e-09
- I-Disease 0 5.295010510053544e-07
long I-Disease 0 2.3462862941414642e-07
- I-Disease 0 1.8588956436360604e-06
chain I-Disease 0 3.240942305637873e-07
acyl I-Disease 0 4.619213882506301e-07
- I-Disease 0 2.7635016408567026e-07
coenzyme I-Disease 0 1.78831829344972e-08
A I-Disease 0 5.633982596009446e-07
dehydrogenase I-Disease 0 6.417434178729309e-06
deficiency I-Disease 0 7.364433986367658e-05
. O 0 3.6790413560083834e-07

Very B-Disease 0 1.8380119115590787e-07
- I-Disease 0 7.061395876917231e-07
long I-Disease 0 1.3227069928234414e-07
- I-Disease 0 3.038240095065703e-07
chain I-Disease 0 4.9211760000389404e-08
acyl I-Disease 0 3.355540911798016e-08
- I-Disease 0 3.2466182631196716e-08
coenzyme I-Disease 0 3.6014102811066095e-09
A I-Disease 0 2.117152853031712e-08
dehydrogenase I-Disease 0 1.9233853620903574e-08
( I-Disease 0 9.505293219191913e-10
VLCAD I-Disease 1 1.0
) I-Disease 0 3.6126330371644144e-08
deficiency I-Disease 0 0.012333613820374012
is O 0 1.6074400699395142e-09
a O 0 5.09461717257409e-09
disorder O 1 0.9981998205184937
of O 0 5.40639803148224e-06
fatty O 0 5.602782403002493e-05
acid O 0 7.523415490595653e-08
beta O 0 2.9751572316882857e-09
oxidation O 0 6.854101730624507e-10
that O 0 4.1928720911910133e-11
reportedly O 0 2.497151818658949e-09
has O 0 1.9999106537493816e-10
high O 0 1.214649802960821e-08
rates O 0 1.1605394423241933e-09
of O 0 3.6800846814344368e-09
morbidity O 0 2.2247379547479795e-06
and O 0 1.1828456081275363e-07
mortality O 0 1.455618712498108e-05
. O 0 4.655118743812636e-07

We O 0 4.1363225733448417e-08
describe O 0 5.2483932755365e-09
the O 0 1.185916920221075e-09
outcome O 0 3.5549339028051463e-09
of O 0 4.085278337839782e-09
a O 0 3.1870825423219173e-10
5 O 0 2.242526164764058e-09
- O 0 1.528380644266747e-09
year O 0 1.4410311832691036e-10
- O 0 1.0769557690082365e-08
old O 0 2.0167094660905605e-08
girl O 0 4.704709954950204e-09
with O 0 5.965939964269751e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.397927995583359e-08
was O 0 1.0592889232441394e-08
first O 0 8.723844979741102e-10
seen O 0 8.605418599927361e-10
at O 0 7.386453670932269e-10
5 O 0 1.4845621398862363e-09
months O 0 1.0851281678769809e-10
of O 0 4.459785318822185e-10
age O 0 1.8480678098953263e-09
with O 0 4.827469535229056e-10
severe O 1 0.9973102807998657
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9183797240257263
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 0 5.3687706724758755e-08
and O 0 4.86660383103299e-07
hypotonia B-Disease 1 0.9999878406524658
. O 0 3.3556452763150446e-06

Biochemical O 0 4.891165190201718e-06
studies O 0 1.6835387839364557e-07
indicated O 0 2.711769957386423e-05
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.9752765183511656e-06
by O 0 2.432916534900187e-09
a O 0 1.122086867866301e-08
stable O 0 7.751389574650602e-08
yet O 0 2.5544801829369135e-08
inactive O 0 6.905625014042016e-07
enzyme O 0 1.312731399139011e-07
. O 0 5.7293679134318154e-08

Molecular O 0 8.090480605460471e-07
genetic O 0 1.3811542132202703e-08
analysis O 0 1.4412601112567813e-09
of O 0 2.0549681067905112e-08
her O 0 4.5993228781071593e-08
VLCAD O 1 1.0
gene O 0 6.964554444266469e-08
revealed O 0 2.8409097296844266e-08
a O 0 8.32135516048993e-09
T1372C O 0 3.1016575121611822e-06
( O 0 7.434571180908733e-09
F458L O 0 3.340653847772046e-06
) O 0 1.694987439293527e-08
missense O 0 6.324991659312218e-07
mutation O 0 2.081500838357897e-08
and O 0 8.781545268732316e-09
a O 0 5.5697366718732155e-08
1668 O 0 0.0004217268724460155
ACAG O 1 0.9999955892562866
1669 O 0 0.0006290582823567092
splice O 0 7.41996118449606e-05
site O 0 3.1520219181402354e-06
mutation O 0 8.300923468596011e-07
. O 0 3.1053107818479475e-07

After O 0 7.426183401548769e-08
initial O 0 2.0761358854315404e-08
treatment O 0 1.971883456519663e-08
with O 0 3.5722305669061427e-10
intravenous O 0 6.233039329117673e-08
glucose O 0 8.48659951202535e-08
and O 0 4.798481167966884e-09
carnitine O 0 1.7783607972887694e-06
, O 0 1.0719098941791572e-09
the O 0 5.610624409513321e-09
patient O 0 2.3129716808512057e-08
has O 0 1.0759820812111798e-09
thrived O 0 1.1647823150440217e-08
on O 0 6.208523473105743e-09
a O 0 7.556457126689509e-10
low O 0 2.9039398441454978e-08
- O 0 7.892431597156246e-08
fat O 0 1.297927809673638e-07
diet O 0 1.3467199799777063e-08
supplemented O 0 1.1728116255937948e-09
with O 0 8.612573154653802e-11
medium O 0 2.3429679174569173e-07
- O 0 1.0265965499911545e-07
chain O 0 2.9121212108407235e-08
triglyceride O 0 2.157234568755939e-08
oil O 0 8.842202525727316e-09
and O 0 1.4146862570285634e-09
carnitine O 0 4.390961407807481e-07
and O 0 4.6512642626339584e-09
avoidance O 0 2.3749544197926298e-05
of O 0 5.700709380107583e-07
fasting O 0 7.252482419062289e-07
. O 0 1.8763756770567852e-07

Her O 0 0.00012988323578611016
ventricular O 1 0.9999994039535522
hypertrophy O 0 0.0008412559400312603
resolved O 0 1.7652340034146619e-07
significantly O 0 6.103202943030794e-10
over O 0 6.391089324431221e-10
1 O 0 4.7465134045410196e-09
year O 0 2.244001512385907e-10
, O 0 1.998518850410136e-10
and O 0 1.299038654423157e-09
cognitively O 0 2.0668400679824117e-07
, O 0 4.13650780295427e-10
she O 0 2.96389024434518e-10
is O 0 6.467520269337612e-11
in O 0 2.6234771299815662e-11
the O 0 4.782689799753825e-10
superior O 0 1.3574071999755688e-07
range O 0 3.367261456332926e-07
for O 0 1.888552247919506e-08
age O 0 1.9696642539202003e-07
. O 0 1.1939944499772537e-07

Clinical O 0 2.4121696696965955e-05
recognition O 0 5.71983491681749e-07
of O 1 0.9997825026512146
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.103498536991765e-08
important O 0 1.6693959548064186e-09
because O 0 8.997555478451602e-11
it O 0 3.8600254936849154e-11
is O 0 2.861483446026103e-11
one O 0 3.5170137635542886e-11
of O 0 5.5025639600359e-10
the O 0 1.7888427406020924e-09
few O 0 4.762964689319915e-09
directly O 0 2.1389858773090964e-08
treatable O 1 0.9805287718772888
causes O 0 1.873756048098585e-07
of O 0 6.787111487938091e-06
cardiomyopathy B-Disease 1 1.0
in O 0 2.8604075552607355e-08
children O 0 5.881667153317949e-09
. O 0 3.1954474621898044e-09
. O 0 5.996748342340652e-08

Cloning O 0 2.1444357400923764e-07
of O 0 2.2555809664481785e-08
a O 0 8.85801487715554e-10
novel O 0 7.160593451516206e-09
member O 0 2.5978391660075317e-10
of O 0 1.2942530380755102e-09
the O 0 1.2770366986103454e-09
low O 0 2.4691669153753537e-08
- O 0 4.241040585384326e-08
density O 0 8.448577837327775e-09
lipoprotein O 0 7.236809324240312e-06
receptor O 0 3.229893081879709e-07
family O 0 1.4234021961101462e-08
. O 0 7.286703151976326e-08

A O 0 1.684495714471268e-06
gene O 0 8.89828832839612e-09
encoding O 0 2.5766278000105558e-08
a O 0 4.0138719015203606e-09
novel O 0 7.760857556604606e-08
transmembrane O 0 2.228529005776636e-08
protein O 0 4.965251321209507e-09
was O 0 1.223561918450855e-09
identified O 0 2.9716042126981534e-11
by O 0 4.770084934685448e-12
DNA O 0 2.305824697845793e-10
sequence O 0 2.075119590050356e-11
analysis O 0 1.0963722985035673e-11
within O 0 2.4327654474243232e-11
the O 0 4.669520325961685e-10
insulin B-Disease 0 2.2999729480943643e-05
- I-Disease 1 0.9999998807907104
dependent I-Disease 1 0.9927895665168762
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 7.636643317709968e-09
IDDM B-Disease 1 1.0
) O 0 4.590451130326301e-09
locus O 0 7.293918997675064e-07
IDDM4 O 0 0.00045165818301029503
on O 0 2.591745555946545e-07
chromosome O 0 7.776926622682367e-07
11q13 O 0 8.75624391483143e-06
. O 0 2.9067308560115634e-07

Based O 0 2.7975376681865782e-08
on O 0 1.2768619939151904e-08
its O 0 3.5708629386732582e-09
chromosomal O 0 2.0420515056684962e-07
position O 0 2.7965615601033278e-08
, O 0 6.919423922724377e-10
this O 0 4.8616277670276986e-11
gene O 0 3.924817137956893e-10
is O 0 2.0994492255788089e-10
a O 0 2.2965415680253898e-10
candidate O 0 1.7415914266294408e-09
for O 0 5.934741031943247e-10
conferring O 0 6.29227443482705e-08
susceptibility O 0 3.3033468298526714e-06
to O 0 2.410782826700597e-07
diabetes B-Disease 1 1.0
. O 0 2.054875949397683e-06

The O 0 4.439455381088919e-07
gene O 0 2.4924803554426944e-08
, O 0 4.594357783105352e-09
termed O 0 4.403235465133548e-08
low O 0 1.5762635996452445e-07
- O 0 1.5715176004960085e-07
density O 0 9.962644931249542e-09
lipoprotein O 0 1.039946141645487e-06
receptor O 0 7.408214042214922e-09
related O 0 9.299180092625647e-09
protein O 0 1.5134065112221151e-09
5 O 0 1.6273005165601262e-09
( O 0 1.0437128244999982e-10
LRP5 O 1 0.9999293088912964
) O 0 4.626064531443319e-10
, O 0 2.986993707931873e-10
encodes O 0 5.564740335195495e-10
a O 0 3.1761712704359013e-10
protein O 0 3.3712819202946775e-09
of O 0 5.7894866678509516e-09
1615 O 0 4.651630547414243e-07
amino O 0 3.3359863760296093e-09
acids O 0 1.1668714605672648e-10
that O 0 3.365430330248831e-12
contains O 0 1.8483417574266525e-10
conserved O 0 3.2951952277926466e-10
modules O 0 2.2066591609526398e-10
which O 0 2.9673997634094285e-12
are O 0 8.919254766183438e-13
characteristic O 0 2.5438443018721557e-10
of O 0 3.739291098980857e-10
the O 0 5.354305332438969e-10
low O 0 7.588958794713108e-09
- O 0 3.9612281454992626e-08
density O 0 1.6455979690022104e-08
lipoprotein O 0 6.903422035975382e-05
( O 0 1.0968361330299103e-08
LDL O 1 1.0
) O 0 1.3855844471777345e-08
receptor O 0 3.0401874795416006e-08
family O 0 1.1748272576994623e-08
. O 0 5.809776837395475e-08

These O 0 6.209094749465294e-08
modules O 0 8.095745585023906e-08
include O 0 8.987324662257379e-09
a O 0 4.176226919838655e-09
putative O 0 4.874104320151673e-08
signal O 0 3.765846745551471e-09
peptide O 0 8.85980566689426e-10
for O 0 1.2987183550805526e-10
protein O 0 1.0484094842277969e-10
export O 0 4.522180407917631e-09
, O 0 6.854049550142349e-10
four O 0 1.435331742349888e-09
epidermal O 0 5.281348762764537e-07
growth O 0 2.044120073207978e-08
factor O 0 2.557312761553021e-08
( O 0 2.1100161617937374e-09
EGF O 0 4.064109452883713e-05
) O 0 1.7896207848977497e-09
repeats O 0 2.2211907868552316e-09
with O 0 1.3839243639957033e-10
associated O 0 3.0498965575276316e-09
spacer O 0 1.4285923555235058e-07
domains O 0 2.2410436173458947e-08
, O 0 1.8920522926180183e-09
three O 0 1.903563306981937e-09
LDL O 1 1.0
- O 0 3.46834676747676e-05
receptor O 0 5.6506426204805393e-08
( O 0 7.115931732748493e-10
LDLR O 1 0.9999995231628418
) O 0 3.9858558120720033e-10
repeats O 0 1.1419957202107867e-09
, O 0 1.0910845144040948e-10
a O 0 3.1595792648886345e-10
single O 0 4.331256686640472e-09
transmembrane O 0 6.2365694830646135e-09
spanning O 0 1.6120587531531783e-08
domain O 0 2.1848752140840588e-08
, O 0 1.0790628390822121e-09
and O 0 2.7086946019494462e-09
a O 0 7.972130511291198e-09
cytoplasmic O 0 5.201120529818581e-07
domain O 0 1.0543402595430962e-06
. O 0 4.205316486149968e-07

The O 0 4.7147105419753643e-07
encoded O 0 1.3583960623009261e-08
protein O 0 6.266533514320827e-09
has O 0 3.379791724267278e-10
a O 0 1.2585402164866366e-10
unique O 0 1.499155799500329e-10
organization O 0 8.205738172284427e-11
of O 0 6.808696273452597e-09
EGF O 0 0.4591889977455139
and O 0 1.0477952372411892e-07
LDLR O 1 1.0
repeats O 0 6.0582521221874686e-09
; O 0 3.148594163171481e-10
therefore O 0 5.803856839570187e-10
, O 0 6.609969238624558e-10
LRP5 O 0 0.0007829883834347129
likely O 0 4.569102429741179e-09
represents O 0 1.6174098171894968e-10
a O 0 1.9710380896875712e-11
new O 0 5.727305088520929e-11
category O 0 5.894388310778709e-10
of O 0 2.841574753276177e-09
the O 0 2.3806059346043185e-08
LDLR O 1 0.9999995231628418
family O 0 1.332239634166399e-07
. O 0 3.512119803872338e-07

Both O 0 4.137613416332897e-07
human O 0 5.713108564009417e-08
and O 0 2.291210599025817e-08
mouse O 0 4.755641839437885e-06
LRP5 O 1 1.0
cDNAs O 0 0.00011421601084293798
have O 0 1.1530091326150682e-09
been O 0 1.131890359218346e-09
isolated O 0 1.9556716246427186e-09
and O 0 4.5901862866237764e-10
the O 0 1.4486102317690097e-09
encoded O 0 5.701443761552127e-10
mature O 0 2.596379333752452e-09
proteins O 0 4.412299692280186e-11
are O 0 1.2356552413217425e-11
95 O 0 1.3436968204771915e-09
% O 0 6.6713204405211e-11
identical O 0 3.8705033622576934e-10
, O 0 1.2283338235441477e-10
indicating O 0 1.6411837444607613e-09
a O 0 4.6173637135993317e-10
high O 0 2.8349445457820366e-08
degree O 0 8.877233170778709e-09
of O 0 2.898919104765696e-09
evolutionary O 0 4.293036148794727e-09
conservation O 0 1.3536526566326756e-08
. O 0 1.4445378226923822e-09
. O 0 3.8175354433178654e-08

The O 0 1.7097667068810551e-06
APC B-Disease 0 3.0782771318627056e-06
variants O 0 3.1775505249242997e-07
I1307K O 0 1.3165746395316091e-06
and O 0 4.627690231018278e-09
E1317Q O 0 5.103085527480289e-07
are O 0 7.284344655245079e-11
associated O 0 1.6556339632600725e-09
with O 0 8.699110480847594e-07
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 5.9663527451903065e-09
but O 0 4.5210203636347757e-11
not O 0 2.2150116810171205e-11
always O 0 1.621722200972897e-10
with O 0 3.919361363236007e-11
a O 0 8.844644461269979e-10
family O 0 2.2269133204133595e-09
history O 0 6.394863305558829e-08
. O 0 1.6869861951818166e-07

Classical O 0 0.006264797877520323
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.5650279237888753e-05
FAP B-Disease 1 1.0
) O 0 6.9002386027250395e-09
is O 0 6.014131415099655e-10
a O 0 5.369154010281818e-10
high O 0 0.00029525114223361015
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.999991774559021
that O 0 7.015477643257384e-10
predisposes O 0 2.407542609716984e-08
to O 0 1.2674920835120673e-10
hundreds O 0 3.785208813056329e-10
or O 0 1.1006365957522135e-10
thousands O 0 6.126646412418779e-10
of O 0 6.27883537163143e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 3.631429353845306e-05
that O 0 9.486167407146695e-10
results O 0 3.958392225111851e-10
from O 0 2.473585780649046e-10
truncating O 0 6.372325600523254e-08
mutations O 0 1.823599271588705e-09
in O 0 2.978460533764604e-10
the O 0 1.7148595432558977e-08
APC B-Disease 0 3.500727871141862e-06
gene O 0 1.3416658362075395e-07
. O 0 1.3889585659399017e-07

A O 0 7.532992185588228e-07
variant O 0 3.5982884583063424e-07
of O 0 1.1389025189600943e-07
FAP B-Disease 1 0.9999942779541016
is O 0 1.0065541289350222e-07
attenuated B-Disease 1 0.9999035596847534
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 7.059413942300807e-09
which O 0 1.6199909469438722e-10
results O 0 9.705897890954773e-11
from O 0 1.039235364430624e-10
germ O 0 5.606391084711504e-08
- O 0 2.811912125366689e-08
line O 0 2.4818302080120702e-08
mutations O 0 2.0745111184439224e-10
in O 0 1.4084224238264387e-11
the O 0 1.448764164191374e-10
5 O 0 7.195858353625795e-10
and O 0 1.1577906688930995e-10
3 O 0 4.023176902734349e-09
regions O 0 1.1418678447228103e-08
of O 0 2.1553757889591907e-08
the O 0 9.293651714870066e-08
APC B-Disease 0 4.931342573399888e-06
gene O 0 1.204659980658107e-07
. O 0 1.745393944929674e-07

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 3.4613883599377004e-06
have O 0 1.3169729196071955e-10
" O 0 1.1081403572532622e-09
multiple O 0 1.172182066966343e-07
" O 1 0.9999092817306519
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 7.211057972966728e-09
typically O 0 3.696488115600971e-10
fewer O 0 9.525651795128098e-11
than O 0 6.3601957901726625e-12
100 O 0 1.7860496415167404e-10
) O 0 3.074083695930874e-11
without O 0 9.683468610299784e-11
the O 0 1.3883270089110056e-09
florid O 0 7.919496738395537e-07
phenotype O 0 3.1415428480841e-08
of O 0 1.5041582202002246e-08
classical O 0 7.740920864307554e-07
FAP B-Disease 0 0.0004024445661343634
. O 0 3.08795762293812e-07

Another O 0 7.085613873414331e-08
group O 0 1.0862386545795744e-09
of O 0 2.448670377575013e-09
patients O 0 9.371735609775556e-10
with O 0 1.3347227489912683e-10
multiple O 0 2.8961414955119835e-07
adenomas B-Disease 1 1.0
has O 0 9.921892640818442e-09
no O 0 2.647189578652842e-09
mutations O 0 1.4483499122253107e-10
in O 0 9.074162254929519e-11
the O 0 4.7002703951193325e-09
APC B-Disease 0 1.1742182692842107e-07
gene O 0 3.7413025455457216e-10
, O 0 1.0630119701149354e-10
and O 0 2.7048624451353476e-10
their O 0 5.301027949933257e-10
phenotype O 0 7.607767193995585e-10
probably O 0 9.055731858831351e-11
results O 0 3.052547450921317e-11
from O 0 2.9829045483653616e-11
variation O 0 5.972808914123107e-09
at O 0 2.386942865584274e-09
a O 0 5.45928469097845e-10
locus O 0 2.999866310915422e-08
, O 0 6.345503567040112e-10
or O 0 5.928099677809939e-10
loci O 0 4.916970386403818e-09
, O 0 3.146307103740753e-10
elsewhere O 0 9.228990904830425e-10
in O 0 4.812796272624098e-10
the O 0 2.2502355534470553e-08
genome O 0 5.2452232779387487e-08
. O 0 1.0340130529584712e-07

Recently O 0 1.3211529221734963e-06
, O 0 9.853527771497284e-09
however O 0 2.464977555405312e-09
, O 0 1.7843140298623439e-09
a O 0 1.3655001573908976e-09
missense O 0 7.369728649564422e-08
variant O 0 2.3395540438286844e-07
of O 0 2.8334582111710915e-06
APC B-Disease 0 0.00019682156562339514
( O 0 3.1361651053885e-09
I1307K O 0 3.234490577597171e-06
) O 0 5.873626029995194e-10
was O 0 3.5862612879355993e-09
described O 0 5.712165740412445e-10
that O 0 3.563144224116854e-11
confers O 0 8.760466130297573e-09
an O 0 3.980406629300326e-11
increased O 0 4.261681285644414e-10
risk O 0 4.690877375423952e-08
of O 0 3.6708613606606377e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.4228680811356753e-07
including O 0 1.362288060136052e-08
multiple O 0 4.612373061263497e-07
adenomas B-Disease 1 0.9961431622505188
, O 0 9.524172561725663e-09
in O 0 2.8961460785126292e-08
Ashkenazim O 0 0.00013274085358716547
. O 0 5.864910690434044e-07

We O 0 7.782425370805868e-08
have O 0 5.766714328281353e-10
studied O 0 1.0761077362531069e-08
a O 0 2.395854348247184e-10
set O 0 5.900935295954923e-10
of O 0 2.9773811194289124e-10
164 O 0 3.75992570411654e-09
patients O 0 1.2945487737336947e-10
with O 0 2.8954250108625956e-10
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 0 0.004034730140119791
carcinoma I-Disease 1 1.0
and O 0 5.148413038114086e-06
analyzed O 0 5.193665515434986e-07
codons O 0 3.9326894807345525e-07
1263 O 0 2.0760585357493255e-06
- O 0 2.482136380876909e-07
1377 O 0 1.337978801529971e-06
( O 0 2.60761034986956e-09
exon O 0 1.9199953271709091e-07
15G O 0 3.8930193113628775e-07
) O 0 2.710042190656736e-10
of O 0 2.827334588673125e-09
the O 0 8.815107754855944e-09
APC B-Disease 0 2.996081320816302e-07
gene O 0 9.233199205205267e-10
for O 0 1.9262984263246352e-10
germ O 0 6.099543270465801e-07
- O 0 3.8109448041723226e-07
line O 0 4.983423309568025e-07
variants O 0 2.6383250428807514e-07
. O 0 9.178354787309217e-08

Three O 0 1.083258212020155e-07
patients O 0 1.7359864656896207e-09
with O 0 7.081942671183228e-11
the O 0 5.496441080055092e-09
I1307K O 0 8.41487860725465e-07
allele O 0 1.0950378381835435e-09
were O 0 3.274769622141349e-10
detected O 0 2.2912092223492664e-09
, O 0 1.986066172632306e-10
each O 0 7.864125323164828e-11
of O 0 4.169804057596593e-09
Ashkenazi O 0 3.800927004249388e-07
descent O 0 7.283841085836684e-08
. O 0 1.390434931636264e-07

Four O 0 9.940172276401427e-07
patients O 0 6.29620089398486e-08
had O 0 1.0330880151343536e-08
a O 0 5.4753046541122785e-09
germ O 0 3.5988553008792223e-06
- O 0 4.44480292571825e-06
line O 0 5.055067958892323e-06
E1317Q O 0 3.397412683625589e-06
missense O 0 4.061180547410004e-08
variant O 0 3.291379613301615e-08
of O 0 3.4371797852372765e-08
APC O 0 6.923416862036902e-08
that O 0 4.924652352578107e-11
was O 0 4.682729204397162e-10
not O 0 2.1004213993092158e-11
present O 0 2.8778162144971198e-11
in O 0 5.052767579338813e-11
controls O 0 1.176190433938018e-08
; O 0 1.5519006912878552e-10
one O 0 8.040842297551976e-11
of O 0 5.342471465219489e-10
these O 0 2.446922942045404e-10
individuals O 0 1.1011840744812318e-11
had O 0 2.880596594589946e-10
an O 0 1.1014640588502544e-10
unusually O 0 1.7955187336937684e-09
large O 0 4.396754516022838e-09
number O 0 1.7304458976852288e-09
of O 0 4.9466979845647074e-08
metaplastic B-Disease 0 0.0004498646594583988
polyps I-Disease 0 1.8440727217239328e-05
of I-Disease 0 1.198418885905994e-06
the I-Disease 0 2.2069659735279856e-06
colorectum I-Disease 0 0.0016338363057002425
. O 0 1.314966084464686e-06

There O 0 4.5934228865007753e-08
is O 0 1.5311030221454303e-09
increasing O 0 5.221520993359263e-10
evidence O 0 2.2980008174133815e-10
that O 0 4.1136417189280294e-11
there O 0 1.622334766526734e-10
exist O 0 6.135241203963915e-10
germ O 0 3.4182004782223885e-08
- O 0 1.3026866696463912e-08
line O 0 2.0433365222061184e-08
variants O 0 5.354461318773929e-09
of O 0 9.33942345682226e-09
the O 0 1.1522225840110423e-08
APC B-Disease 0 2.858698451291275e-07
gene O 0 1.246809544497296e-09
that O 0 6.195836205202809e-11
predispose O 0 6.339168301394693e-09
to O 0 8.822600983116047e-11
the O 0 2.977318669383777e-10
development O 0 6.06528993696287e-10
of O 0 2.4675097520798772e-08
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 1.8280193359032637e-08
but O 0 2.5747237675233237e-10
without O 0 3.240904489221208e-10
the O 0 5.332820296466423e-10
florid O 0 1.1420860346333939e-07
phenotype O 0 7.17042980546978e-10
of O 0 8.422539887753544e-10
classical O 0 1.4249669000321319e-08
FAP B-Disease 0 3.8300051528494805e-05
, O 0 9.086597446694711e-11
and O 0 3.049335089988503e-11
possibly O 0 2.798355470956526e-11
with O 0 1.2127427534425195e-11
importance O 0 2.7364935206719565e-08
for O 0 7.269961344036346e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.6011243815228227e-06
in O 0 1.2802943427647762e-10
the O 0 6.670381469398023e-10
general O 0 4.799677877365127e-10
population O 0 5.472563721631296e-11
. O 0 6.923014383986015e-10
. O 0 4.3954567985338144e-08

Genomic O 0 3.0084271429586806e-07
structure O 0 1.3183490743529092e-08
of O 0 1.2992549258683539e-08
the O 0 6.656229345480824e-08
human O 1 0.9991866946220398
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 9.768423296918627e-07
CLD B-Disease 1 1.0
) O 0 4.7621405485642754e-08
gene O 0 6.948764763592408e-08
. O 0 4.144741083678127e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 4.525841723079793e-05
CLD B-Disease 1 1.0
) O 0 2.2702474566926867e-08
is O 0 8.445060761808065e-10
caused O 0 2.6732491775760536e-09
by O 0 1.801005594659344e-10
mutations O 0 1.4988705832053029e-09
in O 0 1.8875204177426497e-10
a O 0 5.228048549632547e-10
gene O 0 2.8559235532021887e-10
which O 0 1.3929042641525058e-10
encodes O 0 2.2808364086301935e-09
an O 0 1.857719533759905e-09
intestinal O 0 3.9846814615884796e-05
anion O 0 4.8694118959247135e-06
transporter O 0 1.8544051272328943e-05
. O 0 5.840296921633126e-07

We O 0 6.290559184662925e-08
report O 0 1.4743105625214525e-09
here O 0 1.1155237844562294e-10
the O 0 7.427338744037115e-10
complete O 0 9.078702789544479e-10
genomic O 0 2.0894432850582234e-09
organization O 0 2.6094798544207265e-10
of O 0 4.753997639994623e-09
the O 0 1.5903660610661063e-08
human O 0 1.914761504906437e-08
CLD B-Disease 1 0.9879950881004333
gene O 0 9.547033386070325e-09
which O 0 6.532338003850668e-10
spans O 0 1.4114419855104643e-08
approximately O 0 1.3382438490694426e-09
39kb O 0 2.726907268879586e-07
, O 0 1.4001901860183352e-09
and O 0 4.876752335292167e-09
comprises O 0 1.770058588590473e-07
21 O 0 3.782510589189769e-07
exons O 0 2.9860398171877023e-06
. O 0 6.372283678501844e-07

All O 0 6.248947101994418e-06
exon O 0 2.7012334612663835e-05
/ O 0 1.080329002434155e-05
intron O 0 1.685435199760832e-05
boundaries O 0 2.5548902726768574e-07
conform O 0 3.179077978643363e-08
to O 0 2.92922175404442e-09
the O 0 2.9726516359573907e-08
GT O 1 0.9990882873535156
/ O 1 0.9989473223686218
AG O 1 1.0
rule O 0 8.156367584888358e-06
. O 0 1.0962087344523752e-06

An O 0 7.228932563663193e-09
analysis O 0 1.7175788569190331e-09
of O 0 8.966726916526113e-09
the O 0 1.635359936358327e-08
putative O 0 3.2845946407178417e-07
promoter O 0 2.2962344701227266e-06
region O 0 2.6230964067508467e-07
sequence O 0 9.622517893603799e-09
shows O 0 7.928352196984179e-09
a O 0 3.112904822799578e-09
putative O 0 4.04832775302566e-07
TATA O 0 1.4167131666908972e-05
box O 0 2.8963174827367766e-06
and O 0 4.786080154417505e-08
predicts O 0 6.384016870697451e-08
multiple O 0 9.992809246739398e-09
transcription O 0 2.877655980171312e-08
factor O 0 2.5158794159096942e-08
binding O 0 5.378241141329454e-08
sites O 0 2.0469494188546378e-07
. O 0 2.2276095990036993e-07

The O 0 4.933148716190772e-07
genomic O 0 2.4145100496753e-07
structure O 0 4.328351721483159e-08
was O 0 7.852307248867874e-09
determined O 0 1.0118023086036487e-09
using O 0 9.414333895785276e-11
DNA O 0 5.489397270075358e-10
from O 0 2.2315583408927253e-11
several O 0 1.0583668663688428e-10
sources O 0 4.863096036977765e-10
including O 0 5.834189797937483e-10
multiple O 0 2.6578950151900926e-09
large O 0 4.632126149317628e-08
- O 0 2.4133828446792904e-06
insert O 0 4.5730763531537377e-07
libaries O 0 2.335559884159011e-06
and O 0 3.58972429559401e-09
genomic O 0 1.3652612373959983e-08
DNA O 0 9.547999724190959e-09
from O 0 8.388711947304728e-10
Finnish O 0 0.0005656987777911127
CLD B-Disease 1 0.9999995231628418
patients O 0 7.978157157140231e-08
and O 0 1.2314972153149029e-08
controls O 0 1.546585190226324e-05
. O 0 5.067610118203447e-07

Exon O 0 1.2857910405728035e-05
- O 0 3.2161597118829377e-07
specific O 0 1.4132010228706804e-08
primers O 0 2.0221289531718867e-08
developed O 0 6.055799750548374e-10
in O 0 4.0060284950405034e-11
this O 0 1.3381531126233082e-11
study O 0 6.348261499811159e-11
will O 0 5.501763628013023e-11
facilitate O 0 4.769735162390987e-10
mutation O 0 1.3353339267663245e-10
screening O 0 4.5534057080409696e-10
studies O 0 1.7306463206967493e-10
of O 0 5.728771346191763e-10
patients O 0 1.762795326376576e-10
with O 0 1.0255227222977226e-10
the O 0 3.983564411669249e-08
disease O 0 5.479430910781957e-06
. O 0 2.0510725562417065e-07

Genomic O 0 7.090804956533248e-07
sequencing O 0 8.414840380055466e-08
of O 0 1.0203848432865925e-07
a O 0 7.703150828319849e-08
BAC O 1 1.0
clone O 0 1.7046191715053283e-05
H O 1 1.0
_ O 0 9.102253173409736e-09
RG364P16 O 0 1.2762779988406692e-07
revealed O 0 5.088350296666988e-10
the O 0 1.4030740458359503e-10
presence O 0 3.092958389405709e-10
of O 0 2.3444748364909174e-09
another O 0 7.388299971822221e-10
, O 0 2.9744748331062e-10
highly O 0 2.424207945495027e-09
homologous O 0 1.9548239416078417e-10
gene O 0 1.27456850629315e-10
3 O 0 2.0492367802660283e-09
of O 0 2.6597615221390924e-09
the O 0 1.0639237935095025e-08
CLD B-Disease 0 0.00020457810023799539
gene O 0 1.5536547604000361e-09
, O 0 2.1048540688184403e-10
with O 0 7.66009408681434e-11
a O 0 2.508564744818642e-10
similar O 0 3.068812981510405e-10
genomic O 0 2.308311985999012e-09
structure O 0 2.07969397258978e-09
, O 0 1.2718827380187037e-10
recently O 0 4.3343614808399877e-10
identified O 0 7.825103065517425e-11
as O 0 1.1931083898630845e-10
the O 0 1.3867714976356638e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.2862143939382804e-07
( O 0 5.64057156537956e-09
PDS B-Disease 1 0.9999680519104004
) O 0 2.337059212820236e-09
. O 0 4.671090181318505e-09
. O 0 8.957875508031066e-08

The O 0 6.57429154671263e-07
APCI1307K O 1 0.9999998807907104
allele O 0 2.288913520942515e-07
and O 0 3.482435317891941e-08
cancer B-Disease 0 6.239110007300042e-06
risk O 0 2.0372955589209596e-07
in O 0 4.955116317262309e-10
a O 0 5.598883578983305e-10
community O 0 2.5416810323086736e-10
- O 0 1.2655866354904788e-09
based O 0 2.3850030284044976e-10
study O 0 1.2874275256979928e-10
of O 0 8.671621753997272e-10
Ashkenazi O 0 1.6255672363740814e-08
Jews O 0 2.7884496489605226e-08
. O 0 6.162137822229852e-08

Mutations O 0 8.517782248418371e-07
in O 0 5.19534681941991e-09
APC O 0 5.244153271632968e-07
are O 0 3.8755562647985187e-10
classically O 0 4.585535862133838e-08
associated O 0 4.100844996912656e-09
with O 0 3.9651819605524e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.3449867992676445e-06
FAP B-Disease 1 1.0
) O 0 8.141108343018288e-10
, O 0 1.262049909023233e-10
a O 0 7.394065359989099e-10
highly O 1 0.999901533126831
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.1437821001436532e-07
by O 0 2.4734256309777436e-10
multiple O 0 2.10995153793192e-07
intestinal O 1 1.0
polyps B-Disease 1 0.7316324710845947
and O 0 8.828973996344303e-09
, O 0 4.1030648323392427e-10
without O 0 7.957617897957903e-10
surgical O 0 4.7993626139941625e-06
intervention O 0 7.1642682897277155e-09
, O 0 1.9744557377965322e-10
the O 0 5.204160991034712e-10
development O 0 2.4803099574199905e-09
of O 0 0.03097541257739067
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.306561862676972e-08
CRC B-Disease 1 0.9999995231628418
) O 0 2.080262362369467e-08
. O 0 7.54777786937666e-08

APC B-Disease 0 0.00013359542936086655
is O 0 9.578865700632377e-08
a O 0 3.490195155109177e-08
tumour O 1 1.0
- O 0 1.7889890386868501e-06
suppressor O 0 1.5683166338931187e-06
gene O 0 2.4698909584230933e-09
, O 0 4.982504964168299e-10
and O 0 3.1985571968817794e-09
somatic O 0 7.246204631883302e-07
loss O 0 2.95396148430882e-07
occurs O 0 6.371278615802112e-09
in O 0 1.8803644863396585e-08
tumours B-Disease 1 1.0
. O 0 3.086779088334879e-06

The O 0 5.690178568329429e-06
germline O 0 3.525156898831483e-06
T O 0 1.4885373502693255e-06
- O 0 3.217146726797182e-08
to O 0 8.046215915769039e-10
- O 0 2.527191256262995e-08
A O 0 1.6770369981600197e-08
transversion O 0 1.601412975560379e-07
responsible O 0 1.9768608972015045e-09
for O 0 2.3818116923202126e-10
the O 0 6.940469976512986e-09
APC O 0 6.812744572926022e-07
I1307K O 0 1.1687791356962407e-06
allele O 0 7.060128037750246e-09
converts O 0 1.2725894782406044e-09
the O 0 1.4267883541307924e-09
wild O 0 2.7242291977813693e-08
- O 0 1.3201330695267188e-08
type O 0 6.822566955833054e-09
sequence O 0 2.517907549126619e-10
to O 0 1.2093016865666328e-10
a O 0 2.1800370397784263e-09
homopolymer O 1 0.999995231628418
tract O 1 1.0
( O 0 6.265138097205636e-08
A8 O 1 1.0
) O 0 4.919828988647623e-10
that O 0 1.002276733830243e-10
is O 0 1.1838851010637086e-09
genetically O 0 2.556551947918706e-08
unstable O 0 3.134372761337545e-08
and O 0 9.928006861059657e-09
prone O 0 2.4541573111491743e-06
to O 0 7.376520727575553e-08
somatic O 0 6.337209470075322e-06
mutation O 0 5.047911031397234e-07
. O 0 1.3099301554575504e-07

The O 0 1.2317013897700235e-06
I1307K O 0 1.0823720003827475e-05
allele O 0 3.03206810770007e-08
was O 0 1.6677736525139153e-08
found O 0 8.697478293129279e-10
in O 0 1.9291304109714247e-09
6 O 0 9.325717655883636e-07
. O 0 2.5724003194227407e-07

1 O 0 6.308509910013527e-07
% O 0 7.542522162395926e-09
of O 0 1.0757528201565947e-08
unselected O 0 1.0493954505363945e-05
Ashkenazi O 0 2.6098360805804077e-08
Jews O 0 3.780268542641352e-09
and O 0 2.0127532973646112e-10
higher O 0 2.860557346551218e-10
proportions O 0 7.574798011056316e-10
of O 0 2.215905681168806e-09
Ashkenazim O 0 2.5969310968321224e-07
with O 0 5.851731321726561e-10
family O 0 1.4655630042881285e-09
or O 0 1.5211507609080854e-09
personal O 0 1.8652865918511452e-08
histories O 0 5.378794654120611e-08
of O 0 0.008753850124776363
CRC B-Disease 1 1.0
( O 0 1.0514845882880763e-08
ref O 0 4.360519483270764e-07
. O 0 1.2701886209498525e-09
2 O 0 6.725178991473513e-08
) O 0 9.162923753081031e-09
. O 0 7.497058618355368e-08

To O 0 7.775330601589303e-09
evaluate O 0 3.811453197499759e-08
the O 0 4.105023876377345e-09
role O 0 9.261353461909039e-09
of O 0 2.942034349473488e-08
I1307K O 0 2.159908490284579e-06
in O 0 4.446698564919416e-09
cancer B-Disease 0 1.1376523616490886e-06
, O 0 3.4152660699504622e-09
we O 0 4.0339265261479795e-09
genotyped O 0 1.804775024538685e-06
5 O 0 1.1436904401307402e-07
, O 0 1.1895874507672488e-08
081 O 0 6.364264208968962e-06
Ashkenazi O 0 4.6419518895390866e-08
volunteers O 0 4.27614432751966e-09
in O 0 1.8045894778495608e-09
a O 0 5.079315634759496e-09
community O 0 3.6579637097133855e-09
survey O 0 1.0603825373323161e-08
. O 0 5.019252213855907e-08

Risk O 0 3.0668086310470244e-06
of O 0 9.90725936844683e-08
developing O 0 9.555868018651381e-05
colorectal B-Disease 1 1.0
, I-Disease 0 3.5971052056993358e-06
breast I-Disease 1 1.0
and I-Disease 0 2.5679778303810963e-08
other I-Disease 0 6.315514333721239e-09
cancers I-Disease 1 0.9972670078277588
were O 0 5.131938207725284e-10
compared O 0 2.2412253997128317e-10
between O 0 7.953611658173543e-10
genotyped O 0 4.0945351429400034e-06
I1307K O 0 2.780086276743532e-07
carriers O 0 6.360674764671614e-10
and O 0 2.443369395699335e-10
non O 0 8.641180215818167e-09
- O 0 2.87924106778803e-09
carriers O 0 1.6552509363165768e-10
and O 0 3.9851847516425565e-11
their O 0 3.4994090958306856e-11
first O 0 1.292414647524609e-10
- O 0 1.0331885569314636e-08
degree O 0 1.5860736723993796e-08
relatives O 0 4.794254326867531e-09
. O 0 3.492686317940752e-08

Sperm O 0 6.541220898270694e-08
DNA O 0 7.488837994173991e-09
analysis O 0 8.149342312080421e-10
in O 0 1.4927223901395337e-09
a O 0 7.799381052109311e-08
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 0.9999964237213135
carrier O 0 5.916189138588379e-07
suggests O 0 2.4113385066470983e-08
both O 0 2.276741906115376e-09
meiotic O 0 7.104017072379065e-07
and O 0 1.569258500921933e-08
mitotic O 0 4.254343721754594e-08
expansion O 0 6.323628554127936e-08
in O 0 2.8436784038632368e-09
the O 0 7.88326914857862e-08
FRDA B-Disease 1 0.9919047355651855
gene O 0 3.221666986519267e-07
. O 0 3.396397403321316e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 8.981261089502368e-06
usually O 0 1.573232388807355e-08
caused O 0 2.8141371455348008e-09
by O 0 3.3403634025486184e-11
an O 0 1.1980202940797824e-10
expansion O 0 3.68012855744837e-08
of O 0 3.696054662327697e-08
a O 0 3.618142585537498e-08
GAA O 0 0.00010038713662652299
trinucleotide O 0 1.6236406736425124e-05
repeat O 0 9.219797192372425e-08
in O 0 1.8010580804528331e-09
intron O 0 1.8541810220540356e-07
1 O 0 5.001916036917464e-08
of O 0 2.1552645890210442e-08
the O 0 5.304411132556197e-08
FRDA B-Disease 1 0.9994514584541321
gene O 0 2.506313023786788e-07
. O 0 1.7900575244311767e-07

Occasionally O 0 1.0874259714910295e-06
, O 0 2.6100998695710587e-08
a O 0 5.756771948028927e-09
fully O 0 5.078165798977352e-08
expanded O 0 1.4789640623291689e-08
allele O 0 5.881409137487026e-09
has O 0 6.351836834284086e-10
been O 0 2.405763643853476e-10
found O 0 1.483516781641825e-10
to O 0 1.0629998270506036e-10
arise O 0 9.418127389082542e-10
from O 0 2.0146659340802842e-10
a O 0 8.435385723259969e-10
premutation O 0 2.773862490812462e-07
of O 0 5.1644750698187636e-08
100 O 0 3.739943466030127e-08
or O 0 3.5684390997658966e-09
less O 0 1.9428716413472102e-08
triplet O 0 2.707694193304633e-06
repeats O 0 3.919166147170472e-07
. O 0 3.473871572623466e-07

We O 0 2.0253719412721694e-07
have O 0 1.724669629332709e-09
examined O 0 9.32594801383857e-09
the O 0 7.065377727322186e-10
sperm O 0 8.856033961723853e-11
DNA O 0 6.705359045788839e-10
of O 0 2.7371656052821436e-09
a O 0 7.497942711154337e-09
premutation O 0 1.3979773939354345e-05
carrier O 0 5.720576723433624e-07
. O 0 4.0142114698937803e-07

This O 0 6.185052114915379e-08
mans O 0 8.653702025185339e-06
leucocyte O 0 4.852574420510791e-06
DNA O 0 5.682223402914133e-08
showed O 0 3.5498590733595847e-09
one O 0 2.891606121213641e-10
normal O 0 2.6383670248542046e-10
allele O 0 6.432716165294394e-11
and O 0 1.6983513206891843e-10
one O 0 2.8447405542308957e-10
allele O 0 8.651367400247523e-10
of O 0 6.474488056795735e-09
approximately O 0 8.189172895356478e-09
100 O 0 2.4648379337577353e-08
repeats O 0 3.440564100287702e-08
. O 0 1.3104599361213332e-07

His O 0 1.3470073554344708e-06
sperm O 0 4.679142406871506e-09
showed O 0 1.3188891090365473e-09
an O 0 1.2704207130731504e-10
expanded O 0 1.7789447692706517e-09
allele O 0 8.902069636995691e-10
in O 0 7.201844676174574e-10
a O 0 7.575365223999597e-09
tight O 0 5.114789018989541e-07
range O 0 6.538526235999598e-07
centering O 0 1.0827066176943845e-07
on O 0 1.030101248744586e-08
a O 0 9.588784211089774e-10
size O 0 6.8219812021652615e-09
of O 0 3.124083036709635e-08
approximately O 0 3.549556026882783e-08
320 O 0 2.827315483955317e-07
trinucleotide O 0 2.3375443561235443e-05
repeats O 0 1.1833674307126785e-06
. O 0 5.768875439571275e-07

His O 0 2.4931518964876886e-06
affected O 0 1.9026115296583157e-06
son O 0 1.105385990740615e-06
has O 0 1.1095071528188782e-08
repeat O 0 2.6605643910215804e-08
sizes O 0 7.366760090832258e-09
of O 0 1.3948332266977559e-08
1040 O 0 2.6862747404265974e-07
and O 0 3.784476376722523e-08
540 O 0 1.5247759392877924e-06
. O 0 3.480012367162999e-07

These O 0 1.2532672144516255e-07
data O 0 9.674008261129075e-09
suggest O 0 9.91040804976251e-10
that O 0 6.734784258055626e-11
expansion O 0 6.851085920800415e-09
occurs O 0 2.6266263469798545e-11
in O 0 7.2096443398672605e-12
two O 0 1.706422503300331e-11
stages O 0 7.736597473773088e-10
, O 0 1.2895902401499626e-10
the O 0 6.581487577150824e-10
first O 0 5.781273793026287e-10
during O 0 1.224514378783681e-09
meiosis O 0 1.5937267061616467e-09
followed O 0 1.1504082131352789e-09
by O 0 1.4966472505761885e-10
a O 0 2.2975417124371234e-09
second O 0 2.532474852046107e-08
mitotic O 0 4.780149964744851e-08
expansion O 0 1.3149622191122035e-06
. O 0 5.942369512013101e-07

We O 0 5.1347537777246544e-08
also O 0 1.0276144379872676e-09
show O 0 4.683390342208327e-10
that O 0 2.1209570558178292e-11
in O 0 6.05491906613409e-11
all O 0 3.5954167421081706e-10
informative O 0 9.170949333281442e-09
carrier O 0 5.144220605046712e-09
father O 0 1.471602284475182e-09
to O 0 3.103033385798426e-10
affected O 0 2.0001940104208416e-09
child O 0 2.0964210367679925e-09
transmissions O 0 8.94623930491889e-10
, O 0 3.276492271941933e-11
with O 0 1.3743880165895117e-11
the O 0 5.365745625596219e-10
notable O 0 3.1719955551068324e-09
exception O 0 2.757781114581803e-09
of O 0 1.1095367291602543e-08
the O 0 1.7913531991098353e-08
premutation O 0 4.839735538553214e-06
carrier O 0 2.1348000700527336e-08
, O 0 2.3610067234614007e-09
the O 0 8.078328228577902e-09
expansion O 0 1.1462564941666642e-07
size O 0 3.6589355545402213e-08
decreases O 0 5.6580084617507964e-08
. O 0 9.268315892541068e-09
. O 0 1.3673334819941374e-07

The O 0 9.8447935670265e-07
R496H O 0 1.34911279019434e-05
mutation O 0 2.984041813647309e-08
of O 0 2.8786550032577907e-08
arylsulfatase O 0 8.343546505784616e-05
A O 0 8.504762831762491e-07
does O 0 4.6711439161128965e-09
not O 0 3.675588278184705e-09
cause O 0 1.1666764976325794e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 5.28024338564137e-06

Deficiency B-Disease 1 0.9999972581863403
of I-Disease 0 1.8164362700190395e-05
arylsulfatase I-Disease 1 0.9999996423721313
A I-Disease 0 0.002836845349520445
( O 0 8.96370337954977e-08
ARSA O 1 1.0
) O 0 1.7088028769762786e-08
enzyme O 0 2.6336886449485064e-08
activity O 0 1.6947547365475657e-08
causes O 0 3.4983207797267823e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.1647509836620884e-06
MLD B-Disease 1 1.0
) O 0 2.3311663710501307e-07
. O 0 3.2793988680168695e-07

A O 0 5.263553930490161e-07
number O 0 1.1132570421068522e-08
of O 0 7.077996144744247e-08
ARSA O 1 0.9999988079071045
gene O 0 8.593174527504743e-08
mutations O 0 1.2281405226133302e-08
responsible O 0 4.365335204425946e-09
for O 0 3.0869840017544448e-09
MLD B-Disease 1 1.0
have O 0 6.426027265860057e-09
been O 0 2.1229586977256076e-09
identified O 0 3.0669653483528236e-09
. O 0 1.765361190564363e-08

Recently O 0 6.644787049481238e-07
, O 0 1.0319872068009772e-08
the O 0 1.1556164913884004e-08
R496H O 0 1.7045082358890795e-06
mutation O 0 1.468541110938304e-08
of O 0 4.160519040397048e-08
ARSA O 1 0.9999998807907104
was O 0 6.706336819206626e-08
proposed O 0 1.371294988672389e-08
to O 0 4.915467477495383e-10
be O 0 4.727014335514923e-10
a O 0 4.54086490631056e-10
cause O 0 6.9771695088149954e-09
of O 0 1.3948709920441615e-07
MLD B-Disease 1 1.0
( O 0 1.8680852420516203e-08
Draghia O 0 1.3347796993912198e-05
et O 0 4.1001118944450354e-08
al O 0 6.884305125964829e-09
. O 0 7.35702498921853e-10
, O 0 1.6510895983756768e-09
1997 O 0 3.6791110602507615e-08
) O 0 1.99061158667746e-08
. O 0 2.1096596469760698e-07

We O 0 2.418196913822612e-07
have O 0 2.8335647161981115e-09
investigated O 0 3.9678749175209305e-08
the O 0 1.0939007921706434e-08
R496H O 0 8.068012675721548e-07
mutation O 0 1.1065752758554481e-09
and O 0 2.343713556562932e-10
found O 0 9.556917063280324e-11
this O 0 3.5699602995986623e-11
mutation O 0 3.149741578667431e-10
at O 0 1.0485859958109245e-09
a O 0 3.6152555948909537e-10
relatively O 0 4.1945699691403604e-10
high O 0 2.2749448991277177e-09
frequency O 0 4.855615909349353e-10
in O 0 7.543880797822311e-11
an O 0 1.5626680505143042e-10
African O 0 3.313624374889912e-10
American O 0 7.208523777890719e-10
population O 0 2.8053722539445047e-11
( O 0 5.0004202167830414e-11
f O 0 1.1716853265397731e-08
= O 0 1.2924324943597298e-09
0 O 0 1.2065468624200548e-09
. O 0 2.16731604885112e-10
09 O 0 2.915042500717391e-07
, O 0 3.334535980670239e-09
n O 0 6.770932703403787e-09
= O 0 1.1947560274450097e-08
61 O 0 3.709331508616742e-08
subjects O 0 7.074891783531712e-08
) O 0 1.1574076808074096e-08
. O 0 7.975692284389879e-08

The O 0 7.939771421661135e-06
ARSA O 0 0.0011909366585314274
enzyme O 0 1.599904209115266e-08
activity O 0 7.490191245018707e-10
in O 0 2.024116985133162e-11
subjects O 0 1.0890432999843824e-09
with O 0 1.693233574184827e-11
and O 0 2.0888085705550452e-10
without O 0 5.864379537534603e-10
the O 0 2.1799537730515794e-09
R496H O 0 3.2618257250760507e-07
mutation O 0 7.886495345665878e-10
was O 0 1.159174534137719e-09
determined O 0 7.707375848653442e-10
and O 0 4.972527389845993e-10
found O 0 3.0687660745876144e-10
to O 0 7.073063801321666e-10
be O 0 2.764585449455126e-09
normal O 0 8.155149799904393e-08
. O 0 9.11641677703301e-08

It O 0 1.0393279126219568e-07
is O 0 4.7734780572739055e-09
therefore O 0 1.1048396642010516e-09
concluded O 0 7.253707634546913e-10
that O 0 6.460172674582765e-11
the O 0 3.210237187190046e-09
R496H O 0 1.7474704918640782e-06
mutation O 0 1.7293084297875794e-08
of O 0 8.73904255627167e-08
ARSA O 1 0.9852784872055054
does O 0 8.072674972936511e-09
not O 0 4.2015121937133415e-10
negatively O 0 2.3901363110923057e-09
influence O 0 2.7758082499218517e-09
the O 0 1.1600879146200782e-09
activity O 0 8.76042904884855e-10
of O 0 7.374970412143966e-09
ARSA O 1 0.9803666472434998
and O 0 6.527160145708422e-09
is O 0 9.712458615140918e-10
not O 0 2.549444544364121e-10
a O 0 2.1580444098390217e-09
cause O 0 1.5409599996019097e-07
of O 0 4.344233730080305e-06
MLD B-Disease 1 1.0

Down O 0 4.626246209227247e-06
- O 0 3.5689760125023895e-07
regulation O 0 1.1778679720464424e-07
of O 0 1.1134591915151759e-07
transmembrane O 0 7.357256208706531e-07
carbonic O 0 2.7582604161580093e-05
anhydrases O 0 6.933877011761069e-05
in O 0 4.7150795268180445e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 4.917047590424772e-06
by O 0 2.9511939558801714e-09
wild O 0 7.449055374308955e-06
- O 0 3.748596327568521e-06
type O 0 1.247121053893352e-05
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 0 0.038754578679800034
Lindau I-Disease 0 0.0992066040635109
transgenes O 0 0.00020697686704806983
. O 0 1.45051683375641e-06

To O 0 2.5251392798963934e-07
discover O 0 2.1495008439842422e-08
genes O 0 1.0857104104644577e-09
involved O 0 8.070423218597966e-10
in O 0 9.551345270253364e-10
von B-Disease 1 0.9999990463256836
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Lindau I-Disease 1 1.0
( O 0 3.14358743480625e-07
VHL B-Disease 1 1.0
) O 0 2.0878308859550998e-08
- O 0 9.71281679085223e-07
mediated O 0 7.61718297326297e-08
carcinogenesis O 1 0.9892940521240234
, O 0 1.6162882143788693e-09
we O 0 3.1593444527189263e-10
used O 0 1.7848755806681993e-09
renal B-Disease 1 1.0
cell I-Disease 1 0.9999971389770508
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.45720067620277405
stably O 0 1.1179828106833156e-05
transfected O 0 8.82599735518852e-08
with O 0 3.905200329779035e-10
wild O 0 4.1735222566785524e-07
- O 0 2.2215917852008715e-06
type O 0 1.445616999262711e-05
VHL O 1 1.0
- O 0 3.331164043629542e-05
expressing O 0 5.527209054889681e-07
transgenes O 0 1.6457004676340148e-05
. O 0 3.44182836897744e-07

Large O 0 4.6956088795013784e-07
- O 0 1.0951495710287418e-07
scale O 0 1.7554484088577738e-07
RNA O 0 8.856706301685335e-08
differential O 0 2.0084332419401107e-08
display O 0 1.3825168565517743e-08
technology O 0 2.8865929646570976e-09
applied O 0 2.1514807713174378e-09
to O 0 1.365072360703934e-10
these O 0 2.0064440386935445e-10
cell O 0 9.064168859929111e-10
lines O 0 4.837158673609565e-09
identified O 0 5.426395999208466e-10
several O 0 7.938456003664385e-10
differentially O 0 3.7907398109382484e-08
expressed O 0 5.070437403276173e-10
genes O 0 3.176522656023195e-10
, O 0 1.5371563744093208e-10
including O 0 6.024613585786653e-10
an O 0 7.026378368024666e-10
alpha O 0 8.351792502026001e-08
carbonic O 0 6.175446287670638e-07
anhydrase O 0 6.737569037795765e-06
gene O 0 2.169096546822402e-08
, O 0 9.31039689788804e-09
termed O 0 2.718976475080126e-06
CA12 O 1 0.9999998807907104
. O 0 3.963635208492633e-06

The O 0 1.3779146001979825e-06
deduced O 0 2.7836304639095033e-07
protein O 0 5.503385303029518e-09
sequence O 0 7.908804722234208e-10
was O 0 1.7876625735269158e-09
classified O 0 1.0747847056791215e-08
as O 0 9.674742118548352e-10
a O 0 3.0674729423196823e-10
one O 0 4.826787858291937e-10
- O 0 1.425191697990158e-07
pass O 0 8.396977477787004e-07
transmembrane O 0 4.1009883489095955e-07
CA O 1 0.9684402346611023
possessing O 0 6.143391146906652e-07
an O 0 3.788453550868098e-09
apparently O 0 1.2106669444733598e-08
intact O 0 3.326184128127352e-08
catalytic O 0 6.808179620065857e-08
domain O 0 1.1415869138886592e-08
in O 0 9.42909195167374e-10
the O 0 2.5237662626409474e-08
extracellular O 0 1.1970367950198124e-06
CA O 1 0.9938212037086487
module O 0 1.3695531379198655e-05
. O 0 7.041383014438907e-07

Reintroduced O 0 2.7757605494116433e-05
wild O 0 9.79588003247045e-06
- O 0 1.0036618732556235e-05
type O 0 7.228367394418456e-06
VHL B-Disease 1 0.9957358837127686
strongly O 0 2.636619100826465e-08
inhibited O 0 1.3478558713586608e-08
the O 0 2.549514155347765e-09
overexpression O 0 1.6384916534661897e-08
of O 0 8.641542592613405e-09
the O 0 1.023579265790886e-08
CA12 O 1 0.9996888637542725
gene O 0 1.3933114662023627e-09
in O 0 1.9527258976470563e-10
the O 0 4.379019813427476e-09
parental O 0 8.631046512164176e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.9999263286590576
. O 0 1.6699211755621945e-06

Similar O 0 7.776564814321318e-08
results O 0 1.6836384508778224e-09
were O 0 2.9688354552526164e-10
obtained O 0 2.0251529619930153e-10
with O 0 4.653231966411653e-10
CA9 O 0 6.895441765664145e-05
, O 0 3.3982550107225507e-09
encoding O 0 1.2412459504673734e-08
another O 0 7.032013193963849e-09
transmembrane O 0 1.1281755263325977e-07
CA O 0 1.6355636034859344e-05
with O 0 5.98668981055539e-09
an O 0 6.9620549325577485e-09
intact O 0 3.490076494472305e-07
catalytic O 0 3.717594836416538e-06
domain O 0 1.0549356375122443e-06
. O 0 2.7414756686994224e-07

Although O 0 4.4590326098159494e-08
both O 0 2.6019963961232406e-09
domains O 0 2.9785995891984385e-08
of O 0 8.407845797364644e-08
the O 0 1.0201455324931885e-07
VHL B-Disease 0 0.00046285917051136494
protein O 0 3.792314462458535e-09
contribute O 0 8.923556893414286e-10
to O 0 1.7379800376637888e-10
regulation O 0 2.265160858883064e-08
of O 0 1.3506164009413624e-07
CA12 O 1 1.0
expression O 0 2.0424481661507343e-08
, O 0 6.812823638568943e-10
the O 0 3.825930683376555e-09
elongin O 0 8.441990644314501e-07
binding O 0 3.393851955024729e-08
domain O 0 4.2098509567267683e-08
alone O 0 5.579845918646242e-09
could O 0 8.051485700377725e-09
effectively O 0 2.999345838361478e-07
regulate O 0 7.755745173199102e-06
CA9 O 1 0.9978158473968506
expression O 0 2.7718633646145463e-06
. O 0 6.905177087901393e-07

We O 0 8.221884968406812e-07
mapped O 0 5.989392320771003e-06
CA12 O 1 0.9999984502792358
and O 0 1.620980583538767e-06
CA9 O 0 0.0041708326898515224
loci O 0 3.5456525893096114e-07
to O 0 1.1922973719435959e-08
chromosome O 0 9.63300692546909e-08
bands O 0 2.98133954856894e-07
15q22 O 0 9.13634448806988e-06
and O 0 1.8803255841248756e-07
17q21 O 0 8.55688049341552e-05
. O 0 1.1400743460399099e-06

2 O 0 8.542235718778102e-07
respectively O 0 4.336970960139297e-08
, O 0 5.749638987140315e-09
regions O 0 5.810519709825712e-08
prone O 0 1.83258094921257e-07
to O 0 1.375456637475736e-09
amplification O 0 2.0654441712508742e-08
in O 0 1.2559343565143877e-09
some O 0 6.436343902294084e-09
human O 0 7.276953084556226e-08
cancers B-Disease 1 0.9999092817306519
. O 0 3.4759924005811627e-07

Additional O 0 1.2615726063813781e-07
experiments O 0 4.113080986911655e-09
are O 0 3.2429742918838045e-11
needed O 0 7.82523768005916e-11
to O 0 5.164762367781961e-11
define O 0 3.8421121839604666e-10
the O 0 2.6671920227983037e-10
role O 0 1.3426362244217671e-09
of O 0 2.5686293980697883e-08
CA O 0 0.00021870408090762794
IX O 1 1.0
and O 0 2.93388751515522e-07
CA O 0 0.00029956575599499047
XII O 1 0.9999998807907104
enzymes O 0 2.935597986919447e-09
in O 0 1.678872457722136e-10
the O 0 7.556169023814618e-10
regulation O 0 1.4899412370539267e-08
of O 0 2.804567245107137e-09
pH O 0 7.964200676724431e-08
in O 0 3.332092657348795e-10
the O 0 1.3589732672514288e-09
extracellular O 0 1.8857078121214954e-09
microenvironment O 0 2.390579822986183e-08
and O 0 6.324551438119386e-10
its O 0 1.0936478389567128e-09
potential O 0 6.280270081759909e-09
impact O 0 3.935502945751068e-08
on O 0 8.967926845571128e-08
cancer B-Disease 0 3.323443479530397e-06
cell O 0 1.6284228365748277e-07
growth O 0 2.911699823471281e-07
. O 0 2.1919048265317542e-07

A O 0 2.4633820885355817e-06
gene O 0 3.575703644287387e-08
encoding O 0 5.9145417452555193e-08
a O 0 1.3720170777276053e-08
transmembrane O 0 1.2363329915388022e-07
protein O 0 6.253736017924894e-08
is O 0 4.776590789568047e-10
mutated O 0 2.328689241437587e-09
in O 0 5.022730495407579e-11
patients O 0 8.330990897142954e-10
with O 0 3.1899058949846903e-09
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999449253082275
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.740884769674267e-08
. O 0 4.841601253247063e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 7.04945923644118e-05
WFS B-Disease 1 1.0
; O 0 4.2199522454211547e-07
OMIM O 1 1.0
222300 O 0 4.246112075634301e-05
) O 0 4.5976014106940966e-09
is O 0 1.112519854018501e-09
an O 0 5.084210386030463e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.8791147244078275e-09
by O 0 1.7846151639799857e-11
young O 0 5.977239259102873e-10
- O 0 4.6775294748613305e-08
onset O 0 9.277194294554647e-06
non O 1 0.9999997615814209
- O 1 0.9998664855957031
immune O 1 0.9999959468841553
insulin B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
dependent I-Disease 1 0.8703826665878296
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.0569230318069458
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 5.2526847866829485e-06

Linkage O 0 7.2053535404847935e-06
to O 0 7.891422626471467e-08
markers O 0 1.628430254640989e-06
on O 0 4.059392040289822e-07
chromosome O 0 1.9075459931627847e-06
4p O 0 5.559596957027679e-06
was O 0 1.7120131090564428e-08
confirmed O 0 2.4979662782698142e-09
in O 0 1.0783529624802668e-09
five O 0 5.033784056251989e-09
families O 0 3.8749059516618445e-10
. O 0 2.3594322939857193e-08

On O 0 1.1340296168782515e-07
the O 0 1.1243084685474969e-08
basis O 0 1.3067928072985069e-08
of O 0 2.658809172828569e-08
meiotic O 0 2.6515488571021706e-05
recombinants O 1 0.9999945163726807
and O 0 1.6653426371249225e-07
disease O 0 0.001837482675909996
- O 0 1.0399387662118897e-07
associated O 0 3.3437579372019854e-09
haplotypes O 0 2.9202920970305968e-08
, O 0 1.214695566353896e-09
the O 0 2.5611493370547578e-08
WFS B-Disease 1 0.9996860027313232
gene O 0 2.96998798887671e-08
was O 0 1.7369844229619957e-08
localized O 0 6.823402145528235e-07
to O 0 1.4294911920842424e-08
a O 0 1.0105206627031293e-07
BAC O 1 1.0
/ O 0 6.77119824104011e-05
P1 O 0 0.20840400457382202
contig O 0 1.1715103937603999e-05
of O 0 8.179046062650741e-08
less O 0 3.225513633964283e-09
than O 0 5.407653769218257e-10
250 O 0 2.6801529884323827e-08
kb O 0 7.969388207129668e-06
. O 0 3.6091969946028257e-07

Mutations O 0 2.966326064779423e-07
in O 0 5.942004221992647e-09
a O 0 7.790368350413246e-09
novel O 0 1.105508786736209e-07
gene O 0 8.02816124689798e-09
( O 0 2.259524123360279e-09
WFS1 O 1 0.9992738366127014
) O 0 3.518326074924971e-09
encoding O 0 1.557082107694896e-08
a O 0 4.516551577182781e-09
putative O 0 1.0146808193667312e-07
transmembrane O 0 5.168019789891787e-09
protein O 0 6.351751902222702e-10
were O 0 5.727785259979079e-11
found O 0 1.1829832252674422e-11
in O 0 6.419047151456914e-12
all O 0 3.527615352605373e-11
affected O 0 1.2727101317278056e-10
individuals O 0 3.6207174411440057e-12
in O 0 5.5711522201074004e-11
six O 0 2.635149431995387e-09
WFS B-Disease 0 1.9421348042669706e-05
families O 0 2.732885098777338e-11
, O 0 4.200003539400754e-11
and O 0 1.3324005787573867e-10
these O 0 3.556329120080193e-10
mutations O 0 2.618644190377495e-10
were O 0 3.1854401061348625e-11
associated O 0 1.401164601011473e-10
with O 0 5.1795034927693e-10
the O 0 1.0177704723446368e-07
disease O 0 2.8064314392395318e-05
phenotype O 0 6.07361982929433e-07
. O 0 1.7940806174010504e-07

WFS1 O 1 0.9999994039535522
appears O 0 1.2528967374692002e-07
to O 0 1.0901365365967308e-09
function O 0 1.0160589036800616e-09
in O 0 1.93864965747359e-10
survival O 0 4.8151242992844345e-08
of O 0 3.234559642351087e-08
islet O 0 4.590599019138608e-06
beta O 0 8.309986299082084e-08
- O 0 3.718093921634136e-08
cells O 0 1.7944323804641726e-10
and O 0 8.48895564953267e-10
neurons O 0 8.38953262416453e-09
. O 0 4.4742889393489804e-09
. O 0 6.453186784938225e-08

Stable O 0 1.949328634509584e-06
interaction O 0 1.0004232997573581e-08
between O 0 3.3501273977165624e-10
the O 0 5.324607976753271e-10
products O 0 3.702904427527187e-09
of O 0 3.876172272043732e-09
the O 0 5.764312405176497e-08
BRCA1 O 0 1.1384468052710872e-06
and O 0 1.6643423350615194e-07
BRCA2 O 0 1.0082860171678476e-05
tumor B-Disease 0 5.2617447181546595e-06
suppressor O 0 1.4123085065875784e-06
genes O 0 4.645456908036749e-09
in O 0 1.3169209056584918e-09
mitotic O 0 4.134200892735862e-08
and O 0 3.121331459965404e-08
meiotic O 0 9.833263902692124e-06
cells O 0 8.427289088785983e-08
. O 0 1.273819378866392e-07

BRCA1 O 0 8.128023910103366e-05
and O 0 2.4195188075282203e-07
BRCA2 O 0 8.983906809589826e-07
account O 0 1.176985869877356e-10
for O 0 2.974757246088089e-11
most O 0 2.128754637842345e-11
cases O 0 6.548876718692753e-11
of O 0 9.12871056524267e-10
familial O 0 2.742963545188104e-07
, O 0 5.851017448321727e-10
early O 0 1.5585313040133997e-09
onset O 0 1.0716303222579882e-06
breast B-Disease 1 1.0
and I-Disease 0 8.149727364070714e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3015112321212996e-09
encode O 0 1.1483512751819802e-10
products O 0 8.60827464865821e-10
that O 0 1.1087480759897073e-11
each O 0 6.933371238249109e-11
interact O 0 3.9848524480134984e-10
with O 0 1.3103513829548774e-09
hRAD51 O 0 6.497954927908722e-06
. O 0 2.602236577331496e-07

Results O 0 1.9470153489464792e-08
presented O 0 6.707268074279682e-09
here O 0 1.3480369598362074e-10
show O 0 6.407775421379824e-10
that O 0 2.3312746177950316e-10
BRCA1 O 0 8.243650739814257e-08
and O 0 1.949527295153075e-08
BRCA2 O 0 1.632768885428959e-06
coexist O 0 1.0481586265598253e-08
in O 0 2.368967244592568e-10
a O 0 5.139490499850297e-10
biochemical O 0 1.0755107027193844e-08
complex O 0 1.399462057349865e-08
and O 0 2.204615823231393e-09
colocalize O 0 1.3243242165117408e-06
in O 0 6.562149490463298e-09
subnuclear O 0 1.4460195416177157e-05
foci O 0 5.899067332393315e-07
in O 0 1.0567214880907727e-09
somatic O 0 3.9279495211985704e-09
cells O 0 2.7761229079437122e-11
and O 0 5.342347050851792e-11
on O 0 8.439006715654784e-10
the O 0 5.812796910475981e-10
axial O 0 1.718916919912772e-08
elements O 0 2.316480340880389e-09
of O 0 6.831173848809158e-09
developing O 0 3.0203914036519564e-08
synaptonemal O 0 1.0165497769776266e-05
complexes O 0 5.842230166308582e-07
. O 0 2.5255729951823014e-07

Like O 0 7.0032770054240245e-06
BRCA1 O 0 1.8578730305307545e-05
and O 0 4.634909771539242e-07
RAD51 O 1 0.9999997615814209
, O 0 9.487765169069462e-07
BRCA2 O 0 6.116836630098987e-06
relocates O 0 1.1863342308515712e-07
to O 0 4.989316515491282e-09
PCNA O 0 2.296407001267653e-05
+ O 0 1.0612384748753811e-08
replication O 0 5.906272693145809e-10
sites O 0 5.28752652773079e-10
following O 0 2.2293855650445948e-10
exposure O 0 3.1199501648870864e-08
of O 0 1.1204080330173838e-08
S O 0 8.724625217837456e-07
phase O 0 3.8288671788677675e-08
cells O 0 2.1020536700167014e-10
to O 0 1.895841705845669e-09
hydroxyurea O 0 4.47392540081637e-06
or O 0 7.722746175886641e-08
UV O 1 1.0
irradiation O 0 1.7825066606746987e-05
. O 0 3.7038321920590533e-07

Thus O 0 2.32867350291599e-07
, O 0 2.302965640410548e-08
BRCA1 O 0 1.4425815209051507e-07
and O 0 1.7011736019867385e-08
BRCA2 O 0 1.9994517685972824e-07
participate O 0 3.9936562390430197e-10
, O 0 1.279198413861593e-10
together O 0 4.758964403106525e-11
, O 0 1.0527578114816194e-10
in O 0 2.1479001910407192e-10
a O 0 2.6302586775273085e-09
pathway O 0 1.0449528353717596e-08
( O 0 2.392657738603532e-10
s O 0 1.8077450647524529e-09
) O 0 2.8364224163857088e-11
associated O 0 6.697430804392113e-11
with O 0 6.737546631718772e-11
the O 0 6.101317229223469e-10
activation O 0 1.2339277377648727e-09
of O 0 3.621157818045617e-09
double O 0 1.9593677791363007e-09
- O 0 1.7901202298276075e-08
strand O 0 6.36470742776396e-09
break O 0 1.0111507187104962e-08
repair O 0 5.647625656024502e-08
and O 0 1.2453650555244167e-08
/ O 0 2.9943842605462123e-07
or O 0 7.19479142929913e-09
homologous O 0 6.912541650194726e-09
recombination O 0 1.498174029279653e-08
. O 0 5.778920453280989e-08

Dysfunction O 1 0.8338650465011597
of O 0 6.131679128884571e-07
this O 0 1.5042663781272836e-09
pathway O 0 5.695240723468942e-09
may O 0 9.762358976761476e-11
be O 0 6.148698911134787e-11
a O 0 5.5176425928227246e-11
general O 0 1.2296463847150108e-10
phenomenon O 0 2.911696161955746e-10
in O 0 8.403020466951627e-12
the O 0 1.2370990343235633e-10
majority O 0 9.79882494589468e-12
of O 0 1.1686576706360086e-10
cases O 0 2.809067978226665e-10
of O 0 6.530773788426814e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3868217685342188e-08
. O 0 3.553240901510435e-08

A O 0 4.382236511446536e-06
novel O 0 1.100518034036213e-06
Arg362Ser O 0 1.1597218872338999e-05
mutation O 0 1.0051724785853366e-08
in O 0 6.715060174578014e-10
the O 0 3.7044232126248744e-09
sterol O 0 1.1421670933486894e-06
27 O 0 1.2107008728889923e-07
- O 0 3.198547346983105e-07
hydroxylase O 0 7.146076768549392e-06
gene O 0 3.0755373359170335e-08
( O 0 2.280775346363839e-09
CYP27 O 1 0.9999996423721313
) O 0 1.0471570277559294e-09
: O 0 8.655852423711252e-11
its O 0 1.2218634437566323e-10
effects O 0 8.894774694567786e-09
on O 0 3.159557060428142e-09
pre O 0 4.5320092567635584e-08
- O 0 7.396777412793654e-09
mRNA O 0 1.3050660552238469e-09
splicing O 0 3.0265316919297902e-09
and O 0 7.151417791284587e-10
enzyme O 0 4.940980957712782e-09
activity O 0 7.536453239254115e-09
. O 0 3.9302747723013454e-08

A O 0 1.6191452232305892e-06
novel O 0 1.7260830986742803e-07
C O 0 6.848227940281504e-08
to O 0 7.329335471872866e-10
A O 0 1.5444991063873204e-08
mutation O 0 4.834527222996599e-10
in O 0 1.2912344804494325e-10
the O 0 3.807803405919685e-09
sterol O 0 3.266628993969789e-07
27 O 0 7.168699767134967e-08
- O 0 1.500488053807203e-07
hydroxylase O 0 2.3474258341593668e-06
gene O 0 1.2190108478193906e-08
( O 0 8.69220473376231e-10
CYP27 O 1 0.9999997615814209
) O 0 9.46220546360621e-10
was O 0 3.535904680163071e-09
identified O 0 1.866939935979417e-10
by O 0 6.6719053892772e-11
sequencing O 0 1.378688097020131e-08
amplified O 0 2.482481988863583e-07
CYP27 O 1 0.999997615814209
gene O 0 8.75742589556694e-09
products O 0 9.178753757055347e-09
from O 0 2.0619232710128443e-10
a O 0 3.7156724919107376e-10
patient O 0 1.875191779632246e-09
with O 0 1.230245350036796e-09
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 6.351436923068832e-07
CTX B-Disease 1 1.0
) O 0 5.760311339031432e-08
. O 0 1.8720429295626673e-07

The O 0 1.4154367136143264e-06
mutation O 0 1.0695887198153287e-07
changed O 0 1.2805496218959433e-08
the O 0 1.5926730156934354e-08
adrenodoxin O 0 1.4629881661676336e-06
cofactor O 0 1.0350110102308463e-08
binding O 0 2.5902226141738538e-08
residue O 0 4.3976373831355886e-07
362Arg O 0 1.2295490705582779e-06
to O 0 1.6020662130245e-08
362Ser O 0 1.0219863725069445e-05
( O 0 6.187790546618999e-08
CGT O 1 0.998313307762146
362Arg O 0 7.868043212511111e-06
to O 0 6.791889006763085e-08
AGT O 1 1.0
362Ser O 0 1.9217609406041447e-06
) O 0 7.248756039857085e-10
, O 0 1.619354511595006e-10
and O 0 2.2848235803341055e-10
was O 0 2.549684019470533e-09
responsible O 0 1.7040500122078583e-09
for O 0 2.775733864979202e-09
deficiency O 0 1.4602031797039672e-06
in O 0 3.0177758070237815e-09
the O 0 8.331188894317165e-08
sterol O 0 4.935991455568001e-06
27 O 0 1.536592861839381e-07
- O 0 1.1348009820721927e-07
hydroxylase O 0 9.693865195004037e-07
activity O 0 3.858329211681166e-09
, O 0 1.5737379455149636e-10
as O 0 7.901607840254954e-11
confirmed O 0 3.941995341261162e-11
by O 0 5.109189113450263e-11
expression O 0 1.043657604782311e-09
of O 0 1.206768374117928e-08
mutant O 0 8.697868025819844e-08
cDNA O 0 2.4625681049883497e-08
into O 0 7.132431978362774e-09
COS O 0 1.616129702597391e-05
- O 0 1.5617851545357553e-07
1 O 0 1.2335924282069755e-07
cells O 0 3.820323168923778e-09
. O 0 2.1872269329037408e-08

Quantitative O 0 3.488678714802518e-07
analysis O 0 1.9246613192080986e-09
showed O 0 7.042935679102413e-10
that O 0 2.5758570623701793e-11
the O 0 5.178733553101722e-10
expression O 0 1.1761203122517827e-09
of O 0 7.523699885325641e-09
CYP27 O 0 6.886971095809713e-05
gene O 0 7.914961464017267e-10
mRNA O 0 7.353784803321162e-10
in O 0 1.90756022089289e-10
the O 0 5.131656877210844e-09
patient O 0 1.4316031915484473e-08
represented O 0 5.6057678499144e-09
52 O 0 1.6356335663658683e-07
. O 0 1.4109311052834528e-07

5 O 0 1.3452057601170964e-07
% O 0 2.6979181111386197e-09
of O 0 7.53495843497376e-09
the O 0 1.5373601058854547e-08
normal O 0 4.677850640177894e-08
level O 0 2.0902500352804054e-07
. O 0 2.399804372998915e-07

As O 0 1.2370772140002373e-07
the O 0 2.1471159072916635e-08
mutation O 0 1.6806480651609945e-09
occurred O 0 4.56265580872639e-10
at O 0 1.6806738223351658e-09
the O 0 2.338374383015207e-09
penultimate O 0 2.175908875301502e-08
nucleotide O 0 1.4257328651012813e-09
of O 0 7.618516484342308e-09
exon O 0 4.7202625808040466e-08
6 O 0 3.768909806467491e-08
( O 0 1.2825454587250817e-10
- O 0 7.0111205729972426e-09
2 O 0 1.3410091703747185e-08
position O 0 6.177481637337223e-09
of O 0 7.522896083855812e-09
exon O 0 7.956092673566673e-08
6 O 0 7.898289311469853e-08
- O 0 1.5519532325924956e-07
intron O 0 5.319375873114041e-07
6 O 0 3.900388279021172e-08
splice O 0 2.6467768421412075e-08
site O 0 1.2438261531855233e-09
) O 0 6.005668184982937e-11
of O 0 7.488791253784655e-10
the O 0 1.6780377087854959e-09
gene O 0 1.0236881342606807e-09
, O 0 6.285708065156825e-10
we O 0 6.773822613936886e-10
hypothesized O 0 2.3101796031710364e-09
that O 0 5.5529157660938466e-11
the O 0 1.4464125452917642e-09
mutation O 0 2.713922864217011e-09
may O 0 5.178891204771219e-10
partially O 0 2.5350892940423364e-08
affect O 0 1.903450508322635e-09
the O 0 8.527122896673234e-10
normal O 0 3.3613925531916777e-10
splicing O 0 2.0348482621113106e-10
efficiency O 0 1.890086309686012e-09
in O 0 4.594934155388586e-10
exon O 0 6.794648754748778e-08
6 O 0 3.9495798631605794e-08
and O 0 1.5558107024915557e-09
cause O 0 1.6365854227373688e-09
alternative O 0 7.289573944468941e-10
splicing O 0 2.37912856082545e-10
elsewhere O 0 2.781939123508437e-10
, O 0 1.0166671671196781e-10
which O 0 4.503858050397547e-11
resulted O 0 2.337562809984206e-09
in O 0 2.429307588425189e-10
decreased O 0 1.5317960233574013e-08
transcript O 0 3.85343090769652e-09
in O 0 1.4175223217449684e-09
the O 0 5.612874787175315e-08
patient O 0 2.8255848860681e-07
. O 0 1.8805442891789426e-07

Transfection O 0 2.9027714845142327e-06
of O 0 1.9091679348548496e-07
constructed O 0 1.4005627235746942e-07
minigenes O 0 1.940632955665933e-06
, O 0 7.288850634168398e-10
with O 0 6.106273819916908e-11
or O 0 2.5546434412326846e-10
without O 0 6.061184887329318e-10
the O 0 1.6213766995676338e-09
mutation O 0 1.7971736321342746e-09
, O 0 8.579196797420252e-10
into O 0 3.763276357204859e-09
COS O 0 2.047304224106483e-05
- O 0 3.8975844773858626e-08
1 O 0 9.50741974037328e-09
cells O 0 2.4731694123203418e-11
confirmed O 0 3.858972863479693e-11
that O 0 7.160855242105413e-12
the O 0 9.610114926061897e-10
mutant O 0 3.1551923740380516e-08
minigene O 0 5.590031832980458e-07
was O 0 8.674073903591761e-09
responsible O 0 1.7918408978800926e-09
for O 0 5.529465774145592e-10
a O 0 7.051430550575333e-10
mRNA O 0 9.740719342232751e-09
species O 0 5.648148060366509e-10
alternatively O 0 2.700636603236717e-09
spliced O 0 3.973221751607525e-08
at O 0 1.4838069439804258e-08
an O 0 3.0693003694182153e-09
activated O 0 1.0364135505369632e-06
cryptic O 0 1.7509585177322151e-06
5 O 0 1.419915776068592e-07
splice O 0 5.475661737364135e-07
site O 0 1.4674552062388102e-07
88 O 0 1.8956841074668773e-07
bp O 0 1.826395212845e-08
upstream O 0 1.3596636705415222e-08
from O 0 1.883686678860741e-10
the O 0 1.2765324353125607e-09
3 O 0 9.394772959581132e-09
end O 0 4.651965035407102e-09
of O 0 1.875392996453229e-08
exon O 0 8.358962304555462e-07
6 O 0 1.2304334404689143e-06
. O 0 2.8324674872237665e-07

Our O 0 4.4963934442421305e-07
data O 0 8.311900501212222e-09
suggest O 0 1.4595485930968266e-09
that O 0 7.46776251947523e-11
the O 0 1.0591287846750674e-09
C O 0 2.9399924272865974e-08
to O 0 1.0283398577115577e-09
A O 0 3.18752313432924e-08
mutation O 0 7.557566794602621e-10
at O 0 1.1396522614504079e-09
the O 0 1.4640794132603219e-09
penultimate O 0 9.763503783233318e-09
nucleotide O 0 2.9832702974630365e-10
of O 0 1.93375004897689e-09
exon O 0 1.5096938810188476e-08
6 O 0 1.6904124322536518e-08
of O 0 5.5539381982327996e-09
the O 0 8.180009558600432e-09
CYP27 O 1 0.999995231628418
gene O 0 2.2923720699452588e-09
not O 0 8.074545893022034e-11
only O 0 6.772449268055425e-11
causes O 0 7.713685246102386e-10
the O 0 1.7142764985322856e-09
deficiency B-Disease 0 5.2057156807450156e-08
in I-Disease 0 1.0843983488939557e-09
the I-Disease 0 3.417411775785695e-08
sterol I-Disease 0 1.3903331819165032e-06
27 I-Disease 0 1.212749651813283e-07
- I-Disease 0 1.0157981478187139e-07
hydroxylase I-Disease 0 6.382531410054071e-07
activity I-Disease 0 4.233199568659529e-09
, O 0 2.2431968782488099e-10
but O 0 1.121674905735226e-10
also O 0 1.019971440641143e-09
partially O 0 1.2253542536200257e-07
leads O 0 2.6082969117879884e-09
to O 0 1.3650203189996546e-10
alternative O 0 9.79754388730214e-10
pre O 0 5.683596704386673e-09
- O 0 1.6900345567449904e-09
mRNA O 0 6.080939640717986e-10
splicing O 0 7.103849175571497e-10
of O 0 1.433966390074204e-09
the O 0 5.567599270506207e-09
gene O 0 2.625633577224562e-08
. O 0 8.516744998132708e-08

To O 0 3.947283033767235e-08
our O 0 1.0467640976230541e-08
knowledge O 0 9.461321726078609e-10
, O 0 1.4772541523377924e-10
this O 0 1.8395273151949887e-11
is O 0 7.938467244672509e-11
the O 0 2.6287025334248426e-10
first O 0 3.460476072358887e-10
report O 0 3.8734351837099723e-10
regarding O 0 8.434954956726415e-09
effects O 0 5.238614519953444e-08
on O 0 9.131170486398332e-09
pre O 0 4.157108079994032e-08
- O 0 3.642181223284524e-09
mRNA O 0 7.193978190933592e-10
splicing O 0 1.134613847320054e-09
of O 0 1.1128212795696868e-09
a O 0 2.1132050276317926e-10
mutation O 0 1.2014894634759798e-10
at O 0 4.180321089286565e-10
the O 0 6.970541366335681e-10
- O 0 1.1429377444471811e-08
2 O 0 2.071282878546299e-08
position O 0 6.553306342027554e-09
of O 0 1.004940486382111e-08
a O 0 8.360826697639823e-09
5 O 0 1.5488924987039354e-07
splice O 0 2.0120546651014592e-06
site O 0 6.123789830780879e-07
. O 0 3.4973598417309404e-07

ATM O 0 0.0015994110144674778
germline O 0 9.820424565987196e-06
mutations O 0 2.1932262939117209e-07
in O 0 6.702804533631479e-09
classical O 1 0.9766322374343872
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 6.597555852749792e-07
in O 0 1.6930083723831757e-10
the O 0 1.4560089800497167e-09
Dutch O 0 1.0678962780730217e-06
population O 0 9.430638492347043e-10
. O 0 1.366748936248996e-08

Germline O 0 7.832414667063858e-06
mutations O 0 5.2086154056496525e-08
in O 0 1.1138405753285952e-09
the O 0 8.831752218441125e-09
ATM O 0 1.847225121309748e-06
gene O 0 1.1115124376459562e-09
are O 0 9.874716495883451e-12
responsible O 0 5.573989880769403e-11
for O 0 3.7969932753512126e-11
the O 0 1.7446316746827506e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.691632576239499e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.3316461650324527e-08
. O 0 7.681173030960053e-08

In O 0 5.990129636757047e-08
our O 0 1.1498275220844789e-08
study O 0 4.275065579317783e-10
, O 0 1.4566389761050402e-10
we O 0 5.439118253014463e-11
have O 0 2.0916582701979713e-11
determined O 0 2.9952434976721065e-10
the O 0 8.456441102921985e-10
ATM O 0 2.8147621833340963e-07
mutation O 0 1.7090171500200313e-09
spectrum O 0 5.0582493749118385e-09
in O 0 2.4313842605927505e-10
19 O 0 8.421099373379093e-09
classical O 0 4.4773898366656795e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.1606779415938036e-09
, O 0 2.684292718657666e-11
including O 0 3.6111259815729824e-11
some O 0 1.3954139059524362e-11
immigrant O 0 1.6535682545448793e-11
populations O 0 2.0007030754332078e-11
, O 0 1.3505454567186437e-11
as O 0 2.6795151167324782e-11
well O 0 1.071727359636121e-10
as O 0 1.528493581703927e-10
12 O 0 9.046137172674662e-10
of O 0 1.7180638023361894e-09
Dutch O 0 7.84536211995146e-07
ethnic O 0 3.115775726314496e-08
origin O 0 4.245416906911714e-09
. O 0 2.3038882801529326e-08

Both O 0 9.247624888075734e-08
the O 0 4.188402513705114e-08
protein O 0 4.598899927543698e-09
truncation O 0 8.912746807254734e-08
test O 0 9.724512750608483e-09
( O 0 2.953203903643953e-09
PTT O 0 0.00023885098926257342
) O 0 1.8331509643587651e-09
and O 0 9.337690620725425e-10
the O 0 3.3999403292739316e-09
restriction O 0 5.86928372570128e-09
endonuclease O 0 7.18756609785487e-08
fingerprinting O 0 1.081340386122065e-07
( O 0 2.3894937140056527e-09
REF O 0 2.6900611374003347e-06
) O 0 5.975070438424268e-11
method O 0 8.147162111615813e-11
were O 0 9.568366932111161e-12
used O 0 1.9345117521774036e-11
and O 0 3.2329260796215564e-11
compared O 0 5.370985253771998e-11
for O 0 2.5496816463688177e-11
their O 0 1.2719960501561545e-11
detection O 0 9.457279404045948e-10
efficiency O 0 1.8306143267921016e-09
, O 0 8.32680868700919e-11
identifying O 0 1.1396152910236879e-09
76 O 0 2.2165649316008285e-09
% O 0 1.5365340944040184e-11
and O 0 2.668529112959117e-11
60 O 0 3.30009519711183e-10
% O 0 2.6798320507115392e-11
of O 0 4.1263112371403565e-10
the O 0 5.526822111079355e-09
mutations O 0 1.0573772968314188e-08
, O 0 4.425013688802437e-09
respectively O 0 9.557076197097558e-08
. O 0 3.372383901023568e-07

Most O 0 1.0751295320687859e-07
patients O 0 5.688607362941411e-09
were O 0 2.337887383685455e-10
found O 0 6.963668530701739e-11
to O 0 2.71035749399573e-10
be O 0 9.938819767185691e-10
compound O 0 3.186708852354059e-08
heterozygote O 0 1.170595055555168e-06
. O 0 1.614627365142951e-07

Seventeen O 0 1.0299124824086903e-06
mutations O 0 1.5248399209966124e-09
were O 0 1.7667639573559768e-10
distinct O 0 1.493117435247271e-10
, O 0 2.0151800367296246e-11
of O 0 1.6154366733189818e-10
which O 0 1.8051489122927755e-11
10 O 0 2.8148766650915036e-10
were O 0 9.566600983612616e-11
not O 0 1.8587889560883752e-10
reported O 0 6.266725360859482e-09
previously O 0 4.5350483901529515e-07
. O 0 4.831490514334291e-07

Mutations O 0 8.669890689816384e-07
are O 0 3.5098339790096134e-09
small O 0 1.1894400131495786e-08
deletions O 0 2.0683424395429029e-07
or O 0 3.641307699808749e-08
point O 0 2.2387957869796082e-06
mutations O 0 8.542042451153975e-08
frequently O 0 5.41174536294875e-08
affecting O 0 3.246089477215719e-07
splice O 0 1.8639690324562252e-06
sites O 0 5.252962864688016e-07
. O 0 1.9035864795569069e-07

Moreover O 0 2.349981741645024e-06
, O 0 6.712479461157272e-08
a O 0 2.631258588792207e-08
16 O 0 3.334836833346344e-07
. O 0 3.1006703693492454e-07

7 O 0 3.3739518130460056e-06
- O 0 9.490045158599969e-07
kb O 0 1.7645299976720707e-06
genomic O 0 3.8001434887746655e-08
deletion O 0 4.423604593739583e-09
of O 0 1.2459964171540605e-09
the O 0 5.021640880897849e-10
3 O 0 1.6578458605920332e-09
end O 0 5.083374277070618e-10
of O 0 1.2162558737927043e-09
the O 0 7.961124537381181e-10
gene O 0 1.6078563480625974e-10
, O 0 8.161610970391919e-11
most O 0 6.313460171325502e-11
likely O 0 7.8893648558509e-11
a O 0 2.865153600484227e-11
result O 0 8.351239144666067e-11
of O 0 2.3422747075230177e-10
recombination O 0 7.515685122860827e-12
between O 0 7.475657592959095e-11
two O 0 1.16246408332632e-10
LINE O 0 8.107858775474597e-07
elements O 0 3.244493562704065e-09
, O 0 7.893131703795575e-10
was O 0 1.8836310289316316e-08
identified O 0 2.686991251721338e-08
. O 0 1.6470525565637217e-07

The O 0 4.1495118807688414e-07
most O 0 6.947038944105088e-09
frequently O 0 1.4402899983778639e-09
found O 0 1.735131621716235e-10
mutation O 0 1.8854695582604108e-10
, O 0 5.4969598317633483e-11
identified O 0 3.6131861391730524e-11
in O 0 5.884837062097859e-11
three O 0 2.146319511009409e-10
unrelated O 0 6.151050779834577e-09
Turkish O 0 5.529629731881869e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 3.8057393347834534e-10
, O 0 3.106639945293921e-10
was O 0 5.262275948325623e-09
previously O 0 6.7256000768622926e-09
described O 0 3.1121019650193205e-10
to O 0 1.2453305053838903e-10
be O 0 1.0581670956133493e-10
a O 0 2.357221084992034e-10
Turkish O 0 1.89207185030682e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 2.5695422664284706e-05
mutation O 0 1.087238274521951e-06
. O 0 1.2228980494910502e-07

The O 0 1.503112088130365e-07
presence O 0 1.665967630515297e-08
of O 0 6.289214837806867e-08
a O 0 1.8175684957100202e-08
founder O 0 1.0409786455056746e-07
mutation O 0 1.747557654141474e-09
among O 0 9.155595032117603e-11
relatively O 0 7.897103110332537e-11
small O 0 7.833868970186231e-11
ethnic O 0 1.382417930129165e-10
population O 0 1.196260863804699e-12
groups O 0 3.673008620343199e-13
in O 0 9.714598916965578e-12
Western O 0 8.131692652568745e-09
Europe O 0 6.911961225597452e-09
could O 0 1.2064110821441432e-09
indicate O 0 6.240075678398682e-10
a O 0 2.6446395073875806e-10
high O 0 1.164038287981839e-08
carrier O 0 2.767555740135208e-09
frequency O 0 1.3315958335979872e-09
in O 0 5.99395255651558e-10
such O 0 1.400410010177211e-08
communities O 0 6.669191776609296e-08
. O 0 1.3993290792768676e-07

In O 0 1.1070276251246014e-08
patients O 0 1.1676244415781412e-09
of O 0 6.626745818749669e-10
Dutch O 0 7.961056525118693e-08
ethnic O 0 3.5836952849699344e-10
origin O 0 1.1124042659238498e-11
, O 0 6.688720757819233e-12
however O 0 3.105305249051504e-11
, O 0 1.695493467845921e-10
no O 0 2.211788530104286e-09
significant O 0 1.3777943230763867e-08
founder O 0 7.524793232960292e-08
effect O 0 2.646888042079354e-08
could O 0 2.6511357553715698e-09
be O 0 1.4895740196863017e-09
identified O 0 5.529605662246695e-09
. O 0 1.0501621261482796e-07

The O 0 2.0726035643292562e-07
observed O 0 1.644399461042667e-08
genetic O 0 6.078136216558505e-09
heterogeneity O 0 2.4761657613225907e-08
including O 0 1.2991624442904026e-09
the O 0 3.513356716666749e-09
relative O 0 3.4764540135512334e-09
high O 0 5.380682566169526e-08
percentage O 0 7.670891477573605e-09
of O 0 7.458488937572838e-09
splice O 0 3.540864099704777e-07
- O 0 2.2468758231752872e-07
site O 0 4.552125076884295e-08
mutations O 0 6.1938569828612344e-09
had O 0 1.944409300236316e-09
no O 0 9.72163349821642e-10
reflection O 0 2.430736278924428e-09
on O 0 6.6501102402583e-09
the O 0 2.8519307804231175e-08
phenotype O 0 2.1639276326368417e-07
. O 0 1.503585025375287e-07

All O 0 3.145401876736287e-07
patients O 0 1.724144205184075e-08
manifested O 0 1.2631613088842641e-08
classical O 0 2.764940276733796e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 1.9647053761673305e-08
increased O 0 4.1669515837838844e-08
cellular O 0 6.678000374904514e-08
radioresistant O 0 3.3992334920185385e-06
DNA O 0 7.340436525282712e-08
synthesis O 0 6.56797496390027e-08
. O 0 5.026207361424895e-08

Determination O 0 2.3852023787185317e-06
of O 0 1.9245582905114134e-07
the O 0 1.1838337421465894e-08
genomic O 0 1.3552258870674905e-08
structure O 0 3.758075628468305e-09
of O 0 4.81528683593524e-09
the O 0 4.137140852122911e-09
COL4A4 O 1 0.9999943971633911
gene O 0 9.955555269058891e-10
and O 0 1.7096357662893524e-10
of O 0 5.058114371792044e-09
novel O 0 9.952466371032642e-07
mutations O 0 7.883538160058379e-07
causing O 0 7.45290526538156e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.0772998848551651e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.800562981519761e-07
a O 0 3.175859575321738e-08
progressive O 0 0.0032366386149078608
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 2.0220304577378556e-06
by O 0 3.635795442491485e-09
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999998807907104
membrane I-Disease 1 0.9026682376861572
abnormalities I-Disease 1 0.9999992847442627
and O 0 2.054489023350925e-09
associated O 0 1.429416918163895e-09
with O 0 4.986098756099011e-10
mutations O 0 2.724570791201586e-09
in O 0 1.1339425926015778e-10
either O 0 7.96068488906343e-10
the O 0 7.684891834003338e-09
COL4A3 O 1 1.0
or O 0 5.3539199740271215e-09
the O 0 1.6390291790457923e-08
COL4A4 O 1 0.9999797344207764
gene O 0 1.6036305616751179e-09
, O 0 1.5572319822521052e-10
which O 0 3.0975090548057693e-11
encode O 0 1.4607845488789906e-10
the O 0 1.3524853459401243e-09
alpha3 O 0 1.809383206818893e-06
and O 0 2.1412800421671818e-08
alpha4 O 0 4.222630741423927e-05
type O 0 0.0003212649608030915
IV O 1 1.0
collagen O 1 1.0
chains O 0 0.21243572235107422
, O 0 2.568114965129098e-08
respectively O 0 8.651903726786259e-08
. O 0 1.7061721280242637e-07

To O 0 2.346551752907544e-08
date O 0 1.5603703218403098e-08
, O 0 5.333511965410764e-10
mutation O 0 7.989003208974665e-11
screening O 0 4.02666788801298e-10
in O 0 9.232137970771603e-11
the O 0 1.2810399407925388e-09
two O 0 3.87099824417092e-10
genes O 0 6.088646253843422e-10
has O 0 3.284540694981075e-10
been O 0 4.0235356713047565e-10
hampered O 0 5.0673097717890414e-08
by O 0 1.6403660374475493e-10
the O 0 2.355802219966563e-09
lack O 0 1.1701509983197411e-08
of O 0 9.42276834337008e-09
genomic O 0 3.386066893540374e-08
structure O 0 3.4214881594607505e-08
information O 0 6.663225970982012e-09
. O 0 8.963566244801768e-08

We O 0 3.642558255023687e-08
report O 0 1.1762997242925621e-09
here O 0 5.3594316484772975e-11
the O 0 2.384066000171714e-10
complete O 0 2.397024523315139e-10
characterization O 0 9.92675275313104e-10
of O 0 2.1025079455228024e-09
the O 0 2.731501469455111e-09
48 O 0 1.0306927755721063e-08
exons O 0 1.1943391164948025e-08
of O 0 4.2587767978830016e-08
the O 0 1.1032317814851922e-07
COL4A4 O 1 1.0
gene O 0 5.597455832173637e-09
, O 0 4.548189047604012e-10
a O 0 1.7862233914200942e-10
comprehensive O 0 3.982385088363571e-09
gene O 0 2.639932439318926e-10
screen O 0 5.669618996506642e-09
, O 0 1.837820451378036e-10
and O 0 2.0317920956802737e-10
the O 0 3.5036318291048474e-10
subsequent O 0 2.359173412180837e-10
detection O 0 6.58400178821239e-09
of O 0 4.536313547021109e-09
10 O 0 8.166259668485054e-09
novel O 0 3.935015158162969e-08
mutations O 0 1.1627018237092557e-09
in O 0 6.400686924923349e-11
eight O 0 2.962699197084362e-09
patients O 0 1.609624655785069e-09
diagnosed O 0 3.0692728358872046e-08
with O 0 1.825190310000835e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.4498032214760315e-06

Furthermore O 0 1.1413210359023651e-06
, O 0 2.178483526904529e-08
we O 0 2.960258926876236e-09
identified O 0 1.4794994118716431e-09
a O 0 5.426520344187225e-10
glycine O 0 3.969099715561697e-09
to O 0 9.781505605488405e-10
alanine O 0 2.0267741263069183e-08
substitution O 0 4.27436663841263e-09
in O 0 5.562288962757123e-10
the O 0 9.606599959965934e-09
collagenous O 0 2.0445372683752794e-06
domain O 0 9.682277202216483e-09
that O 0 1.6005831382504e-10
is O 0 3.698928385809097e-10
apparently O 0 1.2075345168227614e-09
silent O 0 2.5262657743496675e-08
in O 0 3.9087105774271436e-10
the O 0 4.789712182429184e-09
heterozygous O 0 4.091165184405554e-09
carriers O 0 7.171113702852949e-10
, O 0 4.831697264506829e-10
in O 0 1.4024674754864463e-09
11 O 0 1.295338449835981e-07
. O 0 2.0915720710945607e-07

5 O 0 4.192462554897247e-08
% O 0 7.444187488658827e-10
of O 0 9.039376469566207e-10
all O 0 2.838290991125092e-10
control O 0 1.956973694205999e-09
individuals O 0 1.4792382596606757e-11
, O 0 3.631494757683207e-11
and O 0 1.2963154161216295e-10
in O 0 1.373612890098741e-10
one O 0 7.569208593238841e-10
control O 0 1.3522281960831606e-08
individual O 0 6.328919610609773e-10
homozygous O 0 2.4741910742420714e-09
for O 0 1.8673386448231355e-10
this O 0 1.2517699377045943e-10
glycine O 0 7.693251369289555e-09
substitution O 0 2.7611088526668937e-08
. O 0 8.260098383061631e-08

There O 0 5.911056888407984e-08
has O 0 1.936119486956045e-09
been O 0 3.29700600154581e-10
no O 0 3.3126132392702345e-10
previous O 0 8.457456956989517e-10
finding O 0 4.869221692516135e-10
of O 0 6.598380175582008e-10
a O 0 1.496527346489529e-10
glycine O 0 2.748254401829797e-10
substitution O 0 7.349676423018536e-10
that O 0 2.487556167996008e-11
is O 0 4.177720669407137e-11
not O 0 4.917450561331416e-12
associated O 0 3.141897852998454e-11
with O 0 1.0935680139212423e-10
any O 0 6.919612438593958e-09
obvious O 0 4.2676564504517955e-08
phenotype O 0 6.046892764288714e-09
in O 0 1.9625583380644684e-09
homozygous O 0 3.6592919627764786e-07
individuals O 0 5.166383765242699e-09
. O 0 1.0830990504473448e-07

Founder O 0 7.629073661519215e-05
BRCA1 O 0 9.7175725386478e-06
and O 0 2.4234563511527085e-07
BRCA2 O 0 4.295624421501998e-06
mutations O 0 2.6800446306651793e-09
in O 0 1.9096679793051408e-10
French O 0 4.924406198369979e-07
Canadian O 0 3.840098088403465e-06
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.2767161489412047e-09
. O 0 1.0989344545464519e-08

We O 0 3.529922665279628e-08
have O 0 4.1115177928929825e-10
identified O 0 5.324283236518568e-10
four O 0 5.041638981295726e-11
mutations O 0 4.021270469389826e-11
in O 0 1.4857079108643312e-11
each O 0 4.593337515901297e-11
of O 0 2.0988017990219987e-09
the O 0 3.1406141687284617e-08
breast B-Disease 1 0.9999951124191284
cancer I-Disease 0 5.183984740142478e-06
- O 0 2.4547702537347504e-07
susceptibility O 0 1.7411446151527343e-07
genes O 0 1.8616816976901873e-09
, O 0 4.0862110917139205e-10
BRCA1 O 0 2.7987120176931057e-08
and O 0 4.350854787560365e-09
BRCA2 O 0 3.943099784464721e-07
, O 0 7.404617891060283e-11
in O 0 5.84122403224363e-11
French O 0 9.400547895666023e-08
Canadian O 0 8.274368923366637e-08
breast B-Disease 1 0.7793310284614563
cancer I-Disease 0 0.0001378033048240468
and O 0 2.1825890428317507e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.1327148247142205e-10
from O 0 3.220618494115257e-10
Quebec O 0 2.876032112908433e-06
. O 0 8.740259005435291e-08

To O 0 1.5800428343482054e-07
identify O 0 2.2503563457121345e-07
founder O 0 1.359643420073553e-07
effects O 0 0.00010337954881833866
, O 0 6.467354207728704e-09
we O 0 2.2111390496348804e-09
examined O 0 7.087976428010734e-09
independently O 0 8.315417243665024e-10
ascertained O 0 2.3964874529269764e-08
French O 0 5.779284251161698e-08
Canadian O 0 1.596258591973765e-08
cancer B-Disease 0 4.8517119211055615e-09
families O 0 2.3224050720721534e-12
for O 0 5.31273375986574e-12
the O 0 5.422234189422781e-11
distribution O 0 3.385973168512635e-10
of O 0 2.394370923752831e-09
these O 0 2.48481302200787e-09
eight O 0 1.9833729325569038e-08
mutations O 0 5.535655489552482e-08
. O 0 9.357864172443442e-08

Mutations O 0 1.6277489578442328e-07
were O 0 2.482340333287425e-09
found O 0 2.5448437801500745e-10
in O 0 1.810376987210205e-10
41 O 0 1.0585739396162808e-08
of O 0 8.949384344703049e-09
97 O 0 2.0972626657567162e-07
families O 0 4.092919336784462e-10
. O 0 3.808451864983908e-08

Six O 0 8.418211905336648e-08
of O 0 1.9681522189785028e-08
eight O 0 6.391836393504491e-09
mutations O 0 1.866955035012552e-09
were O 0 4.387085139612168e-10
observed O 0 2.2378219277641165e-09
at O 0 1.045467179494608e-08
least O 0 3.4208336163743525e-09
twice O 0 7.795380696506982e-08
. O 0 2.16520760432104e-07

The O 0 1.2139351383666508e-05
BRCA1 O 0 2.4761624445091e-05
C4446T O 0 1.1337705473124515e-05
mutation O 0 2.4366793027752465e-08
was O 0 5.19585219294072e-09
the O 0 1.4795162872616174e-09
most O 0 4.6311141033150705e-10
common O 0 1.1130123489522248e-09
mutation O 0 5.457535534603153e-10
found O 0 1.217931311359166e-10
, O 0 1.335525023904438e-10
followed O 0 2.813824451219915e-10
by O 0 2.313432501122037e-10
the O 0 1.499298036833352e-07
BRCA2 O 0 9.184497685055248e-06
8765delAG O 0 5.77907485421747e-06
mutation O 0 4.203913306355389e-07
. O 0 2.0488477048274945e-07

Together O 0 4.738456382824552e-08
, O 0 1.9280121943410222e-09
these O 0 2.795209341766025e-10
mutations O 0 1.2129793003357037e-10
were O 0 6.636659971581693e-11
found O 0 2.9223158615199196e-11
in O 0 2.7677745512155738e-11
28 O 0 3.6775447131986994e-09
of O 0 1.8923012046201393e-09
41 O 0 3.568860984515254e-09
families O 0 6.565832946781036e-12
identified O 0 6.563607296561358e-11
to O 0 4.6425760458213006e-10
have O 0 1.3147676281022314e-09
a O 0 1.7152096631889435e-08
mutation O 0 7.95185997048975e-08
. O 0 1.4529186387335358e-07

The O 0 1.976781476287215e-07
odds O 0 2.2654012354905717e-07
of O 0 3.0047548893463727e-09
detection O 0 1.0976775044468923e-08
of O 0 3.2726732435151007e-09
any O 0 7.345990482576781e-10
of O 0 2.6786493023678304e-09
the O 0 2.173344393341381e-09
four O 0 4.8672554875395235e-09
BRCA1 O 0 1.0227034863419249e-07
mutations O 0 7.365580145801687e-09
was O 0 2.3681744565351437e-08
18 O 0 8.166403375753362e-08
. O 0 9.345449569764241e-08

7x O 0 0.0006138415192253888
greater O 0 6.235507044038968e-07
if O 0 6.574590205588038e-09
one O 0 4.355452665194548e-10
or O 0 6.047532613573381e-11
more O 0 2.9570209128526592e-12
cases O 0 2.127132359142081e-10
of O 0 1.7435036170354579e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 6.470472491137969e-10
also O 0 5.017808737961538e-11
present O 0 3.4743031368522637e-11
in O 0 5.460135815704703e-11
the O 0 6.0056168926792e-09
family O 0 1.1455610682276074e-08
. O 0 1.1297970559098758e-07

The O 0 1.8279571634138847e-07
odds O 0 2.7865948482030944e-07
of O 0 4.449201007616921e-09
detection O 0 2.460206793841735e-08
of O 0 7.332876972299118e-09
any O 0 1.9503521020425296e-09
of O 0 4.519852048190387e-09
the O 0 9.643132514725039e-09
four O 0 1.4499323519601148e-08
BRCA2 O 0 8.153670592037088e-07
mutations O 0 3.955646921127709e-09
was O 0 1.1308551428612645e-08
5 O 0 2.2211627026536007e-07
. O 0 1.0865442590102248e-07

3x O 0 4.1505561966914684e-05
greater O 0 1.1576708658367352e-07
if O 0 3.4353493383321165e-09
there O 0 4.1466824418634474e-10
were O 0 2.560160139442047e-10
at O 0 6.926871853885075e-10
least O 0 5.164634345189434e-11
five O 0 3.6229713673563424e-11
cases O 0 1.0031316055592043e-10
of O 0 5.19591170089484e-09
breast B-Disease 1 0.9994159936904907
cancer I-Disease 0 6.268700190048548e-07
in O 0 9.350683560782613e-10
the O 0 4.2764561669628165e-08
family O 0 1.2218274392239437e-08
. O 0 1.0054623800215268e-07

Interestingly O 0 3.453645547324413e-07
, O 0 5.860066654150842e-09
the O 0 2.9227924525088156e-09
presence O 0 4.0852938809621264e-09
of O 0 4.535156605811608e-08
a O 0 3.954713534426446e-08
breast B-Disease 1 0.9960991144180298
cancer I-Disease 0 3.5339553505764343e-06
case O 0 1.0402596117842222e-08
< O 0 1.1803885868744146e-08
36 O 0 1.5060634961372443e-09
years O 0 7.02314525979908e-11
of O 0 5.625891419391849e-10
age O 0 9.79039072035448e-10
was O 0 3.6231045941192974e-10
strongly O 0 1.0126011140698665e-10
predictive O 0 1.524066428615356e-09
of O 0 5.134669911477374e-10
the O 0 1.4499972056380983e-10
presence O 0 5.2985484055856347e-11
of O 0 2.935092446865184e-10
any O 0 4.918168650114296e-10
of O 0 1.2600611665192218e-09
the O 0 3.81368359114731e-09
eight O 0 9.389076183197176e-09
mutations O 0 2.1613326239844355e-08
screened O 0 6.8779024786636e-07
. O 0 2.1262324878534855e-07

Carriers O 0 9.959096303191473e-08
of O 0 1.9413715079963367e-08
the O 0 1.9252486271881253e-09
same O 0 9.132084671792384e-11
mutation O 0 1.2624470913102925e-10
, O 0 2.0565058336807773e-11
from O 0 1.1166515628824314e-11
different O 0 9.293989189362861e-12
families O 0 3.2864923889958098e-12
, O 0 5.941307168466636e-11
shared O 0 6.998477908304324e-10
similar O 0 1.112205882947137e-09
haplotypes O 0 5.8620903686801284e-09
, O 0 4.472426873292079e-10
indicating O 0 1.4553899196911857e-09
that O 0 8.751472463375265e-11
the O 0 1.8567559711968329e-09
mutant O 0 1.815614147915312e-08
alleles O 0 6.678449460117974e-11
were O 0 4.923093183117899e-11
likely O 0 7.038137433967862e-11
to O 0 3.303166420942638e-11
be O 0 3.193908679199886e-11
identical O 0 5.795645907635816e-11
by O 0 1.1679440400924612e-11
descent O 0 2.704336199421675e-10
for O 0 1.000582533494665e-10
a O 0 4.4932124687591113e-10
mutation O 0 9.304427228684631e-10
in O 0 4.097996941787585e-10
the O 0 2.515980312978172e-08
founder O 0 3.0030724929019925e-07
population O 0 5.039961781250213e-09
. O 0 9.660422506385657e-08

The O 0 2.532566689694704e-08
identification O 0 1.1069325900336935e-08
of O 0 1.287374917779971e-08
common O 0 7.260801027086927e-08
BRCA1 O 0 1.2142234027123777e-06
and O 0 1.1535303912069139e-07
BRCA2 O 0 5.611286724160891e-06
mutations O 0 3.0939042439115383e-09
will O 0 5.448036813349155e-11
facilitate O 0 2.134806081910412e-10
carrier O 0 9.841947395949902e-11
detection O 0 5.816437553818332e-09
in O 0 3.6517505686006757e-10
French O 0 1.027863731906109e-06
Canadian O 0 1.2589780453708954e-06
breast B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9521734118461609
and O 0 1.3872895578970201e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 9.851568449903425e-10
. O 0 3.644974766459086e-09

Are O 0 1.617055858105232e-07
Dp71 O 0 0.00015890509530436248
and O 0 5.008178618481907e-07
Dp140 O 0 0.0005000047967769206
brain O 0 1.3968379789730534e-05
dystrophin O 0 3.4784238778229337e-06
isoforms O 0 1.162826723799526e-08
related O 0 2.876130622553319e-08
to O 0 3.7011107512086028e-09
cognitive B-Disease 0 0.0001335516426479444
impairment I-Disease 1 0.9997623562812805
in O 0 3.6838582673226483e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 0 7.8407974797301e-05

Molecular O 0 5.310769211064326e-07
study O 0 4.225551908376701e-09
and O 0 7.072376018157911e-10
neuropsychological O 0 1.7210911096299242e-07
analysis O 0 4.678202825125766e-10
were O 0 1.4773443579585432e-10
performed O 0 9.903755593398955e-10
concurrently O 0 3.3290686873854725e-10
on O 0 6.704233834753381e-10
49 O 0 1.5536823383399678e-08
patients O 0 6.220349790808655e-10
with O 0 1.0101906866566424e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.4901339656935306e-06
DMD B-Disease 1 1.0
) O 0 1.9758872316089082e-10
in O 0 4.1176766857331515e-11
order O 0 2.5639032563695707e-10
to O 0 1.428492185651109e-10
find O 0 9.918079552084791e-11
a O 0 2.99021883642947e-11
molecular O 0 5.804908220774507e-10
explanation O 0 4.784347570896408e-11
for O 0 8.384420935314552e-11
the O 0 4.434950628962042e-09
cognitive B-Disease 0 2.474566372256959e-06
impairment I-Disease 0 1.2144109859946184e-05
observed O 0 1.2701020679628527e-08
in O 0 1.5400477559879278e-09
most O 0 9.88336523732869e-08
DMD B-Disease 1 1.0
patients O 0 5.873788495591725e-07
. O 0 1.0237612713126509e-07

Complete O 0 3.426320915878023e-08
analysis O 0 8.266915485499737e-10
of O 0 3.81542974992044e-09
the O 0 8.148226982029882e-09
dystrophin O 0 3.6976487649553746e-07
gene O 0 3.548403570974301e-09
was O 0 3.510744361889806e-09
performed O 0 2.915720997975768e-09
to O 0 4.0395917166868855e-10
define O 0 2.766663786957224e-09
the O 0 8.116704530714003e-10
localization O 0 3.790732350239523e-08
of O 0 2.0292148406042543e-08
deletions O 0 5.702972316612431e-08
and O 0 1.4545081583605679e-08
duplications O 0 3.38905920216348e-07
in O 0 1.1499036167705867e-09
relation O 0 4.740994707930213e-09
to O 0 5.4294813089939e-10
the O 0 7.291663273178983e-09
different O 0 2.2087668583026243e-08
DMD B-Disease 1 1.0
promoters O 0 1.8641947463038377e-05
. O 0 1.097639824365615e-06

Qualitative O 0 4.332779326432501e-07
analysis O 0 4.690874799706535e-09
of O 0 1.764543178239819e-08
the O 0 1.7799266061047092e-08
Dp71 O 0 8.342839464603458e-06
transcript O 0 5.697413651972738e-09
and O 0 8.505584014883993e-10
testing O 0 6.29842900057298e-10
for O 0 5.0202786372466335e-11
the O 0 1.0203931449792591e-10
specific O 0 1.7465803803240476e-10
first O 0 1.5852190393683685e-10
exon O 0 1.10474536185734e-08
of O 0 1.9123817196486925e-08
Dp140 O 0 8.767112831264967e-07
were O 0 1.0724579002641121e-09
also O 0 6.498870330773343e-10
carried O 0 2.409429322725032e-09
out O 0 6.814750541650483e-09
. O 0 3.4589284325647895e-08

Neuropsychological O 0 7.80254922574386e-05
analysis O 0 2.822675249092299e-08
assessed O 0 2.9066450224490836e-07
verbal O 0 2.3453040398635494e-07
and O 0 2.393938380862437e-08
visuospatial O 0 1.5367642163255368e-06
intelligence O 0 1.3071019822064045e-08
, O 0 1.0684526152715534e-08
verbal O 0 1.3346244713829947e-06
memory O 0 0.17473526298999786
, O 0 1.5121059959710692e-08
and O 0 4.397335118255796e-08
reading O 0 4.927421741740545e-06
skills O 0 1.0432340786792338e-06
. O 0 2.576043698354624e-07

Comparison O 0 8.348557685167179e-07
of O 0 2.3458723319436103e-07
molecular O 0 6.866525126270062e-08
and O 0 9.093403363635844e-09
psychometric O 0 4.419858044002467e-07
findings O 0 3.1787061871568767e-09
demonstrated O 0 1.182461017990022e-09
that O 0 1.243621594593236e-10
deletions O 0 5.142209325015301e-09
and O 0 2.0069197415040207e-09
duplications O 0 5.657576807038822e-08
that O 0 1.5603389413865187e-10
were O 0 2.7120225509769114e-10
localized O 0 4.1873317258023235e-08
in O 0 2.7829316628924516e-10
the O 0 3.4679175087148906e-09
distal O 0 4.066777705702407e-07
part O 0 2.2979108393883507e-08
of O 0 6.052872549844324e-07
the O 0 3.597924660425633e-07
gene O 0 9.204174311605584e-09
seemed O 0 2.019657330265545e-09
to O 0 1.2465663223881762e-10
be O 0 6.471567726151761e-11
preferentially O 0 1.1727937510030984e-09
associated O 0 8.361491499186968e-10
with O 0 4.988821800111509e-09
cognitive B-Disease 0 0.05365809053182602
impairment I-Disease 1 0.9999672174453735
. O 0 4.4763399387193203e-07

Two O 0 1.603011412498745e-07
altered O 0 3.6390449054124474e-07
Dp71 O 0 6.596168077521725e-06
transcripts O 0 9.134466694149523e-08
and O 0 1.7918829087193444e-08
two O 0 5.265167413170957e-09
deleted O 0 5.3100702501751584e-08
Dp140 O 0 1.8630008469244785e-07
DNA O 0 9.500435993459178e-10
sequences O 0 6.736814578411909e-11
were O 0 1.9890677646627886e-11
found O 0 1.3534156434458211e-11
in O 0 1.2669692552036427e-11
four O 0 1.5491415095159056e-10
patients O 0 2.648178065722817e-10
with O 0 8.902629189400102e-10
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 7.523235581174958e-07

These O 0 1.424796209903434e-07
findings O 0 4.962183552947863e-09
suggest O 0 2.5158289340687645e-10
that O 0 1.7247600916925343e-11
some O 0 2.3269953672300225e-11
sequences O 0 4.5518748492678895e-11
located O 0 5.824072335514074e-10
in O 0 5.5800107590098236e-11
the O 0 1.0427443353222543e-09
distal O 0 1.079333387110637e-07
part O 0 1.470634902744905e-08
of O 0 4.9726459394605627e-08
the O 0 6.388570117366044e-09
gene O 0 1.3195301795665415e-10
and O 0 2.3517918168458607e-10
, O 0 8.006102725222064e-11
in O 0 3.174940518824165e-11
particular O 0 4.663370245516774e-10
, O 0 1.5673425057816104e-10
some O 0 6.649320538620884e-10
DMD B-Disease 1 1.0
isoforms O 0 3.821008398574577e-09
expressed O 0 7.174301153156648e-10
in O 0 7.952762337559705e-10
the O 0 4.6921933005705796e-08
brain O 0 1.7040304101101356e-06
may O 0 2.980699298493761e-10
be O 0 5.2788780291468385e-11
related O 0 7.268248780611941e-10
to O 0 1.424139417505188e-10
the O 0 2.875262472556983e-09
cognitive B-Disease 0 1.8458866861692513e-06
impairment I-Disease 0 1.0882032256631646e-05
associated O 0 8.322990296960597e-09
with O 0 3.61777026114396e-08
DMD B-Disease 1 1.0
. O 0 5.722531071228332e-08
. O 0 1.3046054903043114e-07

I1307K O 0 0.00020913477055728436
APC O 0 8.167186933860648e-06
and O 0 7.82775657626189e-08
hMLH1 O 0 2.066391971311532e-06
mutations O 0 7.155678272141586e-09
in O 0 3.262176639928782e-10
a O 0 5.202732134002019e-10
non O 0 4.920640961358913e-08
- O 0 1.949717010063523e-08
Jewish O 0 2.3484043598642756e-09
family O 0 5.847611977971567e-11
with O 0 8.518340893770571e-11
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3099668194627156e-06

We O 0 6.824326703736006e-08
describe O 0 1.2070515253981284e-08
a O 0 1.0332590338890668e-09
French O 0 8.246607308137754e-08
Canadian O 0 8.215444324832788e-08
hereditary B-Disease 1 0.9999997615814209
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.661707291437779e-06
HNPCC B-Disease 1 1.0
) O 0 8.095835113408612e-09
kindred O 0 3.176081122546748e-07
which O 0 3.698885919778405e-10
carries O 0 1.751609524092146e-08
a O 0 4.787545360152023e-10
novel O 0 3.484421995381126e-08
truncating O 0 5.508417757482675e-07
mutation O 0 1.2818546224480087e-08
in O 0 4.544358667146753e-09
hMLH1 O 0 9.397817848366685e-06
. O 0 5.010997483623214e-07

Interestingly O 0 8.690038839631598e-07
, O 0 1.4205273402012608e-08
the O 0 1.733991794594658e-08
I1307K O 0 2.0980878616683185e-06
APC O 0 2.0615917151189933e-07
polymorphism O 0 6.310445055390801e-09
, O 0 3.554443961384379e-10
associated O 0 1.884484374103934e-10
with O 0 9.795708688642435e-11
an O 0 4.906276426797085e-11
increased O 0 8.576840904161998e-10
risk O 0 9.742115736344203e-08
of O 0 2.268818388984073e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.9958733271939764e-09
is O 0 1.4151065041989597e-10
also O 0 7.355380193807548e-11
present O 0 7.315058281331943e-11
in O 0 1.9730514444482594e-10
this O 0 9.34708199729073e-10
family O 0 1.4066904086007526e-08
. O 0 1.529324009652555e-07

The O 0 3.9210578961501596e-07
I1307K O 0 2.4638284230604768e-06
polymorphism O 0 8.085789815481803e-09
has O 0 2.0614210338720795e-09
previously O 0 4.365842798392805e-09
only O 0 9.35360469633828e-11
been O 0 6.011215136769721e-11
identified O 0 3.409034166068636e-11
in O 0 3.448936275463055e-11
individuals O 0 2.8741956731304086e-11
of O 0 5.03961539166653e-09
self O 0 2.779100043426297e-07
- O 0 1.5196499703051813e-07
reported O 0 3.417840233055358e-09
Ashkenazi O 0 4.703976586029057e-08
Jewish O 0 2.8281506914140664e-08
origins O 0 5.10185422797349e-08
. O 0 2.6273919928598843e-08

In O 0 8.247106997316678e-09
addition O 0 3.805603387974088e-09
, O 0 3.8936645574416673e-10
in O 0 6.769479421464553e-11
this O 0 2.2991832396290768e-11
family O 0 1.378975961197071e-10
, O 0 1.3595585768300111e-10
there O 0 8.671881268629278e-11
appears O 0 2.555169409390601e-10
to O 0 6.567101723531366e-11
be O 0 2.198467241587565e-10
no O 0 4.5931117242936637e-10
relationship O 0 1.2942424909567762e-10
between O 0 2.7570065674886735e-10
the O 0 1.2927974246679241e-09
I1307K O 0 3.032686990422917e-08
polymorphism O 0 2.3743185195712613e-10
and O 0 4.00950855850013e-10
the O 0 1.4077901067111043e-09
presence O 0 1.7965533505304165e-09
or O 0 1.757244016964421e-09
absence O 0 2.43482105588555e-08
of O 0 6.04765588718692e-08
cancer B-Disease 0 1.5576546275042347e-06
. O 0 7.39957117801282e-09
. O 0 8.924059358150771e-08

Identification O 0 1.1028046742467268e-07
of O 0 4.150025390003975e-08
a O 0 2.1321702181609226e-09
novel O 0 1.8588474759440032e-08
mutation O 0 7.61665230886166e-10
of O 0 3.5910117102133654e-09
the O 0 7.65319363438266e-09
CPO O 1 0.9949811100959778
gene O 0 2.0387806998201086e-09
in O 0 5.694054117100222e-10
a O 0 3.767348211169974e-09
Japanese O 0 6.900845619384199e-07
hereditary B-Disease 1 0.9980531930923462
coproporphyria I-Disease 1 0.9874352216720581
family O 0 1.9076391311045882e-07
. O 0 3.423205612307356e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.3908840628573671e-05
HCP B-Disease 1 1.0
) O 0 9.381830068377894e-08
is O 0 8.869414536150089e-09
an O 0 9.70716662607174e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
characterized O 0 5.54436985211737e-09
by O 0 8.17008405373798e-11
a O 0 2.9452669192409076e-09
deficiency B-Disease 1 0.9068772196769714
of I-Disease 1 0.5811998248100281
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 0 2.6320898882659094e-07
( O 0 1.3118442998560909e-09
CPO O 1 0.9999994039535522
) O 0 8.494996928121168e-10
caused O 0 1.233494750785269e-09
by O 0 6.596036911110659e-11
a O 0 7.28454241372134e-10
mutation O 0 7.392909062708952e-10
in O 0 7.062467277663131e-10
the O 0 4.2897401186792194e-08
CPO O 1 0.8208619952201843
gene O 0 2.981527416068275e-07
. O 0 3.1931008948049566e-07

Only O 0 4.177065449084694e-08
11 O 0 1.3775894203149619e-08
mutations O 0 1.7439812927122489e-09
of O 0 6.781751160644944e-09
the O 0 1.0004289840992442e-08
gene O 0 1.8183234917756863e-09
have O 0 2.1978718844906098e-10
been O 0 5.681393688838909e-10
reported O 0 1.9288286523533316e-09
in O 0 7.594476159056285e-09
HCP B-Disease 1 1.0
patients O 0 5.441180519483169e-07
. O 0 1.5544269160727708e-07

We O 0 7.985023131595881e-08
report O 0 3.7246932205192707e-09
another O 0 7.336552476644442e-10
mutation O 0 5.178446560449856e-10
in O 0 2.2460396043033626e-10
a O 0 2.232880547126115e-09
Japanese O 0 1.438281742593972e-07
family O 0 1.612489342051049e-08
. O 0 1.4024287509073474e-07

Polymerase O 0 9.75264583757962e-07
chain O 0 1.234663358218313e-07
reaction O 0 2.1512305270476872e-09
- O 0 1.3332255299758344e-08
single O 0 1.0294113339526234e-09
strand O 0 1.8161465664690013e-09
conformational O 0 1.7527373996628626e-10
polymorphism O 0 9.73402261572609e-11
and O 0 1.9907843429312067e-10
direct O 0 4.717646828744648e-10
sequence O 0 6.439406646796542e-11
analyses O 0 3.6406094805485623e-10
demonstrated O 0 7.644975763554385e-10
a O 0 5.264622071621261e-10
C O 0 1.549887862495325e-08
to O 0 5.93833038298186e-10
T O 0 4.27901625243976e-09
substitution O 0 9.017571411806813e-11
in O 0 7.332505436163927e-11
exon O 0 5.006113301675441e-09
1 O 0 4.772403805475278e-09
of O 0 2.5661501812379583e-09
the O 0 6.354566206567824e-09
CPO O 0 2.456415313645266e-05
gene O 0 7.544072033738303e-10
at O 0 1.916843350713293e-09
nucleotide O 0 9.201361339528091e-10
position O 0 1.5522655383293227e-09
85 O 0 7.332023876926996e-09
, O 0 2.1446334985686377e-10
which O 0 1.8261495093874203e-10
lies O 0 2.249111297203399e-08
in O 0 2.436091328661405e-10
the O 0 7.66498331472576e-09
putative O 0 1.4038282358797005e-07
presequence O 0 8.181836506082618e-07
for O 0 4.268305708876596e-09
targeting O 0 8.477248769622747e-08
to O 0 1.2387082470866062e-08
mitochondria O 0 1.7633797710914223e-07
. O 0 3.308108773580898e-07

This O 0 2.563162659896534e-08
mutation O 0 7.410503766180909e-09
changes O 0 1.2635678059425004e-09
the O 0 1.790628090247992e-09
codon O 0 5.361318056174014e-09
for O 0 2.2855645154251647e-10
glutamine O 0 4.685688725913906e-09
to O 0 1.0317032783646596e-09
a O 0 3.262439651763316e-09
termination O 0 5.527911284275433e-08
codon O 0 5.658019475163201e-08
at O 0 1.6675540948085654e-08
amino O 0 1.5381697693328533e-08
acid O 0 3.766717782127671e-08
position O 0 6.360595961041327e-08
29 O 0 3.7710313449679234e-07
. O 0 2.7753603148994443e-07

MaeI O 0 0.0001784010382834822
restriction O 0 1.2230145784997148e-07
analysis O 0 5.951313331031827e-10
showed O 0 9.122932409511009e-10
two O 0 8.279456287230147e-11
other O 0 1.255591047799598e-10
carriers O 0 4.4251549646823207e-10
in O 0 1.6659661150608684e-10
the O 0 1.628766810313209e-08
family O 0 1.84733579544627e-08
. O 0 2.096010831564854e-07

The O 0 5.262424451757397e-07
C O 0 0.00020863604731857777
- O 0 0.19162243604660034
T O 0 0.00010323099559172988
mutation O 0 1.3285369249160794e-08
is O 0 4.500168016008388e-10
located O 0 4.6157633271093346e-09
within O 0 1.0043459397479637e-09
a O 0 6.530556651007657e-10
recently O 0 4.906084427602764e-09
proposed O 0 1.976906993661487e-08
putative O 0 5.952590598212737e-08
alternative O 0 5.50773249230474e-09
translation O 0 3.841901907719603e-09
initiation O 0 6.028490151521737e-09
codon O 0 9.107497866978065e-09
( O 0 1.3531245568465522e-10
TIC O 0 1.1229887064700961e-07
- O 0 9.446738502560947e-09
1 O 0 1.1928160681407007e-08
) O 0 1.2580265995598694e-10
, O 0 1.0808316741606205e-10
supporting O 0 9.09329500586864e-10
that O 0 9.422040231354956e-11
TIC O 0 1.4128377756605914e-07
- O 0 9.308337212132756e-09
1 O 0 8.982320665040788e-09
is O 0 1.8523121925184682e-10
the O 0 4.97203445082306e-10
real O 0 6.559787379956106e-08
TIC O 0 1.5011881941973115e-06
rather O 0 1.4829404371141663e-09
than O 0 2.92932095247167e-10
TIC O 0 6.084066512812569e-07
- O 0 1.688668334054455e-07
2 O 0 1.4583437746296113e-07
. O 0 6.9369630040228e-09
. O 0 5.0729283884720644e-08

Human B-Disease 0 2.6206686243313015e-07
complement I-Disease 0 3.0179907639649173e-07
factor I-Disease 0 2.9986880690557882e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.9971833825111389
associated O 0 4.577880758915853e-07
with O 1 0.9991191029548645
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.49919525635778e-06

This O 0 4.085153104682604e-09
study O 0 6.82687240072255e-10
reports O 0 2.8487964764956075e-10
on O 0 7.603081497720154e-10
six O 0 1.3694195777347318e-10
cases O 0 1.8079132635406836e-10
of O 0 3.209851495711291e-09
deficiency B-Disease 0 1.1783592981373658e-06
in I-Disease 0 1.9635204573376086e-09
the I-Disease 0 1.6239400935091908e-08
human I-Disease 0 7.366306453704397e-10
complement I-Disease 0 3.3695528589561263e-09
regulatory I-Disease 0 2.1558896889928292e-08
protein I-Disease 0 3.8080308684129704e-08
Factor I-Disease 0 1.707619048829656e-06
H I-Disease 1 1.0
( O 0 3.864427444710827e-09
FH O 1 0.9999779462814331
) O 0 1.300994312281034e-10
in O 0 2.417556432821044e-11
the O 0 1.403847732506236e-10
context O 0 1.621388162620363e-10
of O 0 2.6599780711400456e-10
an O 0 6.397223861753787e-10
acute B-Disease 1 0.9992565512657166
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.9105643787042936e-06

Five O 0 3.790609781617604e-08
of O 0 4.823265342679406e-09
the O 0 1.1214466022479996e-09
cases O 0 2.051535469282939e-10
were O 0 2.2820393144606932e-11
observed O 0 3.207522442094657e-11
in O 0 1.0032879908805636e-11
children O 0 3.8582071565373965e-11
presenting O 0 1.846697128549124e-09
with O 0 1.8341662411103243e-08
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2172205060778651e-05
HUS B-Disease 1 1.0
) O 0 4.523010659340798e-07
. O 0 6.545183168782387e-07

Two O 0 6.462039792154428e-09
of O 0 4.933616626345838e-09
the O 0 1.0266818506465825e-09
children O 0 3.1383837195697595e-10
exhibited O 0 3.209791898939329e-08
a O 0 1.1252653031590398e-08
homozygous O 0 4.907612037641229e-06
deficiency O 0 6.7895975917053875e-06
characterized O 0 1.1329854832098363e-09
by O 0 8.217813929345397e-11
the O 0 3.266698689330383e-09
absence O 0 1.4123171965252368e-08
of O 0 1.3759112960087805e-08
the O 0 2.9376872046071867e-09
150 O 0 7.74619479670946e-10
- O 0 3.259454040005494e-09
kD O 0 8.386158469875227e-07
form O 0 1.4166404160853574e-10
of O 0 1.4240804091514292e-09
Factor O 0 2.3236236046386693e-08
H O 1 0.990227460861206
and O 0 1.411704364517874e-10
the O 0 1.9809701101713983e-10
presence O 0 1.2618379952034076e-10
, O 0 9.629485403506166e-11
upon O 0 5.927308643904894e-10
immunoblotting O 0 1.5322042656862322e-07
, O 0 3.994928277073484e-10
of O 0 3.2078866230023095e-09
the O 0 8.717695010318494e-09
42 O 0 1.4937143077986548e-08
- O 0 1.6670261615558957e-08
kD O 0 6.523779120470863e-06
Factor O 0 2.1025053342782485e-07
H O 1 0.7263630032539368
- O 0 3.7566515231901576e-08
like O 0 1.4878702714327119e-09
protein O 0 1.5553063281714685e-09
1 O 0 6.9805903279984705e-09
( O 0 1.922774439666597e-10
FHL O 0 9.121770744968671e-06
- O 0 9.806242928789288e-09
1 O 0 4.113057450183533e-09
) O 0 4.966808908601905e-11
and O 0 1.0191152782779156e-10
other O 0 6.184527889807612e-10
FH O 0 0.00111273187212646
- O 0 2.6218851090220596e-08
related O 0 3.280612048683906e-08
protein O 0 9.441135873089479e-09
( O 0 2.1819661355504394e-10
FHR O 1 0.9987608194351196
) O 0 3.881032384356331e-09
bands O 0 5.995593710395042e-07
. O 0 1.73627128674525e-07

Southern O 0 6.6858078753284644e-06
blot O 0 3.367698809597641e-05
and O 0 6.938193575223295e-09
PCR O 0 5.377130296579935e-09
analysis O 0 2.9879553692380156e-11
of O 0 7.692847747708953e-11
DNA O 0 3.1411562240180047e-10
of O 0 4.6151363286561775e-10
one O 0 3.174893403734558e-10
patient O 0 1.103228619570018e-09
with O 0 1.1503731300877007e-09
homozygous O 0 1.166425681731198e-05
deficiency O 0 0.09253698587417603
ruled O 0 5.8497843014038153e-08
out O 0 1.7716882405593992e-09
the O 0 4.686661059238872e-10
presence O 0 2.6275195907921045e-10
of O 0 1.1220541162870745e-09
a O 0 9.905186393321941e-11
large O 0 1.3710590440751957e-09
deletion O 0 4.978745860029221e-09
of O 0 7.0646675176533336e-09
the O 0 2.5796520475296347e-08
FH O 1 0.9999997615814209
gene O 0 1.4500782796744716e-09
as O 0 2.1626128665630517e-10
the O 0 1.8691248548918793e-09
underlying O 0 5.110054530632624e-07
defect O 0 7.290971382190037e-08
for O 0 3.5245186769117254e-09
the O 0 3.9801173556952563e-07
deficiency O 1 0.9999904632568359
. O 0 1.198077143271803e-06

The O 0 2.3236591317754574e-08
other O 0 3.464576958656096e-10
four O 0 6.17321124773973e-11
children O 0 1.818363168371029e-11
presented O 0 2.42407732775618e-10
with O 0 9.16680009677151e-10
heterozygous O 0 1.46603861139738e-06
deficiency O 0 0.0006741210236214101
and O 0 2.7992618001349e-08
exhibited O 0 1.6482387081850902e-06
a O 0 7.143623026450996e-09
normal O 0 1.2025428652862047e-08
immunoblotting O 0 1.8774872501126083e-07
pattern O 0 3.4003295734663652e-09
of O 0 1.575471753056945e-09
proteins O 0 7.57330587131122e-11
of O 0 2.096269158258224e-09
the O 0 2.059920589658759e-08
FH O 1 1.0
family O 0 5.2540144679369405e-08
. O 0 1.5643759354588838e-07

Factor B-Disease 1 1.0
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999984502792358
is O 0 3.5272287313148354e-09
the O 0 3.0778064541436834e-09
only O 0 4.628740946088783e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 9.547656532049587e-08
with O 0 1.4379197921243758e-07
HUS B-Disease 1 1.0
. O 0 6.091049272072269e-06

These O 0 1.2483717171107855e-07
observations O 0 6.506517280513435e-08
suggest O 0 2.5121285052165376e-09
a O 0 3.2779065572974275e-10
role O 0 1.9954078389616825e-09
for O 0 2.0477912698879663e-09
FH O 1 1.0
and O 0 2.7268077573694427e-08
/ O 0 4.131602509005461e-06
or O 0 3.0229792002955946e-08
FH O 1 0.9979414343833923
receptors O 0 2.1958617146822235e-09
in O 0 2.118407116391552e-10
the O 0 3.603829012988058e-09
pathogenesis O 0 5.1020765567955095e-06
of O 0 3.4548347116469813e-07
idiopathic O 1 0.9999998807907104
HUS B-Disease 1 1.0
. O 0 1.8910580479314376e-07
. O 0 3.8254154333117185e-07

Further O 0 9.507568421440737e-08
evidence O 0 3.5948355403547794e-09
for O 0 6.440588617984133e-10
a O 0 6.124683538111242e-10
major O 0 1.5839271227946483e-08
ancient O 0 2.3386706970995874e-07
mutation O 0 4.059863385919016e-06
underlying O 1 0.7217822074890137
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 5.700633209926309e-07
linkage O 0 6.587044367734052e-07
disequilibrium O 0 1.5328225799748907e-07
studies O 0 1.797471838038689e-09
in O 0 1.0130222355408947e-10
the O 0 6.227781068623983e-10
Japanese O 0 2.112099117823618e-08
population O 0 5.975961947513042e-10
. O 0 2.232787821299098e-08

The O 0 9.521468746243045e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9914888143539429
DM B-Disease 1 1.0
) O 0 2.3342000332604584e-08
mutation O 0 1.2419564043852915e-08
is O 0 3.1349078888354143e-10
an O 0 3.044263452434137e-10
unstable O 0 1.6322600515650265e-07
( O 0 4.396762509628616e-09
CTG O 0 0.00014540528354700655
) O 0 1.1977946412500273e-09
n O 0 1.9628014769068614e-09
repeat O 0 7.875811114388398e-09
, O 0 2.525810671727413e-10
present O 0 2.918913721838834e-10
at O 0 1.2773631041795852e-09
a O 0 1.1438743008351793e-10
copy O 0 8.787204852644948e-10
number O 0 1.68834543567975e-10
of O 0 6.248007666798117e-10
5 O 0 5.1541593215631565e-09
- O 0 2.3494672873880518e-08
37 O 0 1.730502852126392e-08
repeats O 0 8.23930423887731e-10
on O 0 2.1502377656190674e-09
normal O 0 1.3677365906517025e-09
chromosomes O 0 1.0041079079314841e-10
but O 0 4.984175572264604e-11
amplified O 0 8.606358292695404e-09
to O 0 4.5138451310045014e-10
50 O 0 5.314464868177993e-09
- O 0 1.423106343878544e-08
3000 O 0 3.1251601306792054e-09
copies O 0 2.3325701370424667e-09
on O 0 1.347414269048386e-07
DM B-Disease 1 1.0
chromosomes O 0 1.619838911892657e-07
. O 0 9.869067696399725e-08

Previous O 0 3.754273905087757e-07
findings O 0 9.113945154126668e-09
in O 0 8.017415065175726e-10
Caucasian O 0 1.3595007430922124e-07
populations O 0 5.11188424923148e-09
of O 0 2.649479213800987e-08
a O 0 1.3834618073360616e-07
DM B-Disease 1 1.0
founder O 0 5.2128075367363635e-06
chromosome O 0 3.779347679255807e-08
raise O 0 4.370550144017216e-09
a O 0 3.8365466359380207e-10
question O 0 1.2629389756213527e-09
about O 0 7.889123382343044e-11
the O 0 4.780108531221572e-10
molecular O 0 2.7400541835476133e-09
events O 0 4.1238798487164274e-10
involved O 0 2.2820535738876657e-10
in O 0 5.260256119576923e-10
the O 0 1.7555462861196247e-08
expansion O 0 6.650619752690545e-07
mutation O 0 2.2313240322091588e-07
. O 0 1.6347244979897368e-07

To O 0 1.4504087175737368e-07
investigate O 0 1.1816144507292847e-07
whether O 0 1.8872560403337957e-08
a O 0 6.842910682536285e-09
founder O 0 4.3441488628559455e-08
chromosome O 0 1.1430292268244102e-08
for O 0 6.743823832700002e-10
the O 0 3.602332654395468e-08
DM B-Disease 1 1.0
mutation O 0 5.310846873385344e-09
exists O 0 1.2513545755155064e-10
in O 0 9.503688634671104e-12
the O 0 8.397352257993873e-11
Japanese O 0 1.1682682599101213e-09
population O 0 1.1520759173044848e-11
, O 0 7.155998016372678e-11
we O 0 4.314228418955679e-10
genotyped O 0 1.7560127218985144e-07
families O 0 3.858243932675087e-11
using O 0 3.204741749751605e-10
polymorphic O 0 5.543442327393677e-08
markers O 0 2.759688015885331e-07
near O 0 2.9392475653367e-07
the O 0 3.978302842710946e-08
( O 0 9.08811426114653e-09
CTG O 0 0.000201120346901007
) O 0 3.859816022355744e-09
n O 0 1.0234172620471327e-08
repeat O 0 2.2823432033192148e-08
region O 0 2.303984913964996e-08
and O 0 1.0197151567581386e-08
constructed O 0 8.473892876281752e-07
haplotypes O 0 1.6383967249566922e-06
. O 0 2.119545285950153e-07

Six O 0 1.673321747830414e-07
different O 0 1.203292687712576e-09
haplotypes O 0 4.914204154715662e-09
were O 0 1.696272983187086e-10
found O 0 1.0865115751546028e-10
and O 0 2.7644746491972683e-09
DM B-Disease 1 1.0
alleles O 0 3.846506224647328e-09
were O 0 9.095098563172144e-10
always O 0 8.836082976415582e-09
haplotype O 0 2.6623010285220516e-07
A O 0 8.300036711261782e-07
. O 0 4.833177058571891e-07

To O 0 1.66667017964528e-08
find O 0 5.35638922105619e-10
an O 0 1.462785621797469e-11
origin O 0 5.96823632181831e-11
of O 0 5.77169922966192e-10
the O 0 2.619514605228801e-09
( O 0 3.395093317593023e-09
CTG O 0 0.00014256691792979836
) O 0 3.872661746839867e-09
n O 0 5.171016947969065e-09
repeat O 0 4.2061247818026e-09
mutation O 0 4.1500533565219655e-10
and O 0 1.4870892017793125e-10
to O 0 1.0282039109021923e-10
investigate O 0 5.689038684586478e-10
the O 0 3.7586617152030044e-10
mechanism O 0 1.5464026725808822e-09
of O 0 1.4753231969422131e-09
the O 0 1.301772023509784e-09
expansion O 0 1.604986898939842e-08
mutation O 0 2.3551180450276377e-10
in O 0 5.235040526074819e-11
the O 0 5.607903585946872e-10
Japanese O 0 3.32064264974008e-09
population O 0 1.511276173649101e-11
we O 0 3.977007265176802e-11
have O 0 1.3540069239426078e-11
studied O 0 6.9258971890917564e-09
90 O 0 8.413745256063976e-09
Japanese O 0 3.815169691279152e-08
DM B-Disease 1 1.0
families O 0 9.430670827592635e-11
comprising O 0 1.2201960275515233e-10
190 O 0 9.379639287487862e-10
affected O 0 8.212145963248929e-10
and O 0 1.6929478929839092e-09
130 O 0 6.605929314673631e-08
unaffected O 0 3.582944145819056e-07
members O 0 1.9253332261826017e-09
. O 0 1.1366986285565872e-07

The O 0 7.747013910375244e-07
results O 0 1.114442405025784e-08
suggest O 0 2.2244255326597795e-09
that O 0 7.067611773603488e-11
a O 0 2.6532134822510045e-10
few O 0 1.758474477142613e-09
common O 0 2.068924809250916e-09
ancestral O 0 8.063487655363133e-09
mutations O 0 1.757307632743732e-09
in O 0 2.190017334147143e-10
both O 0 1.8845176530390972e-09
Caucasian O 0 2.111829644491081e-07
and O 0 2.4953568100727352e-09
Japanese O 0 3.023538752700006e-08
populations O 0 4.112372664621944e-10
have O 0 4.6811083655173835e-12
originated O 0 2.732838087771139e-11
by O 0 6.269560825361564e-12
expansion O 0 6.0989004957434645e-09
of O 0 5.566845207027882e-09
an O 0 7.113747368947543e-10
ancestral O 0 3.243752288994983e-08
n O 0 4.442587187014624e-09
= O 0 3.6692069382837644e-09
5 O 0 1.1448445746964353e-08
repeat O 0 1.4386214886030757e-08
to O 0 3.4631053580369553e-09
n O 0 9.555031432739725e-09
= O 0 9.561010649861146e-09
19 O 0 1.8332393381115253e-08
- O 0 3.278510263271528e-08
37 O 0 3.5158524980261063e-08
copies O 0 2.349736227813537e-08
. O 0 8.608348878169636e-08

These O 0 4.147509002905281e-08
data O 0 2.4512216700856015e-09
support O 0 8.809842855228567e-10
multistep O 0 4.554748045393353e-08
models O 0 1.1276157785289342e-08
of O 0 6.383882578120392e-08
triplet O 0 1.2413498780006194e-06
repeat O 0 3.329897779735802e-08
expansion O 0 1.1787101961147073e-08
that O 0 1.975588442837406e-11
have O 0 9.238563039581926e-12
been O 0 1.7262377291493713e-11
proposed O 0 2.1795244775635325e-10
for O 0 1.9485031643728945e-10
both O 0 4.95813434753245e-09
DM B-Disease 1 1.0
and O 0 7.10216113475326e-07
Friedreichs B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999997615814209
. O 0 3.3943317134799145e-07
. O 0 1.0303782573828357e-06

The O 0 1.3060433445843955e-07
molecular O 0 3.8453197959142926e-08
basis O 0 1.4042615958942406e-08
of O 0 1.8529450471760356e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.267844356751425e-09
the O 0 2.5308897200204683e-09
western O 0 4.1345220580524256e-09
Cape O 0 1.9545990426195203e-07
, O 0 6.097641280788935e-10
South O 0 1.0184439958038638e-08
Africa O 0 5.9501812366136164e-09
. O 0 5.068566366617233e-08

Deficiency B-Disease 0 0.44338148832321167
of I-Disease 0 1.437255036762508e-06
the I-Disease 0 2.2322177528621978e-07
sixth I-Disease 0 1.6118534063025436e-07
component I-Disease 0 8.728880374064829e-08
of I-Disease 0 3.8323236140058725e-08
human I-Disease 0 4.922638296989135e-09
complement I-Disease 0 1.2729037734970916e-07
( O 0 8.45928393999884e-09
C6 O 1 1.0
) O 0 1.2285827910574199e-09
has O 0 2.230938073166655e-10
been O 0 7.667577683889704e-11
reported O 0 5.60508896241263e-11
in O 0 1.654438912257472e-11
a O 0 2.4434331294398426e-11
number O 0 2.6860444424237073e-11
of O 0 1.0262642818892331e-10
families O 0 7.435591313671719e-13
from O 0 3.7751112999528935e-12
the O 0 1.2080153544147265e-10
western O 0 2.0913450970994063e-09
Cape O 0 2.984887146340043e-07
, O 0 1.6272383440707472e-09
South O 0 1.9752636859493578e-08
Africa O 0 1.7129863749687502e-08
. O 0 6.733740320896686e-08

Meningococcal B-Disease 1 0.9999312162399292
disease I-Disease 1 0.7513695359230042
is O 0 3.4711733487569063e-09
endemic O 0 5.907649924807856e-09
in O 0 1.0166534974986874e-10
the O 0 8.337858181661773e-10
Cape O 0 1.0254849769353314e-07
and O 0 4.323841840125908e-10
almost O 0 5.357121690696687e-11
all O 0 1.205418490718424e-11
pedigrees O 0 7.951230784897234e-10
of O 0 3.539953441489274e-09
total O 0 5.989094916003523e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.6060257951598942e-08
C6Q0 O 1 1.0
) O 0 1.4875807252678896e-09
have O 0 9.055559080373143e-11
been O 0 3.055525554795935e-10
ascertained O 0 5.136496739055474e-08
because O 0 1.3407988053160125e-09
of O 0 1.5950595511071697e-08
recurrent O 1 0.9999969005584717
disease O 1 0.999915361404419
. O 0 5.746067586187564e-07

We O 0 4.553480081881389e-08
have O 0 2.534603360526688e-10
sequenced O 0 1.2259492310207065e-09
the O 0 4.714030832353444e-10
expressed O 0 1.821123390977064e-10
exons O 0 1.2190666254241478e-08
of O 0 2.7256534806952004e-08
the O 0 7.896361609027736e-08
C6 O 1 0.9999834299087524
gene O 0 5.631205501899217e-10
from O 0 4.971832320843639e-11
selected O 0 2.5169230588595326e-10
cases O 0 3.591254377210973e-11
and O 0 1.0813718670510397e-10
have O 0 2.9359421144237174e-11
found O 0 1.0479716400224603e-10
three O 0 2.136427285082121e-10
molecular O 0 6.838945978415722e-07
defects O 1 0.8102822303771973
leading O 0 8.351458546940194e-08
to O 0 7.793459211313802e-09
total O 0 9.373098350806686e-07
deficiency O 1 1.0
879delG O 1 0.8979916572570801
, O 0 1.7865208201683913e-09
which O 0 3.282711602548005e-10
is O 0 2.201127335954567e-10
the O 0 6.218973669369632e-10
common O 0 2.653913533379182e-09
defect O 0 3.449005525624216e-09
in O 0 1.2059479803649964e-10
the O 0 4.19001455753687e-09
Cape O 0 2.867593821065384e-06
and O 0 1.3997156322886894e-08
hitherto O 0 1.3835119716532063e-07
unreported O 0 1.4346844068313658e-07
, O 0 5.160236127288442e-10
and O 0 1.477748035050297e-09
1195delC O 0 1.727196234924122e-07
and O 0 4.2276719902645254e-09
1936delG O 0 3.291760037882341e-07
, O 0 7.225868792204437e-10
which O 0 1.0523321797295537e-10
have O 0 5.051601498218261e-11
been O 0 3.312575214131641e-10
previously O 0 1.2874479260460703e-09
reported O 0 1.615014511013868e-10
in O 0 1.6169779404329176e-10
African O 0 1.0085153823169435e-09
- O 0 6.187825363213051e-08
Americans O 0 1.4701769801561682e-09
. O 0 1.3801588316653124e-08

We O 0 4.0664978939730645e-08
also O 0 1.3539462884182285e-09
show O 0 3.2313740572220695e-10
that O 0 1.2888815015266175e-11
the O 0 4.759457272740519e-10
879delG O 0 1.1062090266023006e-07
and O 0 6.75815936546087e-09
1195delC O 0 3.434913651290117e-06
defects O 0 4.955239774062647e-07
are O 0 6.11892342350373e-11
associated O 0 5.257216884047011e-10
with O 0 4.655293928124138e-09
characteristic O 1 1.0
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 5.347765181795694e-06
DNA O 0 6.41992301098071e-07
marker O 0 3.6502717648545513e-07
haplotypes O 0 9.227306918546674e-09
, O 0 1.0420717760917242e-10
although O 0 3.325876796189675e-10
small O 0 2.7637365729304975e-09
variations O 0 4.494442507052554e-08
were O 0 3.6607414877209976e-09
observed O 0 6.498070348470719e-08
. O 0 1.095026362918361e-07

The O 0 1.2753451983371633e-06
1936delG O 0 2.0960214897058904e-05
defect O 0 1.128923031501472e-06
was O 0 3.898581013572766e-08
observed O 0 4.1186702937068276e-09
only O 0 2.9619631747301867e-10
once O 0 4.5574549689675337e-10
in O 0 3.5939955872477114e-11
the O 0 3.658589819988123e-10
Cape O 0 2.000941492497077e-07
, O 0 7.736582485762256e-10
but O 0 1.6255995161085224e-10
its O 0 8.520246175258706e-10
associated O 0 6.847192590697659e-09
haplotype O 0 1.1878908168228008e-07
could O 0 2.5219330623826863e-08
be O 0 1.8917464927881156e-08
deduced O 0 3.817652327597898e-07
. O 0 2.4939814124991244e-07

The O 0 3.3048704040083976e-07
data O 0 1.2814609817723976e-08
from O 0 1.2963011775113387e-09
the O 0 8.87909568092482e-09
haplotypes O 0 1.1564566193555947e-08
indicate O 0 4.952244170297604e-10
that O 0 3.986446936443677e-11
these O 0 2.1032407759857819e-10
three O 0 1.7019995135481025e-10
molecular O 0 8.577777599327874e-09
defects O 0 3.0320105537384734e-08
account O 0 4.2154529866778034e-11
for O 0 1.636650120984129e-10
the O 0 6.873939639717719e-09
defects O 0 5.062813670519972e-07
in O 0 4.92100193927314e-10
all O 0 2.3870065923858874e-09
the O 0 4.694222788259594e-09
38 O 0 2.4971006595819745e-08
unrelated O 0 6.650899564419888e-08
C6Q0 O 1 1.0
individuals O 0 4.5232217971147293e-10
we O 0 4.851088974966444e-10
have O 0 7.281732855579648e-11
studied O 0 7.90497800551293e-09
from O 0 7.933098067347544e-10
the O 0 1.0121058657830417e-08
Cape O 0 3.519993242662167e-06
. O 0 3.5061697190030827e-07

We O 0 7.366116960838553e-08
have O 0 6.492044124506435e-10
also O 0 5.163563465693244e-10
observed O 0 1.03918829097438e-09
the O 0 2.390337039415158e-09
879delG O 0 4.022220423394174e-07
defect O 0 2.6709775724498286e-08
in O 0 4.93435792225938e-10
two O 0 3.285168803657257e-09
Dutch O 1 1.0
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 2.6208854251308367e-05
, O 0 1.2093760437537071e-09
but O 0 2.615389571580806e-10
the O 0 2.8938587082194545e-09
879delG O 0 4.86312842440384e-07
defect O 0 2.37425759053167e-08
in O 0 4.423003352460597e-10
the O 0 6.270707064714998e-09
Cape O 0 2.6961758976540295e-06
probably O 0 1.9325332445419008e-09
did O 0 4.585321289329869e-10
not O 0 7.457429118673531e-11
come O 0 7.702258275621432e-11
from O 0 4.361269331787376e-11
The O 0 1.8270842616630034e-09
Netherlands O 0 2.5812917670009483e-07
. O 0 1.9801184691914386e-08
. O 0 2.036938013816325e-07

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 9.339212425629739e-08
seven O 0 5.210003539701802e-09
further O 0 3.452316210683648e-09
molecular O 0 1.4147740046155377e-07
defects O 0 2.932066536232014e-07
and O 0 9.570365611111242e-10
their O 0 1.3871517268171374e-09
associated O 0 6.6290000155788675e-09
marker O 0 7.340908723563189e-06
haplotypes O 0 8.143412628669466e-07
. O 0 2.6100232730641437e-07

Seven O 0 1.236652593661347e-07
further O 0 4.416699894704834e-09
molecular O 0 1.2304102625648738e-08
bases O 0 3.2278787642781026e-08
of O 0 1.4697715414513368e-05
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.153793587922337e-08
described O 0 2.30497381181749e-08
. O 0 6.677299779767054e-08

All O 0 3.0118254557010005e-08
these O 0 1.7735106716543214e-09
new O 0 2.3633000001410664e-09
molecular O 0 2.2555386181011272e-07
defects O 0 3.0440551768151636e-07
involve O 0 2.974782864484382e-09
single O 0 5.693119864425e-10
- O 0 5.607671216267818e-09
nucleotide O 0 3.5079934512793898e-09
events O 0 8.767415682342516e-10
, O 0 1.8413148783480437e-10
deletions O 0 4.187857172155418e-09
and O 0 7.149998926259116e-10
substitutions O 0 1.4974597561945302e-08
, O 0 2.5833224448490455e-10
some O 0 1.0139424022614918e-10
of O 0 1.174835673189989e-09
which O 0 2.3272672677876471e-10
alter O 0 9.53676870807385e-09
splice O 0 2.3194525411440736e-08
sites O 0 3.926990288505294e-09
, O 0 7.352017328265958e-10
and O 0 3.861686526107633e-09
others O 0 2.735695048272646e-08
codons O 0 3.5474893138598418e-06
. O 0 3.577563347789692e-07

They O 0 5.835116390073836e-09
are O 0 8.240400722892005e-11
distributed O 0 1.1936342192431226e-10
along O 0 1.6040404560158095e-09
the O 0 6.24739104893024e-09
C7 O 0 0.0010775200789794326
gene O 0 1.2796773640744163e-09
, O 0 1.4661383218594892e-10
but O 0 3.1788606469351777e-11
predominantly O 0 1.1819485667974305e-10
towards O 0 6.132878094256e-10
the O 0 8.014677810308513e-10
3 O 0 4.4318575476154365e-08
end O 0 8.290323449955395e-08
. O 0 2.662153804067202e-07

All O 0 1.0644316006391819e-07
were O 0 3.104390522423728e-09
found O 0 3.5324176916873284e-10
in O 0 3.4757630107407067e-10
compound O 0 3.1966195024324406e-08
heterozygous O 0 4.671190367844247e-08
individuals O 0 1.2013571248914445e-09
. O 0 6.326910551024412e-08

The O 0 3.0483734008157626e-05
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
marker O 0 3.2214018574450165e-05
haplotypes O 0 8.741792356659062e-08
associated O 0 5.025898364152681e-09
with O 0 3.973871898210746e-09
most O 0 8.256434398390411e-07
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999990463256836
are O 0 6.080734138436128e-09
tabulated O 0 7.925603995317942e-08
. O 0 4.152874044649479e-09
. O 0 4.733659864086803e-08

A O 0 3.4180063721578335e-06
genome O 0 5.9187737377897065e-08
- O 0 8.407701557189284e-08
wide O 0 6.255573481439569e-08
search O 0 2.0036037273740703e-09
for O 0 3.0919913851512604e-10
chromosomal O 0 5.110396159579977e-07
loci O 0 2.2296860890946846e-07
linked O 0 1.171118242382363e-07
to O 0 5.277614789633844e-09
mental O 1 0.9992759823799133
health O 0 2.5790966446948005e-06
wellness O 0 1.592605372024991e-06
in O 0 1.2924934733593574e-10
relatives O 0 6.496946036715912e-11
at O 0 1.001472238471024e-10
high O 0 2.3455674735828325e-08
risk O 0 7.236509702579497e-08
for O 0 1.0871988642691122e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.321468268145054e-08
the O 0 1.3260635256528985e-08
Old O 0 6.408526473933307e-07
Order O 0 1.1828117862933141e-07
Amish O 0 3.633198275565519e-07
. O 0 1.2561054063553456e-07

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 7.812354851921555e-06
BPAD B-Disease 1 1.0
; O 0 4.9051057430915534e-05
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 5.609637199199824e-10
is O 0 4.204564474363792e-11
characterized O 0 1.2710847652197543e-10
by O 0 2.292168711781617e-11
episodes O 0 1.8132849888274905e-08
of O 0 8.221510228167972e-08
mania B-Disease 1 0.8901081681251526
and O 0 5.775140721198113e-08
/ O 0 0.017686259001493454
or O 0 1.3500432771706983e-07
hypomania B-Disease 0 0.00010266701428918168
interspersed O 0 1.009703751719826e-07
with O 0 1.3599585901857836e-09
periods O 0 7.128191015226548e-08
of O 0 1.6864763097146351e-07
depression B-Disease 0 3.0388182494789362e-05
. O 0 1.6057808238656435e-07

Compelling O 0 1.6911272950892453e-06
evidence O 0 5.1102883702469626e-08
supports O 0 9.873888018319121e-08
a O 0 2.6408051301274327e-09
significant O 0 5.052762652724141e-09
genetic O 0 3.3298199753062363e-09
component O 0 5.176227002579026e-09
in O 0 8.990778954665046e-11
the O 0 2.56990717595329e-09
susceptibility O 0 6.066071023269615e-08
to O 0 2.274490462639278e-08
develop O 0 0.001134027959778905
BPAD B-Disease 1 1.0
. O 0 1.9929380869143642e-05

To O 0 1.672009730668833e-08
date O 0 1.6775681288550004e-08
, O 0 1.7510943806087198e-09
however O 0 2.009348021303481e-09
, O 0 1.4608995124731905e-09
linkage O 0 1.6824611037691284e-08
studies O 0 1.9413926022338046e-09
have O 0 1.4197783226865823e-10
attempted O 0 5.885931742000139e-09
only O 0 6.964943205511887e-11
to O 0 2.2959065204553042e-10
identify O 0 3.259870817728938e-09
chromosomal O 0 4.696638598034042e-07
loci O 0 2.7515772771380398e-08
that O 0 3.813856175316488e-10
cause O 0 3.2998006549433967e-09
or O 0 9.04464905748803e-11
increase O 0 1.5010155618444543e-10
the O 0 1.7664818496854195e-09
risk O 0 1.6753553211401595e-08
of O 0 5.9687906173167e-08
developing O 0 1.367382901662495e-05
BPAD B-Disease 1 1.0
. O 0 4.208255631965585e-06

To O 0 1.0047258136580695e-08
determine O 0 1.6219953158369549e-09
whether O 0 5.895928745225376e-10
there O 0 1.6752770004568873e-10
could O 0 2.415469768646261e-10
be O 0 3.277625393316441e-10
protective O 0 9.035557724246246e-08
alleles O 0 2.5075744258806765e-10
that O 0 1.5223740670866626e-11
prevent O 0 1.3855572245091707e-09
or O 0 7.073410607238984e-11
reduce O 0 1.6896992693915536e-09
the O 0 4.675437814682937e-10
risk O 0 4.1000318695694205e-09
of O 0 5.522891477482972e-09
developing O 0 6.829775429650908e-07
BPAD B-Disease 1 1.0
, O 0 1.82296289175099e-09
similar O 0 2.4663215913989234e-10
to O 0 7.661233453193361e-11
what O 0 7.679080982203601e-11
is O 0 3.62056044866943e-11
observed O 0 4.9299151566595256e-11
in O 0 4.174550635727137e-11
other O 0 4.848760504216898e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 7.899773613040395e-10
we O 0 4.139664999680548e-10
used O 0 4.056734503876669e-09
mental O 0 0.02685633860528469
health O 0 1.0287885743309744e-06
wellness O 0 1.4464872037933674e-05
( O 0 1.2096454393706324e-10
absence O 0 1.9024235520248567e-09
of O 0 3.080390831300406e-09
any O 0 1.7956153897102922e-08
psychiatric B-Disease 1 0.9999508857727051
disorder I-Disease 0 1.0568675861577503e-05
) O 0 7.342736835225239e-11
as O 0 2.1795867888307896e-10
the O 0 1.9661028360928867e-09
phenotype O 0 4.965033273407471e-09
in O 0 3.5431671485675054e-10
our O 0 4.631328653914579e-09
genome O 0 9.374653053839666e-09
- O 0 1.3214423688623356e-07
wide O 0 1.1964364148298046e-06
linkage O 0 1.1284832623914554e-07
scan O 0 8.954305030783871e-08
of O 0 1.3571840540294033e-08
several O 0 8.226521686083288e-10
large O 0 1.042114483595924e-08
multigeneration O 0 9.964090850189677e-07
Old O 0 1.185090283684076e-07
Order O 0 9.332620898305777e-09
Amish O 0 1.294411777763571e-08
pedigrees O 0 2.2994543158461056e-08
exhibiting O 0 1.8799269696501142e-08
an O 0 3.686490002152709e-10
extremely O 0 1.0063867961207507e-08
high O 0 1.9465072398361372e-07
incidence O 0 4.812379302165937e-06
of O 0 5.713201062462758e-06
BPAD B-Disease 1 1.0
. O 0 1.2620827874343377e-05

We O 0 1.3979098412164603e-07
have O 0 1.1250114173577686e-09
found O 0 2.011966426795908e-10
strong O 0 1.3637736773208786e-10
evidence O 0 1.310188207925833e-10
for O 0 2.1628066004808488e-10
a O 0 8.801629980403902e-10
locus O 0 7.538987034649836e-08
on O 0 8.856739697193916e-08
chromosome O 0 4.282611314465612e-07
4p O 0 2.3548118406324647e-06
at O 0 7.469710538998697e-08
D4S2949 O 0 2.5999147510447074e-06
( O 0 2.9585542904442264e-09
maximum O 0 9.871948947193232e-08
GENEHUNTER O 0 0.0005736806197091937
- O 0 8.520268011125154e-07
PLUS O 0 7.644063089173869e-07
nonparametric O 0 1.427353026883793e-07
linkage O 0 1.6811075198575054e-08
score O 0 6.8012719900423235e-09
= O 0 6.635232918661416e-10
4 O 0 1.4392821379161091e-09
. O 0 3.180372354361083e-10
05 O 0 1.7580949815965141e-06
, O 0 6.985372280610136e-09
P O 0 9.405946599372328e-08
= O 0 4.746882331652102e-10
5 O 0 5.095586175229982e-10
. O 0 4.977791095983619e-11
22 O 0 1.203297239626977e-09
x O 0 7.618425335031986e-10
10 O 0 1.1290356427551274e-09
( O 0 5.0543867702312895e-11
- O 0 1.019672346558309e-08
4 O 0 6.783626993467351e-09
) O 0 2.1118834458988545e-10
; O 0 6.084164838604522e-10
SIBPAL O 0 7.787772483425215e-05
Pempirical O 0 1.7225129340658896e-06
value O 0 9.90160664571249e-09
< O 0 3.4405034377016364e-09
3 O 0 1.2260568116317927e-09
x O 0 9.845669834973592e-10
10 O 0 7.600384210881828e-10
( O 0 4.4787926839484626e-11
- O 0 6.274379682480458e-09
5 O 0 2.5290609606543057e-09
) O 0 9.091902231084248e-11
) O 0 9.988587734710563e-11
and O 0 3.7218508830427766e-10
suggestive O 0 6.768789084787841e-09
evidence O 0 1.8050567984762012e-10
for O 0 1.3260571807283128e-10
a O 0 5.260467061951601e-10
locus O 0 4.8811283903660296e-08
on O 0 8.526074424253238e-08
chromosome O 0 8.274635661109642e-07
4q O 0 3.0669780244352296e-06
at O 0 2.5380309409683832e-08
D4S397 O 0 1.103534373214643e-06
( O 0 9.844243198386948e-10
maximum O 0 3.806708903653089e-08
GENEHUNTER O 0 9.53846174525097e-05
- O 0 3.2295233154400194e-07
PLUS O 0 5.03495868997561e-07
nonparametric O 0 1.031255649763807e-07
linkage O 0 6.786279538317785e-09
score O 0 1.9412000895613346e-09
= O 0 1.099080063071689e-10
3 O 0 2.4130245024345243e-10
. O 0 8.905579745865921e-11
29 O 0 8.614717827981622e-09
, O 0 7.771115417831709e-10
P O 0 4.4856300007722893e-08
= O 0 5.025003746439438e-10
2 O 0 1.1883668493695154e-09
. O 0 1.3147392896595278e-10
57 O 0 3.1499713948335284e-09
x O 0 1.3447275515332535e-09
10 O 0 1.3207922533453598e-09
( O 0 5.743144848580073e-11
- O 0 5.703861383210551e-09
3 O 0 5.885550269368878e-09
) O 0 1.7863358015013375e-10
; O 0 4.4227163598087316e-10
SIBPAL O 0 8.145474566845223e-05
Pempirical O 0 1.6825176771817496e-06
value O 0 7.746893793125764e-09
< O 0 3.3620353168117845e-09
1 O 0 1.3496533890489104e-09
x O 0 1.6281076486990287e-09
10 O 0 1.1799873300688546e-09
( O 0 4.9092060278033145e-11
- O 0 6.745255909379466e-09
3 O 0 2.7366122701266704e-09
) O 0 5.474672798433389e-11
) O 0 2.3318694197804746e-11
that O 0 7.686022825137417e-12
are O 0 7.885663649842556e-11
linked O 0 1.5035041656119574e-08
to O 0 1.4889612209856296e-08
mental O 0 0.0005474101635627449
health O 0 3.2625709991407348e-06
wellness O 0 2.960572783194948e-05
. O 0 1.158026350367436e-07

These O 0 7.454708850218594e-08
findings O 0 3.3551936784448344e-09
are O 0 4.198954378642483e-11
consistent O 0 4.830582600590105e-10
with O 0 2.355925697583583e-11
the O 0 4.922541818608295e-10
hypothesis O 0 3.8157627058055255e-10
that O 0 1.4644523441131874e-11
certain O 0 8.17460876767484e-10
alleles O 0 3.188924957431283e-10
could O 0 3.857083541447537e-10
prevent O 0 1.3435950130258334e-08
or O 0 1.1946391653694377e-09
modify O 0 9.889451924038895e-09
the O 0 2.2736088567398838e-09
clinical O 0 3.206395859933764e-08
manifestations O 0 1.0841863229416049e-07
of O 0 3.0000211381775443e-07
BPAD B-Disease 1 1.0
and O 0 7.16660792932089e-08
perhaps O 0 1.2113361425036828e-09
other O 0 9.006660417476553e-10
related O 0 7.277517579495907e-05
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 5.96733457314258e-07

Segregation O 0 0.0004119966470170766
distortion O 0 0.043166715651750565
in O 0 4.049133167427499e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 7.193245983216912e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 1.5550170928690932e-07
is O 0 6.01103744557463e-09
an O 0 4.954561205749997e-09
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 0.999997615814209
which O 0 1.570298890918309e-10
, O 0 4.1588781030110766e-11
in O 0 2.6676742412301557e-11
the O 0 6.483727998940481e-10
typical O 0 1.6838760386050922e-09
pedigree O 0 8.104115600815476e-09
, O 0 2.530246567822303e-10
shows O 0 7.881878483217974e-10
a O 0 7.835412318968338e-10
three O 0 2.609237492734451e-09
generation O 0 6.707949040674066e-08
anticipation O 0 1.873417886599782e-06
cascade O 0 0.00017119258700404316
. O 0 1.1081049251515651e-06

This O 0 2.496346906966096e-09
results O 0 1.716530806383787e-09
in O 0 1.66684421820662e-09
infertility B-Disease 0 0.005733518395572901
and O 1 0.9633713364601135
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.5125580432595598e-07
CDM B-Disease 1 0.9990621209144592
) O 0 5.667093877503859e-11
with O 0 2.922856748299729e-11
the O 0 2.1754347212521452e-09
disappearance O 0 1.9467034206854805e-08
of O 0 1.2188834830340056e-07
DM B-Disease 1 1.0
in O 0 2.0428885250112216e-08
that O 0 8.419830166417341e-09
pedigree O 0 2.211668743257178e-06
. O 0 2.0162102032372786e-07

The O 0 6.106026262386877e-08
concept O 0 2.0519992816048216e-08
of O 0 5.483895559876828e-09
segregation O 0 1.1682436706905719e-07
distortion O 0 1.6957850448307e-06
, O 0 1.777075431252939e-10
where O 0 1.258357862354842e-10
there O 0 2.2652869163808376e-11
is O 0 1.51331256553755e-11
preferential O 0 1.1993309678715036e-09
transmission O 0 1.1797217647213643e-09
of O 0 9.577798554261108e-10
the O 0 9.116044030754722e-10
larger O 0 1.5765238003950799e-09
allele O 0 1.302409569081675e-10
at O 0 1.0555792906430383e-09
the O 0 1.4665424430404528e-08
DM B-Disease 1 1.0
locus O 0 1.203407691718894e-06
, O 0 1.91531213111773e-09
has O 0 4.084022009465116e-10
been O 0 5.488288157273757e-10
put O 0 1.496734469697003e-08
forward O 0 2.2767604690443477e-08
to O 0 9.97903315536064e-10
explain O 0 2.395626808038287e-09
partially O 0 1.3984053914839478e-08
the O 0 8.141885499135526e-10
maintenance O 0 1.6248826284481765e-07
of O 0 3.591609925024386e-07
DM B-Disease 1 1.0
in O 0 1.6030535121558387e-08
the O 0 3.5807541820531696e-08
population O 0 1.2168777097087968e-09
. O 0 2.6243768047606864e-08

In O 0 4.201917036539271e-08
a O 0 2.0491626173679833e-09
survey O 0 6.211481884399461e-10
of O 0 8.62195115303166e-09
DM B-Disease 1 1.0
in O 0 4.957538823902041e-09
Northern O 0 6.31338480161503e-07
Ireland O 0 7.79927731286989e-08
, O 0 9.640447551362286e-09
59 O 0 6.239843486355312e-08
pedigrees O 0 1.3598301507045107e-07
were O 0 1.2513892144738747e-08
ascertained O 0 3.440772616158938e-06
. O 0 2.4918631424952764e-07

Sibships O 0 2.3987202439457178e-05
where O 0 9.053011673643141e-09
the O 0 6.692326137702764e-10
status O 0 7.777135602182739e-10
of O 0 6.218855430617509e-10
all O 0 1.3028220169353233e-10
the O 0 3.1627689356383826e-10
members O 0 1.3166055919111574e-11
had O 0 4.986992485633834e-10
been O 0 2.435970591907477e-10
identified O 0 2.1862696375496427e-10
were O 0 7.169400489948075e-11
examined O 0 7.440043026107901e-10
to O 0 6.650192202473093e-11
determine O 0 5.27422105989217e-10
the O 0 5.765394828216586e-10
transmission O 0 1.3006682841876227e-08
of O 0 1.1869611427073323e-07
the O 0 2.3341135602095164e-05
DM B-Disease 1 1.0
expansion O 0 0.0002472616033628583
from O 0 3.4171556695383742e-09
affected O 0 5.572231120964943e-09
parents O 0 1.3894548012149954e-10
to O 0 1.2852194308798914e-10
their O 0 1.367191582168914e-09
offspring O 0 3.470328024945957e-08
. O 0 4.837234968135817e-08

Where O 0 7.818818659188764e-08
the O 0 2.7068161045917805e-08
transmitting O 0 1.5664287502659135e-06
parent O 0 5.398466740302865e-08
was O 0 8.64415099499638e-08
male O 0 2.756052452923541e-08
, O 0 5.353797405405203e-09
58 O 0 3.752903126041929e-07
. O 0 2.579839701866149e-07

3 O 0 7.236868526661056e-08
% O 0 7.679304969698819e-10
of O 0 8.371289217379285e-10
the O 0 6.716110445559309e-10
offspring O 0 3.373776258364103e-10
were O 0 2.7388652110160727e-11
affected O 0 2.6295249311303337e-10
, O 0 4.2883918638381147e-11
and O 0 6.193945356613995e-11
in O 0 5.760643351226946e-11
the O 0 2.3036750285143626e-10
case O 0 2.292917522517257e-10
of O 0 7.018342018660917e-10
a O 0 8.626469538697279e-10
female O 0 3.0166418252264293e-09
transmitting O 0 3.03197055018245e-07
parent O 0 2.2792196574528134e-08
, O 0 1.712992947489056e-08
68 O 0 1.2736678627334186e-06
. O 0 4.519595790952735e-07

7 O 0 1.204978730129369e-06
% O 0 1.4238096035512626e-08
were O 0 2.9577982285644566e-09
affected O 0 9.00838657003078e-08
. O 0 1.8599207862735057e-07

Studies O 0 1.8001185253524454e-07
on O 0 6.17835524963084e-08
meiotic O 0 1.9247524960519513e-06
drive O 0 2.275480568414423e-07
in O 0 7.232270338164426e-09
DM B-Disease 1 1.0
have O 0 6.958373877097301e-10
shown O 0 4.620647614528295e-11
increased O 0 2.1465773603068783e-10
transmission O 0 1.1886751583034538e-09
of O 0 5.668210345532998e-10
the O 0 5.130323388335967e-10
larger O 0 3.423954009207364e-09
allele O 0 4.481649218401884e-10
at O 0 2.123549780463918e-09
the O 0 2.042549596126264e-08
DM B-Disease 1 1.0
locus O 0 4.180963628641621e-07
in O 0 3.0554863084120143e-09
non O 0 1.2017908375128172e-05
- O 0 0.0006108213565312326
DM O 1 1.0
heterozygotes O 0 1.9196415905753383e-06
for O 0 4.641553985607061e-08
CTGn O 0 0.00025105939130298793
. O 0 4.934706794301746e-07

This O 0 2.4158270051088948e-08
study O 0 3.1908795605772866e-09
provides O 0 1.8332690920885852e-10
further O 0 2.2212616468397783e-10
evidence O 0 2.007584931629225e-10
that O 0 8.181546412577845e-11
the O 0 2.039442925649837e-08
DM B-Disease 1 1.0
expansion O 0 8.50843389343936e-06
tends O 0 1.8299107296115835e-07
to O 0 4.740180692408558e-09
be O 0 3.4509399782223227e-09
transmitted O 0 2.1793397309011198e-08
preferentially O 0 1.638789228763926e-07
. O 0 1.5060649616316368e-07

Diagnosis O 1 0.9975908994674683
of O 0 0.0004311643133405596
hemochromatosis B-Disease 1 1.0
. O 0 6.509710510727018e-05

If O 0 2.2511944735015277e-06
untreated O 1 1.0
, O 0 1.4234434786430938e-07
hemochromatosis B-Disease 1 1.0
can O 0 1.6451342332857166e-07
cause O 0 1.0866299817280378e-05
serious O 1 1.0
illness O 0 0.07708636671304703
and O 0 7.638475407745204e-10
early B-Disease 0 6.130573826368391e-10
death I-Disease 0 3.639889278872488e-09
, O 0 1.1632669827399411e-10
but O 0 1.0140274731007537e-10
the O 0 1.4566896577861144e-09
disease O 0 1.4112462167759077e-06
is O 0 9.455891625265167e-10
still O 0 1.0572819286736035e-09
substantially O 0 7.069695495687256e-09
under O 0 6.204253111263824e-08
- O 1 0.8981031775474548
diagnosed O 0 4.1033883462660015e-05
. O 0 4.0258049693875364e-07

The O 0 2.079414258560064e-07
cornerstone O 0 3.347280653542839e-06
of O 0 1.5938095287992837e-08
screening O 0 4.9169046612007605e-09
and O 0 5.954662873897121e-10
case O 0 2.505289309340242e-10
detection O 0 9.044796023260915e-09
is O 0 1.4216615384921027e-10
the O 0 3.5397559883243446e-10
measurement O 0 2.660808107179946e-08
of O 0 1.3557999167801427e-08
serum O 0 3.016229044305874e-08
transferrin O 0 9.324102023811065e-08
saturation O 0 8.62777795873626e-08
and O 0 7.848099947693754e-09
the O 0 2.9385235578160973e-08
serum O 0 1.0939805150655957e-07
ferritin O 0 2.2863969206809998e-06
level O 0 3.9572532273268735e-07
. O 0 2.0525675381577457e-07

Once O 0 5.159287184142158e-07
the O 0 1.1068881811127085e-08
diagnosis O 0 3.382994862022315e-07
is O 0 2.039694857458585e-09
suspected O 0 2.4294397604762707e-08
, O 0 1.84031878625035e-09
physicians O 0 1.6763901378169521e-09
must O 0 3.9017011843611726e-10
use O 0 1.2567273888208774e-09
serum O 0 1.7478516411983946e-08
ferritin O 0 4.67636112944092e-07
levels O 0 6.016747420289903e-07
and O 0 1.4309144091839698e-07
hepatic O 1 1.0
iron O 1 1.0
stores O 0 9.42246671797875e-08
on O 0 4.624463656455191e-08
liver O 0 5.028066880186088e-06
biopsy O 0 1.2638317059554538e-07
specimens O 0 1.9545824958555613e-09
to O 0 9.543037193804338e-11
assess O 0 2.0282389101566878e-09
patients O 0 4.4715203761924727e-11
for O 0 7.512560885880593e-12
the O 0 3.9320849354318455e-10
presence O 0 3.4054179476328272e-09
of O 0 1.5342880033131223e-07
iron B-Disease 1 0.9999709129333496
overload I-Disease 0 3.326313890283927e-05
. O 0 4.2292307966818043e-07

Liver O 1 1.0
biopsy O 0 0.15126237273216248
is O 0 9.4058894006821e-09
also O 0 2.0642644538160226e-10
used O 0 5.349984344427128e-11
to O 0 2.4716699173477075e-11
establish O 0 7.756584957663293e-11
the O 0 2.491945261251516e-10
presence O 0 3.8056813256304167e-10
or O 0 1.5787174900694367e-09
absence O 0 4.3755235878961685e-08
of O 0 2.461397343722638e-07
cirrhosis B-Disease 1 1.0
, O 0 2.8226736503711436e-09
which O 0 2.9601671114320993e-10
can O 0 3.8788697254155124e-10
affect O 0 1.5899383143391788e-08
prognosis O 0 3.392193548279465e-06
and O 0 3.607379639447572e-08
management O 0 2.144455265806755e-06
. O 0 5.530968678613135e-07

A O 0 2.8109744221183064e-07
DNA O 0 4.44997372284206e-09
- O 0 2.0401111910928194e-09
based O 0 2.4145899168992457e-10
test O 0 8.599982531665162e-11
for O 0 6.410094677278266e-11
the O 0 4.013450904949423e-09
HFE O 0 0.00024132573162205517
gene O 0 1.8409999080759576e-09
is O 0 4.978028753099828e-11
commercially O 0 3.9745062796470165e-10
available O 0 3.627188827071137e-11
, O 0 3.369813109110886e-11
but O 0 6.989106342281115e-12
its O 0 2.875040136518514e-11
place O 0 1.3383300023761535e-10
in O 0 1.3972808153572824e-11
the O 0 3.2243185899005766e-10
diagnosis O 0 2.388615705228858e-08
of O 0 8.13908229702065e-08
hemochromatosis B-Disease 1 1.0
is O 0 7.912478139360246e-08
still O 0 8.153793196186143e-09
being O 0 4.666352637627824e-09
evaluated O 0 1.0364812652596811e-07
. O 0 4.9168036753144406e-08

Currently O 0 5.783727488051227e-07
, O 0 2.972831536496301e-09
the O 0 6.352769976736283e-10
most O 0 1.7196694068744023e-10
useful O 0 2.4247617802508614e-10
role O 0 1.0017340429380184e-10
for O 0 3.0392029171100177e-11
this O 0 3.8329296334072005e-12
test O 0 4.866971756167793e-11
is O 0 1.0460759862496172e-11
in O 0 6.227537582836895e-12
the O 0 7.950149566449127e-11
detection O 0 1.7688631004375566e-08
of O 0 4.12916527636753e-08
hemochromatosis B-Disease 1 1.0
in O 0 4.858907054483552e-09
the O 0 2.0511931708711018e-08
family O 0 2.648122554571586e-10
members O 0 8.258396570759441e-12
of O 0 6.47394138297841e-10
patients O 0 2.934499310214278e-10
with O 0 3.3591348452821634e-11
a O 0 5.52709378265348e-10
proven O 0 2.0644398190938773e-08
case O 0 2.163538237454077e-09
of O 0 2.3257875625404267e-08
the O 0 3.047380801035615e-07
disease O 0 6.688731082249433e-05
. O 0 4.095477947885229e-07

It O 0 4.7216129672733587e-08
is O 0 2.4821840138855578e-09
crucial O 0 2.3122085579529994e-08
to O 0 1.1218750373132025e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999997615814209
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999793767929077
because O 0 1.435033283314624e-07
phlebotomy O 1 0.9217662215232849
therapy O 0 3.7343059489103325e-07
can O 0 4.78877826282087e-10
avert O 0 9.021744062920334e-07
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 2.2671997612633277e-09
can O 0 1.25110879989343e-10
even O 0 4.1435041508997017e-10
lead O 0 3.874701004491499e-09
to O 0 1.0931952010295731e-09
normal O 0 2.102352425481513e-08
life O 0 3.2077949185804755e-09
expectancy O 0 6.544862429791465e-09
. O 0 9.763984065713771e-10
. O 0 5.0982453814185646e-08

Prevalence O 0 2.6205007088719867e-05
of O 0 9.65888148130034e-07
the O 0 5.691941282748303e-07
I1307K O 0 4.4460011849878356e-05
APC B-Disease 0 1.4667853065475356e-06
gene O 0 2.332098514301606e-09
variant O 0 1.858151854605694e-09
in O 0 6.916979489179909e-11
Israeli O 0 9.959295610428853e-10
Jews O 0 1.2429955675852256e-10
of O 0 4.5788952490743995e-11
differing O 0 3.0123955413463577e-11
ethnic O 0 5.051081081175468e-11
origin O 0 7.475511529242418e-12
and O 0 4.707344236631883e-11
risk O 0 2.1955028017828226e-08
for O 0 8.370323456574624e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.004043037435622e-06

BACKGROUND O 0 6.033431873220252e-06
& O 0 1.0640799246175447e-06
AIMS O 0 1.2059052778568002e-06
Israeli O 0 1.111438763246042e-08
Jews O 0 2.153952571859463e-09
of O 0 2.15015583115985e-09
European O 0 4.870896130881874e-09
birth O 0 2.915220509436267e-09
, O 0 2.901323625792429e-10
i O 0 5.352998044827473e-10
. O 0 6.447382905339083e-11
e O 0 4.082627846901943e-10
. O 0 1.3320397562743835e-10
, O 0 7.356927289592363e-10
Ashkenazim O 0 2.5949111659429036e-07
, O 0 6.192164558882496e-10
have O 0 5.920593876274083e-11
the O 0 1.6813406222837557e-09
highest O 0 5.37039613845991e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 2.2031277694622986e-05
of O 0 7.705678228830948e-08
any O 0 9.969221892447422e-09
Israeli O 0 2.3288503570029206e-08
ethnic O 0 1.5217899829167436e-08
group O 0 3.3961164991325177e-09
. O 0 3.362883305157993e-08

The O 0 5.548071385419462e-06
I1307K O 0 0.00015035078104119748
APC B-Disease 0 1.5168833670031745e-05
gene O 0 4.462802039029157e-08
variant O 0 1.9333680256750085e-07
was O 0 3.45611290697434e-08
found O 0 1.7272835384218865e-09
in O 0 2.479245697628585e-09
6 O 0 8.130282935780997e-07
. O 0 2.608731790587626e-07

1 O 0 5.3511865161226524e-08
% O 0 4.1378650506018744e-10
of O 0 2.64736982336089e-10
American O 0 2.1286990226077052e-10
Jews O 0 4.6449144530669173e-10
, O 0 6.494220439190457e-11
28 O 0 1.0282457107990695e-09
% O 0 6.75558775586893e-11
of O 0 6.963299381546051e-10
their O 0 1.4018076477384511e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 4.054044921986133e-08
, O 0 2.7670830904380495e-11
but O 0 8.331761496005452e-12
not O 0 1.3933712690594735e-11
in O 0 9.175751131129672e-11
non O 0 6.314553502306808e-08
- O 0 1.155702946675774e-07
Jews O 0 3.8775862520878945e-08
. O 0 6.763823279243297e-08

We O 0 2.1207038969350833e-07
assessed O 0 6.03176488311874e-07
the O 0 1.8869537043997298e-08
I1307K O 0 5.487084422384214e-07
prevalence O 0 6.26113338952905e-09
in O 0 4.710469861390898e-11
Israeli O 0 9.940034351174631e-10
Jews O 0 1.7974161048428527e-10
of O 0 8.450502797519022e-11
differing O 0 4.30465038614436e-11
ethnic O 0 3.793127964502041e-11
origin O 0 6.247667747732999e-12
and O 0 4.5334461878931975e-11
risk O 0 2.3085686251533843e-08
for O 0 9.544597645572139e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.778787120405468e-06

METHODS O 0 1.0067967650684295e-06
DNA O 0 1.5375977824305664e-08
samples O 0 3.8774936039764896e-10
from O 0 3.1289800611622454e-11
500 O 0 2.7360991250446887e-10
unrelated O 0 5.521509360839616e-10
Jews O 0 2.4859350689077075e-10
of O 0 5.188086071861164e-10
European O 0 1.4958433380840575e-09
or O 0 1.9701069942090754e-10
non O 0 1.8613194319172521e-09
- O 0 8.566344300575679e-10
European O 0 2.0657414667724083e-10
origin O 0 1.305881444646495e-11
, O 0 1.913093164787605e-12
with O 0 2.0100926131916275e-12
or O 0 2.4006194601633446e-11
without O 0 1.2434317464560252e-10
a O 0 8.43996816879411e-11
personal O 0 2.3731334675147764e-09
and O 0 2.859926073739416e-09
/ O 0 2.806177406000643e-07
or O 0 3.738665377284178e-09
family O 0 8.51001435986376e-10
history O 0 3.320002717188686e-09
of O 0 1.7954954856236327e-08
neoplasia B-Disease 0 0.006980655249208212
, O 0 9.578272619492623e-10
were O 0 2.654924335931952e-10
examined O 0 2.3704826990211814e-09
for O 0 2.72669581358187e-10
the O 0 2.553343758648907e-09
I1307K O 0 1.7030833987519145e-07
variant O 0 4.090205507623068e-09
by O 0 6.043726630267088e-11
the O 0 1.62544544490828e-09
allele O 0 1.4161414263469396e-09
- O 0 1.9818752861056055e-08
specific O 0 1.2697847218134939e-08
oligonucleotide O 0 4.3983251885038044e-07
( O 0 1.0634835234668572e-08
ASO O 0 0.02332678996026516
) O 0 1.8400600154677704e-08
method O 0 4.8381945561004613e-08
. O 0 6.528955509566003e-08

RESULTS O 0 6.461105499511177e-07
In O 0 1.0589354282330987e-08
persons O 0 9.125368238827036e-10
at O 0 4.6364967420942094e-10
average O 0 4.442042567109894e-10
risk O 0 5.571890948630198e-09
for O 0 2.0047934867761796e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.5819155641547695e-08
I1307K O 0 2.4543819563405123e-06
was O 0 9.269005118994755e-09
found O 0 5.091350119279525e-10
in O 0 6.096175786396429e-10
5 O 0 1.4854839491817984e-07
. O 0 1.205801396508832e-07

0 O 0 1.8329357942548086e-07
% O 0 1.6604662089747535e-09
of O 0 2.0255943589120307e-09
120 O 0 7.2096137948562955e-09
European O 0 9.98299753973697e-09
and O 0 1.0822602369842116e-08
1 O 0 7.053790227473655e-07
. O 0 2.3608352250903408e-07

6 O 0 3.7813094877492404e-07
% O 0 2.5103898959599746e-09
of O 0 4.644367113115777e-09
188 O 0 7.28675564332093e-09
non O 0 4.0235629938933926e-08
- O 0 4.773444572947483e-08
European O 0 2.4519899000097212e-08
Jews O 0 9.023756852855058e-09
( O 0 1.2864194154360575e-09
P O 0 1.0772335201636452e-07
= O 0 8.946751672844755e-10
0 O 0 1.541108574087957e-09
. O 0 4.908328743447044e-10
08 O 0 4.4240670149520156e-07
) O 0 1.3288182998394404e-08
. O 0 1.1491176366007494e-07

It O 0 1.3314954117049638e-07
occurred O 0 4.5712230445360547e-08
in O 0 7.853190986395475e-09
15 O 0 2.3172687235728517e-07
. O 0 3.308058467155206e-07

4 O 0 1.7184947864734568e-07
% O 0 1.4367230738443482e-09
of O 0 2.6585034174075872e-09
52 O 0 5.538557168449643e-09
Ashkenazi O 0 1.491303081024853e-08
Israelis O 0 6.950591213694679e-09
with O 0 6.323276569020209e-09
familial O 1 0.9999409914016724
cancer B-Disease 1 1.0
( O 0 4.332644465421254e-09
P O 0 2.2415829903366102e-07
= O 0 3.284885141674465e-10
0 O 0 2.9581070926099073e-10
. O 0 5.659899632304288e-11
02 O 0 5.256771018480322e-08
) O 0 5.141645095796399e-11
and O 0 4.0229372610944836e-10
was O 0 4.994515467870997e-09
not O 0 1.2440225238830038e-10
detected O 0 6.307180333564588e-10
in O 0 2.1218725387850412e-10
51 O 0 1.635597079996387e-08
non O 0 1.4491361000068537e-08
- O 0 1.2863218934455745e-08
European O 0 1.0406505879245742e-08
Jews O 0 2.720364600250491e-09
at O 0 2.191861581124499e-09
increased O 0 1.6783873846293318e-08
cancer B-Disease 0 1.2388946970531833e-06
risk O 0 3.5735772030420776e-07
. O 0 1.0422560592360242e-07

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999997615814209
occurred O 0 7.027322226349497e-07
personally O 0 1.8140693214263592e-07
or O 0 7.061928819496188e-10
in O 0 5.664727367737932e-11
the O 0 3.818237948038927e-10
families O 0 3.982690479492623e-12
of O 0 2.253230935167494e-10
13 O 0 1.6165841998372343e-09
of O 0 3.3857034953399534e-09
20 O 0 1.0823428375772437e-08
Ashkenazi O 0 1.1463434645975212e-08
I1307K O 0 1.5464762270767096e-07
carriers O 0 8.749740931790484e-10
, O 0 1.0477018558274764e-10
8 O 0 1.5719417989501494e-09
of O 0 2.322727565839955e-09
whom O 0 1.8903929532854136e-09
also O 0 2.305113433465067e-09
had O 0 6.0378568811358946e-09
a O 0 1.6483457931926182e-09
personal O 0 1.871762123073495e-08
or O 0 2.2409827327152243e-09
family O 0 7.235122501114688e-10
history O 0 1.7898710069630397e-08
of O 0 4.6645266138511943e-07
noncolonic O 1 0.974314272403717
neoplasia B-Disease 1 0.9999274015426636
. O 0 1.4487596899925848e-06

CONCLUSIONS O 0 6.413873052224517e-06
The O 0 2.4108516072374186e-07
I1307K O 0 2.3940056053106673e-05
APC O 0 5.591532044491032e-06
variant O 0 1.4915924566594185e-06
may O 0 5.97087268516816e-09
represent O 0 5.680819148423666e-10
a O 0 3.1025954028152114e-10
susceptibility O 0 1.879045186115036e-08
gene O 0 1.9999268907611167e-09
for O 0 3.0391478222924206e-09
colorectal B-Disease 1 1.0
, I-Disease 0 5.57404113976645e-08
or I-Disease 0 3.133229453666786e-09
other I-Disease 0 7.406995017333884e-10
, I-Disease 0 5.220366361413653e-10
cancers I-Disease 0 2.616620236040035e-07
in O 0 1.164978946643913e-10
Ashkenazi O 0 2.3917918756666268e-09
Jews O 0 9.630775066327146e-10
, O 0 1.5623699556321924e-10
and O 0 6.720698442208572e-10
partially O 0 1.5178598289367073e-07
explains O 0 2.5001638537247572e-09
the O 0 2.8148228192748093e-10
higher O 0 1.2290726214558845e-09
incidence O 0 1.4137164328076324e-07
of O 0 3.4971637887792895e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 7.776650434720978e-09
European O 0 3.7731822999376163e-08
Israelis O 0 1.3259017883626711e-08
. O 0 2.7573090477517326e-08

Systematic O 0 5.30378429175471e-07
analysis O 0 1.0378279569067672e-08
of O 0 5.086686982735955e-08
coproporphyrinogen O 0 0.00010100926738232374
oxidase O 0 2.4970827325887512e-06
gene O 0 4.482491533508437e-07
defects O 0 1.6870302715688013e-05
in O 0 1.595254239816768e-08
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 1.9404812974244123e-06
mutation O 0 5.771880751126446e-07
update O 0 2.2594569770717499e-07
. O 0 2.2791334686189657e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 3.6621931940317154e-06
HC B-Disease 1 1.0
) O 0 2.9656925448762195e-07
is O 0 3.46035222698049e-09
an O 0 1.4638309453474108e-09
acute O 1 0.9999985694885254
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9993466734886169
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 0 1.4851631931378506e-05
caused O 0 3.655845048911033e-08
by O 0 2.4741947379780527e-10
deficient B-Disease 0 1.3427526823761582e-07
activity I-Disease 0 6.008550101910259e-09
of I-Disease 0 4.394735952928386e-08
coproporphyrinogen I-Disease 0 0.4076714813709259
III I-Disease 1 1.0
oxidase I-Disease 0 1.8836185518011916e-06
( O 0 1.0599134014910305e-08
CPO O 1 0.9999212026596069
) O 0 4.519164775729223e-08
. O 0 2.1249452686333825e-07

Clinical O 0 0.000351612368831411
manifestations O 0 3.770851617446169e-05
of O 0 1.6938167846092256e-07
the O 0 3.808088777645935e-08
disease O 0 4.849228571401909e-05
are O 0 5.96253602047625e-11
characterized O 0 3.934680914419175e-10
by O 0 3.7611483372224086e-11
acute O 0 6.15125316016929e-07
attacks O 0 1.1650177711430842e-08
of O 1 0.9924433827400208
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 1.7947826558284419e-09
precipitated O 0 1.3385910158092429e-09
by O 0 8.064321779799322e-12
drugs O 0 1.527480253393776e-09
, O 0 2.7101917932093045e-10
fasting O 0 1.1824345946820358e-08
, O 0 6.20790796546089e-09
cyclical O 1 0.9988228678703308
hormonal O 0 1.025677102006739e-05
changes O 0 1.541582506092709e-08
, O 0 3.478629606590289e-09
or O 0 2.6437799505174553e-08
infectious B-Disease 0 0.0003814624506048858
diseases I-Disease 0 0.48117461800575256
. O 0 3.226241744869185e-07

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 1.3203502646774723e-07
also O 0 7.36355731945082e-09
be O 0 1.7730878987265442e-09
present O 0 3.932162151443208e-09
. O 0 9.505193077075091e-08

The O 0 5.508176172952517e-07
seven O 0 2.9393813605338437e-08
exons O 0 1.3074016180780745e-07
, O 0 4.644234330442032e-09
the O 0 2.2029734481066043e-08
exon O 0 1.0415004680908169e-06
/ O 0 4.024922191092628e-07
intron O 0 4.4406155552678683e-07
boundaries O 0 1.3215287530954356e-08
and O 0 3.047807561884497e-10
part O 0 1.999408194564012e-09
of O 0 4.040880519085022e-09
3 O 0 1.2064508503328852e-08
noncoding O 0 1.4232860223728494e-07
sequence O 0 5.451604723205605e-10
of O 0 3.307539131469639e-09
the O 0 9.992294991434392e-09
CPO O 0 0.0015394892543554306
gene O 0 5.5092352901908725e-09
were O 0 9.977377812830923e-10
systematically O 0 4.819109111764419e-09
analyzed O 0 6.748211989204833e-10
by O 0 2.5262573283280076e-11
an O 0 2.1819827888958088e-10
exon O 0 5.026610239156071e-08
- O 0 4.355290528224032e-08
by O 0 3.401023684901361e-09
- O 0 2.4934847715485375e-06
exon O 0 5.857526957697701e-06
denaturing O 0 2.2473275748779997e-05
gradient O 0 2.346462935065574e-07
gel O 0 6.896516993037949e-07
electrophoresis O 0 1.0545458906108252e-07
( O 0 1.4826293526226664e-09
DGGE O 0 0.024379635229706764
) O 0 5.376183942473745e-10
strategy O 0 1.7405120678049002e-09
followed O 0 1.1923304010785785e-10
by O 0 1.6209946579470724e-11
direct O 0 3.8359759813033634e-10
sequencing O 0 1.0207420464425354e-09
in O 0 2.0246972154414067e-10
seven O 0 4.368858164127687e-09
unrelated O 0 1.887398752842273e-07
heterozygous O 0 9.192931571533336e-08
HC B-Disease 1 1.0
patients O 0 4.37293534716332e-09
from O 0 6.903364685451052e-11
France O 0 2.8962936493570623e-09
, O 0 1.1374996083945987e-10
Holland O 0 4.060816394257927e-08
, O 0 6.980293565383988e-10
and O 0 2.627460693460648e-09
Czech O 0 0.0012887364719063044
Republic O 0 4.68944817839656e-05
. O 0 1.2767543466907227e-06

Seven O 0 3.4637091061995307e-07
novel O 0 5.9134251273462723e-08
mutations O 0 2.6307152012350343e-09
and O 0 5.734062669127127e-10
two O 0 1.5232781702678722e-10
new O 0 5.854589590903458e-10
polymorphisms O 0 1.1073527872440536e-08
were O 0 5.052887885881319e-09
detected O 0 1.3160935452560807e-07
. O 0 1.3447748870021314e-07

Among O 0 6.123193685425576e-08
these O 0 2.4805795195703695e-09
mutations O 0 1.5260387398186026e-09
two O 0 2.1557640395020172e-10
are O 0 1.4029215289479424e-10
missense O 0 2.2921677000908858e-08
( O 0 5.454746099253782e-10
G197W O 0 5.706410206585133e-07
, O 0 1.5210811499244414e-09
W427R O 0 1.5178453338648978e-07
) O 0 2.150105510301259e-10
, O 0 2.0969999348086077e-10
two O 0 1.0394078653330752e-10
are O 0 1.123299925298582e-10
nonsense O 0 3.7023909271738376e-08
( O 0 4.2125936072778813e-10
Q306X O 0 9.617317573429318e-07
, O 0 1.0364724634115419e-09
Q385X O 0 1.357138046387263e-07
) O 0 3.2982636066769544e-10
, O 0 2.283695177407452e-10
two O 0 1.1422696122309617e-10
are O 0 4.604723199963523e-11
small O 0 3.176839236118667e-09
deletions O 0 3.22915951755931e-08
( O 0 1.3566373580076174e-09
662de14bp O 0 3.313027718832018e-07
; O 0 8.51818282576744e-10
1168del3bp O 0 5.580497486334934e-07
removing O 0 2.3077548405581183e-07
a O 0 1.2737575438848125e-09
glycine O 0 2.470739168813907e-09
at O 0 3.9250882544195065e-09
position O 0 2.382067432193935e-09
390 O 0 2.4595674386063138e-09
) O 0 7.178965755194611e-11
, O 0 1.0837216540826589e-10
and O 0 5.348854692499572e-10
one O 0 3.8056813256304167e-10
is O 0 1.697457452376483e-10
a O 0 3.9860992284701524e-10
splicing O 0 3.3087964368405665e-08
mutation O 0 1.4852000518317254e-08
( O 0 1.0528306004786714e-09
IVS1 O 1 0.9987226128578186
- O 0 9.100899660552386e-07
15c O 0 2.054746573776356e-06
- O 0 2.727250603129505e-07
- O 0 1.9831993824936944e-07
> O 0 3.582735530471837e-08
g O 0 5.504225519814554e-09
) O 0 1.3739666349099622e-10
which O 0 2.2215412842641058e-10
creates O 0 6.533662499919046e-09
a O 0 3.8180486550132287e-10
new O 0 2.0585959603636184e-09
acceptor O 0 7.962840942177252e-10
splice O 0 5.067484494247765e-07
site O 0 2.8152186359875486e-07
. O 0 2.638294915868755e-07

The O 0 3.8496574461532873e-07
pathological O 0 8.235248856180988e-07
significance O 0 1.323736711356105e-07
of O 0 3.081285271377965e-08
the O 0 1.2232312052162797e-08
point O 0 1.1447664149955017e-07
mutations O 0 1.9162949005391283e-09
G197W O 0 1.6405263636443124e-07
, O 0 6.132445107276396e-10
W427R O 0 2.0926054844494502e-07
, O 0 5.065159403017105e-10
and O 0 7.642614319181007e-10
the O 0 1.8467323226190047e-09
in O 0 8.952248387039674e-10
- O 0 1.0273409145611367e-07
frame O 0 7.712912974966457e-08
deletion O 0 2.9886724206562576e-08
390delGly O 0 5.853590323567914e-08
were O 0 8.998481820787774e-11
assessed O 0 2.817193145432384e-09
by O 0 2.454512981753254e-11
their O 0 2.672809473747151e-10
respective O 0 2.973705059972076e-09
expression O 0 4.594478408836977e-10
in O 0 2.5567831185568934e-10
a O 0 9.180587401402818e-10
prokaryotic O 0 4.902109385085396e-09
system O 0 3.8001344293547845e-09
using O 0 6.511464145653179e-10
site O 0 5.03052088873801e-09
- O 0 2.1333347532959124e-08
directed O 0 3.599626552386326e-08
mutagenesis O 0 1.4953504432924092e-05
. O 0 4.0051639871308e-07

These O 0 1.0631391944571078e-07
mutations O 0 5.516374912417632e-09
resulted O 0 3.879677912266288e-09
in O 0 2.814092847636118e-10
the O 0 2.6636146621683565e-09
absence O 0 1.1570434388374906e-08
or O 0 9.389860000652561e-10
a O 0 4.937719122466433e-10
dramatic O 0 1.3783042263071366e-08
decrease O 0 4.696992661479271e-08
of O 0 3.100374783571169e-07
CPO O 1 0.9999995231628418
activity O 0 8.451721669189283e-07
. O 0 2.97983660857426e-07

The O 0 2.1742707190242072e-07
two O 0 1.9219210667387188e-09
polymorphisms O 0 2.1336834521434866e-09
were O 0 4.922645069349585e-10
localized O 0 3.185250463388911e-08
in O 0 9.333488426577219e-10
noncoding O 0 3.347321069213649e-07
part O 0 1.3090755146549782e-08
of O 0 1.3569874113272817e-08
the O 0 4.348789328645353e-09
gene O 0 3.414105387289368e-10
1 O 0 5.956733328815744e-09
) O 0 2.4667731746141897e-10
a O 0 6.883776881849712e-10
C O 0 8.601487877513136e-08
/ O 0 2.5462737696102522e-08
G O 0 2.737913362693689e-08
polymorphism O 0 9.520929183937099e-11
in O 0 9.575491788371693e-11
the O 0 3.0801909911559733e-09
promotor O 0 5.825650077895261e-06
region O 0 1.2253916281679267e-07
, O 0 8.238083104572524e-09
142 O 0 5.66729703166402e-08
bp O 0 2.2931734733333542e-08
upstream O 0 3.870736264843799e-08
from O 0 7.098742704769734e-10
the O 0 2.4101969309242577e-09
transcriptional O 0 1.6151110449058592e-09
initiation O 0 1.919148173712415e-09
site O 0 5.797542002028422e-09
( O 0 3.7110123307648735e-10
- O 0 8.442346910442211e-08
142C O 0 1.0654933930709376e-06
/ O 0 8.333763190648824e-08
G O 0 1.780297509412776e-07
) O 0 1.2348902456160715e-10
, O 0 7.65096735966253e-11
and O 0 2.0013110613170682e-10
2 O 0 7.316768080301017e-09
) O 0 2.9311539306853263e-10
a O 0 1.0065859257224474e-09
6 O 0 1.443282737767504e-08
bp O 0 1.0342454004330648e-08
deletion O 0 2.0481973894703742e-09
polymorphism O 0 8.118433703074857e-11
in O 0 3.3694852463739267e-11
the O 0 2.2279657285739773e-10
3 O 0 1.6056445062417879e-09
noncoding O 0 4.474615522553904e-08
part O 0 3.0185873800547824e-09
of O 0 7.097054055549279e-09
the O 0 1.687390849269832e-08
CPO O 0 0.13984885811805725
gene O 0 1.4350287180775467e-08
, O 0 4.285754862110025e-09
574 O 0 1.1889551387866959e-07
bp O 0 1.2256880843608542e-08
downstream O 0 2.320864211924345e-08
of O 0 1.9382773164267064e-09
the O 0 1.7414418795880238e-09
last O 0 3.6832570327050007e-10
base O 0 6.9873311581147846e-09
of O 0 1.2237772573087113e-08
the O 0 1.8583262928473232e-08
normal O 0 6.079739023334696e-08
termination O 0 6.902254767737759e-08
codon O 0 1.752121647768945e-07
( O 0 8.022604802704336e-09
+ O 0 8.879777624315466e-08
574 O 0 7.244656785587722e-07
delATTCTT O 0 7.84020267019514e-06
) O 0 5.6204168430440404e-08
. O 0 2.609174600820552e-07

Five O 0 8.116802518998156e-07
intragenic O 0 5.6512740229663905e-06
dimorphisms O 0 3.919984010281041e-06
are O 0 1.150109896208562e-09
now O 0 8.448041155517672e-10
well O 0 4.4705417145962656e-10
characterized O 0 7.690254544279185e-10
and O 0 4.658667340784461e-10
the O 0 1.6358895349455338e-09
high O 0 3.512346680167866e-08
degree O 0 9.756411678552013e-09
of O 0 1.3191111314370119e-08
allelic O 0 9.943112218024908e-07
heterogeneity O 0 2.490827171186538e-07
in O 0 5.2438404729571175e-09
HC B-Disease 1 1.0
is O 0 1.2232474588813602e-08
demonstrated O 0 7.150789960164161e-10
with O 0 6.536934188394738e-11
seven O 0 1.096542301404213e-10
new O 0 1.6461918633803307e-11
different O 0 5.85833681912562e-12
mutations O 0 3.598248088376721e-11
making O 0 8.250072153215271e-11
a O 0 5.0180287008982916e-11
total O 0 1.4833470562969353e-10
of O 0 4.4821644173964614e-09
nineteen O 0 6.449255351981265e-07
CPO O 1 1.0
gene B-Disease 0 2.513429535611067e-06
defects I-Disease 0 5.8669873396866024e-05
reported O 0 3.755525224136136e-09
so O 0 5.78653625016301e-10
far O 0 1.602960875146664e-09
. O 0 2.9509856780407517e-09
. O 0 9.31812849103153e-08

Coincidence O 0 4.4517503283714177e-07
of O 0 5.447640205602511e-08
two O 0 2.27896657101212e-09
novel O 0 3.8999715457066486e-08
arylsulfatase O 0 1.2305860082051367e-06
A O 0 8.312189692105676e-08
alleles O 0 1.5434264977187695e-09
and O 0 5.667478042425955e-09
mutation O 0 6.088361459433145e-08
459 O 0 2.7458375484457065e-07
+ O 0 7.577131100333645e-08
1G O 0 7.718202687101439e-05
> O 0 1.1629424534476129e-07
A O 0 7.467175322517505e-08
within O 0 1.8470635021472503e-09
a O 0 3.8736644447645574e-10
family O 0 7.412761515723787e-10
with O 0 8.587091926415269e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 4.3131858085132535e-09
molecular O 0 4.712730206080096e-09
basis O 0 1.6574696060089877e-09
of O 0 7.355822617682861e-09
phenotypic O 0 7.601298875670182e-06
heterogeneity O 0 6.708794899168424e-06
. O 0 4.6144279508553154e-07

In O 0 2.6579927592251806e-08
a O 0 1.4856527119633256e-09
family O 0 9.822612168086664e-11
with O 0 1.0743737843821322e-10
three O 0 5.699965499594839e-10
siblings O 0 4.090502159215248e-09
, O 0 2.4338620008279577e-10
one O 0 1.4795889513585792e-10
developed O 0 7.732024465134657e-10
classical O 0 4.303113598780328e-08
late O 0 6.639897520699378e-08
infantile O 1 0.999991774559021
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 7.071545837789017e-08
MLD B-Disease 1 1.0
) O 0 9.504319109510107e-09
, O 0 1.8460386552732189e-09
fatal O 0 1.4240024270861795e-08
at O 0 1.4925031210921702e-09
age O 0 1.1598955129699107e-09
5 O 0 1.1088422402494302e-09
years O 0 1.4063669673269885e-10
, O 0 8.882644619845337e-11
with O 0 1.5857573587574336e-10
deficient O 0 3.3446721658947354e-07
arylsulfatase O 0 5.358833004720509e-05
A O 0 1.8865920310418005e-06
( O 0 8.30266344564734e-09
ARSA O 1 0.9996191263198853
) O 0 1.3987061509013188e-09
activity O 0 1.5673043973762901e-09
and O 0 7.261500845068269e-10
increased O 0 9.654248067647586e-09
galactosylsulfatide O 0 2.5458875825279392e-05
( O 0 8.742325974253617e-08
GS O 1 1.0
) O 0 7.493026998872665e-08
excretion O 0 6.061283102098969e-07
. O 0 6.67433255330252e-08

The O 0 4.276342124853727e-08
two O 0 1.328736454198065e-09
other O 0 1.2483418743158836e-09
siblings O 0 1.665011595264332e-08
, O 0 2.349632044484906e-09
apparently O 0 9.896509389761832e-09
healthy O 0 1.8747519092698894e-09
at O 0 1.7665459095539404e-09
12 O 0 3.315541619031137e-09
( O 0 7.049275052573023e-11
1 O 0 4.75048089754182e-09
/ O 0 2.444852986727142e-09
2 O 0 1.5130225961001997e-09
) O 0 2.6979926973091928e-11
and O 0 6.27342761072569e-11
15 O 0 2.5552132632000735e-10
years O 0 2.7099888305626152e-11
, O 0 2.0363070604711986e-11
respectively O 0 7.090890374872316e-11
, O 0 2.1193232932481543e-11
and O 0 5.0676404045324475e-11
their O 0 8.626382941301358e-11
father O 0 2.132686693911978e-09
, O 0 1.021926543387508e-09
apparently O 0 3.3279534683572365e-09
healthy O 0 6.745895508863953e-10
as O 0 6.58600465830439e-11
well O 0 1.684260647616398e-10
, O 0 3.813012405817773e-10
presented O 0 2.5664894209853628e-08
ARSA O 1 0.9999905824661255
and O 0 3.266925148182054e-07
GS O 1 1.0
values O 0 8.5800690996507e-09
within O 0 3.6279798609761826e-10
the O 0 2.1278140360792008e-10
range O 0 7.752853292686268e-08
of O 0 1.1116194542637459e-07
MLD B-Disease 1 1.0
patients O 0 1.2749511597576202e-06
. O 0 1.4241604162634758e-07

Mutation O 0 1.9052755817483558e-07
screening O 0 4.473113790481875e-08
and O 0 1.639281599352671e-09
sequence O 0 5.045576179085742e-10
analysis O 0 8.595391065568947e-11
disclosed O 0 1.7452190803624035e-09
the O 0 4.894725735837824e-10
involvement O 0 1.689222428602477e-09
of O 0 1.078692957179328e-08
three O 0 1.5525262186955047e-09
different O 0 2.418610423049472e-09
ARSA O 1 0.9990437626838684
mutations O 0 1.8928869138790105e-08
being O 0 1.6239579680998872e-09
the O 0 9.684046897717735e-10
molecular O 0 5.040115436116821e-09
basis O 0 2.4977375723267414e-09
of O 0 1.5999773950170493e-08
intrafamilial O 0 3.238527642679401e-05
phenotypic O 0 2.9606970201712102e-05
heterogeneity O 0 1.0704040505515877e-05
. O 0 7.46009902741207e-07

The O 0 4.469702332698944e-07
late O 0 2.6520481810621277e-07
infantile O 0 0.00013081829820293933
patient O 0 2.804852954341186e-07
inherited O 0 4.5365234768723894e-07
from O 0 7.615653885295615e-09
his O 0 1.1354462259305365e-07
mother O 0 2.058294512607972e-08
the O 0 7.816414182570952e-09
frequent O 0 2.228001960702386e-08
0 O 0 5.467543218173887e-08
- O 0 4.905160722046276e-07
type O 0 1.1048506394217839e-06
mutation O 0 3.004332995715231e-07
459 O 0 1.354110281681642e-07
+ O 0 1.3184823011158642e-08
1G O 0 4.264858944225125e-06
> O 0 8.97680596523287e-09
A O 0 1.027861884494996e-08
, O 0 1.0839738134871268e-10
and O 0 1.6906494260116034e-10
from O 0 1.3276515997695526e-10
his O 0 1.5717139811854963e-09
father O 0 3.000992121471313e-09
a O 0 4.064314995666507e-10
novel O 0 6.098621163630469e-09
, O 0 5.270791025857591e-10
single O 0 2.01793981524645e-09
basepair O 0 1.2414873253874248e-06
microdeletion O 0 2.1376090444391593e-06
of O 0 7.106768862286117e-08
guanine O 0 3.249982682973496e-08
at O 0 4.105650042163234e-09
nucleotide O 0 2.153529576887081e-09
7 O 0 5.572634798056697e-09
in O 0 5.579566253466339e-10
exon O 0 1.7695792564609292e-07
1 O 0 2.1275263861753047e-07
( O 0 6.469747848569796e-09
7delG O 0 2.6636573693394894e-06
) O 0 3.5393544095541074e-08
. O 0 1.9355599079062813e-07

The O 0 3.626392697242409e-07
two O 0 2.987709279977935e-08
clinically O 0 2.968603212138987e-06
unaffected O 0 6.317625320662046e-07
siblings O 0 6.237058869373868e-08
carried O 0 1.440208396985554e-08
the O 0 2.5037966366880937e-08
maternal O 0 7.883567718636186e-07
mutation O 0 1.957113369144281e-07
459 O 0 3.4861443509726087e-07
+ O 0 7.006818236732215e-08
1G O 0 2.8019170713378116e-05
> O 0 3.605934750794404e-08
A O 0 2.1412596140635287e-08
and O 0 6.847268307907939e-10
, O 0 1.1952995537800604e-10
on O 0 9.38672695127707e-10
their O 0 1.4458795272176417e-10
paternal O 0 6.6057883607584245e-09
allele O 0 1.2238933200237057e-09
, O 0 4.02924943410099e-10
a O 0 1.0163051511469234e-09
novel O 0 2.4816314336817413e-08
cytosine O 0 2.8280911834599465e-08
to O 0 1.3011041133381696e-09
thymidine O 0 1.4828485461748642e-07
transition O 0 1.2204392163539524e-08
at O 0 1.5549629139854915e-08
nucleotide O 0 2.8320480183197105e-08
2435 O 0 3.4190236419817666e-06
in O 0 3.6923746282724323e-09
exon O 0 1.4428428585233632e-07
8 O 0 2.5531893044217213e-08
, O 0 3.2208335998262783e-10
resulting O 0 3.7991829127115295e-10
in O 0 5.5256146880289236e-11
substitution O 0 1.6288965731803273e-09
of O 0 8.009884311377391e-09
alanine O 0 2.273300623301111e-07
464 O 0 5.3306905556382844e-08
by O 0 2.8178164246384085e-09
valine O 0 1.2916078048874624e-05
( O 0 2.154048317493107e-08
A464V O 0 1.2069905096723232e-05
) O 0 7.448654315567182e-08
. O 0 3.222920668122242e-07

The O 0 1.1365929140083608e-06
fathers O 0 4.593072731040593e-07
genotype O 0 6.216382786305985e-08
thus O 0 2.4794267972083617e-08
was O 0 1.3506098639481934e-07
7delG O 0 3.005032158398535e-05
/ O 0 3.887660932377912e-05
A464V O 0 0.00017302893684245646
. O 0 1.9731753582163947e-06

Mutation O 0 5.509959919436369e-06
A464V O 0 5.752686320192879e-06
was O 0 4.1650288551409176e-08
not O 0 3.2010091799428153e-10
found O 0 1.4374296197772196e-10
in O 0 3.2007038686110434e-10
18 O 0 3.328532471869039e-08
unrelated O 0 1.7634147297940217e-06
MLD B-Disease 1 1.0
patients O 0 1.229399515523255e-07
and O 0 1.6648369793870188e-08
50 O 0 1.2637714519314613e-07
controls O 0 8.703594176040497e-06
. O 0 9.078162861442252e-07

A464V O 0 2.5919287509168498e-05
, O 0 1.094378720978284e-08
although O 0 3.3274265565097494e-09
clearly O 0 2.4754621463785043e-08
modifying O 0 6.00056466737442e-07
ARSA O 1 1.0
and O 0 1.2949669780937256e-06
GS O 1 1.0
levels O 0 1.4107118317951972e-07
, O 0 1.1197046623223628e-09
apparently O 0 3.294631234496137e-09
bears O 0 1.625333680976837e-07
little O 0 5.129543012571958e-09
significance O 0 1.7467453261588162e-08
for O 0 5.084237475472264e-10
clinical O 0 5.573615879939098e-08
manifestation O 0 9.010723545088695e-08
of O 0 8.441912058287926e-08
MLD B-Disease 1 1.0
, O 0 3.125000702652869e-08
mimicking O 0 2.914906076512125e-07
the O 0 9.793498634280695e-08
frequent O 0 1.8618370631884318e-06
ARSA O 1 0.9991587400436401
pseudodeficiency O 0 0.00042743029189296067
allele O 0 3.6783012546948157e-06
. O 0 8.261183666036231e-07

Our O 0 2.9662413680853206e-07
results O 0 2.115851716055772e-09
demonstrate O 0 6.836410881838617e-10
that O 0 2.6360115479295843e-11
in O 0 7.897554832325682e-11
certain O 0 7.703069848652433e-10
genetic O 0 6.3454463905543435e-09
conditions O 0 7.021264458728638e-09
MLD B-Disease 1 1.0
- O 0 0.04856652393937111
like O 0 1.7892844539346697e-07
ARSA O 1 1.0
and O 0 2.177748825715753e-07
GS O 1 1.0
values O 0 3.694333061687871e-09
need O 0 1.9663191908048105e-10
not O 0 4.500655056971503e-11
be O 0 8.240526316871666e-11
paralleled O 0 1.1343066486091402e-09
by O 0 7.28139909478287e-11
clinical O 0 2.6168049771513324e-07
disease O 0 2.1951304063350108e-07
, O 0 2.3206406241094157e-10
a O 0 1.2739341526124548e-10
finding O 0 2.673110344186824e-10
with O 0 1.1216941958602789e-10
serious O 0 3.1994198934626183e-07
diagnostic O 0 2.8501954147941433e-05
and O 0 7.601116891464699e-08
prognostic O 1 1.0
implications O 0 0.0001349255908280611
. O 0 3.6273021919441817e-07

Moreover O 0 3.996878604084486e-06
, O 0 1.2886356159924617e-07
further O 0 5.124387598698377e-07
ARSA O 0 0.08447062224149704
alleles O 0 5.153100701704716e-08
functionally O 0 3.965877937162077e-08
similar O 0 7.913421584682112e-10
to O 0 6.159782683923254e-10
A464V O 0 4.0949231561171473e-07
might O 0 9.439924397725008e-10
exist O 0 8.136090412502739e-11
which O 0 2.7754029977011818e-11
, O 0 4.938997821835045e-11
together O 0 5.941700256806293e-12
with O 0 5.6533046473294934e-12
0 O 0 3.604172515991877e-09
- O 0 5.5221047290388015e-08
type O 0 1.1450721615346993e-07
mutations O 0 1.1759369478170356e-08
, O 0 3.632328049452127e-10
may O 0 1.0300044150923782e-09
cause O 0 2.933080800460175e-08
pathological O 0 0.00010928314441116527
ARSA O 1 1.0
and O 0 1.12589532363927e-06
GS O 1 1.0
levels O 0 3.290274719347508e-08
, O 0 6.728262391675344e-11
but O 0 3.856426983306349e-11
not O 0 5.013083004268282e-11
clinical O 0 2.0620305463125987e-09
outbreak O 0 1.80970116669954e-09
of O 0 2.0887180873785383e-09
the O 0 6.156097853704523e-09
disease O 0 1.490867163056464e-07
. O 0 4.0363432596279836e-09
. O 0 8.180636967836108e-08

Human O 1 0.9773568511009216
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.0002516196691431105
to O 0 6.02067302679643e-07
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 2.0321681404311676e-06
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9995762705802917
1 I-Disease 0 0.00019880119361914694
. O 0 2.4835594558680896e-07

Heterozygous O 0 1.0139365258510225e-05
germ O 0 9.846231478150003e-06
- O 0 7.833191375539172e-07
line O 0 2.0291805924443906e-07
mutations O 0 1.1420131507122733e-09
in O 0 7.992538575418706e-11
the O 0 6.372126160059111e-10
DNA O 0 1.970447094379324e-08
mismatch O 0 1.3003181038584444e-06
repair O 0 5.517345584848954e-07
genes O 0 1.4686110993977763e-08
lead O 0 1.8597765105710096e-08
to O 0 1.563751794719792e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.615486305847298e-06

The O 0 3.791007827658177e-07
disease O 0 2.0465473937747447e-07
susceptibility O 0 7.158070047807996e-08
of O 0 1.320204177091e-07
individuals O 0 8.21506029868857e-10
who O 0 3.5662479636044964e-09
constitutionally O 0 3.0261236361184274e-07
lack O 0 1.952038886088303e-08
both O 0 4.89916507362409e-09
wild O 0 5.688539204129484e-07
- O 0 3.8507147337440983e-07
type O 0 2.5164271733046917e-07
alleles O 0 3.5343337145832265e-09
is O 0 6.927637352660554e-10
unknown O 0 1.6248975498456275e-08
. O 0 2.3839138663106496e-08

We O 0 3.3900864337965686e-08
have O 0 1.9609970591805137e-10
identified O 0 3.469510234666018e-10
three O 0 9.584043281218868e-11
offspring O 0 6.483851788807726e-10
in O 0 8.439936249882152e-11
a O 0 3.5079801286030943e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.1090669431723654e-06
who O 0 3.949826687943414e-09
developed O 0 7.03982649952195e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.8224742412567139
at O 0 7.1120682676451e-09
a O 0 1.360492413171599e-10
very O 0 2.3716605068724306e-11
early O 0 9.463500816320192e-11
age O 0 4.2903572361474573e-10
, O 0 2.8564340129322296e-11
and O 0 4.365905553749272e-11
at O 0 5.317767337587043e-10
least O 0 2.5803368122745418e-11
two O 0 1.8144239583017807e-11
of O 0 3.4326883002755437e-10
them O 0 1.0425667967828289e-10
displayed O 0 1.3822163857923897e-08
signs O 0 3.2835046681611857e-07
of O 0 1.300539764770292e-07
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.00028144981479272246
1 I-Disease 0 4.262980382918613e-06
( O 0 5.2061688293747466e-09
NF1 B-Disease 1 0.8148150444030762
) O 0 1.5370231309930205e-08
. O 0 8.73482619567767e-08

DNA O 0 6.545513997480157e-08
sequence O 0 4.932109165523002e-10
analysis O 0 3.384460420252644e-11
and O 0 6.986804190756146e-11
allele O 0 1.287840112329519e-10
- O 0 1.0502894109976069e-09
specific O 0 4.689620358711011e-10
amplification O 0 2.6697128951980176e-09
in O 0 1.1456909032592222e-10
two O 0 3.5605574044694777e-10
siblings O 0 6.11549966222924e-09
revealed O 0 6.070223435017397e-09
a O 0 1.858975196000756e-08
homozygous O 0 2.097759761454654e-06
MLH1 O 1 0.9998095631599426
mutation O 0 1.8860330897041422e-07
( O 0 1.416800676778962e-09
C676T O 0 2.8510280571936164e-06
- O 0 3.6524413644656306e-06
- O 0 4.819199148187181e-06
> O 0 5.245053671387723e-07
Arg226Stop O 0 6.067471258575097e-05
) O 0 2.9249465072211933e-08
. O 0 1.2619504730082554e-07

Thus O 0 5.144988790561911e-07
, O 0 2.660594766723534e-08
a O 0 1.381720782234197e-08
homozygous O 0 3.2298066798830405e-07
germ O 0 7.3418464126007166e-06
- O 0 1.3603995284938719e-05
line O 0 8.31883789942367e-06
MLH1 O 1 0.9999661445617676
mutation O 0 4.076095905247712e-08
and O 0 2.2023547430194412e-09
consequent O 0 4.30133513873443e-06
mismatch O 1 1.0
repair O 1 0.9999994039535522
deficiency O 1 0.9999972581863403
results O 0 8.682416563488005e-09
in O 0 1.0900574887173775e-09
a O 0 7.288590619936031e-09
mutator O 0 1.5679288480896503e-05
phenotype O 0 8.793965555753402e-09
characterized O 0 5.538765557311365e-10
by O 0 7.129378337689118e-11
leukemia B-Disease 1 1.0
and O 0 4.3017845996473625e-07
/ O 1 1.0
or O 1 0.9999967813491821
lymphoma B-Disease 1 1.0
associated O 0 4.798996542376699e-06
with O 0 1.9459163169699423e-08
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 1.5466472177649848e-05
1 I-Disease 0 3.734889730822033e-07
. O 0 1.8944246171770374e-09
. O 0 2.3349437938691153e-08

Missense O 0 3.5214456147514284e-05
mutations O 0 6.134415997394171e-08
in O 0 1.0158632823831226e-09
the O 0 2.5574917739135117e-09
most O 0 4.954284760216865e-10
ancient O 0 4.845543077891534e-09
residues O 0 5.203987996083015e-08
of O 0 2.3233445389791996e-08
the O 0 6.142482789073256e-08
PAX6 O 1 0.9998031258583069
paired O 0 8.126739885483403e-07
domain O 0 1.634446959997149e-07
underlie O 0 4.825283212994691e-07
a O 0 1.8524191069957396e-09
spectrum O 0 2.231864471013978e-07
of O 0 2.7408402729633963e-06
human O 1 1.0
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 5.987199619994499e-05

Mutations O 0 5.103109970150399e-07
of O 0 7.740855778592959e-08
the O 0 1.3503595575059535e-08
human O 0 2.119326580896086e-08
PAX6 O 1 0.9999988079071045
gene O 0 1.4227189240045846e-06
underlie O 1 1.0
aniridia B-Disease 1 1.0
( O 1 0.9999996423721313
congenital B-Disease 1 1.0
absence I-Disease 0 2.5798692604439566e-06
of I-Disease 0 3.667169949039817e-06
the I-Disease 0 7.11920975504654e-08
iris I-Disease 0 8.997144504974131e-07
) O 0 3.155231353968446e-10
, O 0 4.172427126025724e-10
a O 0 2.6077198178597882e-09
rare O 0 5.83595408443216e-07
dominant O 1 0.9999997615814209
malformation B-Disease 1 1.0
of I-Disease 1 0.9185072183609009
the I-Disease 0 3.7566522223642096e-05
eye I-Disease 1 0.9999997615814209
. O 0 1.5440889455931028e-06

The O 0 2.4703123813196726e-07
spectrum O 0 1.1013328276021639e-06
of O 0 6.448621547860967e-07
PAX6 O 1 1.0
mutations O 0 3.9091025882953545e-07
in O 0 9.391584399054409e-09
aniridia B-Disease 1 1.0
patients O 0 3.954275840101218e-08
is O 0 1.1265225557943737e-10
highly O 0 7.017404435316621e-10
biased O 0 2.020208222930364e-09
, O 0 5.843073941358412e-11
with O 0 2.6584552267894246e-11
92 O 0 1.0174479037061701e-08
% O 0 4.3053727249997564e-11
of O 0 4.043245183105171e-10
all O 0 3.099980827592219e-10
reported O 0 9.790296351397387e-10
mutations O 0 2.3456288023027128e-09
leading O 0 6.456040591018564e-09
to O 0 1.3985808067218386e-09
premature O 0 1.1239739805546378e-08
truncation O 0 6.631974258652917e-08
of O 0 7.278077873706934e-08
the O 0 1.3231076678721365e-08
protein O 0 2.7453115336584233e-09
( O 0 7.975346077992995e-11
nonsense O 0 1.0203727640600846e-08
, O 0 1.394483278849279e-10
splicing O 0 2.182333425082561e-09
, O 0 2.5501983857978416e-10
insertions O 0 3.6586473850519496e-09
and O 0 6.749923953108805e-10
deletions O 0 6.135723928935022e-09
) O 0 1.8302503956846294e-10
and O 0 6.362252391589607e-10
just O 0 3.3846817015792396e-10
2 O 0 2.2331061444447187e-09
% O 0 7.428482828863991e-11
leading O 0 1.4219436739182356e-10
to O 0 2.2704171875886914e-11
substitution O 0 5.718378548458247e-10
of O 0 3.840875617555639e-09
one O 0 4.2596662308547195e-10
amino O 0 4.103565820479105e-10
acid O 0 3.31124877517297e-10
by O 0 3.57960848462735e-11
another O 0 3.195788966792179e-09
( O 0 3.4242804147766037e-09
missense O 0 7.039288902888075e-07
) O 0 3.1619279639016895e-08
. O 0 2.8255200845705986e-07

The O 0 8.273990204088477e-08
extraordinary O 0 7.321863559894837e-09
conservation O 0 3.349645183448047e-08
of O 0 1.658172443796957e-08
the O 0 1.7463921864191434e-08
PAX6 O 0 0.0002463134005665779
protein O 0 8.168627552151975e-09
at O 0 2.3129043125180715e-09
the O 0 2.4345874205522477e-09
amino O 0 6.281552167308746e-09
acid O 0 1.0875099043516911e-08
level O 0 1.0769516833875059e-08
amongst O 0 3.002751469693976e-08
vertebrates O 0 3.95567212763126e-07
predicts O 0 5.7173814127509104e-08
that O 0 6.103904937049265e-09
pathological O 0 8.870474630384706e-06
missense O 0 1.8406835522455367e-07
mutations O 0 4.755666083156029e-09
should O 0 1.4379368529215952e-10
in O 0 3.4360798928378955e-11
fact O 0 2.3680321592500775e-10
be O 0 7.362187248727281e-11
common O 0 1.391366882819156e-10
even O 0 5.3220771539796985e-11
though O 0 8.532064638133718e-11
they O 0 1.1021785567555398e-10
are O 0 1.0254288390632027e-10
hardly O 0 9.427083114132984e-09
ever O 0 5.389246382492274e-09
seen O 0 1.168839336429528e-08
in O 0 1.1505316699356172e-08
aniridia B-Disease 1 1.0
patients O 0 4.4737112148141023e-07
. O 0 1.7672148544534139e-07

This O 0 1.4091501299162701e-08
indicates O 0 4.106652795599075e-09
that O 0 8.668822604196436e-11
there O 0 2.0089639674036874e-10
is O 0 1.8372105226038826e-10
a O 0 2.0072020434636073e-10
heavy O 0 2.7869137397829036e-07
ascertainment O 0 6.036476406734437e-06
bias O 0 3.1456021787334976e-08
in O 0 1.836635843410761e-10
the O 0 6.022694565288589e-10
selection O 0 1.2161699425305983e-09
of O 0 1.3448275826277722e-09
patients O 0 5.651380474702705e-10
for O 0 8.488647562643337e-10
PAX6 O 1 0.7176841497421265
mutation O 0 9.903076136907885e-10
analysis O 0 5.037698036503002e-11
and O 0 7.635819754270301e-11
that O 0 4.8594399337797967e-11
the O 0 6.0083098496477305e-09
missing O 0 1.2747904065690818e-07
PAX6 O 1 0.9999037981033325
missense O 0 1.860126394603867e-05
mutations O 0 2.5309304874099325e-07
frequently O 0 1.9570308040783857e-08
may O 0 5.157807958511285e-09
underlie O 0 1.3079095424473053e-06
phenotypes O 0 2.1730456012392096e-07
distinct O 0 6.901791138602675e-09
from O 0 3.7234999528124035e-09
textbook O 0 1.760945815476589e-05
aniridia B-Disease 1 1.0
. O 0 1.5516026223849622e-06

Here O 0 1.9357216274329403e-08
we O 0 1.3944041477031988e-09
present O 0 6.264594398786016e-10
four O 0 7.002429747160477e-10
novel O 0 1.463162391246442e-07
PAX6 O 0 0.0004201574483886361
missense O 0 4.7681942305644043e-07
mutations O 0 1.9324088995631428e-08
, O 0 5.229155441988098e-10
two O 0 9.851638949065489e-11
in O 0 1.2974234187002054e-10
association O 0 3.8191264040143835e-10
with O 0 7.525274292596862e-10
atypical O 0 7.753073987259995e-07
phenotypes O 0 2.824436478476855e-06
ectopia B-Disease 0 0.00043835025280714035
pupillae I-Disease 0 2.0995867089368403e-05
( O 0 4.41501307735237e-10
displaced B-Disease 0 2.6555221910307125e-10
pupils I-Disease 0 9.281544421924082e-10
) O 0 2.018555766980512e-09
and O 0 1.148571027442813e-05
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9986710548400879
( O 0 7.51797180065239e-10
searching B-Disease 0 1.556181628004083e-09
gaze I-Disease 0 2.6519717977180335e-08
) O 0 6.0078227115401e-11
, O 0 8.459065392596443e-11
and O 0 2.792395759065869e-10
two O 0 7.726860817847125e-11
in O 0 1.0374569259230526e-10
association O 0 1.594133158810962e-10
with O 0 1.56844301435477e-10
more O 0 1.0021721230657477e-09
recognizable O 0 3.6247936805011705e-05
aniridia B-Disease 1 1.0
phenotypes O 0 1.1165827345394064e-05
. O 0 3.1055651561473496e-07

Strikingly O 0 1.3331972468222375e-06
, O 0 1.11199005559115e-08
all O 0 2.222652728534058e-09
four O 0 3.107226420606679e-10
mutations O 0 4.998458869032163e-10
are O 0 1.5802192887548472e-11
located O 0 2.8310742639092723e-09
within O 0 6.400690533148179e-10
the O 0 1.095732216072065e-08
PAX6 O 1 0.9966455101966858
paired O 0 1.4547751447935298e-07
domain O 0 2.6279632692194355e-08
and O 0 3.54174312100497e-09
affect O 0 6.124768248128021e-09
amino O 0 9.358195329767227e-10
acids O 0 9.153412056095434e-11
which O 0 3.365969612409425e-12
are O 0 1.661363321220355e-12
highly O 0 1.856698406133006e-10
conserved O 0 3.1495750452137372e-09
in O 0 2.2435305002677097e-10
all O 0 1.0313333520528545e-09
known O 0 3.4430438500265836e-09
paired O 0 9.806265666156833e-08
domain O 0 9.729097882882343e-08
proteins O 0 1.3468998361076956e-08
. O 0 5.3339043404321274e-08

Our O 0 2.5369524792040465e-07
results O 0 2.599238158040862e-09
support O 0 4.4092315909516344e-10
the O 0 8.918333294083425e-10
hypothesis O 0 1.7119786144270677e-10
that O 0 3.78553004914961e-12
the O 0 8.34167179775136e-11
under O 0 3.2772440317074825e-10
- O 0 1.0129072691711372e-08
representation O 0 1.4974846918036633e-09
of O 0 1.395594217967755e-08
missense O 0 8.122005965560675e-07
mutations O 0 4.561981725714759e-08
is O 0 4.619750970658032e-10
caused O 0 1.3561949341323043e-09
by O 0 2.9727961758929666e-10
ascertainment O 0 8.167793566826731e-06
bias O 0 8.608940049725788e-08
and O 0 1.2568880380925407e-09
suggest O 0 2.1816330686430518e-10
that O 0 8.311412322270506e-12
a O 0 3.639170562119709e-11
substantial O 0 2.0758221808137023e-09
burden O 0 4.862943114858354e-07
of O 0 3.838779889520083e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
related I-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
remains O 0 3.871844000968849e-08
to O 0 3.8824146675331406e-10
be O 0 3.2008748429568357e-10
uncovered O 0 4.734508607384669e-08
. O 0 6.432182786397789e-09
. O 0 1.1491263762763992e-07

The O 0 6.851376355143657e-08
chromosomal O 0 1.0348140477844936e-07
order O 0 2.6960251808816338e-09
of O 0 7.604898932811466e-09
genes O 0 3.7054832535687865e-09
controlling O 0 3.1477743505092803e-06
the O 0 5.8913823153261546e-08
major O 0 9.167712960334029e-06
histocompatibility O 1 0.9998908042907715
complex O 0 3.1901499824016355e-06
, O 0 1.4791438074368557e-09
properdin O 0 2.644241874349973e-07
factor O 0 2.5781664803048443e-08
B O 0 3.478437292869785e-06
, O 0 1.006013397586436e-10
and O 0 6.657061568660083e-10
deficiency B-Disease 0 5.781146796834946e-07
of I-Disease 0 1.7444621391859982e-07
the I-Disease 0 8.286055219741684e-08
second I-Disease 0 1.8799557466309125e-08
component I-Disease 0 9.749923179924735e-08
of I-Disease 0 5.982263218129447e-08
complement I-Disease 0 5.435833259070932e-07
. O 0 3.1608396966475993e-07

The O 0 2.365443947383028e-07
relationship O 0 2.8125382023347356e-09
of O 0 1.0202930056379955e-08
the O 0 2.5281636784058037e-09
genes O 0 3.192509312466285e-10
coding O 0 3.9463778911397185e-09
for O 0 1.8402380730364598e-09
HLA O 0 1.9821256103114138e-07
to O 0 6.301156818544484e-10
those O 0 1.3182094305008718e-10
coding O 0 1.654238745985026e-09
for O 0 3.197238307439676e-10
properdin O 0 6.190582553244894e-07
Factor O 0 4.296683897564435e-08
B O 0 2.2195705184913095e-07
allotypes O 0 5.005199099628044e-08
and O 0 2.1585619403019507e-10
for O 0 2.2411954236911669e-10
deficiency B-Disease 0 1.6222969634327455e-07
of I-Disease 0 7.702739424075844e-08
the I-Disease 0 2.7912484767966816e-08
second I-Disease 0 4.6842498768739915e-09
component I-Disease 0 2.0129242273014825e-08
of I-Disease 0 8.790729033592015e-09
complement I-Disease 0 9.569808412379643e-08
( O 0 2.4451092262012253e-09
C2 O 1 0.9794632196426392
) O 0 2.398712062312569e-10
was O 0 5.343776532384936e-10
studied O 0 1.5507091166711007e-09
in O 0 2.6299299543675048e-11
families O 0 4.408680451956082e-12
of O 0 1.475891076019309e-10
patients O 0 4.3561587670382096e-10
with O 0 3.3202118832065253e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 5.418365276455006e-07

Patients O 0 2.3515347891134297e-07
were O 0 6.906475946699686e-10
selected O 0 8.766329329112921e-10
because O 0 1.0136735895116544e-10
they O 0 1.723987098911639e-11
were O 0 1.1321790727158998e-10
heterozygous O 0 4.906833162010571e-09
or O 0 1.4730793251871432e-09
homozygous O 0 2.0182031335025385e-07
for O 0 7.558956554021279e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 8.305024721266818e-07

12 O 0 2.811714523431874e-07
families O 0 3.044664242946027e-10
with O 0 4.0413333790567663e-10
15 O 0 2.0750867690821906e-08
matings O 0 1.619695012777811e-06
informative O 0 9.162138212559512e-07
for O 0 9.253558914679161e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.198549437475549e-08
found O 0 7.647837918511868e-09
. O 0 3.3648017705445454e-08

Of O 0 2.4418261546088615e-06
57 O 0 3.248898394758726e-07
informative O 0 5.974280981035918e-08
meioses O 0 1.8457458281773143e-06
, O 0 1.2196520460250326e-09
two O 0 6.218543735503346e-11
crossovers O 0 3.2661378046583422e-09
were O 0 1.5982981604878432e-10
noted O 0 7.676332347550385e-10
between O 0 2.9081617114457003e-09
the O 0 3.895741826909216e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.4001183263067105e-09
and O 0 9.471378126235663e-10
the O 0 3.2318441256506958e-09
HLA O 0 1.6800292996776989e-06
- O 0 5.764124466622889e-07
B O 0 5.163301466382109e-06
gene O 0 2.3282574479477347e-10
, O 0 2.7682972233988856e-11
with O 0 1.8361515433107378e-11
a O 0 1.8150859981691525e-10
recombinant O 0 8.794581729532069e-10
fraction O 0 3.2791274140464566e-09
of O 0 1.1620572948345398e-08
0 O 0 1.4230933231829113e-07
. O 0 6.273460684269594e-08

035 O 0 0.02488371729850769
. O 0 3.08533817587886e-05

A O 0 1.344527618130087e-06
lod O 0 7.176016424637055e-06
score O 0 4.834689093513589e-08
of O 0 1.0042966458456704e-08
13 O 0 5.041028483532273e-09
was O 0 7.1713324167888e-10
calculated O 0 6.77461087228437e-10
for O 0 2.481785332797415e-10
linkage O 0 3.203605842827528e-07
between O 0 8.152712325681932e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.914000584221867e-08
HLA O 0 4.961409103998449e-06
- O 0 1.0101911129822838e-07
B O 0 2.020710638817036e-07
at O 0 2.5601698538935125e-10
a O 0 1.8969503051691206e-11
maximum O 0 1.8503770737865466e-10
likelihood O 0 1.0109375836453438e-10
value O 0 2.703712254081836e-10
of O 0 4.3822678819083194e-10
the O 0 4.478564463727963e-10
recombinant O 0 4.4463147053086516e-10
fraction O 0 1.7011533293143088e-09
of O 0 8.069380719177843e-09
0 O 0 9.987001448052979e-08
. O 0 5.0373213156262864e-08

04 O 0 0.013283545151352882
. O 0 3.0383198463823646e-05

18 O 0 2.1822852147579397e-07
families O 0 2.35887642752175e-10
with O 0 1.9019870400871497e-10
21 O 0 1.90023392576677e-08
informative O 0 1.435981555886201e-08
matings O 0 4.2499156194253374e-08
for O 0 5.409892533947414e-10
both O 0 5.62006829962769e-10
properdin O 0 8.161091500369366e-07
Factor O 0 7.721332195842479e-08
B O 0 1.2801218645108747e-06
allotype O 0 2.859557355350262e-07
and O 0 2.4938486831160844e-09
HLA O 0 4.4097255340602715e-06
- O 0 1.3270602039483492e-06
B O 0 1.2265775694686454e-05
were O 0 1.1888973139306813e-09
found O 0 1.6870264074597685e-09
. O 0 2.5242670176339743e-08

Of O 0 4.721477580460487e-06
72 O 0 1.2471667787394836e-06
informative O 0 2.980044087053102e-07
meioses O 0 1.882169090094976e-05
, O 0 9.869045136667864e-09
three O 0 1.7141621455607492e-09
recombinants O 0 4.2004668898698583e-07
were O 0 5.850169237930913e-10
found O 0 1.0218129814498766e-10
, O 0 1.1158728802085349e-10
giving O 0 2.1689537665903202e-10
a O 0 7.490987691260997e-11
recombinant O 0 3.410213222920788e-10
fraction O 0 1.2242271640872104e-09
of O 0 1.0083388346515676e-08
0 O 0 1.4933516467863228e-07
. O 0 8.108309401677616e-08

042 O 0 0.006052113138139248
. O 0 2.3960177713888697e-05

A O 0 6.819992677264963e-07
lod O 0 3.3689684642013162e-06
score O 0 7.287884784545895e-08
of O 0 1.5980194945086623e-08
16 O 0 1.1500796759378318e-08
between O 0 1.2445239283565002e-09
HLA O 0 3.3265118304370844e-07
- O 0 5.6871023446092295e-08
B O 0 5.775768272542336e-07
and O 0 4.0441860971185406e-10
Factor O 0 4.182686197395924e-08
B O 0 7.08661389126064e-07
allotypes O 0 4.20904825659818e-07
was O 0 4.178091650430815e-09
calculated O 0 1.1208990402522545e-09
at O 0 3.353669286720873e-10
a O 0 7.79119199711964e-11
maximum O 0 4.949486376304435e-10
likelihood O 0 4.0487785346599026e-10
value O 0 5.793714397128724e-10
of O 0 1.1150967926809585e-09
the O 0 8.069638290919556e-10
recombinant O 0 1.1788715559291063e-09
fraction O 0 3.741240206522889e-09
of O 0 1.3043202073959037e-08
0 O 0 1.5285016274901864e-07
. O 0 7.918834654674356e-08

04 O 0 0.017744550481438637
. O 0 3.2418280170531943e-05

A O 0 7.353938258347625e-07
crossover O 0 1.0619697832225938e-07
was O 0 4.3792702797418315e-09
shown O 0 1.3247425378892785e-10
to O 0 2.1678495110144524e-10
have O 0 3.3946623290148636e-11
occurred O 0 1.0549346812771532e-10
between O 0 1.933290853795011e-11
genes O 0 2.371891051622388e-11
for O 0 2.7969038543518288e-11
Factor O 0 2.8779838512349443e-09
B O 0 4.143421250546453e-08
and O 0 3.8929595658210303e-10
HLA O 0 5.25916846072505e-07
- O 0 3.822727592250885e-07
D O 0 0.0001384096103720367
, O 0 5.200519459513941e-10
in O 0 7.465483786717186e-11
which O 0 1.5878880155195674e-10
HLA O 0 4.452017776657158e-07
- O 0 4.3244116909590957e-07
D O 0 1.8816952433553524e-05
segregared O 0 4.114199327887036e-06
with O 0 1.4776324608334335e-09
HLA O 0 3.4786562537192367e-06
- O 0 2.1023410567977407e-07
A O 0 1.1057851168061461e-07
and O 0 1.4350121979589403e-08
B O 0 2.523487273720093e-05
. O 0 7.6971730322839e-08

These O 0 6.120531281794683e-08
studies O 0 7.410729807588723e-09
suggest O 0 4.5336642773285973e-10
that O 0 9.727057700970043e-12
the O 0 7.787938349768098e-11
genes O 0 2.331816163769762e-11
for O 0 2.902711578045558e-11
Factor O 0 5.161280114407418e-07
B O 1 1.0
and O 0 8.735308256291319e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.7726813072993508e-10
located O 0 1.5872770875446918e-09
outside O 0 4.0104952692132656e-10
those O 0 4.985192814110917e-11
for O 0 9.908549675197165e-11
HLA O 0 1.2335746646385815e-07
, O 0 1.3917331176394043e-10
that O 0 1.4156403480014568e-11
the O 0 2.3436241836094496e-10
order O 0 3.6855618557041225e-10
of O 0 4.735355219054327e-09
genese O 0 2.175063855247572e-06
is O 0 3.3976392810330935e-09
HLA O 0 2.1859969479010033e-07
- O 0 4.500670414131491e-08
A O 0 3.486136890273883e-08
, O 0 7.436265492266614e-11
- O 0 1.8287995562360493e-09
B O 0 3.778511370455817e-08
, O 0 3.6694133842551935e-11
- O 0 2.7177924355470395e-09
D O 0 2.210301488503319e-07
, O 0 1.9812196327961829e-10
Factor O 0 4.419617383177865e-08
B O 0 0.04872379079461098
allotype O 1 0.9999853372573853
, O 0 9.20808088267222e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.025209332514379e-10
that O 0 1.222534226630323e-11
the O 0 1.3618008110061197e-10
genes O 0 3.704082041089407e-10
coding O 0 9.930700173299556e-08
for O 0 4.6184868551790714e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 6.9178169859185346e-09
Factor O 0 1.0899982072487546e-07
B O 0 1.920401899724311e-07
allotypes O 0 4.5219152866593504e-08
are O 0 8.688350386365506e-12
approximately O 0 2.4789404903802215e-11
3 O 0 1.5494132366011826e-10
- O 0 9.079326179772806e-10
- O 0 5.835973482248846e-09
5 O 0 4.0250114352602395e-09
centimorgans O 0 4.7763954569290945e-08
from O 0 7.791593065187286e-11
the O 0 4.511521156658205e-10
HLA O 0 8.744110857605847e-08
- O 0 2.2247236941552728e-08
A O 0 2.3697921847087855e-08
and O 0 1.2789940218027596e-09
HLA O 0 7.541920581388695e-07
- O 0 1.0841490194479775e-07
B O 0 4.3829496121361444e-07
loci O 0 1.1038517877537402e-09
, O 0 1.187155842380383e-11
and O 0 1.3566280911148088e-11
that O 0 3.233966696866708e-12
the O 0 7.652310035632937e-11
apparent O 0 6.121389506397179e-10
lack O 0 1.4268944914519466e-09
of O 0 6.2845364467989384e-09
recombinants O 0 4.0455722682963824e-07
between O 0 8.030898168698286e-10
the O 0 1.1907081987061474e-09
Factor O 0 3.9690073094789113e-07
B O 1 0.9999991655349731
gene O 0 6.718076406286855e-07
and O 1 0.9966145157814026
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.881043456199222e-09
suggests O 0 1.364229007538853e-10
that O 0 4.117587781155008e-12
these O 0 1.874124293255175e-11
two O 0 2.645581670401853e-11
genes O 0 2.6196181335258473e-10
lie O 0 9.50158174362059e-09
in O 0 3.263209702453196e-10
close O 0 3.97134103380381e-09
proximity O 0 2.5654712132450186e-08
to O 0 5.528530522269648e-09
one O 0 1.0000664296683226e-08
another O 0 2.1257230642390823e-08
. O 0 1.997115361973556e-07

Distribution O 0 7.003196742516593e-07
of O 0 1.7404803998033458e-07
emerin O 0 6.457806648541009e-06
and O 0 3.022183392431543e-08
lamins O 0 1.2819225503335474e-06
in O 0 1.0720816456810667e-09
the O 0 1.380906589076858e-08
heart O 0 2.118773352322023e-07
and O 0 2.0339878670228018e-09
implications O 0 4.265125497227018e-08
for O 0 2.1379935599696864e-09
Emery B-Disease 1 0.9999712705612183
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.7256096473138314e-06

Emerin O 0 0.16454146802425385
is O 0 1.1327077231726435e-07
a O 0 6.144507125327436e-09
nuclear O 0 9.822944946336065e-08
membrane O 0 7.547846792022028e-09
protein O 0 1.4547321125490953e-09
which O 0 6.451921635841629e-11
is O 0 2.970738377516824e-10
missing O 0 1.360262125160716e-09
or O 0 3.589174790707972e-10
defective O 0 5.768920630089269e-08
in O 0 1.3966268141984983e-09
Emery B-Disease 1 0.9999963045120239
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0401018926131655e-06
EDMD B-Disease 1 1.0
) O 0 1.2655661407734442e-07
. O 0 2.187239971362942e-07

It O 0 8.519681848895289e-09
is O 0 5.310175632544656e-10
one O 0 1.6886514409009123e-10
member O 0 1.1788349463248693e-10
of O 0 3.144454918668771e-09
a O 0 1.463814180979739e-09
family O 0 1.1164184021694723e-09
of O 0 3.4920532243631897e-08
lamina O 1 0.9999963045120239
- O 0 9.96693188426434e-07
associated O 0 2.33266361782114e-09
proteins O 0 2.893680295379397e-10
which O 0 5.783057366315347e-11
includes O 0 1.4326213548798705e-09
LAP1 O 1 0.999953031539917
, O 0 5.369781952424546e-09
LAP2 O 0 0.11690005660057068
and O 0 5.6513645319000716e-08
lamin O 0 2.1897514670854434e-05
B O 0 0.19608411192893982
receptor O 0 8.393519124183513e-07
( O 0 2.929737163981372e-08
LBR O 1 1.0
) O 0 7.118408262840603e-08
. O 0 1.8227243003821059e-07

A O 0 2.726137381614535e-06
panel O 0 6.730248003350425e-08
of O 0 3.42545831699681e-08
16 O 0 2.5821229598932405e-08
monoclonal O 0 4.4137372867680824e-08
antibodies O 0 1.3124055620039599e-08
( O 0 8.376272453425315e-10
mAbs O 0 9.904989610731718e-07
) O 0 1.7731758283900945e-09
has O 0 1.4441411400056836e-09
been O 0 6.074610259254598e-10
mapped O 0 1.2030086260494954e-08
to O 0 5.447769457767038e-10
six O 0 4.0429520842266697e-10
specific O 0 6.354478609971181e-10
sites O 0 2.738141935409999e-09
throughout O 0 1.0346197232280474e-09
the O 0 8.327435629951196e-09
emerin O 0 9.14321446998656e-07
molecule O 0 5.994273410969697e-10
using O 0 3.461611275401566e-10
phage O 0 2.8373680294180303e-08
- O 0 8.858966005220736e-09
displayed O 0 5.771504163476493e-09
peptide O 0 2.2977957314651576e-09
libraries O 0 9.181200244512411e-10
and O 0 6.759444670656478e-10
has O 0 1.7028145560260555e-10
been O 0 5.53410546555444e-11
used O 0 1.0831368441044376e-10
to O 0 3.06871944522058e-10
localize O 0 4.563382844935404e-07
emerin O 0 2.451485897836392e-06
in O 0 4.587353163998387e-09
human O 0 1.209206068608637e-08
and O 0 3.2776284797364497e-08
rabbit O 0 6.212841981323436e-05
heart O 0 0.00024224621301982552
. O 0 7.294461852325185e-07

Several O 0 3.422526617669064e-07
mAbs O 0 2.008119281526888e-06
against O 0 8.0311828298818e-08
different O 0 3.657482317009908e-09
emerin O 0 1.993687419599155e-06
epitopes O 0 1.4231515876872436e-07
did O 0 2.8269624419152706e-09
not O 0 8.102025716993921e-10
recognize O 0 1.2937404036961198e-08
intercalated O 0 3.1425204838342324e-07
discs O 0 5.877800504094921e-07
in O 0 1.6198805630196489e-09
the O 0 1.513661196383964e-08
heart O 0 1.9361026204478549e-07
, O 0 5.159851990121922e-10
though O 0 4.511839513110516e-10
they O 0 3.028377826286288e-10
recognized O 0 1.9820530994252294e-08
cardiomyocyte O 0 7.726590638412745e-07
nuclei O 0 3.303694384726441e-08
strongly O 0 1.6406015435066479e-09
, O 0 5.536346936452219e-10
both O 0 4.1047870658061925e-10
at O 0 5.119026535993498e-09
the O 0 1.4002283776903823e-08
rim O 0 1.6964660289886524e-06
and O 0 1.483631528742535e-08
in O 0 1.5174190792777154e-08
intranuclear O 0 4.660554259316996e-05
spots O 0 2.0678587588918163e-06
or O 0 5.553771487143422e-08
channels O 0 3.538244754963671e-07
. O 0 4.598384464316041e-07

A O 0 1.6263868019450456e-05
polyclonal O 0 4.074388925801031e-05
rabbit O 0 1.8177090623794356e-06
antiserum O 0 1.7158628224933636e-06
against O 0 4.610922132997075e-07
emerin O 0 3.734784331754781e-05
did O 0 1.5128991392998614e-08
recognize O 0 1.2927882764302012e-08
both O 0 1.3271712617779485e-09
nuclear O 0 8.00367203623864e-08
membrane O 0 4.050217050632909e-09
and O 0 2.302050994273941e-09
intercalated O 0 2.1608425981867185e-07
discs O 0 1.156854096961979e-07
but O 0 7.102318178020539e-10
, O 0 2.1905227631791035e-10
after O 0 2.565209156202286e-10
affinity O 0 5.828061366841553e-10
purification O 0 2.1282463791294504e-08
against O 0 2.3478682109612237e-08
a O 0 4.205097603460217e-09
pure O 0 6.037467414898856e-08
- O 0 6.101625871224314e-08
emerin O 0 1.031054466693604e-06
band O 0 1.60909134905296e-08
on O 0 3.537145687459997e-09
a O 0 4.953793486528468e-10
western O 0 7.957257963653319e-09
blot O 0 8.748756954446435e-06
, O 0 8.081513791502459e-10
it O 0 1.3847613333783926e-10
stained O 0 7.694296044746807e-08
only O 0 5.128836244594481e-10
the O 0 2.2949226963220326e-09
nuclear O 0 1.6840800753925578e-07
membrane O 0 3.6303580941421387e-07
. O 0 1.9599225709043822e-07

These O 0 3.5417652810565414e-08
results O 0 6.306001831823949e-10
would O 0 1.3437115309322678e-10
not O 0 4.837403047575073e-11
be O 0 6.45368203322505e-11
expected O 0 7.379863387058094e-10
if O 0 1.8098530452093087e-09
immunostaining O 0 1.2998940519537427e-06
at O 0 2.197450754692909e-08
intercalated O 0 4.1693178332025127e-07
discs O 0 5.614202223114262e-07
were O 0 1.902514146223666e-09
due O 0 5.8553966120200585e-09
to O 0 5.469278918646125e-10
a O 0 2.31313260212751e-10
product O 0 1.2213654532189366e-09
of O 0 3.879300880527126e-09
the O 0 6.161700927265201e-09
emerin O 0 1.4951730236134608e-06
gene O 0 5.447031714567174e-10
and O 0 5.680700354560031e-10
, O 0 2.406410626321076e-10
therefore O 0 8.209433133288258e-11
, O 0 3.696288761179112e-11
cast O 0 5.278216197446284e-10
some O 0 1.0671338118717344e-10
doubt O 0 1.0742431388877094e-09
upon O 0 2.9826840997060344e-10
the O 0 3.131119252763881e-10
hypothesis O 0 2.9020004177482406e-09
that O 0 2.1348874057469658e-10
cardiac B-Disease 0 0.15550947189331055
defects I-Disease 0 0.00205091736279428
in O 0 9.276964973992108e-09
EDMD B-Disease 1 1.0
are O 0 1.2993632836355573e-09
caused O 0 1.1858806159281698e-09
by O 0 8.938287610060769e-11
absence O 0 1.8150151603890663e-08
of O 0 2.0398948663569172e-07
emerin O 0 0.0066805873066186905
from O 0 5.195072105834697e-08
intercalated O 0 3.324962381157093e-05
discs O 0 0.0005286516970954835
. O 0 2.421140152364387e-06

Although O 0 1.463074568164302e-07
emerin O 0 1.115319537348114e-05
was O 0 2.9664551703945108e-08
abundant O 0 8.378849614132378e-09
in O 0 3.391415204223591e-10
the O 0 2.665932363754564e-09
membranes O 0 9.233820819076755e-09
of O 0 5.443838801966194e-08
cardiomyocyte O 0 7.318066309380811e-06
nuclei O 0 3.5713686230565145e-08
, O 0 2.4939139642299324e-10
it O 0 1.9704865517056191e-10
was O 0 3.4710607721422093e-09
absent O 0 4.870189584949003e-09
from O 0 2.651427688515895e-10
many O 0 6.193086043992935e-10
non O 0 8.370594883899685e-08
- O 0 1.1611891892471249e-07
myocyte O 0 1.224930656462675e-06
cells O 0 3.546473115179083e-10
in O 0 3.600131026626485e-10
the O 0 2.2913241082278546e-08
heart O 0 1.966188165170024e-06
. O 0 2.8328321377557586e-07

This O 0 4.424954624937527e-09
distribution O 0 2.7836456695240486e-08
of O 0 3.42578516665526e-08
emerin O 0 1.2112244803574868e-05
was O 0 1.4953675631090846e-08
similar O 0 3.6720895768560524e-10
to O 0 8.933003642352944e-11
that O 0 5.413667431009017e-11
of O 0 7.458545780991699e-09
lamin O 0 5.749361662310548e-07
A O 0 3.3432436907787633e-07
, O 0 1.2474707933307627e-09
a O 0 7.28837823427142e-10
candidate O 0 1.7880854574769955e-09
gene O 0 3.107048784922739e-10
for O 0 2.1822575690944035e-10
an O 0 5.85442194722674e-10
autosomal O 0 1.473264745754932e-07
form O 0 5.089248844569738e-08
of O 0 0.0004682276339735836
EDMD B-Disease 1 1.0
. O 0 6.7455030148266815e-06

In O 0 3.2616323863976504e-08
contrast O 0 2.877919413890595e-08
, O 0 2.7874285990492353e-08
lamin O 0 2.6455349143361673e-05
B1 O 1 0.9999984502792358
was O 0 2.933053622200532e-07
absent O 0 1.3261374931516912e-07
from O 0 3.464863063129542e-09
cardiomyocyte O 0 2.8015481348120375e-06
nuclei O 0 9.920572097144031e-08
, O 0 1.0287871665681791e-09
showing O 0 3.8859209183783605e-09
that O 0 1.0511090886566876e-09
lamin O 0 4.096229986316757e-06
B1 O 0 0.00017763281357474625
is O 0 3.8685993297704613e-10
not O 0 1.4354397878668657e-11
essential O 0 1.637436991552832e-10
for O 0 3.758036243306506e-11
localization O 0 1.9100124148963005e-08
of O 0 2.0886513851792188e-08
emerin O 0 6.162553745525656e-06
to O 0 1.2210702671211493e-08
the O 0 1.138380198995037e-07
nuclear O 0 1.6797675925772637e-05
lamina O 1 0.9999984502792358
. O 0 3.732686082003056e-06

Lamin O 1 0.9935758709907532
B1 O 1 1.0
is O 0 4.624392957452983e-08
also O 0 6.151942510967956e-09
almost O 0 3.796265968247781e-09
completely O 0 3.107146895331425e-08
absent O 0 2.1916534365118423e-08
from O 0 4.018721355691923e-09
skeletal O 0 3.343990829307586e-05
muscle O 0 2.7076401238446124e-05
nuclei O 0 1.1185364201082848e-05
. O 0 2.0326066874076787e-07

In O 0 2.236343163986021e-07
EDMD B-Disease 1 1.0
, O 0 5.639495981313303e-09
the O 0 5.589045892762101e-10
additional O 0 1.1815728395703218e-09
absence O 0 5.1087067909350026e-09
of O 0 1.4880867205135928e-08
lamin O 0 6.497672438854352e-05
B1 O 1 1.0
from O 0 2.6705189171138954e-08
heart O 1 1.0
and O 0 4.013509624201106e-06
skeletal O 1 1.0
muscle O 1 0.9999467134475708
nuclei O 0 1.6315673292410793e-06
which O 0 3.667155468178862e-10
already O 0 2.407151145078501e-09
lack O 0 1.0530239791251006e-08
emerin O 0 2.835485702235019e-06
may O 0 3.047452845628129e-10
offer O 0 5.887508536250863e-11
an O 0 6.135843569343713e-12
alternative O 0 2.4314214530640754e-10
explanation O 0 1.5200363190359667e-10
of O 0 9.73154001826515e-10
why O 0 1.3207771543122249e-09
these O 0 1.3319539915457312e-09
tissues O 0 2.6992371005007953e-08
are O 0 2.5824503646632024e-10
particularly O 0 1.315984321514918e-09
affected O 0 4.432193279058083e-09
. O 0 5.37516164911267e-09
. O 0 1.2496651891069632e-07

Genetic O 0 6.754411288056872e-07
mapping O 0 4.762994265661291e-08
of O 0 1.8344397290093184e-07
the O 0 3.1814317935641157e-07
copper B-Disease 0 3.814237061305903e-05
toxicosis I-Disease 0 0.007376438472419977
locus O 0 5.992237220198149e-06
in O 0 8.305011078846292e-08
Bedlington O 0 0.00010216736700385809
terriers O 0 4.648521280614659e-05
to O 0 1.9417564445234348e-08
dog O 0 9.9718114654479e-08
chromosome O 0 1.1827414603260422e-08
10 O 0 1.654888781565944e-09
, O 0 1.3779163920979443e-10
in O 0 1.1321574927558586e-10
a O 0 1.323008591569419e-09
region O 0 6.893505855032345e-08
syntenic O 0 3.6687513329525245e-06
to O 0 5.393812063658743e-09
human O 0 5.343687270453756e-09
chromosome O 0 9.788120536313727e-08
region O 0 1.8566299786471063e-07
2p13 O 0 7.872963033150882e-05
- O 0 2.1026284230174497e-05
p16 O 0 1.0619150998536497e-05
. O 0 3.953507246023946e-07

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 0 0.008417020551860332
accumulation I-Disease 0 4.1432718717260286e-05
is O 0 6.173959565813902e-09
recognized O 0 8.509174698190236e-09
as O 0 8.299382292520363e-10
an O 0 2.7285180781433382e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 6.717731082517275e-08
man O 0 3.265317261025302e-08
, O 0 1.3803398424272473e-09
mouse O 0 3.184898389463342e-07
, O 0 2.0820923651854173e-08
rat O 0 0.00010379024752182886
and O 0 5.143713224242674e-07
dog O 0 2.844362643372733e-05
. O 0 1.0144597126782173e-06

The O 0 3.838315194570896e-07
major O 0 2.461977601342369e-06
cause O 0 2.3020579646981787e-06
of O 0 7.409552199533209e-05
hepatic B-Disease 1 1.0
copper I-Disease 1 0.998935878276825
accumulation I-Disease 0 1.7732731066644192e-05
in O 0 5.503994149336222e-09
man O 0 1.6606728436840967e-08
is O 0 1.2760261736133316e-09
a O 0 1.419199646690572e-09
dysfunctional O 0 1.018440443090185e-07
ATP7B O 1 1.0
gene O 0 2.771254692390812e-08
, O 0 1.7213832581575161e-09
causing O 0 1.3426706857444515e-07
Wilson B-Disease 0 2.643411426106468e-05
disease I-Disease 0 0.02196330763399601
( O 0 3.6188051666385945e-08
WD B-Disease 1 1.0
) O 0 1.6375798850276624e-07
. O 0 3.913571333669097e-07

Mutations O 0 1.9155949360083468e-07
in O 0 5.295502703006605e-09
the O 0 1.5223706739675436e-08
ATP7B O 1 0.9968665242195129
genes O 0 2.0782229270821517e-09
have O 0 4.8667028740290164e-11
also O 0 2.490861961135238e-10
been O 0 4.235507222727364e-10
demonstrated O 0 1.6553307613520474e-09
in O 0 1.6675629765927624e-09
mouse O 0 5.287149065225094e-07
and O 0 1.2685120509559056e-07
rat O 0 9.468266216572374e-05
. O 0 7.687063430239505e-07

The O 0 1.721869125503872e-06
ATP7B O 1 0.9999998807907104
gene O 0 2.7092022847341468e-08
has O 0 1.1032770252938917e-09
been O 0 3.328256281687203e-10
excluded O 0 5.804911662465884e-09
in O 0 5.966972749238408e-11
the O 0 8.34617985834285e-10
much O 0 7.435081883500061e-09
rarer O 0 7.050756721582729e-06
human O 0 1.6514674143763841e-06
copper B-Disease 1 0.9999858140945435
overload I-Disease 1 0.9406937956809998
disease O 1 0.9981840252876282
non B-Disease 0 0.03894449770450592
- I-Disease 0 5.020553544454742e-06
Indian I-Disease 0 2.1265341487719525e-08
childhood I-Disease 0 2.64888103629346e-06
cirrhosis I-Disease 1 1.0
, O 0 8.076432855830262e-09
indicating O 0 3.969283213223207e-08
genetic O 0 1.1460422655318325e-07
heterogeneity O 0 2.248143346150755e-06
. O 0 2.79075408116114e-07

By O 0 6.286478448913613e-09
investigating O 0 3.2754783774180396e-08
the O 0 3.8353508813315784e-08
common O 0 2.7147116270498373e-06
autosomal O 1 0.9999932050704956
recessive O 1 0.9999991655349731
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 3.809948623256787e-08
CT B-Disease 1 0.9999958276748657
) O 0 4.0840704151889895e-09
in O 0 7.2807542217390164e-09
Bedlington O 0 0.00010626690345816314
terriers O 0 4.805157004739158e-05
, O 0 2.0647066278911552e-09
we O 0 2.0964879832163774e-10
have O 0 6.711941766268659e-12
identified O 0 2.546401110803398e-11
a O 0 1.013013978257149e-11
new O 0 1.4203145604074763e-10
locus O 0 1.8391896006164643e-08
involved O 0 7.771234211695344e-10
in O 0 2.3538933024980224e-09
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.481301622647152e-07

We O 0 9.766264952304482e-08
examined O 0 5.220321952492668e-08
whether O 0 2.5165500794344098e-09
the O 0 1.0928142835098242e-08
WD B-Disease 1 0.9999680519104004
gene O 0 2.538080252634245e-07
ATP7B O 1 1.0
was O 0 1.0980506459645767e-07
also O 0 5.684149595452936e-09
causative O 0 9.372815412689306e-08
for O 0 7.756233433298121e-10
CT B-Disease 0 2.915016693805228e-06
by O 0 1.0603996847269315e-10
investigating O 0 4.637100037285791e-09
the O 0 5.088993670909758e-09
chromosomal O 0 3.021982308837323e-07
co O 0 2.990622860465919e-08
- O 0 2.929787434879927e-08
localization O 0 6.171747912731007e-08
of O 0 1.7870745239179087e-07
ATP7B O 1 1.0
and O 0 2.0241044396129837e-08
C04107 O 0 7.524161560468201e-07
, O 0 5.919704726409236e-10
using O 0 3.925378355695841e-10
fluorescence O 0 3.5034799505950787e-09
in O 0 2.744557470180098e-09
situ O 0 1.6069282082753489e-06
hybridization O 0 3.553877903073044e-08
( O 0 2.243317753780616e-09
FISH O 0 1.1821902262454387e-05
) O 0 1.380814396156893e-08
. O 0 8.489724478977223e-08

C04107 O 0 0.00011626385094132274
is O 0 3.837136119955176e-08
an O 0 3.4341505195101263e-09
anonymous O 0 5.929915403157793e-08
microsatellite O 0 2.0564716578519437e-06
marker O 0 2.0208083242323482e-06
closely O 0 1.3992503511417453e-07
linked O 0 6.220450359251117e-07
to O 0 8.100055737259027e-08
CT B-Disease 1 1.0
. O 0 1.3010723023398896e-06

However O 0 3.243063417812664e-07
, O 0 1.1654960729856612e-07
BAC O 1 0.9999998807907104
clones O 0 4.467811777431052e-06
containing O 0 4.2786351173162984e-07
ATP7B O 1 0.9999996423721313
and O 0 6.384077977372726e-08
C04107 O 0 2.892869815696031e-06
mapped O 0 1.0789052851123415e-07
to O 0 5.349673593002535e-09
the O 0 2.3170914076331428e-08
canine O 0 6.9105926741031e-06
chromosome O 0 2.664663441009907e-07
regions O 0 1.0049294019154331e-07
CFA22q11 O 0 0.0010321612935513258
and O 0 1.951112160725188e-08
CFA10q26 O 0 0.00034744711592793465
, O 0 1.6417096571075263e-09
respectively O 0 1.0022447316515581e-09
, O 0 2.0280210843992563e-10
demonstrating O 0 1.0678815609566072e-09
that O 0 4.445763479576925e-10
WD B-Disease 0 0.0029736750293523073
cannot O 0 1.3780729446466466e-08
be O 0 7.009860469864293e-10
homologous O 0 2.9260389666774245e-09
to O 0 1.0048714749189003e-08
CT B-Disease 1 0.8101517558097839
. O 0 7.42847817036818e-07

The O 0 1.8436876416672021e-06
copper O 0 1.3034854191573686e-06
transport O 0 3.9798052853257104e-08
genes O 0 1.6140338843229074e-08
CTR1 O 1 0.9999785423278809
and O 0 3.593329367390652e-08
CTR2 O 1 1.0
were O 0 1.1676962508033739e-08
also O 0 2.815753186169445e-09
excluded O 0 3.9614324265357936e-08
as O 0 1.2368330803980143e-09
candidate O 0 2.2989268266826457e-09
genes O 0 3.299912565424279e-10
for O 0 5.238379729988196e-10
CT B-Disease 1 0.9975281357765198
since O 0 2.121695708012794e-09
they O 0 6.853644318738361e-10
both O 0 1.036357777373098e-09
mapped O 0 6.658489581923277e-08
to O 0 4.642657813747064e-09
canine O 0 1.7328469766653143e-05
chromosome O 0 1.182951109512942e-06
region O 0 1.211681933455111e-06
CFA11q22 O 1 0.9938117265701294
. O 0 1.8696019878916559e-06

2 O 0 8.207694918382913e-06
- O 0 8.543069270672277e-06
22 O 0 1.425692175871518e-06
. O 0 4.6521452645720274e-07

5 O 0 4.775982233695686e-05
. O 0 5.687119028152665e-06

A O 0 1.7504360130260466e-06
transcribed O 0 3.66988075484187e-08
sequence O 0 1.259816140297687e-09
identified O 0 2.492073769566616e-10
from O 0 9.079096502384587e-11
the O 0 1.2424936635113681e-09
C04107 O 0 6.682471962449199e-07
- O 0 3.2110600045598403e-07
containing O 0 1.215369849205672e-07
BAC O 1 1.0
was O 0 7.751593145144398e-09
found O 0 5.007616890595479e-11
to O 0 5.895790800014566e-11
be O 0 4.249649590559734e-11
homologous O 0 3.238764464952304e-11
to O 0 1.5936620079148867e-10
a O 0 1.188298792698106e-09
gene O 0 3.2565647956062094e-09
expressed O 0 1.0408823802876555e-09
from O 0 1.8031754978053982e-09
human O 0 5.344094944348399e-09
chromosome O 0 3.201940756980548e-08
2p13 O 0 6.216678798409703e-07
- O 0 1.238164202277403e-07
p16 O 0 7.961071446516144e-08
, O 0 3.3256036813256173e-10
a O 0 2.9161534298438596e-10
region O 0 9.447404636375722e-09
devoid O 0 1.717652651223034e-07
of O 0 6.2842726578082875e-09
any O 0 7.74261010860755e-09
positional O 0 5.910921458962548e-07
candidate O 0 7.552588243697755e-08
genes O 0 3.911518220434118e-08
. O 0 6.98325663961441e-08

Molecular O 0 7.715208028002962e-08
analysis O 0 1.1491998463952768e-09
of O 0 1.002952831896664e-08
the O 0 1.7214761172112958e-08
APC B-Disease 0 5.010811037209351e-07
gene O 0 8.739066692520225e-10
in O 0 1.550953809825728e-10
205 O 0 2.372517959869924e-09
families O 0 1.5226384389444014e-11
: O 0 6.191099022334612e-11
extended O 0 2.995627967905534e-09
genotype O 0 1.316803555084789e-08
- O 0 6.908300065333606e-08
phenotype O 0 3.995471509199433e-09
correlations O 0 3.1182354476300134e-09
in O 0 8.28699261989918e-11
FAP B-Disease 0 5.483501013259229e-07
and O 0 4.683816529071905e-11
evidence O 0 5.018297236092373e-11
for O 0 9.580857808499932e-12
the O 0 1.7730295009954489e-10
role O 0 1.456384013387435e-09
of O 0 1.2775172919532451e-08
APC B-Disease 0 6.906678891027695e-07
amino O 0 7.725453166074203e-09
acid O 0 4.8968384902536854e-09
changes O 0 1.4939984804840378e-09
in O 0 2.845416169350301e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 4.884099666924158e-07

BACKGROUND O 0 2.4379762180615216e-05
/ O 0 3.7574043290078407e-06
AIMS O 0 9.394653716299217e-06
The O 0 3.118526770151675e-09
development O 0 1.1784129227976337e-09
of O 0 3.055517368011351e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.978812473410699e-09
a O 0 9.191077759984623e-11
variable O 0 4.954776033905262e-10
range O 0 5.19286036393396e-09
of O 0 3.9265337647975684e-09
extracolonic O 0 4.500422619457822e-06
manifestations O 0 1.0477447176526766e-06
in O 0 5.282350912239053e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.3495875350599817e-07
FAP B-Disease 1 0.9999985694885254
) O 0 3.7467440261451657e-10
is O 0 5.1577339621466933e-11
the O 0 5.2910148484741626e-11
result O 0 1.0293793595295142e-10
of O 0 7.639174848250718e-10
the O 0 2.317540825913511e-09
dominant O 0 1.8652160349574842e-07
inheritance O 0 6.837577188889554e-07
of O 0 8.005922609299887e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 2.6118778251316144e-08
APC B-Disease 0 1.2167990917077987e-06
) O 0 8.575503862573441e-09
gene O 0 5.975089578669213e-08
mutations O 0 1.6841956096413924e-07
. O 0 7.31516678342814e-08

In O 0 2.3207139321357317e-08
this O 0 4.151027022114562e-10
study O 0 5.466536667775301e-10
, O 0 8.851457067304835e-11
direct O 0 1.5195174285498325e-10
mutation O 0 3.5420503335936715e-11
analysis O 0 4.24686258382323e-11
of O 0 1.551262229781969e-09
the O 0 1.546813344077691e-08
APC B-Disease 0 7.11448592483066e-07
gene O 0 3.0254350136260655e-09
was O 0 4.000885844845925e-09
performed O 0 2.877116545008107e-09
to O 0 5.235472610998215e-10
determine O 0 1.3888804550887812e-09
genotype O 0 7.069816732041545e-09
- O 0 2.8580952715628882e-08
phenotype O 0 3.749126786800616e-09
correlations O 0 5.763154842242102e-09
for O 0 5.733472030478026e-10
nine O 0 5.1903055187096925e-09
extracolonic O 0 4.1718752186170605e-07
manifestations O 0 1.279388044395091e-07
and O 0 8.958875863385174e-10
to O 0 3.8979447447573534e-10
investigate O 0 4.281253129789775e-09
the O 0 8.031266207630949e-10
incidence O 0 1.2807137750314723e-07
of O 0 9.30219954398126e-08
APC B-Disease 0 3.900101546605583e-06
mutations O 0 3.8489869069735505e-09
in O 0 7.538433766107744e-10
non O 0 0.1810634881258011
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.836478630451893e-07

METHODS O 0 4.4987236833549105e-06
The O 0 2.584917808690079e-07
APC B-Disease 0 1.658138330640213e-06
gene O 0 8.04400990261911e-09
was O 0 9.06711328241272e-09
analysed O 0 1.3321630021323472e-08
in O 0 2.889962991137196e-10
190 O 0 1.0638203207236074e-08
unrelated O 0 2.516584984846304e-08
FAP B-Disease 0 7.369520608335733e-05
and O 0 1.7767779469934908e-09
15 O 0 2.5632409972331516e-08
non O 0 1.9446757505647838e-05
- O 1 0.9999988079071045
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.948547882577259e-08
using O 0 1.661014104037406e-09
denaturing O 0 1.2273208085389342e-06
gradient O 0 2.714612890031276e-08
gel O 0 5.9234945837260966e-08
electrophoresis O 0 3.909040202643155e-09
, O 0 2.3859084152810794e-10
the O 0 7.860335160536636e-10
protein O 0 2.6182245260741865e-10
truncation O 0 8.411691787557629e-09
test O 0 4.3080122802408027e-10
, O 0 1.2318036868297355e-10
and O 0 5.938364244784111e-10
direct O 0 6.9497958499198376e-09
sequencing O 0 4.974116407652218e-08
. O 0 7.887525299565823e-08

RESULTS O 0 1.56601017806679e-05
Chain O 0 1.0039404969575116e-06
terminating O 0 8.982204491303492e-08
signals O 0 1.4212474530594932e-09
were O 0 3.365857592640964e-10
only O 0 8.83848411126209e-11
identified O 0 9.039440723723757e-11
in O 0 1.3136890186782324e-10
patients O 0 5.369184541414995e-10
belonging O 0 2.0798437971869532e-10
to O 0 5.601489827533612e-10
the O 0 1.8392809053580095e-08
FAP B-Disease 1 0.9999996423721313
group O 0 3.8354217579694705e-09
( O 0 8.155655595309952e-10
105 O 0 2.9766923148599744e-07
patients O 0 4.964540778473747e-09
) O 0 3.6024410121626715e-09
. O 0 1.0328086830213579e-07

Amino O 0 2.969280785691808e-07
acid O 0 9.3859258143425e-09
changes O 0 3.3339808691579265e-10
were O 0 7.816049196751607e-11
identified O 0 5.182436077499908e-11
in O 0 2.0063589678542826e-11
four O 0 5.1622216917790453e-11
patients O 0 3.64683491738127e-11
, O 0 1.802926037630659e-11
three O 0 5.922423662596543e-11
of O 0 5.954586157486119e-09
whom O 0 2.2618569239796216e-09
belonged O 0 2.784100949781987e-09
to O 0 8.747839119749301e-10
the O 0 1.6658470158859018e-08
non O 0 7.431609265040606e-05
- O 0 2.2490019546239637e-05
FAP O 1 1.0
group O 0 6.559171428222044e-09
of O 0 1.971396523003932e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.9326400838035624e-06
. O 0 1.0141290474052767e-08

Genotype O 0 4.298653220757842e-05
- O 0 5.002224952477263e-06
phenotype O 0 1.0554291662856485e-07
correlations O 0 5.490209531444634e-08
identified O 0 1.2073341215668165e-09
significant O 0 2.312357416656141e-09
differences O 0 4.42077041640232e-09
in O 0 1.5662546259953558e-10
the O 0 8.695653641588308e-10
nature O 0 6.546660547002148e-09
of O 0 6.8641785588852144e-09
certain O 0 1.5355812621464793e-08
extracolonic O 0 7.421308964694617e-06
manifestations O 0 2.5716596496749844e-07
in O 0 2.7905762145508106e-09
FAP B-Disease 1 0.9999991655349731
patients O 0 4.415924514944436e-09
belonging O 0 2.2759506779213012e-10
to O 0 8.158238529176742e-10
three O 0 1.1948722011823065e-08
mutation O 0 2.5046523433047696e-07
subgroups O 0 9.89386876426579e-07
. O 0 8.070831114537214e-08

CONCLUSIONS O 0 2.2932819774723612e-05
Extended O 0 1.3646074421558296e-06
genotype O 0 2.778135410608229e-07
- O 0 2.438534920656821e-07
phenotype O 0 1.3876578996985245e-08
correlations O 0 1.0771119995922618e-08
made O 0 1.5777752437884374e-09
in O 0 1.4423290339848904e-10
this O 0 3.7454275791937164e-11
study O 0 1.4701062589494995e-10
may O 0 5.274630732188257e-11
have O 0 1.2886011702128997e-11
the O 0 1.3209225380172995e-10
potential O 0 5.078024667426462e-10
to O 0 3.4454120112492603e-11
determine O 0 2.2463009230477837e-10
the O 0 2.0917748089210875e-10
most O 0 9.331473094231768e-11
appropriate O 0 4.01145894279864e-10
surveillance O 0 2.6621634674484085e-08
and O 0 9.138331868996374e-09
prophylactic O 0 2.094760930049233e-06
treatment O 0 3.3571925683872905e-08
regimens O 0 1.0913603354367751e-08
for O 0 3.7537091490680297e-11
those O 0 8.908501714088857e-11
patients O 0 3.952068533541464e-11
with O 0 9.02632569382833e-12
mutations O 0 9.818291735186335e-10
associated O 0 5.428797966722243e-10
with O 0 1.812347161234129e-09
life O 0 3.3197132154327846e-08
threatening O 0 6.934094471944263e-07
conditions O 0 3.953262250888656e-07
. O 0 1.818258965613495e-07

This O 0 1.221820422614428e-08
study O 0 9.208190876464073e-10
also O 0 6.348382236565087e-11
provided O 0 2.7253477252742186e-11
evidence O 0 8.70402847019669e-11
for O 0 8.930772094073447e-11
the O 0 2.5600832564975917e-09
pathological O 0 2.534012253363471e-07
nature O 0 1.0243390136110975e-08
of O 0 5.512882594871371e-09
amino O 0 1.7100409976933406e-09
acid O 0 6.005144714826827e-10
changes O 0 7.486244957277677e-11
in O 0 9.121205180040448e-11
APC O 0 1.5185078083845838e-08
associated O 0 8.215259722499368e-11
with O 0 9.240471582350196e-11
both O 0 1.927313642013928e-09
FAP B-Disease 1 0.9999994039535522
and O 0 3.928910174977318e-08
non O 1 0.9999998807907104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.580273334411686e-07
. O 0 4.6096290673425244e-10
. O 0 1.5495094984885327e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.003312737215310335
cancer B-Disease 1 0.9999974966049194
risk O 0 2.447843826303142e-06
of O 0 1.2515114633515623e-07
the O 0 2.4449784064017877e-07
APC O 0 1.1386345249775331e-05
I1307K O 0 9.183209840557538e-06
polymorphism O 0 2.738755142672744e-07
. O 0 1.7815730757320125e-07

Germ O 0 3.0333580070873722e-05
- O 0 1.0356587836213293e-06
line O 0 2.3864438958298706e-07
and O 0 6.7258438818385e-09
somatic O 0 6.672411245745025e-08
truncating O 0 1.8888518127369025e-07
mutations O 0 3.182455188266431e-09
of O 0 4.391876196052635e-09
the O 0 9.437481018892413e-09
APC B-Disease 0 2.655170874277246e-07
gene O 0 1.283781969618758e-09
are O 0 5.0962643827201504e-11
thought O 0 2.865236936600013e-10
to O 0 4.0248251953478587e-10
initiate O 0 1.3367322537760629e-07
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 0 1.3718229183723452e-06
in O 0 5.167785843696038e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 8.38814173675928e-07
sporadic O 1 0.9999641180038452
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.1565121837975312e-07
respectively O 0 1.261488336012917e-07
. O 0 1.545266030689163e-07

Recently O 0 2.669228706508875e-06
, O 0 3.9075512603403695e-08
an O 0 9.532604927642296e-09
isoleucine O 0 3.058314177906141e-05
- O 0 7.49961327528581e-06
- O 0 2.0812883576581953e-06
> O 0 1.0637639036303881e-07
lysine O 0 5.5106781360336754e-08
polymorphism O 0 1.3299434886704375e-09
at O 0 4.776083084578886e-09
codon O 0 3.555016903078467e-08
1307 O 0 2.8332294732535956e-07
( O 0 5.512122980277923e-10
I1307K O 0 1.4983802998358442e-07
) O 0 3.654168356792553e-10
of O 0 6.4965441914921485e-09
the O 0 1.0167999775489989e-08
APC B-Disease 0 2.926934143943072e-07
gene O 0 1.5995097468746167e-09
has O 0 3.1687710788652623e-10
been O 0 1.4758883004617473e-10
identified O 0 2.9226780717817036e-11
in O 0 2.6881764175756828e-11
6 O 0 2.140862376265318e-09
% O 0 4.351323815154906e-11
- O 0 1.225084478306826e-09
7 O 0 2.2036152902416006e-09
% O 0 6.34947233679739e-11
of O 0 2.9320990080350384e-10
the O 0 1.0115495108209416e-09
Ashkenazi O 0 8.6845037827743e-09
Jewish O 0 8.291522135550622e-09
population O 0 5.05047725862795e-10
. O 0 1.29446853236459e-08

To O 0 2.6395170493742626e-08
assess O 0 8.216306213171265e-08
the O 0 4.5675951909629475e-09
risk O 0 1.8361438591796286e-08
of O 0 1.5060462876803626e-09
this O 0 1.8731032003227455e-10
common O 0 6.689572895623996e-09
APC B-Disease 0 7.192419957391394e-07
allelic O 0 1.689096507107024e-06
variant O 0 1.3518692867364734e-06
in O 0 5.9406019659036247e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 5.283358461838361e-08
we O 0 1.5499520555906088e-09
have O 0 8.973475434936873e-11
analyzed O 0 1.0169410868954287e-09
a O 0 8.793302197496189e-11
large O 0 1.8118287981039316e-09
cohort O 0 1.9154262176357406e-08
of O 0 8.283302932454717e-09
unselected O 0 1.1648770851024892e-05
Ashkenazi O 0 1.2011794581212598e-07
Jewish O 0 2.582861924338431e-08
subjects O 0 9.654859667307392e-08
with O 0 3.2977307551362856e-09
adenomatous B-Disease 0 0.0005308982799760997
polyps I-Disease 0 3.996417217422277e-05
and O 0 3.912665302863161e-09
. O 0 2.9108424559609603e-09
or O 0 4.175738013145747e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.6298102867295938e-09
for O 0 8.191980982452662e-10
the O 0 2.3554845185458362e-08
APC O 0 3.1104609661269933e-06
I1307K O 0 5.304176283971174e-06
polymorphism O 0 1.6556337811834965e-07
. O 0 1.3404675769379537e-07

The O 0 3.1624183520762017e-06
APC O 0 8.081234227574896e-06
I1307K O 0 6.788392965972889e-06
allele O 0 1.223662859928254e-08
was O 0 7.038655436275576e-09
identified O 0 6.439483390963119e-10
in O 0 2.714082014687591e-10
48 O 0 1.1785169284905805e-08
( O 0 1.2465591059385162e-10
10 O 0 5.981549699995981e-10
. O 0 5.683721202021097e-11
1 O 0 4.6514063711811104e-09
% O 0 2.4826704581037973e-10
) O 0 2.8049401690211084e-10
of O 0 6.909865568616169e-09
476 O 0 5.390465958043933e-07
patients O 0 3.012830873672101e-08
. O 0 5.706758798851297e-08

Compared O 0 1.1271082733799176e-08
with O 0 1.5338877390469463e-10
the O 0 4.923048635419036e-10
frequency O 0 7.111318756081175e-10
in O 0 1.0504952463463724e-10
two O 0 8.585429589480498e-11
separate O 0 1.8853832384202462e-10
population O 0 1.0134739401868043e-11
control O 0 6.767326699019804e-10
groups O 0 3.91971281821224e-11
, O 0 2.5501789568949107e-10
the O 0 4.202692416299669e-09
APC O 0 1.1051942010453786e-06
I1307K O 0 2.9871562219341286e-06
allele O 0 4.314280044326324e-09
is O 0 1.1036216385207354e-10
associated O 0 1.003935545806911e-10
with O 0 9.854157073663217e-11
an O 0 8.673221862931513e-11
estimated O 0 4.89424945016026e-10
relative O 0 2.41608377749003e-09
risk O 0 2.5454045982087337e-08
of O 0 3.731386044592e-08
1 O 0 2.233061877632281e-06
. O 0 3.333164499963459e-07

5 O 0 4.666489530791296e-06
- O 0 3.6552776236931095e-06
1 O 0 2.270699042128399e-06
. O 0 2.794349427404086e-07

7 O 0 1.7472189028922003e-06
for O 0 1.7460533285884594e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 5.440786665644737e-08
both O 0 3.9174167909550306e-08
P O 0 5.083508767711464e-06
= O 0 8.742972568143159e-09
. O 0 1.2841836483090674e-09
01 O 0 8.071698971434671e-07
) O 0 1.0294471941563188e-08
. O 0 1.1287232837275951e-07

Furthermore O 0 2.505423992715805e-07
, O 0 3.7002991781776018e-09
compared O 0 1.4752838950471414e-09
with O 0 9.181900795240949e-10
noncarriers O 0 6.165507511468604e-05
, O 0 5.844487205308724e-08
APC O 0 5.721838078898145e-06
I1307K O 0 4.679699031839846e-06
carriers O 0 6.437178345919392e-09
had O 0 3.963476491453122e-10
increased O 0 2.125473547165413e-10
numbers O 0 1.3744805293924856e-10
of O 0 4.327994407304914e-09
adenomas B-Disease 1 0.9999895095825195
and O 0 0.00046281551476567984
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 4.967868250105312e-08
patient O 0 1.1664535293220979e-07
( O 0 5.015954873677231e-10
P O 0 2.3330835574597586e-07
= O 0 3.078856058991164e-10
. O 0 7.263949164393324e-11
03 O 0 6.810478225816041e-08
) O 0 6.53508913650569e-11
, O 0 7.17813031236858e-11
as O 0 7.468090035267494e-11
well O 0 2.9566460391095006e-10
as O 0 2.922796449311704e-10
a O 0 3.3465188953307745e-10
younger O 0 3.4748630639569456e-09
age O 0 3.93061760917135e-09
at O 0 1.0065288158500607e-08
diagnosis O 0 3.922965277070034e-07
. O 0 1.7903630578075536e-07

We O 0 1.379621181740731e-07
conclude O 0 3.391729208601646e-08
that O 0 3.201021392396086e-10
the O 0 9.0280778408669e-09
APC O 0 3.3126530070148874e-06
I1307K O 0 9.57723386818543e-06
variant O 0 1.3461981325235683e-06
leads O 0 2.4215244920355872e-08
to O 0 1.9775094894924905e-09
increased O 0 2.198295874222822e-07
adenoma B-Disease 1 1.0
formation O 0 5.227403562457766e-06
and O 0 5.422428728252271e-08
directly O 0 7.486367081810386e-09
contributes O 0 5.978382233706725e-09
to O 0 2.2072232930270275e-10
3 O 0 2.093404560810086e-09
% O 0 3.487807959112743e-11
- O 0 4.6178480483938245e-10
4 O 0 8.757689018423775e-10
% O 0 2.7151782558409998e-11
of O 0 1.0229654623383766e-10
all O 0 2.73659511718094e-10
Ashkenazi O 0 1.2685072192653024e-07
Jewish O 0 2.413999709460768e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.46529065559298e-07

The O 0 1.2018074357911246e-07
estimated O 0 7.802070101092795e-09
relative O 0 6.855007228523391e-09
risk O 0 1.962619222695139e-08
for O 0 7.992024819714061e-10
carriers O 0 8.432767373278693e-09
may O 0 5.255001434001372e-10
justify O 0 3.1664768584960257e-09
specific O 0 3.385456359694672e-10
clinical O 0 1.1748423345281367e-09
screening O 0 1.1567184987626433e-09
for O 0 1.612995154109953e-10
the O 0 1.4040894003031212e-09
360 O 0 1.1018833845355402e-08
, O 0 1.1612939776473041e-10
000 O 0 1.296365348402162e-09
Americans O 0 2.532533904808787e-11
expected O 0 7.40574823687723e-11
to O 0 1.172274360916603e-10
harbor O 0 4.5355545097436334e-08
this O 0 3.114606489384997e-11
allele O 0 2.686594002820897e-10
, O 0 1.3140448451576248e-10
and O 0 2.0447225856923268e-10
genetic O 0 1.1311646064271486e-10
testing O 0 9.32307564482926e-11
in O 0 1.312073193149299e-11
the O 0 1.9173397591831787e-10
setting O 0 2.9666122891569557e-09
of O 0 1.2488468037474831e-09
long O 0 1.688929329723976e-09
- O 0 2.1907130332010638e-08
term O 0 4.091813110562725e-09
- O 0 1.2516112590787998e-08
outcome O 0 5.344390707762159e-09
studies O 0 3.5549591048678053e-10
may O 0 5.735098854153797e-11
impact O 0 1.0941151318277775e-09
significantly O 0 7.295665738205059e-10
on O 0 2.422871716589725e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.1380754585843533e-05
in O 0 2.741908644576796e-10
this O 0 9.856112453965338e-11
population O 0 3.2003436012395525e-10
. O 0 1.2205044086499583e-08

Localization O 0 1.6218125438172137e-06
of O 0 1.4522440494602051e-07
human O 0 1.9486130042878358e-08
BRCA1 O 0 2.3598957454851188e-08
and O 0 4.0763409314692467e-10
its O 0 9.026695502178939e-10
loss O 0 4.948998100218205e-09
in O 0 9.406794787558681e-11
high O 0 1.0070746014889664e-07
- O 0 5.3853032255801736e-08
grade O 0 2.9904575171713077e-07
, O 0 9.306557191557374e-10
non B-Disease 0 2.290366637680563e-06
- I-Disease 0 0.0001813696580938995
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 8.721748599782586e-06

Although O 0 4.324794744547944e-08
the O 0 6.335469482365852e-09
link O 0 6.526463369738167e-09
between O 0 1.2661927062396217e-09
the O 0 5.718057849435354e-08
BRCA1 O 0 1.2814147339668125e-05
tumour B-Disease 1 1.0
- O 0 1.4343562725116499e-05
suppressor O 0 0.0002577074628788978
gene O 0 3.541238413617975e-08
and O 0 1.7571341714983646e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.2140811966876441e-10
established O 0 5.0756211733560264e-11
, O 0 9.286299160193856e-12
the O 0 5.284711210307158e-11
role O 0 3.26012383755625e-10
, O 0 4.3579681530125924e-11
if O 0 3.6072159148581306e-11
any O 0 2.839287138733937e-10
, O 0 1.0986860726758252e-10
of O 0 2.8012419051037796e-09
BRCA1 O 0 8.458643208086869e-08
in O 0 1.5847422263348676e-09
non B-Disease 1 0.9999959468841553
- I-Disease 1 0.9999969005584717
familial I-Disease 1 0.9999997615814209
cancers I-Disease 1 1.0
is O 0 1.9729066380591576e-08
unclear O 0 2.265709397875071e-08
. O 0 4.123986130366575e-08

BRCA1 O 0 1.5773955965414643e-05
mutations O 0 3.4130408721466665e-08
are O 0 7.404424295920364e-10
rare O 0 3.440660867326528e-09
in O 0 9.370501041772172e-10
sporadic B-Disease 0 6.364525688695721e-06
cancers I-Disease 1 1.0
, O 0 2.947975863420993e-09
but O 0 5.546683667922991e-10
loss O 0 7.925392253582686e-08
of O 0 2.26881084586239e-07
BRCA1 O 0 1.4194499442510278e-07
resulting O 0 1.2880816413485263e-09
from O 0 1.2995633735801704e-10
reduced O 0 9.670889866697507e-09
expression O 0 9.944736145683919e-10
or O 0 2.2801044385900582e-10
incorrect O 0 1.8640586851859098e-09
subcellular O 0 4.179416634997324e-08
localization O 0 3.1299638436621535e-08
is O 0 4.992912749912648e-10
postulated O 0 1.694572926425053e-09
to O 0 7.332324331033035e-11
be O 0 4.5767910294980396e-11
important O 0 2.780628505227867e-10
in O 0 2.1973353692139597e-10
non B-Disease 0 4.747394541482208e-06
- I-Disease 0 0.0001098505817935802
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 1.7843168507170049e-06

Epigenetic O 0 0.0002607280039228499
loss O 0 0.0002930890768766403
, O 0 2.769584916961776e-08
however O 0 6.03558891754119e-09
, O 0 1.8406558499606263e-09
has O 0 5.612547648858879e-10
not O 0 6.102757882375798e-11
received O 0 4.0950745572310154e-10
general O 0 6.469830782229735e-10
acceptance O 0 3.2185076825896886e-09
due O 0 4.082286952922232e-09
to O 0 1.313123498825064e-09
controversy O 0 2.981089153308858e-08
regarding O 0 1.837685559280544e-08
the O 0 8.202835743986725e-09
subcellular O 0 1.1387015774744214e-07
localization O 0 1.624383827447673e-07
of O 0 2.2085821171913267e-07
BRCA1 O 0 6.05417653787299e-08
proteins O 0 1.085892140095801e-10
, O 0 3.3983614533550366e-11
reports O 0 1.1471210092928175e-10
of O 0 2.1858912457872748e-09
which O 0 1.3652050323553766e-10
have O 0 2.4375074875182534e-11
ranged O 0 1.8745625052218884e-09
from O 0 6.494529913858571e-11
exclusively O 0 1.2918311975695929e-09
nuclear O 0 1.1182581083346577e-08
, O 0 1.9891747971012563e-10
to O 0 3.411703142219835e-10
conditionally O 0 3.3303233948345223e-08
nuclear O 0 2.1720277132430965e-08
, O 0 4.212191984098723e-10
to O 0 4.340682258074935e-10
the O 0 1.5035960032605544e-08
ER O 1 0.9979099631309509
/ O 0 9.248432775166293e-07
golgi O 0 3.6314452245278517e-07
, O 0 4.526555574813074e-09
to O 0 4.68505412243303e-09
cytoplasmic O 0 2.5557747562743316e-07
invaginations O 0 6.425732408388285e-06
into O 0 2.374230412272027e-08
the O 0 3.361305900284606e-08
nucleus O 0 2.8011103836433904e-07
. O 0 9.865266292763408e-08

In O 0 4.318077273524068e-08
an O 0 1.7483343661695017e-09
attempt O 0 2.983704394665665e-09
to O 0 4.1100595149501373e-10
resolve O 0 3.008103988122457e-09
this O 0 5.7697811806090016e-11
issue O 0 5.615752751708669e-09
, O 0 5.811787717746597e-10
we O 0 7.243531885414711e-10
have O 0 2.754100281165961e-10
comprehensively O 0 8.1899707993216e-07
characterized O 0 3.8256917633816556e-08
19 O 0 9.815958890158072e-08
anti O 0 1.9168462586094392e-06
- O 0 1.6766578482929617e-05
BRCA1 O 0 1.806500449674786e-06
antibodies O 0 1.2847114305714058e-07
. O 0 4.910206286012908e-08

These O 0 3.5930554531660164e-07
reagents O 0 9.962569720300962e-07
detect O 0 4.624437224265421e-07
a O 0 1.0086331769798562e-08
220 O 0 2.8108289029660227e-08
- O 0 1.6071288655439275e-07
kD O 0 1.918394264066592e-05
protein O 0 1.2091507350930897e-08
localized O 0 3.24045643651516e-08
in O 0 2.885446603873021e-10
discrete O 0 4.248073448565037e-09
nuclear O 0 2.8528559070650772e-08
foci O 0 2.171356783264855e-08
in O 0 9.55323528617491e-11
all O 0 2.903687568167612e-10
epithelial O 0 4.778780482439515e-09
cell O 0 3.146524818475882e-09
lines O 0 5.304266803562996e-09
, O 0 1.1390887538764716e-10
including O 0 1.2887271805261946e-10
those O 0 2.0856397164870089e-10
derived O 0 1.1534798671775093e-09
from O 0 3.007914584074456e-09
breast B-Disease 0 5.324673111317679e-05
malignancies I-Disease 0 3.0299230274977162e-05
. O 0 2.7038808525503555e-07

Immunohistochemical O 0 0.00010563375690253451
staining O 0 6.616939572268166e-06
of O 0 7.26553821550624e-07
human O 0 8.193941880563216e-08
breast O 0 5.6971507547132205e-06
specimens O 0 6.2639074371873e-08
also O 0 3.1126379251844583e-09
revealed O 0 4.6493155991811363e-08
BRCA1 O 0 1.4766858384973602e-06
nuclear O 0 5.757729013566859e-07
foci O 0 1.576382487655792e-06
in O 0 6.26868557063176e-09
benign O 1 1.0
breast O 1 1.0
, O 0 4.398845305786381e-07
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 9.181075029118801e-07
low B-Disease 1 0.9999949932098389
- I-Disease 1 0.9999920129776001
grade I-Disease 1 0.9999973773956299
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 3.576481685740873e-05

Conversely O 0 2.131095470758737e-06
, O 0 1.5500805261581263e-07
BRCA1 O 0 7.656561251678795e-07
expression O 0 4.118858587531804e-09
was O 0 2.695367040672636e-09
reduced O 0 3.5594731606636287e-09
or O 0 1.398220011994411e-10
undetectable O 0 3.7155329923876934e-09
in O 0 1.3201588260070007e-11
the O 0 1.9158262476448584e-10
majority O 0 2.7962425777627864e-11
of O 0 5.558958848794759e-10
high O 0 3.5862706226907903e-07
- O 0 1.4388184581548558e-06
grade O 0 9.594455332262442e-05
, O 0 1.7775821703480688e-08
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 5.1706354753378037e-08
suggesting O 0 4.535171349573375e-09
that O 0 1.4370019063569828e-10
absence O 0 1.2674933991263515e-08
of O 0 3.2907642832924466e-08
BRCA1 O 0 1.1563158608396407e-07
may O 0 6.956234199773093e-11
contribute O 0 5.7065976943881935e-11
to O 0 4.6626293104257144e-11
the O 0 9.48649270249291e-10
pathogenesis O 0 6.734305202371615e-08
of O 0 9.141679413460224e-09
a O 0 7.052506356686195e-10
significant O 0 3.3644986796588228e-09
percentage O 0 1.1418002543450712e-08
of O 0 2.2690395340418945e-08
sporadic B-Disease 0 0.033046457916498184
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 3.2820452133819344e-08
. O 0 2.0672580092195858e-07

